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Correction
On page 385, in the Financial Statements section of the Annual Report,
Comparative Operating History 1996-2000, the Net Operating Excess for
the year 2000 was erroneously printed as $1,224 (Dollars in Thousands).
The correct Net Operating Excess is breakeven and should have been
indicated, as in other columns, by "-". All other numbers are correct as
printed.
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Leslie C. Quick, Jr.
Leslie C. Quick, Jr. (1926-2001)
Leslie Quick, who long lived near our Lab in Laurel Hollow, was a happy, generous philan-
thropist who took much pleasure in using his seaplane to commute to and from New York
City. The main office of Quick & Reilly, his extraordinarily successful discount stock broker-
age firm, was in the Wall Street area. His formative school years were on Long Island, where
he attended Andrew Jackson High School in Queens and there met his future wife, Regina
Clarkson. Both of his parents were New Yorkers. His father was of Episcopalian background
and was a manager at Allied Chemical, a position that early in Les's life necessitated frequent
changes of job location before his parents settled in Queens Village. On his mother's side,
he was descended from the Galway man, Henry Gratin Kilroy, who after coming to the United
States became a policeman assigned to harbor patrol. This twist of fate allowed him to open
a speakeasy on Staten Island with contraband collected in exercise of his official duties.
Some 30 years later, his equally entrepreneurial grandson pursued a business degree at
Pennsylvania Military College (now Widener University) after his wartime service in the Army
Air Force in the Pacific. Ten days after his graduation in June 1950, he married Regina and
took a position with the Addressograph Company as a Wall Street representative.
Les stayed with Addressograph for five years before taking a $6000 pay cut to move into
publishing consultantcy. This step soon led to his 13 years at Forbes Magazine, where he
rose to become a Vice President as its business manager. The prospect of being himself in
finance, as opposed to being part of writing about it, led him, in 1969, to join Wallace Forbes
in launching a money management company. Three years later, Les bought the company,
and during the course of the next two years partnered with Kevin Reilly to form the broker-
age firm Quick & Reilly. The days were not easy, with disagreements between the partners
leading to Reilly's departure within two years. By then, the course of Quick & Reilly was irrev-
ocably set by Leslie's decision to become a discount broker. This was the first time any
member of the New York Exchange had ever offered discounted commissions of 50% or
more to all comers. By then the firm had acquired a Palm Beach office, and the phones there
as well as in the New York City office were ringing off the hook. Through all the subsequent
ups and downs of the market, Quick & Reilly never made less than 30% pretax profits. Much
of the success came from Les's uncanny genius for reading market trends as well as his abil-
ity to build long-term friendships through fair dealing and unbending integrity.
His four sons, Leslie III, Tom, Peter, and Christopher, were brought into the family busi-
ness even before they had finished college. With them, he spent one frantic Sunday poring
over the finances of a NYSE specialist firm entering bankruptcy. The next morning, Les
offered to buy the firm for 4 million dollars and so beat a very annoyed Carl Icahn. Now led
by his son Christopher, the specialist firm makes markets in 430 companies that comprise
17% of total big board volume. Earlier, Les founded a clearing firm after rivals, upset by his
successful discounting, had coerced their previous clearing firm to stop handling Quick &
Reilly trades. Within a year, his new business turned a profit. Now it successfully operates
under the leadership of his oldest son, Leslie III. At all times, Les showed real flair for sens-
ing out companies whose stock prices would soon move upward. Upon visiting a drill bit firm
in Texas where he learned that their rival, Hughes Tools, would soon have a superior prod-
uct, he rushed home to tell his brokers to load up on Hughes Tools. That move covered half
the costs of his sons' college tuition.
Quick & Reilly went public in 1983, giving it capital that let it expand faster, eventually to
comprise some 120 investor centers serving more than 1.3 million clients. Three years ago,
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in 1998, Quick & Reilly was sold to the Fleet Financial Group in Boston under an arrange-
ment that would let Leslie and his family continue to control its operations for the five suc-
ceeding years. Although Les had by then passed 70, his was still a vigorous presence, both
physically and intellectually, and he will never be remembered for ever having voluntarily
slowed down. At the age of 60, he acquired the pilot's license to let him, not his pilot, be in
command of his seaplane and no one was surprised when he piloted it under the Brooklyn
Bridge. And at 65, he acquired his very own ocean-going 126-foot yacht that he brought
several times into Kinsdale on trips to Ireland where he hoped to pinpoint the exact birth-
place of his grandfather so as to qualify for dual Irish citizenship.
On Long Island, Les and Jean presided over three successively larger homes. The first
was in Levittown, where mass-assembled homes let denizens of Brooklyn and Queens
move into clean air and safer streets. From there they moved to a Woodbury house that gave
them the space for their ever-growing family, and where their sons used their bikes to deliv-
er the morning papers before they went off to school. By 1978, Les had the means to move
into one of the large comfortable brick homes built on the site of the former Rutherford estate
just to the north of the Laurel Hollow Police Station. Their Florida houses in the Palm Beach
region were likewise increasingly commodious, with the current family home on the beach
near Lost Tree Golf Club. It was formerly Greg Norman's residence. Liz and I were invited
there two winters ago, arriving to find that Les, just six months recovered from a successful
heart by-pass operation, proposed piloting us in his Cessna on a joy ride to and from Vero
Beach. Without hesitation, we accepted, knowing that Les in no way would take a risk that
would cut down a life that gave him so much joy.
To his last days, he was as much a happy kid as he was a caring, honest leader of busi-
ness and a devoted family man. He bought his first Rolls Royce the day Roy Kroc died. He
didn't want to mistakenly not enjoy his new wealth before it was too late. At the same time,
he was increasingly active in supporting Catholic causes, being a key founding Trustee of the
Inner City Scholarship fund set up by Cardinal Terence Cook, as well as playing a major role
in the transformation of St. Francis Hospital in Port Washington into one of our nation's lead-
ing centers for heart surgery. In addition, he was a prime patron of the Alfred E. Smith
Foundation and served on the board of Fairfield University. For all his many services to the
Catholic Church, he became a Knight of Malta and a Knight of the Equestrian Order of the
Holy Sepulchre of Jerusalem. He was also long a Trustee of his alma mater Widener
University.
Once he came on our Board just three years ago, he quickly saw our challenges ahead
and, never being a passive member of any Board, soon was chairing our Board's
Development Committee. Then the chief item on its agenda was funds to support our soon
to be launched School of Biological Sciences. Immediately he stepped up to bat with a mil-
lion-dollar gift to endow a student fellowship, as well as an equally large sum to endow a
fund for our Core Course in Scientific Reasoning and Logic. Soon to follow were 300,000
more dollars to endow one of our faculty lectureships. More recently, Les was excited by
our plans to expand our cancer research efforts in our new Woodbury Genome Center as
well as new facilities on our main campus. But by then he had all too suddenly learned that
the summer pain in his legs that he thought was sciatica had a much more ominous ori-
gin-a malignant chondrosarcoma that had already spread to his lungs. This awful news
came only several days after he had been honored as Irishman of the Year at the Waldorf
Astoria by the Irish Historical Society. It was a proud occasion for him and his family and all
those countless individuals blessed to have felt his warmth and vigor on behalf of the pub-
lic good.
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Although his prognosis was inherently grim, the thought of Les dying did not want to
enter our minds. He was irreplaceable and much too nice to go this way of pain. Just before
Christmas, Liz and I brought him and Jean a Guiness-filled cake to share with his children.
Although his cancer was filling up his lungs, he had just gone with Tom to buy a new motor-
cycle and already been taken for a ride. Later, he had Chris sneak him out of his house to let
him one last time see our Lab buildings and beautiful snow-covered grounds. Later in Palm
Beach, when he knew the end was near, he banished temporarily the thought by ordering a
red Bentley convertible. Learning that one of this color was not available, he settled for a sec-
ond Rolls Royce.
His last days were spent in Boston at the Dana Farber Cancer Center, whose anti-can-
cer drugs five years before had cured a son of his daughter Nancy of leukemia. But even their
newest weapons were not equal to his relentless cancer, and he died with Jean and his chil-
dren about him on Thursday, March 8. On Saturday, a private funeral Mass was said at St.
Dominic's in Oyster Bay, with burial in the beautifully sylvan Locust Valley Cemetery. The fol-
lowing Monday, Cardinal Egan celebrated a Mass for him in a filled St. Patrick's Cathedral on
Fifth Avenue.
At six in the evening, the day after Les's death, the Lab held a long-scheduled, pre-St.
Patrick's Day concert in Grace Auditorium by the Irish-American ballad singer, Cathie Ryan.
Her haunting songs four months before had highlighted the Waldorf banquet honoring Les.
Singing again Danny Boy, the tears it so easily generates flowed even more copiously.
Our good must stop dying of cancer.
16 April 2001 James D. Watson
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There are times when it is exhilarating, but also humbling, to be a member of a privileged fel-
lowship who collectively call themselves scientists. The year 2000 was such a moment, for we
saw extraordinary progress in understanding the fabric of life, the sequence of bases in DNA that
encode our genetic information. Following past successes in the sequencing of the genomes of
many microbes-the yeast Saccharomyces cerevisiae and the small worm Caenorhabditis ele-
gans-a flurry of important genome sequences emerged during 2000, all with great fanfare. Early
in the year, we saw the publication of the sequence of the genome of the fruit fly Drosophila
melanogaster, which was a result of a successful collaboration between academic scientists and
the private sector, a harbinger of future genome projects. In the middle of the year came the high-
ly coordinated, multinational announcement that the drafts of the human genome were com-
plete, following intervention and direction from President Clinton in this country and Prime
Minister Blair in the U.K. The publication of the draft human sequences appeared in early 2001,
again with much public attention. With lesser blowing of the trumpet, the last month of the year
saw the publication of the complete sequence of the first plant genome from Arabidopsis
thaliana. Thus, for the first time, it is possible to gaze into the intimate genetic details of organ-
isms from all kingdoms of life. As a consequence, public interest in biology and medicine is at an
all-time high and probably rivals public interest in science following other monumental scientific
and engineering feats, such as landing a man on the moon and the splitting of the atom. We
have been fortunate to witness and participate in these dramatic advances. A new era of biolo-
gy has blossomed that will long have profound consequences for science and indeed for soci-
ety as a whole.
The revolution of recombinant DNA that emerged in the early 1970s made it possible to
obtain unlimited amounts of virtually any DNA. Imaginations ran wild, but like so many endeav-
ors in science, technical limitations still kept biologists at bay. Perhaps the clearest and most dif-
ficult technical challenge was to figure out how to read the sequence of individual genes. By the
mid 1970s, just as I was entering graduate school in Australia, two vastly different approaches
to DNA sequencing emerged. One from Wally Gilbert's laboratory in Cambridge in the U.S. used
a chemical sequencing approach, whereas that from Fred Sanger's laboratory in Cambridge in
the U.K. employed enzymatic methods. The two different technologies from the two Cambridges
were complementary, but early on, each had its advocates as to which one was best. It was
rather amusing to listen to young Australian scientists returning from studies in either the U.S. or
the U.K. tout the virtues of their favorite approach to gene sequencing, depending on the coun-
try of origin. In those days, both methods were important, and it was necessary to learn both to
be a successful graduate student. In retrospect, these developments proved, unwittingly, to be
the first multinational collaboration in the DNA sequencing era, for the sequencing problem was
essentially solved and now could be scaled up.
Progress was rapid, and within a year, the genome of a bacteriophage (a virus of bacteria)
called 4X174, which contains approximately 5375 nucleotides, was reported from Sanger's
group. It was equally exciting to learn in 1978, during my first visit to Cold Spring Harbor for the
annual Symposium, of Greg Sutcliffe's determination of the complete sequence of the then-
favorite bacterial cloning plasmid, pBR322, using the Maxam and Gilbert technique. It was only
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a matter of time before the concept of sequencing the whole human genome began to be dis-
cussed, notably at a meeting organized by Robert Sinsheimer in 1985 at the University of
California, Santa Cruz. But the idea of determining the complete sequence of the human genome
was controversial, as many biologists saw the cost as being too high. This was a time when
grants were particularly difficult to obtain because of limited funding, and therewas considerable
concern that such an ambitious project could not be completed for technical reasons, even if
sufficient funds could be found. During the Cold Spring Harbor Symposium in 1986, Jim Watson
brought together some of the leading biologists to discuss the genome sequencing proposal:
Was it feasible and, of particular importance, who should fund the considerable cost? Those
days now seem far in the distant past, but it was only 14 years ago, a short time in the history
of molecular biology. Wally Gilbert's prediction at that meeting that we would all carry our genet-
ic sequence on a credit card then seemed far too fanciful, but it is now well within the realm of
possibility.
Shortly after the 1986 meeting, spurred by the start of a human genome project by the
Department of Energy and helped by discussions organized by the National Academy of
Sciences, the National Institutes of Health began the project with considerable enthusiasm.
Much of the early success of the project in the U.S. was due to the outstanding leadership of
Jim Watson in establishing in this country the NIH Human Genome Research Center (lateran
Institute at the NIH). All biology benefited by his promoting the sequencing of model organisms,
such as yeast, Drosophila, and C. elegans, and by focusing early money on ethical issues. The
introduction of new techniques was of great importance to the success of the project, particu-
larly the contribution by Lee Hood and Mike Hunkapiller in developing the automated DNA
sequencing machines that eventually got the job done. Francis Collins, the second and current
director of the U.S. effort, skillfully directed the difficult stage of scaling up the human genome
sequencing project and shepherding the public effort to near completion. In the U.K., John
Sulston and the Wellcome Trust, together with Bob Waterson in this country, played an essen-
tial role early on by committing considerable effort and resources (and their scientific reputations)
to model organism genome sequencing and later, at a critical time to the human genome pro-
ject, when it needed to scale up. Later, the introduction of a private effort by Craig Venter and his
colleagues at Celera dramatically accelerated the progress, although the introduction of the pri-
vate sector into genome sequencing has created the new problem that not all of thesequences
are available to all those who want to use them.
Congratulations are due to the community of genome sequencers, particularly those sup-
ported by public funds, from the heads of the various genome centers down to the technicians
who did much of the work. They have shown that it is possible to undertake large, internation-
ally based science projects and get the job done with a remarkable degree of cooperation. But
more importantly, they have shown that it is possible for very talented scientists to participate in
large multi-investigator science projects that benefit all of science, even though individuals might
not have received the recognition that might have come had they continued to run a conven-
tional, small laboratory. I have observed at the annual Cold Spring Harbor genome meeting a real
sense of purpose and camaraderie among the scientists who cooperated in this project.
Unfortunately, this message has been lost to the public, who have instead been inundated with
the public-private competition issue by the popular press. One hope is that history will focus on
the truly remarkable collegiality that was evident during this time.
The genome projects have also benefited us all in another direct way. Now that many
genomes are complete, funding has picked up because we have captured the imagination of the
public and Congress and because there is a more realistic hope of successfully tackling human
diseases, particularly cancer.
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The first eukaryotic genome to be sequenced was that of the baker's yeast, S. cerevisiae,
completed in 1996. Done in cottage industry style by investigators from many countries, the
yeast genome became the model for how complete genome sequences might be used. My own
work on the replication of chromosomes, in part using yeast as a model organism, has greatly
benefited from the freely available genome sequence. Now that we have the human genome
sequence almost complete, it is perhaps worth reflecting on how the yeast genome has helped
progress in yeast biology and biology in general.
Knowing the entire genome sequence immediately establishes a closed system for under-
standing information flow within the organism. Since all of the genes are known, when a new
activity or function is discovered, it is possible to search the entire genome to discover whether
there are other similar proteins that might perform related functions. In this manner, families of
proteins are rapidly discovered. Because biology reuses protein domains and activities for multi-
ple purposes, progress in understanding one pathway will often lead to insight into other bio-
chemical processes. This iterative accumulation of biological knowledge will not only help us to
understand the biochemical processes in yeast, but, because most yeast genes have functional
or sequence-related homologs in the human genome, also make it possible to predict with high
accuracy protein function in human cells. For this to occur efficiently, it is necessary to know the
entire human genome sequence, and as more genomes are sequenced, including those of other
model organisms, the information flow from one system to another will increase rapidly. This is,
perhaps, the strongest argument for sequencing the genomes of all of the important organisms
used in modern biological and biomedical research.
Developments in the methodology to rapidly analyze proteins by mass spectrometry have also
dovetailed with whole genome sequencing in a most productive and informative way. Very small
amounts of proteins can be fragmented and the mass of the protein fragments determined by
mass spectrometry. These masses can then be compared to a computer-generated database of
all predicted fragments from all predicted proteins encoded in a genome. If sufficient fragments
are determined experimentally, then the proteins can be uniquely identified. So it is now possible,
and indeed routine in the yeast community, to use antibodies to isolate a protein present in a com-
plex mixture of proteins from cells and then rapidly identify all of the proteins with which it inter-
acts. Since most biological functions involve proteins working together in biochemical pathways,
we will move toward the possibility of knowing many of the protein networks in cells, and even the
protein modifications that occur in response to signals that the cell receives. Such an analysis and
the insight it provides were not possible without knowing the entire genome sequence.
Another important technical advance from studies on yeast that has been effectively inte-
grated with whole genome sequencing is the development of DNA microarrays. The concept of
arraying small amounts of DNA for biological analysis emerged from the pioneering studies of Ed
Southern in the 1970s, when he showed that it was possible to transfer DNA to fixed membrane
supports and hybridize DNA or RNA to the arrayed DNA. Once the entire genome of yeast was
known, it became practical to array all the predicted genes on glass slides so that all of the genes
of yeast could be analyzed simultaneously, instead of one gene at a time as was done previous-
ly. In this way, the dynamics of gene expression patterns could be followed as cells responded
to experimentally induced signals such as nutrient starvation, changing of carbon sources, and
commitment to divide or exit from the cell division cycle. The method has become one of the
most powerful tools to study the reaction of an organism to biological perturbations. It has only
been possible by having the complete genome sequence available.
Coupled with the protein analysis described above, DNA microarray experiments allow a very
intimate look at the molecular physiology of a cell and how it functions. We can see, on a whole
genome scale, how cells work and how they adapt to their changing environment. From what we
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have learned from studies on yeast biology during the last few years, it is probable that cell, tis-
sue, and organism physiology will return as a dominant area of investigation but studied now at
the molecular level. When this type of analysis is applied to animal studies, it will be possible to
see how an organism responds to all sorts of perturbations, leading to an unprecedented under-
standing of biology and physiology. This is happening at a rapid pace. Already, DNA arrays are
being used effectively to study the response of animal cells to extracellular signaling and to drugs
used in the clinic. A particularly innovative analysis is under way at Cold Spring Harbor
Laboratory by Tim Tully and Josh Dubnau who have identified fruit fly genes whose expression
is altered during the process of learning a task or consolidating memories of the learned task. It
is almost like watching the brain think!
With so much data, the field of bioinformatics, or computer-assisted analysis of biological
information, has rocketed to become one of the most exciting fields of biology. Judging by the
number of applications we get for a limited number of places available, the two bioinformatics
courses taught each year at Cold Spring Harbor are now the most popular of all our advanced
courses. Again, the yeast community has been a pioneer in the field of bioinformatics because
of the availability of the entire genome sequence during the last six years and because of the
need to deal with the vast amounts of data that derive from whole genome experiments. But
bioinformatics includes much more than the analysis of DNA sequences. Efforts within the yeast
community have developed databases that link the scientific literature to the genome. Genes and
their protein products, and even the pathways in which they function, have become a founda-
tion for computationally organizing biological information. Searching these databases has
become as routine as searching the printed literature. This is perhaps the best argument for sup-
porting a single electronic database of all research papers so that the biological literature can be
fully integrated with the large number of databases that are being developed by computer sci-
entists. Publishers of the scientific literature must strive to make science as easy as possible by
ensuring that the on-line literature is linked in a seamless and accessible way.
Because biomedical and biological research has flourished, the literature is growing at a pace
that far surpasses even the most avid reader. And yet the biological community has only just
begun to use computational approaches to analyzing the literature. Information science will
become a dominant field of biology and computer scientists will need to be integrated as much
as possible with biologists. At Cold Spring Harbor, we are strengthening our already broad bioin-
formatics research by adding computer scientists to our faculty so that they can develop new
technologies in consort with biologists.
Within the yeast community, there have been a number of initiatives aimed at providing whole
genome resources, such as creating a complete set of yeast strains in which all genes have been
deleted; or tagging all proteins with various sequence tags, marking each gene with a unique bar
code; or attempting to identify all possible protein-protein interactions using genetic methods. In
retrospect, some of these initiatives have not been as productive as anticipated in the beginning.
For example, the time it takes to delete a gene is very short compared to the time it takes to
know the consequences of doing such a deletion. Therefore, the availability of a complete set of
gene disruptions has not yet hastened progress. Thus, we should think carefully before whole
genome approaches for other organisms are attempted.
So what of the human genome? Because it is our genome, there have been sophistic writ-
ings in both the scientific and public literature that the gene sequences will reveal what it is to be
human, reveal the nature of the soul, and even explain human behavior. Most of this has been
overly excessive piffle put forth by those who can only be excused for getting too caught up in
the momentous occasion. Many discussions about the implications of the genome sequence
have also been flavored by the advent of cloning animals from single cells and the consequent,
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way too premature talk of human cloning. Knowing our gene sequence, or even a mouse
genome sequence, is not going to help overcome all the very considerable technical obstacles
that still exist in cloning other mammals. We simply do not understand enough about the meth-
ods for producing animals from individual cells. We do not know much about how gene expres-
sion programs are reset before development can occur. Clearly, research on cloning should pro-
ceed, but knowing the full human genome sequence will only marginally help solve the signifi-
cant hurdles that exist, and the two areas of science must not get confused when there is dis-
cussion about future possibilities.
The achievement of obtaining the sequences of many genomes, including the human
genome, is a major milestone in science. Certainly, when the double helix was revealed, it was
unimaginable that the entire nucleotide sequence of a genome could be obtained. I still find it
humbling to realize that we are in a golden age of biology that will have far-reaching conse-
quences not only for our own science, but also for humankind. At the same time, we should have
realistic expectations of what will emerge from these spectacular developments.
On a practical level for most scientists, research has been made much easier because of the
reagents that have derived from the genomics age. Clones of genes and fragments of genomes
are readily available, as are the predicted sequences of most proteins (we do not yet have the
computer tools to predict all protein sequences accurately). These resources have been put to
great use, speeding up the pace of biological discovery manyfold. This progress in itself has been
a silent revolution, perhaps only appreciated by the scientists actually doing the work. Many of
the advantages which have become available to the yeast community during the past six years
are now available to those working on human biology, including arrays of human genes, protein
analysis by mass spectrometry, and comparisons to the predicted "proteome"-the set of all
proteins. It is now possible to analyze the changes in gene expression of the entire set of known
human genes in response to physiological changes in cells and tissues. Although it is early in this
analysis, new and exciting findings have been reported in the literature. Such experiments have
already led to new methods for diagnosing human disease and to the discovery of new targets
for therapy. In some cases, the cause of disease has been discovered by the power of being able
to compare gene sequences between diverse species, such as those of Drosophila and human,
or even yeast and human.
One of the most interesting aspects of whole genome sequencing in humans is the diversity
of sequences that are being uncovered. It is estimated that there is one difference between indi-
viduals for each 1300 bases in the human genetic code of 3,000,000,000 bases. This means
that we are all about 99.9% identical, something that itself is quite remarkable. But if turned
around the other way, then it means that there are about 3 million differences at the primary DNA
level between individuals. Most of this variation will not be expressed, but some of it will. This
means that individuals will not only have different shapes and sizes-something that we all know
about-but also have different probabilities of being afflicted by disease and, when treated, dif-
ferent responses to drugs and other therapy. Such variation will become valuable for predicting
how patients might respond to certain drugs, allowing treatments to be targeted to individuals
who will benefit from the drugs while avoiding adverse effects of the same drugs in others.
Knowing more about human genomic variation also has the potential to change how we view
ourselves as a species. By knowing more about human DNA variation, we will realize that tradi-
tional ethnic and cultural boundaries will not be reflected in our DNA, but rather will be purely a
human invention with no genetic (and maybe even no biological) basis. If this turns out to be true,
and it is really understood by the lay public, then cultural and ethnic differences may not be as
dominant in future human endeavor. But, change will occur only very slowly, and this may be an
unattainable utopian goal.
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Clearly, whole genomic approaches to biology are changing the way we think about deal-
ing with human disease, and perhaps this is what the public finds the most appealing. One
example at Cold Spring Harbor Laboratory is the whole genome analysis of human cancer by
Michael Wig ler, Robert Lucito, Masaaki Hamaguchi, Vivek Mittal, and their colleagues. By
combining a method called RDA (representational difference analysis) developed in Wigler's
laboratory about eight years ago with high-density arrays of human DNA placed on glass
slides, it is now possible to analyze small biopsies from human cancers and compare DNAs
from the normal and cancer cells. Initially focusing on breast cancer, this research is already
leading to exciting new results. There are new possibilities for diagnosing the disease and for
identification of new anti-cancer targets. From such genomic analyses, cancers that look alike
to a pathologist can be molecularly identified and classified, and understood as being sepa-
rate diseases with separate outcomes.
Such analysis of breast cancer has also led to the discovery of new gene mutations in
human cancers. It is already clear from the analysis of breast cancer samples that many
altered regions of the genome have not been characterized, particularly in cancers derived
from patients who have no known family history of the disease, which represents the vast
majority of breast cancer cases. By correlating the alterations with the type and severity of the
cancer, and with the response of the cancer to existing treatments, such knowledge will lead
to better decision-making by oncologists. But the more important goal is to identify those
genome alterations that suggest new, cancer-specific targets for therapy. Already the identifi-
cation of one genetic lesion in a subset of human breast cancers has led to a novel therapy.
In about 25% of breast cancers, a gene called Erb2 is overexpressed. This knowledge led to
the development by Genentech of an antibody-based drug called Herceptin which has proven
effective in treating a subset of breast cancer patients. Our goal for the cancer gene discov-
ery at Cold Spring Harbor Laboratory is to identify the key therapy targets in all classes of
breast cancer. Furthermore, the methods that have been developed and applied for breast
cancer research can easily be applied for other cancers, given sufficient funding.
Such scenarios will play out for many human diseases. But a caution should be noted as
we all celebrate the fantastic achievements of the recent past and speculate on how quickly
genomics will change our real understanding of biology. Genes make proteins, and proteins,
not genes, determine how we look, how we behave, what diseases we get and how they are
treated, and even how we respond to our environment. Because of gene splicing, gene
rearrangements, and developmental diversity in gene expression patterns between individu-
als, biology is much more complex than the genomic view would suggest. Proteins can be
modified in many different ways, thereby changing their function. It is possible for a single gene
to encode many proteins with diverse, and sometimes even opposite, functions. This is not
always apparent from gazing at the gene sequence, even with powerful computers. Our pre-
sent methods for discovering the functions of proteins and the pathways in which they oper-
ate are not yet rapid enough, particularly when applied to mammalian biology. Although inte-
grative approaches, such as comparing gene functions across diverse species, are clearly
paying dividends, biology is much more complex than the set of genes that make up a
genome. We need to think about greatly improving computational approaches to biology, find-
ing better experimental ways to characterize protein diversity, and most importantly, speeding
up discovery of protein function. Once this can be achieved, and we learn how to integrate
this knowledge into a molecular understanding of cell and organism physiology, the true power
of the genome will be unleashed.
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HIGHLIGHTS OF THE YEAR
The research and education programs at the Laboratory continue their strong momentum.
The Watson School of Biological Sciences recruited its second class of students this year,
and the DNA Learning Center underwent extensive renovations that will further its educa-
tional objectives. The Meetings and Courses program and Banbury Center continue to be
invaluable resources for scientific information, and the Cold Spring Harbor Laboratory Press
added new projects and properties to its long list of titles. In this, the year of the Human
Genome, Cold Spring Harbor Laboratory was a bustling center of scientific activity.
Research
Cancer
Malignant melanoma is an aggressive, deadly cancer that does not respond
to conventional chemotherapy. Other aggressive, chemoresistant can-
cers-and approximately half of all cancers-are characterized by muta-
tions in the p53 tumor suppressor gene. Malignant melanomas, however,
do not typically display mutations in the p53 gene.
To explore alternative explanations for the origins and properties of
malignant melanoma, and to identify potential targets and strategies for e 40w.-
therapy, Scott Lowe and his colleagues have examined the status ofother,
genes known to function downstream from p53 in a pathway leading to Lowe
"apoptosis" or "programmed cell death." When intact, this pathway rids the
scoff
body of abnormal, precancerous cells by triggering a cellular self-destruct mechanism. When
this pathway is disrupted (by the loss of p53 function, for example), precancerous cells sur-
vive and proliferate, resulting in cancer.
This year, Scott and postdoctoral fellow Marisol Soengas found that malignant
melanomas often lose a key trigger of programmed cell death, a protein called Apaf-1 (apop-
tosis activation factor-1). They also discovered that the loss of Apaf-1 in melanoma cells is
associated with resistance to the chemotherapy drug adriamycin. Most significantly, Scott
and Marisol showed that restoring Apaf-1 in melanoma cells rescues the ability of these
tumor cells to kill themselves in response to adriamycin. Thus, accurate diagnosis and treat-
ment of malignant melanoma, and perhaps other cancers, should include an assessment of
the status of Apaf-1. Scott and Marisol were joined in this work by Yuri Lazebnik, who is
examining how Apaf-1 acts in concert with an enzyme called caspase-9 to trigger the cell
death machinery.
RNA Splicing and Breast Cancer
In 1977, CSHL scientist Richard Roberts and his colleagues published a paper whose title
began "An amazing sequence arrangement..." Rich's use of the adjective "amazing" in a
serious scientific article was highly unusual and strangely prescient, because the paper
reported a discovery for which he would later win the Nobel prize. A number of papers from
Cold Spring Harbor Laboratory and MIT published the discovery that genes are not usually
contiguous, but rather occur as blocks of relevant coding sequences (later called exons) that
are interspersed with blocks of intervening, noncoding sequences (introns).
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Introns are removed at the level of RNA by a splicing mechanism.
This year, Adrian Krainer and his colleagues discovered why partic-
ular mutations in the BRCA1 gene alter premessenger RNA splicing
and thereby predispose individuals to breast and ovarian cancer.
Although complex in detail, the basic splicing mechanism
involves cutting a premessenger RNA molecule at two sites (the
splice junctions), discarding the intron thus released, and joining
the exons together. This basic splicing mechanism is mediated by
the binding of splicing factors to the splice junctions and the
action (e.g., cutting and joining) of splicing factors at these sites.
Recently, however, additional sites that stimulate splicing have
been identified within exons. These sequences are called exonic
splicing enhancers or ESEs. Adrian and his CSHL bioinformatics
colleague Michael Zhang have developed rules for predicting the
presence of ESEs within genes of particular interest. They discov-
ered that a mutation in the BRCA1 gene-known to alter splicing and predispose individu-
als to breast and ovarian cancer-disrupts an ESE. In addition, Adrian found that disruption
of ESE function may contribute to many other diseases, including cystic fibrosis, neurofibro-
matosis, Wiskott-Aldrich syndrome, and Menkes disease.
Adrian Krainer
Papillomavirus DNA Replication and Cervical Cancer
DNA contains specialized regions-called origins of replication-that enable the stable "seal"
between the two strands of the double helix to be broken. This breaking of the seal between the
strands of DNA is the first step in DNA replication, the process that copies DNA.
It results from the action of enzymes called DNA helicases that bind to origins
of replication and unwind the DNA. Arne Stenlund is investigating how the DNA
helicase of papillomavirus binds to the origin of replication in the viral genome
and initiates the unwinding of viral DNA prior to DNA replication, a process nec-
essary for the virus to multiply and spread. Papillomaviruses are a family of DNA
tumor viruses that infect mammals and cause both benign and malignant
epithelial tumors such as polyps and cancer of the cervix. Virtually all human
cervical cancer can be attributed to papillomavirus infection. Therefore, the
papillomavirus DNA helicase is an attractive target
for antiviral drugs and other treatment strategies.
Arne, together with Grace Chen (now at the
1- University of Michigan Medical School), found that a
complex mechanism governs how the papillo-
Arne Stenlund mavirus DNA helicase works. The enzyme, made up
of a protein called El, binds to the viral origin of replication by nestling
up to another papillomavirus protein, E2. Together, these proteins bind
to adjacent sites at the origin, where El then becomes an active DNA
helicase and begins to unwind the double helix. Arne and Grace have
discovered that E2 acts as a loading factor that deposits El on a spe-
cific sequence of DNA, the papillomavirus origin of replication.
Using X-ray crystallography, Leemor Joshua-Tor and postdoc-
toral fellow Eric Enemark have determined the three-dimensional
structure of a part of El that binds to DNA and to E2. By obtain-
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Leemor Joshua-Tor
ing a detailed view of E1 ’s biochemical properties and structure, Arne and Leemor have 
uncovered interesting clues about how the papillomavirus DNA helicase is put together, how 
it functions, and what steps might be taken to  block the function of this enzyme as a way to 
prevent cervical cancer.
Neuroscience
Brain Development: How does a single cell— a fertilized egg— become a complex organism 
composed of billions of cells of thousands of different kinds? How do cells arise at the cor- 
rect time and place during the development of an organism and adopt the specialized char- 
acteristics that make them bone, muscle, or nerve? How is cell number controlled so that 
tissues, organs, and body parts adopt the correct size? Regulated transitions from cell pro- 
liferation to  cell differentiation— during which cells stop growing and adopt specialized char- 
acteristics— are the key to  these phenomena.
Since 1992, Grigori (Grisha) Enikolopov has made a series of important 
discoveries concerning how the biochemical messenger nitric oxide (NO) 
instructs the cells in a developing organism to  stop dividing, enabling them 
to  differentiate into specialized cell types. Building on that research, Natalia 
(Natasha) Peunova, Hollis dfine, and Grisha found that experimentally alter- 
ing NO levels in the developing brain of tadpoles significantly affects brain 
volume and the number of brain cells. When they artificially decreased NO 
levels in the brains of developing tadpoles, brain cell proliferation increased, 
leading to  larger than normal brains (too little NO, too many brain cells).
Conversely, when they artificially increased NO levels, brain cell proliferation 
decreased, and the resulting brains were smaller than normal (too much 
NO, too few brain cells).
This experiment enabled Natasha, Grisha, and Holly to  provide the first 
definitive demonstration of the essential role of NO as an inhibitor of nerve 
cell proliferation during vertebrate brain development. Fruit flies, frogs, mice, 
and humans all have similar sets of enzymes that produce NO. Thus, Grisha 
and his colleagues are uncovering universal principles concerning the 
antiproliferative power of NO and how this power is harnessed to  create 
everything from diverse blood cell types, to  correctly proportioned body 
parts, to  the complex anatomy of the brain.
Brain Imaging: Forget gigabytes. Even the most powerful computers avail- 
able today are no match for the complexity, efficiency, and information-pro- 
cessing capacity of the human brain. Underlying the brain’s far superior 
design are the billion-million or so connections between brain cells— called 
synapses— that form vast neural networks in which brain cells, or neurons, 
are connected to  thousands of other neurons. These networks— and their 
ability to  be shaped by experience— enable us to  receive, process, store, 
and retrieve all manner of information about our world. Unfortunately, the 
extremely tiny size of synapses and the limitations of conventional experi- 
mental techniques have hampered detailed studies of these essential structures. (One trillion 
synaptic compartments, or “dendritic spines,” could fit into a thimble.) This year, Karel 
Svoboda overcame these technical obstacles to  gain an extremely close look at the proper- 
ties o f dendritic spines and synapses that govern brain function.
9
Using "two-photon" microscopy (a high-resolution imaging technique whose application
to neuroscience Svoboda pioneered), Karel and postdoctoral fellow Bernardo Sabatini
watched calcium flow into single dendritic spines of electrically stimulated brain neurons.
These measurements enabled Karel and Bernardo to determine the number and type of
"calcium channels" present at synapses in a region of the brain important for learning and
memory, the hippocampus. Calcium channels are molecular gates that open in response to
electrical stimulation and allow calcium to flow into dendritic spines. Once inside, calcium
triggers biochemical events in the spine that modify synaptic strength.
The strengthening of synapses between neurons in response to experience is believed
to underlie complex brain functions such learning and memory. Karel, Robert Malinow, and
several other CSHL neuroscientists have made a series of significant discoveries about this
process. Visualizing how neurons communicate with each other on the most basic level, as
Karel has done by imaging calcium, provides important clues for understanding how our
brains outperform the most sophisticated computers and, in so doing, enable us to grasp
the human experience.
Theoretical and Computational Neuroscience
The discoveries made by traditional neuroscientists result from
experiments with living tissue. In contrast, theoretical and compu-
tational neuroscientists use mathematics to describe how the
brain works. Much of Dmitri (Mitya) Chklovskii's theoretical neuro-
science research is based on the idea that biology and evolution
impose several design constraints on the structure of the nervous
system. For example, scientists have long believed that neurons
are positioned and connected in the brain in such a way as to
minimize the length-and hence the volume-of wiring.
Mitya has developed a mathematical formulation of this "wiring
economy" principle that enables several predictions to be made
about how neurons are connected to each other in the brain. Mitya's "wire length minimiza-
tion" model corresponds closely with the observed properties of the mammalian visual cor-
tex, a brain region that processes visual information. The human
brain contains approximately 300 million feet of wiring packed into 4
a 1.5-quart volume, but the brain would be much larger if it did
not employ the strategy Mitya has uncovered for fitting the nec-
essary wiring into the available, limited space.
Recently, Mitya has turned his efforts to understanding the
neurological basis of optical illusions. By determining what hap-
pens when the brain is tricked, e.g., by an optical illusion, Mitya
aims to uncover new principles of brain function.
Dmitri Chklovskii
Plant Molecular Biology and Genetics
Owing to its small size and short generation time (-6 weeks from
seed to adult), the mustard relative Arabidopsis thaliana has
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Robert Martienssen
W. Richard McCombie
become a workhorse of plant molecular biology and genetics. In
addition to pursuing their specific research interests, W. Richard
McCombie and Robert Martienssen helped organize the
Arabidopsis Genome Initiative, a large-scale international effort
established in 1996 to sequence the entire genome of this plant
species.
This year, and well-ahead of schedule, the Arabidopsis
Genome Initiative reached its goal of sequencing the entire
Arabidopsis genome and thus obtained the first-ever complete
genome sequence from a plant. This achievement has profound
implications for biology, medicine, agriculture, and the environ-
ment because it will enable detailed studies of the entire genetic
structure of plants to be carried out. Such studies will yield a great
deal of new information about plant growth; crop yields; disease
and drought resistance; ripening and spoilage; pharmaceutical, vitamin, and "edible vaccine"
production; and many other aspects of plant biology.
Symposium LXV
From May 31 to June 5, biologists from a number of research fields gath-
ered for the 65th annual CSHL Symposium, this year titled "Biological
Responses to DNA Damage." On Sunday, June 4, meeting attendee Jan
H.J. Hoeijmakers of Erasmus University in Rotterdam delivered the annual
Dorcas Cummings Memorial Lecture to a scientific and public audience, a
very successful annual event hosted by the CSHL Association.
Hoeijmakers' talk, "Maintaining Nature's Perfection: Cancer and Aging and
the Condition of Our Genes," was timely because of its relevance to cancer,
but also fascinating because we must inherit and maintain our DNA in as
best shape as we can to avoid acquired genetic diseases. The lecture,
Symposium, and program were an unparalleled success.
Cancer Center Designation Renewed
Jan N.J. Hoeijmakers
Cold Spring Harbor Laboratory has been a National Cancer Institute (NCI)-designated basic
cancer center since 1987. After a recent review and site visit, CSHL's cancer center status
was renewed by the NCI, which rated the Laboratory's overall program in cancer research
as "outstanding." CSHL was one of only a handful of NCI designees to receive this distinc-
tion. Designated cancer centers receive a Cancer Center Support Grant from the NCI, which
helps fund the scientific infrastructure of the cancer research program. Funds from the NCI
enable cancer centers to take advantage of new research opportunities, state-of-the-art
technologies, and other NCI-supported resources to advance cancer research.
Scott Lowe, a CSHL Professor since 1995, has been named Deputy Director of the
CSHL Cancer Center. Scott has made leading contributions to the identification and char-
acterization of genetic pathways that suppress tumor development and, when disrupted,
make tumors resistant to cancer therapy. As Deputy Director, Scott will help me lead the
Cancer Center in new directions and ensure that its resources continue to flourish. Scott's
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appointment follows Winship Herr's seven-year role as an energetic and very effective
Deputy Director. Winship has stepped down to focus on the development of the Watson
School (for which he serves as Dean) and his other duties as Assistant Director of the
Laboratory.
Denise Roberts, the Laboratory's new Research Administrator, has also assumed the
administrative duties for the Cancer Center.
Watson School of Biological Sciences
CSHL's graduate school-the Watson School of Biological Sciences-welcomed its second
class of students this fall. On August 28, nine new students joined the Watson School's
ranks, the second class to enter the program. Hailing from across the country and around
the world, the students dove quickly into their rigorous programs, enrolling in the core cours-
es and beginning the laboratory rotations that mark their first year of study.
Honorary Board of Trustees member David L. Luke Ill continues to lead the fund-raising
efforts to fully fund the Watson School programs. This year, nearly $7 million was raised to
support the Watson School, its graduate program, and its students.
Presidential Events
James D. Watson, president of CSHL, has had another busy year, most recently promoting
his newest book, A Passion for DNA: Genes, Genomes, and Society. The collection of
essays, published by the CSHL Press, was nationally publicized through an exhausting 4-
month book tour. Locally, Jim was a big hit at Huntington's Book Revue, where hordes of
fans lined up for the Nobel Laureate's autograph. Jim was also honored on July 4 with the
prestigious Philadelphia Liberty Medal. Jim received the award, together with Francis H.C.
Crick, for the "tremendous impact of their science on our lives and public policies."
Lewis Miller, an Australian artist and winner of the prestigious Archibald Prize-Australia's
premier award for portraiture-returned to CSHL for a month this summer. Miller, who visit-
ed the Laboratory during the 1998 Symposium to sketch attendees and Laboratory per-
sonnel, has many works exhibited throughout Blackford Hall. His mission this summer was
more specific: I commissioned Miller to paint a full-sized portrait of James D. Watson.
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James Watson meets young fans
while promoting A Passion for DNA.
Miller's efforts were a success: A seven-foot
representation of CSHL's President now hangs in
a place of honor inside Grace Auditorium, where
Jim has spent countless hours lecturing to public
and scientific audiences. While at the Laboratory,
Miller also completed several other portraits,
including sketches of Charles and Helen Dolan,
long-time supporters of the Laboratory. Mrs.
Dolan, who currently serves on the Laboratory's
Board of Trustees, was particularly pleased with
the charcoal drawings Miller presented to the cou-
ple. In all, Miller completed more than 15 portraits
while at the Laboratory, and each was framed for
display around the Laboratory campuses.
30th Anniversary Reunion of Yeast Course
Helen Dolan Charles Dolan
Since the inception of CSHL's Yeast Genetics Course 30 years ago, nearly 500 scientists
from around the world have traveled to Cold Spring Harbor to learn more about this relatively
simple organism. Although simple in structure, yeast undergoes many of the
complex biological processes of higher-order organisms, making it a model
system for the study of molecular biology. CSHL's Yeast Genetics Course
has helped to elevate yeast to its present "stardom," and most of the out-
standing yeast geneticists/molecular biologists of the past half-century have
either taken the course, taught the course, or both.
To celebrate the great science and lifelong friendships that have resulted
from the Yeast Genetics Course, the Laboratory held a reunion for course
participants on August 11. The event brought together students and instruc-
tors of the course-both past and present-for 2 days of reminiscing and
sharing of current research. The reunion illustrated the influence that the
course has had on its participants, as well as the impact that these investi-
gators have had on science. "It's hard to imagine where we'd be today with-
out yeast," said Jim Watson, who kicked off the reunion celebration. More
than 35 alumni of the Yeast Genetics Course attended the reunion, taking
part in the 2-day mélange of lectures, reflections, and activities, including the
now-famous "plate race."
Banbury Center
Jim Hicks, Ira Herskowitz,
and Chris Kaiser at the reunion.
One of the highlights of the Banbury Center year is the annual Executives' Conference.
Begun in 1986 to bring top executives in the pharmaceutical and biotechnology industries
together to learn about the newest concepts and technologies, the meetings attracted both
speakers and invited guests of the highest quality. The 2000 meeting, entitled "Human
Consciousness and Intelligence," lived up to this tradition. The keynote speaker was Oliver
Sacks, the eminent psychologist and best-selling author. Oliver is the first Banbury Center
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visitor to have been immortalized by Hollywood, when he was played by Robin Williams in
the film Awakenings, based on his book. Howard Gardner spoke on his theory of multiple
intelligences, and there was a spirited discussion of human intelligence following a presen-
tation by Charles Murray, coauthor of The Bell Curve. Participants were treated to appear-
ances by Alex the African Gray Parrot (by Irene Pepperberg) and, at the other extreme,
robots (by Howard Gardner). In between, Stephen Pinker discussed his ideas on language,
while Vilayanur Ramachandran reviewed the neuropsychological basis of sensory percep-
tion. We are grateful to David Deming of J.P. Morgan for helping us to present such an extra-
ordinary meeting.
Some years ago, the world was astonished and shocked by the cloning of Dolly, the
sheep. It seemed to be an extraordinary step in the manipulation of living organisms.
However, Dolly herself was the only success of many attempts, and subsequent studies
have only achieved limited success. Cloning is very difficult. The Banbury Center meeting
"Mammalian Cloning: Biology and Practice" tried to identify those elements of the biology
underlying cloning that might be responsible for the low success rate. Almost all of the lead-
ing scientists cloning a wide variety of animals participated, including Ian Wilmut, leader of
the team that cloned Dolly.
A special feature of the 2000 program at Banbury Center was the large number of meet-
ings on neuroscience, reflecting the increasing research effort in neuroscience at the
Laboratory. The topics ranged from the experimental ("Structure, Mechanism, and Function
of CaMKII") to the theoretical ("Natural Stimulus Statistics"). Neural Networks and Cognition
was particularly noteworthy because neural networks underlie the Palm operating system.
The meeting was funded by Jeffrey Hawkins, the developer of the Palm OS and cofounder
of Handspring, Inc., who is now a Trustee of the Laboratory. The Swartz Foundation, estab-
lished by another good friend of the Laboratory, Jerry Swartz, funded a meeting called
"Toward Animal Models of Attention and Consciousness," discussing how the brain is able
to focus selectively on items of interest in the world around us.
Robertson Research Fund
Since 1973, the Robertson Research Fund has been the primary in-house support for sci-
entists at Cold Spring Harbor Laboratory. The fund has grown from its original 1973 total of
$8 million to more than $95 million for the year 2000. This year, Robertson funds supported
cancer research in the labs of David Helfman, Michael Hengartner, Tatsuya Hirano, Ryuji
Kobayashi, Yuri Lazebnik, Greg Hannon, and Dick McCombie; neurobiology research in the
labs of Grigori Enikolopov, Roberto Malinow, Tim Tully, Jerry Yin, and Yi Zhong; and plant
research in the lab of Robert Martienssen. Robertson funds also supported several new
investigators, including Andrew Reiner, Shivinder Grewal, David Jackson, Zachary Mainen,
and Anthony Zador.
The Marie H. Robertson Memorial Fund, devoted to neuroscience, provided support to
Grigori Enikolopov and Zachary Mainen and provided funds for a neurobiology seminar pro-
gram and a Banbury Center meeting on neuroscience.
Cold Spring Harbor Laboratory Board of Trustees
Cold Spring Harbor Laboratory's Board of Trustees has led the Laboratory through another
year. At its two annual meetings, the Board members continued to help shape the vision and
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drive of this institution. This year, the Board welcomed the addition of Jacob
Goldfield, a private investor.
The Board of Trustees bid a fond farewell to two long-standing Board
members, Martha Farish Gerry and John J. Phelan. Mrs. Gerry has served
on the Board for more than 10 years, serving on the Banbury Program,
Building, DNA Learning Center, and Development Committees; she was
also Secretary of the Board from 1997 to 2000. Mr. Phelan, who led the
Board's Commercial Relations Committee since 1996, served the
Laboratory for more than 8 years and was also represented on the Board's
Audit and Executive Committees. Both Trustees were honored at the
Board's November 4 meeting for their outstanding service and unwavering
loyalty to Cold Spring Harbor Laboratory.
CSHL Association
The CSHL Association (CSHLA) held its annual meeting on February 5, 2000.
The membership honored its retiring directors, including Mary Ann Charlston
and Mary D. Lindsay (who was simultaneously named an Honorary Director).
The Association also elected several new directors, including William F. Gerry,
Lynn M. Gray, Susan Ho llo, and Allen Dulles Jebsen. George W. Cutting, Jr.,
a former president of the CSHLA and a former honorary director, was reelect-
ed and returned as an active director this year.
The annual meeting also featured a lecture by Dr. Steven Pinker,
Professor of Psychology in the Department of Brain and Cognitive Sciences
at the Massachusetts Institute of Technology. His lecture, titled "Words and
Rules: The Ingredients of Language," discussed the components and
importance of human communication.
On April 15, 2000, the Association hosted Jazz at the Lab 2000, its sec-
ond jazz benefit. The performance featured The Harold Betters Quartet, with Harold Betters
on trombone, Kevin Moore on piano, Charles Ramsey on bass, and Cecil Brooks III on
drums. Kenny Blake, a saxophonist, and Eric Johnson, a guitarist, were also featured in the
performance.
The annual major donors' cocktail party was held in the Lloyd Harbor home of Mrs. John
W.B. (Robin) Hadley. The event, held November 11, 2000, provided an elegant and enjoy-
able setting in which the Laboratory's scientists were able to personally thank the generous
individuals who help to support their work.
John J. Phelan
Martha Farish Gerry
DNA Learning Center
During the year, the DNA Learning Center (DNALC) multimedia group opened a major new
Internet site, Image Archive on the American Eugenics Movement. The site provides students,
teachers, scholars, and the interested public with an extraordinary window into a "hidden"
chapter of history and a cautionary tale for our current rush to exploit the human genome.
Through more than 1500 images and documents, most never publicly released before, the
archive traces the rise and fall of this ill-guided experiment to protect the "American germ plasm
from pollution by 'bad genes.- With the support of many prominent geneticists and public cit-
izens, eugenicists successfully lobbied for coercive social legislation to restrict European immi-
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the American Eugenics
gration, to prevent race mixing, and to sterilize "hered-
itary defectives." The Eugenics Archive makes no
attempt to lead users to a "correct" interpretation of
the materials; however, contextual narratives remind
users that the vast majority of scientific "facts" pre-
sented by eugenicists were fundamentally flawed and
have been discredited by modern research standards.
It is especially appropriate that the Laboratory should
sponsor this effort, because from 1910 to 1940, the
Eugenics Record Office at Cold Spring Harbor was an
epicenter of the American movement.
By far, the most exciting event at the DNALC was
the completion of the BioMedia Addition. Construction
began on April 18, 2000, and included the addition of
a suite of administrative offices, an additional teaching
lab, a computer lab, a lunchroom, and additional exhi-
bition space. Through the generosity of The Dolan
Family Foundation, established by CSHL Trustees
Charles and Helen Dolan, the DNALC also gained a
state-of-the-art facility for multimedia production, now
called the "multitorium." The facility includes high-tech
equipment and the latest technology, which will
enhance the DNALC's mission to educate the students of Long Island. In June, 2001, the site
will be dedicated and renamed The Dolan DNA Learning Center.
CSHL Press
The Cold Spring Harbor Laboratory Press had a very successful year. One highlight was the
eagerly anticipated December appearance of the celebrated laboratory manual Molecular
Cloning, in a new edition by Joe Sambrook and David Russell that is already a best-seller.
Eleven other new titles were published, including three manuals, a monograph on translation-
al control, the annual symposium volume, an elegant book on embryonic development, and a
compendium of classic papers in cell biology. A memorial volume for Alfred Hershey was also
released. Several of the new titles were aimed at nonspecialist readers, most notably Jim
Watson's essay collection A Passion for DNA, which was particularly popular. Altogether, 220
books are in print and are available at the attractively redesigned Web Site CSHLPress.com.
The book program's sales support was strengthened through contracts with major booksellers
and distributors in the U.S. and the creation of a European sales team centered in Oxford.
In the textbook division, four major projects were initiated and discussion of co-publish-
ing contracts initiated with three major textbook marketing firms. Particularly satisfying was
the agreement reached with Benjamin Cummings for a fifth edition of Jim Watson's classic
text Molecular Biology of the Gene.
The journal program continued to advance. Subscriptions increased, advertising sales
rose, and the measurable impact of all three journals was either maintained or strengthened.
The on-line editions were enhanced with new features such as freely accessible back issue
archives. The Protein Society's journal Protein Science, acquired from another publisher, was
redesigned both in print and on-line and relaunched under the CSH banner in December.
Major Gifts
2000 was an exciting year for fund-raising. Several major campaigns continue to be suc-
cessful: the campaign to fund the new Genome Research Center; the BioMedia Addition to
the DNA Learning Center; and a continuing campaign for the Watson School of Biological
Sciences. Results for all were astounding, and we are very fortunate to have such generous
and supportive friends at Cold Spring Harbor Laboratory.
The Genome Research Center
As the Genome Research Center in nearby Woodbury nears completion, the fund-raising
effort to support this new facility is already under way. A pledge of support was made by Mrs.
Joy Levy, wife of the late Senator Norman J. Levy, who has offered to make the Genome
Research Center the beneficiary of the efforts of the Norman J. Levy Foundation. To start the
process, Mrs. Levy has pledged $250,000; her brother and sister-in-law, Jerry and Linda
Saslow, have pledged $50,000 as well. The William & Maude Pritchard Charitable Trust has
made a gift of $280,500 to support the Genome Research Center, and Arrow Internet
Business Group and the Irving A. Hansen Memorial Foundation pledged $30,000 each.
Other major gifts were received from Mr. Lawrence Flinn, who donated $50,000; Nathan E.
Saint-Amand, M.D., who made a gift of $50,000; and the Mary G. Turner Charitable Lead
Unitrust, which made a gift of $20,000 to the project. The Seraph Foundation, Inc., also gave
a leadership gift of $100,000 to support the new facility.
Architectural rendering of the Genome Research Center.
The BioMedia Addition to the DNA Learning Center
The DNA Learning Center facility was updated and expanded this year, brought to the cut-
ting-edge of technology with a new BioMedia Addition. The campaign was anchored by a
generous donation from The Dolan Family Foundation, which made a total commitment of
$3,000,000 to finance the renovations, build the new facilities, and equip the new lab areas.
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PE Biosystems made a gift-in-kind of $130,570 to furnish the addition with equipment, and
Mr. and Mrs. Denis J. O'Kane made a generous gift of $35,000 to further fund the facility.
The New York Stock Exchange also made a gift of $10,000 to the project.
The Watson School of Biological Sciences
Cold Spring Harbor Laboratory Trustee David L. Luke III continues to lead the campaign to
fund the Watson School of Biological Sciences. This year was a particularly fruitful year for
the fund-raising effort. Bristol Myers Squibb, The Charles A. Dana Foundation, and The
Florence Gould Foundation each pledged $1,000,000 to support the Watson School. Mr.
Alan Goldberg pledged $500,000 to support the School, and Lazard Freres & Company,
LLC, and The Koshland Foundation each gave $100,000 to the campaign. Laboratory
Trustee Robert D. Lindsay and his wife pledged $500,000, and CSHLA President David H.
Deming and his wife pledged $50,000. Mr. and Mrs. Charles E. Harris made a gift of
$103,075 to the Watson School Campaign, and The Rathmann Family Foundation made a
commitment of $300,000. The Lita Annenberg Hazen Foundation, a long-time Laboratory
supporter, made a pledge of $825,000 to continue the School's educational programs. Dr.
Michael Wig ler, a CSHL professor, made a pledge of $55,000 to support the School, and
Mrs. John H. Livingston and the Fairchild Martindale Foundation each gave $50,000 to the
Campaign. Among many other donations made, significant commitments and gifts of sup-
port were made by the Alan B. Slifka Foundation; Biogen, Inc.; Mrs. Gertrude W. Conner;
Mrs. Frances Elder; Mr. and Mrs. Edward Giles; Dr. and Mrs. Walter C. Meier; Mrs. Wendy
Vander Poel Russel; and Karen and Mark J. Zoller, Ph.D. All told, nearly $7 million was raised
this year to support the Watson School, and we continue to be grateful to our many donors
and friends.
Research Support
We have received the following generous gifts in support of research in the year 2000: The
Arthur and Barbara Crocker Charitable Trust gave $200,000 to the Young Incoming Scientists
Endowment; the Goldring Family Foundation gave
$60,000 to support postdoctoral fellowships; and
Mr. and Mrs. Edmond J. Nouri gave $84,551.70 to
support the work of Dr. Tim Tully, part of a 3-year
pledge of more than $130,000.
The Arnold 0. and Mabel M. Beckman
Foundation
The Arnold 0. and Mabel M. Beckman Foundation,
a long-time Laboratory supporter, continued its
generous support in 2000. The Foundation
pledged $1,000,000 to support the students of the
Watson School of Biological Sciences, and
pledged $250,000 for Core Course support in the
School.
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James Watson standing beside a bust of
Arnold 0. Beckman, CSHL benefactor.
Members of 1 in 9: The Long Island
Breast Cancer Coalition present a gift to
Michael Wig ler to fund breast cancer
research.
Breast Cancer Support
A new decade did nothing to hamper the efforts of the numerous breast cancer groups who
support the Laboratory's cancer program.
1 in 9: The Long Island Breast Cancer Action Coalition-which celebrated 10 years of
support to the Laboratory in 2000-presented a check in the amount of $240,000, its
largest single gift in the organization's history. To date, the support from 1 in 9 has surpassed
$650,000.
Several other groups continued their support of breast cancer research, including The
Breast Cancer Research Foundation, The Huntington Breast Cancer Action Coalition, The
Long Island Foundation for the Elimination of Breast Cancer, and Breast Cancer Awareness
Day in Memory of Elizabeth McFarland. The West Islip Breast Cancer Coalition also made a
generous donation to support the work of Dr. Michael Wigler, the first time the group has
made a donation to the Laboratory.
We were also pleased to welcome the members of Long Islanders Against Breast Cancer
(L.I.A.B.C.). The group announced with its formation that it would raise funds to benefit Cold
Spring Harbor Laboratory, and its 2000 gifts-since its October formation-already total
more than S65,000.
President's Council
This year's President's Council meeting was on "The Dog and Its Genetics: Breeds, Evolution
& Behavior," an unbeatable combination of cutting-edge genetic research and humanity's
closest friend. An eminent roster of speakers began with Roger Caras, internationally known
for his encyclopedic knowledge of dogs and as Master of Ceremonies at the annual
Westminster Club Show. Mr. Caras talked on the special relationship between human beings
and animals. Elaine Ostrander (University of Washington) and Greg Acland (Cornell
University) then described the dog genome project, and how the dog is afflicted by genetic
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disorders that may have a genetic basis identical to disorders of human beings. But perhaps
the most fascinating feature of dogs is their behavior. Raymond Coppinger (Hampshire
College) has specialized in studies of the behavior of working dogs, and he described the
differing characteristics of the sheepdogs that guard flocks and those that herd flocks. All-
in-all, the speakers introduced us to a wonderful blend of science and our everyday experi-
ences of the animal that has been associated with human beings for at least 14,000 years.
Gavin Borden Visiting Fellow
Douglas A. Melton, Ph.D., of the Howard Hughes Medical
Institute and the Department of Molecular and Cellular Biology
at Harvard University was the Laboratory's sixth Gavin Borden
Visiting Fellow. Dr. Melton's lecture, titled "Construction of the
Pancreas," was held on October 2 in Grace Auditorium. The
Lecture series was named in memory of Gavin Borden, a sci-
ence writer whose work on Molecular Biology of the Cell and
several other books made a lasting impression on the
Laboratory.
Building Projects Douglas A. Melton, Ph.D.
The historic landscape of Cold Spring Harbor Laboratory changed again this year, with the
completion of three new building projects. On May 3, the Laboratory dedicated the Samuel
Freeman Building, located adjacent to Urey Cottage. The Freeman Building-part of the
Laboratory's neuroscience program-is a state-of-the-art facility for neuroscientists who use
computer technologies to aid in the study of the brain. The building was made possible
through a generous gift from the Samuel Freeman Charitable Trust, led by CSHL Trustee Bill
Samuel Freeman Building dedication.
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Townsend J. Knight (second from right) joins his family at the building that bears his name.
Murray. The building, designed by Jim Childress of Centerbrook architects, is an Adirondack-
style structure, accented by dark wood siding and a gabled roof of copper-foil-coated shin-
gles. The Freeman Building-which will house three faculty in the field of computational neu-
roscience-is reminiscent of the cabins that formerly occupied the site.
On June 10, the Laboratory dedicated the newly renovated Knight House, across Cold
Spring Harbor from CSHL's main campus. The 190-year-old structure was an original home
of the Jones Family, the Laboratory's earliest benefactors. Named for CSHL Honorary
Trustee Townsend J. Knight-a descendant of the Jones family-the historic, two-story
white structure is a beacon of the Cold Spring Harbor shoreline. Following extensive reno-
vations, the Knight House is now being used as a residence for students of the Watson
School of Biological Sciences. The interior contains six bedrooms, a living area, television
room, kitchen, and laundry facilities.
Renovations continue on the Genome Research Center in nearby Woodbury. The build-
ing, now near completion, is a 72,000-square-foot facility that houses four research com-
ponents: a Bioinformatics Center, a Cancer Research Center, a Genome Sequencing Center,
and a Plant Genomics Center, as well as new space for the CSHL Press, and other admin-
istrative departments. A campaign is under way to fully fund the complex. Its first tenants-
CSHL's Purchasing Department and the CSHL Press-are expected to occupy the building
in Spring 2001.
Undergraduate Research Program
The 2000 summer Undergraduate Research Program (URP) consisted of 27 students-14
men and 13 women-from 8 countries. They were chosen from among 546 applicants from
more than 59 nations.
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The objective of the program is to provide a greater understanding of the principles of
biology. It instills in the students an awareness of major topics of investigation, helps devel-
op intellectual tools necessary for modern research, exposes students to the process of
research, and allows them to meet the top scientists who visit CSHL.
The program received financial support in 2000 from the C. Bliss Memorial Fund, the
Burroughs Wellcome Fund, Robert Cummings, Dr. Ira Herskowitz, the Jephson Educational
Trust, the JM Foundation, the National Science Foundation, and the URP Endowment Fund
(composed of the Emanual Ax Fund, the Garfield Fund, the Glass Fund, the Libby Fund, the
Olney Fund, the Read Fund, the Shakespeare Fund, and the Von Stade Fund).
Partners for the Future
The CSHL Partners for the Future program was established in 1990 to give young students
a taste of the real world of biomedical research. Each year, six or eight Long Island high
school students entering their senior year are chosen from a large pool of nominees to par-
ticipate in the program. The selected students spend a minimum of 10 hours per week,
October through March, doing original research under the guidance of a Cold Spring
Harbor Laboratory scientist. At the conclusion of the program, students present their
research project to an audience of scientific mentors, high school teachers, friends, and rel-
atives.
The program, now in its 11th year, is an overwhelming success. To date, 53 students
have completed the program, and all of them are now or have been enrolled in top-ranked
colleges and universities.
Back row: Maria Reimels, Brian
Mohr, Daniel Mc Alvin, Owen Martin
Front row: Eric Van Nostrand,
Jacqueline Rho, Deborah Yom,
Allison Brincat
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Community Outreach
Grateful for the overwhelming support that CSHL receives, a number of employees set out
this year to "give back" to the Long Island community.
CSHL "road-runners" were on-hand at the Cigna 5K Walk/Run, to support 1 in 9: The Long Island
Breast Cancer Action Coalition, held at Eisenhower Park in East Meadow on August 24. The CSHL
group is grateful for more than 10 years of support from 1 in 9. Lynn Cannon, Administrative
Assistant in the Development Office, came in third for her age group in the run. In all, the event
raised more than $100,000.
Members of the W. Richard McCombie lab made a generous contribution to the North Shore
Pediatric Oncology Unit to purchase holiday gifts for the patients. In their certificate of appreciation,
administrators at North Shore noted how the gifts really touched the children.
Special Events
Neuroscience Lecture Series
This year, the Laboratory continued a series of public education lectures by hosting its first
Neuroscience Lecture Series. The three public lectures attracted more than 900 visitors to
Grace Auditorium. The first lecture was given by Dr. Michael Merzenich on November 14,
titled "Training Strategies for Brain Illnesses and Disabilities in Children." Dr. Merzenich is the
Francis A. Sooy Professor of Otolaryngology at the Keck Center for Integrative
Neurosciences at the University of California, San Francisco. The second lecture, held
November 21, was given by Dr. Charles F. Stevens, a professor from The Salk Institute for
Biological Sciences. Dr. Stevens' lecture was titled "Synapses: The Neural Information
Highway." The final lecture in the series was given by Dr. Larry Squire, Professor of
Psychiatry and Neurosciences at the University of California School of Medicine in San
Diego. Dr. Squire's lecture, held November 28, was titled "Memory Systems of the Brain."
Dr. Michael Merzenich
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Other Lectures
Cold Spring Harbor Laboratory continued to host the Huntington Hospital Lecture Series,
which ran from February to June. This year's topic was "Keeping Your Heart Healthy," part
of Huntington Hospital's Heart Health Lecture program.
On June 26, the Laboratory welcomed Viviana Risca, the 2000 winner of the Intel
Science Talent Search, and Laura F. Landweber, an assistant professor at Princeton
University, for a special public lecture on "DNA Games: From Computing to Espionage."
The event attracted a large group of teens and adults interested in DNA and the human
genome.
On October 28, Phillip Valentine Tobias, Professor Emeritus at the University of the
Witwatersrand in Johannesburg, presented a special public lecture titled "Humanity's
Cradle: 75 Years of Evolutionary Studies in Africa." As part of a special Halloween program,
"Bones and Strings," Dr. Tobias lectured on his research of the human biology of the peo-
ples of Southern Africa. A special public concert by famed violinist Viviane Hagner followed
the lecture.
Concerts
As part of the Laboratory's Millennium Cultural Series, several concerts were held this year.
Attended by the participants of CSHL's Meetings program and the public, the free concert
series was a huge success. The concerts included:
May 6
May 20
May 27
August 19
August 26
September 9
September 16
October 28
November 11
Karen Gomyo, violinist
Adam Neiman, pianist; Stefan Malenkovich, violinist;
Ani Aznavoorian, cellist
Margarita Shevchenko, pianist
Julia and Irina Elkina, duo piano
Randall Scarlata, baritone and accompanist
Makoto Nakura, marimbist
Eric Johnson, jazz guitarist, with band
Viviane Hagner, violinist
Mark Ptashne (CSHL Board of Trustee Member), violinist
Millennium Cultural Series
In addition to the concert series, the Millennium Cultural Series brought several art events to
the Laboratory for the year. Dale Chihuly, famed glass sculptor, presented a lecture on May 2
titled "Chihuly on Chihuly: The Jerusalem Project." The lecture, cohosted by the Hecksher
Museum of Art, examined the sculptor's year of work in Israel. The Laboratory's second out-
door art show, Sculpture by the Sea, ran from May 28 through October 31 and featured 17
original works. On August 31, sculptor Charles Jencks unveiled his sculpture Spirals Time-
Time Spirals and lectured on his work, particularly how the structure of DNA had inspired this
latest piece. On November 4, the Laboratory hosted Labscapes 2000, a painting show which
featured 25 pieces depicting the beautiful grounds and historic buildings of the Laboratory's
property. Many of the exhibits were possible due to the generosity of Jim and Liz Watson.
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Stefan Malenkovich, violinist; Ani Aznavoorian, cellist; Adam Neiman, pianist
Sculpture by the Sea
Viviane Hagner
Margarita Shevchenko
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Laboratory Employees
Long-term Service
First Row (top): Bruce Stillman, James Watson,
Harry Wozniak, Frank Carberry
Second Row: Michael Riggs, G. Morgan Browne,
Madeline Wisnowksi, David Spector
Third Row: Steven Tang, Linda Rodgers, Marlene
Rubino, Patricia Hinton-Stenko
Fourth Row: Andrea Stephenson, Lisa Manche,
Bruce Fahlbusch
On June 29th, employees celebrating milestone anniversaries with the Laboratory were hon-
ored at a special poolside dinner at Robertson House, on the Banbury Center property.
Congratulations to all! Honorees included:
30 Years Madeline Wisnewski
20 Years Bruce Fahlbusch, Michael Riggs, Linda Rodgers, Marlene Rubino and
Andrea Stephenson
15 Years G. Morgan Browne, Frank Carberry, Patricia Hinton-Stenko,
Lisa Manche, David Spector, Wanda Stolen, Steven Tang and
Harry Wozniak
Awards and Honors
I was honored to be elected to the National Academy of Sciences (NAS) in May, 2000.
Membership in the Academy is one of the highest honors a scientist can receive from an
American organization.
Changes in Administrative Staff
Annette Gangitano joined us this year as the Executive Director of the Cold Spring Harbor
Laboratory Association. Annette came to the Laboratory from a position with the firm of J&W
Seligman.
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Jeff Picarello joined us as the Director of Public Affairs. Jeff formerly worked at the C.W.
Post Campus of Long Island University, where he was Director of Media Affairs.
Charles Prizzi joined the Laboratory staff as Director of Special Events. Charlie was for-
merly Director of Special Events for Long Island University.
New Faculty and Staff
Z. Josh Huang joined the Laboratory this year as an assistant professor and Bhubaneswar
Mishra, as an adjunct professor. Other new hires included Gilbert (Lee) Henry and Terence
Strick, who joined the Laboratory as Cold Spring Harbor Laboratory Fellows.
Promotions
Scott Lowe was promoted to professor and deputy director of the CSHL Cancer Center.
Greg Hannon, Lincoln Stein, Karel Svoboda, Rui-Ming Xu, and Jerry Yin were each appoint-
ed associate professor, and Robert Lucito and Vivek Mittal were promoted to assistant pro-
fessors.
Departures
After many years of association with Cold Spring Harbor Laboratory, David Beach, an
adjunct professor, left the Laboratory to focus on his role as president of Genetica. Bruce
Futcher, an associate professor, left Cold Spring Harbor for a position at the State University
of New York at Stony Brook.
Visiting Scientists
Five visiting scientists joined us this year: Vincent Co lot will spend his sabbatical year in the
lab of Robert Martienssen; Anna Giulini joined the lab of David Jackson; Edith Heard will
spend her sabbatical year in the lab of David Spector; Jacqueline Vitali joined the lab of Rui-
Ming Xu; and Ying-hua Zhu joined the lab of Yi Zhong. Five scientists also wrapped up their
stays at Cold Spring Harbor Laboratory: Christine Berthier, Daniel Bogenhagen, Hilde
Grasmo-Wendler, Nathalie Paw, and Fumio Shiobara.
Postdoctoral Departures
The following postdoctoral researchers left Cold Spring Harbor Laboratory in 2000:
Guy Birkenmeier Daniel Hoeppner
James Chong Jianzhong Jiang
James Dezazzo Keiji Kimura
Nicholas Edgington Zhixin Lin
Ludwig Englemeier Hong Liu
Francisco Ferrezuelo Tohru Mizushima
Andrew Groover Michael Murray
Mariko Hayashi Jairaj Puthenveettil
Yasunori Hayashi Keiichi Shibahara
Javor Stolarov
Suzanne Tharin
Venugopal Valmeekam
Daniel Vaughn
Michael Weinreich
Herman Wijnen
Jianlong Zhou
Jian Zhu
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Graduate Student Departures
The following graduate students left Cold Spring Harbor Laboratory in 2000:
Eric Gillitzer
Tina Gumienny
Susan Harrington
Shirty Pinto
Julia Polyakova
Alex Rai
Bjorn Schumacher
Setareh Sepehri
Concluding Remarks
Beth Trumbull
Helena (Xiaohong) Yang
Lee Zou
Constant change has been the theme at Cold Spring Harbor for much of its history, and this
past year has been no exception. This dynamism, coupled with results emerging from the
various genome projects, has opened new doors and revealed tremendous opportunities for
biology and biomedicine, possibilities that were unheard of when I first came to Cold Spring
Harbor Laboratory 21 years ago. It is time once again for this institution to rise to the chal-
lenges before us, enjoying, but not resting on, our significant past achievements.
Cold Spring Harbor Laboratory is a unique research and educational institution, more like
an advanced research university now than ever before. More than many other universities,
we have the flexibility to rapidly adapt to the fast pace of modern science. However, to
remain at the leading edge of research in areas such as cancer and neuroscience, we will
require major new infrastructure, significant new funding, dedication, and much energy from
our already efficient and busy staff. This institution has never shied away from a challenge,
and I am confident that with the right help, we will go on to an even brighter future.
April 2001 Bruce Stillman
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ADMINISTRATION
The year 2000 marked the continuation of a period of transition for our Administration
Departments. In recent years, the Laboratory has grown very rapidly; virtually all of our
research and education programs have expanded and added new activities. We have a new
Genome Research Center on an 11-acre campus in Woodbury. The DNA Learning Center
has doubled in size with a new BioMedia Addition in the Village of Cold Spring Harbor.
Already, the Watson School is recruiting its third class of graduate students, and the first
publication will appear later this year from the new textbook division of the Cold Spring
Harbor Laboratory Press. The first building of the new Broad Hollow Bioscience Park in
Farmingdale is open and filled to capacity, and a second building is already in the planning
stage. The Laboratory has, in fact, been transformed into a very diverse small university of
advanced research. There are many new staff, new buildings, and new locations for which
the Administration is responsible, and so our institution has become a larger and more com-
plex place to manage.
Traditionally, the Administration at Cold Spring Harbor Laboratory has functioned as a
very lean and close-knit group of departments with very short lines of communication.
Decisions are made quickly, and requisitions, for example, for new equipment or facility ren-
ovations, are processed in hours or at most a few days. Overhead costs have been kept low,
especially when compared with those of larger institutions. Now, the challenge for
Administration is to maintain these traditions while fully keeping pace with the expanding
needs of our institution.
One year ago, we initiated an important first step in the transition with the selection,
installation, and start-up of new Laboratory-wide business-computing software, which
replaced previous technology of many years' vintage. The new software is modern and ver-
satile, with all the growth potential and back-up support that one could wish. During 2000,
the administrative departments learned to use its basic features and gained appreciation for
the power and flexibility of its more advanced modules, such as electronic order processing
and purchasing, to be brought on-line during 2001.
During the year, we added cautiously to administrative staff and created a small amount
of additional office space. A space shortage remains a difficult and continuing problem at the
Laboratory. The Grants Department, bursting at the seams, was given an office that became
available in Wawepex. It was decided to move the Purchasing Department to the new
Woodbury Campus this summer, freeing the top floor of the Nichols Building. A beginning
was made on the long-delayed project to fully renovate Nichols and to create there a badly
needed conference room for Administration and for the Tech Transfer Department. Progress
was made in rationalizing pay scales in the Facilities Department and in other areas where
we have not been fully competitive with other Long Island businesses.
Perhaps most important, the Board of Trustees approved my recommendation for the
planned succession in administrative leadership outlined in last year's Annual Report. Dill
Ayres, at the Laboratory since 1998 as Associate Administrative Director, was appointed to
lead the Administration with the new title of Chief Operating Officer. We have great confi-
dence in Dill and are pleased to have such talented and younger leadership in this important
position. For the next year or so, I will continue at the Laboratory in the role of Chief Financial
Officer and be available to help with other matters as needed.
100,000,000
90,000,000
80,000,000
70,000,000
60,000,000
50,000,000 -
40,000,000 -
30,000,000
20,000,000
10,000,000
30
"` Consists of Full-time and Part-time Technical Support, Core Services, Publications,
Meetings, Library, Public Affairs, Building and Grounds, Administrative, Personnel,
Banbury Center, and DNA Learning Center
BOO
700
600
500
1 400
300
200
100
OPERATING EXPENSE
I
STAFF
I Scientists
=Support.
-M-Total
I ir
0 Actual Expense
Expense Adjusted for Inflation
81 82 83 64 BS B6 87 88 89 90 91 92 93 94 95 96 97 98 99 00
Years
8000
7000
6000 -
5000
4000
3000
2000
1000
92 93 94 95 96 97 98 99 00
Years
MEETINGS & COURSE PARTICIPANTS
81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00
Years
Meanwhile, we are pleased to report that 2000 was another good year financially for the
Laboratory. A strong financial position was maintained, backed up by a budget that was balanced,
after allowing for depreciation, for the twelfth consecutive year. Revenues increased to a new high
level of just over $66 million. There was an operating excess of $297,000 that will be added to our
reserves for start-up expenses at the Genome Research Center and for other future research pro-
grams. Overall, the financial results were more than $850,000 better than the original budget for
the year. There was positive cash flow from operations of approximately $4.3 million, which as in
past years was available to fund capital expenditures, for renewal of capital plant and for the pur-
chase of ever more expensive scientific equipment. The success of our scientists in obtaining fed-
eral and other grants was again key to the good results for the year. Other positives were the con-
tinued good attendance at the Meetings and Courses Program, a surplus at the DNA Learning
Center despite the dislocations resulting from the BioMedia Addition expansion, and good years
for Banbury Center and the CSHL Press, which published the eagerly awaited third edition of its
all-time best-selling manual, Molecular Cloning. The Watson School, completing its second year
and benefiting from its growing endowment, succeeded in balancing its revenues and expenses.
It was also not a bad year, relatively speaking, for the Laboratory's permanent endowment,
which collectively consists of the Robertson and Cold Spring Harbor Funds. After a string of years
of extraordinary gains, the overall equity markets were down in 2000. It was a very difficult year for
many investment managers. Nevertheless, at December 31, 2000, the Laboratory's endowment
totaled $227 million, an increase of $7 million from the previous year-end. It should be noted that
the Laboratory has $45 million of tax-exempt bonds outstanding, issued by the Nassau and Suffolk
County Industrial Development Agencies, which mature in the amounts of $3 million in 2023 and
$42 million in 2034. Throughout the year, the endowment was invested in a balanced mix of equi-
ty, long-term and short-term fixed income securities, and a small commitment to alternative invest-
ments. The asset allocation was approximately 55%/45% equity/fixed income during most of the
year. Total return was a positive 2.9% as compared to (1.1%) for an index of comparable alloca-
tion. Our value and large cap equity managers, U.S. Trust Company and Vanguard PRIMECAP
Fund, returned 9.2% and 5.1%, respectively, while small cap growth-oriented Essex Investment
Management had a down year. Fixed-income manager Miller Anderson & Sherrerd returned a
strong 11.3%. The Laboratory's policy on draw-down from the endowment is a conservative 4%
per annum based on a 3-year moving average of year-end market values. This policy has been
maintained over a number of years and has served well in supporting our research and education
programs while permitting the endowment to increase handsomely.
Worthy of mention again is the Science Fund that was established by our Board of Trustees in
1992 as a permanent component of the endowment, designated specifically for the support of sci-
ence at the Laboratory. Since 1992, all equity and a major portion of royalties from technology
transfer activities have been accumulated in the Science Fund, allowing Cold Spring Harbor
Laboratory to lead the way toward assuring that financial gains from research funded by public and
other grants are recycled back into more science. It has also been our expectation that this Fund
would help to replace substantial funding received in recent years from an important patent used
extensively by the biotech industry that expired last June 30. At year-end, the Science Fund had a
market value in excess of $30 million, and in 2001, it will provide $1.2 million in support of our sci-
ence program.
In September, a landmark ceremony was held to celebrate the opening of the new Broad
Hollow Bioscience Park located on a 20-acre site at the State University of New York at
Farmingdale, just 20 minutes from the main Laboratory campus. The concept for the Park had
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come from the realization that a number of fledgling new bioscience companies-spawned from
Lab technology-were locating away from Long Island because of the lack of appropriate facilities
and an academic/bioscience cluster locally. The Park's impressive 50,000-square-foot first build-
ing was fully funded by the State of New York. Many of those whose vision and leadership made
the Park possible attended or spoke at the ceremony. These included New York State Senators
Kemp Hannon and Carl Fuschillo, SUNY Farmingdale Acting President Michael Vinciguerra, and
Long Island businessman Horst Saalbach. In particular, the Laboratory owes a debt of gratitude
to Honorary Trustee John Cleary, who shepherded the creation of the Park through the vagaries
of State government and who has served as Chairman of the Board of Broad Hollow since its
incorporation in 1998. Many from the Laboratory were also present, including Jim Watson, Bruce
Stillman, and all of the members of our Tech Transfer Department: Director John Maroney, Carol
Dempster, and Barry Braunstein. We had all been confident of the eventual success of the Park,
but none of us could have expected that all of its space would be taken and an expansion planned
even before the opening ceremony. Currently, there are active discussions under way with the
State concerning the urgent need for a second building.
This is my final report as Administrative Director. It has been a great privilege for the past 15
years to be associated with an extraordinary group of individuals who lead and staff our adminis-
trative departments. The Laboratory's reputation and success belong to them as well as to our sci-
entists, and they should take great pride in their accomplishments.
G. Morgan Browne
April, 2001 Administrative Director
It is with a good deal of anticipation and excitement, together with a healthy degree of trepidation,
that I begin my leadership of the Laboratory's administration and operations. To have a hand in the
management of an institution of this caliber, as well as to work in partnership with the likes of Bruce
Stillman, Jim Watson, Morgan Browne, and all of the other wonderful professionals here, is an
extraordinary opportunity. The challenges are many and daunting. We are in the midst of a sub-
stantial expansion of our facilities and our employee base. Management is in the process of plan-
ning the long-term future of our research and academic programs. The implications of this plan for
our physical infrastructure, administration, and fund-raising are profound.
I have large shoes to fill. Morgan Browne has done an exemplary job as Administrative Director
for the last 15 years. He has overseen growth in our employee population of 320 in 1984 to the
current count of 825. He has instilled a sense of financial discipline without compromising impor-
tant expansion. Our Trustees have come to expect operating surpluses, which Morgan has deliv-
ered for 12 consecutive years. This is not an insignificant accomplishment. The Laboratory tends
to attract perfectionists, whether at the senior faculty level or in the Facilities Department, who
demand the best in equipment and resources in order to satisfy their very high standards.
Balancing institutional excellence, across all fronts, with fiscal discipline is one of the formidable
challenges of this office.
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Part of my responsibility is to anticipate problems without being negative. 2001 will be a more
challenging year, from a budgetary perspective, than we have recently experienced.The costs asso-
ciated with bringing the Genome Research Center on-line, in combination with the expiration of cer-
tain patent-related income, will make it difficult to achieve a balanced budget this year. The equity
markets are in disarray, putting pressure on the value of our endowment funds and creating a more
difficult environment for fund-raising should current market conditions persist.
Nevertheless, there is much reason for optimism. The Laboratory continues to excel with its
research and academic programs and continues to attract scientific and staff personnel of the very
highest quality. I take great comfort in the fact that Morgan has agreed to serve as Chief Financial
Officer. His experience and judgment are invaluable to me. Other recent appointments of note are the
promotion of Assistant Comptroller Lari Russo to Comptroller; Jeff Picarello from Long Island
University to Director of Public Affairs; and Charlie Prizzi, also from LIU, to Director of Special Events.
Bill Keen, our veteran Comptroller, has taken on an important new assignment as Finance Director of
the Cold Spring Harbor Laboratory Press in addition to acting as Assistant to the Chief Financial
Officer. We are also most fortunate to be able to attract prominent and influential Trustees. While we
will miss the services of Martha Gerry and John Phelan, I look forward to working with Doug Morris,
Jeff Hawkins, and David Deming-all leaders in their respective industries.
Several months ago I was discussing, with Jim Watson, Time Magazine's selection of Albert
Einstein as their "Man of the Century." Jim agreed with the choice, saying that the 20th would be
thought of as the century of physics but that the 21st would, undoubtedly, be the century of biology.
Cold Spring Harbor Laboratory is a place where the best and brightest minds in biology come to
work, study, teach, share information, and solve problems critical to mankind. The overriding goal of
the Administrative staff is to facilitate this work by creating and maintaining an environment that is
conducive to these ends. We undertake this responsibility with great pride, dedication, and serious-
ness of purpose.
W. Dil laway Ayres, Jr.
April, 2001 Chief Operating Officer
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TUMOR VIRUSES
The investigators in the Tumor Viruses Section are unified by the shared use of viruses to probe cell
function and to understand cell transformation. The viruses used include adenovirus, human and
bovine papillomaviruses, simian virus 40, herpes simplex virus, and human and simian immunodefi-
ciency viruses.
Arne Stenlund and Bruce Stillman use papillomavirus and SV40, respectively, to study DNA repli-
cation. The Stillman laboratory also studies cellular DNA replication in human and yeast cells, and
how DNA replication is linked to the establishment of inherited states of gene expression.
Winship Herr and Adrian Krainer study the control of gene expression, particularly the control of
gene transcription and pre-mRNA splicing.
William Tansey studies control of gene expression via modulation of transcription factor stability by
regulated proteolysis, using the Myc oncoprotein as a model.
Yuri Lazebnik and Scott Lowe focus their research on the cellular defenses against cancer includ-
ing programmed cell death or apoptosis and senescence.
Jacek Skowronski studies how the human and simian immunodeficiency viruses disrupt signal
transduction and the expression of cell surface receptors in infected T cells.
See previous page for photos of the following scientific staff.
Row 1: Mile McCurrach; Masashi Narita; Julie Thomas; Dmitri Chklovskii; Rebecca Ewald, Mirjana
Maletic-Savatic
Row 2: Kurt Haas; Terence Strick; Anitra Auster; Said Ahmad Zia; Joseph West
Row 3: Vivek Mittal; Kimberly La Vine; Marja Timmermans; Linda Van Aelst, Ming Ming Zhao
Row 4: Barbara Mish; Michelle Cilia; Tzu-Ching Meng; David Jackson
Row 5: Ira Hall, Zachary Lippman; Robert Lucito, Pablo Rabinowicz; Kenneth Seidenman, Songhai Shi
Row 6: Lidia Nascimento; Lidia Serina; Ahmet Den li; Vane Vil
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TRANSCRIPTIONAL REGULATION
W. Herr D. Aufiero P. Reilly
A. Bubulya T. Tubon
E. Julien J. Wysocka
S. Lee X. Zhao
We are interested in the mechanisms of transcription-
al regulation in human cells. We use the human herpes
simplex virus (HSV) as a probe to uncover these
mechanisms and to study virushost cell interactions.
Viruses provide simple regulatory networks in which
the cellular transcriptional machinery is altered to
achieve the goals of virus infection. In a cell infected
by HSV, the virus can grow lytically or remain latent
for many years.
In the lytic cycle, HSV gene expression is initiated
by a viral transcription factor called VP16, which is
carried in the infecting virion. Before activating tran-
scription, VP16 forms a multiprotein-DNA complex-
the VP16-induced complex-on viral immediate-early
promoters with two cellular proteins: HCF-1, a protein
that regulates cell proliferation, and Oct-1, a POU-
homeodomain transcription factor. Once the VP16-
induced complex is assembled, VP16 initiates viral
gene transcription through a potent transcriptional
activation domain.
Our research continues to focus on three princi-
pal issues: (1) How do transcriptional regulators acti-
vate the basal transcriptional machinery? (2) How do
transcription factors, as in the VP16-induced com-
plex, modify their transcriptional activity through
selective protein-protein and protein-DNA interac-
tions? (3) What are the natural cellular roles of HCF-
1 and Oct-1, and how do they influence HSV infec-
tion?
Transcriptional
Activation
I Tubon, X. Zhao
Our current studies on how transcriptional regulators
activate the basal transcriptional machinery focus on
the activities of two basal transcription factors, the
TATA-box-binding protein TBP and TFIIB. TBP is
interesting because it is involved in transcription by all
three eukaryotic RNA polymerases: pol I, pol II, and
pol III. We study the activity of TBP in transcription
by both po1 II and po1 III from promoters containing
and lacking TATA boxes by using four types of pro-
moters: (1) promoters that direct the synthesis of
mRNAs by pol II and contain a TATA box core pro-
moter element (e.g., adenovirus major late and c-fos
promoters); (2) promoters that direct the synthesis of
small nuclear RNAs (snRNAs) by pol II and lack a
TATA box (e.g., Ul and U2 snRNA gene promoters);
(3) a promoter that directs the synthesis of an snRNA
by pol III and contains a TATA box (i.e., U6 snRNA
gene promoter); and (4) a TATA-less pol III promoter
(e.g., the adenovirus VAI promoter).
We are currently studying the activity of TBP in
these varying promoter contexts to understand how it
can support transcriptional activation in such varying
promoter contexts. Unlike TBP, TFIIB is only known
to be involved in transcription by pol II, but it is inter-
esting because it has a central role in the transcription
initiation process by associating with the TATA-box-
bound TBP molecule at the core promoter and inter-
acting with pol II. As with TBP, we are studying the
different activities of TFIIB in various promoter con-
texts for both mRNA-type and snRNA-type pol II
transcription.
VP16-induced
Complex
D. Aufiero, R. Babb, A. Bubulya
We study how transcription factors modify their tran-
scriptional activity through selective protein-protein
and protein-DNA interaction, by studying the struc-
ture and function of the VP16-induced complex. On
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its own, VP16 displays little if any sequence-specific
DNA-binding activity: It is only through association
with Oct-1 and HCF-1 that it can bind DNA well and
specifically. Thus, whether VP16 binds DNA directly
in the VP16-induced complex has been controversial.
Last year, we described the three-dimensional crystal
structure of the core region of VP16 that is sufficient
for VP16-induced complex assembly. The results
revealed a novel, concave seat-like protein structure.
We have now shown that, within the VP16-induced
complex, the VP16 core has an important role in
DNA binding. Mutation of basic residues on the sur-
face of the VP16 core reveals a novel DNA-binding
surface involving a conserved region of the concave
seat-like surface. These results illuminate how,
through association with DNA, VP16 is able to inter-
pret cis-regulatory signals in the DNA to direct
assembly of a multiprotein-DNA transcriptional regu-
latory complex.
Cellular Functions of HCF-1
and Oct-1
A. Bubulya, E. Julien, S. Lee, P. Reilly,
J. Wysocka
HSV must maintain an intimate relationship with the
host cell to remain latent for many years and yet retain
the ability to grow lytically. Because VP16 associates
with the cellular proteins HCF-1 and Oct-1 to initiate
HSV gene expression during lytic infection, we
hypothesize that HCF-1 and Oct-1 are key regulators
of which mode of infection-latent or lytic-HSV
enters. We are therefore interested in the natural cellu-
lar roles of HCF-1 and Oct-1, and how these roles may
influence HSV infection. We focus primarily on the
cellular functions of HCF-1 because HCF-1 has been
highly conserved during evolution and is involved in
cell proliferation.
Human HCF-1 is synthesized as a large approxi-
mately 2000-amino-acid precursor protein, which is
proteolytically cleaved to generate a family of associ-
ated amino (HCF -1N)- terminal and carboxy (HCF -1c)-
terminal polypeptides. The majority of HCF-1 in the
cell is a complex of associated HCF-1N and HCF -lc
subunits. In collaboration with K. Johnson and A.
Wilson (New York University), we have characterized
the structure and function of sequences required for
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HCF-1N- and HCF-1,-subunit association. HCF-1
contains two matched pairs of self-association
sequences called SAS1 and SAS2. One of these
matched association sequences-SAS1-consists of a
short 43-amino-acid region of the HCF-1N subunit,
which associates with a carboxy-terminal region of the
HCF-1, subunit that is composed of a tandem pair of
fibronectin type-3 repeats, a structural motif known to
promote protein-protein interactions. Unexpectedly, a
related protein called HCF-2, which is not prote-
olyzed, also contains a functional SAS1 association
element, suggesting that this element does not func-
tion solely to maintain HCF-1N- and HCF-1, -subunit
association.
We have also continued our studies of a functional
homolog of HCF in the worm Caenorhabditis elegans
(called CeHCF). We have now demonstrated develop-
mental regulation of CeHCF phosphorylation: A
hyperphosphorylated form of CeHCF is present in
embryos, whereas a hypophosphorylated form is pre-
sent in L1 larvae. The phosphorylation patterns of
FIGURE 1 Hypothetical structure of HCF-1 bound to chro-
matin. In this model, HCF-1 is targeted to the DNA (black box)
in chromatin by its VP16-interaction domain (VID) through pro-
tein-protein interaction with a DNA-binding protein or protein
complex. Other regions of HCF-1, basic (+), acidic (-), and the
HCF-1N and HCF-1c SAS1 association regions, are shown.
Hypothetical effectors of HCF-1, proteins X and Y, are also
shown.
endogenous CeHCF in worms and ectopically synthe-
sized CeHCF in mammalian cells are remarkably sim-
ilar, suggesting that the way CeHCF can be recog-
nized by kinases is conserved in animals.
Phosphorylation site mapping of endogenous CeHCF,
however, revealed that phosphorylation occurs at four
clustered sites in the region of the protein that is not
highly conserved among HCF proteins and is not
required for VP16-induced complex formation.
Indeed, phosphorylation of either CeHCF or human
HCF-1 appears dispensable for association with
VP16. All four CeHCF phosphorylation sites match
the consensus recognition site for the cell-cycle kinas-
es CDC2 and CDK2. Consistent with this similarity
and with the developmental phosphorylation of
CeHCF in C. elegans embryos, CeHCF phosphoryla-
tion is cell-cycle-regulated in mammalian cells.
Finally, during the past year, we have discovered
that HCF-1 is an abundant cellular protein that is nat-
urally tethered to chromatin in uninfected cells
through its amino-terminal 380-amino-acid VP16-
interaction domain as illustrated in Figure 1. A single
proline-to-serine substitution in the HCF-1 VP16-
interaction domain, which is known to cause a tem-
perature-induced cell proliferation arrest in hamster
tsBN67 cells and prevent transcriptional activation by
VP16, interferes with HCF-1 association with chro-
matin: At permissive temperature, HCF-1 is chro-
matin-bound in tsBN67 cells, but it dissociates from
chromatin before tsBN67 cells stop proliferating at
nonpermissive temperature, suggesting that loss of
HCF-1 chromatin association is the primary cause of
the temperature-induced tsBN67 cell proliferation
arrest. We propose that, as during HSV infection, the
role of HCF-1 in cell proliferation is to regulate gene
transcription, in this instance, by associating with a
multiplicity of DNA-bound transcription factors
through its VP16-interaction domain.
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RNA SPLICING
A.R. Krainer M. Aaron L. Manche S. Shaw
L. Cartegni M. Murray Q.-S. Zhang
M. Hastings X. Roca J. Zhu
MECHANISMS OF CONSTITUTIVE AND ALTERNATIVE
PRE -MRNA SPLICING
RNA splicing is an essential step for the expression of
most eukaryotic protein-coding genes. The selection
and pairing of authentic splice sites within the spliceo-
some occur with a very high degree of fidelity, requir-
ing precise interpretation of limited and dispersed
sequence information present throughout introns and
exons. The expression of many cellular and viral genes
occurs via alternative splicing, which involves substan-
tial flexibility in the choice of splice sites, allowing the
expression of multiple protein isoforms from individ-
ual genes. The choice of alternative splice sites is com-
monly regulated to alter gene expression, either tissue-
specifically or in response to a developmental program
or to extracellular signals. The fact that multiple pro-
tein isoforms can be expressed from individual genes
demonstrates that the classical "one gene-one
enzyme" paradigm is no longer valid, and provides an
explanation for the unexpectedly small number of
genes uncovered by genome-sequencing projects.
Both constitutive and alternative splicing mecha-
nisms involve multiple protein components, as well as
RNA components that are part of small nuclear
ribonucleoprotein (snRNP) particles. Our lab has
focused on the identification, purification, and molec-
ular characterization of protein factors that are neces-
sary for the catalysis and fidelity of splicing and/or for
the regulation of alternative splice site selection.
RS DOMAIN STRUCTURE AND FUNCTION
SR proteins are a conserved family of protein splicing
factors, which consist of one or two RNA-recognition
motifs and a characteristic arginine/serine-rich car-
boxy-terminal RS domain. The RS domain, which is
extensively phosphorylated, mediates subcellular
localization and shuttling of individual SR proteins
and also functions as a splicing activation module,
apparently by engaging in protein-protein interactions.
The RS domain of SF2/ASF is dispensable for the
concentration-dependent effects of this prototype SR
protein on alternative splice site selection. However,
this RS domain is highly conserved phylogenetically
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and was shown to be required for constitutive splicing
in vitro and for cell viability. J. Zhu has now demon-
strated that the RS domain of SF2/ASF is, in fact, dis-
pensable for splicing of several substrates, including
constitutive and enhancer-dependent pre-mRNAs. The
requirement for this RS domain is substrate-specific
and correlates with the strength of the splicing signals.
When the 3' splice site is weak, both the SF2/ASF RS
domain and its interacting partner U2AF" (the small
subunit of the splicing factor U2AF) are required for
splicing. These results demonstrate the existence of an
RS-domain-independent function of SR proteins in
constitutive and enhancer-dependent splicing, and sug-
gest mechanisms for their role in enhancer function
besides U2AF recruitment. J. Zhu further showed that
in the case of pre-mRNAs that do require the SF2/ASF
RS domain for in vitro splicing, it is possible to replace
the natural 51-residue RS domain by ten RS dipeptide
repeats. This simplified RS domain is efficiently phos-
phorylated in vitro during the early stages of splicing,
suggesting that the critical feature of an RS domain, at
least for splicing in vitro, is the alternating charge
structure.
EXONIC SPLICING ENHANCER MOTIFS
AND EXON SKIPPING
We have continued to study the nature and function of
exonic elements that stimulate the removal of adjacent
introns. These elements are thought to be involved in
exon definition, splicing fidelity, splicing efficiency,
and regulation of alternative exon inclusion. Splicing
enhancers are recognized specifically by individual
members of the SR protein family. L. Cartegni has
been pursuing the analysis of SR protein recognition
motifs previously initiated by H.-X. Liu (in collabora-
tion with M. Zhang). We analyzed a previously identi-
fied nonsense mutation in exon 18 of the BRCA 1 gene
that causes skipping of that exon, thereby inactivating
the gene and resulting in breast and ovarian cancer
predisposition. We demonstrated that the single-base
change disrupts an exonic splicing enhancer (ESE)
that is recognized by the SR protein SF2/ASF. We
were able to reproduce the nonsense-associated exon
wt mut
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FIGURE 1 Nonsense-associated exon skipping of BRCA1
axon 18 can be reproduced in vitro. Radiolabeled BRCA1
three-exon minigene transcripts were prepared by in vitro tran-
scription, spliced in HeLa nuclear extract, and analyzed by
denaturing PAGE and autoradiography. Time courses of in vitro
splicing are shown for the wild-type transcript (lanes 1-4) and a
transcript with a nonsense mutation at position +6 in the mid-
dle exon (lanes 6-9). The respective input RNAs are shown in
lanes 5 and 10. (Unshaded boxes) Exons 17 and 19; (shaded
box) exon 18. Introns 16 and 17 have internal deletions.
skipping phenomenon in vitro, using BRCA1 mini-
gene transcripts (Fig. 1). Using our previous SR pro-
tein motif-scoring matrices, in conjunction with in
vitro splicing assays, we further showed that a mis-
sense mutation in exon 18 that also disrupts the
SF2/ASF-recognition motif likewise causes skipping
of the exon, whereas a nonsense mutation that main-
tains a high-score SF2/ASF motif does not result in
exon skipping.
Nonsense, missense, and silent mutations that
cause skipping of the exon harboring the mutation are
very common among disease-associated point muta-
tions. Our analysis of SR protein motif scores in 50
such mutations in human genes suggested that approx-
imately half of the mutations result in disruption of
recognition motifs for the SR proteins SF2/ASF,
SC35, SRp55, or SRp40. We conclude that protein-
coding exons comprise interspersed signals that are
very important for splicing fidelity. Point mutations in
exons that are identified only at the genomic DNA
level may be misclassified, unless the mRNA splicing
patterns are also determined. L. Cartegni is currently
applying this type of analysis to other clinically impor-
tant genes, in particular the survival-of-motor-neuron
genes, SMN1 and SMN2, which are important in spinal
muscular atrophy.
AT-AC PRE -MRNA SPLICING PATHWAY
M. Hastings is pursuing the characterization of AT-AC
pre-mRNA splicing. AT-AC introns represent approxi-
mately 0.1% of introns in mammals. AT-AC introns
have conserved signals that differ from those of the
major class of introns, and their processing requires a
distinct set of snRNAs. We found that this pathway
requires the same set of SR proteins that are involved
in conventional splicing. SR proteins are required for
FIGURE 2 Model of exon-definition interactions involving an AT-AC intron and a convention-
al intron. A pre-mRNA with three axons (boxes) and two introns (lines) is shown. The first
intron is of the AT-AC class, and the second intron is a conventional one. Their conserved 5'
splice site, 3' splice site, and branch site sequence elements are indicated. The 5' splice site
of a third, downstream conventional intron is also shown. The second and third exon have
exonic splicing enhancers (ESEs), which are recognized by SR proteins. Selected protein and
snRNP components of the major and minor spliceosomes are shown, with the arrows denot-
ing presumptive protein-protein or protein-RNA interactions.
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the basal AT-AC splicing reaction and also appear to
participate in AT-AC splicing stimulation via exonic
enhancers or exon-definition interactions with adja-
cent conventional introns (Fig. 2). Thus, SR proteins
function in both major and minor splicing pathways
and in coordinating the activities of both spliceosomes
by exon definition.
An AT-AC intron in a sodium channel pre-mRNA
failed to splice in 5100 extract complemented by SR
proteins, unless an additional nuclear fraction was also
present. In contrast, another AT-AC intron from the
P120 gene did not require the additional fraction.
Moreover, the two AT-AC introns differed with respect
to their ability to splice in the presence of individual
recombinant SR proteins. Analysis of chimeric sodi-
um channel/P120 transcripts showed that partially
redundant information dispersed throughout the
introns and flanking exons dictates SR protein speci-
ficity and the requirement for the additional nuclear
fraction. These and other results show that, despite the
substantial differences in intron consensus sequences
and in four of the five snRNPs in each spliceosome, at
least some of the interactions involving SR proteins
are conserved between the two pathways.
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REGULATION OF APOPTOSIS IN CANCER CELLS
Y. Lazebnik D. Duelli
L. Faleiro
P. Lassus
S.-C. Lin
X. Opitz-Araya
J. Raychaudhuri
J. Rodriguez
Apoptosis is a type of cell death that is critical for
maintaining tissue homeostasis. An intense effort to
understand apoptosis has been fueled in large part by
the hope that the apoptotic machinery can be used
for curing cancer. The accumulated knowledge is
sufficient to design and implement tools that kill
cells quickly and efficiently by inducing apoptosis.
However, because the apoptotic machinery is present
in most if not all mammalian cells, the major prob-
lem is how to induce apoptosis in cancer cells selec-
tively. One approach to solving this problem is to
learn how apoptosis is induced by oncogenic trans-
formation. This approach is based on a paradoxical
observation that some oncogenes, including myc and
adenovirus El A, either induce apoptosis or sensitize
cells to cytotoxic agents, including those used for
chemotherapy. One implication of this observation is
that some oncoproteins are pro-apoptotic activities
that are specific for transformed cells. We think that
understanding how the apoptotic machinery is acti-
vated in response to the expression of oncogenes,
and how apoptosis is prevented in transformed cells,
will help to develop ways to kill cancer cells selec-
tively.
Central to the apoptotic machinery are caspases,
a family of cysteine proteases. Caspases are activat-
ed at the onset of apoptosis and cause death by cleav-
ing a number of proteins in a coordinated manner. If
caspase activation is prevented, a cell can become
drug-resistant. Caspase activation occurs in two
steps. At the first step, pro-apoptotic signals lead to
autocatalytic activation of caspases that are called
initiators. Activated initiator caspases process effec-
tor caspases, which in turn cause cell collapse by
cleaving a specific set of substrates. Each initiator
caspase is activated in response to a subset of signals,
indicating that a prerequisite for understanding how
a specific signal activates apoptosis is finding the
initiator caspase that mediates it. We investigate
which caspases are involved in apoptosis and study
how they are activated, how this activation leads to
cell death, and what prevents this activation in drug-
resistant cells. The ultimate goal is to understand
how caspases can be activated selectively in cancer
cells.
To investigate how caspases are activated by
oncogene expression, we previously developed a cell-
free system that mimics apoptosis dependent on
expression of E1A, an adenoviral oncogene. Using
this system, we found that E1A-dependent apoptosis
is mediated by caspase-9 and that the expression of
E1A sensitizes cells to apoptosis by facilitating acti-
vation of this caspase. This is achieved in at least two
ways: facilitating the release from mitochondria of
cytochrome c, a cofactor required for caspase-9 acti-
vation, and regulation of an unidentified subsequent
step in caspase-9 processing. During the last year, we
investigated how E1A regulates caspase-9 activation
and continued to study basic mechanisms of caspase
functioning.
Caspases Break the Nuclear
Cytoplasmic Barrier
L. Faleiro
During apoptosis, caspases disassemble a cell by
cleaving a set of proteins. Caspase-3 has a major role
in disassembly of the nucleus by processing several
nuclear substrates. The question was how caspase-3,
which is usually cytoplasmic, gains access to its
nuclear targets. This problem was part of a general
puzzle: How does the apoptotic machinery, which is
activated in the cytoplasm, reach the nucleus. It was
suggested that caspase-3 is actively transported to
the nucleus through nuclear pores. In contrast, we
found that caspase-9, which is activated before cas-
pase-3, directly or indirectly inactivates nuclear
transport and increases the diffusion limit of the
nuclear pores. This allows caspase-3 and other mol-
ecules that cannot normally pass through the nuclear
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pores in living cells to enter or leave the nucleus by
diffusion. Hence, we concluded that caspases enter
the nucleus because caspase-9, directly or indirectly,
disrupts the nuclear-cytoplasmic barrier. Interest-
ingly, we found that caspase-8, another initiator cas-
pase, is unable to change the diffusion limit of the
nuclear pores and disrupt nuclear transport; this
argues that the current model, that initiator caspases
directly converge on the common effector caspases,
is an oversimplification.
Compensatory Activation
of Caspases
Y. Lazebnik [in collaboration with R. Flavell,
Yale University]
Caspases are considered attractive targets for thera-
peutic intervention, even though it is not known with
certainty how these enzymes are regulated. One ques-
tion is to what degree are caspase activities redundant.
For example, would eliminating one caspase result in
compensatory activation of another caspase? We col-
laborated with the laboratory of Dr. Richard Flavell to
address this question experimentally, using an animal
model of apoptosis induced by Fas, a receptor whose
activation leads to cell death. In this model, mice are
injected with an antibody that acts as a Fas agonist.
Activation of Fas, in turn, leads to activation of cas-
pase-8, which is thought to initiate two pathways. One
involves direct processing of caspase-3, and the other,
processing of Bid. The truncated Bid then promotes
the release of cytochrome c, thus activating caspase-9.
As a result, injection of Fas antibody leads to massive
apoptosis in the liver, causing death of the animal. A
deficiency in Bid prevents death, predicting that a
deficiency in caspase-9 should have the same effect.
However, we found that a deficiency in caspase-9
failed to protect animals from death. Biochemical
analysis revealed that the set of caspases activated in
mice lacking caspase-9 differed from that observed in
wild-type mice. Although we did not identify the cas-
pase that compensates for the capase-9 deficiency, our
unexpected observations provided direct experimental
evidence for compensatory pathways of caspase acti-
vation. These observations provided another reminder
that developing caspase inhibitors and activators for
clinical applications must be preceded by an effort to
better understand caspase regulation.
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E1A and Myc Promote Apoptosis
by Suppressing Inhibitors
of This Process
D. Duelli
We have found that adenovirus oncogene E1A sensi-
tizes cells to pro-apoptotic drugs by facilitating activa-
tion of caspase-9. In principle, E1A can promote acti-
vation of caspase-9 in three ways. The prevailing
model (Fig. la) is that E1A directly or indirectly
enables expression of pro-apoptotic proteins, such as
Bax. An alternative possibility is that normal cells are
protected from apoptosis by inhibitors that are inacti-
vated in response to E1A expression (Fig. lb). The
third possibility is a combination of the first two (Fig.
1c). We tested these models using a cell-fusion com-
plementation assay. In this assay, we fused primary
human fibroblasts with fibroblasts that express E1A
and immediately treated the resulting heterokaryons
with etoposide, an anti-cancer drug that induces DNA
damage. We reasoned that if the induction of dominant
pro-apoptotic proteins is sufficient for apoptosis, then
the heterokaryons would undergo apoptosis, as would
the cells expressing E1A. However, if expression of
the apoptosis inhibitors were repressed by El A, then
the heterokaryons would be resistant to the drug treat-
ment. We found that the heterokaryons remained resis-
tant to drug for at least 40 hours after fusion. We con-
cluded that primary cells contain inhibitors of apopto-
sis which we called IODA (inhibitor of oncogene-
dependent apoptosis). Our subsequent studies indicat-
ed that IODA inhibits apoptosis by preventing
cytochrome c release, whereas additional preliminary
results suggest that other activities may prevent the
subsequent steps of caspase-9 activation. Our current
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FIGURE 1 In principle, El A can promote activation of caspase-9
in three ways: (a) by inducing pro-apoptotic proteins; (b) by inacti-
vating inhibitors of apoptosis; and (c) by a combination of both.
model is that oncogenes suppress several activities
that prevent caspase-9 activation at multiple steps. Of
interest, IODA is repressed not only by E1A, but also
by Myc, which suggests that this activity is regulated
by multiple oncogenic stimuli. Here, we propose to
identify IODA, as our preliminary results place it as a
link between oncogenes and the apoptotic machinery.
E1A Enables a Link between
DNA Damage and Trans location
of Bax to Mitochondria
D. Duelli
IODA could be a direct inhibitor of cytochrome c
release or could prevent E1A from activating pro-
apoptotic factors that are required for release. To dis-
tinguish between these two possibilities, we focused
on the Bax protein. Bax can release cytochrome c by
binding to mitochondria. It has been reported that
induction of Bax by ElA contributes to sensitization
to cytotoxic drugs. We found that Bax was distrib-
uted diffusely both in primary cells and in cells
expressing E1A. Following etoposide treatment, Bax
concentrated at the mitochondria of E1A-expressing
cells, but remained diffuse in primary cells. Hence,
expression of El A establishes the link between DNA
damage, which is the primary effect of etoposide,
and Bax translocation. Bax also translocated in het-
erokaryons between primary and E1A-expressing
cells following treatment with etoposide, indicating
that IODA does not sever the link between DNA
damage and Bax translocation. Thus, we concluded
that expression of ElA sensitizes cells to an anti-can-
cer drug by at least two pathways (as in Fig. 1c). One
establishes a link between the drug and Bax, where-
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FIGURE 2 E1A facilitates apoptosis by at least two pathways:
(1) repressing inhibitors (IODA) and (2) promoting activators
(Bax) of apoptosis.
as the second suppresses IODA, which blocks
cytochrome c release even if Bax is translocated to
mitochondria (Fig. 2).
Is Caspase-9 Required for
Chemotherapy-induced
Apoptosis in All Tumor Cells?
X. Opitz-Araya, Y. Lazebnik [in collaboration with S. Lowe, Cold
Spring Harbor Laboratory, and S. Kaufmann, Mayo Clinic]
The strict requirement for caspase-9 for E1A-depen-
dent apoptosis makes fibroblasts a good model for
studying the basic mechanisms that link oncogenic
transformation and the apoptotic machinery. However,
an important question is whether conclusions reached
studying E1A-transformed fibroblasts can be applied to
tumor cells. Studies by Dr. Scott Lowe, in which we
participated, indicated that a deficiency in APAF-1 is
linked to drug resistance in some melanomas. However,
studies by Dr. Scott Kaufmann, to which we also con-
tributed, found that in acute myelogenous leukemia
(AML) and acute lymphocytic leukemia (ALL), levels
of caspases and APAF-1 did not correlate with progno-
sis or with response to chemotherapy. These observa-
tions suggested several possibilities: that chemotherapy
kills these tumor cells in a caspase-independent way,
that as yet unidentified caspases are involved, or that
regulation of known caspases is affected in drug-resis-
tant cells in ways that we still need to understand.
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REGULATION OF APOPTOSIS AND SENESCENCE BY
CANCER GENES
S. Lowe E. de Stanchina A. Lin E. Querido
G. Ferbeyre M. McCurrach C. Rosenthal
J. Fridman Z. Nahle A. Samuelson
W. Jiang M. Narita C. Schmitt
J. Jin J. Polyakova M. Soengas
Apoptosis is a genetically controlled form of cell
death that is important for normal development and
tissue homeostasis. Senescence produces "genetic
death" in that the senescent cell is incapable of further
propagation. Both processes are frequently disrupted
in cancer cells, implying that each can limit tumor
development. Moreover, radiation and many
chemotherapeutic agents can induce either apoptosis
or senescence, raising the possibility that the integrity
of these programmed responses influences the out-
come of cancer therapy in patients. The goal of our
research is to understand how cancer genes control
apoptosis and senescence in normal cells, and how
mutations that disrupt these processes impact tumor
development and therapy. Our approach emphasizes
genetics, and we typically exploit simple cellular sys-
tems to study cancer gene function. More recently, we
have studied human tumors and animal models to con-
firm the relevance of our simple systems for tumor
development and cancer therapy in vivo.
Much of our research stems from our interest in
the p53 tumor suppressor. p53 functions as a key com-
ponent of several cellular stress responses and as such
acts at a variety of levels to protect against cancer. For
example, p53 can be activated by DNA damage to
trigger cell cycle checkpoints or apoptosis, such that
cells lacking p53 are prone to certain forms of muta-
tion and genomic instability. This implies that p53 can
indirectly suppress tumorigenesis by acting as a
"Guardian of the Genome," i.e., to promote the repair
or elimination of cells that have sustained potentially
deleterious mutations. Remarkably, since most current
anticancer agents damage DNA, the integrity of this
p53 response may contribute to the outcome of cancer
therapy. In addition, certain mitogenic oncogenes can
activate p53 to promote apoptosis or senescence. Loss
of p53 prevents these homeostatic responses, leading
to oncogenic transformation or tumor progression.
This implies that p53 can directly suppress tumorige-
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nesis by acting in a fail-safe mechanism to counter
hyperproliferative signals. We currently study many
aspects of p53, including how oncogenes or DNA-
damaging agents signal p53, how p53 executes a bio-
logical response, and the factors that influence
whether p53 induces a cell cycle checkpoint, cellular
senescence, or apoptosis.
Oncogene-induced Apoptosis
E. de Stanchina, J. Jin, M. McCurrach, Z. Nahle,
J. Polyakova, A. Samuelson [in collaboration with
Y. Lazebnik, Cold Spring Harbor Laboratory]
Our laboratory was the first to demonstrate that onco-
genes can activate p53 to promote apoptosis. Our cur-
rent research focuses on how oncogenes sensitize cells
to apoptotic stimuli and the execution of apoptosis in
these oncogene-primed cells. Using murine fibroblasts
as a model, we have produced a working framework
for this process (Fig. 1). Current questions include:
What are the cellular targets of E1A in promoting
apoptosis? How does p 1 9A" couple oncogenes to
p53? How do oncogenes promote apoptosis indepen-
dently of p53? To what extent does disruption of
oncogene-induced apoptosis contribute to tumor
development in vivo? To address these questions, we
continue to use the murine fibroblast system, which
has proven effective in the past, but we are also invest-
ing in new gene expression and transgenic technolo-
gies that will impact this project in future years.
E1A promotes apoptosis using at least two separa-
ble functions: The first involves inactivation of Rb,
and the second requires an amino-terminal E1A
region. Although our previous studies have suggested
that it is the p300/CBP interaction which is the rele-
vant amino-terminal target, our recent work shows that
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FIGURE 1 The p53 apoptotic pathway. Shown is a model for the p53 apoptotic program as determined from genetic studies using
primary murine fibroblasts. Although the regulation of this pathway is clearly more complex than indicated here, this model provides
a framework for much of our current investigation.
the regions of E1A required to promote apoptosis are
distinct from those required to bind p300/CBP (A.
Samuelson, in prep.) and instead correlate with those
required to associate with a poorly characterized E1A-
binding protein known as p400. In parallel, we have
shown that E1A induces several caspases through a
transcriptional and translational mechanism that
involves deregulation of the Rb pathway (J. Polyakova,
in prep.). Hence, caspase induction strictly depends on
the El A-Rb interaction and occurs both in Rb-defi-
cient fibroblasts and in normal fibroblasts overex-
pressing E2F-1. Interestingly, E1A also induces cas-
pases in fibroblasts lacking ARF or p53, implying that
caspase induction occurs independently of the ARF-
p53 tumor suppressor pathway. Although pro-caspase
induction by E1A cannot solely explain its pro-apop-
totic activity, it seems likely that this contributes to the
p53-independent apoptosis induced by oncogenes. We
hope that our efforts to understand caspase
will lead to a better understanding of this E1A action
in apoptosis.
Effector Mechanisms of
p53-dependent Apoptosis
W. Jiang, M. McCurrach, M. Soengas [in collaboration with
L. Attardi and T Jacks, Massachusetts Institute of Technology;
D. McCombie, Cold Spring Harbor Laboratory; M. Esteller
and J. Herman, Johns Hopkins University; W. Gerald and
C. Cordon-Cardo, Memorial Sloan-Kettering Cancer Center]
We have had a long-standing interest in how p53 pro-
motes apoptosis and the importance of this process for
its tumor suppressor functions. This year, we worked
with L. Attardi and T. Jacks (MIT) to identify a new
p53 transcriptional target that is specifically induced
by p53 during apoptotic cell death (Attardi et al.
2000). This gene, called PERP (p53 apoptosis effector
related to PMP-22), was identified from a differential
gene expression screen using fibroblasts expressing or
lacking E1A. It encodes a plasma membrane protein
with sequence similarity to the tetraspan membrane
protein PMP-22/gas3 and is a candidate tumor sup-
pressor. How this molecule might promote apoptosis
will be the subject of future research by Dr. Attardi,
and we will continue to contribute to her analysis.
Last year, we showed that the cell death effectors
Apaf-1 and Casp9 mediate the p53 apoptotic signal in
oncogene-expressing cells, such that loss of either gene
substituted for p53 loss in facilitating the oncogenic
transformation (Soengas et al., Science 284: 156
[1999]). As such, this study identified Apaf-1 and
Casp9 as candidate tumor suppressors. This year, we
showed that metastatic melanomas (which rarely have
p53 mutations) often lose Apaf-1, a cell death effector
that acts with cytochrome c and caspase-9 to mediate
p53-dependent apoptosis (AS. Soengas et al., in press).
Loss of Apaf-1 expression is accompanied by allelic
loss in metastatic melanomas, but it can be recovered in
melanoma cell lines by treatment with the methylation
(SazaCdR). Apaf- 1-
negative melanomas are invariably chemoresistant and
unable to execute a typical apoptotic program in
response to p53. Restoration of physiologic Apaf-1 lev-
els through gene transfer or SazaCdR treatment
markedly enhanced chemosensitivity and rescued the
apoptotic defects associated with Apaf-1 loss.
Therefore, these studies demonstrate that Apaf-1 is
inactivated in metastatic melanomas leading to defects
in the execution of apoptotic cell death. We suspect that
Apaf-1 loss may contribute to the low frequency of p53
mutations observed in this highly chemoresistant tumor
type. We are continuing to explore the basis of Apaf-1
inactivation in melanoma and are interested in extend-
ing our understanding of Apaf-1 loss on the biology of
melanoma.
Control of Cellular Senescence
G. Ferbeyre, A. Lin, E. de Stanchina, M. McCurrach,
M. Narita, E. Querido
We previously showed that expression of oncogenic
ras in primary human or rodent fibroblasts results in a
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permanent arrest accompanied by accumulation of
p53, p16, and p 19A' and is phenotypically indistin-
guishable from cellular senescence. We hypothesize
that this program limits the transforming potential of
oncogenic ras. Currently, we are addressing several
questions: How does ras signaling activate a perma-
nent cell cycle arrest? How do tumor suppressors such
as p53, p16, and p 1 9ARF initiate and maintain this
arrest? What is the relationship between ras-induced
arrest and replicative senescence? How do epithelial
cells respond to ras?
We previously used cDNA array technology to
compare ras-induced arrest to replicative senescence.
In collaboration with W Funk (Geron Corporation),
we showed that the transcriptional profiles of cells
arrested by oncogenic ras or by serial passaging
("senescent") are quite similar (Shelton et al., submit-
ted). Independently, we characterized some of these
changes in more detail. For example, we noted that
one of the genes up-regulated during ras-induced
arrest was the promyelocytic leukemia (PML) protein,
a potential tumor suppressor that encodes a compo-
nent of nuclear structures known as promyelocytic
oncogenic domains (PODs) (Ferbeyre et al. 2000). We
have shown that PML levels increase during both ras-
induced arrest and replicative senescence, leading to a
dramatic increase in the size and number of PODs.
And importantly, in a series of genetic experiments,
we have provided strong evidence that PML con-
tributes to premature senescence. Precisely how this
works remains to be established, but we have noted
that a portion of p53 migrates to the PODs in ras-
arrested cells. Together, our data imply that PML acts
with Rb and p53 to promote ras-induced senescence
and provides new insights into PML regulation and
activity.
Although our analysis of fibroblasts clarifies
aspects of senescence control, an important goal of
our research is to demonstrate that this process actual-
ly suppresses tumor development. One potentially rel-
evant setting is during chemically induced skin car-
cinogenesis in mice. In this paradigm of epithelial
neoplasia, oncogenic ras mutations precede p53 and
INK4a/ARF mutations during the progression toward
malignancy. This year, we have shown that, as in
fibroblasts, oncogenic ras induces keratinocyte cell
cycle arrest in a manner involving the pl9A', p 1 6m4a,
and p53 tumor suppressors. This arrest clearly limits
tumor development, since ARF-null keratinocytes
expressing oncogenic ras rapidly formed carcinomas
in immunocompromised mice, whereas their wild-
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type counterparts were not tumorigenic. Importantly,
the mechanism of ras-induced arrest in cultured ker-
atinocytes can explain some of the mutational events
observed during carcinoma progression in vivo:
Specifically, selective pressure to override ras-induced
arrest may enrich for cells with p53 or INK4a/ARF
mutations. Future work will continue to explore this
hypothesis.
Molecular Genetics of Drug
Sensitivity and Resistance
J. Fridman, Z. Nahle, C. Rosenthal, C. Schmitt
A major goal of our research is to understand the bio-
logical and molecular basis of drug sensitivity and
resistance in tumors. Conventional approaches to
identify factors that dictate treatment sensitivity rely
on human tumor cell lines treated in vitro or as ectopic
xenografts. As an alternative approach, we are using
transgenic mouse models to study drug action in spon-
taneous tumors. Our system exploits the Ep -myc
transgenic mouse, which develops B-cell lymphomas
at short latency with high penetrance. Last year, we
established this model as a tractable system to study
drug action and showed that tumors with disrupted
p53 or INK4a/ARF genes were severely compromised
in their ability to respond to conventional chemother-
apeutic agents. We wish to use this system to identify
additional factors that affect treatment sensitivity.
This year, we have developed new methods to
manipulate the genetics of these lymphomas to fur-
ther dissect treatment response (Schmitt et al. 2000;
C.S. Schmitt et al., in press; C.S. Schmitt and S.
Lowe, in press]. Our approach uses primary Eµ -myc
lymphomas and retroviral gene transfer to rapidly
generate a series of spontaneous tumors differing only
in a gene of interest, allowing us to study the impact
of the test gene on the treatment sensitivity in a high-
ly controlled but physiological context. Using this
system, we have demonstrated that the Bcl -2 onco-
protein produces multidrug resistance when assessed
in primary lymphomas. In contrast, this effect was
dramatically reduced when the primary lymphomas
were subjected to long-term culture and completely
missed in the standard clonogenic survival assay.
Hence, by comparing results from our in vivo system
to more conventional assays, we have shown that
some determinants of treatment sensitivity are missed
in vitro or when using established lymphoma cell
lines. We will continue to use this system to improve
our understanding of drug action and, ultimately, to
provide relevant preclinical settings to test new anti-
cancer agents.
We are also taking more nonbiased approaches to
studying treatment sensitivity. To this end, we have
produced a series of lymphomas that are resistant to
different therapies and are beginning to use genome-
wide approaches to identify the molecular basis for
drug resistance (C.S. Schmitt et al., in press). In one
approach, drug-sensitive and drug-resistant lym-
phomas are analyzed by transcriptional profiling. To
this end, we are working with V. Mittal here at the
Laboratory to produce a microarray consisting of
approximately 7000 murine genes and expressed
sequence tags. Larger microarrays are in production,
and preliminary results indicate that high-quality
transcriptional profiles can be obtained using lym-
phoma RNA (Z. Nahle, V. Mittal, C. Schmitt,
unpubl.). We fully expect this and other genome-wide
approaches to provide important new insights into
drug sensitivity and resistance.
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski M.E. Greenberg N. Shohdy
B. Hi T. Swigut
A. Janardhan
Our interest is in understanding the molecular mecha-
nisms underlying the pathogenesis of AIDS and, in
particular, in understanding the functional conse-
quences of the interactions between viral proteins and
the cellular regulatory machinery. The focus of our
research is to understand the functions of Nef, a regu-
latory protein of human and simian immunodeficien-
cy viruses (HIV and SIV) that is an important deter-
minant of virulence. Viruses with defects in Nef can
replicate poorly in the host, and this correlates with
attenuated development of AIDS. Deleting the nef
gene is a common strategy to generate attenuated
immunodeficiency viruses for use as live vaccines.
NEF FUNCTIONS
Natural Nef protein isolates have three conserved
classes of effects on signal transduction and protein-
sorting machineries that probably enhance viral viru-
lence in vivo. One effect of Nef is to disrupt the mol-
ecular machinery mediating normal T-cell responses
to antigens. This is accomplished by down-regulating
the cell surface CD4 molecule, an essential compo-
nent of the T-cell antigen receptor (TCR) on class II
major histocompatibility complex (MHC)-restricted T
lymphocytes, and by blocking signal transduction via
the CD3 signaling component of the TCR. Another
effect of Nef is to down-regulate expression of class I
MHC complexes at the cell surface. Class I MHC
molecules are critical elements of the immune system
detection machinery that allow elimination of virally
infected cells. Thus, this effect of Nef may enable
infected cells to evade the immune response in the
infected host. Finally, Nef also stimulates infectivity
of SIV and HIV virions and stimulates replication in
natural T cells.
In previous years, we probed and described the
molecular mechanisms that mediate the effects of
HIV- l Nef on CD4 and class I MHC expression and
initiated a structure-function analysis of Nef protein
encoded by a pathogenic strain of SIV. These experi-
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ments identified mutant SIV Nef proteins that were
selectively defective for subsets of functions and
paved the way to experiments addressing the contribu-
tion of these individual functions toward enhancing
viral virulence in a rhesus macaque model of human
AIDS. These experiments continued to be the major
focus of our recent research.
SURFACES OF NEF REQUIRED FOR
DOWN-REGULATION OF CD4 AND FOR THE
ENHANCEMENT OF VIRION INFECTIVITY
ARE CRITICAL FOR EFFICIENT SIV
REPLICATION IN VIVO
We demonstrated previously that the effects of Nef on
CD4 expression, class I MHC expression, and the sig-
nal transduction machinery are genetically separable
and map to different surfaces in the SIV Nef molecule.
During the last year, we completed a series of experi-
ments that addressed the individual roles of SIV Nef
surfaces involved with CD4 down-regulation,
enhancement of SIV infectivity, and in vitro replica-
tion on SIV replication in rhesus macaques. These
experiments were performed in collaboration with Dr.
Frank Kirchhoff and Dr. Christiane Hennig-Stahl
(University of Erlangen and German Primate Center,
Germany).
We constructed an SIVmac239 variant containing
three amino acid substitutions in Nef that disrupted its
ability to down-regulate CD4 (EDR mutation). This
mutant Nef protein also lost the ability to stimulate
SIV infectivity and replication in simian peripheral
blood mononuclear cells, suggesting that these func-
tions are linked to the CD4 down-regulation function
of Nef. Importantly, the EDR mutation had no
detectable effect on other Nef effects such as down-
regulation of TCR-initiated signaling and the class I
MHC.
Six rhesus macaques were infected with an SIV
variant carrying the EDR mutation in Nef, and addi-
tional animals were infected with control viruses con-
taming either an intact or a nonfunctional nef gene.
Interestingly, in all animals inoculated with SIV con-
taining the EDR-mutated Nef, viral loads early in
infection were unusually low and similar to those seen
in infection with SIV containing the nonfunctional nef
gene. Subsequent increases in viral loads coincided
with the selection of amino acid changes that restored
Nef functions disrupted by the EDR mutation. Our
results indicate that surfaces of the SIV Nef protein
that mediate molecular interactions important for
CD4 down-regulation and in vitro replication are
important for optimal in vivo replication early in the
infection.
ANTIVIRAL IMMUNE RESPONSE
AND SIV VIRULENCE
Presentation of antigens derived from viral proteins by
class I MHC molecules to competent effector T cells
is the key event required for the recognition and elim-
ination of infected cells by the immune system of the
host. Notably, EDR-mutated Nef retained the ability
to down-regulate class I MHC molecules from the cell
surface and was therefore likely to promote survival
of infected cells in the face of an active immune
response. On the other hand, SIV with EDR-mutated
Nef replicated poorly in the infection. These findings
indicate that class I MHC down-regulation by Nef is
not sufficient for SIV virulence early in infection,
possibly because the immune response against SIV is
not yet fully developed, or because other factors are
limiting viral replication at this early phase of infec-
tion.
MUTATIONS IN SIV NEF THAT SELECTIVELY
DISRUPT CLASS I MHC DOWN-REGULATION
Down-regulation of class I MHC expression could be
very important for the establishment of persistent
SIV/HIV infection once strong antiviral responses
develop in the infected host. To directly address the
role of this Nef function as well as the broader issue
of the role of the immune response during immuno-
deficiency virus infection and progression to AIDS,
we studied class I MHC down-regulation by SIV Nef
in detail. Initially, we compared the mechanisms used
by SIVmac239 Nef and HIV-1 Nef to down-regulate
class I MHC and found that the ability of SIV Nef to
down-regulate class I MHC requires a unique car-
boxy-terminal region of the mac239 Nef molecule,
which is not found in HIV-1 Nef. However, similar to
HIV-1 Nef, we found that down-regulation of class I
MHC by SIV Nef requires a conserved tyrosine in the
cytoplasmic domain of the class I MHC heavy chain
and involves accelerated endocytosis of class I com-
plexes. Thus, although SIV and HIV-1 Nef proteins
use a similar mechanism to down-regulate class I
MHC expression, they have evolved different surfaces
for molecular interactions with cell factors that regu-
late class I MHC traffic. Notably, mutations in the car-
boxy-terminal domain of SIVmac239 Nef selectively
disrupt class I MHC down-regulation, having no
detectable effect on other functions of Nef such as the
down-regulation of CD4 and CD3 surface expression,
or the stimulation of SIV virion infectivity and induc-
tion of SIV replication from peripheral blood mononu-
clear cells infected in the absence of stimulation.
Finally, we contructed several mutant Nef proteins
with small deletions in the carboxy-terminal region.
These mutations likewise selectively disrupt only class
I MHC down-regulation, but they are less likely to
revert in vivo than point mutations. We hope that these
mutants will be useful reagents to study the impor-
tance of class I MHC down-regulation for SIV repli-
cation in the context of a functional immune system in
rhesus macaques.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund C. Sanders H. Maats
E. Gillitzer G. Chen
A. Lee
The papillomaviruses are a group of viruses that infect
and transform the basal epithelium, inducing prolifer-
ation of the cells at the site of infection. The resulting
tumors (warts) are in most cases benign and will usu-
ally regress after some time, but certain types of
human papillomaviruses (HPVs) give rise to tumors
that are prone to progress toward malignancy, espe-
cially frequently cervical carcinoma. Indeed, HPV
infection appears to be a necessary cause of invasive
cervical carcinoma and thus represents the few firmly
established links between viral infections and the
development of cancer.
An impediment to the study of papillomaviruses
has been the inability to define simple in vitro cell cul-
ture systems for analysis of the viral life cycle. These
viruses normally require specialized differentiating
cells that only with difficulty can be generated in cell
culture. However, for a bovine papillomavirus (BPV-1),
a convenient cell culture system exists where viral gene
expression, oncogenic transformation, and viral DNA
replication can be studied. Thus, BPV has become a
useful model for these aspects of the viral life cycle.
The DNA replication properties of the papillomavirus-
es show some unique and interesting characteristics. As
part of their normal life cycle, these viruses can exist in
a state of latency, which is characterized by mainte-
nance of the viral DNA as a multicopy plasmid in
infected cells. The copy number of the viral DNA is
tightly controlled, and the viral DNA is stably inherited
under these conditions. Papillomaviruses therefore
provide a unique opportunity to study plasmid replica-
tion in mammalian cells. In addition, the viral DNA
replication machinery represents one of the most
promising targets for antiviral therapy.
In previous years, we have reported the character-
ization of the papillomavirus replicon and the identifi-
cation of the viral components that are required for
viral DNA replication. In recent years, we have direct-
ed our attention toward the biochemical events that are
associated with initiation of DNA replication. We are
studying the biochemical properties of the viral El
and E2 proteins and how these two proteins interact
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with the viral origin of DNA replication to generate
initiation complexes. Our studies demonstrate that the
El protein has all the characteristics of an initiator
protein, including on recognition, DNA-dependent
ATPase activity, and DNA helicase activity. The tran-
scription factor E2, whose function has remained
more elusive, appears to serve largely as a loading fac-
tor for El . Through direct physical interactions with
both El and the ori, E2 provides sequence specificity
for the formation of the initiation complex.
We are currently attempting to elucidate how the
El and E2 proteins orchestrate the precise biochemi-
cal events that precede initiation of DNA replication at
the viral ori. These events include binding of the ini-
tiator to the ori, the initial opening of the DNA duplex,
and the assembly and loading of the El replication
helicase at the replication fork. Our studies so far indi-
cate that these activities are generated in an ordered
process that involves the sequential assembly of El
molecules on the ori. This sequential assembly gener-
ates different complexes with different properties that
in turn recognize ori, destabilize the double helix, and
function as the replicative DNA helicase.
Initiator Complex Assembly
C. Sanders
An intriguing aspect of viral initiator proteins is their
ability to perform several different, seemingly unrelat-
ed, biochemical functions. Our model to explain how
these activities can reside in one single polypeptide is
that different oligomeric forms of the protein may
have different activities. In agreement with such a
model, we have previously demonstrated that a dimer-
ic form of El recognizes the ori together with E2 and
that the form of El which has helicase activity is a
hexamer. Our current understanding of the assembly
pathway of these complexes is that a sequence-specif-
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FIGURE 1 Ribbon diagrams of the three-dimensional structures of El DBD and the
SV40 T antigen DBD showing the similarity of the fold.
is complex of a dimer of El and a dimer of E2 togeth-
er bind to the on and initially recognize the ori. In an
ATP-dependent manner, the E2 dimer is displaced and
additional El molecules are added to the complex.
These are bound sequence specifically, forming a
tetramer on the four paired E1- binding sites in the
core.
The Crystal Structure
of the El DBD
G. Chen [in collaboration with E. Enemark, D. Vaughn,
and L. Joshua-Tor, Cold Spring Harbor Laboratory]
To understand the DNA-binding properties of the El
DNA-binding domain (DBD), we undertook structur-
al analysis of the El DBD in collaboration with L.
Joshua-Tor here at the Laboratory. The El DBD has a
central five-stranded 13-sheet and flanking a helices
on either side of the sheet. Previous mutational analy-
ses have revealed that a number of positively charged
residues are critical for DNA binding. These residues
are present in two conserved regions, which form a
continuous area on the surface of the protein. The first
region is located on an extended loop between a2 and
[31 (which we refer to as the DNA-binding loop) and
the second is amino-terminal to helix a4 (which we
refer to as the DNA-binding helix). The DNA-binding
loop (residues 180-190), which contains the several of
the residues shown to be critical for DNA binding, is a
very striking feature of the structure. Although this
loop does not contain internal secondary structure, it
is very well-defined in the crystal and adopts an
extended path.
As mentioned earlier, both full-length El and E1
DBD are monomers in solution, although they bind to
the ori as a dimer together with a dimer of E2. One of
the El/E1 interactions that is present in the crystal
places the DNA-binding surfaces of the two
monomers approximately 34 A apart on the same face
of this putative dimer. This distance corresponds to
one helical turn of a B-DNA double helix. Since the
El- binding sites on DNA are positioned one helical
turn apart, this dimeric form is particularly appealing.
To test whether this interaction was relevant for
dimerization, we substituted two small hydrophobic
residues at the dimer interface with the large charged
residue arginine. Since El DBD can bind to a half-site
ori as a monomer in the presence of E2 DBD, El
defective for dimerization should retain the DNA-
binding activity but bind DNA as a monomer. The
mutant proteins and wild-type El DBD were com-
pared for DNA binding, and as predicted, both
53
mutants had significant dimerization defects,
although DNA binding and interaction with E2 DBD
were not impaired. Finally, comparison of the struc-
ture of the El DBD to the NMR (nuclear magnetic
resonance) structure of the DBD of SV40 T antigen
shows quite remarkable similarity, despite only 6%
sequence identity (Fig. 1). Given that the homology in
other regions of the two proteins is similar or greater
than that observed for the DBD, it is likely that E 1 and
T antigen have highly related structures.
Structural Changes in the on
Induced by Cooperative
Binding of El and E2
E. Gillitzer
Cooperative binding of the El and E2 proteins to the
on is essential for viral DNA replication in vivo. We
have previously demonstrated that the interaction
between the El and E2 proteins has two separate com-
ponents. The DBDs of the two proteins interact with
each other, and the activation domain of E2 interacts
with the helicase domain of the El protein. The inter-
action between the activation domain of E2 and El is
the productive interaction, whereas the interaction
between the two DBDs serves to facilitate this interac-
tion. To determine how the physical interaction
between the two DBDs triggers the productive interac-
tion, we have analyzed the structure of the on in
response to binding of the two DBDs. Both the El and
E2 DBDs individually generate modest bends in the
DNA upon binding. However, when the two proteins
are bound cooperatively, a much sharper bend cen-
tered between the two binding sites results. This sharp
bend (which approaches 90°) could result either from
the combined intrinsic bends contributed by the indi-
vidual proteins or from the interaction between the
two proteins. To distinguish between these possibili-
ties, we utilized mutants in the E2 DBD that fail to
interact with the El DBD. Interestingly, although the
intrinsic bend generated by the mutant E2 DBDs was
of a magnitude similar to that generated by wild-type
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E2 DBD, the mutant E2 DBDs failed to generate a
sharp bend in combination with the El DBD. This
suggested that the physical interaction between El and
E2 DBDs gives rise to the bend between the two sites.
To determine whether bending of the DNA also was a
requirement for cooperative interaction, we changed
the bendability of the DNA sequence between the El-
and E2-binding sites. It is well established that
homopolymeric A and T stretches are intrinsically
stiff. We therefore changed two A-T base pairs to T-A
base pairs, creating a T4 sequence that is intrinsically
stiff as measured by DNase cleavage. As expected,
these mutations did not have a significant effect on
binding of El or E2 alone. However, the double muta-
tion with increased stiffness resulted in a severe reduc-
tion of both cooperative binding and bending, consis-
tent with the idea that bendability of the DNA
sequence is important for the interaction between the
two DBDs and that bending of the DNA is a prerequi-
site for cooperative DNA binding. The interaction
between the E 1 and E2 DBDs therefore seems to serve
a predominantly architectural role, analogous to the
function of cellular factors such as HMG proteins,
which can modify the architecture of a protein-DNA
complex by introducing bends in DNA.
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Our studies on the inheritance of DNA and chromatin
continue, with an emphasis on the proteins that are
required for DNA replication and how they coordinate
with processes that mediate inheritance of chromatin
and that control cell cycle progression. In prior years,
we have identified the proteins that are required for
synthesis of DNA at a replication fork and for initia-
tion at origins of replication. Although the repertoire
of proteins is well known, it is very likely that we still
do not fully understand how replication occurs. But
more importantly from the view of genome stability,
there is still much to determine how DNA replication
is monitored during the cell division cycle to ensure
accurate inheritance.
INITIATION OF DNA REPLICATION
One of the key protein complexes in initiation of
DNA replication is the origin recognition complex
(ORC) because it recognizes origins of replication
and recruits key proteins at different times during the
cell cycle to facilitate initiation of DNA replication.
One of these key proteins is Cdc6p that we have
demonstrated in yeast to interact with ORC and help
recruit the minichromosome maintenance (MCM)
protein complex to form what has been called a pre-
replication complex (pre-RC). This recruitment ren-
ders chromosomes competent for initiation of DNA
replication when cells are committed to undergo cell
division. In the yeast Saccharomyces cerevisiae,
Cdc6p is loaded onto the chromosome-bound ORC as
cells exit from mitosis and remains there until it is
degraded at the G1- to S-phase transition. Thus,
Cdc6p is bound to chromosomes only during the G,
phase of the cell cycle.
During the past few years, we have completed the
cloning and characterization of the human ORC genes
and have demonstrated that it is possible to reconsti-
tute a six-subunit ORC complex. Unlike yeast, how-
ever, we found that the human ORC complex is
dynamic, with the largest Orcl subunit assembled
onto chromatin as cells exit mitosis and enter early G,
phase. The human Orcl subunit is then degraded by
ubiquitin-mediated proteolysis at the Gi- to S-phase
transition, creating the need to reassemble the full
ORC complex after mitosis. Thus, in terms of protein
stability, human Orcl behaves more like the yeast
Cdc6p. All the other ORC subunits are bound to chro-
matin throughout the cell division cycle, except dur-
ing mitosis.
The human Cdc6 protein is also subject to cell-
cycle-regulated, ubiquitin-mediated proteolysis, but in
this case, we found that Cdc6 is synthesized as cells
passage through late G, phase and binds to chromatin
during the remainder of the cell cycle. The excess
Cdc6 protein is degraded during mitotic exit.
Although we do not know the biochemical functions
of Orcl and Cdc6 in humans like we do in yeast, it is
possible that the two proteins have reversed roles in
human cells compared to yeast cells.
In tissues, most normal human proliferating cells
pause for long periods of time in the Gi phase of the
cell cycle, and the Cdc6 and Orcl proteins would be
present at very low levels. The genes encoding these
proteins are regulated by the E2F transcription factors,
and thus, when cells are stimulated to go through cell
division, Orcl and Cdc6 are synthesized in late Gi
phase. The pre-RC can thus be formed either immedi-
ately as cells exit mitosis or just before the G1- to S-
phase boundary when cells are mitogenically stimulat-
ed to re-enter the cell division cycle.
The process of initiation of DNA replication is
therefore a highly regulated event, and it is likely that
many other proteins have a role in this process. In the
last year, another protein called Cdtl was found by the
laboratories of Paul Nurse and Marcel Mechali in
Schizosaccharomyces pombe and Xenopus, respective-
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ly. Cdtlp is required for the loading of the MCM pro-
teins onto chromatin. Independently, we have
searched for novel proteins that interact with ORC
with the expectation that they will have a role in either
the establishment or regulation of initiation of DNA
replication. Using a panel of monoclonal antibodies
directed against S. cerevisiae ORC, we have immuno-
precipitated the ORC complex and identified by
mass-spectrometry-mediated protein sequencing (in
collaboration with Ryuji Kobayashi) a number of pro-
teins that appear to interact with ORC. One of these
has been the focus of our attention during the past 2
years because it contains a BRCT motif that is also
found in the breast cancer tumor suppressor protein
BRCA 1 . This protein is also very similar to a protein
in zebrafish called pescadillo, which, when altered by
mutation, causes a severe proliferation phenotype in
embryos. We have demonstrated that the yeast
pescadillo protein associates in a very large complex
with ORC and also with a number of other proteins
involved in DNA replication and cell cycle and check-
point control. The function of this complex and the
essential pescadillo protein is under intense study.
CHROMATIN ASSEMBLY AND EPIGENETIC
INHERITANCE
During the last 2 years, we have made significant
progress in understanding how chromatin is inherited
during cell division and how this process is linked to
DNA replication. A central protein complex, called
chromatin assembly factor-1 (CAF-1), is bound to
newly synthesized histones H3 and H4 and loads them
onto replicating DNA during S phase. CAF-1 also
facilitates the assembly of the mature nucleosome
containing histones H2A and H2B, as well as the
inheritance of epigentically determined states of gene
expression. The latter complexes in yeast include the
silent mating-type loci and telomere-associated
silencing complexes. We recently reported that CAF-
1 connects with the replication fork by a direct inter-
action with the proliferating cell nuclear antigen
(PCNA) and that PCNA is also required for epigenet-
ic inheritance.
The histones that are associated with CAF-1 are
modified by acetylation on lysine residues in the
amino-terminal tail of histones H3 and H4. Since the
pattern of acetylation on these newly synthesized his-
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tones is unique, there has been considerable specula-
tion that the acetylation is required for assembly and
for marking the newly replicated chromatin. Although
in yeast, mutation of the amino-terminal tail of either
histone H3 or H4 has no obvious effect, mutation of
both tails simultaneously is lethal, suggesting an
important role in chromatin.
We tested whether the amino-terminal tails of his-
tones H3 and H4 are required for nucleosome assem-
bly by reconstituting the CAF-1-histone H3-14 com-
plex with recombinant proteins, including histones
that either retained or lacked both amino-terminal
tails. Unexpectedly, neither tail was required for DNA-
replication-dependent assembly of nucleosomes.
These results suggest that the amino-terminal tails of
histones H3 and H4, both of which can be modified by
acetylation and possibly methylation, are required
after formation of the mature nucleosome. Further-
more, since the pattern of modification on these tails
can change after replication, acetylases and deacety-
lases must be recruited to the replicated DNA,
although how this happens is not known. One clue
might be the finding that the small subunit of CAF-1
is also a subunit of known nucleosome remodeling
complexes, histone deacetylases, and histone acety-
lases. Perhaps the CAF-1 small subunit remains asso-
ciated with the newly formed nucleosome and recruits
the chromatin modifying enzymes.
CAF-1 was originally identified from human cell
extracts, and later, the identification of the yeast pro-
tein complex led to discovery of its role in inheritance
of epigentically determined states of gene expression.
In the last year, in collaboration with Takahasi Araki's
group at the University of Kyoto, we have shown that
CAF-1 is conserved in plants (and therefore most like-
ly all eukaryotes). The cloning of the genes encoding
the two large subunits of CAF-1 led to the interesting
discovery that the FASCIATA genes in Arabidopsis
thaliana encode CAF-1 subunits. The genes encoding
the two largest subunits of CAF-1 were expressed in
cells in the shoot apical meristem and root apical
meristem, both of which contain the rapidly proliferat-
ing stem cells. Mutations in these genes caused an
unusual thickening and shortening of the shoot or root
and misexpression of genes that determine cell fate in
these two growing parts of the plant. As a conse-
quence, genetically identical plants display a highly
varied appearance, reminiscent of the variegated phe-
notype of mutation in the PCNA gene in both yeast
and Drosophila. Thus, it is likely that CAF-1-mediat-
ed inheritance of chromatin will greatly influence
development in all multicellular eukaryotes.
PUBLICATIONS
Chong J.P., Hayashi M.K., Simon M.N., Xu R.M., and Stillman
B. 2000. A double-hexamer archaeal minichromosome
maintenance protein is an ATP-dependent DNA helicase.
Proc. Natl. Acad. Sci. 97: 1530-1535.
Mendez J. and Stillman B. 2000. Chromatin association of
human origin recognition complex, cdc6, and minichromo-
some maintenance proteins during the cell cycle: Assembly
of prereplication complexes in late mitosis. Mol. Cell. Blot
20: 8602-8612.
Mizushima T., Takahashi N., and Stillman B. 2000. Cdc6p mod-
ulates the structure and DNA binding activity of the origin
recognition complex in vitro. Genes Des 14: 1631-1641.
Shibahara K., Verreault A., and Stillman B. 2000. The N-termi-
nal domains of histones H3 and H4 are not necessary for
chromatin assembly factor-1-mediated nucleosome
assembly onto replicated DNA in vitro. Proc. Natl. Acad.
Sci. 97: 7766-7771.
Zhang Z., Shibahara K., and Stillman B. 2000. PCNA connects
DNA replication to epigenetic inheritance in yeast. Nature
408: 221-225.
Zou L. and Stillman B. 2000. Assembly of a complex contain-
ing Cdc45p, replication protein A, and Mcm2p at replica-
tion origins controlled by S-phase cyclin-dependent kinas-
es and Cdc7p-Dbf4p kinase. MoL Cell. Biol. 20: 3086-
3096.
In Press
Kaya H., Shibahara K., Taoka K., Iwabuchi M., Stillman B., and
Araki T. 2001. FASCIATA genes for chromatin assembly
factor-1 in Arabidopsis maintain the cellular organization of
apical meristems. Cell 104: 131-142.
Ola A., Waga S., Ellison V. Stillman B., McGurk M., Leigh I.M.,
Waseem N.H., and Waseem A. 2001. Human-
Saccharomyces cerevisiae proliferating cell nuclear antigen
hybrids: Oligomeric structure and functional characteriza-
tion using in vitro DNA replication. J. Biol. Chem. 276:
10168-10177.
Y.-J. Sheu
57
TRANSCRIPTION AND PROTEOLYSIS
W.P. Tansey A. Gaudy
J. Chenowith
S. Hart
A. Herbst
S.Y. Kim
S. Salghetti
K. Tworkowski
The maintenance of normal cellular growth and differ-
entiation ultimately depends on mechanisms that regu-
late cell cycle progression. Two of the most important
of these regulatory mechanisms are transcriptional
activation and proteolytic destruction, which together
control the appropriate appearance and disappearance
of key cell cycle players. Work in our laboratory
explores the intersection between these two processes
to understand how oncogene transcription factors are
regulated at the level of their own destruction.
REGULATION OF MYC DESTRUCTION
As a paradigm for transcription factor destruction, we
study Myc. Myc is a basic helix-loop-helix transcrip-
tion factor that features prominently in the regulation
of cell proliferation and in cancer. Myc is also a high-
ly unstable protein that is destroyed within minutes of
its synthesis. The rapid destruction of Myc has an
important role in keeping intracellular levels of the
Myc protein low and responsive to environmental
stimuli. Our laboratory studies how cells control Myc
activity by controlling Myc destruction, and how this
process goes wrong in cancer.
We have previously shown that Myc is an unstable
protein because it is destroyed by a process known as
ubiquitin-mediated proteolysis. In this process, the
covalent attachment of Myc to the protein ubiquitin
(Ub) signals its destruction by a large protease com-
plex called the proteasome. Protein ubiquitylation is a
highly specific process that begins when an element
within the target protein-termed a degron-is recog-
nized by the cellular ubiquitylation machinery. After
the degron is recognized and bound, Ub is then trans-
ferred to a lysine residue within the target protein. This
process is then repeated many times to produce a high-
ly ubiquitylated substrate that is rapidly destroyed by
the proteasome. Because proteasomal destruction
depends on prior substrate ubiquitylation, selectivity
in degron recognition by the ubiquitylation machin-
ery-and regulation of this process-is central to the
control of Ub-mediated proteolysis.
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We have characterized several elements in Myc
that regulate its stability. Our previous studies identi-
fied two of these elements (see Fig. 1): (1) Degl,
which signals Myc destruction by Ub-mediated prote-
olysis, and (2) Stab 1 , which promotes Myc stability,
probably by association with a protein called Miz-1.
Degl is an interesting element because it overlaps
with the transcriptional activation domain (TAD) of
Myc, and because it is the major site of cancer-associ-
ated mutations within Myc. Indeed, we have previous-
ly shown that cancer-associated mutations within
Degl, which are observed in a very high percentage of
lymphomas, subvert the Ub-mediated destruction of
Myc and allow the protein to accumulate, suggesting
that enhanced protein stability is a mechanism of Myc
activation in cancer.
In the past year, we have identified a second
degron, Deg2, that lies within the interior of the Myc
protein (see Fig. 1). Deg2 displays a number of inter-
esting characteristics. First, although Deg2 is required
for rapid Myc turnover, it does not appear to signal
Myc ubiquitylation. On the contrary, deletion of Deg2
promotes Myc ubiquitylation at the same time as it
TAD DBD transcription
0-11---6-----11211 evolution
Degl Deg2
I 111111111 1 111 I I 1111 I III
Stabt stability
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FIGURE 1 Myc. The cartoon shows the domain structure of the
Myc protein and indicates the relationship between different
functional elements within Myc. "Transcription" refers to ele-
ments required for transcriptional activation: the TAD, DNA-
binding domain (DBD), and nuclear localization signal (N).
"Evolution" refers to the highly conserved sequence elements
within Myc: the three Myc boxes (I, II, and Ill), and the helix-loop-
helix (HLH) DNA-binding motif. "Stability" refers to elements that
regulate Myc destruction (see text for details). "Mutations"
shows the position and frequency with which residues within
Myc are mutated in lymphoma.
stabilizes the protein. This unusual behavior has led us
to speculate that Deg2 specifically has a role in the
destruction of ubiquitylated Myc; we are currently
exploring this possibility. Second, Deg2 appears to
function in a cell-specific manner. We have used our
recently developed HAM-epitope tag-which
improves the sensitivity of in vivo metabolic labeling
experiments-to probe the destruction of Myc in a
variety of primary and established cell lines. These
studies have revealed that Deg2 is active only in a sub-
set of cell types. This activity of Deg2 reveals that
Myc stability is regulated differently in different cell
types and implies that the destruction of Myc is a
highly controlled event that is modulated to control
specific aspects of Myc activity. Finally, Deg2 is inter-
esting because it overlaps structurally and functional-
ly with a highly conserved sequence element within
Myc called Myc box III (MbIII). MbIII was discov-
ered many years ago as an element present within
almost all Myc proteins, yet its function has remained
elusive. Our demonstration that MbIII has a role in
Myc destruction provides a function for this "orphan"
element within Myc and suggests that the proteolytic
destruction of Myc has a major role in directing the
conservation of this element. We are currently explor-
ing how Deg2 works and attempting to understand the
basis of its cell-specific function.
ACTIVATION DOMAIN-DIRECTED
PROTEOLYSIS
Our studies of Myc proteolysis not only have con-
tributed to our understanding of the biology of Myc,
but have also given insight into more general aspects
of how transcriptional activators are targeted for Ub-
mediated destruction. Many transcription factors, par-
ticularly those involved in the control of cell growth
(e.g., p53, E2F, etc.), are unstable proteins that are
destroyed by Ub-mediated proteolysis. Our demon-
stration that Degl of Myc overlaps with the Myc TAD
prompted us to further explore the relationship
between these two types of elements. We have since
learned that the overlap of TADs and degrons is com-
mon, intimate, and reciprocal: TADs and degrons
overlap in most unstable transcription factors, we can-
not separate the two activities by mutagenesis of these
domains, and degrons, when fused to a DNA-binding
domain, can activate transcription. On the basis of
these observations, we conclude that activation
domains are a type of degron and have coined the term
DADs (destruction and activation domains) to refer to
these elements. The realization that TADs and degrons
overlap has practical value-it can aid in the discovery
and analysis of instability determinants in transcrip-
tion factors-and it implies that a common mecha-
nism underlies transcription factor destruction; per-
haps transcription factors share a common set of ubiq-
uitylating enzymes.
In the past year, we have attempted to understand
why it is that these two (apparently) very different bio-
logical activities have converged in DADs. Our
approach to this problem has been to analyze the activ-
ity of DADs in yeast, where genetics makes it possible
to manipulate the factors that control DAD activity. In
our yeast studies, we have not focused on Myc, but
instead have analyzed the function of another DAD,
the prototypical acidic activation domain from the her-
pes simplex virus activator VP16. We have used genet-
ics to identify the cellular machinery that targets the
VP16 DAD for destruction and have shown that the
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FIGURE 2 Degron function is required for the VP16 activation
domain to activate transcription. (a) Lex-VP16 destruction
requires the Ub-ligase Met30. The VP16 DAD was fused to the
LexA DBD and expressed in yeast either carrying (+Met30) or
lacking (-Met30) a wild-type Met30 gene. The figure shows the
results of pulse-chase analysis, measuring the stability of Lex-
VP16 in the two different yeast backgrounds. "CT" refers to
chase-time (in minutes). (b) LexA-VP16 activity requires the Ub-
ligase Met30. The figure shows the results of transcriptional
analyses, measuring the ability of Lex-VP16 to activate a
reporter gene in the presence or absence of Met30, as indicat-
ed. Also shown are the transcriptional activities of the LexA
DBD alone (A) and LexA fused to the Myc DAD.
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degron function of the VP 16 DAD requires a ubi-
quitylating enzyme called Met30. In yeast deficient
for Met30, the VP16 DAD cannot signal protein
destruction, as shown in Figure 2. Surprisingly, in
yeast deficient for Met30, we also find that the VP16
DAD cannot activate transcription. Thus, both the
degron and activation domain function of the VP16
DAD require Met30. This result further cements the
tight relationship between activation domains and
degrons and suggests that, in order to activate tran-
scription, transcription factors need to be unstable.
But why would activation domain function require
proteolysis? We suspect that the intimate relationship
between transcriptional activation and protein destruc-
tion reflects a mechanism of "activator licensing," in
which transcriptional activation domains are permitted
to activate transcription only under conditions in
which they will be destroyed. This mechanism makes
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efficient use of the proteolytic machinery (by ensuring
that only active proteins are destroyed) and could
serve as an important regulatory step to limit uncon-
trolled gene activation. Future studies will test this
hypothesis and will explore the mechanistic link
between TADs and degrons.
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MOLECULAR GENETICS
Dr. Hengartner's group continued their effort to understand how C. elegans responds to DNA dam-
age. They published this year the first report showing that DNA damage response pathways in C.
elegans were likely to be conserved with those found in humans and yeasts.
Dr. Hannon's lab has succeeded in identifying a combination of viral and cellular oncogenes that can
successfully transform normal human cells into cancer cells. They are now investigating the cellular
pathways that are altered by these oncoproteins to effect transformation. In addition, they have
made substantial progress in understanding the mechanism by which double-stranded RNA
induces gene silencing in organisms ranging from plants to Drosophila and, under some circum-
stances, mammals. A detailed picture of this mechanism may allow the development of novel
experimental tools and possibly even new therapeutic approaches.
Dr. Jackson's lab is studying the mechanisms of cell-to-cell communication in the shoot meristem
and has characterized mutations in a receptor that is involved in controlling stem cell proliferation
and may be a target for improving crop yields. They have also shown that the cell-to-cell movement
of a homeodomain protein can be tracked using fusions to the green fluorescent protein, providing
a tool to characterize this novel pathway of cell-to-cell communication.
Dr. Martienssen's group has completed the first plant genome sequence, that of the laboratory
model Arabidopsis thaliana (mouse-ear cress), clearly the highlight of the year in plant genetics. The
sequence is being used at CSHL to perform systematic functional genomics, to investigate the epi-
genetic properties of heterochromatin, and to positionally clone genes important in development.
One example is asymmetric leaves 1, a gene required for leaf patterning and stem cell fate that
encodes a homolog of the maize gene roughsheath2.
Dr. Lucito's group is designing a genomic microarray to identify regions of the genome that under-
go copy number fluctuations in cancer and is exploring the use of microarrays for gene mapping.
This method relies heavily on the technique of genomic representations, populating the array with
representational fragments and hybridizing genomic representation samples to these microarrays.
Dr. Mittal's group, with collaboration from Wigler's lab, have used an ecdysone-inducible mam-
malian expression system and human cDNA microarrays (containing 15,000 elements) to analyze
changes in patterns of gene expression upon induction of either the wild-type or mutant PTEN
tumor suppressor in the glioblastoma cell line U87MG (which lacks a functional PTEN). Also, in col-
laboration with Wigler and Lucito's groups, they have been exploring the use of cDNA microarrays
for gene mapping.
Dr. Hamaguchi's lab has isolated six genes from the deleted region at human chromosome 8p22,
including TRAILR2, DBC1, and DBC2. TRAILR2 has been screened for mutations in both familial
and sporadic breast cancer cases and no significant genetic alterations have been detected. They
have discovered that DBC2 is inactivated in many breast cancer cells by deletions, somatic muta-
tions, or transcriptional inactivation, which makes DBC2 a strong candidate for a tumor suppressor
gene involved in breast cancer development.
Dr. Wigler's group has been exploring the use of microarrays for functional genomics, gene map-
ping, and mutation detection in cancer and spontaneous genetic disease. They have continued the
analysis of the PTEN tumor suppressor, confirming its role in the phosphatidyl inositol signaling
pathways, and confirming its role as a tumor suppressor. Additionally, the group has been devel-
oping algorithms for automated anotation of the human genome.
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CELL CYCLE CONTROL IN SACCHAROMYCES CEREVISIAE
B. Futcher J. Donovan T. Volpe
N. Edgington H. Wijnen
F. Ferrezuelo J. Zhou
S. Honey
Our main interest is the regulation of Start and mitosis
in Saccharomyces cerevisae. We are most interested in
the tethering of division to cell growth and in the gen-
eration of the basic cell cycle oscillation. Many key
cell cycle events are regulated by protein kinase com-
plexes formed between Cdc28 and one of nine cyclins.
These fall into two broad groups: the G1 cyclins,
which include Clnl, Cln2, and Cln3, that regulate
Start; and the mitotic, B-type cyclins Clbl, C1b2,
C1b3, and C1b4. Two other cyclins, C1b5 and C1b6, are
very important for DNA replication, but they also have
roles at Start and perhaps also in early mitosis. A sec-
ond interest is yeast and human telomerase, and how
telomere length relates to cell senescence.
A Network for Exit
from Mitosis
J. Donovan
High Cdc28 kinase activity is required for mitosis. At
the end of anaphase, this Cdc28 kinase must be inac-
tivated to allow the mitotic spindle to dissolve. This
inactivation can be thought of as consisting of two
steps: (I) a signaling step, in which the completion of
anaphase triggers some unknown signal, and (2) an
inactivation step, in which Cdc28 kinase is inactivated
by destruction of cyclins, production of the CDK
inhibitor Sic 1 , and possibly by other mechanisms. A
network of genes including CDC5, CDC15, TEM1,
DBF2, DBF20, and CDC14 is required for this signal-
ing and inactivation pathway. The typical loss-of-func-
tion phenotype is a large budded cell with divided
nuclei and a long mitotic spindle.
In a screen for high-copy suppressors of the tem-
perature-sensitive dbf2 mutation (a mutation that
blocks exit from mitosis), we isolated the novel gene
SLK19. Slk19 is a centromere- and spindle-associated
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protein and has a role in the maintenance of spindle
integrity. Although SLK19 is not essential, we have
shown that S1k19 has a role in completion of M phase
in concert with the mitotic exit network kinases Dbf2
and Cdc15. Furthermore, SLK19 becomes essential
when cells are defective in Clb proteolysis, or other-
wise have an excess of Clb2 -Cdc28 kinase activity. We
believe that Slk19 may use its position at the cen-
tromere to help signal to the cell when anaphase has
been completed, and so may have a role in triggering
the events that end mitosis, such as destruction of the
Clb cyclins.
Dissection of Nuclear and
Cytoplasmic Roles of Cyclins
N. Edgington
Nine different yeast cyclins bind to and activate the
Cdc28 protein kinase. Although the enzymatic proper-
ties of these complexes are similar, they have very dif-
ferent biological roles. We asked how many of these
differences could be accounted for by differences in
location. We have localized various G and mitotic
cyclins by various methods and, in addition, hare cre-
ated "forced localization" tags, which, when appended
to a protein, force it to be either cytoplasmic or
nuclear. These allow the functional importance of any
particular location to be evaluated.
For instance, the G, cyclin Cln2 is found in both
the cytoplasm and the nucleus. The cytoplasmic Cln2
is mostly at the sites of bud growth or polarized
growth, a very interesting location given that Cln2 is
known to be important for budding.
Neither cytoplasmic nor nuclear Cln2 can fully
complement cln2, showing that the Cln2 in both loca-
tions has important functions. The clnl cln2 clb5 clb6
quadruple mutant and the clnl cln2 kar3 triple mutant
are inviable, and these two mutants are rescued by the
nuclear form of Cln2 but not the cytoplasmic form,
suggesting that these functions of Cln2 are nuclear. On
the other hand, the inviable pal pc12 clnl cln2 and
bud2 clnl cln2 mutants are rescued by the cytoplasmic
form of Cln2 but not the nuclear form, suggesting that
these functions of Cln2 are cytoplasmic. Finally, the
swi4 swi6 mutant is rescued by wild-type Cln2, but it is
not rescued by cytoplasmic Cln2, or by nuclear Cln2, or
by the simultaneous combination of cytoplasmic and
nuclear Cln2. We suggest that shuttling of Cln2 from
nucleus to cytoplasm and back again is essential for
some role of Cln2.
Whi3 Binds the mRNA of the Gi
Cyclin CLN3 to Modulate Cell Fate
in Budding Yeast
T. Volpe, B. Futcher [in collaboration with E. Gari, H. Wang,
C. Gallego, and M. Aldea, Universitat de Lleida, Spain]
WHI3 is a novel size control gene. Mutant Whi3 cells
have small cell sizes, and this is because they under-
take Start and cell division at smaller cell sizes than
wild-type cells. We have shown that Whi3 is a nega-
tive regulator of the G, cyclin Cln3, which promotes
Start. Whi3 contains an RNA-recognition motif that is
essential for Whi3 function. This RNA-recognition
motif allows Whi3 protein to bind specifically to the
CLN3 mRNA. This seems to restrict CLN3 mRNA to
discrete cytoplasmic foci, which also contain Whi3
protein. In the absence of Whi3, CLN3 mRNA is not
restricted to these foci, CLN3 activity is increased, the
transcription factors SBF/MBF become hyperactivat-
ed, and cells go through Start prematurely. The physi-
ological role of WHI3 seems to be to restrain CLN3
activity in preparation for meiosis, filamentous
growth, and mating, and perhaps also when certain
kinds of nutrient deprivations occur.
Mechanisms of Transcriptional
Activation by Cyclin-Cdc28
Complexes
H. Wijnen
The Cln3-Cdc28 complex promotes passage through
the Gi/S transition by activating two transcription fac-
tors, SBF and MBF, which in turn induce the tran-
scription of more than 200 genes. We are trying to dis-
cover the mechanism of SBF/MBF activation.
One model for activation is that CLN3 inhibits an
inhibitor of SBF/MBF. This would be parallel to the
system in mammalian cells, where cyclin D /CDK4
(analogous to Cln3/Cdc28) inhibit Rb, an inhibitor of
E2F (analogous to SBF). To look at this model, we
have selected for mutants in which SBF is active even
in the absence of CLN3 (and the coactivator BCK2).
Several such mutants have been found. One is in the
CHD1 gene, a chromatin remodeling protein contain-
ing chromodomains. The CHD1 gene is highly con-
served throughout evolution, with homologs in
humans. It seems to be involved in repression.
Interestingly, Rb recruits a similar chromatin remod-
eling protein to E2F-regulated promoters. Other
mutations allowing SBF activity in the absence of
CLN3 and BCK2 were also found. Strikingly, several
of these, like chdl, were mutations in genes involved
in chromatin modification or remodeling. Further-
more, some of these mutants were nonresponsive to
CLN3, consistent with the idea that in the mutants, the
pathway from Cln3 to SBF/MBF is no longer func-
tional.
Use of Multiple Affinity
Purification Tags
S. Honey, B. Schneider
We have designed a small multiple affinity purifica-
tion tag. It consists of (1) the calmodulin-binding
peptide, which allows binding to calmodulin resin in
the presence of calcium, and allows elution by
EGTA; (2) six histidines, which allow binding to a
nickel column, and allow elution by imidazole; and
(3) a triple hemagglutinin (HA) tag, which allows
immunoprecipitation by antibody 12CA5. When this
"CHH" (Calmodulin, Histidine, HA) tag is appended
to any protein, the protein can then be purified by
two affinity steps and an immunoprecipitation step
can be applied in tandem. In practice, we have found
that application of any two of the steps in tandem
leads to essentially pure protein, plus associated pro-
teins. We have tagged the yeast mitotic cyclin Clb2
with the CHH tag and have purified Clb2 and associ-
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ated proteins. The associated proteins were identified
by mass spectrometry. They included Cdc28, Sicl,
and Cksl.
Identification of Bdfl as a
Transcription Factor for
Ribosomal Proteins
J. Zhou, K. Hidaka, B. Futcher [in collaboration
with M. Tyers, Samuel Lunenfeld Research Institute,
University of Toronto]
Bdfl is a bromodomain protein that helps regulate
telomere length. In addition, it is a basal transcription
factor. S. Buratowski (Harvard Medical School,
Boston) and colleagues have recently shown that Bdfl
is functionally similar to the carboxy-terminal domain
of mammalian TAF(II)250, whereas the yeast protein
Tafl45 is functionally similar to the amino-terminal
domain of TAF(II)250. That is, in yeast, Tafl45 plus
Bdfl form the equivalent of mammalian TAF(II)250.
Bdfl has a homolog called Bdf2, and the bdfl bdf2
double mutant is inviable. We constructed a condition-
al allele of bdfl and carried out microarray analysis to
see what genes were controlled by Bdfl/Bdf2. A strik-
ing result was that most genes encoding ribosomal
proteins, and many other genes involved in protein
synthesis, were strongly down-regulated when Bdfl
activity was lost. Few other genes responded.
However, among the other genes that did respond were
genes involved in secretion. It is known from the work
of J. Warner (Albert Einstein College of Medicine,
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New York) and colleagues that defects in secretion
quickly lead to defects in the transcription of riboso-
mal protein genes. We are now asking whether the loss
of transcription of ribosomal protein genes in the bdfl
mutant is a direct effect (i.e., due to Bdfl acting at the
promoters of these genes) or an indirect effect via the
secretion genes. We are also assaying the presence of
Bdfl at telomeres.
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TUMOR SUPPRESSOR GENES INVOLVED IN
BREAST CANCER
M. Hamaguchi D. King T. Odawara
J. Meth M. Reimels
TUMOR SUPPRESSOR GENES AND
BREAST CANCER
Cancer cells have multiple genetic alterations such as
amplifications, deletions, insertions, translocations,
single nucleotide substitutions, and chromosomal
abnormalities. These alterations affect two classes of
genes: oncogenes that are activated or altered in func-
tion and tumor suppressor genes that are down-regu-
lated or abolished in cancer cells. Our interest lies in
tumor suppressor genes because we believe that analy-
sis of tumor suppressor genes will provide further
insights into the relationship between cancer develop-
ment and cellular function. We also believe that under-
standing the biological function of tumor suppressor
genes will have an impact on several aspects of cancer
treatment. A new screening test might facilitate risk
assessment, precise molecular characterization of can-
cers might facilitate diagnosis and therapeutic choice,
and a new treatment can be established on new knowl-
edge about tumor suppressor genes.
In the case of breast cancer, isolation of BRCAI
and BRCA2 has resulted in a better understanding of
hereditary breast cancer. BRCAI and BRCA2 genes are
utilized for identification of those who are at high risk
of developing the breast cancers. Sequence alterations
in BRCAI and BRCA2 account for approximately 85%
of hereditary breast cancer cases. It is possible that
other genes responsible for inherited breast cancer
exist. Furthermore, the majority of breast cancer is
nonhereditary, and the somatic mutations responsible
for these cases remain to be elucidated.
The short arm of human chromosome 8 frequent-
ly suffers loss of heterozygosity (LOH) in sporadic
breast cancer cases, which means a part of a chromo-
some is missing and only one copy (instead of a pair)
of genes remains in the affected region. Frequent LOH
has been a clue to the presence of tumor suppressor
genes on that chromosomal arm. In addition, we dis-
covered homozygous deletion (HD) of 8p22 at a fre-
quency of 3.5% in surgical specimens. HD results in
elimination of genes in the region. It is a good indica-
tor of tumor suppressor genes because loss of tumor
suppressors is advantageous to malignant cells and is
observed commonly in many types of cancer. Analysis
of HD at 8p22 has led to isolation of six genes from
the commonly deleted region.
Deleted Genes
M. Hamaguchi, J. Meth, T. Odawara [in collaboration
with R. McCombie and M. Wigler, Cold Spring
Harbor Laboratory]
We have isolated six genes from the deleted region at
human chromosome 8p22. Sequence analysis of the
six genes revealed that three were known genes, anoth-
er partial sequence was registered in GenBank with no
information regarding biological function, and the
other two were new genes. We named the new genes
DBCI (GenBank accession number: AF293335) and
DBC2 (GenBank accession number AY009093). DBC
stands for deleted in breast cancer. The three known
genes were TRAILR2, Decoy Receptor, and EGR3,
among which TRAILR2 had been demonstrated to have
mutations in lung cancer. We conducted mutation
analysis of DBC1, DBC2, and TRAILR2.
MUTATION ANALYSIS
Several methods are available for mutation analysis.
The protein truncation test (PTT) is a rapid way to
screen frameshifts and nonsense mutations, which are
most likely to result in alteration of the protein func-
tion. By PTT, an entire open reading frame (ORF) can
be screened in a reaction. The drawback, however, is its
inability to detect missense mutations. Additionally, it
requires RNA as a starting material, which makes
analysis more expensive and tedious than using DNA
as the starting material. Single-strand conformation
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polymorphism (SSCP) analysis is one of the most
commonly used methods for mutation detection.
SSCP is based on the mobility shift of mutants in elec-
trophoresis due to their conformational changes. It is
conceivable that not all mutations will result in the
mobility shift, which limits the sensitivity of SSCP.
Another method is denatured high-performance liquid
chromatography (DHPLC), which relies on a differ-
ence of retention time in a column between mutant
and wild-type fragments under a half-denatured con-
dition. DHPLC is high-throughput, but not all genom-
ic regions are suitable for the analysis. It is difficult to
determine a running condition for a DNA fragment
with uneven distribution of bases because a selected
condition will be optimized for a part of the fragment
and mutations in the other part will not be revealed.
We utilized all three methods for mutational analysis
to supplement each other.
Mutation Analysis
of DBC1
M. Hamaguchi, J. Meth
We searched for mutations of DBC1 in 60 cell lines by
PTT and DHPLC. Neither analysis detected a muta-
tion. Expression analysis by reverse transcriptase-
polymerase chain reaction (RT-PCR) and Northern
blot analysis revealed that DBC1 was expressed ubiq-
uitously not only in normal tissues, but also in many
tumors including breast cancer. We believe that DBCI
has a remote possibility of being a tumor suppressor
gene involved in breast cancers.
Mutation Analysis
of TRAILR2
M. Hamaguchi, J. Meth [in collaboration with M.C. King,
University of Washington, and M. Wigler, Cold Spring
Harbor Laboratory]
Since DBC2 and TRAILR2 were found to reside in the
deletion epicenter, they were considered stronger
candidates for being tumor suppressor genes.
Further-more, TRAILR2 was shown to be involved in
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the apoptosis pathway. In fact, several groups have
published mutational analyses of TRAILR2. One
group demonstrated frequent mutations in the "death
domain" in non-small-cell lung cancer. Another
group reported mutational analysis of colorectal can-
cer, but found no mutations. A germ line mutation of
TRAILR2 that caused premature termination of trans-
lation was demonstrated in a head and neck cancer.
HD of TRAILR2 has been reported in nasopharyngeal
cancer.
TRAILR2 was analyzed for mutations in cancer
cells, using PTT, DHPLC, and SSCP. In 60 cell lines
(including 20 breast cancer cell lines) and 90 primary
breast tumors, we found two previously identified
polymorphisms and two new single-nucleotide intron-
ic alterations, but no new mutations in coding regions.
Because linkage to this locus has been reported by
other investigators in one family with a predisposition
to breast cancer, we determined the status of the
TRAILR2 gene in 427 breast cancer patients and 372
normal controls. Two new rare missense mutations
were identified in the germ line DNA of breast cancer
patients, and one of these in normal controls. Analysis
of germ line DNA of probands of 44 high-risk families
(unlinked to BRCAI or BRCA2), however, revealed
only previously known common polymorphisms in
TRAILR2. Our findings tend to eliminate mutation of
TRAILR2 in somatic breast cancer development.
Analysis of DBC2
M. Hamaguchi, D. King, J. Meth, T. Odawara,
M. Reimels [in collaboration with M. Zhang and
M. Wigler, Cold Spring Harbor Laboratory]
Mutation Analysis of DBC2. Elimination of TRAILR2
leaves DBC2 as a leading candidate for a tumor sup-
pressor in the deletion epicenter. A cDNA clone com-
posed of ten exons was isolated from a cDNA library
of a normal breast tissue (Genbank accession number
AY009093). This transcript is found in the placenta,
colon, and stomach and is considered a major tran-
script. An alternatively spliced transcript was found in
a lung tissue. It lacks exon 1 and a part of exon 2 but
contains three unique exons derived from further
upstream to the promoter region of the major tran-
script. Although the ORFs of both transcripts seem to
be identical, their transcriptional regulation may be
different since CpG islands for the major transcript are
located in an intron of the variant transcript.
We first performed mutation analysis of the com-
mon exons (exons 3 through 10) of DBC2. We applied
PTT on 60 tumor cell lines and found no truncating
mutations. Exons 3-10 were also analyzed by DHPLC
on 96 cell lines, resulting in identification of three
missense mutations and six polymorphisms/silent
mutations.
Expression Analysis. We investigated the expression
of three genes, DBC1, DBC2, and TRAILR2, in 59
tumor cell lines by RT-PCR. All three were expressed
in the normal breast tissues we examined. The DBC2
transcript was detected only in 44% of breast tumors
and in 50% of lung cancer, but in as much as 90% of
cancer of the other origins such as colon and kidney.
In contrast, both DBC1 and TRAILR2 were expressed
in at least 80% of any tumor. Some of the results were
confirmed by Northern blot analysis.
Computational Analysis ofDBC2. Analysis of a novel
gene can be initiated with computational analysis of
the sequence. Similar sequences to the query can be
searched by the basic local alignment search tool
(BLAST) (Altschul et al., Nucleic Acids Res. 25: 3389
[1997]). Motif and promoter searches are also avail-
able. These results will sometimes provide a clue to
hypothesize the function of the gene product, but a
gene in an entirely new class will produce only
insignificant output and call for other approaches.
We utilized a program, CpGpromoter, to locate
CpG islands of the major transcript and found one
about 500 by upstream of exon 1. The BLAST search
of DBC2 revealed that amino acids 12 to 308 of DBC2
had homology with RAC1 with 38% identities
(76/200), 53% positives (106/200), and 3/200 gaps. It
also showed homology with an anonymous gene,
KIAA0740. The conserved protein regions were also
searched for by Pfam HMM (Bateman et al., Nucleic
Acids Res. 28: 236 [2000]). Two BTB/POZ (254-472
and 485-598) domains and a ras (16-258) domain
were located (Zollman et al., Proc. Natl. Acad. Sci. 91:
10717 [1994]). DBC2 is a gene of new class because a
BTB/POZ domain is often observed with MATH,
Kelch repeats, or a C2H2-type zinc finger, none of
which are present in DBC2, and because no known
gene has both ras and BTB/POZ domains.
DBC2 as a Candidate for a Tumor Suppressor. We
believe that the 8p22 locus is likely to contain a new
tumor suppressor gene on the basis of our findings:
Homozygous deletion at 8p22 is observed in 7 of 200
breast tumors; DBC2 is the most frequently deleted
gene located in the deletion epicenter; it suffers muta-
tions, although the frequency is not high, and it is
silenced in more than half of the breast cancer cell
line. These results make DBC2 a good candidate for a
tumor suppressor gene involved in breast cancer and
urge us to scrutinize it further.
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GROWTH CONTROL IN MAMMALIAN CELLS
G. Hannon S. Boettcher
D. Conklin
S. Hammond
Y. Seger
J. Du
M. Carmel!
A. Caudy
A. Dent
My laboratory focuses on two general areas. First, we
probe the mechanisms by which normal cells evolve
into cancer cells. Our approaches to this problem are
varied. The mainstay of our cancer program is the abil-
ity to manipulate cultured cells and to confer upon
those cells the properties of tumor cells. This past year,
we achieved the goal of beginning with normal,
human diploid cells and converting these into cancer
cells through a series of three genetic alterations. This
opens the door to an investigation of cellular path-
ways, which can be altered to create a cancer cell de
novo. We are presently attempting to extend this initial
finding to the creation of cell-type-specific cancer
models for a variety of human neoplasms. Second, we
are interested in the mechanisms by which double-
stranded RNA can silence gene expression in organ-
isms ranging from plants to worms, flies, and mam-
mals. We are using biochemical approaches to under-
stand the mechanism underlying this phenomenon.
During the past year, we have made substantial
progress developing in vitro systems that recapitulate
double-stranded RNA (dsRNA)-induced gene silenc-
ing and identifying some of the proteins that partici-
pate in this process. In addition, we have begun to
weave together the two threads in the laboratory, initi-
ating a project to harness dsRNA-induced silencing in
high-throughput "phenomics." Using cultured cells
from Drosophila as a model system, we hope to inves-
tigate genetic pathways that have proven to be central
to the transformation process in humans. Our ultimate
goal is to extend the ability of dsRNA to silence gene
expression to human cells, enabling cancer-related
questions to be asked in the relevant organism, rather
than in a model system.
Human Cancer Cells
Y. Seger
Cellular transformation processes require a series of
genetic and epigenetic events that result in a normal
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cell being converted into one that is cancerous. This
process is most commonly initiated by an increase in
proliferative signals coupled with the inactivation of
tumor suppressor mechanisms. Although the use of
rodent model systems has provided a significant
amount of information regarding precise genetic alter-
ations involved in cellular transformation, it is appar-
ent that these models do not directly reproduce the
processes, which lead to human cancer. Namely,
whereas primary rodent cells can be transformed by
the combined overexpression of the myc and ras onco-
genes, human cells expressing this same gene combi-
nation undergo irreversible growth arrest or senes-
cence.
We have found that normal human diploid fibro-
blasts (BJ cells) expressing the combination of E1A
and Ha-RasV12 are capable of soft agar colony forma-
tion. This reflects one property of transformed cells, a
decreased reliance on proper attachment to an extracel-
lular substrate. These coinfected cells, however, were
incapable of tumor formation in nude mice. Previous
analysis of this oncogene combination in rodent cells
indicated that tumor formation was aided by a con-
comitant hit in the p53 pathway. We therefore chose
MDM2, the negative regulator of p53, as a candidate
third oncogene in our transformation equation. BJ cells
expressing the combination of adenovirus E 1 A,
MDM2, and Ha-RasV12 are capable of both soft agar
colony formation and tumor formation in nude mice.
Substitution of wild-type E1A with deletion
mutants has allowed us to characterize the functional
interactions that may be important for both transfor-
mation processes and evasion of normal mortality
controls in this human fibroblast model. Interactions
at the amino terminus of E1A, namely, those with the
transcriptional coactivator p300/CBP and with p400,
appear to be vital for transformation. The CR2 region,
which directs interactions with Rb, is also indispens-
able. We are particularly interested in the ability of
cellular oncogenes such as c-myc to rescue the trans-
formation defects of these mutants with the hope of
establishing a transformation equation based solely on
cellular oncogene expression.
Mechanisms That Contribute
to Genetic Instability
in Cancer
J. Du
An almost invariant characteristic of human tumors is
that they display genetic instability. This has been
touted as an obligate step in the genesis of a tumor and
dismissed as simply a consequence of the transforma-
tion process. In fact, reality probably lies between
these extreme views. We have begun to investigate the
mechanistic basis of chromosome instability by focus-
ing on the organelle that organizes the mitotic spindle.
Mitotic spindles are responsible for correctly parti-
tioning the genome between two daughters that are
generated by cell division. The spindle is nucleated by
an organelle known as the centrosome, which serves
to position the spindle for proper segregation of the
genome. Replication of the centrosome is tightly reg-
ulated during the cell cycle so that a single centro-
some in early G1 -phase cells is duplicated to yield the
two centrosomes that anchor the bipolar spindle.
However, in human cancer cells, centrosome numbers
are often abnormal, leading occasionally to multipolar
spindles and possibly to improper chromosome segre-
gation. We have begun to investigate the mechanisms
that regulate centrosome duplication in an attempt to
understand how abnormal centrosome numbers are
generated in cancer cells and to probe the relationship
between deregulation of centrosome duplication and
genomic instability in cancer.
We have investigated the ability of oncogene
expression to provoke centrosome amplification in
NIH-3T3 cells. Among many oncogenes and other
tumor-related genes that were tested, AKT and Jun
are capable of inducing centrosome amplification.
Other centrosome defects observed in these cells
include aberrant centrosome morphology, stronger
microtubule nucleating capacity (abnormally strong
staining with anti-(3-tubulin antibodies), and abnor-
mal centrosome localization (away from nuclear
envelope). These defects may be primary effects of
these oncogenes because just 48 hours after introduc-
ing the genes into cells by infection, centrosome
numbers are well above controls. Live-cell imaging
shows that cells with multiple, green fluorescent pro-
tein (GFP)-tagged centrosomes go through mitosis
and occasionally divide into more than two daughter
cells. This strongly suggests that the presence of mul-
tiple centrosomes can induce aberrant division to gen-
erate cells with potentially abnormal chromosome
contents.
We are also taking a biochemical approach, focus-
ing on a kinase that has been linked to the centrosome
cycle in yeast, worms, and mammals. Using anti-
STK15 antibodies, we have isolated an STK15 com-
plex, which is composed of at least six components
(SAF160, SAF55 [CDC20], SAF46 [STK15/aurora],
SAF37, SAF35, and SAF31). We are currently purify-
ing the complex and identifying these proteins. With
two-hybrid screening and IP Western, we also find that
STK15 associates with Nm23-H1, a human metastasis
suppressor protein that is localized at the centrosome.
Its Drosophila counterpart, awd, is microtubule-asso-
ciated, and null mutations are arrested in metaphase of
cell cycle. In the coming year, we will investigate the
role of these proteins in regulating centrosome dupli-
cation and the relevance of this process to genomic
instability in human cancer.
Genetic Investigation of
Calcium Regulation of
Cellular Proliferation
D. Conklin
Although calcium ion is arguably the most important
second messenger in excitable cell signaling, a con-
siderable amount of work has indicated an important
role for Ca'-` signaling in the regulation of prolifera-
tion in nonexcitable cells. At present, both the mecha-
nisms of calcium release and the downstream effects
during the cell cycle are poorly understood. The
importance of these signals to cellular proliferation,
however, is underscored by the ability of calcium
antagonists to inhibit cell cycle progression in a num-
ber of eukaryotic cells.
In an effort to identify gene products involved in
the calcium regulation of cell proliferation, genetic
screens have been carried out in eukaryotic cells to
identify cellular components with roles in Ca" regula-
tion of mitogenesis. Thirty independently isolated
yeast mutants have been found that are resistant to cal-
cium antagonists. Interestingly, all of these strains
exhibit a late G1 cell cycle arrest when grown under
normal conditions. When grown in media containing
elevated concentrations of Ca'', these strains grow
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normally. Genetic analysis indicates that the lesions
which give rise to this phenotype are duplication and
translocation mutations within the yeast genome.
Current efforts are directed at discerning which genes
contribute to the Ca" remedial arrest phenotype in
these strains.
In mammalian cells, retroviral cDNA libraries
have been screened for genes that, when overex-
pressed, allow cells to escape calcium channel antago-
nist-induced prereplicative cell cycle arrest. Several
known genes involved in signal transduction have
been isolated in these screens. One gene selected for
the ability to confer resistance to the inorganic calci-
um channel blocker cobalt also conferred resistance to
the 1,4 dihydropyridine calcium channel antagonist,
nifedipine. This gene, HXCT1, encodes a member of
the CD98 light-chain family of amino acid trans-
porters. Functional analysis indicates that HXCT1
encodes the human x-c transport system, which carries
out cystine uptake. Overexpression of this gene results
in increased cystine uptake and increased intracellular
reduced thiol levels, which in turn affect the impact of
drugs on Ca.-"- signaling. Since HXCT1 overexpression
does not confer increased resistance to a number of
other drugs and xenobiotics that are known to inhibit
proliferation, the increased calcium antagonist resis-
tance does not result from increased levels of general
stress response or drug detoxification. Current efforts
are directed at investigating links between cellular
thiol status and Ca" release.
Dicer Is a Nuclease That
Generates Guide RNAs
for PTGS
E. Bernstein, A. Gaudy, S. Hammond
The phenomenon of RNA interference (dsRNA-
induced gene silencing or PTGS) is a gene silencing
mechanism that is not well understood. dsRNAs
induce gene silencing, in part, by provoking degrada-
tion of homologous endogenous mRNA. RNA inter-
ference (RNAi) has been demonstrated in a diverse
group of organisms including Caenorhabditis elegans,
Drosophila, trypanosomes, plants and fungi, and the
early mouse embryo.
Various genes involved in RNAi have been identi-
fied through genetic screens in plants and worms,
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although none have been given a definitive role in the
RNAi pathway. Recently, the identification of a small
RNA species of about 25 nucleotides was linked to
RNAi in plants undergoing silencing. We have demon-
strated that these small RNAs form a part of the effec-
tor nuclease that degrades mRNAs and most likely act
as the specificity subunit of the enzyme. Another
group discovered that Drosophila embryo extracts
contained an activity that cleaved dsRNA to generate
these small "guide" RNAs.
Our lab has previously established a very efficient
biochemical system to probe the mechanism of RNAi
in Drosophila S2 cells, which has allowed for the iden-
tification of an RNA nuclease capable of degrading
the target mRNA (RNA-induced silencing complex
[RISC]). We have since created similar in vitro sys-
tems from Drosophila embryos. Biochemical purifica-
tion and candidate gene approaches led to the identifi-
cation of Dicer, the enzyme responsible for cleaving
the dsRNAs that provoke interference into 22-
nucleotide "guide" RNAs. This enzyme is quite
unique in its structure in that it contains two RNase III
domains and an RNA helicase domain. It also contains
a motif of unknown function called the PAZ (piwi/arg-
onaute/zwille) domain, which is also present in the
argonaute family of proteins, which have also been
implicated in RNAi. Dicer probably acts at the top of
the pathway by creating small guide RNAs that allow
the RISC protein complex to find its homologous tar-
get mRNA. It is the first protein to be given a precise
role in the mechanism of RNAi.
Argonaute Is a Component
of the RNAi Effector
Nuclease
S. Hammond, S. Boettcher
Our studies have indicated that RNAi is mediated by a
sequence-specific nuclease which destroys mRNAs
homologous to the inducing dsRNA. During the past
year, we have taken a biochemical approach to unde-
standing this effector nuclease. We have purified the
nuclease substantially but not to homogeneity from
Drosophila cultured cells. This effector nuclease,
which we termed RISC, is a stable entity containing all
of the necessary information for the targeting and
destruction of appropriate mRNAs. The activity is a
ribonucleoprotein complex of approximately 500 kD,
consisting of (four to five so far) protein components,
and one RNA component. Microsequencing reveals
that one of the protein components is a homolog of C.
elegans rde-1 and Arabidopsis thaliana argonaute.
This gene family has a role not only in RNAi, but also
in development and stem cell maintenance. This is the
first assignment of a previously identified mutation to
a specific biochemical point in the RNAi pathway.
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CAENORHABDITIS ELEGANS DEVELOPMENTAL GENETICS
M. Hengartner A. Calixto T. Gumienny J. Kinchen M. Spector
A. Elewa (URP) D. Hoeppner S. Milstein S. Tharin
L. Englmeier R. Hofmann B. Schumacher J. Ye
S. Granat
Our laboratory uses Caenorhabditis elegans to study
two basic biological problems: programmed cell death
(apoptosis), and nervous system development and
function. The value of C. elegans for such studies
derives from its simplicity at the anatomical and
developmental levels, from its powerful genetics and
reverse genetics, and from the ready availability of
genetic and molecular reagents (mutant collections,
genome sequence, and so forth).
Despite its humble dimensions and simple anato-
my, one should not lose sight of the fact that C. elegans
is a metazoan-a multicellular animal-and as such
shares with humans many fundamental molecular and
cellular programs. It is this similarity at the level of
genes and biochemical pathways that allows the nema-
tode worm to be a useful model system.
PROGRAMMED CELL DEATH
Programmed cell death (PCD), or apoptosis, is a high-
ly regulated program of cell suicide. Apoptosis is
ubiquitous in humans. It is used during development
to remove unnecessary cells; in adults, it contributes to
the maintenance of cell populations and to the elimi-
nation of potentially dangerous (e.g., cancer-prone)
cells. Defects in cell death have been implicated in the
pathogenesis and/or etiology of many human diseases
including cancer, various neurodegenerative diseases,
and AIDS. A better understanding of the molecular
mechanisms underlying the regulation and execution
of cell death may thus lead to significant improve-
ments in how these diseases are treated.
The proximal cause of apoptosis in C. elegans is
the activation of the caspase homolog CED-3 from the
inactive zymogen (proCED-3) into the mature pro-
tease. This activation is mediated by the Apaf-1
homolog CED-4. In cells that should survive, CED-3
and CED-4 are kept in check by the Bcl -2 family
member CED-9. All three proteins are structurally and
functionally conserved between nematodes and mam-
mals, strongly suggesting that all metazoans share a
common mechanism of apoptotic cell killing.
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Physiological Cell Death in the C. elegans Germ
Line: How is the apoptotic machinery regulated? In
mammals, cells must integrate a large number of inputs
(coming from various pro-death and pro-survival sig-
nals) before a decision to live or die can be taken. To
understand how individual cells control activation of
the death pathway in C. elegans, we set out to deter-
mine how a single cell type-the germ cell-makes
this fateful decision.
PCD is very common in the adult hermaphrodite
germ line: More than half of the germ cells that dif-
ferentiate along the oogenic pathway undergo PCD. To
identify genes that control the extent of germ cell
death, we screened for mutations that result in
increased germ line apoptosis (gla mutations). So far,
we have identified at least six gla genes; mutations in
these genes specifically affect germ cell death, but not
developmental death. To understand why mutations in
gla genes lead to increased germ cell apoptosis, we are
now cloning these genes, using a combination of posi-
tional cloning and genome-wide RNA interference
(RNAi).
DNA-damage-induced Apoptosis in C. elegans: We
reported last year our discovery that C. elegans, like
mammals, possesses DNA damage checkpoints that
promote the elimination of damaged cells via apopto-
sis. DNA damage response pathways are intimately
implicated in tumor development and in response to
chemotherapy and radiotherapy. Thus, a better insight
into the molecular basis of DNA-damage-induced
apoptosis might lead to new avenues for prevention or
treatment of cancer.
To date, we have identified mutations in three
checkpoint genes that are required for DNA-damage-
dependent cell proliferation arrest and apoptosis. One
of these genes, mrt-2, encodes a homolog of the con-
served Schizosaccharomyces pombe radPiSaccharo-
myces cerevisiae RAD17 checkpoint gene. In the last
year, we have focused our attention on a second check-
point gene, hus-1, which encodes the C. elegans
homolog of the S. pombe checkpoint protein Hus 1. We
isolated mutations in hus-1 using a forward genetic
cytoskeleton
FIGURE 1 Getting rid of the bodies. Two partially redundant pathways, comprising CED
2, CED-5, CED-10, and CED-12 and CED-1, CED-6, and CED-7 mediate the removal of
apoptotic cell corpses in C. elegans. Arrows represent proposed order of action. Known
physical interactions are shown. (Adapted from Hengartner 2001.)
approach as well as through a directed reverse genetic
effort. We found that loss of hus-1 function leads to a
defect in both cell proliferation and apoptosis follow-
ing DNA damage. These results confirm the con-
served nature of the DNA damage response pathway
between yeasts and metazoans and encouraged us to
develop tools that will allow us to perform large for-
ward genetics screens and to properly classify the
mutations that we will obtain in these screens.
Engulfment Genes Can Kill: Once a cell turns on the
apoptotic machinery, a number of downstream "sub-
programs" are activated, with the goal of rapidly
breaking down the cell and removing it from the body.
One important subprogram results in the generation of
signals that promote recognition and phagocytosis of
the dying cell by other cells. At least seven genes are
required for the recognition and efficient removal of
apoptotic cells in C. elegans (Fig. 1). Inactivation of
any one of these seven genes delays clearance of
apoptotic cells, resulting in the accumulation of per-
sistent cell corpses.
Surprisingly, a functional engulfment program
appears to also be required for efficient cell killing: In
collaboration with Ralf Schnabel (TU Braunschweig,
Germany), we found that mutations that lead to
reduced engulfment result in a significant decrease in
apoptotic cell death. In other words, engulfment genes
not only remove cells that are already dead, but can
also kill cells that are still alive! This observation
stands in stark contrast to the classic view (previously
shared by us) that phagocytosis functions solely to
remove already dead or doomed cells. We are now
investigating the mechanism by which the phagocytic
machinery might be able to influence the fate of cells
at the edge of death.
Because much of the cell death pathway is con-
served between C. elegans and vertebrates, we predict
that the ability of the phagocytic program to kill cells
may be a general phenomenon in metazoans. This real-
ization might have important clinical implications. For
example, in mammals, the phagocytosis process might
contribute to the elimination of cells under pathologi-
cal conditions, in which cells are exposed to sublethal
pro-apoptotic stimuli. Such conditions can often be
found in chronic neurodegenerative diseases, following
a stroke, or in developing tumors. Modulating the
activity of the engulfing machinery in neighboring
cells might thus offer a new target for therapies to treat
these diseases.
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NERVOUS SYSTEM FUNCTION AND DEVELOPMENT
A second area under investigation in the lab is the ner-
vous system in C. elegans. The small size and relative
simplicity of the nematode nervous system allows us
to readily address complex questions at the genetic
and molecular levels.
Cell Death in the Developing Nervous System: As is
the case in mammals, programmed cell death is very
common in the developing C. elegans nervous system.
To understand how developing neurons decide
between differentiation and death, we initiated a
detailed study of one particular motor neuron-the
sexually dimorphic hermaphrodite-specific neuron
(HSN). The HSN drives egg laying in hermaphrodites
but dies by PCD in males. We have isolated more than
a dozen mutations in at least three genes that specifi-
cally rescue the HSN from death. Two of these genes,
which we have called sue -1 and sue-2 (for suppressor
of egl-1), share a number of pleiotrophic defects, sug-
gesting that they act in a common pathway. Not only
do mutations in sue -1 and sue-2 strongly and specifi-
cally rescue HSNs from apoptotic death and restore
egg-laying function in egl-1 mutants, but they also
affect the differentiation and/or function of several
other neurons. We expect that a genetic and molecular
analysis of these genes will lead to a better under-
standing of how the HSN controls activation of the
apoptotic machinery, and how life-vs-death decisions
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integrate into the larger problem of neuronal differen-
tiation and nervous system development.
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PLANT DEVELOPMENT
D. Jackson S. Archer-Evans J.Y. Kim
V Bapat G. Sabino
G. Birkenmeier F. Taguchi Shiobara
M. Cilia J. Thomas
A. Giulini Z. Yuan
Developmental patterning of multicellular organisms
usually requires that cells communicate with each
other to coordinate their final fate. Genetic analysis of
plant development indicates a predominance of non-
cell autonomy, implying the importance of cell-to-cell
signaling. Our research is aimed at understanding the
molecular mechanisms of plant development, with the
eventual goal of improving crop yields. Unique fea-
tures of plants include a complex and expansive extra-
cellular matrix-the cell wall-and cytoplasmic chan-
nels or plasmodesmata that interconnect plant cells.
These features suggest that mechanisms of cell-to-cell
communication in plants may differ from those that
control animal development.
Plants make new body parts-leaves, flowers, and
roots-throughout their lifetime from groups of unde-
termined stem cells called meristems. The activity of
the meristems is paramount in creating the basic archi-
tecture of the root and shoot systems. Although meris-
tems are tiny structures, they control many of the basic
aspects of plant form. Our studies in plant development
focus on genes that regulate the shoot apical meristems,
including those that control stem cell identity, cell pro-
liferation, and the geometry of leaf initiation patterns.
Intercellular Trafficking of
GFP Fusion Proteins
Z. Yuan, M. Cilia
Cell-to-cell trafficking of regulatory proteins, such as
transcription factors, is a novel mechanism by which
plant cells communicate during development. We are
interested in how trafficking is regulated, in particular
which proteins are able to traffic through plasmodes-
mata, and whether there exist specific trafficking target
signals. To this end, we have made fusions of the green
fluorescent protein (GFP) to several proteins and are
testing their ability to traffic between cells following
biolistic bombardment of constructs into single cells in
the leaf. We and others have noticed that GFP itself is
able to move freely through plasmodesmata that con-
nect leaf epidermal cells, suggesting that the size
exclusion limit is larger than previously thought. GFP
has a molecular mass of 27 kD, implying that proteins
of up to this size can diffuse through the plasmodesmal
pore. We found that a fusion of GFP to the yellow flu-
orescent protein (YFP) is unable to traffic through
plasmodesmata, suggesting that proteins of this size
(-55 kD) or larger probably use a targeted mechanism
for trafficking. For example, a GFP-KN1 fusion, which
is 69 kD, is able to traffic between cells in the
Arabidopsis leaf. We are currently making deletion
derivatives of KNOTTEDI (KN1) to look for plas-
modesmal targeting signals, and our initial studies sug-
gest that one region of KN1 is able to promote traf-
ficking of an inert reporter protein. Although an
increasing number of plant and viral proteins have been
found to move through plasmodesmata, no targeting
signals have been identified, and we will therefore pur-
sue these experiments with KN1 to see if we can iden-
tify a conserved targeting sequence or domain.
Cell-to-cell Trafficking of
GFP-KNOTTED1 in the
Shoot Apical Meristem
D. Jackson [in collaboration with P Benfey,
New York University]
KM normally functions in the shoot meristem to
maintain cells in an undifferentiated state, and evi-
dence from localization studies in maize suggests that
cell-to-cell movement of KN1 protein may be impor-
tant for communication between meristem cells. To
directly test whether KN1 protein can move in the
meristem, we used the SCARECROW (SCR) promoter,
which drives expression in the outer layers of the
75
meristem, to express our GFP-KN1 fusion protein. In
plants carrying the SCR promoter driving a cell,
autonomous endoplasmic-reticulum-localized GFP,
we observed GFP fluorescence only in the LI and L2
layers of the meristem. However, when the same pro-
moter drives GFP-KN1 expression, we observe fluo-
rescence additionally in the underlying L3 cells, sug-
gesting that GFP-KN1 can indeed move between cell
layers in the meristem. Studies performed at Cold
Spring Harbor Laboratory in the 1930s first identified
lineage restrictions in the outer layers of shoot meris-
tems and indicated that communication between cell
layers in the meristem must be important to coordinate
the development of the different layers. Intercellular
trafficking of KN1 could be one such communication
pathway, and we hope to directly test this idea by mak-
ing trafficking-defective mutants of KN1.
Genetic Complementation of
shootmeristemless by
KNOTTED1
J. Thomas, Z. Yuan [in collaboration with K. Barton,
University of Wisconsin, Madison]
The K_NOTTED1 or "knox" class of genes was the
first of the homeobox gene family to be characterized
in plants, although function has been assigned only to
a small number of family members. Higher plants
have about three to eight of the class I knox genes that
are expressed specifically in shoot meristems and
down-regulated in lateral determinate organ primordia
such as leaves. Two of the class I genes, SHOOT-
MERISTEMLESS (STM) from Arabidopsis and K_N1
from maize, function to maintain the meristem in an
indeterminate state; mutations in each of these genes
cause premature termination of the shoot and loss of
the stem cells. Together with their similar patterns of
expression, it seems likely that these genes are func-
tional homologs. However, sequence analysis suggests
that KAU is orthologous to a different class I gene
from Arabidopsis, knatl. To test directly whether
maize KNJ is a functional homolog of STM, we used
the STM promoter to drive KS] expression and intro-
duced this construct into stm mutants; we transformed
heterozygotes because stm homozygotes are seedling-
lethal. Transformants were selfed to recover stm
homozygotes carrying the STM promoter -KNJ trans-
gene and scored for rescue of the stm phenotype. Most
transgenic lines showed some degree of rescue, and
one line flowered and produced seed, suggesting that
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KN1 can complement for STM function throughout
vegetative shoot and flower development. These
results help to clarify functional relationships between
knox genes of maize and Arabidopsis and also ratio-
nalize our use of Arabidopsis for function studies of
cell-to-cell trafficking of KN1.
An Excision Screen for New
abphyll Alleles
A. Giulini, Z. Yuan
The abphyll mutation causes a switch in phyllotaxy, or
leaf patterning, from alternate to opposite and is rather
unique because no other mutations that cause a simple
change in the phyllotactic pattern have been isolated.
The correct arrangement of leaves is an important trait
for photosynthetic efficiency, as it ensures efficient
light capture. During the past 3 years, we have isolated
three new alleles of abphl, using active Mutator (Mu)
transposon lines. The Mu transposon system has the
advantage of a high forward mutation rate and near
random insertion patterns. We are presently using these
alleles in an attempt to clone the abphl gene. However,
it would be useful to have alleles tagged with other
types of transposons, such as those of the Ac/Ds, Spm,
or Bergamot families, because these have a higher
somatic and germinal excision rate and are useful for
the generation of derivative alleles and for mosaic
analysis. These transposons generally hop to sites
closely linked to the original transposon donor site.
We mapped abphl eight map units proximal to the
B (Booster) color locus on 2S, and therefore chose to
use transposons at B because we can select for exci-
sions from B by reversion to full color in the kernels.
To make a useful B allele for screening of excisions,
we made an intragenic recombinant between B-Peru, a
stable allele that colors the aleurone layer of the seed,
and B-V (Bergamot), an unstable allele that colors the
leaves and stems but not the aleurone. The resulting
recombinant has color sectors in the aleurone and a
germinal excision frequency of about 1%. We generat-
ed approximately 300,000 F, seeds in an open pollina-
tion plot where active transposon plants were pollinat-
ed by abphl males and picked the full color revertant
seed for screening. In an initial screen of approxi-
mately 1000 revertants, we recovered several candi-
dates and are growing them for genetic analysis. Any
novel alleles we recover will be useful for cloning and
perhaps for mosaic analysis of abphl.
Isolation of a New fasciated ear2
Allele and Confirmation of the
fae2 Candidate Gene
F Taguchi Shiobara, G. Sabino, Z. Yuan
We previously reported the isolation of a candidate
gene for the fasciated ear2 (fae2) locus of maize. The
fae2 mutation affects the proliferation of stem cells in
the ear inflorescence apical meristem, leading to an
enlarged and fasciated or flattened ear with an
increased number of rows of seed. To prove that the
candidate gene we cloned was the correct one, it was
necessary to isolate a novel allele offae2 and to demon-
strate independent disruption of the same candidate
gene. To this end, we screened 30,000 plants from a
cross of fae2 to lines carrying active Mu transposons.
Screening in the F1, we expected to recover the reces-
sivefae2 phenotype only if a novel mutation in fae2 had
occurred in the Mu parent. After 4 days of screening,
we identified a single plant with a strong fasciated ear
phenotype, and the DNA from this plant had a novel
insertion into the single large exon offae2. To show that
this was a new allele, we also needed to demonstrate a
fasciated phenotype when homozygous. This last sum-
mer, we planted the families at Uplands Farm, and as
hoped, the homozygotes for the novel allele, fae2-846,
had a strong fasciated ear phenotype. Therefore, the
clone that we isolated is the correct gene. Molecularly,
the new allele contains an insertion of the Mu7 trans-
posable element toward the 5' end of the coding
sequence, and it is likely a null allele. We have also iso-
lated the complete fae2 cDNA and have confirmed its
identity as a putative transmembrane protein with pre-
dicted extracellular leucine-rich repeats (LRRs).
Therefore, we predict that fae2 acts as a cell surface
receptor for an unidentified ligand that together func-
tion to regulate stem cell proliferation in the maize ear.
We also mapped fae2 and found that it maps close to a
quantitative trait locus (QTL) for row number, a mea-
sure of the number of vertical rows of seeds on the ear.
An association with this QTL is intriguing, because
fae2 ears make many more rows of seed than normal,
between 30 and 36 vertical rows compared to 16-18 in
normal sibs. In addition, in the tassel, fae2 mutants are
not fasciated, but they do have an increase in the num-
ber of flowers ("spikelet density"), an important agro-
nomic trait in other cereals such as rice and wheat. We
are planning experiments to test whether FAE2 is
responsible for the row number QTL, which could indi-
cate a use for this gene in controlling crop yields.
Subcellular Localization of
the FAE2 Protein
S. Archer-Evans, D. Jackson
Targeting prediction programs indicate that FAE2 is
likely a transmembrane protein, with the bulk of the
protein-including the leucine-rich repeats-being
extracellular, and only a short cytoplasmic tail of
about 15 amino acids. To test this hypothesis, we made
a fusion of FAE2 to the GFP, attaching GFP at the car-
boxyl terminus so that it would be cytoplasmic if our
predictions were correct. In general, GFP is not fluo-
rescent when targeted to the plant extracellular matrix
because the pH is too low. We introduced the construct
by microprojectile bombardment into onion leaf epi-
dermis and observed GFP localization by fluorescence
confocal microscopy. We observed fluorescence in a
peripheral location, fully consistent with the predicted
plasma membrane localization. We are currently
preparing FAE2 antibodies, which will be used to con-
firm this localization.
Isolation of New Fasciated Mutants
from the MTM Collection
D. Jackson
The MTM (Mutator-targeted mutagenesis) system,
developed here at the Laboratory by Rob Martienssen
and collaborators from other institutions, is a large
collection of selfed Mu transposon plants for forward
and reverse genetics. During the last 2 years, we and
others (M. Running, Berkeley) have screened the pop-
ulation for new mutants and have recovered several
new fasciated ear mutants. I have shown that at least
six of these are heritable, and I am now in the process
of introgression into standard genetic backgrounds for
complementation test and developmental studies. Of
particular interest are a couple of new mutants that
affect tassel as well as ear development; many of the
existing fasciated mutants exert their effect predomi-
nantly in the ear. Therefore, the MTM collection is
proving to be an excellent resource for forward as well
as reverse genetics.
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GENOMIC MICROARRAY ANALYSIS
R. Lucito J. Alexander
A. Bug lino
S. Rostan
MEASURING GENOME COPY NUMBER
FLUCTUATIONS IN BREAST CANCER
Progression of breast cancer, as for all cancers, is a
multistep process. Mutations occur in the genome of
precancerous cells and accumulate until growth goes
unchecked. The large majority of these mutations
occur sporadically, i.e., they are not inherited. Only a
small percentage of breast cancers occur due to an
inherited predisposition. Therefore, the genes respon-
sible for sporadic breast cancer must be identified if
we are to understand why a cell becomes cancerous;
yet, to date, few of these mutations have been identi-
fied. To identify and characterize genes affected by
sporadic mutation, we can look to the genome of the
cancer cell itself. Often, mutations in the genome
result in increased or decreased gene-copy number,
namely, amplifications or deletions, and these changes
can be used as markers to locate oncogenes or tumor
suppressor genes, respectively, that are involved in the
promotion of cancerous growth. The function of these
oncogenes and tumor suppressors, once identified, can
be investigated to understand the role of these genes in
the progression to tumorigenesis. To identify genome
copy-number fluctuations in breast cancer, we have
developed a genomic microarray technique, borrow-
ing the methodology of representations developed for
representational difference analysis (RDA). A repre-
sentation is a reproducible sampling of the genome,
produced by cleavage of the genome with a restriction
enzyme, ligation of adaptors, and subsequent poly-
merase chain reaction (PCR) amplification. The repre-
sentation produced is composed of fragments from the
genome in the size range of 200-1200 bases. The rep-
resentation produced is reduced in complexity to
approximately 3% of the genome, allowing increased
hybridization efficiency to the microarray.
Although representations have previously been
shown to be accurate in the reporting of copy-number
changes between two genomes, a significant amount
of time and effort was spent demonstrating that repre-
sentations are accurate enough to be used with our
microarray format. A pilot microarray was designed
that contained representational probes, namely, small
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BglII fragments, either from specific regions or ran-
domly from the human genome. As a first test, repre-
sentations were compared to representations prepared
separately, or in parallel. Ideally, we should obtain a
ratio of 1.0 when comparing identical samples. The
ratio of features from these experiments rarely went
above 1.5, demonstrating that there was no more sig-
nificant noise when comparing a representation to
itself than when comparing a representation prepared
in parallel. This demonstrates not only that the repre-
sentational procedure is accurate, but also that there is
little variation in our labeling with the two fluo-
rochromes. To determine if the microarrays reported
accurate copy-number changes, BglII representations
were prepared from two breast cancer cell lines and
compared by hybridization. Comparison of experi-
ments performed independently showed little varia-
tion, testament to the reproducibility of our procedure.
Copy-number values obtained from microarray results
were verified by Southern blotting, and we found
close concordance.
As proof of the utility of microarrays for analysis
of primary breast tumors, a tumor sample was sorted
based on ploidy into diploid and aneuploid nuclei, rep-
resenting normal and tumor, respectively, and repre-
sentations of this material were compared by array
hybridization. A significant amount of genome copy-
number information has been accumulated for this
particular tumor as it has been analyzed previously by
other methods, such as RDA, quantitative PCR, and
Southern blotting. From our analysis, we have deter-
mined that there is close concordance between these
methods. In fact, the microarray results were found to
be more accurate than RDA. This experiment displays
our ability to extract copy-number information from
primary tumors.
We are now constructing an array for genome-
wide scanning of tumor samples. Within the next year,
we should have an array of 30,000 probes with a reso-
lution of 1 probe for every 100 kb. This array will be
used for the hybridization and analysis of a large set of
primary breast tumors. By comparing invasive tumors
with the noninvasive tumors, we hope to identify the
regions of the genome that, when mutated, cause the
progression to invasiveness. The epicenter or common
region of mutation will be delimited for the loci iden-
tified to undergo genome copy-number fluctuations,
and these data will be used along with the information
available from the genome sequencing project for the
identification of gene candidates. Future knowledge
of the function of these genes will lead to a better
understanding of the disease and improvements in
therapy and diagnosis.
RAC SIGNALING
This work was done in collaboration with Linda Van
Aelst and Arndt Schmitz here at the Laboratory. We
have used cDNA-RDA as a procedure to identify genes
that are regulated by the Rac protein. This method is
based on the genomic technique RDA, established in
Michael Wig ler's laboratory. This technique is a sub-
tractive hybridization method used to compare two
mRNA populations. The technique relies on making a
representation of the samples being compared.
Representations are prepared from the mRNA by con-
verting to cDNA, digestion with a restriction enzyme,
ligation of adaptors, and PCR amplification. The rep-
resentations are compared by hybridization, and the
differences are identified by PCR amplification and
then subcloning. A cell line with an inducible RacV12
gene, a constitutively active form of the gene, was used
comparing uninduced Rac to the induced Rac. To
increase the throughput of screening the clones isolat-
ed as differences, approximately 1500 clones were
grown in 96-well plates processed and arrayed on glass
slides. These slides were screened for true differences
by hybridizing differentially labeled representations
from the uninduced and induced cells. We are current-
ly characterizing the genes that show expression
changes due to the presence of the rac gene.
MAIZE MUTAGENESIS LIBRARY SCREENING
This work, being done in collaboration with Robert
Martienssen, Pablo Rabinowicz, and Erik Vollbrecht
here at the Laboratory, is the development of a high-
throughput screen of a maize insertion mutagenesis
library. The probes on the array are picked from a
gene-enriched methyl-filtering library. The basis of
this library relies on the fact that much of the maize
genome is methylated repeat sequences, but the gene-
rich regions are not methylated. This method enriches
the genes represented by subcloning unmethylated
genomic regions. The mutant plant library was pro-
duced by random insertion of a transposable element.
The samples are produced by first pooling the individ-
ual plant DNAs in a plate-wise fashion, accumulating
50 individual plants per pool. Representations are pre-
pared from these samples by PCR amplification of
this pool using one oligo to the transposable element
inserted and a second random oligo. The representa-
tions are then used for hybridization to the arrays to
identify which individual plants have a gene insertion.
This information will be cross-referenced to pheno-
typic data to identify the gene regions with transposon
insertions.
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PLANT DEVELOPMENTAL GENETICS AND FUNCTIONAL
GENOMICS
R. Martienssen J. Arroyo
A. Dabrowski
D. Roh
T. Singer
B. Bartel le
A. Groover
A. Landman
M. Ronemus
E. Vollbrecht
M. Byrne
B. May
T. Volpe
V Colot
C. Kidner
P. Rabinowicz
J. Simorowski
The first sequence of a plant genome, Arabidopsis
thaliana, was completed at the end of 2000. We are
taking advantage of this landmark achievement in our
study of epigenetics and plant development. Endoge-
nous transposons are heavily methylated in maize and
Arabidopsis, and we have demonstrated that methyla-
tion and activity are dependent on chromatin remodel-
ing. We are using transposons to develop libraries of
maize and Arabidopsis from which mutant seed can be
selected in silico. We also study the genetic basis for
plant architecture. In Arabidopsis, asymmetric leaves]
affects the proximodistal axis in leaves and floral
organs, whereas argonaute disrupts dorsoventral
polarity. In maize, ramosal affects higher-order
branching in the inflorescence. Each of these genes
encodes a protein involved in transcriptional regula-
tion or RNA interference (RNAi), and genetic interac-
tions implicate each gene in stem cell fate. We are
using Schizosaccharomyces pombe as a simple genet-
ic system to study the mechanism of RNAi. In 2000,
we were joined by postdocs Mike Ronemus and Tom
Volpe, as well as visiting scientist Vincent Colot from
the Evry Plant Genome Center in Paris. Donna Roh
and Ben Bartelle joined our lab as research techni-
cians, and Chuck Kopec as our intrepid URR We said
goodbye to Andrew Groover who left for a faculty
position at the University of California, Davis.
Differential Methylation of
Genes and Retrotransposons
in Complex Plant Genomes
P. Rabinowicz, C. Yordan, R. Martienssen
[in collaboration with W.R. McCombie, Cold
Spring Harbor Laboratory]
It has been proposed that, regardless of the large range
of genome sizes, all diploid higher-plant genomes
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share essentially the same set of genes. This set, called
the "gene space" includes approximately 25,000
genes, as estimated for the recently completed
Arabidopsis genome sequence. The difference in
diploid plant genome sizes is explained by the differ-
ence in the content of highly repetitive DNA.
Repetitive DNA is composed mainly of transposable
elements, many of which are heavily methylated. On
the other hand, genes are usually located in nonmethy-
lated regions of the genome. We have shown that
repeat sequences in maize, because of their sensitivity
to bacterial restriction-modification systems, can be
largely excluded from genomic shotgun libraries by
the selection of an mcr+ host strain. In contrast,
unmethylated genic regions are preserved in these
genetically filtered libraries if the insert size is less
than the average size of genes.
We are currently applying this approach to shot-
gun-sequence other complex plant genomes.
Preliminary results show that low-copy regions can be
efficiently selected from the large hexaploid wheat
genome. This further supports the hypothesis that the
gene space can be selectively isolated from any com-
plex plant genome.
Epigenetic Regulation
of Transposable
Elements in A. thaliana
T Singer, C. Yordan, R. Martienssen
Fifteen percent of the Arabidopsis genome consists of
transposable elements (TEs) or their remnants, most
of which are found in intergenic and heterochromatic
regions (The Arabidopsis Genome Initiative 2000;
Consortium, C.W.P.A.S., 2000). Despite their high-
copy number, most TEs are silenced, highly methy-
lated at cytosine residues, and not active in wild-type
plants. We are interested in the epigenetic mecha-
nisms involved in TE regulation, which may be
important in gene silencing and genome stability. We
have identified more than 200 Mutator-like elements
(MULEs) in the Arabidopsis genome with similarity
to the MURA transposase of the Robertson's Mutator
elements from maize; 21 elements with well-con-
served terminal inverted repeats (TIRs) and murA
transposase genes (AtMu elements) became demethy-
lated in ddml mutant plants. Two AtMu elements
were also shown to transpose under these conditions,
reinserting at unlinked positions in the genome.
DDM1 encodes an SWI2 /SNF2 -like chromatin
remodeling protein (Jeddeloh et al., Nat. Genet. 22:
94 [1999]), and loss of DDM1 gene function results
in genome-wide demethylation of heterochromatic
repeats (Vongs et al., Science 260: 1926 [1993]).
Thus, MULEs are regulated by chromatin remodel-
ing and methylation. Plants carrying newly trans-
posed AtMu elements were outcrossed to wild-type
plants and will be analyzed for AtMu methylation and
activity. We are analyzing other TEs in mutants
impaired in cytosine methylation and chromatin
remodeling.
Construction of
Chromosomal Microarrays
in Arabidopsis
V. Colot, C. Yordan, R.A. Martienssen [in collaboration
with V. Mittal, N. Dedhia, and W.R. McCombie,
Cold Spring Harbor Laboratory]
We are studying the effects of DNA/chromatin modi-
fication and genome organization on transposon
activity and transposon-mediated regulation of genes,
which could account for many of the epigenetic phe-
nomena observed in plants. More specifically, we
want to examine chromosome-wide expression differ-
ences in polyploid Arabidopsis as well as in mutants
that affect DNA methylation, chromatin remodeling,
and histone acetylation. To this end, we are making
DNA microarrays that will cover the entire 17 Mb of
chromosome IV in contiguous or nearly contiguous
fragments of approximately 1 kb. Most of the predict-
ed 3825 protein-coding genes present on chromosome
IV are more than 2 kb long and will therefore be cov-
ered by three or more contiguous fragments.
Intergenic regions will also be represented and should
provide a means to identify DNA sequences that are
associated with specific proteins by the use of chro-
matin immunoprecipitation assays. Finally, chromoso-
mal microarrays should allow us to discover new
genes (such as those encoding untranslated RNAs)
that cannot be identified by current gene-finding pro-
grams.
Primer pairs specific to each of the 17,000 fragments
are being determined using the PRIMER3 program and
verified by electronic polymerase chain reaction (PCR)
using the whole Arabidopsis genome sequence as tem-
plate. At present, we have constructed a microarray that
covers 1.5 Mb around the heterochromatic knob located
on the short arm of chromosome IV and are conducting
tests of its many potential applications.
Systematic Transposon
Mutagenesis in Maize
and Arabidopsis
B. May, A. Groover, E. Vollbrecht, P. Rabinowicz,
C. Yordan, J. Simorowski, J. Arroyo, D. Roh,
R. Shen, B. Bartelle, Y. Liu, R. Martienssen
[in collaboration with N. Dedhia, J. Healy, H. Liu,
A. Reiner, L. Stein, and W.R. McCombie,
Cold Spring Harbor Laboratory]
We have established large collections of maize and
Arabidopsis plants that have been mutagenized by
transposons. In maize, we have a collection of 50,000
plants each carrying hundreds of Mutator transposons,
from which mutants in any gene can be selected by a
simple PCR procedure (http://mtm.cshl.org). We are
working on methods to systematically determine the
genes disrupted in each line. In Arabidopsis, we have
developed a large population of seeds carrying a sin-
gle enhancer trap or gene trap Ds (Dissociation) trans-
poson. DNA is made from each line as it is selected,
and the flanking sequence is determined using PCR.
The sequence data are automatically processed and
annotated using the completed Arabidopsis genome as
a guide. We are using this population to construct a
database of gene knockouts that can be searched by
text or sequence similarity (www.cshl.org/genetrap).
The results of individual screens were described in
more detail in last year's Annual Report.
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FIGURE 1 ramosal imposes determinacy on branches in the tassel. (A) In normal tassels, most
branches toward the tip are short and determinate. (8) In rat mutants, all branches become
indeterminate.
asymmetric leavesl Mediates
Leaf Patterning and Stem Cell
Function in Arabidopsis
M. Byrne, J. Arroyo, M. Dunham, R. Martienssen
Meristem function in plants requires both the mainte-
nance of stem cells and the differentiation of founder
cells from which lateral organs arise. Coincident with
their initiation and growth, lateral organs are patterned
along proximodistal, dorsoventral, and mediolateral
axes. The Arabidopsis mutant asymmetric leaves]
(as1) disrupts this process. AS1 encodes a Myb
domain transcription factor, closely related to PHAN-
TASTICA in Antirrhinum and ROUGH SHEATH2 in
maize, both of which negatively regulate knotted-class
homeobox genes. AS] negatively regulates the home-
obox genes KNAT1 and KNAT2 and is, in turn, nega-
tively regulated by the meristematic homeobox gene
SHOOT MERISTEMLESS. This genetic pathway
defines a mechanism for differentiating between stem
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cells and founder cells within the shoot apical meris-
tem and demonstrates that genes expressed in organ
primordia interact with meristematic genes to regulate
shoot morphogenesis. We are investigating these inter-
actions further using second-site suppressor screens,
enhancer and gene-trap mutagenesis, as well as
microarrays to identify downstream targets.
ramosal Regulates
Branching in the Maize
Inflorescence
E. Vollbrecht, C. Kopec, R. Martienssen
Regulated branching patterns define plant architec-
ture. Branches may be determinate, in which the api-
cal meristem is capable of initiating only a few organs
before ceasing to function, or indeterminate, in which
the meristem may iterate many initiation cycles during
its lifetime. The maize tassel and ear have similar
underlying architecture, but differential activity of
second-order meristems results in differing morpholo-
gies. In the ear, all second-order meristems are deter-
minate, whereas in the tassel, second-order meristems
may be indeterminate and form long branches, or
determinate as in the ear. In ramosal mutants, ears
and tassels are fully branched and architecturally
equivalent (Fig. 1). We cloned ral by transposon tag-
ging with Spm and have identified molecular lesions
in ten mutant alleles, including weak alleles with point
mutations. The ral gene is expressed in developing
tassels and ears but not in vegetative shoots and
encodes a 19-1(D protein with a single TFIIIa-type
zinc finger, suggesting that RA1 functions as a tran-
scriptional regulator. ral is expressed in a narrow spa-
tiotemporal window consistent with a function in sec-
ond-order meristems. Mutation in a distinct gene,
ramosa2, is epistatic to the ral-R mutation in the tas-
sel, and ral is expressed at lower levels in ra2-R
mutants, placing ral genetically downstream from
rat. These data indicate that ral gene function impos-
es determinacy to inhibit second-order meristems
from becoming long branches. At least two genetical-
ly separable pathways regulate branching in the tassel.
We have begun to examine the evolutionary conserva-
tion of branching programs by looking at ral- related
genes in selected grasses such as sugar cane, rice, and
sorghum.
The Function of RNAi
in Plants and Yeast
C. Kidner, M. Ronemus, T. Volpe, R. Martienssen
[in collaboration with S. Grewal, and G. Hannon,
Cold Spring Harbor Laboratory]
Double-stranded RNA (dsRNA) results in the silenc-
ing of cognate genes when introduced into cells. This
process is known as RNA interference (RNAi), and it
has been widely used to study hypomorphic pheno-
types in systems from worms to mice. But neither the
function nor the mechanism of RNAi is fully under-
stood. Genetic and biochemical studies have identi-
fied a number of factors of known function involved
in RNAi, including an RNA helicase, an RNase III,
and an RNA-dependent RNA polymerase (RDRP). A
family of related genes of unknown function-includ-
ing ARGONAUTE (AGO) and ZWILLE of Arabidop-
FIGURE 2 Strong (left) and weak (right) mutant alleles of the
argonaute gene result in leaf polarity and stem cell defects in
Arabidopsis.
sis, Piwi and Sting of Drosophila, and RDE1 of
Caenorhabditis elegans---have also been identified as
modifers of RNAi.
In contrast to most modifiers of RNAi, which do
not produce apparent phenotypic abnormalities when
mutated, disruption in AGO function results in severe
defects in stem cell maintenance and organ polarity
in Arabidopsis (see Fig. 2). Using weak mutant alle-
les of AGO, we have been investigating the interac-
tion of AGO with key developmental regulators.
Through analysis of double mutants, we and others
have shown that SHOOT MERISTEMLESS (STM)
and AGO closely interact to control organ develop-
ment and stem cell maintenance. These and other
double-mutant phenotypes reveal a requirement for
the RNAi mechanism in plant development. As muta-
tion of the AGO homolog of C. elegans, RDE1, does
not perturb development in the worm, these findings
indicate that RNAi may have become specifically
adapted to regulate the expression of endogenous
genes in plants.
Many of the genes involved in RNAi are repre-
sented in Schizosaccharomyces pombe. These include
a single AGO ortholog, as well as genes encoding an
RDRP and an RNase III. We are taking advantage of
the comparative ease of genetic and biochemical
manipulation available in S. pombe to study these
genes. Although RNAi has yet to be demonstrated in
S. pombe, we have shown that the AGO ortholog of S.
pombe is required for silencing at the centromere as
well as proper chromosome segregation. Additional
studies of RNAi in S. pombe will be performed to
identify other components of the RNAi apparatus and
to elucidate their functions.
We have also initiated studies to investigate further
the function of AGO and RNAi in control of gene
expression and genome stability in Arabidopsis. Using
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microarrays, we are examining genome-wide expres-
sion in ago lines containing weak and strong muta-
tions at multiple stages of development. Genes repre-
senting candidates for regulation by RNAi will then be
characterized in depth by detailing their mutant phe-
notypes. DNA methylation, an agent of genome sta-
bility, is altered in transgenes that undergo RNAi in
AGO mutant lines. We are extending these observa-
tions by assessing the methylation states of endoge-
nous loci in Arabidopsis; preliminary results indicate
that a subset of sites are specifically demethylated in
ago lines.
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DNA ARRAY TECHNOLOGY AND MOUSE MODELS
OF HUMAN CANCER
V. Mittal K. Lavine
DNA microarray technology is a powerful tool for
functional genomic research. The transcriptional pro-
filing by microarray analysis holds the promise of
yielding excellent molecular markers for the clinical
classification of tumors. In particular, the patterns of
genes expressed in a tumor can indicate important bio-
logical features such as responsiveness to therapy,
predilection to invasion and metastasis, and the long-
term survival of the patient. Several studies have
recently shown how DNA arrays can be applied to the
analysis and classification of cancers like leukemia
and lymphoma.
We are developing and implementing the DNA
array technology to understand (1) the molecular
determinants of cancer pathways, using the mouse as
a model system, by examining both patterns of gene
expression and genetic lesions and (2) the molecular
basis of drug sensitivity and resistance in tumors in
response to chemotherapy. To do this, we have set up
a reliable system for fabrication of high-density
human and mouse expression arrays and informatics
tools for quantitative analyses of the array data. We
have assembled a collection of 15,000 mouse cDNAs
and expressed sequence tags (ESTs) from the
National Institute of Aging and 40,000 human cDNAs
and ESTs from the Image Consortium. Kimberly
Lavine and Jennifer Troge have processed these
clones and have successfully printed, hybridized, and
analyzed microarrays of greater than 10,000 cDNA
probes.
UNDERSTANDING GENOME-WIDE CHANGES
IN PRIMARY LYMPHOMAS IN RESPONSE TO
CHEMOTHERAPEUTIC DRUGS
A major focus in cancer research is the search for mol-
ecular determinants of anticancer drug responses and
resistance. These are likely to have an impact on the
determination of clinical courses and treatment
responses. In collaboration with Scott Lowe's lab here
at the Laboratory, we have started to identify gene
expression changes associated with drug response and
resistance. These studies will help in identifying mol-
ecular pathways involved at the onset of drug treat-
ment and how these pathways mature in the tumor to
achieve drug resistance. We are using the Eµ -myc
transgenic lymphoma mouse (Adams et al., Nature
318: 533 [1985]) as a tractable disease model for
studying the therapy-induced response of lymphoma
in vivo. The strengths of this model are as follows: (1)
The genetics and histopathology of ER-myc lym-
phomas resemble human non-Hodgkin's lymphomas;
(2) the tumor burden can be easily monitored by
lymph node palpation or blood smears, or by monitor-
ing green fluorescence protein (GFP) fluorescence in
blood samples, a property that facilitates the examina-
tion of responses to therapy; (3) therapy is performed
in immunocompetent mice; and (4) pure lymphoma
cells can be transplanted into numerous syngeneic
mice. Strikingly, the clinical and histopathological
characteristics of a given lymphoma are virtually iden-
tical when portions of the same population are propa-
gated in separate recipients, thus allowing enormous
flexibility in conducting parallel studies.
The molecular signatures of tumor responses to
various anticancer treatments alone and in combina-
tions will be monitored in a time-dependent manner
by high-density cDNA microarrays. Typical data from
an array experiment are shown in Figure 1. A web-
accessible database of reference gene expression pro-
files will be developed. To examine the molecular sig-
natures of drug response, the data will be clustered
based on positive and negative expression pattern cor-
relation, similarity in promoter sequences, and func-
tional annotations of cDNAs (an ongoing project in
my laboratory). The drug response of tumors from
human patients will be examined in parallel in collab-
orations with clinical experts. A comparison of the
human and mouse gene expression patterns is essen-
tial not only to validate the mouse as a model for
human cancer, but also to help us better understand
treatment sensitivity of human cancers, facilitate the
design of better anticancer agents or treatment regi-
mens, and thus lead to more rational ways of design-
ing combination therapies.
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FIGURE 1 Scatterplot from a mouse cDNA microarray experiment. Microarrays were printed from a collection of 10,000 murine cDNA
and EST clones. These were hyrbidized with mRNA derived from two different lymphoma samples (labeled with red and green fluo-
rescent dye, respectively). The normalized ratios of red versus green channel is plotted for each spot. Each feature in the scatter plot
has been assigned a standard deviation value from the mean (refer to the bar on the right). Genes whose ratios are within 1 standard
deviation are assumed to be unchanged and genes with standard deviation above 1 or below 1 are used for further analysis. Overall,
this scatter shows that more then 98% genes are unchanged (are within a twofold range).
IDENTIFICATION OF GENES INVOLVED IN Id
SIGNALING IN ENDOTHELIAL CELLS
The Id family of proteins are essentially dominant
negative helix-loop-helix transcription factors.
Normal Id expression is required to support angiogen-
esis and vascularization of tumor xenografts. Blood
vessels in Id knockout mice lack the ability to branch
and sprout to support growth or metastasis of tumors,
and any tumor growth present shows poor vascular-
ization and extensive necrosis.
In collaboration with Robert Benezra and
Marianna Russinova (Memorial Sloan-Kettering
Cancer Center, New York), we are interested in under-
standing the molecular mechanisms by which Id exerts
its effects on angiogenesis. We will use mouse cDNA
arrays to examine differences in the expression of
mRNAs in endothelial cells isolated from tumors
grown in Id wild-type and knockout backgrounds.
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Benezra's group has previously shown that there is a
dramatic difference in the growth of blood vessels into
VEGF-impregnated matrigel plugs supplanted subcuta-
neously in Id knockout versus wild-type animals. We
will also perform the array analysis on endothelial cells
isolated from these plugs. This will allow us to deter-
mine which differences are inherent in the endothelial
cells isolated from the wild-type and mutant mice and
which may be attributed to tumor-specific alterations.
Although it is difficult to predict the outcome of such
experiments, our efforts after the identification of gene
expression changes will be focused on molecules that
might make good targets for anti-angiogenic drug
design. Surface markers that are down-regulated, for
example, in the absence of Id expression may mediate
the effects of loss of Id. Antagonists of such markers
would be sought for testing in the matrigel plug assays
in an attempt to phenocopy the perturbed blood vessel
development observed in the Id knockout backgrounds.
FUNCTIONAL ANALYSIS OF CANCER GENES
We have two collaborative projects with Mike Wig ler's
lab here at the Laboratory. One is to understand the
mechanistic role of tumor suppressors and oncogenes
in cancer by determining their specific cellular and
physiological function. We have begun by examining
the mechanistic role of the human tumor suppressor,
PTEN. The PTEN gene product shares homology with
protein tyrosine phosphatase family members and
antagonizes phosphatidylinositol 3-kinase (PI3-
kinase) by dephosphorylating its substrate PIP3.
Because many of the PTEN cancer-related mutations
have been mapped to its phosphatase catalytic domain,
it has been suggested that the phosphatase activity of
PTEN is required for its tumor suppressor function.
We used an ecdyson-inducible mammalian expression
system (developed in Mike Wig ler's lab) and human
cDNA microarrays (containing 15,000 elements) to
survey changes in patterns of gene expression upon
induction of either wild-type or mutant PTEN in the
glioblastoma cell line U87MG (which lacks a func-
tional PTEN). In parallel, we also compared changes
upon induction of wild-type PTEN with changes
caused by the compound LY294002, an inhibitor of
PI3-kinase. The effects of wild-type PTEN induction
on transcription shared common signatures with the
effects of inhibition of PI3-kinase, consistent with the
model positioning PTEN as an inhibitor of PI3-kinase
signaling. In addition, comparison of wild-type and
mutant PTEN array data identified PTEN-regulated
genes, which were validated by sequencing, Northern
blotting, and RNase protection assays. A majority of
these genes were involved in cell proliferation,
cytoskeleton restructuring, and signal transduction
pathways. Strikingly, at least five genes in the cluster
were involved in the sterol biosynthesis pathway. The
role of this pathway in the pathophysiology of PTEN
loss is a subject for future investigation. These results
illustrate the power of a robust inducible expression
system in conjunction with cDNA microarrays in
understanding gene expression patterns induced by a
tumor suppressor gene. Such an approach is directly
applicable to the functional analysis of other cancer
genes.
The other project is to measure gene copy number
by using mirrored representation and cDNA microar-
rays. The main problem with most of the existing
methodologies for measuring gene copy number on a
genome-wide scale is inferior signal to noise, which is
due to the high nucleotide complexity of the human
genome. To solve this problem, a new strategy to
detect amplifications and deletions in the cancer cell
genome is currently under development. The principle
of operation is to extract the nucleotide complexity
from the genome of a cancer cell that matches (mir-
rors) the complexity of cDNA probes on the array by
using a substractive hybridization method. The great-
est strength of this approach will be much superior
hybridization kinetics with a concomitant improve-
ment in signal to noise. In addition to measuring gene
copy number changes, these arrays also have the
potential to detect the expression status of genes from
the same tumor samples.
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MAMMALIAN CELL GENETICS
M. Wig ler J. Alexander D. Esposito
J. Brodsky E. Hatchwell
A. Bug lino J. Healy
K. Chang M. Riggs
J. Douglas A. Reiner
L. Rodgers
S. Rostan
L. Serina
J. Stolarov
Cancer is caused by mutations in critical genes. Some
of these mutations may be inherited, but much more
frequently, they are acquired during the lifetime of the
individual. The critical genes that are at risk are still
largely unknown, both in the general sense (i.e., which
gene targets ever contribute to cancer) and in the spe-
cific sense (i.e., which genes are targeted in an individ-
ual's cancer). Without this knowledge, it is likely that
our attempts to control cancer will be incomplete.
Therefore, work in our group is centered upon cancer
genomics. We have developed several methods for
detecting genetic alterations in cancers, identifying the
genes that are the targets of these alterations, and
exploring the functional analysis of these genes by a
variety of means. PTEN, a tumor suppressor gene iso-
lated by our methods, continues to be the subject of our
most intensive study. We continue to work intensively
on developing tools to find additional genes, and
explore their function, using microarray and inducible
gene expression. All aspects of our work have now
been strongly influenced by the publication of a work-
ing draft of the human genome. Recently, we added a
genome informatics component in order to exploit this
new resource. We are also applying the methods that
we develop to analyze the spontaneous mutations that
underlie some human genetic diseases, especially those
that cause sporadic disease in children.
Discovery of Loci and Genes
Altered in Cancer
C. Yen, D. Esposito [in collaboration with R. Lucito,
M. Hamaguchi, R. McCombie, and M. Zhang, Cold
Spring Harbor Laboratory, and S. Powers,
Tularik Corporation]
The main engine for gene discovery in our lab has
been representational difference analysis (RDA), a
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subtractive hybridization technique that allows us to
search for amplified loci and homozygously deleted
regions in cancers (Lisitsyn et al., Science 259: 946
[1993]; Lisitsyn et al., Proc. Natl. Acad. Sci. 92: 151
[1995]). We have applied it to the study of breast can-
cer, analyzing a total of 18 pairs of tumor/normal
pairs. This has resulted in the discovery of numerous
amplified loci, many of them previously characterized,
such as the loci for ErbB2, c-myc, and cyclin D, but
the majority are uncharacterized. Of these, the 8811
region has been analyzed by Scott Powers and col-
leagues at Tularik for further analysis. Probes from
this region detect gene amplification in 6 out of 70 pri-
mary breast tumors, and they have narrowed the can-
didate region to two overlapping BACs (bacterial arti-
ficial chromosomes). We have also discovered with
RDA nine regions of confirmed homozygous deletion.
One of these was the region on 10823 containing the
PTEN tumor suppressor; one was the region contain-
ing the tumor suppressor p16(INK4), on chromosome
9p (Serrano et al., Nature 366: 704 [1993]; Kamb et
al., Science 264: 436 [1994]); one was the region on
chromosome 3p14 that contains the FHIT candidate
tumor suppressor gene (Ohta, Cell 84: 587 [1996]);
and one mapped near the p53 tumor suppressor. Five
homozygously deleted regions remain that are not yet
fully characterized. Two of these reside on chromo-
some 8q22, within 10 Mb of each other, one on chro-
mosome 4p16, one on chromosome 21p11, and one on
chromosome 20p11. All but one of these loci have
been observed to be deleted in a number of clinical
specimens and/or cell lines and have been confined to
regions from a few megabases to a few hundred kilo-
bases. In collaboration with the laboratories of Dick
McCombie and Michael Zhang, the gene candidates
from these regions are being identified using infor-
matic tools.
In collaboration with Dr. Hamaguchi, seven tran-
scripts have been identified from one candidate locus
on 8q22. Further analysis, in collaboration with the
laboratory of Mary-Claire King at the University of
Seattle, has helped us to focus on one candidate gene
from this region, which encodes a heretofore unrecog-
nized gene. See Dr. Hamaguchi's section for a more
comprehensive report on this locus and its genetic
content.
Development of Inducible Gene
Expression Systems
J. Stolarov, K. Chang [in collaboration with V. Mittal,
Cold Spring Harbor Laboratory]
In our early studies of PTEN, we used constitutively
expressing retroviral vectors, and immediately
encountered the problem of great variability in the
phenotypes of the clones that emerged. Clonal vari-
ability, and lingering questions about the cellular
adaption to the chronic expression of PTEN, prevent-
ed us from reaching clear conclusions. Thus, we
sought to develop inducible expression systems in
which, ideally, paired cultures could be compared for
their acute responses to controlled levels of expression
of the tumor suppressor.
In the ideal system, the inducer would be physio-
logically inert but would rapidly induce nearly 100%
of modified cells to express close to endogenous lev-
els of the target gene. Modified cells would not
express this gene in the absence of inducer. Such a
system would enable the observation of acute effects
of expressing tumor suppressors in cells, both when
growing in cell culture and when growing as a tumor
in an animal. We chose a retroviral delivery system as
it had the additional attraction that the expression sys-
tem could be easily introduced into a variety of cell
backgrounds. We chose the ecdysone system of Evans
and co-workers (No et al., Proc. Natl. Acad. Sci. 93:
3346 [1996]) over the tetracycline system (Saez et al.,
Carr. Opin. Biotechnol. 8: 608 [1997]) because it has
no background in the uninduced state and very swift
kinetics of induction. In brief, we produce both
amphotropic and ecotropic viruses using high-titer
packaging lines that were derived by David Beach and
Greg Hannon (Hannon et al., Science 283: 1129
[1999]) at Cold Spring Harbor Laboratory. Typically,
we infect cells with the receptor viruses together, and
the cells undergo double selection with puromycin
and G418. Single-cell clones are selected, expanded,
and tested for their ability to serve as a good "host,"
i.e., respond to inducer following infection and
hygromycin selection with a third virus containing an
inducible P-galactosidase gene.
Our first experiments were performed with
U87MG, a human glioblastoma cell line known to
have no functional PTEN gene. After double infection
with receptor viruses, and double selection, five can-
didate host clones were selected. These were then
infected with a target gene (lacZ) under the control of
ecdysone. For all five hosts, virtually all cells in the
colonies were inducible, and none showed detectable
background expression in the absence of inducer.
We have now extended this system to other human
and mouse host cells, and streamlined the selection of
inducible hosts, and are exploring the inducibility of
other genes in known signal transduction pathways.
Unfortunately, in our first attempts to test the
induction system in transplantable tumors, we
observed that the U87MG hosts expressed PTEN con-
stitutively. We are currently exploring whether this is a
defect in the expression system, a defect of the partic-
ular host, or an unavoidable consequence of the loos-
ening of transcriptional controls in dying cells.
Analysis of PTEN
Tumor Suppressor
J. Stolarov, K. Chang [in collaboration with V. Mittal
and N. Tonks, Cold Spring Harbor Labortatory,
and D. Durden, University of Indiana]
In previous years, we collaborated with Nick Tonics
and Mike Myers on the study of PTEN in animal cells.
This work led to the observation that PTEN, predicted
and shown to be a protein phosphatase, was also a
PIP3,4,5 phosphatase (Myers et al., Proc. Natl. Acad.
Sci. 94: 9052 [1997]). Since PIP3,4,5 is an important
second messenger that mediates such fundamental cel-
lular processes as response to growth factors and inhi-
bition of cell death, this lipid phosphatase activity
appeared to be a logical explanation of PTEN's func-
tion as a tumor suppressor. This was confirmed by
studies of mutant PTEN (Myers et al., Proc. Natl.
Acad. Sci. 94: 9052 [1997]; Myers et al., Proc. Natl.
Acad. Sci. 23: 13513 [1998]).
We have utilized the retroviral induction system
described above for further studies on PTEN.
Expression of PTEN was clearly controllable in
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U87MG hosts with muristirone, an ecdysone analog,
with induction levels up to 50-fold above a negligible
background. At physiological levels of expression,
induction of PTEN did not alter cellular growth rates.
This result is in contrast to most reports in the litera-
ture, in which the levels of expression of PTEN were
not so well controlled. Induction did cause a notice-
ably flattened cellular morphology, most clearly seen
when cells were grown in low serum. An essentially
identical change in morphology was induced by
LY294002, a known small molecular inhibitor of PI3
kinase, the enzyme that produces PIP3,4,5. Even more
striking results appeared following analysis of tran-
scription patterns using cDNA microarrays. Of 6218
probes, 0.4% of transcripts appeared to be suppressed
by greater than threefold upon PTEN induction, and
0.25% of transcripts appeared to be induced by greater
than threefold upon PTEN induction. An essentially
identical pattern of change in transcription was
observed when U87MG cells were treated with
LY294002. Enzymatically inactive mutants of PTEN
produced essentially no transcriptional changes when
induced. These results clearly confirm the hypothesis
that PTEN action results from its perturbation of the
PIP3,4,5 metabolism.
In collaboration with D. Durden, we have
explored the effect of PTEN expression on tumori-
genicity of the host-cell U87MG. PTEN expression
suppresses the tumorigenicity of this cell line, reduc-
ing tumor growth and tumor vascularization. This
happens without an apparent reduction of cell repli-
cation or increase in cell death within the tumor. Our
present hypothesis is that the effect must be at the
tumor margins, i.e., that PTEN retards invasiveness,
and this is in keeping with the observation that loss of
PTEN in glioblastomas is found most commonly in
invasive tumors. The physiological mechanisms at
play here are not at all clear, and warrant further
investigation.
Microarray Analysis of
Mutations in Tumors
J. West, A. Reiner, D. Esposito [in collaboration
with R. Lucito and R. McCombie, Cold Spring
Harbor Laboratory]
The search for tumor suppressors and oncogenes by
RDA has been slow. The bottleneck has been the time
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and labor spent on "epicenter mapping." Once a locus
has been identified, we need to demonstrate that the
locus is affected in multiple cancers. Then, because
these loci are large, we need to find the minimum
region affected so as to facilitate identification of can-
didate genes. This process, which we refer to as epi-
center mapping, has required more than 6000 individ-
ual quantitative polymerase chain reaction (Q-PCR)
tests for the various loci we have identified. We there-
fore decided to develop a microarray-based method
for gene-copy measurements. Our expectation is that
once fully established, this method will accelerate the
rate of gene discovery by a factor of perhaps 1000 -
fold, as well as provide a detailed way of categorizing
clinical cancers.
Microarrays, although widely utilized for expres-
sion profiling, cannot be effectively used for measur-
ing gene-copy numbers in a straightforward manner.
Using the entire human genome for hybridization is
inefficient due to its nucleotide complexity. To solve
this problem, the microarray system we have devel-
oped is based on representations. A representation is a
reproducible amplification of the genome with
reduced complexity. In brief, a representation is pro-
duced by first cleaving the genome with a restriction
enzyme, and adaptors are then ligated and used for a
subsequent PCR amplification. The complexity of a
representation based on BglII cleavage is approxi-
mately 5% of the genome, which is comparable to that
of the complexity of transcripts within a cell. Single
fragments from the representation are then cloned and
arrayed on a slide. Representations from tumor and
normal, prepared in the same manner as that of the
array, are then hybridized to the array, and the results
are analyzed to define regions that have undergone
copy number changes such as deletion and amplifica-
tion.
To determine the fidelity of our microarray for-
mat, we carried out several experiments. We made
multiple BglII representations of the cell line SKBR-3
on different days. A representation derived from the
cell line was labeled separately with Cy3 and Cy5 (two
fluorescent dyes in common use) and compared. We
found that there was very little deviation from a ratio
of one. These experiments validate the extreme repro-
ducibility of representations and suggest that making
well-controlled parallel representations introduces no
more noise than is inherent in the measurements made
by the system as we practice it.
We also examined the reproducibility of our
microarray measurements between multiple experi-
ments. Multiple representations of two different
human breast cancer cell lines, SKBR-3 and MDA-
MB-415, were compared by hybridization. The ratios
obtained from one experiment were compared to
those obtained from another parallel experiment.
There was excellent concordance between indepen-
dent microarray measurements and excellent agree-
ment with measurements of gene copy number by
Southern blot hybridization. These experiments again
attest to the reproducibility of representations and
also to the reproducibility of printing, labeling, and
hybridization.
Due to the use of representations, we are able to
use minute amounts of starting material. Thus, we are
able to measure genomic changes in the sorted tumor
and normal nuclei of a cancer biopsy. The results of
the microarray hybridization completely corroborate
the results obtained by other methods. A summary of
this work has been published recently (Lucito et al.
2000).
The project is currently being scaled-up. Our col-
lection of BgIII representational fragments is about
12,000 and 8,000 have been sequenced. Greater than
80% of these fragments map to the "golden path," the
publicly assembled human genome. Many do not
map, indicating gaps in the genome data, and many
map to multiple chromosomes, suggesting either
miss-assembly of the genome or multiple regions of
large chromosome duplications. Many of the probes
contain repeat sequences, and we are presently deter-
mining which probes will be useful. To accomplish
this, we are using partitions of BAC libraries, which
we can use as quality control reagents for determining
which probes can detect deletions and which can
detect amplifications.
At present, we do not know what percentage of
probes will be useful for arraying. To produce a useful
tool, we will need microarrays with coverage of 1
probe every 100 kb, on average. This will require
about 30,000 probes, and to achieve this, we may need
to clone and characterize greater than 60,000 probes.
This microarray will be used to scan the genomes of
breast cancers to uncover regions that have undergone
copy number changes. Our hope is that our scan will
be done at such precise coverage, and against such a
large number of tumors, that we will uncover new can-
didate loci for the location of tumor suppressors and
oncogenes. Furthermore, by analyzing many tumors,
we should also be able to limit the size of the region
in which we need to search for genes. This method
also has other potential uses, including measuring
mutational load in cancers, monitoring DNA methyla-
tion patterns, genome-wide genetic typing, and detec-
tion of de novo mutations in humans.
Analysis of De Novo Mutation
in the Human Germ Line
E. Hatchwell
Approximately 1-2% of all children are born with
some degree of learning difficulty. The vast majority
are likely due to genetic factors. In many cases, the
intellectual problems are part of a more global syn-
drome, including various physical abnormalities.
Conventional approaches to diagnosis include bio-
chemical and cytogenetic analyses and, in specific cir-
cumstances, direct testing of suspect genes. When
exhaustive testing has been performed, however, at
least 50% of cases remain undiagnosed, either because
the syndrome presentation is not specific enough or
because the genetic abnormality is simply not
detectable using conventional methods.
In recent years, a number of syndromes have been
shown to result from submicroscopic genomic alter-
ations (i.e., deletions, duplications, or inversions). In
the vast majority, the knowledge gained depended
heavily on serendipity. It is likely that many of the syn-
dromes that are currently undiagnosed result from a
similar general mechanism. Currently, no general
method exists for detection of submicroscopic genom-
ic alterations. This project aims to develop methods
that will detect hemizygous loss, one of the known
mechanisms by which sporadic mutations arise. Using
the techniques of microarray analysis, one pilot study
has shown the feasibility of detecting half-copy gene
copy in children with William's syndrome. We are
presently testing "unknowns."
Array-based Genomic
Mapping
J. West, A. Reiner, L. Serina [in collaboration
with R. Lucito and V. Mittel, Cold Spring Harbor
Laboratory, and B. Mishra, Courant Institute,
New York University]
Microarrays have potential uses in genome mapping.
We have designed two major algorithms and run sim-
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ulations of them to guide us in experimental design.
Additionally, we have conducted experiments with
BAC pools and a new form of representation, called
reflective representations, with which we have
demonstrated the successful assignment of arrayed
probes to BACs. In principle, these tools can be
applied to confirmation of the assembled map of the
human genome, correction of errors in assembly, and
the identification of probes and BACs from gaps in
the assembled genome. The sequencing of these
BACs could accelerate the completion of a correctly
assembled genome.
Computational Genomics
J. Healy, A. Reiner, E. Thomas [in collaboration with
R. Sachidanandam, Cold Spring Harbor Laboratory,
and J. Schwartz, Courant Institute, New York University]
We have started a new informatics group within our
lab group which is absolutely required for the tumor
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microarray project. However, we have begun to focus
on other applications as well. One effort has been cen-
tered on probe characterization and the relation of
probes to the human genome map and putative tran-
scription units. The tools for this project have spun out
other projects, including one to detect deletions/inser-
tion alleles in the human genome, one to design a
more efficient repeat masker, one to detect new
repeats in the genome, and one to discover ancient
segmental duplications.
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CELL BIOLOGY
This section comprises labs studying a diverse set of interests including signal transduction events that
regulate gene expression and ultimately growth in normal and cancer cells.
Shiv Grewal's laboratory studies the epigenetic control of gene expression.
David Helfman's group is studying how specific actin assemblies are organized and regulated and
how alterations in actin filament assembly contribute to the abnormal control of cell growth in
cancer.
Nouria Hernandez and her colleagues work on fundamental mechanisms of transcription using two
model systems, the human snRNA genes and the HIV-1 LTR.
Tatsuya Hirano's laboratory studies the molecular mechanisms that regulate higher-order chromo-
some dynamics in eukaryotic cells, with a focus on the roles of SMC (structural maintenance of
chromosome) proteins in chromosome condensation and segregation.
David Spector's laboratory studies the structural-functional organization of the mammalian cell
nucleus, examining the nuclear organization of factors associated with pre-mRNA splicing and the
RNA substrates with which these factors interact.
Nick Tonks' laboratory takes a variety of approaches to the study of the structure, regulation, and
function of the protein tyrosine phosphatase (PTP) family of signal transducing enzymes.
Linda Van Aelst and her colleagues study the function of the Ras and Rho family of small GTPases
in cell growth and development, together with the mechanisms by which they exert their effects.
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EPIGENETIC CONTROL OF GENE EXPRESSION
S. Grewal J. Nakayama
K. Noma
C. Xiao
During cellular differentiation, the fate of individual
cells is determined by the specification of unique pat-
terns of gene expression. Once established, these
expression patterns are faithfully maintained through
multiple rounds of cell division and DNA replication
to ensure proper development. It is believed that dif-
ferentiated cells rely on an epigenetic cellular memo-
ry system, whereby nonmutational reversible alter-
ations of the chromosomes promote stable transmis-
sion of determined states to progeny cells. Apart from
controlling the expression of developmentally impor-
tant genes, epigenetic modifications can also influ-
ence diverse processes ranging from dosage compen-
sation to faithful transmission of chromosomes during
cell division. Moreover, epigenetic changes are often
suspected to be the main driving force for critical
changes in gene expression and genome instability in
cancer cells.
Among the diverse classes of epigenetic phenom-
ena, some are regulated by reversible modifications of
DNA, such as methylation, and some depend on post-
transcriptional events, but a surprising majority seems
to involve chromatin structure as an integral compo-
nent of the epigenetic gene repression mechanism.
Our laboratory is interested in understanding the role
of chromatin and DNA replication proteins in the
inheritance of epigenetic states. For this purpose, we
are studying heterochromatin-mediated transcriptional
silencing at the mating-type locus, centromeres, and
telomeres of the fission yeast Schizosaccharomyces
pombe. Previous studies have revealed that these
domains share many regulatory features and that,
together, they share many parallels with heterochro-
matin from higher eukaryotes. For example, silenced
domains in the fission yeast and metazoan heterochro-
matin exert region-specific, rather than gene-specific,
transcriptional repression. Second, silenced domains
in yeast are associated with specific hypoacetylation
of histones, which is also associated with heterochro-
matin in Drosophila and mammals. Third, similarities
among the epigenetic silencing systems can be
inferred from the homology of proteins involved.
Interestingly, proteins affecting silencing in S. pombe,
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including Swi6 and C1r4, share homology with modi-
fiers of position-effect variegation (PEV) in Drosoph-
ila, such as heterochromatin-specific protein HP-1
and Su(var)3-9, respectively. Likewise, fission yeast
silencing factors C1r3 and Clr6 share structural and
functional similarities to histone deacetylases from
higher eukaryotes, including humans.
During the past year, we have made considerable
progress toward understanding the mechanism of epi-
genetic inheritance. Our work suggests that the chro-
matin proteins contribute to the cellular memory,
facilitating the inheritance of epigenetically deter-
mined states of gene expression; i.e., the unit of inher-
itance, the "gene," in some instances might comprise
DNA plus the associated chromatin protein complex-
es. We also found that the DNA replication protein,
Pola, might have a direct role in the recruitment and
maintenance of chromatin proteins, such as Swi6, at
the mating-type region and centromeres. These results
might help us understand how chromosomal structures
acting as epigenetic imprints are duplicated at the
replication fork.
INHERITANCE OF EPIGENETIC STATES THROUGH
CHROMATIN REPLICATION
Our previous studies have revealed that an epigenetic
imprint marking the mating-type region contributes to
the maintenance of a heterochromatin-like structure,
which controls silencing throughout the mat2/3 inter-
val. In addition to the donor mating-type loci, mat2
and mat3, silencing extends to an 11-kb interval
between these loci called the K-region. Replacement
of a part of the K-region, which shares homology with
centromeric repeat sequences, with the ura4+ marker
gene (KA::urail+) results in variegation of ura4+
expression and efficiency of mating-type switching.
The Ura- efficiently switching (ura4-off) and the Ura+
inefficiently switching (ura4-on) states are inherited in
cis and controlled by an epigenetic mechanism. A sig-
nificant component contributing to efficient silencing
is the ability of the repressed state to promote its own
reassembly; i.e., the persistence of macromolecular
protein complexes associated with the mating-type
region presumably contributes to the propagation of
the silenced state. Supporting this notion, we found
that the Swi6 protein, a member of the highly con-
served chromodomain family of proteins, is a dosage-
critical component required for the establishment and
maintenance of the imprint at the mating-type region.
Chromatin immunoprecipitation analysis revealed
that the Swi6 protein is differentially localized at the
mating-type region of the ura4-off and ura4-on cells.
Interestingly, ura4-off cells contain significantly high-
er levels of Swi6 at the mat2/3 region when compared
to ura4-on cells. Transient overexpression of Swi6
results in a heritable change from the ura4-on state to
ura4-off state, and this change requires other trans-
acting factors including the histone deacetylase, C1r3,
as well as C1r4 protein. Moreover, the Swi6-induced
establishment of the ura4-off state was tightly corre-
lated with the increase in Swi6 levels at the mat locus.
Once recruited, however, Swi6 was found to remain
associated with the mating-type region throughout the
cell cycle, presumably providing a molecular book-
mark to clonally propagate a silenced chromatin state
during cell division.
To further address the role of chromatin in epige-
netic marking, we tested whether the differential Swi6
localization patterns at the mating-type region of ura4-
off and ura4-on state cells are maintained even when
both epialleles are present in the same nucleus. ura4-
on and ura4-off parent strains were mated to construct
a diploid. The diploid was allowed to grow for about 20
generations, sporulated, and then subjected to tetrad
analysis. As shown previously, we found that ura4-on
and ura4-off states are linked to the mating-type region
as indicated by their cosegregation with respective
alleles of his2 (Fig.l), a marker closely linked to the
mat locus. More importantly, chromatin immunopre-
cipitation (ChIP) analysis revealed that the his2- and
his2' meiotic segregants, which inherited their mat
locus from ura4-off and ura4-on parents, respectively,
maintained their original Swi6 localization patterns;
i.e., the mating-type region of His segregants contains
significantly higher levels of Swi6 than His segre-
gants (Fig. 1). This situation is analogous to X-chro-
mosome inactivation in mammals, in which active and
inactive chromosomes behave differently in the same
nucleus, and strongly suggests that a self-templating
chromatin structure might help promote inheritance of
the silenced state at the mating-type region during both
mitosis and meiosis. In other words, the "gene" at the
mat2/3 region comprises DNA plus the associated
Swi6 protein complex.
ROLE OF DNA POLYMERASE (I IN THE EPIGENETIC
CONTROL OF TRANSCRIPTIONAL SILENCING
DNA replication may directly influence inheritance of
epigenetically set chromatin complexes. In collabora-
tion with Amar Klar's laboratory (National Cancer
Institute), we showed that a mutation in pola alters the
epigenetic imprint and suppresses the variegation of
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FIGURE 1 The unit of inheritance that is the "gene" at the mat-
ing-type locus comprises DNA plus the associated Swi6-con-
taining protein complex. The ura4-off (his2) and ura4-on (his2)
derivatives of K4::ura4+ strains were crossed to construct a
diploid. The diploid cells were sporulated and subjected to
tetrad analysis. The four spores from each ascus were placed
on nonselective (N/S) rich medium in a horizontal row by micro-
manipulation. After growth for 3 days, colonies formed by
spores were replicated onto indicated medium. The medium
lacking uracil (AA-URA) or histidine (AA-HIS) selects for Ura+ or
His+ cells, respectively, whereas FOA counterselective medium
selects for the growth of Ura- cells. The levels of Swi6 protein
present at the mat2/3 region of segregants were measured
using the ChIP assay. The DNA recovered from anti-Swi6
immunoprecipitated chromatin fractions was analyzed using a
competitive polymerase chain reaction (PCR) strategy, whereby
one primer pair amplifies 694-bp and 426-bp size products
from the Kd :ura4+ gene and the ura4DS/E minigene, contain-
ing a small deletion, at the endogenous location, respectively.
PCR products were resolved on a polyacrylamide gel and then
quantified using a phosphorimager. The relative enrichment of
the K4,:ura4+ sequences is shown underneath each lane.
95
marker gene expression at the mating-type locus.
Moreover, this mutation seems to globally affect
silencing throughout the matt /3 interval, as indicated
by the derepression of markers inserted at different
locations in this region. In keeping with the fact that
the mating-type region and centromeres in fission
yeast share many features including cis-acting
sequences and trans-acting factors, we found that Po la
also affects centromeric silencing. ChIP analysis
revealed that the pola mutation affects both recruit-
ment and maintenance of Swi6 at the mating-type
region; i.e., significantly lower levels of Swi6 were
found at the mat locus of pola mutant cells, when
compared with wild-type cells. Moreover, we found
that pola mutant cells are defective in Swi6 localiza-
tion at centromeres and telomeres. Biochemical analy-
sis revealed that Pola binds directly to Swi6 protein in
vitro. Significantly, the silencing-defective pola
mutant displays reduced binding to Swi6 protein.
Whether the Pola requirement in silencing is cou-
pled to its role in DNA replication remains to be
explored and is the focus of our future work. It can be
imagined that the silencing defects in the pola mutant
might be through alteration in replication timing of the
heterochromatic regions. In this model, Swi6 protein
through its association with Pola might affect timing of
DNA replication and hence epigenetic marking at cen-
tromeres and the mating-type region. Considering that
Swi6 remains associated with chromatin throughout
the cell cycle, its interaction with Pola might provide a
mechanism for the maintenance of the stable chromo-
somal structures during cell division, ensuring the
inheritance of a silenced state onto both chromatids.
CHARACTERIZATION OF HISTONE
DEACETYLASE C1r6
Molecular analyses of three loci clr3, clr6, and hdal,
which also affect silencing at the mating-type region
and centromeres, have provided a link between genet-
ically defined silencing proteins and a class of bio-
chemically defined histone modifying enzymes
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known to have chromatin remodeling activity.
Interestingly, factors encoded by these genes share
homology with histone deacetylases. C1r6 and Hdal
share strong homology with Saccharomyces cerevisiae
Rpd3 and human HDAC I, whereas C1r3 is similar to
Hdal from S. cerevisiae and HDAC4 and HDAC5
from humans. Interestingly, C1r6 acts in a partially
redundant manner with C1r3, suggesting that silencing
might be regulated by overlapping histone deacetylase
activities. In addition to silencing, the clr6 mutation
also causes temperature as well as ultraviolet light sen-
sitivity, suggesting a general chromatin assembly
defect. Moreover, haploid segregants carrying the clr6
deletion allele possessed a very short replicative life
span of approximately eight generations.
We are now further characterizing C1r6 to under-
stand its precise function in heterochromatin assem-
bly and epigenetic control of gene expression.
Immunofluorescence analysis revealed that C1r6 is
localized to the nucleus on chromatin, forming a spot-
ted pattern. Biochemical analysis revealed that C1r6
displays histone deacetylase activity. Moreover, a
mutation in clr6 causes overall strongly elevated
acetylation levels of lysine residues at the histone H3
and H4 amino-terminal tails. This increase in acetyla-
tion of histones in mutant cells was correlated with
silencing defects and increased missegregation of
chromosomes. Purification of C1r6 revealed that it is
part of a highly conserved mutiprotein complex.
Future studies are aimed at characterizing the other
members of the C1r6 protein complex and studying
their effects on heterochromatin assembly at the
silenced chromosomal domains.
PUBLICATIONS
Grewal S.I.S. 2000. Transcriptional silencing in fission yeast. J.
Cell. Physiol. 184: 311-318.
Nakayama J., Klar A.J.S., and Grewal S.I.S. 2000. A chromo-
domain protein, Swi6, performs imprinting functions in fis-
sion yeast during mitosis and meiosis. Cell 101: 307-
317.
THE CYTOSKELETON IN NORMAL AND TRANSFORMED CELLS
D.M. Hellman E. Araya S.-W. Lee
L. Connel G. Pawlak
E. Kim A. Rai
We are studying how alterations in actin filament
assembly, a common characteristic of transformed
cells, contribute to aberrant cell growth control and
how specific actin structures are organized and regulat-
ed. The actin cytoskeleton is involved in a wide range
of motile events such as cell movement, cell division,
intracellular transport, phagocytosis, exocytosis, mem-
brane ruffling, formation of microspikes and filopodia,
growth cone formation, cell spreading, adhesion, and
changes and maintenance of cell shape. In addition, the
cytoskeleton has critical roles in the regulation of vari-
ous cellular processes linked to transformation, includ-
ing proliferation, contact inhibition, anchorage-inde-
pendent cell growth, and programmed cell death (apop-
tosis). Below is a description of our studies during the
past year to better understand the role of the cytoskele-
ton in normal and transformed cells.
Signaling Pathways Implicated
in Actin Cytoskeleton Disruption
during Ras Transformation
G. Pawlak
Oncogenic transformation by Ras is characterized not
only by alterations in growth control, but also by pro-
nounced morphological changes resulting from alter-
ations in the organization of the actin cytoskeleton
and adhesive interactions. Changes in the organiza-
tion of actin filaments are highly correlated with both
anchorage-independent growth and tumorigenicity,
suggesting a fundamental role for actin filaments in
cell growth control. Activation of multiple down-
stream signaling pathways is required to trigger the
full spectrum of phenotypic traits associated with
transformation by oncogenic Ras. We have used both
normal and Ras-transformed rat fibroblasts (NRK
and NRK/ras, respectively) to determine which of
these pathways are important for disruption of the
actin cytoskeleton.
NRK/ras cells have been treated with various
inhibitors of signaling molecules, namely, LY294002
(an inhibitor of the phosphatidylinositol 3-kinase
[PI3K] pathway), PD098059 (an inhibitor of mitogen-
extracellular-regulated protein kinase kinase [MEK])
or U0126 (an inhibitor of MEK kinase). Whereas
inhibition of the PI3K pathway has no effect on the
cell morphology, inhibition of MEK with either com-
pound leads to a striking restoration of actin stress
fibers in a time- and dose-dependent manner (Fig. 1).
This is accompanied by assembly of focal adhesions,
in which structural (vinculin) and signaling molecules
(FAK, paxillin) are recruited.
FIGURE 1 Reorganization of the actin
cytoskeleton in Ras-transformed NRK cells after
treatment with a MEK inhibitor. NRK/ras cells
were left untreated (a) or treated with 50 um
PD098059 for 10 (b), 24 (c), 48 (d) or 72 (e) hr,
and then actin was visualized with oregon-
green-conjugated phalloidin. Untransformed
NRK cells are shown as a control (t). Bar, 20 pm.
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To determine whether activation of the Ras/mito-
gen-activated protein kinase (MAPK) pathway alone
is sufficient to disrupt actin cytoskeleton and focal
contacts, untransformed NRK cells have been trans-
fected with the Ras effector loop mutants RasV12S35
(activates the Raf pathway), RasV12C40 (PI3K path-
way), and RasV12G37 (Ra1GDS pathway). The
RasV12S35-transfected cells exhibited a spindle-
shaped morphology and grew in multiple layers.
Indirect immunofluorescence analysis shows that like
NRK/ras cells, RasV12S35-transfected cells exhibit
disrupted actin stress fibers and focal contacts. In con-
trast, both RasV12C40- and RasV12G37-transfected
cells retain organized stress fibers and abundant focal
contacts characteristic of NRK cells.
Collectively, these studies show that a MEK-
dependent pathway is involved in the disruption of the
actin cytoskeleton during Ras transformation of NRK
cells. The mechanism is currently under investigation,
and preliminary studies implicate inactivation of Rho-
kinase (ROCK), an effector molecule for the small
GTPase Rho, whose activity has been shown to be
critical for the formation of stress fibers.
Expression of Tropomyosin
Isoforms in Normal and
Transitional Cell Carcinoma
of the Bladder
G. Pawlak [in collaboration with T. McGarvey and
B. Malkowicz, University of Pennsylvania, Philadelphia]
Various studies have shown that specific tropomyosin
(TM) isoforms are down-regulated in oncogene-trans-
formed fibroblasts and human breast carcinoma cell
lines. However, an analysis of expression of
tropomyosin isoforms in patient tumor tissue is limit-
ed. We have examined the expression of the
tropomyosin isoforms at the protein level in normal
bladder mucosa and transitional cell carcinoma of the
bladder. Protein was extracted from normal bladder
mucosa (n = 5), and transitional cell carcinoma (a total
n = 32, superficial) samples and Western blots were
performed with antibodies specific for TM4, TM5,
and TM1,2,3 isoforms. Protein levels were quantitated
by densitometry. We found that normal bladder
mucosa expresses the TM1 and TM2 isoforms, where-
as TM3 and TM5 isoforms are not expressed. On the
other hand, TM5 is expressed in 91% (29/32) and
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TM3 is present in 72% (23/32) of tumor specimens.
TM1 protein levels were reduced in 27/32 (84%)
tumors. TM1 was reduced by greater than 60% in
19/32 (59%) tumors and by 20-60% in 8/32 (25%)
tumors. TM2 protein levels were reduced in 26/32
(81%) tumors. TM2 was reduced by greater than 60%
in 16/32 (50%) tumors and by 20-60% in 10/32 (31%)
tumors. There appeared to be no difference in
tropomyosin isoform expression patterns between
muscle invasive and superficial bladder tumors. In
contrast, TM4 is expressed in normal human bladder
mucosa and all translational cell carcinoma samples.
In conclusion, we have demonstrated alterations in
tropomyosin isoforms in bladder carcinoma, which
may provide further insight into malignant transfor-
mation in transitional cell carcinoma.
The Cytoskeleton and
Apoptosis
L. Connell
Disruption of the interaction of normal epithelial cells
with the extracellular matrix (ECM) results in induc-
tion of apoptosis, a phenomenon termed "anoikis."
This process is believed to have a critical role in pre-
venting the growth of cells outside their local environ-
ment, i.e., metastasis. Conversely, inhibition of anoikis
in tumor cells allows them to invade surrounding tis-
sues. Several molecules and signaling pathways
induced by interaction of cells with the ECM have
been implicated in the regulation of anoikis, among
them focal adhesion kinase (FAK), PI3K, Akt, nuclear
factor (NF)-KB, and MAP kinases. Activation of FAK
is a critical component as it prevents anoikis. The
downstream effectors remain to be established, but
recent studies indicate that FAK can suppress p53-
mediated programmed cell death. In addition, p53
serves to monitor survival signals from ECM/FAK,
since apoptosis is suppressed by dominant negative
p53. In addition to FAK, a second component of focal
adhesions, namely, CAS, has been implicated in regu-
lation of apoptosis. The CAS proteins (p130Cas,
HEF1/Cas-L and Efs/Sin) are a family of docking pro-
teins that contain multiple interaction domains, and
they are important components of integrin receptor
signaling. Thus, cell-matrix interactions have an
essential role in preventing apoptosis in normal cells,
and this property is abrogated in transformed cells. It
still remains to be determined how these pathways
interact to regulate cell growth and survival and what
role cytoskeletal elements have in their function. The
generation of signals induced by the interaction of
cells with the ECM requires the maintenance of an
intact cytoskeleton. We are studying the signaling
pathways involving cell attachment to the ECM and
the actin cytoskeleton, and the role of the cytoskeleton
in the regulation of apoptosis in normal and trans-
formed cells.
Function of Caldesmon in the
Regulation of Actomyosin
Contractility and Oncogenic
Transformation in Nonmuscle Cells
S.-W. Lee
Regulation of actomyosin contractility has been shown
to be critical in the control of focal-adhesion-depen-
dent cell growth. Caldesmon is a cytoskeletal protein
containing actin-, myosin-, and tropomyosin-binding
domains. Caldesmon is thought to inhibit actomyosin
ATPase activity by blocking interaction between actin
and myosin. Recent studies have provided important
information about the role of caldesmon in contractil-
ity and transformation. First, we showed for the first
time that overexpression of caldesmon in fibroblast
cells inhibits cell contractility, and thereby interferes
with contractility-dependent formation of focal adhe-
sions (Helfinan et al., Mol. Biol. Cell. 10: 3097
[1999]). Second, we found that MAP kinase (ERK)
targets nonmuscle caldesmon in vivo when cellular
contractility is stimulated by an external growth factor
such as lysophosphatidic acid (LPA). Nonmuscle
caldesmon has also been found to be hyperphosphory-
lated in Ha-RasV12-transformed mouse fibroblast
cells (NIH-3T3) in which the ERK pathway is consti-
tutively active. We hypothesize that transformation-
sensitive changes including hyperphosphorylation of
caldesmon by ERK might contribute to aberrant
growth control in Ras-transformed cells by inhibiting
the ability of caldesmon to negatively regulate acto-
myosin contractility. Consequently, this results in con-
stitutive activation of downstream signaling pathways
dependent on actomyosin contractility. Work is in
progress to determine the physiological role of
caldesmon phosphorylation in the control of contrac-
tility-dependent growth.
Characterization of the
Metastasis-associated
Protein, S100A4
E. Kim
Distinct changes occur to propel a tumor from benign
to malignant. Increased motility, invasiveness, and
survival in foreign environments are some of the
changes that confer a metastatic phenotype. One
potentially key protein involved in generating these
changes is S 1 00A4, a member of the S100 family of
small calcium-binding proteins. Although the proteins
in this family share relatively high homology, their
expression, distribution, protein partners, and putative
roles are quite diverse. Elevation of A4 expression has
been correlated with increased invasiveness and with a
worse prognosis in the case of breast cancer. In vitro
biochemical assays have suggested calcium-dependent
protein-protein interactions between A4 and three
cytoskeletal proteins: actin, tropomyosin, and myosin.
We have confirmed a calcium-dependent interaction
between A4 and the heavy chain of nonmuscle myosin
in vivo, and experiments are currently in progress to
identify additional protein partners. Future experi-
ments will utilize mutational analysis to further char-
acterize these interactions.
Molecular Organization and
Regulation of Actin Filaments
E. Araya [in collaboration with C. Berthier,
University of Lyon, France]
In nonmuscle cells, the formation of actin filaments
and their assembly into various structures, e.g., stress
fibers, contractile ring, filopodia, lamellipodia, are
dynamic processes. How these different structures are
formed and regulated within a single cell is not known.
In addition to actin and its associated motor molecules
(myosin I and II), other actin-filament-associated pro-
teins, such as tropomyosin, have essential roles in the
assembly, function, and regulation of these structures.
We have been studying the dynamic localization of
tropomyosin isoforms using green fluorescent protein
(GFP)-tagged constructs. Tropomyosins are a family of
actin-binding proteins that bind to both grooves of fil-
amentous actin. Although they are expressed in all
eukaryotic cells, different forms are characteristic of
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specific cell types. In fibroblasts, tropomyosins exist
as high-molecular-weight isoforms (HMW) contain-
ing 284 amino acids (TM1, TM2, and TM3) or low-
molecular-weight isoforms (LMW) containing 248
amino acids (TM4, TM5[NM-1], TM5a, and TM5b).
The multiple tropomyosins found in fibroblasts are an
integral part of the actin filaments, although how the
different isoforms contribute to actin filament assem-
bly and function is poorly understood. In addition, in
fibroblasts, HMW tropomyosins exist as homod-
imers, whereas LMW tropomyosins can exist as het-
erodimers. How these coiled-coiled interactions are
regulated and how they effect the interaction of
tropomyosins with actin filaments and their subse-
quent cellular functions are under study. We have
found that specific tropomyosin isoforms are
involved in different subsets of actin filaments. For
example, we have found that during cytokinesis, only
a subset of tropomyosin isoforms is found in the con-
tractile ring. The mechanism(s) involved in isoform-
specific sorting is currently under study. We antici-
pate that elucidating the molecular bases for the dif-
ferential localization of the specific tropomyosin iso-
forms during various cellular events involving reorga-
nization of the actin-cytoskeleton will provide impor-
tant new insights into the regulation of distinct actin
structures.
Snapin, a Ubiquitously Expressed
Protein Involved in Intracellular
Vesicular Transport, Is
Phosphorylated in a
Cell-cycle-dependent Manner
A. Rai
Snapin was first identified as a brain-specific compo-
nent of the SNARE complex involved in calcium-sen-
sitive regulation of synaptic vesicle fusion (Ilardi et
al., Nat. Neurosci. 2: 119 [1999]). We have found that
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human snapin is encoded by a single-copy gene which,
in contrast to previous reports, is expressed ubiqui-
tously in a wide variety of tissues and cell types.
Furthermore, snapin homologs are found in
Caenorhabditis elegans, Drosophila melanogaster,
zebrafish, and rodents. Consistent with its proposed
function in secretion, snapin was found to be localized
to a cytoplasmic vesicular compartment with a strong
juxtanuclear concentration. Overexpression of an epi-
tope-tagged full-length snapin results in a tabulation
phenotype, consistent with perturbation of membrane
traffic through the secretory pathway, whereas expres-
sion of truncated forms of snapin suggests that differ-
ent domains have distinct roles in its transport through
the secretory pathway. Snapin was found to be phos-
phorylated on Ser-133, which lies within a Cdc2
kinase consensus site. Phospho-snapin is enriched
during the G2/M phase of the cell cycle, when Cdc2
kinase-cyclin B activity is high, suggesting that
snapin is a Cdc2 substrate. In vitro kinase assays using
recombinant proteins demonstrate that Cdc2-cyclin B
can phosphorylate GST-snapin in vitro. Collectively,
these data demonstrate that snapin functions in a wide
variety of metazoan organisms, having a role in both
neuronal and nonneuronal membrane fusion process-
es, and is phosphorylated in a cell-cycle-dependent
manner during the G2/M transition on Ser-133.
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INITIATION AND TERMINATION OF TRANSCRIPTION IN
HUMAN sNRNA GENES AND HIV-1
N. Hernandez F. Emran A. Saxena Y. Sun
P. Hu L.M. Schramm X. Zhao
B. Ma S. Sepehri A. Zia
P.S. Pendergrast M. Shanmugam
We use the human small nuclear RNA (snRNA) genes
and the human immunodeficiency virus type-1 (HIV-
1) long terminal repeat to study fundamental mecha-
nisms of transcription. The human snRNA genes form
a family of genes, of which some members are tran-
scribed by RNA polymerase II and others are tran-
scribed by RNA polymerase III. The promoters of the
RNA polymerase II and III snRNA genes are, however,
very similar in structure. In both cases, the enhancer
region (called the distal sequence element or DSE)
contains an octamer sequence that recruits the tran-
scription factor Oct-1, and the core region contains a
proximal sequence element (PSE). In the RNA poly-
merase II snRNA promoters, the PSE is sufficient to
recruit, in vitro, RNA polymerase II and direct basal
transcription. In the RNA polymerase III snRNA pro-
moters, the core region contains a second element, a
TATA box, which functions in concert with the PSE to
recruit RNA polymerase III and direct basal transcrip-
tion.
We use this model system to study how transcrip-
tion complexes are assembled on core promoters and
then recruit the correct RNA polymerase, and how
enhancers mediate activation of transcription. In the
last year, we have concentrated on the characterization
of novel transcription factors required for RNA poly-
merase III transcription of snRNA genes. As described
in more detail below, this has resulted in the identifica-
tion of two new members of the RNA polymerase III
initiation complexes formed on snRNA promoters. We
have also pursued our studies on the characterization of
the snRNA activating protein complex (SNAP), which
binds to the PSE of both the RNA polymerase II and III
snRNA promoters, and completed a map of the sub-
unit-subunit interactions within the complex.
The HIV-1 promoter gives rise, in a regulated man-
ner, to two types of transcripts: short prematurely ter-
minated transcripts and full-length transcripts. We pre-
viously characterized FBI-1, a protein that binds to an
element located downstream from the HIV-1 transcrip-
tion start site called the inducer of short transcripts or
IST. IST is a DNA element that specifically activates
the formation of short transcripts. We have continued
our characterization of the function of this protein.
Factors Required for snRNA
Transcription by RNA
Polymerase III
L. Schramm, P.S. Pendergrast, Y. Sun,
N. Hernandez
The U6 snRNA promoter is recognized by RNA poly-
merase III, and its core region contains a PSE and a
TATA box. We have known for a long time that the PSE
recruits SNAP, and the TATA box recruits the TATA-
box-binding protein (TBP). Typical gene-internal RNA
polymerase III promoters, such as the promoters of the
tRNA gene or the 5S RNA gene, also depend on TBP
for transcription, but, in this case, TBP is recruited as
part of a complex called TFIIIB. The TFIIIB complex
in yeast is completely defined and consists of two sub-
units besides TBP: the TFIIB-related factor BRF and a
polypeptide called the B- polypeptide.
Like yeast TFIIIB, mammalian TFIIIB contains
TBP and a homolog of the yeast BRF, human BRF
(hBRF), which associates strongly with TBP.
However, it was unclear whether a homolog of yeast
B" existed. Furthermore, we had shown that hBRF,
although required for transcription of RNA poly-
merase III genes with gene-internal promoters, was
not required for transcription of the human U6 gene.
Thus, two main questions remained concerning mam-
malian TFIIIB. First, it was unclear whether a mam-
malian homolog of yeast B" existed and whether it
was required for RNA polymerase III transcription of
both genes with internal promoters, such as the VAI
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gene, and genes with external promoters that recruit
SNAP, such as the human U6 gene. Second, the
apparent lack of requirement for hBRF in U6 tran-
scription raised the possibility that the mammalian
snRNA-type RNA polymerase III promoters use a
factor different from, but related to, hBRF.
We searched the human and mouse EST databas-
es and identified a mouse EST encoding a short
polypeptide with strong similarity to part of the yeast
B" protein. The similarity mapped to a region of yeast
13" that had been shown to be important for function.
We used the mouse EST to design oligonucleotides
and screen human cDNA libraries by polymerase
chain reaction (PCR). Through a combination of PCR
screening and database searches, we were able to iso-
late a cDNA encoding a full-length protein that is a
functional homolog of yeast 13". Human 13" is
required for RNA polymerase III transcription from
both gene-internal and U6-type RNA polymerase III
promoters. The protein shows similarity to the yeast
protein over an internal region and diverges from it at
both the amino and carboxyl termini. The carboxy-ter-
minal region of human 13" is striking because it con-
sists of a series of repeats that are completely absent
from the yeast protein and that contain a number of
potential phosphorylation sites, reminiscent of the
carboxy-terminal domain of the largest subunit of
RNA polymerase II. This region is not required for
transcription in vitro, suggesting that it may serve a
regulatory role.
We also searched the database for proteins related
to hBRF that might be involved in U6 transcription.
The search identified TFIIB as well as another protein
with no known function. This other protein, which we
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call BRFU, is equally similar to both TFIIB and BRF.
Very strikingly, when a transcription extract is deplet-
ed of both BRF and BRFU with antibodies that recog-
nize both proteins, transcription from gene-internal
RNA polymerase III promoters is restored by addition
of BRF but not by addition of BRFU. Conversely, tran-
scription from the U6 gene is restored by addition of
BRFU but not by addition of BRF. Thus, BRFU is
specifically required for RNA polymerase III tran-
scription from U6-type promoters.
Together, these results show that there are different
forms of the basal RNA polymerase III transcription
factor IIIB in mammalian cells. They also identify the
first transcription factors uniquely required for tran-
scription of RNA polymerase III, but not RNA poly-
merase II, snRNA promoters. Together with our previ-
ous results indicating that TFIIB is required for tran-
scription of the human RNA polymerase II snRNA
genes, they suggest that the key event in the determi-
nation of RNA polymerase specificity in the human
snRNA promoters is the recruitment of hBRFU versus
TFIIB.
Protein-Protein
Interactions among
SNAP. Subunits
B. Ma, N. Hernandez
SNAP is a complex containing five different types of
subunits. From previous experiments, we knew that
SNAP45
869 912 1281 1393
334
1469
FIGURE 1 Subunit-subunit interactions within SNAP. The various subunits are symbolized by boxes, and the
regions sufficient for association with other subunits are indicated by thin lines. The numbers above the boxes
indicate amino acid numbering. The Myb and Oct-1 interacting domains (01R) in SNAP190 are also indicated.
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SNAP19 and SNAP45 can each associate with
SNAP190 and that SNAP43 can associate with
SNAP50. SNAP43 can also associate with SNAP190,
but in coimmunoprecipitations of in-vitro-translated
proteins, this association is not detectable unless
SNAP19 is present. This suggests that SNAP43 has
weak contacts with both SNAP190 and SNAP19, only
the sum of which is measurable by the stringent coim-
munoprecipitation assay.
To map more precisely the protein-protein contacts
within SNAP, we generated truncated or mutated ver-
sions of the various SNAP subunits by translation in
vitro, mixed them in various combinations, and deter-
mined their ability to coimmunoprecipitate with each
other. In this way, we were able to generate the map
shown in Figure 1. Within SNAP190, amino acids
84-133 were sufficient for association with SNAP19
alone and with SNAP43 together with SNAP19. This
SNAP190 region and the amino-terminal part of
SNAP19 are likely to form a helices and may be
involved in a coiled-coil type of interaction with each
other. Indeed, SNAP19 contains five leucines spaced
by six amino acids, and mutations of these leucines had
a strong negative effect, whereas mutation of a leucine
out of register had little effect. Similarly, SNAP190
contains six leucines and glutamines which are sepa-
rated by six amino acids and are therefore predicted to
reside on the same face of an a-helix. Mutations that
change subsets of these amino acids debilitated associ-
ation with SNAP19 and SNAP43 together with
SNAP19, whereas a double mutation that changed two
amino acids predicted to reside on another face of the
helix, one of which is a leucine, had a much weaker
negative effect on these associations. Interestingly,
changing in register glutamines to leucines (mutations
Q94L and Q115L) was as debilitating as changing
them to alanines. Thus, although this SNAP190 region
is likely to form an a-helix involved in a coiled-coil
type of interaction, it does not correspond to a classical
leucine zipper. In SNAP43, amino acids 164-268 were
sufficient for association with SNAP190 and SNAP19,
and amino acids 1-163 were sufficient for association
with SNAP% Thus, these two association domains in
SNAP43 are completely separable.
Carboxy-terminal to the SNAP 19 /SNAP43 associ-
ation domain, SNAP190 contains an unusual Myb
domain extending from amino acid 263 to 503, with
four and one half Myb repeats designated the Rh (for
R half), Ra, Rb, Rc, and Rd repeats. The last two Myb
repeats (Rc and Rd), but not the first two and one half
(Rh, Ra, and Rb), are required for binding to the PSE.
Within the carboxy-terminal half of SNAP190 are two
additional regions involved in protein-protein con-
tacts: the Oct-1 interaction domain (OIR) lies between
amino acids 869 and 912 and the region required for
interaction with SNAP45 lies between amino acids
1281 and 1393. Thus, the SNAP190 regions required
for association with SNAP19/SNAP43 and with
SNAP45 lie at opposite ends of the linear molecule.
We then tested whether the assumption that pro-
tein-protein contacts between isolated subunits reflect-
ed protein-protein contacts within SNAP, was likely to
be true by assembling partial SNAP complexes from
truncated subunits containing little more than the
regions mapped as required for subunit-subunit inter-
actions. Such complexes could indeed be assembled
and shown to bind specifically to the PSE. Together,
these results provide a detailed map of a basal tran-
scription complex.
Mechanism of SNAP
Auto-down-regulation of
DNA binding
A. Saxena, N. Hernandez
SNAP, binds relatively poorly to DNA, but a subcom-
plex of SNAP, called mini-SNAP, and consisting of
the amino-terminal third of SNAP190, SNAP43, and
SNAPS° binds very efficiently to the PSE. The pres-
ence or absence of SNAP19 has no effect on DNA
binding, suggesting that it is the carboxy-terminal two
thirds of SNAP190 and/or SNAP45 that are responsi-
ble for the down-regulation of DNA binding. We are
studying the mechanism involved.
Identification of
SNAP -associated
Factors
F. Emran, N. Hernandez
Some of the transcription factors required for RNA
polymerase II and III snRNA gene transcription are
likely to associate with SNAP,. We are developing a
yeast screen as well as cell lines to identify such
SNAP,-associated factors.
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Characterization of a Human
RNA Polymerase Ill Holoenzyme
S. Sepehri, P. Hu, N. Hernandez
We are purifying an RNA polymerase III complex
that, together with TBP and a SNAP° fraction, is suf-
ficient for U6 transcription. The goal is to determine
the composition of this complex and thus identify new
factors required for U6 transcription.
Transcription from Chromatin
Templates
X. Zhao, N. Hernandez
The goal of this project is to study the transcription of
snRNA genes wrapped into chromatin templates and
to determine the role played by cooperative interac-
tions between the Oct-1 POU domain and SNAP, and
SNAP, and TBP, for transcription from such templates.
Protein Transduction
M. Shanmugam, N. Hernandez
Proteins fused to a small peptide derived from the
HIV-1 Tat protein have been shown by other investi-
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gators to have the capacity to enter cells. We are test-
ing the ability of various proteins fused to the Tat pep-
tide to enter cells and elicit a biological response.
Function of FBI-1
P.S. Pendergrast, R Stavropoulos, N. Hernandez
Through a combination of transfection and co-
immunoprecipitation experiments, we are deciphering
the function of FBI-1 in HIV-1 transcription and local-
izing it in the cell.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano 0. Cuvier A. Losada
M. Hirano D. Mac Callum
K. Kimura
Our laboratory is interested in understanding the mol-
ecular mechanisms that regulate higher-order chromo-
some dynamics in eukaryotic cells. Our previous
efforts, primarily using a cell-free extract derived from
Xenopus laevis eggs, have identified two protein com-
plexes, 13S condensin and 14S cohesin, that have cen-
tral roles in chromosome condensation and sister chro-
matid cohesion, respectively. Each of the complexes
has a different pair of structural maintenance of chro-
mosome (SMC) subunits, implicating a mechanistic
connection between condensation and cohesion. The
long-term goal in our laboratory is to understand how
the two eukaryotic SMC protein complexes work at a
mechanistic level and how they interact with other
proteins to execute their essential functions in the cell.
We also use a bacterial SMC homodimer as a model
system to dissect the basic mechanisms of SMC
actions.
Identification of Two Different
Cohesin Complexes in
Xenopus and Human Cells
A. Losada, T. Yokochi, T. Hirano [in collaboration with
R. Kobayashi, Cold Spring Harbor Laboratory]
We showed previously that the cohesin complex is
required for the establishment and maintenance of sis-
ter chromatid cohesion in Xenopus egg extracts.
During the past year, we have found that two distinct
cohesin complexes exist in the extracts. A 14S com-
plex (termed cohesins") contains XSMC1, XSMC3,
XRAD21, and a newly identified subunit, XSA 1 . In a
second 12.5S complex (cohesins"), XSMC1,
XSMC3, and XRAD21 associate with a different sub-
unit, XSA2. Both XSA1 and XSA2 belong to the SA
family of mammalian proteins and exhibit similarity
to the yeast cohesin subunit Scc3p. In Xenopus egg
extracts, cohesins" is predominant, whereas
cohesins" constitutes only a very minor population.
We also found that human cells have a similar pair of
cohesin complexes, but the SA2 type is the dominant
form in somatic tissue culture cells.
Cell Cycle Regulation of
Sister Chromatid Cohesion
A. Losada, T. Hirano
Immunolocalization experiments suggest that the asso-
ciation of cohesins"' and cohesins" with interphase
chromatin may be differentially regulated at the level
of nuclear transport in the early embryonic cell cycle.
In somatic cells, however, the two cohesin complexes
exhibit no major differences in their kinetics of chro-
matin association and dissociation. Most cohesins (up
to 95%) dissociate from chromatin at the onset of mito-
sis, both in vitro (in the cell-free extracts) and in vivo
(in tissue culture cells). A very small population of
cohesin (-5%), however, can be found on the
metaphase chromosomes by immunostaining. This
population is likely to have a role in holding the sister
chromatids until the onset of anaphase. These results
suggest that the linkage between sister chromatids is
resolved by a two-step mechanism in vertebrate cells.
The first step takes place during prophase when tight
cohesion between interphase chromatids is partially
released, allowing each chromatid to condense. The
second step occurs at the metaphase-anaphase transi-
tion and results in complete separation of the sister
chromatids. This is in striking contrast to the regulation
of cohesion in Saccharomyces cerevisiae. In this organ-
ism, most of cohesin stays bound to chromatin until the
metaphase-anaphase transition when their dissociation,
triggered by cleavage of the Seel/ RAD21 subunit,
leads to a single-step dissolution of cohesion.
We have investigated the mechanisms that drive
the prophase dissociation of cohesins in vertebrate
cells. At least in the cell-free extracts, none of the
cohesin subunits are cleaved upon entry into mitosis.
Instead, release of cohesins from chromatin correlates
with phosphorylation of XSA1. Purified Cdc2-cyclin
B can phosphorylate XSA1 in vitro and reduce the
ability of x-cohesins"' to bind to DNA and chromatin.
Evidence from other laboratories indicates that the
RAD21 subunit of vertebrate cohesin is cleaved coin-
cidentally at the onset of anaphase in human cells. We
therefore propose that two different mechanisms regu-
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late cohesin's dissociation from chromatin at two dif-
ferent stages of mitosis in vertebrates. The major
release, which takes place at prophase, is likely to
involve phosphorylation of the SA subunit. The final
release of the minor mitotic population is probably
promoted by separin-mediated cleavage of Scc 1/
RAD21, as has been shown in S. cerevisiae.
Structural and Functional Dissection
of Xenopus Condensin
K. Kimura, T. Hirano
Condensin reconfigures DNA structure in an ATP-
dependent manner in vitro and has a central role in
mitotic chromosome condensation in Xenopus egg-
cell-free extracts. The Xenopus 13S condensin com-
plex (13SC) is composed of two subcomplexes: an 8S
core subcomplex (8SC) consisting of two SMC sub-
units (XCAP-C and -E) and an 11S regulatory sub-
complex (11SR) containing three non-SMC subunits
(XCAP-D2, -G, and -H). During the past year, we have
performed a biochemical and functional dissection of
this chromosome condensation machinery. Although
both 8SC and 13SC can bind to DNA in vitro and con-
tain the SMC ATPase subunits, only 13SC is active as
a DNA-stimulated ATPase and supports ATP-depen-
dent supercoiling activity. In the cell-free extracts,
13SC is the active form that binds to chromosomes and
induces their condensation. Neither 11SR nor 8SC
alone is able to bind to chromatin. Our results suggest
that the non-SMC subunits have dual roles in the reg-
ulation of condensin functions: One is to activate SMC
ATPases and the other is to allow the holocomplex to
associate with chromatin in a mitosis-specific manner.
Identification of HEAT Repeats
in Condensin Subunits
T Hirano [in collaboration with A. Neuwald, Cold Spring
Harbor Laboratory]
HEAT repeats are highly degenerated repeating motifs
that have been found in a wide variety of proteins with
diverse functions. They form tandemly arranged bihe-
lical structures that may serve as flexible scaffolding
on which other proteins can assemble. In collabora-
tion with Andy Neuwald here at the Laboratory, we
have found that two of the non-SMC subunits, XCAP-
D2 and XCAP-G, share HEAT repeats. The former
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and the latter have at least 12 and 9 repeats, respec-
tively, which distribute along the entire length of the
polypeptides. Intriguingly, we also found that two
other proteins genetically implicated in sister chro-
matid cohesion (Scc2/Mis4 and BimD/Pds5) have
HEAT repeats. Although neither of the cohesion fac-
tors are stoichiometric components of cohesin, they
may work closely with the complex in establishing sis-
ter chromatid cohesion. These results further empha-
size the structural similarity between the condensation
and cohesion machinery. The HEAT proteins could
function as regulators of SMC ATPases or could have
an architectural role in SMC functions.
Human Condensin Complex
K. Kimura, 0. Cuvier, T. Hirano
A long-term goal in our lab is to understand how the
condensin complex works at a mechanistic level. To
determine the functional contribution of individual
subunits and of structural motifs conserved in each
subunit, we wish to reconstitute a whole condensin
complex from recombinant polypeptides. For a num-
ber of technical reasons, we decided to use human
cDNAs and their protein products as starting materials
for such reconstitution. Since the existence of the con-
densin complex in mammalian cells had not yet been
fully established, it was important to demonstrate first
that human cells have a complex that is equivalent to
Xenopus 13S condensin. Using a peptide antibody
raised against one of the putative subunits of human
condensin, we affinity-purified a 13S complex from
HeLa cell nuclear extracts. We found that the human
complex has exactly the same size and subunit com-
position as its Xenopus counterpart, being composed
of two SMC (hCAP-C and hCAP-E) and three non-
SMC (hCAP-D2, hCAP-G, and hCAP-H) subunits.
Human condensin purified from asynchronous HeLa
cell cultures fails to reconfigure DNA structure in
vitro. When phosphorylated by purified Cdc2-cyclin
B, however, it gains the ability to introduce positive
supercoils into DNA in the presence of ATP and topoi-
somerase I. Strikingly, human condensin can induce
chromosome condensation when added back into a
Xenopus egg extract that has been immunodepleted of
endogenous condensin. Thus, the structure and func-
tion of the condensin complex are highly conserved
between Xenopus and humans, fully justifying our
plan to reconstitute the condensin complex starting
from human cDNAs.
Chromatin Remodeling Complexes in
Xenopus Egg Extracts
D. Mac Callum, T. Hirano [in collaboration with R. Kobayashi,
Cold Spring Harbor Laboratory]
We previously characterized major protein compo-
nents of chromosomes assembled in Xenopus egg
extracts and collectively referred to them as Xenopus
chromosome-associated polypeptides (XCAPs). They
included five subunits of the condensin complex
(XCAP-C, -E, -D2, -G, and -H) and topoisomerase II
a (XCAP-B), all of which have been shown to be
essential for chromosome condensation. In an effort to
identify novel proteins required for chromosome con-
densation, we have isolated XCAP-F, a 135-kD
polypeptide, and identified it as the Xenopus homolog
of the Drosophila ISWI protein (termed XISWI).
ISWI is known to act as the core ATPase subunit of
different chromatin remodeling complexes, such as
NURF, CHRAC, and ACF in Drosophila.
We have cloned a cDNA encoding XISWI and
raised antibodies against the carboxy-terminal peptide.
Immunoprecipitation experiments show that XISWI
exists in two different heterodimeric complexes. In the
first complex, XISWI associates with a 190-kD
polypeptide that is homologous to Drosophila ACF1.
The second one is a novel complex that contains the
Xenopus homolog of the human Williams syndrome
transcription factor (WSTF), a gene deleted in the
developmental disorder Williams syndrome. We have
cloned cDNAs of these partner proteins (termed
XACF1 and XWSTF) and raised antibodies against
them. We have shown by immunodepletion that XISWI
is not required for bulk assembly of nucleosomes on
sperm chromatin or naked DNA templates, but it is
required for regular spacing of the nucleosomes. This
regular nucleosome spacing is not apparently neces-
sary for chromosome condensation because immun-
odepletion of XISWI from the extracts has little effect
on their ability to condense chromosomes. We have
also analyzed the effect of immunodepletion on other
chromatin-related activities, including DNA replica-
tion and transcription, and found no essential role for
these XISWI-containing complexes. Thus, our initial
expectations of a role for XISWI in higher-order chro-
matin structure may not be the case. Nevertheless,
XISWI is clearly required for regular spacing of nucle-
osomes, and it is likely that a lack of nucleosome spac-
ing has important consequences on chromatin func-
tion. One possibility is that each of the two XISWI-
containing complexes may possess its unique function
and have antagonistic roles in chromatin remodeling.
To test this hypothesis, we are currently studying the
specific role of each complex.
Bimodal Regulation of BsSMC ATPase
M. Hirano, T. Hirano
SMC proteins are conserved not only among eukary-
otes, but also in bacterial and archaeal species. We use
a bacterial SMC homodimer from Bacillus subtilis
(BsSMC) as a model system for understanding the
basic mechanisms of SMC actions. A previous elec-
tron microscopy study showed that BsSMC is com-
posed of two antiparallel coiled-coil arms, each having
an ATP-binding domain in its distal end. Although this
structural model suggests an intriguing model of the
action of SMC proteins as ATP-modulated DNA
cross-linkers, no direct biochemical evidence for this
model has been available. During the past year, we
have constructed a number of BsSMC mutant deriva-
tives including "single-armed" BsSMC and have pro-
vided the first set of biochemical evidence to support
the antiparallel dimer model. We have shown further
that the two-armed structure connected by a flexible
hinge has a crucial role in modulating intra- and inter-
molecular interactions of BsSMC and is responsible
for bimodal regulation of its ATPase cycle. This novel
mode of ATPase modulation is likely to provide fun-
damental implications for our understanding of the
actions of eukaryotic SMC protein complexes.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector S. Janicki T. Howard
P. Sacco-Bubulya J. Herbst
N. Saitoh
Studies in our laboratory are focused on the structur-
al-functional organization of the mammalian cell
nucleus. Our research program evolves around under-
standing the nuclear organization of factors associated
with pre-mRNA splicing and the RNA substrates with
which these factors interact. The microscopy core
facility has been used extensively during the past year,
and numerous collaborations were pursued with the
excellent technical expertise of Tamara Howard.
Organization of Interchromatin
Granule Clusters
P. Sacco-Bubulya
Pre-mRNA splicing factors are localized in a speck-
led pattern when mammalian cell nuclei are examined
by immunofluorescence microscopy using anti-splic-
ing factor antibodies. At the electron microscopic
level, this localization pattern corresponds to inter-
chromatin granule clusters and perichromatin fibrils.
Splicing factors are recruited from interchromatin
granule clusters to regions of active transcription
(perichromatin fibrils), where they function in cotran-
scriptional pre-mRNA processing. We have previous-
ly observed this recruitment in living cells by time
lapse microscopy of green fluorescent protein (GFP)-
tagged splicing factors. Although there is a continu-
ous flow of GFP-tagged splicing factors in and out of
nuclear speckles, the position of nuclear speckles
within the nucleus is maintained for many hours. We
would like to understand how interchromatin granule
clusters (IGCs) are organized within the nucleus and
elucidate their relationship to specific aspects of gene
expression. Many splicing factors contain an RS
domain that when hyperphosphorylated results in the
release of these factors from IGCs and may be a cru-
cial step for recruitment to sites of pre-mRNA syn-
thesis. The release of SR proteins from IGCs is regu-
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lated by SR protein kinases. Overexpression of SR
protein kinases in cultured cells alters the organiza-
tion of nuclear speckles and can ultimately cause
complete redistribution of SR proteins from their typ-
ical speckled nuclear localization to a diffuse nuclear
localization.
We are using one of these SR protein kinases,
cdc2 -like kinase (Clk/STY), as a tool to disassemble
nuclear speckles in vivo to test the hypothesis that
IGCs may be held together by a specific underlying
framework and to assess the function of IGCs in living
cells. We speculated that a structural protein would
maintain its position upon SR protein hyperphospho-
rylation, whereas RNA processing factors would be
dispersed. Alternatively, if a specific framework is not
present, SR proteins would simply be released and we
would see no underlying structure.
Overexpression of wild-type Clk/STY in A-431
cells causes a dramatic reorganization of the SR pro-
tein SC35 from its typical nuclear speckled localiza-
tion to a diffuse nuclear localization (Fig. 1A,B). All
nuclear speckle constituents tested, including SR pro-
teins, small nuclear ribonucleoprotein (snRNP) pro-
teins, stable poly(Ar RNA, and other novel IGC con-
stituents, behaved identically. Redistribution of
nuclear speckle constituents to a diffuse nuclear local-
ization upon hyperphosphorylation of SR proteins is
therefore a general response. However, overexpression
of a kinase-dead mutant Clk/STY (Fig. 1C,D) does not
result in a reorganization of splicing factors.
At the ultrastructural level, the IGCs of untrans-
fected nuclei appear as large clusters of electron-dense
granules that contain SR proteins when labeled using
immunogold-conjugated antibodies. In cells that over-
express wild-type Clk/STY, there are no intact IGCs,
and immunogold labeling for SR proteins is distrib-
uted evenly throughout the nucleus. Furthermore,
upon overexpression of Clk/STY, we did not detect
any underlying filaments or specific regions in the
transfected cell nuclei that may serve as a scaffold to
specifically cluster interchromatin granules. On the
Wild
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FIGURE 1 A-431 cells transiently transfected with wild-type
GFP-CIWSTY (A and 8) or GFP-Clk/STY K190R (C and D) were
fixed in 2% formaldehyde and processed for fluorescence
microscopy using anti-SC35 antibody followed by Texas Red-
coupled secondary antibodies. Whereas catalytically dead
mutant Clk/STY K190R colocalizes with SC35 in nuclear
speckles (compare C and D), overexpression of wild-type
Clk/STY induces a reorganization of SC35 from its typical
nuclear speckle localization to a diffuse nuclear localization (8).
basis of these data, we conclude that individual inter-
chromatin granules may be held within the cluster
through RS-RS interactions that are disrupted upon
hyperphosphorylation of SR proteins. We are current-
ly investigating the importance of the integrity of
IGCs for supplying factors involved in RNA metabo-
lism to active genes. For example, splicing factors
may arrive at transcription sites in preassembled com-
plexes that are completely functional only if they orig-
inate from IGCs. Interestingly, transcription is not
affected in cells that have disrupted IGCs for up to 16
hours. Studies are currently under way to evaluate
how IGC disassembly affects splicing activity in vivo.
Proteome Analysis of lnterchromatin
Granule Clusters: Identification of IGC
Components by Mass Spectrometry
N. Saitoh [in collaboration with S. Patterson and C. Spahr,
Amgen, Inc., and A. Neuwald, Cold Spring Harbor Laboratory]
To address the molecular mechanism of the assembly
and maintenance of IGCs in mammalian cell nuclei
and the dynamic properties of IGCs, especially the
process of recruitment of splicing factors to the site of
active transcription, it is crucial to identify the protein
complement of this nuclear compartment. We have
purified approximately 1 mg of IGCs from mouse
liver nuclei and applied the final fraction to proteome
analysis using liquid chromatography and tandem
mass spectrometry (LC-MS/MS) combined with
automated database searching. Ionization patterns
were compared to protein sequences in databases by
automated searches. As a result, 2214 peptide
sequences were obtained. From these sequences, we
have identified 138 proteins that are known to be
localized in the IGCs, or whose functions are associ-
ated with the IGCs. As expected, numerous splicing
factors as well as 5' and 3' pre-mRNA processing
factors, some transcription factors, and several sub-
units of RNA polymerase II were identified. Most
interestingly, 22 new proteins (sequences have been
deposited in databases, but no biological characteri-
zation has been reported) and 25 EST clones have
been identified. To obtain insight into the function of
these proteins, each of the identified proteins were
analyzed for known sequence motifs (Fig. 2). Many
of them have RNA-binding/recognition motifs, sug-
gesting a possibility that they are novel RNA process-
ing factors located in IGCs. In addition, the presence
of clones containing motifs that are thought to have
chaperone-like functions (AAA ATPase and cyclo-
philin domains) suggests a possibility that these are
good candidate proteins responsible for assembly of
the IGCs or individual IGC particles.
Currently, investigations are under way to directly
compare IGC protein composition from normal
mouse liver cells versus cells that are treated with a-
amanitin. In the drug-treated cells, transcription by
RNA polymerase II is turned off, and the morphology
of the IGCs is dramatically changed as these struc-
tures are reorganized into fewer (4-6) and larger
rounded-up structures as compared to the large num-
ber (20-30) of irregularly shaped clusters observed in
actively transcribing cells. We have begun to use a
recently developed technology to perform quantita-
tive proteome analysis using a class of chemical
reagents called isotope-coded affinity tags (ICATs) in
combination with tandem mass spectrometry. We
have prepared identical amounts of IGC proteins from
both the a-amanitin-treated cells and nontreated cells.
Preliminary evaluation by immunoblot analysis of
these fractions has shown that a hyperphosphorylated
form of RNA polymerase II in IGCs is decreased
109
Motifs Present in Newly Identified IGC Protein Candidates Motif Designations
-
-.11111.0
-a
--*
-,-4111111111111111111.-.-
11111110
FIGURE 2 Domains present in newly identified IGC proteins.
upon treatment with a-amanitin, although the amount
of the splicing factor SF2/ASF is unchanged upon
treatment with a-amanitin. We are currently survey-
ing changes in all of the IGC proteins by quantitative
proteome analysis. Using this approach, we anticipate
identifying important proteins having a role in tran-
scriptionally active IGCs, or in the formation and
maintenance of IGCs.
Role of SCAF10 in IGC Organization
and in Coordinating the Recruitment
of the Transcription and Pre-mRNA
Processing Machinery
S. Janicki
The role that IGCs have in organizing the large number
of proteins required for gene expression is being inves-
tigated by studying the function of SCAF10, an IGC
component that may link transcription and pre-RNA
processing. SCAF10 localizes to both nuclear speckles
and the nucleoplasm and was identified in yeast two-
hybrid screens for proteins that interact with the CTD
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of RNA polymerase II (Bourquin et al., Nucleic Acids
Res. 52: 2055 [1997]) and Clk/STY kinase (Nestel et
al., Gene 180: 151 [1996]). SCAF10 is a 106 -kD pro-
tein with an amino-terminal cyclophilin domain and a
carboxy-terminal serine/arginine-rich RS domain.
Cyclophilins have been reported to act as chaperones
in protein trafficking and macromolecular assembly,
and they contain peptidyl-prolyl cis-trans isomerase
(PPIase) domains which catalyze cis-trans isomeriza-
tions about Xaa-Pro peptide bonds. The peptide fold-
ing activity of this protein may regulate interactions
between RNA processing factors and the CTD or have
a role in the assembly and disassembly of the macro-
molecular complexes involved in splicing.
SCAF10 dynamics are being studied in a cell line
(clone 2), developed in our laboratory, in which a reg-
ulatable genetic locus can be visualized in living cells
(Tsukamoto et al. 2000). BHK cells were selected for
the integration of a construct composed of a tetracy-
cline-responsive promoter which drives the expression
of an intron-containing cyan fluorescent protein (CFP)
gene preceded by a series of lac operator repeats.
When a yellow fluorescent protein (YFP) Lac
repressor fusion protein is expressed in these cells,
the genetic locus can be visualized directly in living
cells. When pTet-On is expressed and doxycycline
RNA FISH
a
YFP- SF2JASF Merge
FIGURE 3 YFP-SF2/ASF is recruited to the active transcription site in clone 2 cells (a-c) and colocalizes
with the transcribed RNA as detected by RNA fluorescence in situ hybridization (RNA FISH). When the
locus is actively transcribing, RNA FISH or YFP -lac repressor can be used to localize the transcription site.
The presence of two transcription sites in this cell is due to polypoidy.
added to the culture medium, transcription is initiat-
ed and the CFP protein which is fused to a peroxiso-
mal targeting signal can be visualized in peroxisomes
within the cytoplasm. We have been able to demon-
strate recruitment of the splicing factor SF2/ASF to
the genetic locus in living cells (Fig. 3), and we are
presently investigating the dynamics of SCAF10 in
this system. Additionally, polyclonal antibodies to the
carboxyl terminus and monoclonal antibodies to the
amino terminus of SCAF10 have been generated, and
immunoprecipitation combined with mass spectrom-
etry will be used to identify SCAF10 interacting fac-
tors. The combination of live-cell microscopy and
biochemical studies will advance our understanding
of how the processes involved in gene expression are
coordinated within the structural framework of the
nucleus.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL OF
CELLULAR SIGNALING RESPONSES
N.K. Tonks J.N. Andersen T.C. Meng K.A. Pennino
H.H. Chen M.P. Myers Y. Shen
R.L. Del Vecchio H.L. Palka L. Zhang
T. Fukada
The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes including cell proliferation and differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed
in a target substrate reflects not only the activity of the
kinases that phosphorylate it, but also the competing
action of protein phosphatases that catalyze the
dephosphorylation reaction. We study the expanding
family of protein tyrosine phosphatases (PTPs) which,
like the kinases, comprise both transmembrane recep-
tor-linked forms and nontransmembrane cytosolic
species and represent a major family of signaling
enzymes. The structures of the PTPs indicate impor-
tant roles in the control of key cellular functions. We
are utilizing a variety of strategies to characterize the
normal physiological function of several members of
the PTP family. Disruption of normal patterns of tyro-
sine phosphorylation has been implicated as a contrib-
utor to several human diseases. Therefore, insights
into the mechanisms involved in modulating PTP
function may ultimately yield important information
to help counter such diseases.
During the last year, we were joined by Jannik
Andersen, a visiting graduate student who is complet-
ing the academic component of his Industrial Ph.D.
Educational Program in our lab, sponsored by the
Danish Academy of Technical Sciences.
PTP1B AND THE REGULATION OF SIGNAL
TRANSDUCTION IN HUMAN DISEASE
Targeted disruption of the PTP1B gene was reported
to yield apparently normal mice that displayed
enhanced sensitivity to insulin and resistance to
weight gain when fed a high-fat diet (Elchelby et al.,
Science 283: 1544 [1999]; Klaman et al., Mol. Cell.
Biol. 20: 5479 [2000]). These effects were reported to
coincide with changes in the phosphorylation status of
the insulin receptor (IR), suggesting that the IR may
be a physiological substrate of PTP1B. We have
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explored this possibility further by characterizing the
recognition of synthetic peptides modeled on the
sequence of the activation loop of the IR as substrates
by PTP1B. These studies were performed in collabora-
tion with David Barford (Institute of Cancer Research,
Charles Beatty Labs, London, U.K.). Our approach,
involving crystallographic, kinetic, and binding analy-
ses, has revealed at the molecular level the mechanism
underlying the specificity of the interaction between
PTP IB and the IR. Furthermore, many elements of the
PTP1B-IR interaction are unique to PTP1B, suggesting
that it may be possible to generate specific, small mol-
ecule inhibitors of this interaction. Such inhibitors
would offer a novel strategy for therapeutic interven-
tion in diabetes and obesity.
The activation loop of the IR contains three sites of
autophosphorylation, pTyr -1158, pTyr -1162, and
pTyr-1163. In the inactive state of the IR, the activa-
tion loop impedes access to the catalytic center, with
pTyr-1162 occupying the position of the tyrosyl side
chain of a potential substrate. Following hormone
binding and autophosphorylation, the activation loop
moves out of the active site and is then accessible for
dephosphorylation. When the activity of PTP1B
toward synthetic peptides modeled on the activation
loop of the IR was examined, it was found that the
phosphatase displays the lowest Km for peptides in
which both Tyr-1162 and Tyr-1163 are phosphorylat-
ed. Furthermore, PTP1B substrate-trapping mutants
preferentially recognize forms of the peptide that are
doubly phosphorylated on these adjacent sites. Crystal
structures of complexes between the PTP1B C>A
mutant and phosphorylated forms of the IR activation
loop peptide reveal how selectivity is achieved. The
pTyr-1162 residue binds to the active site of PTP1B in
a manner identical to that which we described previ-
ously for the pTyr residue in the PTP1B-EGF receptor
peptide complex. Specificity for pTyr-1162, the criti-
cal autophosphorylation site for regulation of the
activity of the IR, is determined by extensive and spe-
cific interactions between residues on the surface of
PTP1B and on both the amino- and carboxy-terminal
sides of this phosphorylation site in the IR activation
loop. Most striking is the fact that the adjacent phos-
photyrosyl residue, pTyr-1163, is located within a
shallow groove on the surface of PTP1B, which is
connected to the catalytic site by a channel. The inter-
actions of pTyr-1163 in this "second pocket" are dom-
inated by salt bridges between its phosphate group and
the side chains of Arg-24 and Arg-254 in PTP1B. The
positioning of these arginyl residues also confers
specificity for pTyr to the pocket. Interestingly, among
PTP superfamily members, Arg-24 is unique to
PTP and TC-PTP. Moreover, access to the second
pocket is possible because of the presence of a glycine
at position 259 in PTP1B. Nearly all other PTPs have
a bulky hydrophobic residue at the cognate position.
In addition to the tandem pTyr residues, there are
further interactions between PTP1B and the IR activa-
tion loop. The guanidinium side chain of Arg-47 of
PTP1B, a residue that is poorly conserved within the
PTP family, hydrogen-bonds to the carboxylate group
of Asp-1161 on the amino-terminal side (P-1) of the
pTyr-1162 substrate site. Similar interactions were
noted previously with other substrates and explain the
preference of PTP for acidic residues at the P-1 and
P-2 positions. The side chain of Arg-47 is flexible and
can accommodate various combinations of acidic
the substrate pTyr site.
There are further interactions between PTP1B and
residues carboxy-terminal to the phosphorylation site.
In particular, the guanidinium side chain of Arg-1164
at the P+2 position in the substrate forms a classical
fc-cation interaction with Phe-182 in the closed con-
formation of the WPD loop, highlighting the concert-
ed nature of the PTP-substrate interaction.
These observations provide definition at the mo-
lecular level of the recognition of substrate and deter-
mination of specificity for PTP1B. Interestingly, the
third pTyr residue in the IR activation loop, pTyr-1158,
is not recognized by PTPIB in any of the structures
determined to date. Presumably, other PTPs dephos-
phorylate this site. The critical role of the Asp/Glu-
pTyr-pTyr-Arg/Lys motif for optimal substrate recog-
nition by PTPIB may suggest additional potential
physiological substrates. Several interesting candidates
contain this motif, including the receptor PTKs Trk,
FGFR, and Axl. This motif also is found in the JAK
family of PTKs, which have critical roles in transmit-
ting signals from cytokine receptors. This raises the
intriguing possibility that the effects of PTP on obe-
sity may be mediated via effects on JAK2, which is
associated with the receptor for the satiety hormone
leptin. We are currently investigating this possibility.
Changes in the levels of PTP have been noted in
several human diseases, particularly those associated
with disruption of normal patterns of tyrosine phos-
phorylation. Previous work in our lab showed that the
expression of PTP1B is induced specifically by the
p210 bcr-abl oncoprotein, a PTK that is directly
responsible for the initial manifestations of chronic
myelogenous leukemia (CML). We have also observed
that PTP1B, but not TC-PTP, its closest relative, sup-
presses p210 bcr-abl-mediated signaling and transfor-
mation. Therefore, PTP1B may function as an antago-
nist of the p210 bcr-abl oncoprotein PTK in vivo. We
have observed that the effects of p210 bcr-abl on
expression of the PTP1B gene are manifested at the
transcriptional level. To define the mechanism by
which PTP1B gene expression is regulated, we cloned
the 5' flanking region of the human gene. We found
two elements that are important for expression from
the human PTP1B promoter. A sequence motif that
possesses features of a site of interaction with GATA-
binding proteins was identified at -167 to -151 by
from the transcription start site. Disruption of this site
inhibited promoter activity in the presence of p210
bcr-abl, but responsiveness to the oncoprotein PTK
was maintained. However, a p210 bcr-abl-stimulated
element, termed PSE, which was important for stimu-
lation of activity in response to the PTK, was identi-
fied at -49 to -37 by from the transcription start site.
The PSE is contained in a sequence that displays fea-
tures of a stress response element (STRE), a feature
originally identified in Saccharomyces cerevisiae and
which functions as a binding site for C2H2 zinc finger
proteins. In our study, we have shown that three mam-
malian C2H2 zinc finger proteins, Egr-1, Spl, and Sp3,
bind to PSE. Of these, both Spl and Sp3 function as
positive regulators, whereas Egr-1 represses Sp3 -
mediated trans-activation of the PTP1B gene.
Furthermore, expression of p210 bcr-abl results in
down-regulation of the levels of Egr-1. Our data illus-
trate that the reciprocal actions of the Sp 1 /Sp3 and
Egr-1 C2H2 zinc finger transcription factors are an
important aspect of the regulation of PTP1B expres-
sion in response to the p210 bcr-abl oncoprotein.
CHARACTERIZATION OF DUAL SPECIFICITY
PHOSPHATASES
By searching the human expressed sequence tag
(EST) database for sequences that have homology
with the signature motif of members of the PTP fami-
ly, 11 novel dual specificity phosphatases (DSPs) have
been identified and cloned. These are currently being
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expressed and characterized in a collaborative project
with Ralf Luche and Bo Wei at CEPTYR Inc.
(Bothell, Washington). A variety of properties, includ-
ing structural features, expression pattern, and chro-
mosomal localization, are being used to prioritize
these DSPs for future analysis.
Among these novel enzymes is JSP-3, which com-
prises 184 residues and is expressed broadly. In light
of the fact that members of the DSP family have been
implicated in the regulation of the MAP kinase family
of signal transducing enzymes, including previous
work from our own lab on the characterization of the
DSP MKP-1, we tested whether JSP-3 affected the
activation of MAP kinases. The result was striking.
Whereas DSPs, such as MKP- I , have been implicated
previously in down-regulating the activity of MAP
kinases, we found that co-overexpression of JSP-3
with either the JNK, p38, or Erk-1 MAP kinases led to
specific up-regulation of JNK and did not effect the
activity of p38 or Erk-1 (hence the name JNK stimu-
latory phosphatase-1). The inactive C-S mutant form
of JSP-3 did not activate INK, suggesting that this
effect required the enzymatic activity of the phos-
phatase. In addition, our data indicate that JSP-3
induced activation of MKK4, the MAP kinase kinase
immediately upstream of JNK in the signaling path-
way. Furthermore, we have preliminary data to suggest
that JSP-3 may be required for full activation of JNK
in response to Rho family GTPases and stresses such
as anisomycin, heat shock, and sorbitol. Currently, we
are trying to identify the critical substrates of JSP-3
that mediate these effects.
FURTHER STUDIES OF THE PTEN TUMOR
SUPPRESSOR
PI3-kinase produces phosphoinositide second messen-
gers, phosphorylated at the D3 position of the inositol
sugar ring, that regulate many of the pathways
involved in tumor progression, including cell cycle
and apoptosis. In previous years, in collaboration with
Dr. Mike Wigler's lab here at the Laboratory, we have
shown that PTEN antagonizes the actions of PI3
kinase by dephosphorylating the D3 position in inosi-
tol phospholipids. We have generated a series of
glioblastoma cell lines in which PTEN expression was
reconstituted, and we saw no effects on cell cycle or
apoptosis. However, PTEN reconstituted cell lines did
not grow as tumors when injected into immunodefi-
cient mice, suggesting that another pathway important
for tumor progression has been altered by PTEN
expression. In collaboration with Dr. Don Durden and
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his colleagues at the Indiana School of Medicine in
Indianapolis, we have found that reconstitution of
PTEN inhibits the ability of these cells to induce the
formation of new blood vessels, effectively limiting
tumor volume. Significantly, the clinical prognosis of
glioblastoma is strongly affected by the ability of these
tumors to induce the production of new blood vessels,
suggesting that intervention in this pathway will be
important for therapeutic intervention in the disease.
SUBSTRATE-TRAPPING MUTANT PTPs-STYX
We have developed a method by which we can exam-
ine PTP substrate specificity in a cellular context, by
the production of mutant PTPs that maintain a high
affinity for substrate but do not catalyze dephosphory-
lation effectively. We refer to these mutants as "sub-
strate traps." Following expression, the mutant PTP
binds to its physiological substrates in the cell, but,
because it is unable to dephosphorylate the target effi-
ciently, the mutant and substrate form a complex.
Upon isolation of this complex, the substrates can be
identified, yielding important insights into the func-
tion of the PTP. Progress has been made in defining
the substrate specificity of several members of the
PTP family using this approach.
superfamily is characterized the pres-
ence of a conserved signature motif LI/VRICX-
AGXXR[S/T]G, containing many residues that are
required for catalysis. Interestingly, proteins have been
identified that look similar to the PTPs, but bear alter-
ations in the signature motif that would preclude cat-
alytic activity. The first example of such a "dead" phos-
phatase was characterized by Jack Dixon and his col-
leagues (Ann Arbor, Michigan) and termed STYX. In
STYX, the nucleophilic cysteine from the signature
motif is replaced by glycine. Site-directed mutagenesis
of STYX to produce a cysteine residue in the signature
motif created a catalytically competent enzyme. This
led to the hypothesis that STYX may represent a novel
phosphotyrosine-binding protein with the potential to
function on a naturally occurring "substrate trap." Now,
additional STYX-like proteins have been identified,
including some that have been implicated in human
disease. We have identified two potential STYX pro-
teins from database searches. One of these, termed
STYX2, shows significant homology with MKP I and
may have a role in regulating the MAP kinase pathway.
Importantly, we have found that changing two residues
restores phosphatase activity to STYX2. Restoration of
activity also changes the pattern of coimmunoprecipi-
tating proteins, which may indicate that these proteins
are STYX2 "substrates." We are currently trying to
identify these proteins and verify their interaction with
STYX2 so as to characterize the physiological function
of this interesting protein.
PROTEOMIC STRATEGIES FOR THE ANALYSIS
OF PTP FUNCTION
The presence of the signature motif both confers
unique properties to the PTP family of enzymes and
facilitates their identification within the sequence of
the human genome. In this postgenomic era, we have
embarked on a proteomics-based approach to defining
the complement of PTPs/DSPs from various cellular
sources or subcellular locations. Such analyses not
only will provide insights into function, but also will
allow us to examine changes in the levels of PTP pro-
teins in various pathological conditions. The strategy
involves the use of nonspecific PTP/DSP inhibitors,
targeted to the active site, as affinity reagents to puri-
fy the complement of PTPs present in a particular
sample. This is combined with mass spectrometric
sequence analyses to identify the PTPs present in the
sample. We hope that this technology can be adapted
further to the identification of PTPs based on their
substrate specificity and to explore the selectivity of
various PTP inhibitors, particularly in the context of
their development as therapeutics.
A striking feature of the cysteine residue at the
active site of members of the PTP family is its unusu-
ally low pKa. Although this enhances the nucleophilic
properties of the cysteine residue, it also renders the
PTPs susceptible to oxidation with concomitant inhi-
bition of activity. A variety of studies, particularly
from the laboratory of Sue Goo Rhee, have illustrated
that certain PTPs are susceptible to inactivation
through oxidation of this invariant cysteine. We have
examined further the potential role of such a modifi-
cation as a mechanism for the control of PTP function
in vivo. We have shown that various PTPs could be
oxidized quickly by treatment of Rat-1 cells with
H202. Those PTPs were visualized by a modified "in-
gel" PTP activity assay. Our results demonstrated that
the oxidation of PTPs in the cell was a reversible
process and that the reduction/reactivation of PTPs
was dependent in part on the level of intracellular glu-
tathione. Our data also suggested that the
oxidation/inactivation of PTPs was a key step in the
activation of tyrosine phosphorylation-dependent sig-
naling in response to H202. We examined further
whether the receptor PTK-induced production of reac-
tive oxygen species (ROS) leads to oxidation of PTPs.
By utilizing the modified "in-gel" PTP activity assay,
we showed that platelet-derived growth factor (PDGF)
induced a rapid and selective oxidation of one major
PTP of 70 kD. Immunodepletion experiments identi-
fied PTP as the SH2 domain-containing phosphatase,
SHP-2. The transient oxidation of SHP-2 was con-
comitant with autophosphorylation of the PDGF
receptor (PDGFR). Furthermore, when PDGF-
induced oxidation of SHP-2 was inhibited by an
antioxidant, N-acetyl cysteine, the ligand-induced
tyrosine phosphorylation of PDGFR and the activation
of MAP kinases were suppressed. Therefore, our data
suggest that the PDGFR-induced production of ROS
leads to a burst of PTK activity, augmented by a tem-
porary inactivation of PTPs, that promotes a signaling
response. We propose that this situation may apply to
the regulation of tyrosine-phosphorylation-dependent
signaling in general and are currently developing
methods for the identification of PTPs that become
transiently inactivated through oxidation in response
to various mitogenic signals.
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SIGNAL TRANSDUCTION
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Research in our laboratory is focused on the role of the
Ras and Rho family members of small GTPases in sig-
nal transduction and the mechanisms by which they
exert their effects. These proteins are signal transduc-
ing GTPases that cycle between GDP-bound inactive
states and GTP-bound active states, relaying signals
from various membrane receptors to the nucleus to
mediate cellular activities such as cell growth control
and morphogenesis. The ratio of the two states is reg-
ulated by the opposing effects of guanine nucleotide
exchange factors (GEFs) which promote the exchange
of bound GDP for GTP, and the GTPase-activating
proteins (GAPs) which stimulate hydrolysis of bound
GTP. In particular, our research efforts during the past
year have been focused on the following topics: (1)
further analysis of a protein, AF-6, which we had iden-
tified as a novel Ras-binding protein; (2) the function-
al characterization of p62d°k, a Ras-GAP-associated
protein, which was found to be constitutively tyrosine-
phosphorylated in chronic myelogenous leukemia
(CML) progenitor cells; (3) identification and charac-
terization of Rac effectors mediating Rac's effects on
the cytoskeleton and invasion; and (4) assessment of
the role of the Rho GTPases and their regulators on
neuronal development.
RAS GTPases
Members of the Ras GTPases include the Ha-Ras, Ki-
Ras, N-Ras, and Rap proteins. The importance of Ha-
Ras, Ki-Ras, and N-Ras genes in the etiology of
human cancers is made evident by the frequent find-
ings of activating mutations in these ras genes in a
wide variety of cancers. In addition to deregulated
proliferation, these cancer cells, and oncogenic Ras-
transformed cell lines, are characterized by changes in
morphology and cell-cell adhesion. Previous studies
have shown that oncogenic Ras proteins signal
through the well-established Raf/MEK/MAPK,
Ra1GDS, and PI3-kinase pathways and that all of these
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pathways participate in the cell-transforming activity
of oncogenic Ras. In addition to the above effector
molecules, we had identified AF-6 as a Ras-binding
protein and found that AF-6 accumulates at cell/cell
contact sites. More recently, we showed that AF-6
binds with even higher affinity to the Rap 1 GTPase.
Although the Rap GTPase, which contains a virtually
identical effector loop region as the above Ras pro-
teins, was originally identified in a screen for rever-
tants of the morphology exerted by Ki-Ras-trans-
formed cells, more recent studies support fundamental
differences between Ras- and Rapl-controlled signal-
ing pathways. The functions of Rap proteins seem to
be primarily related to morphological and differentia-
tive events, rather than to those that govern prolifera-
tion and cell-fate specification, phenomena that often
require signaling via conventional Ras proteins. Thus,
we have initiated studies to define whether AF-6 is a
bona fide effector of Ras and/or Rap GTPases in spe-
cific cellular events.
FUNCTIONAL CHARACTERIZATION
OF THE AF-6/CANOE PROTEIN
The AF-6 gene was originally found as a fusion part-
ner of the ALL-1 gene in a subset of acute lym-
phoblastic leukemias caused by chromosomal (t6;11)
translocation events; hence, the name ALL-1 fused
gene on chromosome 6. Subsequent database analysis
led to the prediction of an array of motifs, such as two
amino-terminal Ras-binding domains (RBDs), U104
and DIL motifs that were initially described in micro-
tubule and actin-based motor proteins, respectively,
and a PDZ domain followed by an extended carboxy-
terminal tail interspersed with proline-enriched patch-
es. Various subcellular localization experiments per-
formed in polarized epithelial cells and tissue sections
of intestinal epithelia suggest its distinct residency in
cell-cell junctional complexes. We observed that in
MDCK and MCF7 cells, AF-6 colocalizes with zona
occludens (ZO-1), an integral component of tight
junctional complexes. Furthermore, we isolated pro-
filin as an AF-6-associated protein. Profilin has a crit-
ical role in actin polymerization events, and hence, the
AF-6/profilin interaction might provide a dynamic
link between junctional complexes and the actin
cytoskeleton.
To examine whether Ras and/or Rap GTPases use
AF-6 as a bona fide effector in specific cellular
events, we turned to Drosophila as a model system
(in collaboration with Ulrike Gaul at The Rockefeller
University, New York). A Drosophila homolog of AF-
6, known as Canoe, was first identified by virtue of
its severe rough eye phenotype, and it has genetically
been placed in the Notch signaling pathway, a path-
way that determines various cell fates in a multitude
of developmental processes. Furthermore, Canoe is
involved in a process called dorsal closure, the dor-
salward movement of the lateral and ventral epider-
mis to enclose the embryo. We first confirmed that
Canoe interacts with the Drosophila homologs of Ras
and Rapl (DRas1 and DRap 1) and then investigated
the effects of the Drosophila GTPase on dorsal clo-
sure. Through the use of dominant negative and
active mutant forms of Drosophila Ras and Rapl
GTPases, we established that DRapl, but not DRasl,
has a crucial role in dorsal closure. This phenotypic
similarity between DRapl and Canoe strongly sup-
ports the idea that Canoe is a true effector of DRapl.
To further manifest this, we are presently performing
genetic epistasis analysis between DRapl and Canoe
genes.
FUNCTIONAL CHARACTERIZATION OF P6200.
p62"' has been identified as a substrate of many
oncogenic tyrosine kinases such as the CML chimeric
p210b"-abl oncoprotein, as well as of hematopoietic and
nonhematopoietic growth factor receptors. Upon
phosphorylation, p62da associates with p120 Ras
GTPase-activating protein (Ras GAP), and it is by
virtue of its ability to bind Ras GAP that p62d°' was
isolated. The protein contains a PH and a PTB domain
at its amino terminus, and it harbors 15 tyrosines, 9
proline-rich domains, and numerous serine/threonine
residues at its carboxy-terminal tail. To address the
role of p62da, we initiated a collaboration with P.P.
Pandolfi and colleagues (Memorial Sloan-Kettering
Cancer Center, New York), who generated a null
mutation in the dok gene. We obtained evidence that
p62d'k acts as a negative regulator of growth-factor-
induced cell proliferation, since p62d°k-deficient cells
possess a higher proliferation rate in response to
growth factors. Furthermore, p62"' inactivation caus-
es a significant shortening of the latency of the fatal
myeloproliferative disease induced by retrovirus-
mediated transduction of p210b"-abi in bone marrow
cells. In addition, we obtained evidence that p62d°'
exerts its negative effect on growth-factor-induced cell
proliferation, at least in part, by negatively influencing
the Ras/MAPK pathway. We further demonstrated that
recruitment of p62d" to the membrane is essential for
its function as a negative regulator of the platelet-
derived growth factor receptor (PDGFR)/MAPK path-
way. Moreover, we found that the PDGF-triggered
translocation of p62d°' to the plasma membrane
involves the activation of phosphatidylinositol -3
kinase (PI3-kinase) and binding of its PH domain to
3 "-phosphorylated phosphoinositides.
RHO GTPAsEs
Members of the Rho family, namely, RhoA, Rac, and
Cdc42, are best known as regulators of the actin
cytoskeleton. It is well established that alterations in
the actin cytoskeleton triggered by the Rho proteins
contribute to their effects observed on adhesion, inva-
sion, transformation, and, more recently, neuronal
development. In addition to their role in controlling
the actin cytoskeleton, the Rho GTPases are also
known to regulate gene expression, which contributes
to their effects on the above activities. To date, most of
the identified Rho GTPases' effector molecules are
proteins mediating their effects on actin cytoskeleton
organization. Among them, we had identified PORT as
a Rac 1-interacting protein. To identify genes whose
transcription is regulated by Rac, we made use of rep-
resentational difference analysis (cDNA-RDA), in
combination with the microarray technique to identify
genes whose expression is altered as a consequence of
activated Rac expression. With regard to the role of the
Rho GTPases on neuronal development, it is interest-
ing to note that of the eight genes thus far identified to
be involved in nonspecific X-linked mental retarda-
tion (MRX), three of them are regulators or effectors
of the Rho GTPases. These regulators and effectors
are oligophrenin-1, which is a putative Rho GAP,
PAK3, which is a downstream serine/threonine target
of Rac and Cdc42, and a novel exchange factor for
Rac, called PIX. Of particular interest to our lab is
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how a lack of oligophrenin-1, a potential Rho GAP
and regulator of GTPases, results in a phenotype of
mental retardation on a molecular and morphological
level.
POR1, A RAC-INTERACTING PROTEIN
INVOLVED IN ACTIN REMODELING
In a search for Rac-interacting proteins, we had iden-
tified PORI in a yeast two-hybrid screen and demon-
strated a role for PORI in cytoskeletal organization.
Further studies revealed that POR1 also interacts with
ARF6, a GTPase shown to regulate endocytic traffic at
the cell periphery. In addition to its role in membrane
trafficking, ARF6 also mediates cytoskeletal organiza-
tion. We obtained data showing that PORI is localized
at the perinuclear region and is translocated toward the
plasma membrane in response to various growth fac-
tors known to activate Rac, as well as in the presence
of activated Rac. The above observations hint at a
potential role for PORI in membrane trafficking. In
light of this, in collaboration with C. D'Souza-
Schorey (Notre Dame, Indiana) we found that the Gq-
coupled agonist, bombesin, triggers the redistribution
of vesicle-associated ARF6 and Racl to the plasma
membrane, resulting in peripheral actin rearrange-
ments. This bombesin-induced translocation of vesi-
cle-associated ARF6 and Racl to the cell surface is
regulated by ARF6 activation. These findings support
a role for vesicle transport in cortical actin remodeling
at the cell periphery.
IDENTIFICATION OF RAC TARGET GENES
USING cDNA-RDA
To identify specific genes whose expression is regu-
lated by Rac, we performed cDNA-RDA. In this tech-
nique, one cDNA population (called the driver) is
hybridized in excess against a second population (the
tester) to remove common hybridizing sequences,
thereby enriching target sequences unique to the
tester. To confirm the differential expression of the
isolated clones obtained after two rounds of poly-
merase chain reaction (PCR), we made use of
microarray technology (in collaboration with R.
Lucito and M. Wig ler here at the Laboratory). The
PCR-amplified inserts were printed on a glass slide
and then driver and tester cDNAs, each labeled with a
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different fluorophore, were hybridized simultaneous-
ly to this chip. The fluorescence intensities of each of
the two labels were quantified for each clone and as
such we were able to discern which clones were up-
regulated or down-regulated as a consequence of
RacV12 expression. At present, 100 clones have been
sequenced, resulting in 36 independent gene frag-
ments, of which 14 are novel. We found a total of 22
apparently down-regulated and 14 apparently up-reg-
ulated candidate genes. We have been taking two
approaches to prioritize genes for further analysis. (1)
We started to explore the effects of various drugs
known to activate or to interfere with previously char-
acterized downstream signaling pathways of Rac on
the transcription of these genes using microarray.
Numerous growth factors, including PDGF, epider-
mal growth factor (EGF), and hepatocyte growth fac-
tor (HGF) are known to stimulate Rac's activity, and
activated Rac has been shown to activate the JNK,
p38, and ERK MAPK pathways. (2) To assure that the
differences we observed when comparing two repre-
sentations of cDNAs reflect true differences in mRNA
abundance, we performed Northern blot analysis for
approximately 20 clones. These analyses confirmed
the differential expression observed in the cDNA-
RDA and microarray experiments.
ROLE OF RHO GTPases
AND THEIR REGULATORS IN
NEURONAL DEVELOPMENT
Recent studies have demonstrated that Rho GTPases
are important at different stages of neuronal develop-
ment, including neuroblast migration, axon pathfind-
ing, and growth cone morphology and function. There
is also in vivo evidence that perturbing the activity of
the Rho GTPases causes abnormal dendritic arbor
development. In collaboration with Z. Li and H. Cline
here at the Laboratory, we investigated whether Rho
GTPases regulate branch dynamics and branch exten-
sions in optic tectal neurons in live Xenopus tadpoles.
These studies indicated that the three members of the
Rho GTPases have distinct effects on dendritic arbor
development, namely, Rac and Cdc42 regulate branch
additions and retractions, whereas RhoA regulates the
elongation of existing branches. The importance of the
fine-tuned regulation of the neuronal dendritic arbor is
emphasized by reports suggesting that children with
mental retardation have reduced dendritic arbors. We
have initiated studies on the functional characteriza-
tion of oligophrenin-1. Oligophrenin-1 contains a
domain which is typical of Rho-GTPase-activating
proteins (Rho GAP), and this oligophrenin-1 GAP
domain acts as a GAP for Rac, Rho, and Cdc42 in
vitro, thus down-regulating the activity of these mole-
cules. Oligophrenin-1 also contains a conserved
amino-terminal domain of unknown function, a PH
domain, and a unique carboxy-terminal domain. We
recently performed in situ hybridization experiments
which indicate that oligophrenin-1 is expressed in all
tissues of the developing mouse brain, including the
hippocampus. The hippocampus is the part of the
cerebral cortex involved in the formation of new
declarative memories. We initiated experiments to
determine what effect oligophrenin-1 has on cellular
morphology in developing neurons by doing live-cell
imaging of biolistically transfected pyramidal cells in
hippocampal slices over time, using confocal and two-
photon microscopy. We have already established the
effects of the Rho GTPases on dendritic length in
pyramidal cells. Furthermore, we performed a yeast
two-hybrid screen using oligophrenin-1 as bait to
identify interacting proteins. This screen resulted in
the identification of two potentially interesting
oligophrenin-binding proteins. We believe that a
detailed analysis of oligophrenin-1 will contribute to a
better understanding of neuronal plasticity and how
modulation of molecules involved in Rho signaling
may result in MRX.
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STRUCTURE AND GENOMICS
Major strides have been made in the past year in the structure and genomics area. These advances
have been both in determining the structure of biologically important macromolecules and in further
improving the technology by which we do such work. The former enhances our knowledge of biology
while the latter ensures our future progress. The structure and genomics group has determined the
structure of both protein and DNA structures as well as structures relating to the interaction of the two.
In the classical wet laboratory setting, the Joshua-Tor lab has continued their studies of bleomycin
hydrolase. They have identified several potential specific inhibitors of the activity of this protein. They
have also expanded their studies of protein DNA interactions, determining the structures of the
DNA-binding domain of the papillomavirus initiator protein El as well as using mutagenesis to
determine the role of the DNA repair enzyme MutY.
The lab of Rui-Ming Xu has determined the structure of an evolutionarily conserved silent informa-
tion regulator protein (SIR). These proteins are involved in the transcriptional silencing of genes in
certain genomic regions. This structural information is being used to determine the molecular basis
of the silencing phenomenon.
The Kobayashi lab has set up a new high-sensitivity mass spectrometer to enable rapid identifica-
tion of small protein samples.
The McCombie lab, working as part of an international consortium, completed the determination of
the primary structure of the genome of Arabidopsis thaliana. This is the first plant genome to be
completed and is now being used to determine the function of all of the roughly 25,000 genes iden-
tified as well as in studies of centromere structure and function. They are also actively working to
determine the sequences of the rice and mouse genomes.
On a strictly computational front, the Neuwald lab has used a combination of computational tech-
niques to identify repeat-containing proteins. They have also developed a new approach to find pro-
tein structure components more accurately and rapidly.
The Zhang lab has focused a significant amount of their efforts on the detection of promoters and
exon selection variation. They have also carried out comparative analyses on the cadherin family
and have worked to identify new cell cycle genes using computational means.
The Stein lab has continued their efforts to integrate and make accessible the wealth of genome
information being developed worldwide. They have developed a database comprising the first high-
density maps of human sequence polymorphisms. This map contains on average one polymor-
phism every 2.3 kb. They have also made significant enhancements to the Caenorhabditis elegans
community database, Worm Base, and significant progress in developing ATIDB, a database of
insertional mutants for functional genomics in Arabidopsis. They are extending their work in plants
by beginning the Gramene database, which will serve as a database for the grasses, particularly
rice, which is currently being sequenced.
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STRUCTURAL BIOLOGY OF REGULATION OF PROTEOLYSIS
AND DNA REGULATORY MOLECULES
L. Joshua-Tor A. Auster
E. Enemark
T. Messick
P.R. Kumar
P. O'Farrell
N. To lia
D. Vaughn
H. Zhou
D. Weinstein
We study the molecular basis of cell regulatory
processes, combining the tools of structural biology
and biochemistry to examine the molecular interac-
tions associated with these processes. X-ray crystal-
lography enables us to obtain the three-dimensional
structures of individual proteins and their complexes
with other molecules. We use biochemistry and mole-
cular biology to characterize properties that can be
correlated with protein structure, and we use informa-
tion from molecular biology and genetics in collabo-
rative efforts to study protein function.
Our current efforts center around two distinct
themes. The first is the regulation of proteolysis. Here
we are studying caspase activation in apoptosis and a
conserved family of oligomeric self-compartmental-
izing intracellular proteases, the bleomycin hydro-
lases, which are involved in drug resistance. The sec-
ond theme in the lab involves structural studies of
protein complexes involved in DNA regulatory
processes.
The DNA-binding Domain of
the Papillomavirus Initiator
Protein El
E. Enemark, G. Chen, A. Auster [in collaboration with
A. Stenlund, Cold Spring Harbor Laboratory]
Papillomaviruses are a large family of closely related
viruses that give rise to warts in their hosts. Infection of
the genital tract by the human papillomaviruses
(HPVs) from this group represents one of the few firm-
ly established links between viral infection and the
development of cervical cancer, as HPV DNA is found
in practically all cervical carcinomas. Although the
progression to malignancy represents a low-frequency
event, due to the high frequency of infection, this dis-
ease affects a large number of individuals. Bovine
papillomavirus (BPV) has served as a prototype for
this group, especially regarding viral DNA replication.
The El protein belongs to a family of multifunctional
viral proteins whose main function is related to viral
DNA replication. These proteins bind to the origin of
DNA replication and also have other activities related
to DNA replication, including a DNA distortion and a
DNA helicase activity, the latter activity generated by a
hexameric form of the protein. Furthermore, these pro-
teins interact with cellular replication proteins such as
DNA polymerase a and replication protein A (RPA).
Thus, this group of proteins is intimately involved with
initiation of DNA replication. In collaboration with
Arne Stenlund's group here at the Laboratory, we
embarked on structural studies to provide high-resolu-
tion structural information about El and its DNA-bind-
ing activity. These studies would provide general
insight into the biochemical events that are involved in
viral DNA replication. They can also provide a basis
for the development of clinical intervention strategies.
Second, the viral DNA replication machinery itself
represents an obvious target for antiviral therapy, and
detailed information such as high-resolution structures
of viral proteins required for replication will greatly
facilitate the development and testing of antiviral
agents.
This year, we determined the crystal structure of
the DNA-binding domain of El to 1.9 A resolution
(Fig. 1). Residues critical for DNA binding are locat-
ed on an extended loop and on an a-helix. The DNA-
binding loop adopts a rather extended path, and
although it does not possess any secondary structure,
it is well defined in the three-dimensional structure.
We identified the El dimerization surface by selective
mutations at an El/El interface observed in the crys-
tal. On the basis of these observations, we propose a
model for the (E1)2-DNA complex (Fig. 2), important
for initial on recognition. However, recognizing the
origin is not its sole function. The El DNA-binding
domain has an important role in double-stranded DNA
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FIGURE 1 Stereo ribbon diagram of the three-dimensional
structure of El -DBD.
melting and formation of the hexameric replicative
helicase. These and other observations suggest how
the El DNA-binding domain might orchestrate the
assembly of the hexameric helicase on the mi. Further
insight will be gained with the elucidation of struc-
tures of higher-order complexes.
Role of the Fe-S Cluster in the
DNA Repair Enzyme MutY
T. Messick [in collaboration with N. Chmiel and S. David,
University of Utah]
DNA is subject to a variety of chemical modifications
resulting from hydrolytic reactions, the action of alky-
lating agents, radiation, and oxidative stress. Such
modifications can cause disruptions in DNA synthesis
and produce permanent alterations in the genome.
Fortunately, elaborate repair pathways exist in all
organisms to protect them from the potential deleteri-
ous and mutagenic effects of DNA damage and mis-
matches. An increasing number of examples show that
such pathways may be involved in the prevention of
diseases such as cancer.
The base excision repair (BER) pathway is pri-
marily responsible for the repair of damage to hetero-
cyclic DNA bases. In this pathway, the marquee play-
ers are the DNA glycosylases that recognize mis-
matched or damaged bases and catalyze N-glycosidic
bond cleavage. The subsequent actions of apurinic/
apyrimidinic (AP) endonucleases and phosphodi-
esterases provide the appropriate 3' hydroxyl and 5'
phosphate ends for restoration of the DNA by DNA
polymerase and DNA ligase. The oxidation of 2'-
deoxyguanosine (G) to 7,8-dihydro-8-oxo-2'-deoxy-
guanosine (OG) is one of the most common types of
damage to DNA in cells. When an OG is present in
DNA, it can mispair with an adenine (A) during a
replication event and introduce a permanent G-to-T
transversion mutation. In Escherichia coli, the "GO"
repair pathway is dedicated to the prevention of muta-
tions caused by oxidative damage to guanine. This
pathway relies on the action of three proteins: MutT,
MutM, and MutY. The MutT protein catalyzes the
hydrolysis of d(OGTP) to remove it from the dNTP
pool and prevents its incorporation in DNA. Both
MutM and MutY are DNA glycosylases; MutM (also
called FPG protein) removes OG from DNA, whereas
MutY removes A when mispaired with an OG.
Although OG:A is the preferred substrate, MutY is
able to remove A mispaired with G or C.
An interesting feature of MutY is that it contains a
[4Fe-45]" cluster that has been suggested to have an
important role in substrate recognition. The presence
of a [4Fe-4Sr cluster in several DNA repair enzymes
is unusual since iron-sulfur clusters are most com-
monly found in proteins involved in electron transfer
. CAC
asCAC TTATTAACAACAATTGTTATTAGTG
E1 3 El 1
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FIGURE 2 Model for DNA binding and dimerization by the
El DNA-binding domain. A crystallographic interaction
between El monomers reveals a potential model for
El /El interaction in which the distance between the two
DNA-binding surfaces corresponds to the separation
between two major grooves of DNA. The resulting El
dimer was docked onto a DNA double helix containing the
ori sequence. The El -binding sites occupied in the initial
complex are sites El -2 and 4. The DNA-binding loop and
the amino-terminal portion of the DNA-binding helix of
each monomer fit nicely into the major groove. Monomer-
monomer contacts are made primarily through helix a3.
Shown below is the sequence of the ori with the E1- and
E2-binding sites indicated. Sites E1-5 and 6 are putative
El -binding sites.
reactions. However, there are many nonredox roles for
Fe-S clusters that have been uncovered, suggesting
that they are versatile cofactors. A relatively new role
for Fe-S clusters is the participation in sensing of
small molecules for regulation of gene expression or
enzymatic activity. We are studying the role of the Fe-
S cluster in this system by examining the functional
and structural consequences of mutating residues that
are involved in cluster ligation, solvent accessibility of
the cluster, and other features surrounding the Fe-S
cluster. The structures of three such mutants were
solved, and their correlation with the activity of the
enzyme is shedding light on the role of the Fe-S clus-
ter in MutY.
Bleomycin Hydro lases
P. O'Farrell [in collaboration with F. Gonzalez and
S.A. Johnston, University of Texas Southwestern Medical
Center, and S.J. Keding and D.H. Rich, University of
Wisconsin, Madison]
Bleomycin hydrolase (BH) is a 300-kD cysteine pro-
tease with unusual structural and biological features. It
was discovered due to its ability to deactivate the gly-
copeptide antibiotic bleomycin, which is used as a
therapeutic agent in the treatment of a number of dif-
ferent forms of cancer. The clinical use of bleomycin
is limited due to drug resistance and dose-dependent
production of pulmonary fibrosis. The endogenous
enzyme, BH, is overexpressed in some tumor cells and
is thought to be a major cause of tumor cell resistance
to bleomycin therapy. It was shown that, both in yeast
and in mammalian cells, BH is the only enzyme with
bleomycin deamidation activity. Interest in its clinical
relevance was heightened by a recent report of the
genetic linkage of an allelic variant to the nonfamilial
form of Alzheimer's disease. BH was also found to
bind amyloid precursor protein (APP).
Since mammals rarely encounter bleomycin,
bleomycin hydrolysis is probably not the normal func-
tion of the enzyme. On the basis of studies with BH
knockout mice, it was shown that BH is important for
neonatal survival. BH is widely distributed throughout
nature. There are homologs in bacteria, yeast, birds,
and mammals, with high sequence identity among the
different forms. The yeast form negatively regulates
the galactose metabolism system and also binds sin-
gle-stranded DNA and RNA with high affinity.
Nucleic-acid-binding activity was also reported for
other members of the family.
Previously, we determined the crystal structures of
the yeast BH, Ga16, and the human enzyme (hBH).
These structures revealed several unique features of
these proteases. They both have a hexameric ring-bar-
rel structure with the active sites embedded in a cen-
tral cavity. The only access to the active sites is
through the cavity. BH has little substrate specificity
so it is reasonable to assume that this sequestration of
the active sites is necessary to prevent indiscriminate
proteolysis. This places BH in the class of "self-com-
partmentalizing proteases" with, for example, the pro-
teasome and the tricorn protease. The carboxyl termi-
nus of BH lies in the active site, in much the same
position as that taken by inhibitors complexed with
papain. Our previous work on the yeast BH, Ga16, has
shown that it acts as a carboxypeptidase on its car-
boxyl terminus to convert itself to an aminopeptidase
and peptide ligase. The carboxyl terminus anchors the
substrate into the active site and confers "positional"
specificity. This model also serves to explain
BH/Ga16's unique ability to inactivate bleomycin.
In collaboration with Dan Rich's laboratory at the
University of Wisconsin, Madison, we embarked on
an iterative study to design specific, tight-binding
active site inhibitors of BH activity to increase the
efficacy of bleomycin, and perhaps reduce dosage lev-
els in cancer treatment. The emerging link between
hBH and Alzheimer's disease is another incentive,
since an inhibitor to hBH may be useful in under-
standing this connection and may also be useful in
therapy. We are using our crystal structure to create
novel inhibitors by use of computerized structure-gen-
erating programs. Using this approach, we can create
both peptide-like and nonpeptide inhibitors by a com-
binatorial process. We identified four compounds in
our initial screens that are good inhibitors and have
solved two cocrystal structures of hBH with these
compounds. These structures are the basis of further
drug design.
PUBLICATIONS
Enemark E.J., Chen G.Y., Vaughn D.E., Stenlund A., and
Joshua-Tor L. 2000. Crystal structure of the DNA-binding
domain of the replication initiation protein El from papillo-
mavirus. Mol. Cell 6: 149-158.
van Aalten D.M.F., Chong C.C., and Joshua-Tor L. 2000.
Crystal structure of carboxypeptidase A complexed with o-
cysteine at 1.75 A: Inhibitor-induced conformational
changes. Biochemistry 39: 10082-10089.
van Aalten D.M.F., Crielaard W., Hellingwerf K.J., and Joshua-
Tor L. 2000. Conformational substates in different crystal
forms of the photoactive yellow protein: Correlation with
theoretical and experimental flexibility. Protein Sci. 9: 64-72.
123
PROTEIN CHEMISTRY
R. Kobayashi A. Ahmed S. Lopez
L. Hurton D. Wurtz
David Sargent and Andrew Lin left our lab this year,
with David moving to a pharmaceutical company in
Manhattan and Andrew returning to the private sector.
Professor Daniel Bogenhagen returned to Stony Brook
after a 6-month sabbatical in our lab. Aysha Ahmed
and Lenka Hurton joined the lab in the last year.
Our lab has been making an effort to elucidate the
primary structure of novel proteins and posttransla-
tional modification. We hope that characterization of
these proteins will contribute to our knowledge of nor-
mal cellular pathways and how they are modified dur-
ing disease development. The analysis of posttransla-
tional modifications may provide novel insights into
the regulation of protein activities in normal and can-
cer cells.
IMPROVEMENT IN PROTEIN IDENTIFICATION
The three general strategies we use for protein identi-
fication are shown in Figure 1; these strategies are
used either individually or in combination to study
protein chemistry. In 1999, the ion-trap electrospray
ionization mass spectrometer (ion-trap ESI MS) was
introduced to our lab and has provided unparalleled
sensitivity for the identification of peptides in com-
plex mixtures. We have integrated the ion-trap ESI MS
Protein /Protein complex
SDS PAGE
In-gel digestion
HPLC peptide mapping
MALDI-MS TOF MS
(2)
Edman degradation
(1)
124
Proteolytic digestion
LC-MS/MS
(3)
with reversed-phase high-performance liquid chro-
matography (HPLC) to perform LC-MS/MS analysis.
This set up allows us to analyze as little as 100-200
fmoles of protein; this is at least one order of magni-
tude more sensitive than traditional Edman-degrada-
tion-based strategies. Although we routinely use this
set up to analyze peptides generated by in-gel diges-
tion, this system is capable of analyzing mixtures of
polypeptides without prior gel separation. This
approach has been used successfully in collaboration
with Dr. Stillman's lab to identify ORC interacting
proteins.
PROTEOMICS STUDY OF HUMAN
MITOCONDRIAL PROTEINS
Mitochondria are highly conserved organelles in
eukaryotic cells required for oxidative phosphoryla-
tion, the TCA cycle, heme biosynthesis, and metabo-
lism of amino acids and lipids. Mitochondria have a
significant role in oxidative damage and apoptosis. It
is estimated that in humans, one half to two thirds of
mitochondrial proteins have not yet been identified.
Prof. Bogenhagen at SUNY Stony Brook spent 6
months on sabbatical in our lab and studied human
mitochondria' proteomics. We separated mitochondri-
FIGURE 1 Three general strategies for protein identification. (1)
Direct sequence determination. Proteins are first resolved by
SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and
digested "in-gel." Fragments are separated by HPLC and direct-
ly sequenced by Edman degradation. This technique requires at
least 2 pmoles of protein. (2) MALDI-TOF mass spectrometry.
Proteins are separated by SDS-PAGE, and digested in-gel to lib-
erate peptide fragments. Molecular weights of peptides are
determined by MALDI-TOF mass spectrometry either in a mix-
ture or following HPLC purification. Proteins are identified by
matching the molecular weights of the peptides to those pre-
dicted from DNA databases. This technique requires 500-2000
fmoles of protein. (3) LC-tandem mass spectrometry. This
method is conceptually similar to the MALDI-TOF method, but it
utilizes the ability of the ion-trap electrospray ionizing mass spec-
trometer (ion-trap ESI MS) to directly break down and analyze
peptides from a primary proteolytic digestion (LC-MS/MS). This
technique requires as little as 100-200 fmoles of protein.
al proteins by two-dimensional gel electrophoresis
and identified each protein spot by mass spectrometry.
We are continuing our collaboration with Dr.
Bogenhagen's lab to study mitochondrial protein in
apoptosis.
TYROSINE PHOSPHORYLATION OF P62D°K IN CHRONIC
MYELOGENOUS LEUKEMIA
The Philadelphia chromosome translocation is found
in almost all patients with chronic myelogenous
leukemia (CML). Hematopoietic progenitors isolated
from CML patients in the chronic phase contain con-
stitutively tyrosine-phosphorylated p62da protein. We
investigated the role of tyrosine phosphorylation of
p62da in CML. We demonstrated that p62da is direct-
ly tyrosine-phosphorylated by p210 Bcr-Abl and associ-
ates with the Ras GTPase-activating protein
(RasGAP) but only when p62da is tyrosine-phospho-
rylated. By using MALDI-TOF mass spectrometry,
truncation constructs, and mutants of p62da, we iden-
tified five tyrosine residues that are involved in in
vitro RasGAP binding. We also found that tyrosine-
phosphorylated p62da inhibits RasGAP activity. We
are currently studying other proteins that have site-
specific interaction with tyrosine-phosphorylated
p62dok by Bcr-Abl.
BCR-ABL SIGNALING IN PHILADELPHIA
CHROMOSOME-POSITIVE LEUKEMIA
In addition to p210Bcr-Abl, which causes CML,
Philadelphia chromosome translocation generates two
additional forms of fusion proteins: p190Bcr-Abl and
p23 OBcr-Abl. Interestingly, p190Bcr-^b' is usually associat-
ed with acute lymphoblastic leukemia (ALL) and is
only rarely associated with CML, acute myelogenous
leukemia (AML), or other diseases such as multiple
myeloma or B-cell lymphoma; p230Bcr-Abl has been
found in chronic neutrophilic leukemia (CNL). The
mechanism by which these three different Bcr-Abl
fusion proteins contribute to CML, ALL, and CNL is
not well understood. We hypothesize that the tyrosine
kinases of the different Bcr-Abl fusions have shared
and distinct signals and that these signaling molecules
may contribute to the differences in the development
of leukemia. Identifying the substrate(s) of the three
types of Bcr-Abl fusion proteins may provide impor-
tant insights into the protein molecules that are
responsible for the progression of leukemia. We are
interested in studying how these Bcr-Abl protein sig-
nal transduction pathways are related to disease phe-
notypes.
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SEQUENCE-BASED ANALYSIS OF COMPLEX GENOMES
W.R. McCombie M. de la Bastide
M. Bell
L. King
A. O'Shaughnessy
L. See
M. Vil
A. Bahrat
D. Cunnius
K. Kirchoff
R. Preston
R. Shah
T. Zutavern
During the last several years, our lab has evolved from
largely developing tools and infrastructure to carry out
genome analysis to using those capabilities to carry
out sequence analysis in biologically important organ-
isms or to address biologically important problems. At
the same time, our efforts to improve our technology
and infrastructure are ongoing. This year, we reached
important milestones in those efforts. The first
sequence of a higher plant was completed in the past
year by a consortium in which we had a major role.
Our group, in combination with the Washington
University Genome Sequencing Center, completed
about 10% of the Arabidopsis thaliana genome and
two of the five Arabidopsis centromeres.
Sequencing the A. thaliana
Genome
M. de Is Bastide, E. Huang, L. Spiegel, L. Gnoj,
A. O'Shaughnessy, R. Preston, K. Habermann,
M. Bell, N. Dedhia, L. Parnell, R. Shah, M. Rodriguez,
L. Hoon See, M. Vil, J. Baker, K. Kirchoff, K. Toth,
L. King, A. Bahret, B. Miller, W.R. McCombie
[in collaboration with the Washington University
Genome Sequencing Center and The Cold Spring
Harbor Laboratory Plant Biology Group]
We began sequencing the Arabidopsis genome on a
large scale in 1996. This year, we finished our
assigned region on chromosome V as well as an addi-
tional region that was not completed by one of our col-
laborators. All together, our consortium sequenced
4,153,198 bases in the past year. Of this amount,
2,202,098 was sequenced here at the Laboratory, with
the reminder being sequenced by our collaborator
Washington University.
This region included much of the centromere of
chromosome V Figure 1 shows a diagram of this
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region. These clones were extremely difficult to
sequence. While this region was being sequenced, our
collaborators in the Arabidopsis Genome Initiative
were completing the remainder of the genome. The
Arabidopsis genome is the first plant genome to be
completed (The Arabidopsis Genome Initiative 2000).
It is also one of the most complete and highly accurate
genomes completed to date. There were a number of
significant findings from this work. In general terms,
two of the most noteworthy were the large number of
genes contained in the Arabidopsis genome, nearly
25,000, and the large degree of duplication in the
genome (The Arabidopsis Genome Initiative 2000).
Approximately 60% of the Arabidopsis genome is rep-
resented in large duplications (The Arabidopsis
Genome Initiative 2000). Another point of importance
uncovered by the completion of the sequence is the
large percentage of Arabidopsis genes that are in rela-
tively large multigene families when compared to ani-
mal genomes (The Arabidopsis Genome Initiative
2000). From an even broader perspective. the
sequence revealed that although Arabidopsis shares
the genes involved in some biological processes with
mammals, including humans, other genes thought to
be crucial to animals appear not to be present in the
Arabidopsis genome (The Arabidopsis Genome
Initiative 2000).
The large number of genes in Arabidopsis relative
to humans raises fundamental issues of how each
organism generates complexity in its proteome.
Arabidopsis likely generates this diversity with its
large number of genes, many of which appear to be
specific transcription factors that regulate gene
expression (The Arabidopsis Genome Initiative 2000).
A large amount of the diversity in humans is likely
generated by altemative splicing.
As the first plant genome sequenced, it will allow
comparison between the complete gene content of
plants and animals. This has already led to the discov-
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FIGURE 1 Diagram showing much of the region of the centromere of chromosome V.
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ery of surprising differences between plants and ani-
mals (The Arabidopsis Genome Initiative 2000).
Second is the impact of the sequence of the
Arabidopsis genome on plant biology. The availability
of this sequence will allow the subsequent dissection
of the function of each gene in the organism and their
interactions with one another.
It is obvious, although nonetheless important, to
reiterate that these observations and the future efforts
to determine the function of all Arabidopsis genes
would not be possible without the complete, finished
sequence of the Arabidopsis genome.
Rice Genome Sequencing
M. de la Bastide, L. Gnoj, L. Spiegel, M. Bell, V Balija,
N. Dedhia, A. O'Shaughnessy, H. Bal, E. Huang,
K. Kirchoff, L. King, R. Preston, R. Shah, A. Bahret,
J. Baker, M. Vil, M. Rodriguez, L. Hoon See, T. Zutavern,
L. Santos, B. Miller, S. Rodriguez, D.-M. Cunnius, K. Kuit,
W.R. McCombie [in collaboration with the Clemson
University Genome Institute and the Washington
University Genome Sequencing Center]
Rice is the major staple food crop in the world. It also
has the smallest size genome of any monocot plant
(Arabidopsis is a dicot). This makes it an ideal target
for concerted genomics efforts. We are part of a con-
sortium that began sequencing the genome of rice in
late 1999. To date, we have sequenced about 2,933,074
bases in rough form and have finished sequencing
1,451,243 bases. We have found, as have other groups
in the International Rice Genome Sequencing
Program, that the rice genome offers particular chal-
lenges for finishing sequence to higher accuracy. We
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are working with our collaborators at Clemson
University and Washington University to address these
challenges. Our consortium and The Institute for
Genomic Research are scheduled to complete chro-
mosome 10 of rice in 2001. Initial analysis of the rice
genome indicates that it has a relatively high gene den-
sity (9.4 kb per gene) which means that the genome
may have significantly more genes than does the
Arabidopsis or even the human genome.
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SEQUENCE-BASED PREDICTION OF PROTEIN
STRUCTURE AND FUNCTION
A.F. Neuwald A. Poleksic N. Kannan
N. Hata F. Tan
Our goal is to improve sequence-based prediction of
protein structure and function and thereby enhance our
understanding of cellular processes mediated by their
associated proteins. Advancement toward this goal fol-
lows a certain logical progression. First, a better under-
standing of the relationship between sequence and pro-
tein structure and function is obtained. This under-
standing then guides the improvement of statistical and
algorithmic methods for modeling proteins. Next, these
methods are incorporated into data analysis tools,
which are then applied to the study of specific protein
families. Moreover, as biological analysis enhances our
understanding, this often leads to further improvements
in the statistical and algorithmic methods that, in turn,
lead to even better analytical tools. Indeed, to ensure
consistent progress, it is helpful to iterate this entire
process, and, as a result, our strategy is to work con-
currently and synergistically on all four areas: under-
standing basic principles, developing new models,
implementing new tools, and applying these and exist-
ing tools to biological discovery. Of course, the ulti-
mate goal, namely, a better understanding of the cellu-
lar processes mediated by the proteins under investiga-
tion, is what drives and guides our research-not the
development of new methods as such. This year's focus
has been the continued characterization of sequence
motifs corresponding to protein structural repeats, the
development of a fast method for searching a database
of hidden Markov models, and the development and
application of a new approach to functional prediction
called CHAIN analysis.
PSI-BLAST SEARCHES USING HIDDEN MARKOV
MODELS OF STRUCTURAL REPEATS
We have made substantial progress on the modeling of
protein families characterized by subtly conserved
repeats, an important yet underdeveloped area of com-
putational biology important to our understanding of
many cellular processes. Focusing on short elements
keeps the alignment models simple and therefore easi-
er to understand in terms of basic structural principles.
Our hope is that this will lead not only to more accu-
rate alignments and more sensitive searches, but also to
useful insights into principles of protein folding.
The modeling approach we used combined hidden
Markov models (HMMs), Gibbs sampling, and PSI-
BLAST. (An HMM is a standard statistical model
used to represent protein families within a computer
program. Gibbs sampling is a mathematically rigorous
procedure to optimize the parameters of a HMM. PSI-
BLAST, developed at the National Center for Biotech-
nology Information, is a very fast iterative multiple
alignment and database search procedure that has
proved to be considerably more effective than pairwise
search methods at detecting distant relationships
between proteins.) More specifically, we have devel-
oped HMMs with insertion and deletion (indel) penal-
ties based on secondary structure predictions derived
from multiple alignment data. Basing these penalties
on secondary structure predictions indirectly provides
an estimate of the actual likelihood of insertions and
deletions because gaps are inherently more likely in
loops than in helices or strands. This yielded signifi-
cant improvements in sequence alignments as judged
from comparison to structural alignments. Alignment
of short repeats was achieved using a new HMM-
based Gibbs sampling procedure. This procedure
works by iteratively sampling alignments of individual
sequences against the HMM, where sampling is based
on the degree of statistical uncertainty associated with
the residue match scores of the HMM. Finally, for
database searches, we used PSI-BLAST initialized
with "checkpoint-recovered" profiles derived from
simulated repeat-containing sequences generated by
the (optimized) HMM. These searches detected distant
structural relationships with, in some cases, substan-
tially greater sensitivity than a normal PSI-BLAST
search.
Our recent discovery and analysis of repeat-con-
taining proteins illustrates the biological and medical
significance of these new methods. These include sev-
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eral discoveries that involve DNA- and RNA-associat-
ed proteins with structurally conserved repeats. In
particular, an unusual putative sliding DNA clamp
protein was detected in the thermophilic bacterium
Thermotoga maritima. This protein appears to have
arisen by way of a duplicated (3-clamp gene that then
acquired features of a proliferating cell nuclear anti-
gen (PCNA)-like clamp-perhaps to accommodate
the substantial archaeal DNA present in this organism.
(This archaeal DNA was presumably acquired through
lateral gene transfer.) In another example, 13-propeller
domains were predicted in the large subunit of UV-
damaged DNA-binding protein and in related proteins
including the large subunit of cleavage-polyadenyla-
tion specificity factor, the yeast Rselp and human
SAP130 pre-mRNA splicing factors, and the fission
yeast Rik 1 p gene silencing protein. UV-damaged
DNA-binding protein is associated with the hereditary
disease xeroderma pigmentosa (XP) group E, which is
characterized by sensitivity to UV light and a disposi-
tion to skin cancer. XP cells are defective in
nucleotide excision repair. For details, see our article
referenced below.
FAST AND SENSITIVE SEARCHES OF A DATABASE
OF PROTEIN DOMAIN HIDDEN MARKOV
MODELS
A key development coming out of our efforts to merge
PSI-BLAST, HMM, and other technologies are fast
search procedures involving HMMs. An important
component of the PSI-BLAST program in this regard
is the gapxdrop routine developed by Webb Miller's
group at Pennsylvania State University. It works by
extending a gapped alignment from the center of a
short ungapped aligned region detected by the
BLAST heuristic. Within PSI-BLAST, these short
ungapped regions correspond to an alignment of a
sequence against a profile. We have generalized this
profile version of the gapxdrop routine to allow align-
ment of a sequence against an HMM with position-
specific gap penalties. This HMM version of gapx-
drop has been incorporated into a new program for
searches of a query sequence against a database of
HMMs, which is analogous to Sean Eddy's hmmpfam
program in the HMMer software package. In particu-
lar, our program, which also incorporates other heuris-
tic procedures used in BLAST and PSI-BLAST,
allows fast searches of the PFAM and SMART data-
bases because it adopts the HMMer format for
HMMs. For this program, we have fit the HMM scores
to extreme value distributions, which will provide
measures of statistical significance comparable to
those used in PSI-BLAST and HMMer. In addition,
this HMM version of gapxdrop will be generally use-
ful in other future applications.
IDENTIFYING DETERMINANTS OF PROTEIN
STRUCTURE AND FUNCTION THROUGH
CHAIN ANALYSIS
An alignment of distantly related protein sequences
reveals patterns of conserved residues reflecting the
structural and functional constraints acting on these
proteins during evolution. Deciphering the biological
significance of these patterns, however, is a formida-
ble task, especially when a set of related sequences
contains hundreds or thousands of functionally diverse
proteins. Moreover, when particular protein subfami-
lies within this set manifest a high degree of cross-
phylum or cross-kingdom sequence conservation, the
interpretation of conserved patterns becomes even
more complicated. To address these issues, we have
devised a strategy called CHAIN (Comparative
FIGURE 1 CHAIN analysis of subfamily 1 of the G-protein a-subunit. The hierarchical alignment shown, which our program automat-
ically generated, corresponds to the switch regions of seven subfamily 1 G subunits (from rat, starfish, snail, hydra, lobster, round-
worm, and sponge, respectively). Below the top alignment is a series of telescoping alignments corresponding to increasingly larger
sets of related sequences at higher levels in the GTPase functional hierarchy. (For each alignment, only those sequences present in the
top alignment are shown. The second through fifth alignments contain additional GTPases that are represented by consensus residues
below each of these alignments.) The top alignment highlights conserved residues in G subfamily 1 using a standard background
model, which ignores the evolutionary and functional implications of more distantly related GTPases. Below this, the series of five align-
ments are highlighted to reveal those residues specifically conserved (respectively) within the G subfamily 1 (6 proteins), the G fami-
ly (263 proteins), the GJArf /Sar family (437 proteins), the Ras-like GTPases (1532 proteins), and P-loop GTPases as a whole (3185
proteins). The histograms above these alignments correspond to the degree of functional category-specific sequence conservation (i.e.,
log-binomial tail probabilities) at each position. Conserved residues within each functional category often correspond to key structural
features within that category. For example, the most conserved residues in the bottom alignment correspond to residues contacting
the bound GTP or GDP. The most conserved residue among Ras-like GTPases (Q203 in 1ARGA of alignment 4) is known to work in
conjunction with GTPase-activating proteins (GAPs). Similarly, a conserved residue among members of the Ga family (R177 in 1 ARGA
of alignment 3) undergoes an ADP-ribosyl modification, a characteristic of this family.
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Hierarchical Alignment with Interpretive Notation)
analysis, which quantitatively visualizes conserved
patterns characteristic of specific functional cate-
gories within a (typically large) set of related protein
sequences. The acronym "CHAIN" also alludes to the
presumed evolutionary process examined through this
approach, namely, a series or chain of increasingly
specialized functional adaptations leading to the
divergence of related sequences into superfamilies,
superfamilies into families, families into subfamilies,
and so forth. CHAIN analysis relies on a "hierarchical
alignment" and on corresponding three-dimensional
structural images to quantitatively highlight function-
al-category-specific conserved patterns and their cor-
responding structural features, respectively. More pre-
cisely, a hierarchical alignment consists of a series of
telescoping multiple sequence alignments, each of
which corresponds to the next higher category in the
functional hierarchy (and, thus, to a superset of the set
of sequences in the previous category).
We have performed CHAIN analyses on various
proteins leading to specific functional predictions.
Figure 1, for example, shows a hierarchical alignment
for subfamily 1 of the G protein a-subunit. The legend
to this figure explains aspects of this analysis in more
detail. Notably, the programs we have developed allow
such an analysis to be performed quickly and require
little computational expertise to use. In another exam-
ple, we constructed a hierarchical alignment using as
query the NSF D2 ATPase module-a domain of
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known structure that is involved in vesicle membrane
fusion. This revealed conserved patterns specific to the
NSF D2 ATPase module that map to structural regions
located at the interface between adjacent subunits,
which is consistent with the role of this module in
hexamer formation. When structural coordinates for a
particular family are unavailable, our procedures can
construct a homology-based structural model. This
allowed us to perform, for example, an analysis of the
NSF D1 module (a second ATPase domain present in
NSF and related to the D2 module) leading to the iden-
tification of subfamily-specific conserved residues
presumably important for NSF's chaperone function.
CHAIN analyses were also performed on other
domains and on domains that interact with these
domains, thereby revealing additional functional
aspects of various proteins.
PUBLICATIONS
Neuwald A.F. and Hirano T. 2000. HEAT repeats associated
with condensins, cohesins, and other complexes involved
in chromosome-related functions. Genome Res. 10: 1445-
1452.
Neuwald A.F. and Poleksic A. 2000. PSI-BLAST searches using
hidden Markov models of structural repeats: Prediction of
an unusual sliding DNA clamp and of 8-propellers in UV-
damaged DNA binding protein. Nucleic Acids Res. 28:
3570-3580.
Wilbur W.J. and Neuwald A.F. 2000. A theory of information
with special application to search problems. Comput.
Chem. 24: 33-42.
STRUCTURAL BIOLOGY
R.-M. Xu M. Hayashi H. Shi
J. Jiang J. Vital
J. Min Y. Zhang
0. Merkel J. Hu
During 2000, Jiangzhong Jiang left to take a job at
Morgan Stanley Dean Witter & Co. in Manhattan, and
Mariko Hayashi went to the Massachusetts Institute of
Technology as a research associate. Two new postdocs,
Jingrong Min and Olaf Merkel, and a visiting scientist,
Jacqueline Vitali, joined us last year.
RNA Splicing
J. Jiang, H. Shi, Y. Zhang
In the past year, heterogeneous nuclear ribonucleo-
protein (hnRNP) Al, SR proteins, and U2AF
remained the focus of our structural studies of pre-
mRNA splicing. In collaboration with Adrian Krainer
here at the Laboratory, we previously solved two
crystal structures of the two-RRM (RNA-recognition
motif) domain of hnRNP Al alone and in complex
with single-stranded telomeric DNA. Structure and
function studies are being pursued of hnRNP Al con-
cerning (1) protein-RNA interaction, (2) protein-pro-
tein interactions in hnRNP Al multimers, and (3) the
structure of the carboxy-terminal domain of hnRNP
A 1. SR proteins are among the most extensively char-
acterized metazoan splicing factors. They contain
either one or two RNA recognition motifs at the
amino terminus and a variable number of arginine-
serine repeats at the carboxyl terminus. SR proteins
are important in constitutive splicing, as well as in
enhancer-dependent splicing. The structural basis of
protein-RNA interaction and protein-protein interac-
tion governing the function of SR proteins is not well
understood. We have made significant progress in
crystallizing an SR protein, and this should lead to
crystal structure determination in the near future. We
are also pursuing crystallographic studies of U2AF,
an essential splicing factor in splice site recognition
and spliceosome assembly.
Transcriptional Silencing
M. Hayashi, J. Min, 0. Merkel, Y. Zhang
Genes located in certain regions of eukaryotic chro-
mosomes are permanently repressed. This heritable,
transcriptionally silent state is caused by an altered
chromatin structure that can be propagated from one
generation to the next. In Saccharomyces cerevisiae,
silencing is observed for at least three genomic loci:
the silent mating-type loci, HML and HMR, telomeres,
and the ribosomal DNA region. Several protein com-
plexes are known to be critical for the establishment
and maintenance of transcriptional silencing in yeast,
including the silent information regulator (SIR) pro-
teins, Sirlp, Sir2p, Sir3p, and Sir4p, and several
sequence-specific DNA-binding proteins, the origin
recognition complex (ORC), Rap 1p, and Abflp.
During 2000, we crystallized and determined the
crystal structure of an archaeal homolog of Sir2p and
the amino-terminal domain of Orc 1p. Sir2p is unique
among the SIR proteins because it is required for
silencing at all three known silenced genomic loci,
and it is the only SIR protein that has been evolu-
tionarily conserved. Recently, Sir2p and homologous
proteins have been shown to be nicotinamide-ade-
nine dinucleotide (NAD)-dependent protein deacety-
lases. Significantly, they can deacetylate lysine
residues at the amino termini of histones that are
known to be critical for silencing. In collaboration
with Rolf Sternglanz at SUNY, Stony Brook, we have
determined two crystal structures of a SIR2 homolog
from Archaeglobus fulgidus (SIR2-Afl) complexed
with NAD, one at 2.1 A and the other at 2.4 A reso-
lution. The structures reveal that the protein consists
of a large domain having a Rossmann fold and a
small domain containing a three-stranded zinc ribbon
motif. NAD is bound in a pocket between the two
domains (Fig. 1). A distinct mode of NAD binding
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FIGURE 1 Overall view of the structure of A. fulgidus SIR2-Af1
complexed with NAD. The protein is shown as a ribbon repre-
sentation and the NAD molecule is shown in a ball-and-stick
model. A zinc ion, part of the zinc ribbon motif, is shown as a
ball.
and an unusual configuration of the zinc ribbon
motif are observed. The structures also provide
important insights into the catalytic mechanism of
NAD-dependent protein deacetylation by this family
of enzymes.
The amino-terminal domain of Orclp, the largest
subunit of ORC, functions specifically in transcrip-
tional silencing. This domain shares high sequence
homology with the amino-terminal domain of Sir3p
and contains the recently identified bromo-adjacent
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homology (BAH) structural motif found in many chro-
matin-associated proteins. In collaboration with Bruce
Stillman here at the Laboratory, we have determined
the crystal structure of the BAH domain of Orc 1 p to
2.0 A resolution. The structure of the BAH domain has
a novel fold. The structural implication of the Orclp
domain in transcriptional silencing is currently being
tested.
DNA Replication
M. Hayashi, J. Vitali, Y. Zhang
In collaboration with James Chong in Bruce
Stillman's lab, we had previously shown that an
archaeal minichromosome maintenance (MCM) pro-
tein forms a double hexamer. It binds to DNA in an
ATP-independent manner, and it has a DNA-stimulat-
ed ATPase activity and a helicase activity. The
archaeal MCM protein serves as a simplified system
for understanding the structure and function of the
more complicated eukaryotic MCM proteins.
Crystallographic study of the archaeal MCM protein
complex is currently on-going.
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COMMUNITY ACCESS TO GENOME RESOURCES
L.D. Stein T. Harris N. Pavy
J. Kakol D. Priimak
H. Liu R. Sachidanandam
M. Mangone S. Schmidt
P. Van Buren
D. Weissman
G. Wu
During the calendar year 2000, our lab reached sever-
al important milestones:
A HIGH-DENSITY MAP OF HUMAN SINGLE
NUCLEOTIDE POLYMORPHISMS
Single nucleotide polymorphisms, or SNPs, are the
most common source of genetic diversity in mankind,
accounting for more than 90% of differences between
individuals' genomes. These single-base-pair changes
occur approximately once every 1300 nucleotides and
are usually silent. However, SNPs are of keen medical
and research interest because they provide a fast and
covenient way of mapping and identifying the genes
responsible for genetically linked diseases.
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The ability of geneticists to identify the genes
responsible for human disease is directly proportional
to the density of available genetic maps. The current
generation of human genetic maps are based on the
older technologies of restriction-fragment-length
polymorphisms (RFLPs) and simple sequence repeats
(SSR5). These maps typically contain several thousand
mapped markers, providing a resolution of at most 1
Mb. This means that even after establishing tight
genetic linkage between a trait and a map marker, the
researcher still must search through a million or more
bases of DNA sequence data in order to identify can-
didate genes that might be responsible for the trait.
In contrast, by virtue of the abundance of SNPs, an
SNP-based map can contain hundreds of thousands or
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FIGURE 1 A searchable view of SNPs contained on chromosome 1.
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millions of markers, giving the map a theoretical reso-
lution of a few thousand bases. This means that
researchers can skip the tedious search for candidate
genes and immediately hone in on the gene of interest.
Furthermore, a highly dense genetic map allows
researchers to design studies that take advantage of
linkage desequilibrium in isolated populations. This
technique obviates the need to collect large detailed
family pedigrees and instead allows geneticists to
search for association between an SNP and a genetic
trait in the general population.
Other uses for SNPs include the design and devel-
opment of diagnostic tests for genetically linked disor-
ders and the use as a potent tool for studying the evo-
lution and migration of human populations.
Under a grant from The SNP Consortium, our lab
is coordinating a large multicenter study to identify
SNPs in human sequences. The identified SNPs are
verified, archived, and mapped to the human genome
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using the emerging working draft sequence. After
mapping, the data are released into the public
domain and to GenBank and other major sequence
databases.
To date, we have identified and mapped more than
900,000 SNPs (for example, see Fig. 1). These
mapped SNPs have been combined with data from
other publicly financed SNP-discovery efforts and
with gene prediction data from the human working
draft, to yield an integrated map containing more than
1,430,000 SNPs. This map contains 1 SNP every 2.3
kb of DNA on average and represents an increase of
two orders of magnitude in resolution over previous
maps of the genome. This work resulted in a major
publication in the journal Nature, "A High-density
SNP Map of the Human Genome."
An unexpected feature of the SNP map is that the
SNPs are not distributed evenly in the genome, but
show occasional areas of high and low density. We are
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FIGURE 2. WormBase provides access to predicted genes and other important
features of the C. elegans genome.
currently working with our collaborators to interpret
this finding, which may indicate the existence of long-
range structure in the genome.
WORMBASE: A RESOURCE FOR C. ELEGANS
GENOME AND BIOLOGY
During the past year, our lab received a major grant to
develop WormBase (Fig. 2), an online resource for the
small free-living nematode, Caenorhabditis elegans.
This organism is favored as a simple model animal
because of its small genome size, experimental mal-
leability, and well-understood cellular anatomy.
WormBase is a curated model organism database
developed as part of an international collaboration with
the California Institute of Technology, Washington
University at St. Louis, and the Sanger Centre. Our lab
is responsible for the Web Site, user interface, and soft-
ware architecture for the project.
The resource, which is available to the public at
www.wormbase.org, contains the complete C. elegans
genome and key annotations, including predicted
genes, alternative splicing patterns, oligonucleotide
probes, and evolutionarily conserved segments. It also
contains many other types of biological information,
including the C. elegans cell pedigree, the organism's
neuroanatomy, its genetic map, and the physical map
from which the genomic sequence was derived. Last
year, we added the following key features to
Wormbase:
A cell pedigree browser, which allows researchers
to quickly determine the developmental derivation
of any cell, cell group, or tissue in the organism.
A genome browser, which provides researchers
with the ability to select a region of the genome and
retrieve the DNA sequence and annotations in a
variety of formats.
Expression pattern pages, which provide
researchers with searchable access to the results of
gene-tagging experiments.
RNA interference pages, which provide access to
the results of recent large-scale studies in which C.
elegans genes are selectively disabled.
The WormBase project resulted in a publication,
"Wormbase: Network Access to the Genome and
Biology of C. elegans," which appeared in the January
issue of the journal Nucleic Acids Research.
ATIDB: A DATABASE FOR
INSERTIONAL MUTAGENESIS
EXPERIMENTS
It is increasingly common in genomics to probe the
function of genes by systematically knocking them out
using transposon-mediated mutagenesis, or similar
technology. For example, both Arabidopsis thaliana
and Zea mays have been probed this way. After gener-
ating a large collection of mutant strains, the transpo-
son insertion sites are sequenced to determine the
gene that has been knocked out, and the plant is stud-
ied for morphologic or physiologic consequences of
the knockout. A closely related technology are gene-
tagging studies, such as the "GeneTrap" technique
pioneered by Robert Martienssen here at the
Laboratory. In this technique, genes are not knocked
out, but are replaced by a visible tag, which can then
be used to study the gene's spatial and temporal
expression pattern.
In 1999, our lab designed and deployed MTMDb,
a database for a specific maize insertional mutagene-
sis project. On the basis of this experiment, we
designed and implemented a portable, generic system
for managing this type of research protocol. The sys-
tem includes an Open Source database, a Web server,
a user interface system, and a series of software mod-
ules for loading and maintaining the system. With this
package, a researcher can rapidly determine the
genomic location of an insertion site, find the gene or
genes affected by the insertion, manage the pedigree
of the manipulated strains, and store phenotypes asso-
ciated with each individual. The system is Web-acces-
sible and can be used to publish the results of inser-
tional mutagenesis studies and to make correlations
between genes and phenotypes.
The database has been used successfully to curate
GeneTrap data from the Martienssen lab and to man-
age a large-scale insertional mutagenesis project in the
lab of our collaborator, Michael Bevan. We plan to
release the software to the public under an Open
Source license in late January or February and are
preparing a manuscript to describe it.
DISTRIBUTED SEQUENCE ANNOTATION
SYSTEM
DAS, the distributed sequence annotation system, is a
software architecture that allows researchers from
around the world to share and exchange annotations
on the genome without the need for the error-prone
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and time-consuming reformatting currently required.
Although the project is still under way, we passed
important milestones during 2000.
The release of Geodesic, a graphical DAS client.
This software is a genome browser. With it,
researchers can retrieve genomic data from multi-
ple on-line annotation databases and view the data
as an integrated whole. Heretofore, it was difficult
or impossible to integrate data from disparate
annotation data sources.
The adoption of DAS as the output format by sev-
eral key data sources. DAS has been adopted as the
data exchange format by Ensembl, the Joint
Genomics Initiative at Oak Ridge and the
University of California at Santa Cruz, three major
sources of human genome annotation data; by
FlyBase and WormBase, two model organism data-
bases; and by Incyte, a commercial venture. These
adoptions give the DAS standard significant
momentum.
We continue to develop other key components of
the DAS system, including a lightweight annotation
server that will allow small laboratories to publish
comments on the genome with minimal investment in
hardware and software.
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GRAMENE: A RESOURCE FOR COMPARATIVE
MAPPING IN RICE AND OTHER GRAINS
In October, our lab was awarded a highly competitive
USDA IFAFS grant to develop a comprehensive
resource for comparative mapping in rice and other
monocots. This resource will contain the emerging
rice genomic sequence and associated annotations,
plus a series of comparative genetic and physical maps
comprising the major monocot crops, maize, barley,
oats, millet, sorghum, and wheat. By following these
evolutionarily conserved segments, researchers will be
able to identify and clone candidate genes in monocots
that have not been sequenced by analogy with corre-
sponding sequenced rice genes. We have set up an ini-
tial Web Site, www.gramene.org, and are proceeding
with the design of the database and other software.
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COMPUTATIONAL GENOMICS
M.Q. Zhang R.V. Davuluri T. Zhang
G. Chen N. Banerjee
Z. Xuan N. Pavy
A. Kel
M. Vichnevskaia
J. Hizver
J. Zhu
Our research interest continues to be the identification
and characterization of the genetic elements in nucleic
acid sequences by computational means. As the Human
Genome Project entered its large-scale sequencing
phase, developing efficient computational methods for
identification of genes and their control/regulatory ele-
ments has become extremely important. Knowing the
organization of a gene often becomes the prerequisite
for further functional studies. In the past, we studied
statistical characteristics of exons and introns in pro-
tein-coding regions and developed coding-exon predic-
tion programs by applying multivariate statistical pat-
tern recognition techniques. Recently, we started look-
ing into more difficult problems of finding regulatory
cis-elements in noncoding regions. This year, we con-
tinue to focus on splicing enhancers, promoters, and
transcriptional start site and polyadenylation site
regions in order to develop new computational methods
for identification of these functional elements. To facil-
itate large-scale gene expression data mining, we have
also developed several computational tools for cluster-
ing and promoter analysis.
We have also worked jointly with other investiga-
tors here at the Laboratory. In collaboration with the
Krainer lab, we have studied the mechanism of exon
skipping caused by a nonsense mutation in the BRCAI
gene; and in collaboration with the Wigler and
McCombie labs, we have been developing computa-
tional methods and searching for tumor suppressor
genes. For a more detailed description of these studies,
please see the Krainer, Wigler, and McCombie sec-
tions of this Annual Report.
CART Classification of Human
UTR Sequences
R. Davuluri, M.Q. Zhang (in collaboration with S. Sugano,
University of Tokyo]
A nonredundant database of 2312 full-length human
5'-untranslated regions (5 'UTRs) was carefully pre-
pared using state-of-art experimental and computa-
tional technologies. A comprehensive computational
analysis of these data was conducted for characteriz-
ing the 5 'UTR features. Classification and regression
tree (CART) analysis was used to classify the data into
three distinct classes. Class I consists of mRNAs that
are believed to be poorly translated with long 5 'UTRs
filled with potential inhibitory features. Class II con-
sists of TOP (terminal oligopyrimidine tract) mRNAs
that are regulated in a growth-dependent manner.
Class III consists of mRNAs with favorable 5 'UTR
features that may help efficient translation. The most
accurate tree that we found has 92.5% classification
accuracy as estimated by cross-validation. The classi-
fication model included the presence of TOP, sec-
ondary structure, 5 'UTR length, and the presence of
upstream AUGs (uAUGs) as the most relevant vari-
ables. The present classification and characterization
of the 5'UTRs provide precious information for better
understanding the translational regulation of human
mRNAs. Furthermore, this database and classification
can help investigators build better computational mod-
els for predicting the 5'-terminal exon and separating
the 5 'UTR from the coding region.
JTEF: A novel 3"-terminal Exon
Recognition Algorithm
J. Tabaska, R. Davuluri, M.O. Zhang
JTEF, a new program for finding 3 "-terminal exons in
human DNA sequences, is based on quadratic dis-
criminant analysis, a standard nonlinear statistical pat-
tern-recognition method. The quadratic discriminant
functions used for building the algorithm were trained
on a set of 3'-terminal exons of type 3tuexon (those
containing the true STOP codon). We showed that the
average predictive accuracy of JTEF is higher than the
best presently available programs (GenScan and
Genemark.hmm) based on a test set of 65 human DNA
sequences with 121 genes. In particular, JTEF per-
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forms well with larger genomic contigs containing
multiple genes and significant amounts of intergenic
DNA. It will become a valuable tool for genome anno-
tation and gene functional studies.
A Database and Statistical
Analysis of Alternative Exons
J. Zhu, M.O. Zhang [in collaboration with S. Stamm, Max-
Planck Institute, and K. Nakai, University of Kyoto]
We compiled a comprehensive database of alternative
exons from the literature and analyzed them statisti-
cally. Most alternative exons are cassette exons and
are expressed in more than two tissues. From all exons
whose expression was specific for a certain tissue, the
majority was expressed in the brain. On average, alter-
native exons are shorter than constitutive exons, and
their splice sites deviate more from the consensus,
where their 3' splice sites are characterized by a high-
er purine content in the polypyrimidine stretch and
their 5' splice sites deviate mostly at the +4 and +5
positions from the consensus sequence. Furthermore,
exons expressed in a single tissue use more adenosine
at the -3 position of the 3' splice site. In addition to
the known adenosine/cytosine-rich and purine-rich
exonic sequence elements, sequence comparison
using a Gibbs algorithm identifies several motifs in
exons surrounded by weak splice sites and in tissue-
specific exons. Together, these data indicate a combi-
natorial effect of weak splice sites, short exon length,
atypical nucleotide usage at certain positions, and
supplementary enhancers as a cause of alternative
exon usage.
Computational Characterization
of Liver-specific Promoters
T Zhang, M.Q. Zhang
This work focuses on developing computational tools
to detect regulatory regions (i.e., promoters) that con-
fer tissue-specific gene expression. We demonstrate
our approach using liver-specific gene promoters,
mainly because of the recent advances in the studies
of liver-specific transcription factors.
Our approach consists of the following steps. First,
we have collected all liver-specific transcription-fac-
tor-binding sites that are experimentally verified in lit-
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erature. Second, we have constructed PWMs (position-
al weighted matrices) that summarize the binding sites
in our collection. Third, we have applied linear regres-
sion analysis to combine matches to multiple binding
sites into a single model. For various test sets, our mod-
els have achieved state-of-the-art performance.
We are currently investigating ways to enhance the
performance of our models. The most promising direc-
tion is to incorporate additional regulatory elements
into these models. Such elements could bind to tran-
scription factors other than the four factors already
examined in building the existing models, or they
could be related to secondary structures. To identify
such elements, we have developed new algorithms
searching for motifs that are significantly over/under-
represented in the given promoter sequences. Different
from the previous motif-finding methods, we allow
both mismatches and gaps in our motifs, which reflect
more realistically the actual DNA and protein interac-
tion. Another approach to discover pUtative motifs is by
comparing promoters from distantly related species. In
general, functional regions are more likely to be con-
served over evolution than nonfunctional regions. By
carefully selecting the organisms under examination,
we can identify conserved regions, which are the puta-
tive functional regions.
Comparative DNA Sequence
Analysis of Mouse and Human
Protocadherin Gene Clusters
T. Zhang, M.Q. Zhang [in collaboration with T. Maniatis,
Harvard University, and R.M. Myers, Stanford University]
The genomic organization of the human protocadherin
a, pi, and y gene clusters (designated Pcdha, Pcdhf3,
and Pcdhy) is remarkably similar to that of
immunoglobulin and T-cell receptor genes. The extra-
cellular and transmembrane domains of each proto-
cadherin protein are encoded by an unusually large
"variable" region exon, whereas the intracellular
domains are encoded by three small "constant" region
exons located downstream from a tandem array of
variable region exons. Here, we report the results of a
comparative DNA sequence analysis of the ortholo-
gous human (750 kb) and mouse (900 kb) protocad-
herin gene clusters. The organization of Pcdha and
Pcdhy gene clusters in the two species is virtually
identical; the mouse Pcdhf3 gene cluster is larger and
contains more genes than the human Pcdhl3 gene clus-
ter. We identified conserved DNA sequences upstream
of the variable region exons and found that these
sequences are more conserved between orthologs than
between paralogs. Within this region, there is a highly
conserved DNA sequence motif located at about the
same position upstream of the translation start codon
of each variable region exon. In addition, the variable
region of each gene cluster contains a rich array of
CpG islands, whose location corresponds to the posi-
tion of each variable region exon. These observations
are consistent with the proposal that the expression of
each variable region exon is regulated by a distinct
promoter, which is highly conserved between ortholo-
gous variable region exons in mice and humans.
Microarray Study of Mouse
ES Cell Differentiation
G. Chen, N. Banerjee, M.O. Zhang in collaboration
with M. Ko, NIA/N11-1]
To understand the genetic pathways controlling
embryonic stem (ES) cell differentiation, we have
been using cDNA microarrays ("NIA mouse 15K
microarray") containing 15,000 distinct mouse genes,
50% of which were newly identified and derived from
preimplantation mouse embryo cDNA libraries.
Undifferentiated mouse R1 ES cells were maintained
in the presence of both leukemia inhibitory factor
(LIF) and BRL-conditioned media without feeder lay-
ers. For the time course experiments, ES cells were
cultured and harvested at various time points after
withdrawal of LIF and conditioned media: 4 hours, 8
hours, 18 hours, 24 hours, and 36 hours. In addition,
aggregates of ES cells were generated using the
"hanging-drop" technique. After 7 days in culture,
these aggregates contain a heterogeneous mixture of
highly differentiated cells. Total RNAs were extracted
from these cells and used for cDNA microarray
hybridizations. All microarray analyses were done in
triplicate, and the F-test was used to identify 3508
genes for their statistically significant expression
changes during the ES cell differentiation.
A program based on the K-mean analysis was used
to group 3508 genes into 36 clusters according to the
similarity of their expression patterns. Among them,
12 different clusters containing 1424 genes showed a
dramatic decline of gene expression levels at 4 and/or
8 hours after the withdrawal of LIF and conditioned
media. Functionally, these genes fall into six cate-
gories. The first category contains well-characterized
genes, such as Stat3, Oct4, and Rexl, which are known
to be down-regulated by the withdrawal of LIE Genes
in the second category, including Maid and Hail
(hepatocyte growth factor activated inhibitor type 2),
are known to function as negative regulators of genes
that are important in cell differentiation. Genes in the
third category, including HMGI and Brgl, are
involved in chromatin remodeling. Genes in the fourth
category, including Cdc25A and p33qIK kinase, are
involved in cell cycle regulation and apoptosis. Genes
in the fifth category, including TGF-13 receptor inter-
acting protein 1 and 13-ig-h3, are growth factors and
growth factor responsive genes. The last category
includes 790 newly identified genes.
To elucidate the potential functions of the newly
identified genes, we have developed a bipolar cluster-
ing program "sdclust." In contrast to other clustering
programs, this program can identify both negatively
correlated genes and positively correlated genes. For
example, we used the Oct4 gene as the "center of clus-
ter" and identified 65 genes (45 of them novel) whose
expression patterns show positive correlation with that
of Oct4. Further analyses of these novel genes may
provide critical insights into the characteristic features
of ES cells, such as pluripotency and self-renewal.
Computer-assisted Identification of
Cell-cycle-related Genes: New Targets
for E2F Transcription Factors
M.O. Zhang [in collaboration with the laboratories of A. Kel,
Russian Academy of Science; K Farnham, University of
Wisconsin; and E. Wingender, Gesellschaft fur
Biotechnologische Forschung mbH]
The processes that take place during development and
differentiation are performed through coordinated reg-
ulation of expression of a large number of genes. One
such gene regulatory network provides cell cycle con-
trol in eukaryotic organisms and, in this work, we have
studied the structural features of the 5' regulatory
regions of cell-cycle-related genes. We developed a
new method for identifying composite substructures
(modules) in regulatory regions of genes consisting of
a binding site for a definite transcription factor and
additional contextual motifs-potential targets for
other transcription factors that may synergistically
regulate gene transcription. Applying this method to
cell-cycle-related promoters, we created a program for
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context-specific identification of binding sites for
E2F transcription factors, key regulators of cell cycle.
We found that E2F composite modules are found at a
high frequency and in close proximity to the start of
transcription in cell-cycle-related promoters in com-
parison with other promoters. Using this information,
we then searched for E2F sites in genomic sequences
with the goal of identifying new genes that have
important roles in controlling cell proliferation, differ-
entiation, and apoptosis. Using a chromatin immuno-
precipitation assay, we then experimentally verified
the binding of E2F in vivo to the sites predicted by the
computer-assisted methods. Our identification of new
E2F target genes provides new insight into gene regu-
latory networks and provides a framework for contin-
ued analysis of the role of promoter context in tran-
scriptional regulation. Tools are available at
http://compel.bionet.nsc.ru/FunSite/SiteScan.html.
Identification of CREB Targets
in Drosophila melanogaster
M. Vichnevskaia, T. Zhang, G. Chen, M.Q. Zhang [in
collaboration with T. Tully, Cold Spring Harbor Laboratory)
cAMP response element-binding protein (CREB) is a
conserved transcription factor present in a number of
organisms, including Homo sapiens and Drosophila
melanogaster. It has an important role in long-term
memory formation, and it is also implicated in human
neurological diseases, such as Alzheimer's. To under-
stand the learning and memory microarray expression
results, we set out to identify CREB targets in the fly
by searching for the promoter element (CRE). Since
there was very little known about fly CRE elements,
we decided to use an in silico phylogenetic approach:
collecting known CRE elements and CREB targets in
higher organisms as the training set and then identify-
ing the corresponding fly orthologs. We obtained the
following results: (1) A database of the known CREB
targets in various organisms was created and soon will
be published; (2) the approach used to produce the
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ortholog set of genes was validated, and it can be used
in the future for other transcription factors research;
(3) the matrix for the CRE site was produced, and it
can be used in the future for identification of CRE
sites; and (4) putative CREB targets were suggested
from the set of candidate genes and from the set of
potential orthologs of non-Drosophila CREB targets.
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NEUROSCIENCE
The last generation of neuroscientists has contributed tremendous insight to the cellular basis of neu-
ronal function. A basic electrophysiology and cell biology of the neuron has emerged, which includes
molecular models of synaptic plasticity and cellular models of associative processes. Intuitively, we all
know that these mechanisms likely underlie the various forms of behavioral plasticity-learning and
memory-that animals display. Unbeknownst to those who pioneered this effort in various animal mod-
els, the modern-day convergent view holds that these basic mechanisms may be evolutionarily con-
served. The "neuron" appears to have been invented once. Hence, study of plasticity in animal mod-
els now holds great promise to inform the basic biology of cognition in humans.
The diversity of behavioral responses-both within a given animal and among the species-appears
to reside at two levels of biological organization: the network of gene products within a neuron, which
interact to yield cellular function, and the network of connections among neurons, which translates cel-
lular function into behavioral response. These two computational networks are enormously complex
and largely unresolved. The next generation of neuroscientists will need to derive the computational
algorithms at each level of biological organization in order to achieve an adequate understanding of the
genetics of memory. From this vertical integration will emerge effective new strategies to diagnose and
treat cognitive dysfunction in humans.
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PRINCIPLES OF BRAIN DESIGN
D.B. Chklovskii A. Stepanyants
The goal of our laboratory is discovering key organiz-
ing principles of brain design and applying these prin-
ciples to understand brain function. One such princi-
ple, that of wiring economy, proved to be particularly
useful for understanding the organization of the brain.
This principle, which goes back to Cajal, asserts that
the brain has evolved under pressure to keep its vol-
ume to a minimum. Thus, for a given circuit, the lay-
out of brain components, such as neuronal bodies and
synapses, should minimize the length of wiring, i.e.,
of axons and dendrites. By solving the optimization
problem, we establish a link between the connectivity
and spatial layout of brain circuits, thus making exper-
imentally testable predictions.
Ocular Dominance Patterns
in the Visual Cortex
D.B. Chklovskii [In collaboration with A.A. Koulakov,
Salk Institute]
The primary visual area (V1) of the mammalian brain
is a thin sheet of neurons. Activity of most neurons is
dominated by the inputs from either the right eye or
the left eye. The spatial arrangement of neurons dom-
inated by different eyes is known as the ocular domi-
nance (OD) pattern. We propose a theory for OD pat-
terns based on the premise that they are evolutionary
adaptations to minimize the length of intracortical
connections. Thus, the existing OD patterns are
obtained by solving a wire length minimization prob-
lem. We divide all the neurons into two classes: right-
eye-dominated and left-eye-dominated. We find that if
the number of connections of each neuron with the
neurons of the same class differs from that with the
other class, the segregation of neurons into monocular
regions indeed reduces the wire length. The shape of
the regions depends on the relative number of neurons
in the two classes. If both classes are equally repre-
sented, we find that the optimal OD pattern consists of
alternating stripes. If one class is less numerous than
the other, the optimal OD pattern consists of patches
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of the underrepresented (ipsilateral) eye-dominated
neurons surrounded by the neurons of the other class.
We predict the transition from stripes to patches when
the fraction of neurons dominated by the ipsilateral
eye is about 40%. This prediction agrees with the data
in macaque and Cebus monkeys (Fig. 1). Our theory
can be applied to other binary cortical systems.
Orientation Preference Patterns
in the Visual Cortex
D.B. Chklovskii [in collaboration with A.A. Koulakov,
Salk Institute]
Different edge orientations in the visual scene are rec-
ognized by different neurons. In the visual cortex,
FIGURE 1 Ocular dominance pattern in macaque visual cortex:
(Gray) Neurons dominated by the left eye; (white) neurons dom-
inated by the right eye. Transition from stripy to patchy pattern
takes place when the fraction of left-eye neurons is about 40%
(black line) as predicted by our theory.
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these neurons are arranged in spatial patterns known
as orientation preference patterns. The appearance of
these patterns varies between different species. We
propose that the observed interspecies variability of
the orientation preference patterns reflects the vari-
ability of intracortical neuronal circuits. By using the
wire-length minimization approach, we establish a
link between the statistics of interneuronal connectiv-
ity and map appearance (Fig. 2). This link can be used
to make testable predictions about interneuronal con-
nectivity from map appearance. Because intracortical
neuronal circuits underlie visual processing, our
results may help to understand how different animals
see the world differently. In addition, our work pro-
vides the first explanation of "singularities" in the
origination preference patterns, i.e., locations where
orientation preference changes abruptly (Fig. 2G-J).
We suggest that they arise to minimize wiring
between neurons of opposite as well as of similar ori-
entation preference.
Information Storage Capacity
of the Human Brain
A. Stepanyants, D.B. Chklovskii
How much information can be stored in a human
brain? The answer to this question depends on the
time scale available for information storage. One
major component of information storage underlying
learning and memory is the formation and elimina-
tion of dendritic spines, which happens on the time
scale from a few minutes to a few hours. We estimate
the information storage capacity associated with this
component. To do this, we derive an expression for
the potential number of synapses a neuron could
make. Under minimal assumptions, we find that the
number of potential synapses is equal to the product
of dendritic, axonal, and spine lengths and neuronal
density. By using existing anatomical data, we evalu-
ate this expression and find that the ratio of existing
to potential synapses is about 0.2. Therefore, the
information storage capacity associated with synaptic
patterns is about 3 bits per synapse. Because the
human brain contains about 10" synapses, the infor-
mation storage capacity associated with changes in
synaptic patterns is on the order of 10' bits or 100
Terabytes.
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FIGURE 2 Statistics of interneuronal connections in the visual
cortex (left column) and corresponding orientation preference
patterns (right column) obtained by minimizing the length of
these connections. On the basis of these results, we propose
that the interspecies variability in orientation preference pat-
terns can be accounted for by the differences in interneuronal
connectivity.
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Why Is Each Half of the Brain
Responsible for the
Opposite Half of the World?
D.B. Chklovskii [in collaboration with A.A. Koulakov,
Salk Institute]
A surprising and ubiquitous feature of vertebrate
design is that the representation of each half of the
external world is localized in the opposite half of the
brain. Why should this be? Of course, nerve fibers
have to cross the body midline in order to pass infor-
mation between sensory organs on the one side of the
body to the motor organs on the other side. However,
this does not answer the original question because the
representation of the world can be localized before or
after the crossing. Our hypothesis is that the represen-
tation of the world is located according to the relative
number of sensory inputs and motor outputs. To illus-
trate this hypothesis, we consider the neuroanatomy of
fish. If the number of incoming sensory fibers is
greater than the outgoing motor fibers, then the inte-
gration unit should be located ipsilaterally to the half
of the world it represents. An example of such
arrangement is the Mauthner neuron. If the number of
motor outputs exceeds the number of sensory inputs,
then the integration unit should be located closer to the
motor outputs, or contralaterally to the half of the
world it represents. An example of such arrangement
is optical tectum. This could explain contralateral rep-
resentation in the mammalian cerebral cortex because
it is strongly coupled to the brainstem.
What Determines the Shapes of
Dendritic and Axonal Arbors?
A. Stepanyants, D.B. Chklovskii
Dendritic and axonal arbors come in a dazzling vari-
ety of different shapes that have been known for over
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a century but remain unexplained. We have shown in
the past that the wiring economy principle explains the
sizes (diameters) of arbors as well as the typical mesh
size. However, the topology of arbors as characterized
by the branching points remains unconstrained. We
pursue two hypotheses to explain the branching of
dendritic and axonal arbors. The first one (we call it
plasticity potential) is due to the fact that the shape of
the arbor cannot be completely specified by the genes.
Arbor shape must accommodate the inevitable vari-
ability in the possible location of synapses. Branching
of the processes enhances plasticity potential because
branches can be formed or eliminated locally, without
global remodeling of the arbor shape. The second
hypothesis invokes the cost of neuronal processes
being distant from the cell body. This cost could be
due to the intracellular transport of material or delay
and attenuation of the nerve pulses.
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ACTIVITY-DEPENDENT NEURONAL DEVELOPMENT
H. Cline C. Aizenman
K. Bronson
I. Cantallops
I. Cohen
M. Davenne
L. Foa
K. Haas
A. Javaherian
K. Jensen
Z. Li
G. Munoz
E. Rial Verde
E. Ruthazer
W.-C. Sin
Normal brain development requires brain activity, sug-
gesting some kind of positive feedback. We are inter-
ested in understanding the function of neuronal activi-
ty in brain development. We address this issue by
examining the development of the visual system in
amphibian tadpoles. These animals are transparent,
which allows us to observe brain development in the
living animal. Many of the experiments we perform
involve in vivo imaging of neuronal structure during
periods up to several weeks. We combine these studies
with gene transfer methods that allow us to test the
function of genes of interest in brain development. In
addition, we assess neuronal function using electro-
physiological assays of synaptic connectivity and
synaptic plasticity. This range of technical approaches
allows us to identify key regulatory mechanisms gov-
erning the development of brain structure and function.
TECHNICAL ADVANCES
Time-lapse Imaging Using
Two-photon Laser Scanning
Microscopy
E. Ruthazer [in collaboration with P. O'Brien, B. Burbach,
and K. Svoboda, Cold Spring Harbor Laboratory]
E. Ruthazer modified an Olympus Fluoview confocal
scan box mounted on an Olympus microscope body to
enable two-photon imaging. This work was done
under the tutelage of K. Svoboda with technical assis-
tance from P. O'Brien and B. Burbach.
Single-cell Electroporation
for Gene Transfer In Vivo
K. Haas, W.-C. Sin, A. Javaherian, Z. Li, H.T. Cline
K. Haas, W.-C. Sin, A. Javaherian, and Z. Li have
developed an electroporation technique for targeting
gene transfer to individual cells in intact tissue.
Electrical stimulation through a micropipette filled
with DNA or other macromolecules delivers the
DNA into a single cell at the tip of the micropipette.
Electroporation of a plasmid encoding enhanced
green fluorescent protein (GFP) into the brain of
intact Xenopus tadpoles or rat hippocampal slices
resulted in GFP expression in single neurons (Fig.
1). In vivo imaging showed morphologies, dendritic
arbor dynamics, and growth rates characteristic of
healthy cells. Coelectroporation of two plasmids
resulted in expression of both proteins, whereas elec-
troporation of fluorescent dextrans allowed direct
visualization of transfer of molecules into cells. Due
to its versatility, this single method can be used to
deliver genes, antisense oligonucleotides, fluores-
cent dyes, drugs, and other macromolecules to a
variety of cell types including neurons, muscle cells,
and glia in the intact animal. Application of this
technique allows unprecedented spatial and temporal
control of gene delivery and permits experiments
that cannot be performed with current gene transfer
technology.
Application of Electroporation to
Target Gene Expression to Selected
Populations of Neurons in Xenopus
Brain In Vivo
L. Foa, K. Haas, Z. Li, H.T. Cline
We have made extensive use of viral gene transfer to
deliver genes of interest into neurons in the Xenopus
brain. In addition to the use of vaccinia virus, we now
use electroporation to introduce plasmid DNA into
neurons within the optic tectum. We obtain wide-
spread gene expression targeted to a single optic tee-
tum. Targeted electroporation allows exquisite spatial
and temporal control over gene expression in the brain
of living animals.
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FIGURE 1 Single-cell electroporation with pEGFP targets gene delivery to individual neurons. Shown are
confocal images of a single GFP-labeled neuron in the tadpole optic tectum (a), CA1 (b), and CA3 (c)
regions of rat hippocampal slice cultures. Arrows point to axons in each cell. Higher magnification of the
CA1 pyramidal cell from b demonstrates that GFP expressed following electroporation completely fills
dendritic spines (d, open arrowheads) and axonal varicosities (e, closed arrowhead). Bars: (a,d) 10 gm;
(b,c) 50 gm; (d,e) 20 gm.
VISUAL SYSTEM DEVELOPMENT
Visual Stimulation Enhances the
Development of Tectal Cell
Dendrites In Vivo
W.-C. Sin, H.T. Cline
Extensive evidence indicates that sensory system
stimulation is required for normal development of
central connections pertaining to sensory information.
Nevertheless, there has been no direct demonstration
of an effect of visual system stimulation of the struc-
tural development of neurons within the visual projec-
tion. W -C. Sin addressed this question by collecting
time-lapse images of single optic tectal neurons in
vivo under conditions in which the animals received a
simulated motion stimulus. Sin compared the dendrit-
ic arbor growth rates of neurons during a 4-hour peri-
od without visual stimulus and a subsequent 4-hour
period with visual stimulation. Light stimulation sig-
nificantly increased dendritic arbor growth rates. The
light-induced increase in dendritic arbor growth was
abolished when the stimulus was provided in the pres-
ence of glutamate receptor blockers. The results indi-
cate that visual stimulation has a direct effect on den-
dritic arbor growth rate and that this effect requires
glutamatergic synaptic transmission.
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Competition-based
Dynamics of Retinotectal
Axon Morphology
in Xenopus Optic
E. Ruthazer, H.T. Cline
Axon terminal arbors in the developing brain are high-
ly dynamic structures, capable of rapid morphological
rearrangements. E. Ruthazer examined whether
dynamics are related to competition-based mecha-
nisms between arbors. He surgically ablated one tectal
lobe, which causes the retinal axons that normally
innervate that tectum to project to the remaining tectal
lobe. The inputs to the dually innervated tectal lobe
segregate into eye-specific zones of left-eye and right-
eye afferents. Repeated time-lapse imaging of single
retinal axons was performed on a two-photon micro-
scope, and the dynamics of individual branches was
related to their location within territory from the same
or competing eye. Branches tended to be more stable
if they were in territory dominated by the competing
eye and more dynamic if they were in territory domi-
nated by the same eye. The differences in dynamics
were blocked by N-methyl-o-aspartate (NMDA)
receptor antagonists. The data are consistent with the
idea that dynamic branches occur in locations where
arbors are actively growing.
Regulation of Dendritic Morphology
by RhoA GTPases
Z. Li, H.T. Cline [in collaboration with L. Van Aelst,
Cold Spring Harbor Laboratory]
Members of the Rho family of small GTPases, Rac,
Cdc42, and RhoA, mediate morphological changes in
neurons by regulating the cytoskeleton. Z. Li investi-
gated the function of the GTPases Rac, Cdc42, and
RhoA in regulating dendritic arbor development in
vivo. She used time-lapse in vivo imaging combined
with viral gene transfer to express either constitutive-
ly active or dominant negative forms of the GTPases
in optic tectal neurons. Li found that decreasing RhoA
activity promoted dendritic branch extension.
Furthermore, NMDA receptor-mediated dendritic
arbor elaboration appears to be mediated through
RhoA. Rac and Cdc42 activities enhance the additions
of small branches to the dendritic arbor. These data
indicate that Rac activity promotes local branch addi-
tions to the dendrites. The new branches are main-
tained (or not) also as a result of Rac activity. Local
decreases in RhoA activity, possibly triggered by
synaptic NMDA receptor activity, promote the exten-
sion sequence of
events indicates that the different GTPases have dis-
tinct roles in controlling dendritic arbor elaboration.
CANDIDATE PLASTICITY GENES
Candidate Plasticity Genes
I. Cantallops, M. Davenne, L. Foa, K. Haas, K. Jensen,
H.T. Cline, K. Bronson [in collaboration with P. Worley,
Johns Hopkins University, and E. Nedivi, Massachusetts
Institute of Technology]
Our experiments have demonstrated the important role
of synaptic activity in promoting the development of
the brain. One potential effect of synaptic activity is to
induce gene transcription. The activity-induced genes
may then promote the further development of the
brain. We have continued our investigations of several
activity-induced genes to test their potential function
in brain development.
The activity-regulated candidate plasticity gene 15
(cpg15) encodes a glycosylphosphatidylinositol
(GPI) -linked protein. E. Nedivi, G.-Y. Wu, and H.T.
Cline previously demonstrated that CPG15 expression
in vivo increases the dendritic arbor growth rate of
Xenopus optic tectal cells. Expression of truncated
CPG15, lacking its GPI anchor, does not promote den-
dritic arbor elaboration.
CPG15 Gene and Protein
Expression
A. Javaherian, K. Bronson, H.T. Cline
A. Javaherian cloned cpg15 from Xenopus. This gene
is highly homologous to the cpg15 gene from rats,
cats, and humans. The cpg15 message is highly
expressed in retinal ganglion cells, but not in other
cells in the retina. In the brain, the cpg15 message is
widely expressed in differentiated neurons. CPG15
protein is targeted to the axons of retinal ganglion
cells and to axons of central nervous system neurons.
Postsynaptic Expression of
CPG15 Promotes Synaptic
Maturation In Vivo
K. Haas, H.T. Cline
K. Haas tested whether CPG15 expression affects
synaptic maturation. He made whole-cell voltage-
clamp recordings from optic tectal neurons in animals
infected with vaccinia virus expressing either P-galac-
tosidase, CPG15, or tCPG15. Haas demonstrated that
CPG15 expression promotes synaptic maturation by
increasing the a-amino-3-hydroxy-5-methy1-4-isoxa-
zole (AMPA)/NMDA ratio and by decreasing the frac-
tion of silent NMDA-R-only retinotectal synapses.
Furthermore, CPG15 increases the frequency of
AMPA-R-mediated miniature excitatory postsynaptic
currents (mEPSCs). These data indicate that CPG15
enhances the maturation of retinotectal synapses by
promoting the insertion of functional AMPA-R into
synapses previously mediated solely by NMDA-R.
Expression of tCPG15 appears to block the normal mat-
uration of retinotectal synapses by preventing the deliv-
ery of functional AMPA-R to synapses. This interpreta-
tion is consistent with the decreased AMPA/NMDA
ratios and increased fraction of pure NMDA-R synaps-
es in mature neurons, as well as the decreased mEPSC
frequency, seen with tCPG15 expression. These data
indicate that one function of CPG15 is to promote
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synapse maturation. CPG15 may also be required to
maintain synapses, since the increased fraction of
NMDA-R-only synapses seen with tCPG15 may be due
to loss of AMPA-R from synapses.
Postsynaptic Expression of
CPG15 Promotes
Presynaptic Retinal Axon
Elaboration In Vivo
I. Cantallops, H.T. Cline
To test the potential role of CPG15 in regulating
presynaptic axonal arbor structure, I. Cantallops
imaged single DiI-labeled retinal ganglion cell (RGC)
axons within the optic tectum of Xenopus laevis tad-
poles during a period of 2 days. Cantallops infected
their postsynaptic partners, the optic tectal cells, with
vaccinia virus expressing the reporter 13-galactosidase,
with virus expressing CPG15, or with virus express-
ing a truncated form of CPG15, lacking the GPI con-
sensus sequence.
Cantallops identified two phases of RGC axonal
growth in control axon: a fast-growing phase seen in
axons with simple morphologies and a slower grow-
ing phase seen in more complex axons. Analysis of
branch dynamics in simple and complex arbors
demonstrates that once axons become more complex,
branch dynamics change such that relative rates of
branch retractions increase. Postsynaptic expression
of CPG15 significantly increased the growth rate of
presynaptic retinal axons, in a GPI-linkage-depen-
dent manner. The growth-promoting effect of CPG15
was selective for complex axons, which normally
have relatively slow growth rates. Postsynaptic
expression of CPG15 enhances growth rates of com-
plex presynaptic axons by maintaining them in a fast-
growing and dynamic growth state, characteristic of
simple axons.
SYNTHESIS OF OUR DATA ON CPG15
Brain development is characterized by a period of
axonal and dendritic arbor elaboration and synapto-
genesis. During this period, the elaboration of neu-
ronal morphology and the formation of synaptic con-
nections are intimately entwined. These observations
suggest the existence of mechanisms that might
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coordinate several aspects of circuit formation. One
potential scenario for the coordinated development
of pre- and postsynaptic neuronal structures and
synaptic connections within a circuit is as follows:
Newly extended branches on axons and dendrites
form synapses with only NMDA-R. As these synaps-
es mature, AMPA-R is recruited to the synaptic sites.
Mature AMPA-R-containing synapses stabilize the
branches on which the synapses are located.
Stabilized branches can then support the addition of
new branches. These branches in turn establish new
NMDA-R-only synapses, which are either stabilized
through the addition of AMPA-R or retracted. As
both tectal cell dendrites and RGC axons become
more complex, the lifetime and stability of the arbor
branches are determined by the strength of the
synapses they make: Branches that have established
mature synaptic contacts remain, whereas those that
fail to add AMPA-R retract. In this way, during the
growth phase of the circuit, the overall number of
synaptic contacts is increased, as is the complexity of
both axons and dendrites.
We propose that CPG15 expression in tectal neu-
rons increases the elaboration of tectal cell dendrites
and retinal axons through the same sequence of
events including branch initiation, synapse forma-
tion, synapse maturation, and branch stabilization.
The increased retinal axon arbor growth rate is
accomplished by a significant and selective decrease
in axon branch retractions. Therefore, a major mech-
anism of regulating arbor elaboration is through the
stabilization of newly added branches. Correlated
with the stabilization of axonal branches is an
increase in the strength of retinotectal synaptic trans-
mission following CPG15 expression. This suggests
that the strengthening of synaptic contacts between
axonal and dendritic branches stabilizes the axon
arbor branches. Therefore, the increased dendritic
and axonal growth rates occur hand in hand with the
increased number of mature synapses.
Analysis of Axon
Pathfinding In Vivo
L. Foa, K. Jensen, K. Bronson, H.T. Cline [in collaboration
with P. Worley, Johns Hopkins]
The establishment of connections within the brain
requires that the axonal growth cones navigate to the
target region, recognize the target, and elaborate an
axon arbor. Axon guidance is dependent on the detec-
tion of environmental cues, the interpretation of the
cues as attractive or repulsive, and the transduction of
this signal to machinery governing growth cone motili-
ty. The Homer family of proteins has been postulated to
act as cytosolic scaffold proteins, possibly linking cell
surface transmembrane receptors and intracellular cal-
cium stores. New experiments by L. Foa together with
earlier experiments by I. Rajan provide evidence that
Homer proteins perform a previously unrecognized
function in axon pathfinding and target recognition in
optic tectal neurons. We suggest that Homer forms part
of a protein scaffold complex in axonal growth cones
which links guidance receptors to machinery governing
growth cone behaviors. K. Jensen is testing whether
Homer proteins function in retinal axon guidance.
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SIGNAL TRANSDUCTION AND DIFFERENTIATION
G. Enikolopov J. Hemish
S. John
P. Krasnov
B. Kuzin
T. Michurina
J. Mignone
B. Mish
M. Packer
N. Peunova
I. Pugach
V. Scheinker
Y. Stasiv
A. Vaahtokari
K. Vogeli
N. Nakaya
The long-standing interests of our lab are the signals
that guide the cells in the developing and adult organ-
ism along pathways of differentiation and how these
signals are linked to cell activity. Our efforts have
been focused mostly on nitric oxide (NO), a versatile
signaling molecule. During the last several years, we
have found strong evidence that NO is important for
tissue differentiation in a variety of models of animal
development, acting as an essential negative regulator
of cell proliferation in the developing tissue. We are
now focusing on the genetic and molecular interac-
tions of NO with the major signaling pathways in the
differentiating cell, especially those that control cell
proliferation. Our studies of NO have led us closer to
the questions about the biology of stem and progeni-
tor cells, which has now become an important new
area of interest for our laboratory. We have generated
several mouse models in which selected classes of
neural stem cells are marked, and we are using these
mice to investigate the origins and plasticity of neur-
al stem cells.
NO and Gene Expression
J. Hemish, B. Mish, N. Nakaya
Many studies of NO signaling have focused on the
immediate targets of NO in the cell. However, less is
known about the molecular mechanisms involved in
long-term effects of NO, such as cessation of cell pro-
liferation, apoptosis, or acquisition of differentiated
phenotype, which are presumably due to the ability of
NO to affect gene expression. We have used immobi-
lized cDNA arrays to identify NO-induced changes in
gene expression and to discern the signaling cascades
that mediate the long-term effects of NO. Several gene
targets were discovered and NO-induced changes in
their expression were validated by Northern or reverse
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transcriptase-polymerase chain reaction (RT-PCR)
analysis. We have found that a subset of these genes is
dependent on p53 for activation by NO, as revealed by
using cells from knockout mice deficient in p53,
whereas other subsets depend on guanylate cyclase,
protein kinase C, and PI3-kinase activity, as revealed
by using selective inhibitors of these enzymes. More
recently, we have extended our studies by using print-
ed microarrays composed of 7000 known genes and
expressed sequence tags (ESTs). Results from these
experiments have confirmed previously known gene
targets of NO, supporting the feasibility of this
approach. Furthermore, we have also identified addi-
tional new genes whose expression levels are affected
by NO. We are currently validating and further char-
acterizing these new candidates. By identifying an
extended set of genes whose expression is affected by
NO, we seek to determine the direct and indirect tar-
gets of NO-related signaling cascades.
NO and Drosophila
Development
Y. Stasiv, B. Kuzin [in collaboration with M. Regulski and
T. Tully, Cold Spring Harbor Laboratory]
NO is directly involved in organ development, synapto-
genesis, and response to hypoxia in Drosophila. Flies
have only one NOS gene, dNOS, which is an ortholog of
the mammalian neuronal NOS. We found that to a large
degree, dNOS expression in Drosophila is regulated on
the posttranscriptional level through the use of alterna-
tive splicing. We identified four new alternatively
spliced transcripts of the dNOS gene. Structurally, all
splicing events in the dNOS locus can be described as
single and multiple exon insertions or deletions and as
alternative usage of the splicing sites. Alternative splic-
ing affects both the 5"-end untranslated regions and the
coding region of the gene. All splicing events in the cod-
ing region of the gene lead to a premature termination
of the open reading frame and production of truncated
proteins that lack various carboxy-terminal regions of
dNOSJ (the full-length product). As a result, none of
alternative transcripts code for the enzymatically active
protein. However, these truncated proteins very effec-
tively inhibit enzymatic activity of the full-length
dNOS1, when coexpressed in cultured cells, thus acting
as dominant negative regulators of NO production. One
of the alternative transcripts, dNOS4, is widely
expressed during fly development. We have shown that
overproduction of dNOS4 in developing Drosophila eye
under the control of the GMR promoter suppresses the
antiproliferative action of dNOS1, causing a severe
hyperproliferative eye phenotype in adult flies. To fur-
ther investigate the biological role of dNOS4, we gener-
ated heat shock promoter-driven dNOS4 and upstream
activation sequence (UAS) (Ga14 target)-driven dNOS4
transgenic flies and are now studying the consequences
of tissue- and organ-specific expression of the dNOS4
dominant negative regulator on Drosophila develop-
ment.
Xenopus laevis
NOS Gene
V Schenker, Y. Stasiv, N. Peunova
We have cloned NOS cDNA from Xenopus laevis
(XNOS) and showed that it is an ortholog of the mam-
malian neuronal isoform of NOS. We found five dif-
ferent transcripts that originate from the XNOSI gene.
They are generated due to five unique variants of
XNOS exon 1 (exons IA to 1E) which are expressed
in a tissue- and developmental-stage-specific manner.
To confirm the presence of these alternative exons and
of multiple regions of transcription initiation, we
cloned and mapped the XNOS gene from the Xenopus
genome. Our data demonstrate a high complexity of
the XNOS gene structure. The five variants of exon 1
span a region of the genome of at least 100 kb. We
used in situ hybridization with each of the variant
exon 1 probes and found that their expression is high-
ly tissue- and developmental-stage-specific. The
appearance of some of the transcripts, for instance,
marks the zygotic induction of the genome, and the
appearance of others marks neurulation, organogene-
sis, etc. Our findings suggest that the biological activ-
ity of NO is tightly and specifically regulated during
Xenopus development by a complex pattern of alter-
native transcription initiation and splicing.
NO and Early Xenopus
Development
N. Peunova, V. Scheinker, K. Vogeli
In situ hybridization with XNOS probes reveals a com-
plex pattern of alternative promoter activation during
early Xenopus development. Remarkably, we found
that only one of the alternative sites of transcription
initiation is used in unfertilized oocytes, producing
maternal XNOS RNA. Further examination of this
maternal transcript demonstrated that it is localized
exclusively at the animal pole of the oocyte in a high-
ly asymmetric pattern. This is the first indication that
NOS transcripts are present as maternal RNA during
organism development. We have generated dominant
negative inhibitory XNOS variants, and we are cur-
rently using these recombinant inhibitors in parallel
with chemical inhibitors of NOS to investigate
whether maternal XNOS may be important for setting
the dorsoventral axis of the embryo.
Various alternative transcripts of XNOS appear at
key steps of early Xenopus embryo development and
during organogenesis. We have used the tools men-
tioned above to alter NOS activity in order to investi-
gate the potential role of NO in setting of the germ lay-
ers of the embryo and control of cell proliferation dur-
ing gastrulation. Together, our data suggest that NO
may be used at a number of critical steps in Xenopus
development, extending back from our previous
demonstration that NO has an essential antiprolifera-
tive role during Xenopus brain development.
NO and Mouse Hematopoiesis
T. Michurina, P. Krasnov
We are studying the role of NO in the regulation of
hematopoietic maturation in vivo. We have found that
NO has a critical function during early stages of
hematopoiesis such that we can change the proportion
of stem and early progenitor cells in the bone marrow
by regulating production of NO. To understand the
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mechanisms of NO function in the bone marrow, we
searched for the expression of specific isoforms of NO
synthase in the bone marrow. Using RT-PCR, we were
able to demonstrate the presence of mRNA transcripts
for all three NOS isoforms-neuronal, endothelial,
and inducible-in mouse bone marrow cells and
human umbilical cord blood cells. We characterized
the expression of particular NOS isoforms in restrict-
ed cell populations in the bone marrow. We have iso-
lated subpopulations of bone marrow cells that are
greatly enriched in hematopoietic stem and early prog-
enitor cells. When lysates from such cell populations
were examined, Western blots revealed a dramatic
enrichment in specific NOS isoforms. Thus, NOS pro-
tein is synthesized in hematopoietic stem and progen-
itor cells, supporting our hypothesis that regulation of
NO production has an important role in the control of
hematopoietic cell proliferation.
Targeted Disruption of the
Active Center of the Mouse
Neuronal NO Synthase
Y. Stasiv [in collaboration with A. Grinberg
and H. Westphal, NICHD, National Institutes of Health]
To test the role of neuronal NO synthase (nNOS) in
development, we decided to inactivate the mouse
nNOS gene by homologous recombination. Previous
attempts to mutate the nNOS gene in the mouse
genome targeted exon 2 of the gene. The resulting
mutants, while providing an invaluable research
model, still produce variant nNOS isoforms with low
levels of enzyme activity. In our experiments, we have
chosen to target exon 6 which codes for the essential
heme-binding domain. In preliminary experiments
with cultured cells, we have proven that with the
removal of exon 6, the enzymatic activity of nNOS is
undetectable. To mutate the nNOS gene, we cloned
mouse genomic fragments surrounding the sixth exon
of the gene into the pPNT vector, introduced them into
129/SVJ embryonic stem (ES) cells, selected trans-
formed clones using G418 and ganciclovir, and identi-
fied properly targeted clones by PCR and Southern
blots. Two lines of germ-line-transmitting mice from
two independently derived ES cell clones were gener-
ated and used to obtain homozygous nNOS( / )
mutants. We are currently analyzing the phenotypes of
these nNOS knockouts, focusing on the patterns of cell
division during development.
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NO in Neuronal Differentiation
and Cell Death in the Brain
M. Packer [in collaboration with S. Goldman,
Cornell Medical School]
NO has been shown by our group to be an important
modulator of cell growth in various models. We are
looking at how this small free radical molecule con-
trols the proliferation, differentiation, and survival of
neural cells in adult animals. We have developed trans-
genic mice that overexpress the neuronal form of NO
synthase under the calcium/calmodulin protein kinase
type IIa (CaMKIIa) promoter. This promoter is
strongly activated beginning 2 weeks postnatally in the
brain regions close to and overlapping with the zones
of adult neurogenesis and remains active throughout
adult life. We are using these mice to look at the
effects of NO on the life of the new cells in these
regions. We are using surgical placement of mini-
osmotic pumps to infuse the brains of adult animals
with drugs that modulate the activity of NO synthase.
With these two systems combined with the use of bro-
modeoxyuridine (BrdU), a reagent used to label divid-
ing cells, serial sectioning, immunohistochemistry,
and various imaging techniques, we have shown that
NO exerts a cytostatic influence on the pool of prog-
enitor cells. Furthermore, under some treatments, we
have been able to dramatically increase the rates of
proliferation of cells in the brain areas that normally
have very little adult neurogenesis. Our results suggest
that it may be possible to use NO-related compounds
as therapies for treating neurodegenerative disorders
or trauma where benefits might be gained by repopu-
lation of neural cells.
Neural Stem and Progenitor
Cells in the Developing
and Adult Brain
J. Mignone
We have generated transgenic mice that express green
fluorescent protein (GFP) under the temporal and spa-
tial control of the nestin gene regulatory elements.
These mice allow the selective marking of neural stem
and progenitor cells by GFP expression. We are now in
a position to study the biological roles that these cells
perform in the brain throughout the life of the animal,
by being able to visualize and follow individual stem
cells while they are still alive. This work is further sup-
plemented by the use of transgenic lines that have been
generated in our lab and that use differential labeling
of various lineages of the brain cells. By using mice
with differentially labeled subgroups of cells, we will
be able to pursue the fate of a neural stem cell.
Currently, with Mike Packer in the lab, we are per-
forming transplantation of the nestin-GFP cells to the
brains of recipient animals to further understand the
plasticity of these cells as well as their ability to func-
tionally integrate into the recipient neural network.
Furthermore, in collaboration with Sang Yong Kim
here at the Laboratory, we have been transplanting the
nestin-GFP cells to mouse blastocysts to determine the
true potential of these cells. We want not only to
understand their ability to initiate various neuronal lin-
eages, but also to discern to what degree these cells are
multipotent and are able to contribute to other, non-
neuronal, lineages in the developing organism.
A Transgenic Mouse Model for
Studying Cell Cycle Progression
of Neural Stem and Progenitor Cells
A. Vaahtokari
To gain insight into the regulation of the cell cycle of
neural stem and progenitor cells, we generated trans-
genic mice that express a modified version of GFP in
neural stem cells in a cell-cycle-dependent manner.
When the expression pattern of modified GFP was
analyzed in embryonic and adult transgenic mice, sev-
eral striking features were discovered, including clus-
tering of dividing cells in the developing nervous sys-
tem. We are currently testing the hypothesis that the
distribution of GFP in these transgenic animals
reflects the synchronous cell cycle of clonally related
neural stem and progenitor cells. We have also devel-
oped an in vitro method for growing embryonic corti-
cal explants that is suitable for time-lapse imaging.
Thus, we can analyze dynamic changes in the expres-
sion of GFP in neuronal tissue. In addition, we are
using our tissue culture system to study the effects of
various factors on cell cycle progression of neuronal
stem and progenitor cells, e.g., epidermal growth fac-
tor and fibroblast growth factor.
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CONSTRUCTION AND EXPERIENCE-DEPENDENT REFINEMENT
OF NEOCORTICAL CIRCUITS
Z.J. Huang H. Higashiyama
J. Walls
B. Chattopadhyaya
We are interested in understanding the basic design
principles of the neocortical circuits and the role of
experience in shaping the function of these circuits.
Although the cellular architecture of the neocortex is
exceedingly complex, there are well-defined cell types
and stereotyped synaptic connectivity patterns that are
strikingly conserved between different cortical areas
and among different mammalian species. One of the
best examples of such conservation comes from the
GABAergic inhibitory circuits, which control cortical
excitability and information processing at precise spa-
tial and temporal domains. A fascinating yet puzzling
feature of the cortical GABAergic system is the rich
array of interneuron cell types. These cell types often
display remarkably distinct morphology, intrinsic
physiological properties, synaptic input and output
patterns, and gene expression profiles. In addition, the
functional maturation of the GABAergic system is
strongly influenced by experience deprivation during
early postnatal ages and, as a result, may contribute to
the experience-dependent refinement of neocortical
circuits. Our general hypotheses are that (1) distinct
GABAergic cell types have evolved to execute defined
types of inhibitory mechanisms which regulate specif-
ic aspects of the development and function of cortical
circuits and (2) there are molecular mechanisms that
determine the highly stereotyped synaptic innervation
patterns among different GABAergic cell types.
To test these hypotheses, it is necessary to manip-
ulate the physiological property and visualize the mor-
phology of defined types of GABAergic interneurons
in living tissue and in vivo. For decades, GABAergic
cell-type-specific manipulations have not been possi-
ble. We are now using the mouse genetic approach,
including bacterial artificial chromosome (BAC)
transgenics and knockins, to achieve such cell-type-
specific manipulations. Our strategy is based on the
observation that an increasing number of genes are
shown to be expressed in distinct classes of
GABAergic interneurons. BACs containing the tran-
scriptional promoters of these genes can therefore be
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engineered to express either a functional gene or a
green fluorescent protein (GFP)-based fluorescent
marker in these specific cell types. Combined with
physiological and imaging techniques, we are studying
the following set of questions in the mouse visual cor-
tex: How do different types of interneurons mature
morphologically and physiologically during the criti-
cal period of visual cortical development? What are
the effects of visual deprivation on the maturation of
GABAergic circuits? How do neurotrophic factors
regulate the experience-dependent maturation of
GABAergic interneurons? How do specific types of
GABAergic circuits contribute to critical period plas-
ticity?
Maturation of GABAergic Circuits
during the Critical Period
H. Higashiyama, J. Walls, Z.J. Huang [in collaboration
with K. Svoboda, Cold Spring Harbor Laboratory]
In the visual cortex, the fast-spiking (FS) basket-type
interneurons send off horizontal axons, selectively
innervate the soma of target neurons, are capable of
high-frequency nonadaptive firing, and express parv-
albumin. On the other hand, the low-threshold spiking
(LTS) bitufted cells send off vertical axons, selective-
ly innervate the distal dendrites of targets, fire broad-
er spikes that show pronounced adaptation of firing
frequency, and express somatostatin. How do
GABAergic interneurons develop such distinct mor-
phology, synaptic connectivity, and physiologic prop-
erties? To address these questions, we are using a
series of GABAergic transcriptional promoters to sys-
tematically label specific GABAergic cell types with
GFP variants using BAC transgenic mice. These pro-
moters include GABA synthetic enzymes (GAD67),
calcium-binding proteins, and neuropeptides. For
example, we have constructed BACs expressing yel-
low fluorescent protein (YFP) under the control of the
somatostatin promoter, and GAD67 promoter. We have
also constructed BACs expressing GFP under the con-
trol of the parvalbumin promoter and have produced
transgenic founders (Pv-GFP). These transgenic mice
will allow us (1) to characterize the intra- or interlam-
inar patterns of axon growth in basket and bitufted
interneurons, (2) to characterize the development of
somatic versus distal dendritic patterns of synaptic
innervation in basket and bitufted interneurons, (3) to
examine the maturation of distinct firing properties of
these interneuron cell types, and (4) to examine the
effects of visual deprivation (e.g., dark rearing) on the
maturation of these interneuron cell types.
Role of GABAergic Inhibition in
Critical Period Plasticity in the
Visual Cortex
B. Chattopadhyaya, Z.J. Huang [in collaboration
with L. Maffei, Institute of Neurophysiology, Italy)
GABAergic inhibitory circuits have been implicated
in the regulation of experience-dependent develop-
ment of the visual cortex. For example, ocular domi-
nance (OD) plasticity-the capacity of visual cortical
neurons to modify their eye preferences following
visual deprivation to either eye-was abolished in
mice deficient in an isoform of the GABA synthetic
enzyme (GAD65). However, the specific types of
GABAergic circuits and inhibitory mechanisms
involved in the regulation of OD plasticity remain
unknown. Because GAD65-1- mice do not show criti-
cal period plasticity yet are normal in other aspects of
visual physiology and function, this mutant strain pro-
vides an ideal genetic background to systematically
study the role of specific classes of interneurons in
OD plasticity using a transgenic "rescue" approach.
We have constructed BACs expressing GAD65 under
the control of the parvalbumin promoter and have
produced transgenic founders. The same strategy is
being applied to the somatostatin promoter. We will
introduce BAC transgenes expressing GAD65 in
either the basket or bitufted interneuons into the
GAD65-/- mice by breeding. We will then test whether
expression of GAD65 in a specific class of interneu-
rons can restore critical period plasticity in GAD65-' -
mice. In addition, this strategy will allow us to corre-
late the specific types of inhibitory mechanisms that
are restored by cell-type-restricted expression of
GAD65 with the rescue of critical period plasticity.
Role of BDNF in the
Experience-dependent
Maturation of GABAergic Circuits
B. Chattopadhyaya, Z.J. Huang
The brain-derived neurotrophic factor (BDNF) has
been an attractive candidate for mediating activity-
dependent plasticity. The production of BDNF in the
visual cortex is stimulated by neuronal activity and by
visual experience. BDNF in turn has potent effects on
neurite growth and synaptic strength. We have shown
previously that BDNF regulates the critical period of
OD plasticity in part by promoting the maturation of
GABAergic inhibitory circuits. However, the specific
GABAergic cell types that respond to BDNF and the
cellular mechanisms of BDNF regulation remain
unclear. BAC transgenic mice expressing GFP in spe-
cific GABA cell types will allow us to address these
questions. For example, we hypothesize that BDNF
regulates the synaptic innervation of basket interneu-
rons to pyramidal neurons during the critical period. To
test this, we will prepare visual cortical slices at differ-
ent ages from Pv-GFP transgenic mice. We will then
cotransfect cortical pyramidal neurons with constructs
expressing BDNF and RFP (red fluorescent protein) or
RFP alone. The low frequency of biolistic transfection
allows single RFP-transfected pyramidal neurons to be
visualized in the background of GFP-labeled
GABAergic neurons. This will allow us to answer the
following questions: Is the effect of BDNF on promot-
ing GABAergic innervation "cell autonomous," or
does it also spread to nearby non-BDNF overexpress-
ing neurons? Is the effect of BDNF on promoting
GABAergic innervation restricted to the soma region
of transfected neurons or does it also occur in apical
and basal dendrites? What is the time course of BDNF-
stimulated GABAergic innervation? This preparation
will also allow pharmacological treatment to study the
role of neuronal activity and signaling pathways in
BDNF-stimulated GABAergic innervation.
Cre /IoxP Recombination-activated
Neuronal Markers in Mouse Brain
Z.J. Huang
We are developing a Cre/loxP recombination-activated
GFP marker system in the mouse brain. This binary
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system consists of a reporter strain and a deleter strain.
In reporter mice, the expression of a reporter gene is
driven by a strong and ubiquitous promoter but is pre-
vented from expression by the presence of a transcrip-
tion STOP cassette. In deleter mice, the Cre recombi-
nase is driven by a cell-type-specific promoter. In a
double transgenic strain, the expression of the GFP-
based reporter gene is activated by the removal of tran-
scription STOP cassette upon Cre/loxP recombination.
The advantages of such a system include its combina-
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torial power and compatibility with a Cre/loxP-mediat-
ed gene knockout. We have previously demonstrated
the feasibility of this system using the dendrite-target-
ed GFP reporter strain. We have now produced a
reporter strain in which a fusion gene expressing a
membrane-targeted GFP (which is expected to label
the entire neuron) is "knocked-in" to the strong and
ubiquitous Rosa26 locus. We are now breeding this
strain with several lines of Cre transgenic mice to
access the quality of cell labeling in this reporter strain.
J. Walls
NEURAL ORGANIZATION OF OLFACTORY PERCEPTION
AND BEHAVIOR
Z. Mainen S. Macknik V. Egger
R. Gasperini N. Caporale
N. Uchida
Our laboratory is working toward understanding the
general principles of neural organization that allow
organisms to perceive, remember, anticipate, and act
on complex sensory information. The goal is an inte-
grative understanding that relates information pro-
cessing at the microscopic level (individual synapses
and neurons) to its macroscopic function. Our
research is currently centered on the olfactory system.
The principles of chemical sensation are still poorly
understood, but the olfactory system offers numerous
experimental advantages including known receptor
genes linked directly to the initial encoding of stimuli,
accessibility by optical imaging techniques, a simpler
neuronal architecture compared to the neocortex, and
a very direct connection between sensory periphery
and central processing.
Neural Correlates of
Olfactory Perception
S. Macknik, N. Uchida, Z. Mainen
Why do flowers smell more similar to one another
than to trees? What is the neural basis for the per-
ceived qualities, similarities, and differences between
odors? To address these questions, we are combining
optical imaging techniques to probe neural representa-
tions with human and rat psychophysical techniques to
quantify perceptual characteristics of odors. Because
each glomerulus in the olfactory bulb is targeted by
neurons expressing a single olfactory receptor type, it
is thought that the olfactory glomeruli form a map of
chemical structure. Any odor, either a single molecule
or a mixture of many different molecules, activates a
specific subset of odor receptors and hence a particu-
lar pattern in the olfactory bulb. Because the location
of particular receptors within the glomerular map is
preserved from individual to individual, the receptor
map could provide the basis for the invariant percep-
tual qualities of odors. Our main hypothesis is that
perceptual qualities of odors are direct correlates of
the spatial patterns of activity produced across the
glomerular input layer to the olfactory bulb (Fig. 1).
Alternative hypotheses include the possibility that
such perceptual maps are only formed later in the
olfactory pathway, such as in the olfactory cortex, and
the possibility that perceptual qualities are not direct-
ly related to any kind of spatial map, but instead rely
on nonspatial factors such as synchronization of neur-
FIGURE 1 Do glomerular representations in
the olfactory bulb code for the qualities of odor
sensations? This figure plots the similarity of
glomerular responses to several natural odor-
ants (measured in the anesthetized rat with
intrinsic signal imaging). It can be seen that
odorants with similar sensations (e.g., citrus
fruits) produced more similar glomerular pat-
terns.
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al activity. We are testing the main hypothesis by com-
paring the perceptual discriminability of pairs of
odors, measured by errors made by rats in a behavioral
task, with the similarity of their glomerular activity
patterns, measured by intrinsic imaging of odor-
evoked responses in anesthetized rats.
Neural Representation of
Individual Identity
N. Caporale, Z. Mainen
Do "grandmother" neurons exist? Primate social
behavior relies heavily on visual (and auditory) com-
munication. Recent work in monkeys and humans has
revealed neural systems that appear to be devoted
specifically to processing socially significant stimuli
such as eyes and faces. The origins of social behavior
lie in chemical communication. In the rodent, both the
main olfactory and the vomeronasal system are
known from behavioral studies to be major channels
of social information, but very little is known about
the neural mechanisms underlying social olfactory
function. Using a combination of behavior, intrinsic
imaging, and neurophysiology, we are studying the
neural basis of one important building block of social
organization, the recognition of individual identity.
Psychophysics of Human and
Rat Olfactory Quality
S. Macknik, Z. Mainen
How different are two odors from each other?
Standard psychophysical measurements involve find-
ing the perceptual difference between two intensities
of the same stimulus. The way one does this is by
adding (or taking away) more and more stimulus until
the subject notices that the stimulus has changed in
perceptual intensity. This unit, in which the subject
notices the smallest possible difference between
intensities, has been named the just-noticeable-differ-
ence (JND). We are extending the concept of the JND
to mixtures of equally intense but qualitatively dis-
similar odors. We systematically vary the mixture of
two odorants from a single pure odorant through a
series of stepwise mixtures of the two odorants, until
we arrive at the other pure odorant. The task of the
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subject is to notice when the mixture has changed. By
counting the number of JNDs there are between two
pure odors, we can obtain a quantitative measure of
the qualitative difference between those odors. These
experiments are being carried out first in humans and
will subsequently be transferred to a similarly
designed rodent behavioral paradigm. Finally, we will
optically image the olfactory bulb of rats while pre-
senting the same stimuli in order to measure the phys-
iological change associated with a minimal qualitative
perceptual change.
Coupling of Blood Flow
to Neural Activity
N. Uchida, Z. Mainen
Several important modern imaging techniques, such
as fMRI and intrinsic optical imaging, make use of
correlations between neural activity and blood flow. It
is apparent that blood flow parameters such as the rel-
ative concentration of oxyhemoglobin and deoxyhe-
moglobin are modulated by the level of local neural
activity, but the details of the relationship are still
mostly unknown. Our aim is to describe a quantitative
relationship between neural activity parameters such
as presynaptic release rate or postsynaptic firing and
these blood flow signals. To do so, we are using a com-
bination of intrinsic optical imaging and pharmacolo-
gy in the olfactory bulb (Fig. 2). Because of the unique
anatomy of this preparation, it is possible to pharma-
cologically manipulate the olfactory glomerular sig-
nals without fear of interfering with upstream circuit-
ry (as is a major concern in the neocortex). The results
of these studies will have implications not only for the
interpretation of optical signals in the olfactory bulb,
but more generally for our understanding of the rela-
tion of blood flow imaging to the underlying neural
activity.
Two-photon Imaging of Calcium
Dynamics of a Rat Olfactory
Bulb Synapse
V Egger, Z. Mainen
The goal of this project is a better understanding of
early olfactory processing, in which the large dendro-
ACSF
TTX
Caproic acid
FIGURE 2 Pharmacology of intrinsic signal images from olfac-
tory bulb. Control solution (ACSF) and subsequently solution
containing tetrodotoxin (TTX, 20 1.1m) were pressure-injected at
a site in the anterior OB (cross). TTX injection produced local
blockade of blood flow responses.
dendritic reciprocal synapse between mitral cells and
granule cells is a main player. The approach is based
on simultaneous application of two-photon imaging of
calcium dynamics and conventional electrophysiology
of synaptic transmission in vitro. Given a long-term
goal of understanding the nature of neuronal process-
ing of olfactory information in the bulb, two lines of
research are ongoing: First, we aim to measure the
influence of the emotion- and arousal-related neuro-
modulator norepinephrine on calcium transients and
on long-term plasticity in the mitral cell-granule cell
synapse. There are strong neuromodulatory projec-
tions into the olfactory bulb, and neuromodulatory
action on this synapse has been implicated in olfacto-
ry learning and memory.
Second, we aim to investigate transmission at the
mitral cell-granule cell reciprocal synapse in the con-
text of a more intact circuit, including the influence of
distributed glomerular activation and centrifugal
inputs from the olfactory cortex. To do so, we are
developing an "integrative" slice preparation contain-
ing extrabulbar elements including olfactory cortex or
the olfactory epithelium. Together, these two lines of
research will help to elucidate the function of an
important synapse in olfactory function.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN
CENTRAL SYNAPSES
R. Malinow A. Barria
N. Dawkins
I. Ehrlich
J. Esteban
Y. Hayashi
F. Kamenetz
A. Piccini
K. Seidenman
S. Shi
T. Takahashi
J. Zhu
J. D'amore
P. Waseling
This laboratory addresses issues directed toward an
understanding of learning and memory by studying the
physiology of synapses. We study synaptic transmis-
sion and plasticity in rodent brain slices. This prepara-
tion is sufficiently complex to show glimpses of emer-
gent properties as well as simple enough to allow hard-
nosed biophysical scrutiny. To monitor and perturb the
function of synapses, we use a combination of electro-
physiology, microscopic imaging, and molecular trans-
fection techniques. This allows us to examine a cellular
and molecular basis for changes in electrophysiologi-
cal function. It is our philosophy that synapses have
key properties whose understanding will provide
insight into phenomena at higher levels ofcomplexity.
The main result of this year was to begin to deci-
pher the mechanisms by which glutamate receptors are
delivered to synapses during plasticity. We find that
during long-term potentiation (LTP), the GluR1 sub-
unit of ct- amino -3- hydroxy -5- methyl -4- isoxazole
receptors (AMPA-Rs) has a critical role: It must inter-
act with PDZ domain proteins for LTP to occur. A
similar process occurs during synaptic potentiation
early in postnatal development. This involves the
synaptic delivery of GluR4-containing AMPA-Rs;this
is driven by "spontaneous" neural activity. Once these
G1uR4-containing AMPA-Rs are delivered, they can
be replaced by a different class of AMPA-Rs, those
containing GluR2. This subunit-specific delivery and
replacement can account for long-term changes in
synaptic transmission.
DELIVERY OF GLUTAMATE RECEPTORS
TO SYNAPSES DURING LTP
To elucidate mechanisms controlling and executing
activity-dependent synaptic plasticity, AMPA-Rs with
an electrophysiological tag were expressed in hip-
pocampal neurons. LTP or increased activity of the
calcium/calmodulin-dependent protein kinase II
(CaMKII) induced delivery of tagged AMPA-Rs into
synapses. This effect was not diminished by mutating
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the CaMKII phosphorylation site on the GluR1
AMPA-R subunit, but was blocked by mutating a pre-
dicted PDZ domain interaction site. These results
show that LTP and CaMKII activity drive AMPA-Rs to
synapses by a mechanism that requires the association
between G1uR1 and a PDZ domain protein. We are
currently trying to identify which PDZ domain pro-
teins interact with GluR1 to bring about LTP.
SPONTANEOUS ACTIVITY DELIVERS
GLUR4-CONTAINING AMPA-Rs INTO
SILENT SYNAPSES DURING EARLY
DEVELOPMENT
Spontaneous activity early in postnatal development is
crucial for the formation of functional neuronal cir-
cuits. During this early period, many glutamatergic
synapses contain only N-methyl-D aspartate receptors
(NMDA-Rs) and are largely "silent," becoming func-
tional by acquiring AMPA-Rs. In this series of studies,
we show that spontaneous oscillatory activity in the
hippocampus makes silent synapses functional by
selectively delivering G1uR4-containing AMPA-Rs.
This differs from LTP seen in older animals, which
delivers GluR1 -containing AMPA-Rs and requires
CaMKII activity. Consistent with this special role,
GluR4 expression in the hippocampus is largely
restricted to the first postnatal week. Once delivered
by activity, synaptic G1uR4-AMPA-Rs are exchanged
with GluR2-containing AMPA-Rs in a manner that
requires little neuronal activity and maintains the
enhanced strength of the synapse despite protein
turnover. This "delivery and exchange" represents a
new form of activity-dependent long-term synaptic
plasticity that may be responsible for the initial estab-
lishment of functional neuronal circuitry.
SYNAPTIC DELIVERY OF NMDA RECEPTORS
NMDA-Rs have a critical role in plasticity, distinct from
AMPA-Rs. NMDA-Rs likely have a different set of
rules governing their trafficking. Thus, we have devel-
oped optical and electrophysiological tools to monitor
and perturb the delivery of NMDA-Rs to synapses.
We use gene-gun technology to deliver engineered
NMDA subunit genes into neurons. Optically, we can
monitor the appearance of green fluorescent protein
(GFP)-tagged NMDA-R subunits at spines. As an
electrophysiological monitor of receptor delivery, we
have developed an "electrophysiologically tagged"
NMDA-R. We engineer the NR1 pore so that it is
insensitive to Mg', and this renders the receptor volt-
age insensitive; thus, when this receptor reaches
synapses, an NMDA-R-mediated response can be
seen at -60 mV. We are using these tools to determine
the mechanisms underlying the delivery of NMDA-Rs
to synapses.
QUANTITATIVE OPTICAL MEASUREMENTS
OF RECEPTOR DELIVERY TO SPINES
We have developed quantitative techniques to measure
the relative amounts of recombinant GFP-tagged pro-
teins within small neural structures. To achieve this, we
first deliver recombinant genes of interest encoding
GFP-tagged proteins into neurons using gene-gun or
viral transfection. After expression is allowed to take
place, the protein
are identified, and a vital dye, Texas Red, is delivered
intracellularly using a whole-cell patch pipette. After
the dye is allowed to equilibrate within the cell (-30
minutes), we obtain two-photon scanning laser micro-
scopic three-dimensional images, capturing emitted
photons in the green (GFP) as well as the red (Texas
Red) channels. We can use the red channel to demar-
cate the volume anatomy of small structures, whereas
with the green channel, we can determine how much of
the GFP-tagged protein is in this structure. With this
technique, we have shown that AMPA-Rs traffic dif-
ferently, depending on their composition. GluRl-con-
taining AMPA-Rs are delivered throughout dendritic
arbors, but they are restricted from entering dendritic
spines, sites of synaptic contacts. In contrast, GluR2-
containing AMPA-Rs traffic to dendrites and dendritic
spines. We are using this technique to characterize
where proteins go and do not go, and how much vari-
ability there is within a single neuron.
13-AMYLOID AS A HOMEOSTATIC NEGATIVE
REGULATOR OF SYNAPTIC TRANSMISSION
We are testing the hypothesis that (3- amyloid acts as a
homeostatic negative regulator of synaptic transmis-
sion. That is, we propose that (increased neural activi-
ty)->(increased (3- amyloid formation) -*(decreased
synaptic transmission)->(decreased neural activity).
In support of this, we find that organotypic slices
secrete less f3- amyloid if transmission is depressed and
they secrete more (3- amyloid if transmission is
enhanced. Furthermore, we find that acute overex-
pression of amyloid precursor protein (APP) in neu-
rons leads to increased secretion of (3- amyloid and
depression of synaptic transmission onto those neu-
rons. The physiological effect (depression of synaptic
transmission) requires formation of 3- amyloid from
APP because (1) mutations in APP that prevent 13-
amyloid formation block this effect and (2) drugs that
block (3- amyloid from APP (y- secretase inhibitors)
also block this effect. Furthermore, if neural activity is
pharmacologically depressed onto these APP-express-
ing neurons, then normal transmission is preserved. If
this hypothesis is correct, it will have a significant
impact on the proposed therapeutic use of agents that
reduce (3- amyloid secretion for Alzheimer's disease.
In conclusion, we are continuing to elucidate the
basic mechanisms involved in central synaptic trans-
mission and plasticity.
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PLASTICITY OF CORTICAL NEURONS AND THEIR CIRCUITS
K. Svoboda B. Burbach
B. Chen
K. Greenwood
M. Maravall
E. Nimchinski
P. O'Brien
T. Oertner
T. Pologruto
B. Sabatini
E. Stern
R. Yasuda
C. Zhang
K. Zito
The neocortex underlies most cognitive functions in
mammals. Even though these functions are extremely
diverse, the underlying anatomy is relatively uniform
across functional areas and is arranged in a modular
fashion into columns. However, cortical tissue is
dauntingly complex: 1 mm3 of tissue contains nearly 1
million neurons, each of which connects to thousands
of other neurons. How does electrical and biochemical
dynamics in this awesome network produce our per-
ception of the world? How does this network change
in response to experience? Answers to these questions
will profoundly change our understanding of the func-
tion and diseases of the brain.
To begin to unravel neocortical function, we are
studying how the basic units of the network, neurons
and their synapses, work within the intact network. For
this purpose, we build and use sensitive optical tools:
Two-photon laser-scanning microscopy (TPLSM)
allows us to detect the excitation of single synapses in
brain slices and in the intact brain by measuring intra-
cellular calcium accumulation associated with activa-
tion of synaptic receptors. Intrinsic signal imaging
allows us to keep track of the dynamics of networks of
neurons in vivo. We combine these optical methods with
electrophysiological measurements of synaptic currents
and potentials and molecular manipulations of neurons.
We use both in vivo measurements to address sys-
tem level questions and in vitro methods to get at
detailed mechanisms. For our in vivo measurements,
we use the rodent barrel cortex. Similar to other sen-
sory areas in the mammalian cortex, the barrel cortex
is arranged in maps. Each whisker is represented by a
small cortical region (barrel). Whisker maps are
shaped by experience during development and
reshaped in the adult. Plasticity in these maps can be
induced by trimming specific whiskers for hours to
days. The cellular mechanisms underlying sensory
map plasticity are likely to share mechanisms with
those underlying learning and memory. Because of the
precision of the barrel map, it is possible to predict
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where in the brain experience-dependent changes are
likely to occur, simplifying the search for the cellular,
synaptic, and molecular basis for plasticity. For our in
vitro measurements, we use brain slices from barrel
cortex or hippocampus.
Ca** in Single Dendritic Spines
B. Sabatini, R. Yasuda
Long-term changes in synaptic efficacy occur when a
postsynaptic neuron consistently fires an action poten-
tial within approximately 10 msec after the arrival of a
particular synaptic input. These changes are triggered
by increases in [Cal in the postsynaptic neuron. We
have used whole-cell patch-clamp recordings and
TPLSM to measure [Cal signals that are evoked in
spines and small dendrites of CAI pyramidal neurons
by back-propagating action potentials and synaptic
stimuli. By contrasting the properties of action-poten-
tial-evoked [Ca *-] transients in the main apical dendrite
with those of distal dendrites and spines, we were able
to define functionally distinct neuronal compartments
for Ca-- signaling. We now know everything we ever
wanted to know about [Cal handling in individual
spines: After Ca'. ions enter the cell, 95% are bound to
intracellular buffers, whereas 5% remain free. The life-
time of Ca" in the cytoplasm is remarkably brief,
about 10 msec; 50% of the ions are sequestered into the
SER, and the other 50% are pumped out of the cell.
Diffusion from spine into dendrite has a negligible role
in Ca" clearance from spines. Therefore, spine heads
operate as isolated compartments and subserve
extremely rapid Ca-" signaling. Steep gradients in
[Cal can be maintained between spine head and den-
drite on a micrometer length scale.
We also developed a new type of optical fluctua-
tions analysis to estimate the number, location, and
properties of voltage-sensitive calcium channels and
FIGURE 1 Two-photon imaging of calcium dynamics in small neuronal compartments. (A) Neuron labeled with a calcium-
sensitive fluorophore (Bar, 20 gm). (8) Blow-up of boxed region in A, showing dendritic spines (Bar, 1 gm). (C) Line-scan
image along dashed line in 8, showing temporal dynamics of calcium in response to an action potential (arrow) (Bars: hor-
izontal, 1 gm; vertical, 20 msec). (D) Histogram of responses to single action potentials (solid line). The histogram shows
failures of responses (gray shaded region), a large peak of responses mediated by single channels, and a smaller peak
due to two channels. Overlaid is the expected Poisson distribution (black curved line).
synaptic receptors. We find that [Ca "] responses to
back-propagating action potentials often open only a
single channel (Fig. 1). Similarly, only a few N-
methyl-o-aspartate receptors (NMDA-Rs) are opened
with the release of a synaptic vesicle. Therefore,
synapses transmit quanta of information using only a
few signaling molecules.
Optical Studies of Single Synapses
T. Oertner, E. Nimchinsky
Central nervous system (CNS) synapses release vesi-
cles of glutamate stochastically in an all or none fash-
ion. We can detect these successes and failures at sin-
gle synapses by imaging Ca" in postsynaptic spines.
We can also measure the amount of glutamate
released during a success as follows: NMDA-Rs have
high affinities for glutamate and are therefore perfect
detectors for synaptic glutamate. We have previously
shown that NMDA-Rs sense glutamate in a roughly
linear manner. Furthermore, NMDA-Rs admit Ca"
that can be measured in spines. Thus, the amount of
glutamate released can be inferred from the Ca
accumulations mediated by NMDA-Rs.
The ability to image transmission at single synaps-
es allows us to address old questions in synaptic phys-
iology that have important implications for the nature
of information transmission in the brain and the mech-
anisms of plasticity. One question we have addressed
is: Can a synapse release only single vesicles of neu-
rotransmitter or can it also simultaneously release
multiple vesicles? To address this question, we stimu-
late single synapses under a variety of conditions that
are known to modulate the probability of vesicle
release. If multivesicle release does occur, conditions
of high release probability should favor the simultane-
ous release of two or more vesicles. Such multivesicu-
lar release would be reflected in larger-amplitude Ca"
responses. Contrary to the textbook view of synaptic
transmission, we find clear evidence for multivesicu-
lar release.
A second question concerns the cross-talk between
neighboring synapses. Do synapses in fact function as
independent information transmission channels? Can
mixing of signals occur by diffusion of glutamate
released at one synapse to postsynaptic receptors of a
neighboring synapse? To address this question, we
measured Ca" responses in individual spines and
monitored signals in their neighbors less than 1 gm
away. We find that under a wide range of conditions,
spillover of glutamate to neighboring synapses does
not occur. To understand this remarkable observation,
we are now using pharmacological and molecular
tools to understand the mechanisms of clearance of
glutamate from the extracellular space.
Spine Morphogenesis and
the Cellular Basis of the
Fragile X Syndrome
E. Nimchinsky, K. Greenwood
The Fragile X mental retardation syndrome is the most
common form of inherited mental retardation. The
molecular basis of the syndrome is a large expansion
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of a triple repeat (CGG) in the 5 "-untranslated region
(UTR) of the FMRI gene that renders it transcription-
ally silent. The protein encoded by this gene, called
FMRP (Fragile X mental retardation protein) is an
RNA-binding protein of unknown function. One sug-
gested function is the transport of mRNA out of the
nucleus and into neuronal dendrites. Interestingly, the
only cellular abnormality in the brains of affected
individuals appears to be restricted to dendritic spines,
the targets of excitatory synapses. These spines have
been described as unusually long, thin, and tortuous
and more numerous than in normal brains. Since the
gene is functionally knocked out in humans suffering
from Fragile X syndrome, a reasonable animal model
of this disease is a mouse lacking FMRI. In these
mice, as in patients, dendritic spines have been
described as being longer and more numerous than in
control mice. Long, thin spines are suggestive of
immature spines, found early in development, that are
highly motile and presumably are in search of the cor-
rect presynaptic partners.
To understand the nature of this abnormality, we
characterized the developmental aspects of structural
defects. We used in vivo transfection of mouse barrel
cortex neurons with green fluorescent protein (GFP)-
expressing virus. Fluorescent neurons were analyzed
postmortem. We find that there is a transient large
abnormality in spine structure and density in the
developing brain (PND 14) that decreases as the brain
matures. To investigate the dynamic aspects of these
spines, we are studying the motility of spines in slice
cultures prepared from mutant mice at a time when
dendritic spines are known normally to be highly
motile. Finally, we are investigating the effects of rein-
troduction of FMRP into knockout mice, on both mor-
phology and motility.
Morphological Basis of Experience-
dependent Plasticity In Vivo
B. Chen, J. Trachtenberg
The rodent somatosensory cortex contains a map of
the facial whiskers (barrel cortex) where the neuronal
responses in each barrel-column are dominated by a
particular principal whisker. Whisker deprivation
changes the responses in the whisker map. It has long
been debated whether changes in neuronal structure
underlie such experience-dependent cortical plasticity.
We used time-lapse TPLSM of layer-2/3 pyramidal
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neurons in developing rat barrel cortex to image the
structural dynamics of dendritic spines and filopodia.
We have previously shown that protrusions are highly
motile throughout development: Spines and filopodia
appeared, disappeared, or changed shape over tens of
minutes, suggesting that synaptic lifetimes during
development might be relatively short in vivo
(-10-100 hours). Motility of spines is driven by sen-
sory experience. We are now using transgenic mice
that express GFP and other fluorescent proteins in spe-
cific subpopulations of their neurons. These animals
allow us to look at the structure of neurons over chron-
ic time scales of approximately days, allowing us to
measure the lifetime of synapses in the adult brain.
Furthermore, we are trying to determine if the struc-
ture of neurons and their circuits is stable in the adult
brain and if this stability can be perturbed by sensory
experience.
Neocortical Experience-dependent
Plasticity In Vivo
E. Stern, I. Bureau
We are exploring the experience-dependent physiolog-
ical properties of neocortical neurons in vivo. How
does sensory experience early in life shape the devel-
opment of topographic maps in the barrel cortex? In
contrast to previous studies that have employed extra-
cellular recordings, we are using intracellular record-
ings in vivo. In addition to neuronal spiking activity,
intracellular recordings measure synaptic potentials
that reflect the structure of neural circuits. We find that
brief whisker trimming (a couple of days) has a pro-
found effect on the structure of sensory maps in layer
2/3. However, layer 4, the input layer to cortex, is not
perturbed by sensory experience. The large scale of
the defects in deprived animals suggests large-scale
rearrangements of axonal structure. Our results show
that sensory experience is required for the construc-
tion of well-ordered sensory maps.
Experience-dependent Changes
in the Properties of Neocortical
Pyramidal Neurons
M. Maravall
Some subtle experience-dependent changes in cellular
properties are difficult to study in the intact brain. For
example, the sizes of quantal synaptic currents cannot
be measured in vivo, but they can be measured in
brain slices. We are comparing the properties of neo-
cortical pyramidal neurons in brain slices derived
from deprived and control animals. To discover possi-
bly diverse modes of plasticity, we are using a barrage
of electrophysiological and imaging approaches to
look for effects of sensory experience on neuronal
Ca-' dynamics, excitability, and synaptic currents. So
far, we have not found significant differences in mem-
brane excitability between deprived and spared ani-
mals. These results strongly point toward primarily a
synaptic locus for experience-dependent plasticity.
Experience-dependent Gene
Expression in the Neocortex
K. Zito, B. Burbach
Progress in sequencing the mouse genome and the
availability of cDNA and oligonucleotide expression
arrays offer an opportunity to discover genes ("plas-
ticity genes," pgs) regulated by sensory experience.
We trim mouse whiskers to induce receptive field
plasticity in particular neocortical barrels. To isolate a
population of neurons that has undergone plasticity,
we have developed protocols to rapidly isolate and
freeze tissue from particular barrels of the living
mouse. The procedure is brief (20 minutes per ani-
mal), allowing large quantities of tissue (hundreds of
milligrams) and mRNA (micrograms) to be harvested,
sufficient for expression array studies. mRNA is iso-
lated from deprived and control brains at various
times after deprivation and used to make a fluorescent
probe. The probe is then hybridized to microarrays.
We are presently using Affymetrix oligonucleotide
arrays. Fluorescence images of the arrays are analyzed
for patterns of expression.
Algorithms for Automated
Morphometric Analysis
E. Nimchinsky, K. Zito [in collaboration with I. Koh and
B. Lindquist, SUNY Stony Brook]
Changes in the structure of neurons are intimately
related to neural development and plasticity and its
dysfunctions. It is of interest to define the signaling
systems that control aspects of neuronal shape. We use
the gene gun to transfect neurons with candidate genes
together with GFP and subsequently analyze the struc-
ture of transfected cells down to the level of single
synapses. An underappreciated problem with this sim-
ple approach is that structural data are extremely dif-
ficult to analyze. Mind-numbing, laborious manual
analysis invariably limits the throughput in such stud-
ies. For these reasons, we have invested considerable
effort in developing software that allows essentially
automated analysis of neuronal structure. Our
approach consists of three steps: digital filtering by
deconvolution; image segmentation; and image analy-
sis. We now have a reliable and user-friendly algorithm
running.
Instrumentation
K. Svoboda, P. O'Brien, B. Sabatini, T. Pologruto [in
collaboration with R. Eifert and E. Ruthazer, Cold
Spring Harbor Laboratory]
Our instrumentation efforts during the last year have
focused on getting further microscopy/physiology sta-
tions working and others updated. We are also cur-
rently developing new software tools for image acqui-
sition and microscope control. We think that this soft-
ware will have many advantages over our current sys-
tem; for example, it will accomplish many of the tasks
that previously required custom electronics.
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MOLECULAR NEUROBIOLOGY OF LEARNING AND
MEMORY IN DROSOPHILA
T. Tully J. Christensen J. Dubnau L. Grady P. Smith
J. DeZazzo R. Gasperini S. Pinto S. Xia
J. Di Leo S. Gossweiler M. Regulski L. Zhang
We have felt the impact of genome sequencing first-
hand. In the latter part of the 1980s, we identified four
mutants with defective olfactory memory. Most of the
1990s then was consumed by the basic molecular-
genetic identification of the relevant transcription unit
disrupted in these mutant flies. To date, we have pub-
lished on three of these four "memory" genes. In the
latter part of the 1990s, we identified another 57 can-
didate mutants with defective 1-day memory after
spaced training. Because the full genome sequence
now is available in Drosophila, molecular-genetic
identification has been accomplished for 40 of these
mutants. This effort triples the number of "memory"
mutants identified in Drosophila and greatly expands
our potential to understand the molecular mechanisms
underlying this form of behavioral plasticity.
Identification of New Genes Involved
with Associative Learning
T. Tully, S. Pinto, J. Christensen, J. DeZazzo, P. Smith,
L. Grady
The Hartford Screen: The behavioral screen (forward
genetics) for new Pavlovian learning/memory mutants
is complete. In all, more than 6700 transposant lines
were generated and assayed for 1-day memory after
spaced training using a 48 array of Robotrainers. From
this screen, we have identified 107 candidate mutants.
Of these candidate mutants, 47 have abnormally low
memory scores but normal (>90%) learning and sen-
sorimotor scores. We designate these as "memory"
mutants. Ten candidate mutants have abnormally low
scores for both learning and memory. We designate
these as "learning" mutants. This yields a total of 57
new learning/memory mutants, which triples the num-
ber of mutants known to affect olfactory memory in
Drosophila. We have named these mutants after
Pavlov's dogs.
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To date, 40 of these 57 mutations have been iden-
tified molecularly. The candidate transcription units
comprise a variety of cell biologies, including gene
regulation, RNA processing, translational control,
trafficking, signal transduction, and cell adhesion.
Genomics with Drosophila
DNA Chips
T. Tully, J. Dubnau, S. Gossweiler, J. DiLeo
[in collaboration with M. Zhang, Cold Spring Harbor
Laboratory, and G. Latter, Cold Spring Harbor Laboratory
and Helicon Therapeutics, Inc.]
Functional Genomics: Using a prototype fly DNA
chip from Affymetrix containing 1542 genes (12% of
the genome), we are trying to identify candidate genes
involved in long-term memory formation in normal
flies. By comparing chips hybridized with probes
derived from the whole heads of wild-type flies sub-
jected to spaced versus massed training, we can focus
our search for those transcripts specifically involved
in transcription-dependent long-term memory forma-
tion. By looking at several time points after training,
we are identifying clusters of coordinately regulated
genes, using our 129 statistically significant candidate
memory genes (CMGs) as focal points.
Pharmacogenomics: A drawback of the approach
above derives from the notion that olfactory memory
formation may occur only in a few cells in the brain.
For DNA chip hybridizations, however, we can extract
RNA only from whole heads. Thus, a significant sig-
nal-averaging may result. To address this issue, we
have taken advantage of the well-established fact that
olfactory associative learning in Drosophila requires
normal cAMP signaling. By feeding flies drugs that
enhance cAMP signaling systemically, the signal-to-
noise ratio from cAMP-responsive transcription can
be boosted. This approach has yielded 75 statistically
significant candidate genes, 8 of which are also
included among the CMGs.
Dysfunctional Genomics: Another approach to
increase the signal-to-noise ratio from our DNA chip
analyses is to compare levels of gene expression of
wild-type (normal) flies to those of a single-gene
mutant. Here again, these differences may exist in
many more cells. To date, we have compared whole-
head RNA from wild-type flies to that from amnesiac
and from nalyot mutants. The former appears to
encode a neuropeptide that may activate adenylyl
cyclase during middle-term memory formation; the
latter encodes the ADF I transcription factor, which
appears to be involved in long-term memory forma-
tion. Wild-type versus amnesiac comparisons have
yielded 162 candidate genes, 9 of which are also
included among the CMGs. Wild-type versus nalyot
comparisons have yielded 86 candidate genes, 7 of
which are included among the CMGs. Interestingly,
24 candidates were in common between the pharma-
cological treatment and the amnesiac mutant compar-
isons, and 18 candidates were in common between the
pharmacological treatment and the nalyot mutant
comparisons.
Bioinformatics: Issues exist here on two levels. The
first concerns the basic signal-to-noise analysis of
data from DNA chips. We have addressed this prob-
lem with traditional statistical approaches. Proper
consideration of underlying assumptions has greatly
improved our ability to identify true positives and to
eliminate false positives. The second concerns true
bioinformatics: cluster analysis of coregulated genes
and promoter analysis among genes in a cluster. Our
ongoing analysis suggests that the quality of bioinfor-
matics improves as our signal-to-noise analysis
improves. The two issues go hand in hand.
Behavioral Analyses
T. Tully, S. Xia, J. Dubnau [in collaboration with T. Kitamoto,
Beckman Research Institute of the City of Hope]
Olfactory Discrimination: For the proper behavioral
identification of associative learning/memory
mutants, sensorimotor responses must be shown to be
normal. To this end, we have developed "task rele-
vant" assays of olfactory acuity and shock reactivity
for our Pavlovian conditioning paradigm. This condi-
tioning procedure is inherently discriminative, howev-
er, requiring trained flies to choose between two dif-
ferentially reinforced odors during a test trial. To do
so, the flies must be able to discriminate between the
two odors when they are presented simultaneously in
the T-maze. This "quality choice" may be distinctly
different from the "quantity choice" presented to the
flies in our olfactory acuity assay. Hence, we have
been interested in developing a valid assay of odor dis-
crimination. Traditional assays of discrimination,
however, have trained animals with associative proto-
cols to yield a discriminative response between two
stimuli. Obviously, such an approach cannot be used
when trying to identify associative learning mutants.
With this caveat in mind, we have developed three
different measures of discrimination, each of which
does not depend on associative learning per se. Most
of the extant learning/memory mutants show normal
responses in each of these discriminability assays,
supporting the notion that they have been validly iden-
tified. We now seek single-gene mutations that specif-
ically disrupt discriminability.
Acute, Reversible Disruption of Synaptic Trans-
mission: Across the animal kingdom, memory has
been shown to exist in two basic forms, first as a tran-
sient, labile short-term memory (STM) and then as a
persistent, stable long-term memory (LTM). Some
theories have suggested that the neural basis of STM
is a "reverberating circuit" that keeps newly acquired
information online until the LTM (structural change)
can be formed. We have begun to test this theory in
Drosophila using a novel genetic tool.
Mutant shibirel flies originally were identified in a
screen for temperature-sensitive paralytics. Subsequent
molecular cloning of this gene revealed it to encode the
fly homolog of dynamin, a synaptic protein involved in
vesicle recycling. In shil" mutants, synaptic transmis-
sion fails within seconds after shifting flies to restric-
tive temperature. We generated UAS-shi"' transgenic
flies carrying the mutant form of dynamin. When over-
expressed widely using a central nervous system
(CNS)-wide GAL4 driver line, these transgenic flies
become paralyzed within seconds after shifting to the
restrictive temperature (29°C) and recover within sec-
onds after shifting back to the permissive temperature
(20°C). When expression of UAS-shi' is restricted to
the mushroom body, in contrast, the perceptions of
odors and footshock are normal at both permissive and
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FIGURE 1 Disruption of synaptic transmission in the mush-
room body abolishes memory retrieval but not acquisition or
storage. CONTROL: When trained (closed arrows) and then
tested (open arrows) 30 min thereafter at permissive tempera-
ture (20°C; see stimulus schedules above each panel), all three
genotypes display robust performance (although some non-
specific effects on 30-min memory are apparent in UAS-
si-PI/C747 and UAS-shits1/C309 transgenic lines). ACQUISI-
TION: When first shifted to restrictive temperature for 30 min,
trained, and then shifted back to permissive temperature for 30
min before testing, memory retention levels are unaffected in all
three genotypes. STORAGE: When trained at permissive tem-
perature, shifted to restrictive temperature for a 30-min reten-
tion interval, and then shifted back to permissive temperature
for 5 min before testing, memory retention levels again are
unaffected in all three genotypes. RETRIEVAL: When trained at
permissive temperature, shifted to restrictive temperature
immediately thereafter, and then tested for 30-min retention,
memory is normal in control flies but abolished in transgenic
shit' lines.
restrictive temperatures, revealing that synaptic trans-
mission from mushroom body neurons is not required
for the normal sensorimotor responses used during
olfactory associative learning.
We then looked at Pavlovian learning. With the
rapid, reversible nature of the transgenic tool, howev-
er, we were able to restrict the disruption of synaptic
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transmission spatially (only in the mushroom body)
and temporally (only during acquisition, storage, or
retrieval of olfactory memory) in our Pavlovian exper-
iments. Surprisingly, we found that blocking synaptic
transmission during acquisition or the first 30 minutes
of memory storage had no effect on 30-minute reten-
tion. In contrast, blocking synaptic transmission dur-
ing memory retrieval completely blocked 30-minute
retention (see Fig. 1).
Taken together, these data indicate that a persistent
neural activity (reverberating circuit) in the mushroom
body is not required for the acquisition and storage of
olfactory memory. Rather, it is needed for its retrieval.
Moreover, these data suggest that the Hebbian neu-
ronal process underlying this associative process must
reside in the dendrites of mushroom body neurons.
This view now permits the development of computa-
tional models in the fly model system to "vertically
integrate" neuronal function with conditioned behav-
ioral responses.
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Atypical PKC and
Memory Formation
E. Drier, M. Cowan, M. Tel lo, P. Wu [in collaboration
with T. Sacktor, SUNY Health Science Center,
Brooklyn, New York]
Transgenic flies carrying mouse, atypical, full-length
( MaPKC]), or truncated (MaPKCO genes have been
analyzed for their effects on memory formation.
Induction-dependent enhancement of memory forma-
tion occurs when the MaPKM] transgene is induced
after a single training trial or after massed trials, but
not spaced trials. This enhancement requires persistent
kinase activity, since neither the full-length kinase
(PKC) nor a kinase-dead point mutation on the trun-
cated gene (K.D-Plalc) can enhance. We can detect
induction-dependent expression of all of the different
kinases and can measure an induction-dependent
increase in atypical (calcium-independent and DAG-
independent) PKC activity in crude fly extracts. There
is a striking temporal window to the enhancement;
enhancement only occurs if the transgene is induced
after behavioral training, but within a 2-hour time win-
dow.
Chelerythrine, a specific inhibitor of atypical
PKM kinase activity (when used at the proper concen-
tration), inhibits memory formation after massed
training, but does not affect learning (immediate
memory after a single training trial). The kinase-dead
PKM] transgene functions as a dominant negative
molecule and inhibits memory formation after massed
training, but does not affect learning (single-trial train-
ing). Therefore, induction of the PKIvIc transgene is
sufficient to enhance memory formation, and atypical
PKC activity is necessary for memory formation.
Since manipulating atypical PKC activity can enhance
or disrupt memory formation, but does not affect
learning, we believe that atypical PKC activity is
involved in the maintenance of memories, not their
establishment. These results, and this interpretation,
are consistent with experimental data in the hip-
pocampal slice culture, where "gain-of-function" and
"loss-of-function" phenotypes can be achieved with
exactly the same proteins (T. Sacktor et al., pers.
comm.). In that context, these authors interpret their
results to show that PICMc is involved in the mainte-
nance, but not induction, of long-term potentiation
(LTP).
The 2-hour temporal window is a particularly
striking result. Experiments in hippocampal slices and
Aplysia cultured neurons have led to a hypothetical
concept, the "synaptic tag," which has a 2-3-hour
duration. Although it may be coincidental, we believe
that the PKMC temporal window is intimately related
to the duration of the tagging system and that PK1Vg
may be directly acted upon by the tagging system or
may participate in it. Cell biological experiments on
atypical PKC proteins in development suggest that
atypical PKC is part of a general marking process
which evolved very early and may be utilized in neu-
rons for more specialized purposes.
Characterizing the
DaPKC Gene
M. Tel lo, E. Drier, P. Wu in collaboration with T. Sacktor,
SUNY Health Science Center, Brooklyn, New York]
Analysis of the completed fly genome indicates that
flies contain only a single atypical PKC gene,
although there are a total of seven PKC genes. A num-
ber of characteristics distinguish an atypical gene from
its closely related conventional and novel genes,
including domain structures (which are ultimately
responsible for cofactor binding) and distinctive
amino acid substitutions. We have been characterizing
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the gene structure of the DaPKC gene, as well as its
mRNA and protein products.
The fly gene is distributed over approximately 20
kb and consists of nine coding exons, with a large 12-
kb intron between exons 2 and 3. Overall, there is
more than 60% identity between the fly gene and the
mouse or human PKCc genes and slightly less when
compared to the other mammalian atypical gene,
PKCILIk. Multiple antibodies suggest the existence of
two bands in fly extracts. Consistent with the available
information on the mammalian PKCc gene, it is like-
ly that the larger protein band corresponds to the full-
length protein, and the shorter band corresponds to the
PICMc protein.
When adult head mRNA is analyzed using
Northern blots, a probe from the 5' end of the gene
results in a single mRNA transcript of about 5 kb.
When a probe is made from the 3' end of the gene,
two additional transcripts are recognized. The 3'
probe corresponds to regions of the gene 3' to the
large 12-kb intron. Consistent with the rat PKC] gene,
this pattern of transcripts suggests that there is alter-
native transcription initiation, or splicing, of the
DaPKC gene.
Recently, a report described the participation of
the DaPKC gene, and its products, in asymmetric cell
division in the neuroblast. The authors describe a P-
element insertion, which results in a homozygous
recessive, lethal phenotype during early development.
Mapping of the insertion site shows that the P-element
is located within the 12-kb intron, approximately 3 kb
from the 3' end of the intron. We are currently ana-
lyzing imprecise revertants of this insertion. It is our
expectation that some existing revertants may remove
an internal promoter that is primarily responsible for
initiating the two 3 "-specific transcripts.
In addition to alternative promoter usage, evi-
dence in the literature suggests that the PKM] protein
may be produced through calpain-mediated, proteoly-
tic cleavage of the PKC] protein. Calpain is a calci-
um-activated protease, and it is suspected that it is one
of the early events following synaptic activation and
calcium influx at the nerve terminal. It is known that
the PKMC protein, which is found in all regions of the
brain, is distributed in a punctate pattern in dendrites,
near synaptic terminals. Our behavioral analysis of
transgenic flies shows that enhancement of memory
formation requires induction of a (truncated) PKIK,
but not (full-length) PKC, transgene. We are looking
for behavioral conditions that activate calpain and
thus allow the full-length protein to enhance memory
formation.
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Role of Circadian Genes
and Sleep in Memory
Formation
M. Cowan, P. Wu [in collaboration with J. Hendricks,
University of Pennsylvania]
Ever since our demonstration of periodic cycling
CRE-binding transcription in transgenic flies, we have
been interested in the possible connection between this
nighttime activity and memory formation. After some
initial experiments using manipulations of light:dark
to try to disrupt circadian rhythms, we have resorted to
manipulating genes that are known players in the cir-
cadian system. Induction of a dominant negative clock
protein affects long-term memory, without affecting
memory after massed training. This inhibition can
occur even if the transgene is induced 24 hours after
the end of training. Preliminary experiments show that
mutations in the per gene, a central component of the
circadian clock, affects memory formation. It is
unclear if these effects are due to (1) effects on the cir-
cadian system (which indirectly affects memory for-
mation), (2) effects on the circadian system affecting
sleep (which affects memory formation), or (3) if the
proteins participate directly in the process
of memory formation.
Tetracycline-inducible
Expression Systems
M. Stebbins [in collaboration with G. Byrne, Nextran,
and W. Hillen, Erlangen]
We have completed our optimization and analysis of
the Tet-Off and Tet-On systems in transgenic flies. For
each system, we have characterized both a ubiquitous-
ly expressed version and a spatially restricted version.
In addition, we have compared the effects of altering
trans-activators. Altering the trans-activator includes
removal of a cryptic splicing site in the TetR portion of
each trans-activator, reformatting codon usage for
mammalian expression, and using SCS and SCS'
insulator elements to remove the effects of position
effects.
For the ubiquitous Tet-Off system, we have char-
acterized the dosage and kinetics for gene repression
(addition of antibiotic to fly food) and gene induction
(drug withdrawal), the leakiness, and the amount of
induction. Total repression can be easily achieved
within 12 hours of placing flies on drug-containing
food, and total induction occurs within 24 hours of
placing flies on drug-free food. There is virtually no
leakiness (defined as the difference between target
gene expression in single transgenic flies without a
trans-activator and expression when double transgenic
flies are fed antibiotic). Drug withdrawal results in
about 125-fold induction, and the amount of induction
is dosage-sensitive to the copy number of the trans-
activator gene. The system works equally well in adult
flies, embryos, and larvae.
By combining the Gal4 and Tet-Off transgenes in
a tripartite system, it is possible to achieve robust
induction of target genes that is both temporally and
spatially regulated. From the widely available collec-
tion of Ga14 drivers, a desired driver line is crossed
together with a UAS-tTA transgene, resulting in Tet-
Off trans-activator expression in the tissues where
Ga14 is expressed. When the TetO- target transgene is
also crossed into the same fly, doxycycline delivery or
withdrawal regulates target gene expression. In the
adult eye, 115-fold induction occurs upon doxycycline
withdrawal, with little leakiness. Similar spatially
restricted expression occurs in embryos when appro-
priate drivers are used and the mothers are fed dox-
free or dox-containing food. Collectively, these data
show that the spatially restricted expression system is
comparable in its properties to the ubiquitously
expressed system in terms of induction ratio, leaki-
ness, and kinetics.
The ubiquitous Tet-On trans-activator is now a
viable system for gene disruption. Two modifications
were key to the improvement of this system: altering
the trans-activator, which resulted in greater expres-
sion, and the development of a second-generation Tet-
On trans-activator. This trans-activator resulted from a
second mutagenesis screen for mutations that reversed
the binding properties of the TetR protein. This new
trans-activator outperforms the first-generation Tet-
On protein and, when altered, results in induction
ratios that are about 50% of the Tet-Off protein.
Dosage and kinetic experiments show that maximal
induction occurs within 24-48 hours when flies are
fed very practical concentrations of doxycycline in
regular fly food. Maximal induction can occur within
30 minutes if flies are directly injected with the antibi-
otic. The leakiness is slightly greater than with the Tet-
Off systems, but it is insignificant when compared to
the induction ratio. Gene-dosage experiments indicate
that the amount of trans-activator still limits the induc-
tion ratio. The system works well in adult flies,
embryos, or larvae.
The spatially restricted Tet-On system has proper-
ties similar to those of its ubiquitous version. We are
currently characterizing the use of this system both for
tissue-specific gene induction and for tissue-specific
ablation of cells. The ablation system works well dur-
ing development and is currently being tested for its
efficacy in postmitotic cells.
The Tetracycline System in
Primary Neurons
Z. Lin
The study of gene function in neurons would benefit
greatly from an inducible system. We have tested the
altered, first-, and second-generation Tet-On trans-acti-
vators in transiently transfected, rat cortical, primary
neurons. The altered, first-generation Tet-On trans-
activator performs poorly in primary neurons, whereas
the second-generation Tet-On trans-activator results in
20-fold induction of target gene expression, shows lit-
tle leakiness in the absence of antibiotic, and only
requires 24 hours of drug treatment to achieve maximal
induction.
Three different target genes can be induced in a
doxycycline-dependent manner, indicating that robust
induction is not just a function of particular target
genes. When enhanced green fluorescent protein
(EGFP) is used as the target gene, all of the transfect-
ed neurons, as judged from EGFP-mediated fluores-
cence, also show green fluorescence. Thus, it is likely
that the amount of induction in each transfected neuron
is relatively equal, or at least great enough to result in
saturated green fluorescence.
Regulation of dCREB2
Activity
J. Horiuchi, P. Wu
We have shown previously that a set of phosphoryla-
tion sites inhibit dCREB2 DNA binding in vitro.
These sites can be phosphorylated by the endogenous
Drosophila casein kinase II protein in crude, cell-free
extracts. Mutation of these residues to alanine not only
allows DNA binding in vitro, but also changes the
subcellular fractionation properties of the protein.
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Most of the endogenous or transgenically overpro-
duced dCREB2-b protein fractionates in the cytoplas-
mic fraction, and mutation of these casein kinase sites
results in much greater nuclear localization of the pro-
tein. All dCREB2 protein isoforms contain a consen-
sus nuclear localization signal.
We suspect that the dCREB2-b protein normally
exists in a cytoplasmic, multiprotein complex and that
phosphorylation of the casein kinase sites may be nec-
essary for complex formation. We are initiating bio-
chemical analyses of crude extracts to test this hypoth-
esis. The existence of this complex may help explain the
cytoplamic localization of the dCREB2-b protein and
its inability to bind DNA and lead to an understanding
of how this protein inhibits memory formation.
Functional Anatomy of
Memory Formation
C. Margulies, P. Wu
We are using the Ga14 system to determine which
parts of the adult fly brain are needed for long-term
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memory formation. We are expressing the dCREB2-b
transgene in different regions of the brain and are ask-
ing which expression patterns disrupt long-term mem-
ory formation. Ultimately, we anticipate using the Tet-
On spatially restricted system to refine this analysis.
Temporal and spatial regulation will remove any doubt
about the acute, as opposed to developmental, role of
particular brain regions in memory formation.
Mouse Behavior
E. Friedman, R. Filipkowski
We have established training procedures for the
Morris water maze and contextual discrimination that
produce long-lasting memory, or shorter-lasting mem-
ory, depending on training parameters. A constant
number of training trials are given, but the intervals
between individual training trials, or blocks of trials,
are varied. Using these procedures, we are examining
the effects of pharmacological agents for their effects
on memory formation, especially their ability to
enhance these processes.
M. Tello-Ruiz, P. Wu
NEURAL SUBSTRATE OF SELECTIVE AUDITORY ATTENTION
IN THE CORTEX
A. Zad or M. DeWeese L.-H. Tai
M. Morgan G. Tervo
S. Edgar
We use a combination of theoretical and experimental
approaches to study how the brain computes. The
brain is able to solve hard computations that remain
far beyond the reach of the fastest computers. Our goal
is to understand this computation at the synaptic, cel-
lular, behavioral, and algorithmic levels.
One example of such a hard computation is the
"cocktail party problem." When we tune in to one
voice at a cocktail party and tune out the others-a
task that remains beyond the capacity of modern
computers-we are engaging in a form of selective
auditory attention. Our ability to attend selectively is
not limited to the auditory domain: Analogous tasks
demand selective attention in the visual and even
somatosensory domains. In monkeys, visual atten-
enhances neural activity even in the
most peripheral (i.e., near the retina) areas of the
visual cortex. This enhancement is surprising
because the brain areas associated with these first
stages of visual processing have traditionally been
thought of as representing the sensory world faith-
fully, in a way that depends only on the properties of
the sensory input itself. The discovery of attentional
modulation overturns the notion that the peripheral
sensory cortex is a passive "TV screen" available for
viewing by a "homunculus" buried deep within the
cortex.
The specific projects in our lab fall into two main
categories. First, we are interested in how neurons rep-
resent auditory stimuli, and how these representations
are computed from the cochlear inputs half a dozen
synapses away. To address these questions, we are
using electrophysiological and imaging approaches in
anesthetized rats as well as computational approaches
to characterize the properties of natural sounds.
Second, we are interested in how these representations
are modified dynamically-within seconds-in awake
behaving rats by the demands imposed by attentional
tasks.
In Vivo Whole-cell Patch-clamp
Recordings of Sound-evoked Synaptic
Responses in Auditory Cortex
M. DeWeese, L.-H. Tai
Neurons in the auditory cortex respond to some
sounds but not to others. What determines this selec-
tivity? We are using whole-cell patch-clamp recording
methods in vivo to measure the synaptic currents
elicited by simple and complex auditory stimuli.
Patch-clamp recordings provide a much richer source
of information than do conventional single-unit extra-
cellular recordings because they allow us to monitor
not just the output of the neuron-the spike train-but
the input as well (see Fig. 1). These data provide clues
about the representations with which the cortex solves
hard problems in auditory processing.
Activity-dependent GFP as a
Real-time Measure of
Synaptic Activity In Vivo
M. DeWeese [in collaboration with J. Sullivan, Salk Institute]
With conventional electrophysiological recording
techniques, it is difficult to study how one popula-
tion of neurons influences the activity of another
population. For example, when a neuron in the pri-
mary auditory cortex responds to a sound, how much
of the activity arises from the upstream regions (e.g.,
the thalamus) and how much from the cortex? To
address such questions, we are using an engineered
synaptic vesicle protein that has been tagged with
green fluorescent protein (GFP) and which can be
delivered to cortical neurons in vivo. This engi-
neered protein fluoresces during the vesicular fusion
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FIGURE 1 Whole-cell patch-damp recording of sound-evoked
responses in an auditory cortical neuron. Each trace represents
the membrane voltage response to 25-msec pure tone pips of
variable frequency and intensity. Only 15% of the pips caused
spikes, but more than half caused robust subthreshold respons-
es. These subthreshold responses provide insights into how
neurons in the auditory cortex generate selective responses.
events underlying synaptic activity, and so can be
used to monitor the synaptic activity in an anatomi-
cally or genetically defined subpopulation of neu-
rons. This new technology-a kind of population-
specific local field potential-may emerge as an
important complement to conventional electrophysi-
ological methods in vivo.
Statistical Structure of
Natural Sounds
G. Ten/0
To develop the best strategy for processing a complex
signal, such as a natural sound, we need to understand
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the properties of the sounds likely to be encountered.
We are therefore using a variety of mathematical
approaches to characterize the statistical structure of
natural sounds. An understanding of these statistics
provides a foundation for understanding the con-
straints on any algorithm, biological or artificial, that
solves the cocktail party problem.
Behavioral Paradigm for
Studying Selective Auditory
Attention
G. Tervo, L.-H. Tai, S. Edgar, M. DeWeese
More than a decade has passed since the first reports
of a neural correlate of selective attention in monkeys,
but the mechanism underlying the enhancement of
neural activity remains a mystery. We are therefore
developing a simpler preparation within which to
study the mechanism. We are training rodents to per-
form a simple selective auditory attention task. We
will then use extracellular recording methods
(tetrodes) to look for a neural correlate-a change in
the firing rate-of this selective attention in the audi-
tory cortex. This simple rodent preparation will have
many advantages over the existing primate prepara-
tion, as it will permit us to bring to bear the full cellu-
lar and molecular armamentarium available to modern
neurobiology.
PUBLICATIONS
deCharms R.C. and Zador A. 2000. Neural representation and
the cortical code. Annu. Rev. Neurosci. 23: 613-647.
DeWeese M. and Zador A. 2000. In vivo whole cell recordings
of synaptic responses to acoustic stimuli in rat auditory cor-
tex. Soc. Neurosci Abstr. 637.14
Zador A. 2000. The basic unit of computation. Nat. Neurosci. 3:
1167.
NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong F. Hannan J. Tong
H.-F. Guo I. Hakker
Y. Wang Y.-H. Zhu
J. Pathenveettil
We are interested in the neural basis of learning and
memory and are taking an approach of combining
functional analyses with genetic manipulation in the
study of Drosophila. Currently, we are pursuing two
major projects. First, we are establishing Drosophila
models for studying genes involved in human neuro-
disorders that impair learning and memory. In partic-
ular, we are interested in genes known to contribute to
neurofibromatosis 1 (Nfl) and Alzheimer's disease.
Nfl patients are identified by neurofibromas and other
symptoms including learning defects. We are investi-
gating the hypothesis that the tumor-suppressor gene
Nfl not only acts as a Ras-specific GTPase-activating
protein (GAP), but also is involved in mediating G-
protein-stimulated activation of adenylyl cyclase
(AC), and this NF1-dependent AC pathway is required
for learning. In the case of Alzheimer's disease, our
study has been limited to examining how presenilin
and accumulation of AP affect age-dependent decline
of learning ability. This approach, on the one hand,
serves as a new way to identify biochemical cascades
underlying learning and memory in Drosophila. On
the other hand, it may also provide insights into patho-
genesis of the diseases. Second, we are investigating
how odors are encoded by population neuronal activi-
ty in the fly brain and will ultimately study learning
and memory at the level of population neural activity.
Such studies are carried out by optical recordings from
living flies. The specific projects are described below.
Site-directed Mutagenesis
in Human NF1
F. Hannan, I. Hakker
The tumor-suppressor gene Nfl encodes a large pro-
tein containing a fragment homologous to Ras-GAPs,
which inhibit Ras activity. Drosophila NF1 is highly
conserved since 60% of its 2803 amino acids are iden-
tical to human NF1. Our previous electrophysiologi-
cal, biochemical, and behavioral analyses of
Drosophila NF1 mutants have indicated that, in addi-
tion to functioning as a Ras-GAP, NF1 regulates acti-
vation of adenylyl cyclase (AC). This NF1-dependent
cAMP pathway is crucial for learning and memory.
Our recent effort in biochemical assay of AC activity
has revealed that G-protein-stimulated AC activity
consists of two components, i.e., NF1-dependent and
NF1-independent. The NF1-dependent component is
largely mediated via the rutabaga (rut)-encoded AC,
which is required for learning in Drosophila. To
understand how NF1 regulates AC activity, we are
investigating how point mutations identified in NF1
patients affect cAMP-pathway-related functions. We
have shown that, in transgenic flies, the human NF1
gene is capable of rescuing NF1 mutation-induced
phenotypes or defects, including small body size,
reduction in G-protein-stimulated AC activity, and
olfactory learning. Transgenic flies carrying different
mutations, two within the GAP domain (directly relat-
ing to Ras activity) and one outside of the GAP
domain, have been generated, and we are in the
process of testing how these mutations affect the abil-
ity of human NF1 to rescue NF1 defects in mutant
flies. We are hoping to gain insight into whether Ras
activity is required for AC regulation and whether
there is a specific domain in the NF1 molecule desig-
nated to AC regulation.
NF1-regulated cAMP Pathway
in Vertebrates
J. Tong, Y.-H. Zhu
All studies related to NF1- regulated AC activity have
been confined to Drosophila. Thus, it is important to
determine whether NF1 also regulates AC activity in
vertebrates in order to determine whether a defect in
such regulation may contribute to the wide range of
symptoms observed in NF1 patients. The observation
that expression of human NF1 rescues phenotypes in
flies resulting from impaired NF1-regulated AC activ-
ity suggests that the structure and function of NF1
molecules are conserved across invertebrates and ver-
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tebrates. During last year, we studied this issue by
assaying AC activity in an Nfl mouse knockout. Since
these Nfl mutant mice are embryonically lethal at the
E13.5 stage, we used brain tissue from embryos at
E12.5 to E13.5. Data from assays of dissected brain
tissues or from assays of cultured neurons all consis-
tently indicated that GTPyS-stimulated AC activity
was reduced in homozygous NF1 nulls as compared
to heterozygous or wild type.
Modeling Alzheimer's Disease
in Drosophila
Y. Wang, J. Pathenveettil, D. Yom, Y. Zhong
The most common cause of familial Alzheimer's dis-
ease is mutation of the gene encoding presenilin 1 and
2, which alters y-secretase activity to increase the pro-
duction of the highly amyloidogenic AP42. Drosophila
has a highly conserved homolog of the human prese-
nilin gene. By overexpressing the wild-type
Drosophila presenilin homolog gene, or by introduc-
ing one with mutations found in Alzheimer's disease,
we are trying to build a simple Drosophila model to
study Alzheimer's disease. Our preliminary results
show that the fly's life span is greatly reduced by
expression of both wild-type presenilin and the mutat-
ed genes. In addition, learning ability shows age-
dependent deterioration. This may afford us a simple
system to understand the pathological mechanisms of
Alzheimer's disease.
Notch in Learning and
Neural Plasticity
FL-F. Guo
Another known target of presenilin is Notch, which
has been shown to be a key signaling molecule in
determination of cell lineage across different species.
Notch is also expressed in the adult nervous system,
but its function in the adult remains to be revealed. As
a substrate of presenilin, it has been speculated that
Notch may have an important role in the pathogenesis
of Alzheimer's disease. However, it has been difficult
to investigate Notch's role in the adult nervous system
because of lethality induced by mutations in the gene.
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In Drosophila, the existence of temperature-sensitive
mutants and heat-shock-inducible active or dominant
negative Notch may facilitate our understanding of its
role in the adult. Our preliminary data indicate that
Notch activity has a role in learning and memory and
in activity-dependent nerve terminal plasticity.
Role of Drosophila Mushroom
Bodies in Odor Perception:
Imaging and Behavioral Studies
Y. Wang
Drosophila mushroom bodies (MBs) are the olfacto-
ry-related associative learning center. Using a Ca''
imaging technique, we have recorded neural activities
in the MBs in response to odor stimulation. It is shown
that odors evoke spatial neural activities in the MB
that are both odorant- and concentration-specific. In
an olfactory-binding protein mutant where the
response to an attractive odor is disrupted, the spatial
activity pattern in the MB loses its dependency on the
odor concentration. This has led us to a hypothesis that
the MB may be required only for perceiving attractive
odors. To test this hypothesis, we introduced a
shibireisi transgene to the MB, which blocks synaptic
transmission upon elevating the temperature to over
28°C. We found that although temperature-dependent
expression of shibire'° disrupted the response to
attractive odors, it had no obvious effect on repulsive
odors. In future studies, in addition to testing more
odors, we will investigate the changes in neural activ-
ities in the MB with Car' imaging.
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COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity for
these young scientists to work independently at the Laboratory for a period of up to 3 years on pro-
jects of their own choosing. Fellows are provided with a salary, research support, and technical assis-
tance so that they can accomplish their goals free of distraction. The interaction among research
groups at the Laboratory and the program of courses and meetings on diverse topics in biology con-
tribute to a research environment that is ideal for innovative science by these Fellows.
Previous Cold Spring Harbor Laboratory Fellows Adrian Krainer (1987) and Scott W. Lowe (1995)
are currently members of the faculty at the Laboratory. After 9 years at the Laboratory, Carol Greider
(1988) left to join the Department of Molecular Biology and Genetics at Johns Hopkins University
School of Medicine. Eric Richards (1989) is currently in the Department of Biology at Washington
University. After finishing his fellowship, David Barford (1991) returned to the Laboratory of Molecular
Biophysics at Oxford University. Ueli Grossniklaus (1994) was a member of our faculty before leaving
to join the Friedrich Miescher Institut in Basel, Switzerland in 1998. Marja Timmermans, who joined us
from Yale in 1998, will end her fellowship in June, 2001, when she will become an assistant professor
at the Laboratory.
In 2000, two new CSHL Fellows joined the Laboratory. Terence Strick joined us after earning his
Ph.D. in molecular and cellular biology at Ecole normale superieure in Paris with David Bensimon and
Vincent Croquette. Terence is using single-molecule biophysics to study the mechanical response of
DNA to stretching and twisting by enzymes that alter DNA topology, thus elucidating properties of
these enzymes. Gilbert (Lee) Henry joined us from Doug Melton's laboratory at Harvard University
where he earned his Ph.D. for studies on Xenopus development. Lee is studying the mechanisms that
regulate the formation of taste buds and the maintenance of their structure in the adult. Lee is not new
to CSHL. He was a participant in the Undergraduate Research Program for three consecutive sum-
mers in the labs of David Helfman and Winship Herr from 1990 to 1992.
L. Henry
T. Strick
M. Timmermans
The Development and Maintenance
of Taste Bud Structure
L. Henry
The goal of our research is to understand the molecu-
lar mechanisms that are required for the formation of
taste buds during embryogenesis and the maintenance
of their structure and function in the adult. The senso-
ry cells of gustation are housed within ovoid structures
called taste buds, which are embedded in the epitheli-
um of the tongue, and to a lesser extent the epithelium
of the palate and upper pharynx. Consisting of 70-100
cells, the vertebrate taste bud is a highly dynamic
structure that possesses both epithelial and neuronal
qualities. Like all other sensory cell types, the taste
receptor cells of the bud undergo membrane depolar-
ization in the presence of a suitable stimulus. Similar
to the epithelial cells that line the intestine and other
areas of the gut, cells within the bud turn over at a
rapid rate (-8-10 days in rodents). Unlike the olfacto-
ry system, where newly formed receptor cells extend
their axons back toward glomeruli in the olfactory
bulb, newly formed taste receptor cells synapse onto
sensory afferents that remain at the bud during its
entire lifetime.
Taste buds are embedded in epithelial specializa-
tions called papillae. In most mammals, there are three
distinct classes of papillae. Toward the back of the
tongue, there is a centrally located circumvallate
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papilla; two groups of foliate papillae are found to the
lateral extremes of the posterior tongue, and scattered
over the anterior tongue are reddish-colored fungi-
form papillae. The papillae form late during embryo-
genesis in the mouse (E 1 3-E16) as the tongue begins
to bud away from the pharynx. Soon after their for-
mation, sensory afferents enter the papillae, and
approximately 8-10 days after birth (P8-P10), taste
buds form. In rodents, there is a single bud per fungi-
form papilla, tens of buds within the two foliate papil-
lae, and hundreds of buds are found in the single cir-
cumvallate.
An intimate relationship between both the devel-
oping papillae and the mature taste bud with innervat-
ing sensory afferents has been established through a
number of denervation studies. Papilla formation does
not require innervation; however, the maintenance of
these structures does in some way require contact with
sensory afferents. Similarly, in adult animals, dener-
vation of the tongue leads to the loss of taste buds. For
both findings, basic morphological criteria were used
to evaluate the dependency of each structure on inner-
vation.
Turnover in the adult taste bud creates special con-
straints on this structure. As new receptor cells are
formed, they must acquire an appropriate synapse with
one or more sensory afferents. It is possible that the
molecular biology of this process is very similar to that
required for the initial formation of the taste bud. For
this reason, we believe that there will be overlapping
mechanisms in the formation and maintenance of taste
bud structure. Keeping this possibility in mind, we will
specifically address the following problems. How do
papillae form in the appropriate pattern during late
gestation and what role do innervating sensory affer-
ents play in this process? How do taste buds form and
are the already present afferents somehow involved?
How diverse is the mature receptor cell population? Is
there a true stem cell in the adult taste bud whose
daughters become mature differentiated receptor cells?
Do sensory afferents in the bud regulate either progen-
itor or receptor cell development? To tackle these prob-
lems, we will use a variety of molecular biological,
organ culture, and genomics techniques.
HOW MANY TYPES OF CELLS ARE CONTAINED
WITHIN THE DEVELOPING PAPILLAE?
To understand how papillae are formed and innervat-
ed, it is imperative that we first ask what are papillae,
at the molecular level? The papillae of the tongue are
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very similar in structure to the various ectodermal pla-
codes that cover the epidermis and give rise to hair,
feathers, and teeth. The secreted signaling factor sonic
hedgehog (shh) is expressed in cells that will form
these structures and that expression is maintained after
the papilla or placode has formed. We plan to exploit
this finding by using the shh locus to ectopically
express green fluorescent protein (GFP) in developing
papillae. Bacterial artificial chromosome (BAC)
clones carrying the shh gene are being isolated, and
using a recently described recombination technique,
we will insert GFP into this locus. Transgenic mice
will be generated using the modified BACs. Single
GFP-positive cells from the lingual epithelium of
E12-E17 embryos will be isolated and transcriptional-
ly profiled using a single-cell cDNA synthesis
method. Profiles will be obtained by screening
microarrays, tongue-specific macroarrays, and direct
sequencing of cDNAs. From this work, we hope to
determine the molecular diversity of the papilla during
its formation and innervation. Once we can "finger-
print" the cells of the papillae in this manner, it should
be possible to analyze the mechanisms that regulate
this diversity, in particular, the contribution of inner-
vation to the development of papillae.
HOW DIVERSE ARE BOTH THE MATURE RECEPTOR
CELL POPULATION AND THE PROGENITOR POOL
FROM WHICH IT IS DERIVED?
Morphologically, there are three types of cells within
the adult taste bud. Highly elongated differentiated
receptor cells are found at the apex of the bud. Mitotic
progenitor cells are found almost entirely at the bud's
base. Packed in between these two cell types are less
elongated cells that are believed to be the daughters of
the progenitors. Detailed electron microscopic obser-
vations have further divided the mature receptor cell
population into two to three distinct classes. The
recent identification of taste-specific seven-trans-
membrane receptors and heterotrimeric G-proteins
has demonstrated that within the mature receptor cell
population, there is a great deal of cellular diversity at
the level of expression of these genes.
We would like to analyze the molecular diversity
of both mature receptor and mitotic basal cells in
detail, without a bias toward a particular gene family.
In an approach that is similar to what is planned for the
developing papillae (see above), we will isolate both
murine and amphibian taste buds and generate tran-
scriptional profiles from single cells. We will screen
microarrays and taste-bud-specific macroarrays and in
some cases, directly sequence cDNA to obtain rele-
vant profiles. Once the internal make-up of the taste
bud is understood, it will be possible to analyze a num-
ber of issues. Does synapse formation have an instruc-
tive or permissive role in receptor cell maturation? Are
the progenitors identical at the molecular level? If so,
then how is receptor cell diversity achieved? If not,
then how are the progenitors themselves created?
DEVELOPMENT OF AN IN VITRO SYSTEM FOR
THE STUDY OF TASTE BUD FORMATION
There already exist in vitro culture methods for the
study of papilla formation and their innervation. There
is, however, no equivalent method for the study of
taste bud formation at the postnatal period. We will
attempt to culture either whole papillae or slices of
P7-P10 tongue. Both approaches have the drawback
that sensory afferents will be disturbed. The soma for
these neurons are located near the brain stem far from
the tongue, which makes it very difficult if not impos-
sible to imagine a preparation that could contain both
the lingual epithelium and the sensory afferents that
provide its innervation. However, taste bud formation
might resemble papilla formation in that innervation is
not required for the earliest stages of the process.
Single-molecule Analysis of
Enzyme Kinetics
T.R. Strick
In the next 3 years, our lab will develop and use sin-
gle-molecule techniques to quantitatively study DNA
supercoiling and its interactions with proteins
involved in transcription, replication, and chromo-
some compaction. Supercoiling describes the wrap-
ping of the two strands of DNA one about the other,
as well as the writhing of the double helix through
space (a twisted phone cord is a somewhat useful
analogy). Controlled in vivo by the topoisomerase
enzymes, it is both a regulator and a by-product of
DNA transcription, replication, and packaging.
Although supercoiling has been extensively studied in
the past using bulk experimental techniques such as
sedimentation or gel electrophoresis, new methods
now make it possible to mechanically control the
supercoiling of an individual DNA molecule. The
major advantage of performing experiments at the
level of single molecules is that it allows one to
observe in real time the behavior of the molecule,
eventually giving the researcher access to the time
course of a reaction between the DNA and a protein.
In this report, I briefly describe the methods to be
used as well as some of the results obtained previous-
ly in the study of DNA-topoisomerase interactions.
The single-molecule experiment we have just
implemented is depicted in Figure 1. An approximate-
ly 10-kbp linear DNA molecule is shown anchored at
one end to a glass surface and at the other end to a 1-
micron- diameter magnetic bead. The field generated
by magnets located above the sample is used to pull on
and rotate the magnetic bead, thus stretching and
twisting the tethered DNA. The stretching force
applied to the DNA depends solely on the distance
between the magnets and the sample (the closer the
magnets, the higher the force), whereas the twist
imparted to the DNA is exactly equal to the number of
clockwise or counterclockwise turns performed by the
magnets. The double helix is thus quantitatively and
reversibly supercoiled. By determining the position of
the magnetic bead, one measures the end-to-end exten-
FIGURE 1 Sketch of the experimental setup. A glass capil-
lary tube is mounted on an inverted microscope whose
focus is controlled by a computer. The computer also con-
trols the displacements (translation and rotation) of the mag-
nets used to manipulate the bead. A CCD camera connect-
ed to the microscope relays video images of the magnetic
bead to the computer. The computer extracts from these
images the mean position and the Brownian fluctuations of
the bead, which can be used to determine the applied
stretching force and the DNA's end-to-end extension.
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FIGURE 2 (Left) Sketch of the relaxation of supercoils by a topoisomerase II molecule, (Right) Discrete
steps in the DNA's extension were observed in the presence of limiting amounts of ATP and topoiso-
merase II, corresponding to single enzymatic cycles of the enzyme.
sion of the DNA molecule, and thus its mechanical
response to stretching and twisting.
Three types of structural transitions have been
observed in supercoiled DNA using this micromanip-
ulation technique. For low levels of mechanical tor-
sion, and in a manner which is identical for positive or
negative supercoiling, the molecule will writhe and
trace out loops ("plectonemes") similar to those
observed on a twisted phone cord (see Fig. 2, left).
This is evidenced by a rapid contraction of the bead
toward the surface. If the torsion becomes greater, the
double helix responds by locally hypertwisting (when
it is positively supercoiled) or by locally denaturing
of the topics
of research for the coming year in our lab will be to
study the onset of denaturation on a single supercoiled
DNA. Indeed, preliminary results indicate that the
supercoiled DNA undergoes reversible thermal melt-
ing on an approximately 30-bp scale and that this
process has a very slow dynamic. A better under-
standing of this denaturation will then be used to
study processes such as promoter melting prior to
transcription and the initiation of replication.
We will also pursue the analysis of plectonemes
using this apparatus, since these structures are very
useful in the analysis of DNA-protein interactions. As
an example, the interactions between topoisomerase II
and supercoiled DNA were recently studied at the sin-
gle molecule level. Type II DNA topoisomerases are
ubiquitous ATP-dependent enzymes capable of trans-
porting a DNA through a transient double-strand
break in a second DNA segment. This enables them to
untangle DNA and relax the plectonemes that arise in
twisted DNA. In vivo, they are responsible for untan-
gling replicated chromosomes and their absence at
mitosis or meiosis ultimately causes cell death. Here,
we monitored the supercoiled DNA's extension in the
presence of ATP and topoisomerase II and directly
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observed the removal of two supercoils during a single
catalytic turnover (see Fig. 2, right). Furthermore, spe-
cific steps of the enzymatic cycle could be studied by
withholding ATP or by modulating the applied stretch-
ing force. These results demonstrate that single-mole-
cule experiments are a powerful new tool for the study
of DNA-protein interactions.
Plant Developmental Genetics
M. Timmermans, M. Juarez, P Vahab, J. Thomas,
W. Songnuan
The long-term objective of the research in our lab is to
elucidate the molecular basis underlying the initiation
and patterning of lateral organs in plants. Pattern for-
mation during organogenesis in plants and animals is
likely a distinct process. For instance, small protein
morphogens such as wingless and hedgehog have not
been identified in the Arabidopsis genome. Plants are
also unique in that organogenesis continues beyond
the period of embryogenesis. Lateral organs such as
leaves arise progressively from a group of stem cells in
the shoot apical meristem. In the first step in organo-
genesis, founder cells are recruited from the meristem
and new developmental axes are specified relative to
the main body axis. Subsequently, the fate of the organ
becomes determined, resulting in the differentiation of
appropriate cell types in response to the basic pattern.
Early surgical experiments suggested that signals from
the meristem have an important role in the patterning
of lateral organs. However, the genes involved in the
initiation and patterning of lateral organs in plants are
still largely unknown.
We are using forward and reverse genetic
approaches to generate mutants in maize that affect
lateral organ initiation and patterning. In particular,
we are analyzing the roles of two genes: Leafbladelessl
(Lb11) and Rough sheath2 (Rs2). Lbll is required to
establish dorsal cell identity in leaves and leaf-like
lateral organs. Rs2 has an important role in the
repression of stem cell fate during organ initiation
and growth. A better understanding of the function
of these and other genes involved in pattern forma-
tion will provide new insights into fundamental con-
cepts of plant development. Variations in the expres-
sion patterns of such genes are likely to contribute to
the diversity of leaf shapes among many plant
species. More importantly, however, the isolation
and characterization of genes involved in the pat-
terning of leaves may facilitate the manipulation of
plant architecture, which has become increasingly
more important for aspects of crop yield such as
shade tolerance.
ROLE OF ROUGH SHEATH2 IN THE REPRESSION OF
STEM CELL FATE
Homeobox genes related to Knotted], the Knox genes,
are expressed in the shoot apical meristem and are
required for stem cell fate. Determinate lateral organs
such as leaves are initiated by the recruitment of
founder cells, which is facilitated by the down-regula-
tion of Knox gene expression in a subset of cells with-
in the meristem. Dominant neomorphic mutations in
Knox genes in maize result in displacement of proxi-
mal leaf features, sheath, ligule, and auricle to more
distal positions within the leaf blade. The recessive rs2
mutant causes a similar proximodistal patterning
defect. We have shown that the rs2 phenotype results
from the misexpression of KNOX proteins in leaf pri-
mordia, suggesting that Rs2 acts as a negative regula-
tor of Knox gene expression.
We have previously shown that the Rs2 gene
encodes a Myb-domain protein related to the
Antirrhinum gene Phantastica and that it is expressed
in young leaf primordia. Interestingly, KNOX protein
accumulation in leaves of rs2 null mutants occurs in
just a subset of cells that express Rs2 in wild type.
KNOX proteins accumulate in patches with sharp lat-
eral boundaries, suggesting that rs2 leaves are clonal
mosaics of Knox' and Knox sectors. The numbers and
sizes of such sectors vary among leaves and do not
correlate with normal developmental domains.
Furthermore, the down-regulation of Knox gene
expression during leaf initiation precedes the onset of
Rs2 expression, suggesting that Rs2 is required for
maintenance of Knox gene repression. On the basis of
these observations, we proposed that Rs2 acts as an
epigenetic regulator to keep Knox genes in an "off"
state. Rs2 may thus prevent differentiated daughter
cells from reverting into indeterminate stem cells. We
have generated RS2-specific monoclonal and poly-
clonal antibodies that we are using to determine more
precisely the temporal and spatial expression patterns
of RS2 and the KNOX proteins and to analyze
changes in RS2 accumulation in other maize mutants
affecting leaf initiation and patterning.
We are also studying the mechanism by which Rs2
regulates Knox gene expression by identifying genes
that act together with Rs2. We have constructed and
screened a two-hybrid library made from young maize
leaf primordia cDNAs. We have identified just over
200 cDNA clones that interact with RS2, and these
include homologs of several genes with known func-
tions in transcriptional repression or chromatin remod-
eling, but the specificity of their interaction has not yet
been confirmed.
DORSOVENTRAL PATTERNING OF LATERAL ORGANS
IN MAIZE
Normal maize leaves develop as flattened dorsoventral
organs with distinct cell types on the adaxiaUdorsal
and abaxial/ventral sides. We have previously shown
that the recessive leafbladeless] (lbll) mutation caus-
es a loss of dorsal cell types. Partial loss of Lbll gene
function results in the formation of ventralized radial-
ly symmetric leaves or in ectopic laminar outgrowth
surrounding ventralized sectors on the dorsal leaf sur-
face. In addition, we have shown that the number of
founder cells incorporated into lbll leaf primordia is
strongly reduced. These observations suggest (1) that
Lbll has a direct or indirect role in the down-regula-
tion of Knox genes during organ initiation, (2) that
dorsoventral patterning of the maize leaf primordium
occurs within the meristem during initiation, and (3)
that lateral growth of the organ occurs at the boundary
between dorsal and ventral domains. This latter point
is particular intriguing because lateral growth of insect
wings occurs similarly at the dorsoventral boundary.
We have identified three new alleles of lbll from
EMS- and transposon-mutagenized populations, and
we have introgressed these alleles into diverse maize
backgrounds which affect the severity of their pheno-
types. The ragged seedling] (lbll -rgdl) allele is the
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FIGURE 3 Expression pattern of the maize yabby gene,
Zmyab9, in the vegetative SAM. (A) Longitudinal section; (8)
transverse section. Not unlike the Arabidopsis YABBY genes,
Zmyab9 is expressed in the incipient primordium (arrow in A),
and in older leaf primordia, expression becomes restricted to
the vasculature and the margins of the leaf. However, in con-
trast to the ventral expression pattern of the Arabidopsis YABBY
genes, expression of Zmyab9 is restricted to the dorsal side of
the leaf (arrow in 8). The thin black lines highlight the circumfer-
ence of some leaf primordia.
most severe allele, and in particular maize back-
grounds, this allele results in embryo lethality. The
most penetrant lb 11 phenotype is male sterility. We are
currently analyzing the embryo-lethal and male-sterile
phenotypes in more detail. Our data suggest that
homozygous Ibll-rgd1 embryos develop a distorted
and more rounded scutellum (comparable to a cotyle-
don) and lack a shoot apical meristem (SAM). These
results suggest that establishment of dorsoventral
polarity in the scutellum may be required to initiate or
maintain a SAM, and they reveal a mutual relation-
ship between the dorsal leaf domain and SAM func-
tion. Signals from the SAM are required to specify the
dorsal leaf domain, and signals from the dorsal
domain of the scutellum (embryonic leaf) are required
to initiate or maintain normal meristem function.
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We have isolated several other mutants that affect
dorsoventral patterning. The phenotypes of two of
these mutations resemble lb11, but both mutations are
not allelic to Ibll. A third mutant is an allele of
Rolled] (Rid]) in maize. This is a semidominant
mutant that causes an inversion in leaf polarity. We
have begun double-mutant analyses between the dif-
ferent polarity mutants. The double mutant between
Rldl and Ibll resulted in a mutual suppression of both
phenotypes, suggesting that lbll and rldl act in an
opposing fashion on the same pathway or that Ibll and
rldl negatively regulate each other.
To characterize Ibll and the new dorsoventral pat-
terning mutants in more detail, we have cloned the
maize homologs of several Arabidopsis genes that are
expressed specifically in either the dorsal or ventral
domains of the leaf (Fig. 3). The Arabidopsis YABBY
genes act in the ventral domain of lateral organs and
are required for the maintenance or interpretation of
dorsoventral signals. We have isolated cDNAs for sev-
eral Yabby homologs from maize. We are currently in
the process of analyzing their expression patterns in
wild type and in the different dorsoventral patterning
mutants in maize. Preliminary data suggest that the
expression pattern of the maize Yabby genes is differ-
ent. As in Arabidopsis, the maize Yabby genes are
expressed throughout the incipient primordium, but
interestingly, expression later in development becomes
restricted to the dorsal side and to the margins of the
leaf. The basis for and the consequence of the opposite
Yabby expression patterns in Arabidopsis and maize is
currently under investigation.
In Press
Byrne M., Timmermans M., Kidner C., and Martienssen R.
2001. Development of leaf shape. Cum. Opin. Plant Biol. 4:
38-43.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
DEAN'S REPORT
We made it! The Watson School survived its first year! Happily, there are no casualties to report, as all
of the students in the first entering class of 1999 finished the year in good standing. The faculty and
School administration also survived. The first academic year of the Watson School doctoral program
was a great learning experience for all-the constructive feedback and advice from students, faculty,
and advisors improved and streamlined the curriculum as the year progressed. In addition, on August
28, we opened the doors to a new class of nine students from across the country and around the
world. It was truly an exciting year.
The Spring Curriculum
If the first Fall Course term in 1999 was intensive, the following Spring term from January to May was
hardly a walk in the park. Students returned from a 2-week holiday recess at the beginning of January
to face (1) laboratory rotations, (2) teaching at the DNA Learning Center, (3) a Topics in Biology course,
and, all importantly, (4) selection of a research mentor. The laboratory rotations ran the course of the
spring curriculum together with teaching at the DNA Learning Center. The Topics in Biology course, a
week-long "retreat" to study a specialized topic that lies outside the expertise of the Cold Spring Harbor
Laboratory faculty, was held in the fourth week of February. By the close of the spring term, the stu-
dents had sampled three different laboratory rotations and, after a week of discussion and reflection
on possible mentors, had made decisions concerning their selection of a research mentor.
Teaching at the DNA Learning Center
One of our goals for the graduate program has been to educate biologists who can communicate
effectively with nonscientists. This goal is one of the reasons that we devote a core course to scientif-
ic exposition during the fall term. For the spring, the School has taken advantage of the Laboratory's
unique DNA Learning Center, situated in Cold Spring Harbor village, to provide students hands-on
experience in communication to the layperson. The DNA Learning Center pioneered the teaching of
DNA science with laboratory instruction to high school and middle school students. The Watson
School students were given the opportunity to lead classes at the Center as part of a teaching pro-
gram developed especially for them.
In the first week of January, DNA Learning Center Director David Mick los met with all of the students
and described how the Center's instructors, led by Scott Bronson and Trisha Maskiell, would teach the
students how to lead the high school and middle school classes. The students would work in pairs and
begin by observing the instructors before progressing to co-teaching with the instructors and eventu-
ally teaching on their own. Once on their own, the students had to develop individual strategies to
explain the lessons being taught to the young students and be prepared to answer the questions of
the inquisitive minds of the students.
I sat in on three classes, one taught by each of the three pairs of students-Elizabeth Thomas and
Emiliano Rial Verde, Michelle Cilia and Niraj Tolia, and Amy Gaudy and Ahmet Den li-and was
impressed with both the quality and diversity of the lesson plans developed by the students. In the end,
the teaching experience was a great success and, were it not for the impending qualifying exam in June
and the need to focus on their thesis research, the students would have enjoyed continuing teaching
longer.
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Topics in Biology Course
Two other goals of the Watson School are to provide a broad education in the biological sciences-thus
demonstrating to the students how discoveries in seemingly unrelated fields influence one another-and
to teach that learning is a lifelong process that goes hand in hand with research. Providing a broad edu-
cation in the biological sciences at a small institution like Cold Spring Harbor Laboratory, with its focus
on plant genetics, cancer, neuroscience, and bioinformatics, is a challenge. To help meet this challenge,
we take advantage of the Laboratory's Banbury Conference Center, where its director Jan Witkowski,
together with Lilian Gann, organized the first Topics in Biology course this spring. After making a collec-
tive decision that immunology was an important area in which we could not offer firsthand instruction,
Jan identified Hidde Ploegh as just the person to organize and teach a 1-week course on this topic. I
was excited with the selection because I have known Hidde since we were both graduate students at
Harvard during the 1970s.
The selection was a resounding success. Hidde came to Banbury with his family to spend the last
week of February teaching what turned out to be an outstanding course; he is a lecturer par excellence
and provided an outstanding overview of immunology. He was aided by two visiting lecturers, Diane
Mathis and Uli von Adrian, and three teaching fellows, Margot Furman, Ben Gewurz, and Madelon
Maurice. Perhaps the most indicative measure of his success was that three non-Watson School stu-
dents who chose to audit the course stayed from beginning to end. The success of the course was
further enhanced by the beautiful Robertson House on the Banbury estate where Katya Davey hosted
dinner for the students and instructors each evening. In toto, students and teachers alike felt that the
course was an unqualified success.
Hidde Ploegh teaching the Topics in Biology course.
Laboratory Rotations and Selection of a Research Mentor
Throughout the spring term, the students participated in laboratory rotations and attended building-
wide group meetings. The goals of the 6-week rotations were to provide students with hands-on lab-
oratory experience, to give students and faculty opportunities to get to know each other, and to explore
possibilities for doctoral thesis research. The rotations were short but, nevertheless, by the end of each
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Student
ENTERING CLASS OF 1999
DOCTORAL THESIS RESEARCH
Academic Research
Mentor Mentor Thesis Research
Amy Anne Caudy Hollis Cline Gregory Hannon The biological function of RNA
George A. and Marjorie H. Anderson interference
Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Michelle Lynn Cilia Nouria Hernandez David Jackson Mechanisms of intercellular
William R. Miller Fellow trafficking via plasmodesmata
Beckman Graduate Student
Ahmet M. Dent Adrian R. Krainer Gregory Hannon Biochemical analysis of post-
David Koch Fellow transcriptional gene silencing
in plants
Emiliano M. Rial Verde Jan Witkowski Hollis Cline In vivo analysis of Arc function
David and Fanny Luke Fellow in Xenopus visual system
Howard Hughes Medical Institute development
Predoctoral Fellow
Elizabeth Ellen Thomas
Farish-Gerry Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
Niraj H. Tolia
Leslie C. Quick, Jr. Fellow
William Tansey Michael Wigler
Deed Helfman
A de novo approach to identi-
fying repetitive elements in
genomic sequences
Leemor Joshua-Tor Structural framework and
molecular mechanism of
caspase-9 activation
rotation, the students were able to make short presentations of their
studies to the other students, their rotation advisors and academic men-
tors, and the Scientific Exposition and Ethics core course instructors,
who commented on the students' performances. These talks allowed
the students to share their laboratory experiences, while providing them
with another opportunity to hone their presentation skills.
At the end of the three rotations in mid May, the students spent a
week discussing possibilities for thesis research with potential research
mentors, their academic mentors, and others. All of the students felt
comfortable making their decisions by the end of the week. I was
pleased that, in the end, the students displayed a diverse set of interests
and joined labs representing nearly all segments of the Laboratory's
research program.
Qualifying Exam
Emiliano Rial Verde with Lisa Foa during his lab-
oratory rotation in Hollis Cline's lab.
At the end of June, the students took an oral qualifying exam. The students were expected to possess
a broad basic knowledge of biology and to display the ability to acquire and articulate in-depth scien-
tific information by defending their knowledge of two assigned topics. The exam also tested the limits
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of each student's knowledge in the assigned topics. The aim of the exam was to assess whether stu-
dents had learned how, on their own, to acquire and synthesize critically scientific information on a new
topic. With this goal in mind, each student orally defended their knowledge in two topics-individually
assigned to each student at the end of May-over the course of 2 hours in front of three examiners.
One of the assigned topics was in the area of the student's planned thesis research, whereas the sec-
ond topic lay outside the thesis research area. Students were encouraged to meet with their examin-
ers to discuss the limits and expectations for the designated topics.
A critical element of this process was to ensure that the oral exams, which by their very nature will
differ in content and style from one student to the next, were fair and equitable to the students. The
School therefore established a "parent" committee-the Qualifying Exam Committee (QEC)-to over-
see the process. The inaugural QEC was composed of Gregory Hannon, Robert Martienssen, and
Linda Van Aelst, with me as its chair. The QEC established the list of topics offered to the students for
examination and made the final topic selections. The three examiners at each individual qualifying
exam were all members of the Watson School faculty. Greg, Rob, and Linda served as both examin-
ers and the chairs of two examining committees, while I sat in on each exam as a nonparticipating
observer to ensure parity in the examining process. The QEC assessed the reports of each examin-
ing committee and prepared reports for the Watson School Executive Committee, which made the
final decisions concerning the outcome of the qualifying exam. The QEC did an excellent job in mak-
ing this critical element of the School's curriculum a success. Strengths and weaknesses were
revealed through the course of the qualifying exam process, but in the end, all of the students suc-
cessfully completed this element of their curriculum and were able to begin focusing on their doctor-
al research in earnest.
Elizabeth Thomas Spends the Fall Term at MIT
From the very beginning, we were cognizant that, in establishing a doctoral degree program at Cold
Spring Harbor Laboratory, there would be areas in which we could not provide expertise on site. One
such area is instruction in mathematics. Even before she decided to join the founding class of the
Watson School, Farish-Gerry fellow Elizabeth Thomas had expressed her desire to improve her math-
ematical skills so that she could complete a doctoral thesis in the area of bioinformatics. Therefore, this
fall, Elizabeth attended courses in mathematics at the Massachusetts Institute of Technology. We were
pleased to learn at the end of the year that she had completed the courses
successfully, and we welcomed her back to Cold Spring Harbor.
Michelle Cilia performing thesis research
in David Jackson's lab.
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Thesis Proposal
Toward the end of the year, as the first class entered its second year of stud-
ies, the students began the process of preparing and orally defending a writ-
ten thesis proposal. The preparation and defense of the thesis proposal is a
defining step in our curriculum. With the proposal, the students provide a clear
outline of the goals and specific aims of their thesis research and place the
proposed research in the larger context of the ongoing debates in the field. It
is the time, early in the doctoral thesis work, for the students to think deeply
about their research. It is also the time when students can receive extensive
guidance and mentoring from diverse sources such as their research and aca-
demic mentors, thesis committee members, and the Scientific Exposition and
Ethics core course instructors. Therefore, the Watson School has devoted
much attention to developing a process for the thesis proposal that is most
beneficial to the students and mentors alike.
ENTERING CLASS OF 2000
Santanu Chakraborty, Indian Institute of Technology,
Bombay
George A. and Marjorie H. Anderson Fellow
Elena S. Ejkova, Moscow State University
Engelhorn Scholar
Rebecca C. Ewald, King's College, London
Engelhorn Scholar
Ira Hall, University of California, Berkeley
Arnold and Mabel Beckman Graduate Student
Guillaume Lettre, Universite de Sherbrooke, Quebec
George A. and Marjorie H. Anderson Fellow
Zachary Bela Lippman, Cornell University
Arnold and Mabel Beckman Graduate Student
Marco Mangone, La Sapienza University, Rome
Charles A. Dana Foundation Fellow
Masafumi Muratani, University of Tsukuba, Japan
George A. and Marjorie H. Anderson Fellow
Patrick J. Paddison, Evergreen State College,
Olympia, Washington
Arnold and Mabel Beckman Graduate Student
Back row (left to right): Patrick Paddison; Guillaume Lettre; Masafumi Muratani; Santanu Chakraborty
Front row (left to right): Elena Ejkova; Marco Mangone; Ira Hall; Zachary Lippman; Rebecca Ewald
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Preparation of the proposals began in October with the selection of thesis proposal committees.
The thesis proposal committee is composed of four members-the academic mentor and three facul-
ty members, one of whom may be external to Cold Spring Harbor Laboratory. At the end of the thesis
proposal defense, the research mentor joins the committee, at which time it becomes the student's
thesis advisory committee.
The written thesis proposal is ten pages long and follows the format of a National Institutes of Health
postdoctoral fellowship proposal, with the specific aims of the proposed research, an in-depth back-
ground and significance, and research design and methods provided. The experimental plan was
expected to be the result of extensive interactions between the student and research mentor and to
be focused on a specific biological question that can be appropriately addressed in the course of
approximately two and a half years of laboratory research. To aid the students-and true to form-the
Scientific Exposition and Ethics core course instructors, Adrian Krainer, William Tansey, and Jan
Witkowski, ran an excellent workshop in early November on the mechanics of the thesis proposal
preparation. Furthermore, they provided individual tutoring and guidance to each student once a draft
of the proposal had been prepared. Except for two justified exceptions for Elizabeth Thomas and Niraj
Tolia, the students submitted their written proposals in mid December and were expected to defend
them orally in front of their respective thesis proposal committee in January.
Recruiting a New Entering Class
Since the idea of a graduate school at Cold Spring Harbor Laboratory was first mentioned by James
Watson at a Trustees meeting in November 1995, the process of establishing the Watson School-
from developing a curriculum to obtaining accreditation to recruiting and teaching students-has been
a series of new challenges. This year, for the first time, those challenges began to repeat themselves
with the recruitment of a second entering class. Thus, for the first time, the School had to think of more
than one class at a time. I am pleased to report that the School administration and faculty both were
up to the challenge.
This year, Janet Duffy took over the reins of organizing the admissions process and working with
the Admissions Committee. The deadline for applications was advanced from February 1 to January
1 to allow more time for the admissions and recruitment process. The number of applications
increased to more than 150, and the School was fortunate that all the members of the first year's
Admissions Committee agreed to stay on for a second year, bringing their collective experience to bear
on the task ahead. We selected 25 applicants for interviews, of whom 24 agreed to come for a 1- to
3-day visit. Each visit was organized by Lilian Gann, who orchestrated approximately 300 different indi-
vidual interviews with faculty! Among the most dedicated were James Watson, who met with all of the
candidates, and Bruce Stillman, who met with all but one of the candidates. In the end, we made 12
offers of which 9 were accepted, an unexpectedly high acceptance rate of 75%. The 9 students who
accepted come from across the United States-California, New York, and Washington-and
abroad-India, Italy, Japan, England, Russia, and Canada-and are interested in a wide range of fields
(see box on page 193).
The Engelhorn Scholars Program Is Launched
This year saw the start of the new Engelhorn Scholars program. This program, endowed by a gift from
Curt Engelhorn through the European Foundation for the Advancement of Medicine, provides the nec-
essary 4-year support for one or two European students a year to enter the Watson School and per-
form their doctoral studies. In its inaugural year, we had two Engelhorn Scholars, Elena Ejkova from
Russia and Rebecca Ewald from Germany. We look forward to a rich tradition of Engelhorn Scholars.
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Nicholas C. Forstmann
1947-2001
The Watson School shares the widespread sense of personal loss occa-
sioned by the tragically early death of the very public-spirited investment
banker, Nicholas C. Forstmann. Two years ago, Les Quick invited Nick to
have lunch on his yacht, after first giving him a tour of our Lab, and learn
about our new Ph.D. granting program. In my office, I captured Nick's high-
ly curious mind by saying that the really big objective ahead in brain
research, if not for all of biology, was to find how information, say a tele-
phone number, is represented by precise synaptic connections between
groups of nerve cells. Then I conveyed my hope that Watson School stu-
dents would soon join the still limited number of bright minds trying now to
decipher the language by which information is stored in our brains.
By the time Nick's subsequent boat deck lunch with Les and Bruce
Stillman was over, Nick knew how he wanted to help us-through a gener-
ous gift toward the endowment of our core course on Scientific Exposition
and Ethics. Through it we aim to give our students an overview of how sci-
ence should proceed at the human level. That Nick chose this way to help
us was a natural extension of his athlete's sense of fair play and the pleasure that comes from being part of
endeavors in which competitors respect and learn from each other.
Nick was born in New York in 1947 and educated at the Lawrenceville School and Georgetown
University from which he received a Bachelor's Degree in Business Administration. Starting his career at J.P.
Morgan, he soon moved to join Kohlberg, Kravis and Roberts as the era of leveraged buyouts began. In
1978, he and his older brother Teddy and Brian Little founded their own buyout firm, Forstmann, Little and
Company. With time, it became spectacularly successful. So Nick had the means to respond to his deep-
felt philanthropic impulses, particularly through his leadership role in Catholic educational charities, among
them the Inner-city Scholarship Fund that helps economically destitute grammar and high schools.
Just a year ago, uncharacteristically feeling run down, Nick learned he had advanced small cell lung
cancer. Though Nick all too well knew his chances of beating it were small, he was determined to beat the
odds. He loved so much his life, in particular, his talented wife Lana and their three very young children. But,
alas, the best of anti-cancer drugs remained not equal to the worst of all cigarette-caused cancers. On
February 2, at the age of only 54, he died in his home in Manhattan. The funeral mass celebrated in a very
filled St. Patrick's Cathedral was an occasion of much grief for a universally admired man of exemplary hon-
esty, generosity, and fortitude.
James D. Watson
A Dedicated Endowment Grows
One of the very special features of the Watson School is that, in large part through an endowment,
the School covers the costs of the 4-year training of the graduate students, including tuition, stipend,
and research expenses. In this manner, the School can guarantee that the education of each student
remains focused on his or her academic development. The Watson School's capital campaign has
continued to be immensely successful largely owing to the dedicated efforts of its chairman David
Luke and Richard Cosnotti, Chief Development Officer, to whom we are most thankful for all their
efforts. Among many generous contributions this year, I am also very thankful to Cynthia and Leon
Polsky for establishing the Dean's Chair in Lita Annenberg Hazen's name. This chair is what cements
the School together by providing the essential administrative support that has been so important to
its success. Also critical this year was a gift to support four students and core course instruction over
a 5-year period by the Arnold and Mabel Beckman Foundation. This gift could not have been more
timely with the one or two extra incoming students who joined us this year.
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Undergraduate Research Program Alumni Join the Watson School
Since 1959, the Cold Spring Harbor Laboratory Undergraduate Research Program has been recruit-
ing outstanding undergraduate students for a 10-week summer sojourn at the Laboratory to perform
hands-on research. One of our hopes has been that we would be able to recruit such high-quality stu-
dents to our new graduate program. This hope is rapidly becoming a reality. In the first class, Elizabeth
Thomas is an alumna of the URP class of 1997 and, in the second class, three URP alumni joined the
class: Masafumi Muratani from the class of 1998 and Rebecca Ewald and Marco Mangone from the
class of 1999. The School is most grateful for the outstanding work that URP co-directors Michael
Hengartner and Leemor Joshua-Tor and administrator Jane Reader do to make the program so suc-
cessful each year.
A Second Fall Course Curriculum
The new students arrived during August and matriculated on August 28. This time, we were much
more prepared-we had been there once before!
With the advent of a new Fall Course term, many of the courses underwent changes and improve-
ments. The faculty teaching the School's flagship core course, the Leslie C. Quick, Jr. Core Course
on Scientific Reasoning and Logic, rotated. David Jackson decided to devote more time to his
research efforts, and W. Richard McCombie became an instructor of the new Specialized Disciplines
course on the genome. In their place, Gregory Hannon and Leemor Joshua-Tor joined the Scientific
Reasoning and Logic course. This year, the course became more integrated and the faculty made an
extraordinarily successful effort to give students timely feedback on their efforts by grading the week-
ly problem sets within an agreed upon and very tight schedule. On the Monday following each week-
ly module, the faculty responsible for that module returned the graded problem sets and met with the
students to review both the problem sets and themes of the previous week. Additionally, at David
Helfman's prompting, a final exam was instituted. This exam provided the students an opportunity to
review the 12 different weekly modules and to integrate what they had learned over the fall term.
Some of the students-while regretting having to say so!- commented that the exam had served its
purpose well.
The Norris and Henriette Darrell Core Course on Scientific Exposition and Ethics also had a change
in teaching faculty. Deborah Barnes, a founding course instructor, left the Laboratory early this year, and
a replacement had to be found. William Tansey, the course's lead instructor, was able to interest Jan
Witkowski, who has a long-standing interest in writing and ethics, to join as an instructor. I also took the
opportunity to join the course as a guest instructor. This year, the instructors provided the course with
more cohesion by adopting a novel format in which the syllabus was organized around the process by
which scientific research is accomplished-from the original idea for an experiment to the results, pre-
sentations and publication, funding, and the impact on scientists and society. The new format was most
engaging. I found that participating in the course was invigorating and valued my involvement in the core
course for the opportunity it afforded me to get to know the new crop of students.
The Specialized Disciplines courses also underwent an evolution. This year, the Specialized
Disciplines course on bioinformatics was replaced by a course on the genome led by Robert
Martienssen, with W. Richard McCombie and Lincoln Stein as co-instructors. The course retained a
heavy emphasis on bioinformatics and had the original bioinformatics course instructors Andrew
Neuwald and Michael Zhang as guest lecturers. It was also strengthened by more emphasis on the
biological import of genome structure and function. The transcription course taught by William Tansey
and me also evolved. This year, we placed much more emphasis on recent developments in our under-
standing of transcriptional control in both prokaryotes and eukaryotes, while maintaining a cherished
historical perspective. We also engaged the students much more effectively in the course by having
them read and discuss in class two selected articles during each week of the 3-week lecture segment
of the course. Hollis Cline, Roberto Malinow, and Karel Svoboda also came back this year for a repeat
performance of their very successful neurobiology course.
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In all, the Fall Course term was a success, showing improvements over the first year as the School
and its faculty gained experience.
Two-tier Mentoring
One of the special attributes of the Watson School curriculum is the high degree of mentoring and
tutoring offered to the students, and its most innovative feature in this regard is the two-tier mentoring
program in which each student eventually acquires both an academic and a research mentor. The idea
of two-tier mentoring originated with William Tansey, and he leads its academic mentoring program,
which continues to go from strength to strength. Shortly after matriculation, each student is assigned
a faculty member as an academic mentor. To make the mentor assignments, self-selected faculty put
their names forward as eligible mentors, and students interview those of their choice. After the inter-
views, the preferences of students and faculty are identified before mentors and students are matched.
This year was most encouraging as the number of faculty who put themselves forward as potential
mentors more than doubled-from 12 to 26. Listed below are the pairings of the new students with
mentors.
Student Mentor
Santanu Chakraborty David Hellman
Elena S. Ejkova Jan Witkowski
Rebecca C. Ewald Bruce Stillman
Ira Hall Shiv Grewal
Guillaume Lettre Zachary Mainen
Zachary Bela Lippman William Tansey
Marco Mangone Linda Van Aelst
Masafumi Muratani Nouria Hernandez
Patrick J. Paddison Adrian R. Krainer
Through regular meetings over the course of their graduate education, the academic mentors will
follow each student's progress and guide them through their academic development.
Shared Graduate Programs
Not only nine Watson School students joined the Laboratory in 2000. Although the Laboratory only
became a degree-granting institution in 1998, it has been involved in graduate education leading to
the Ph.D. degree in the biological sciences for more than 25 years. Graduate students from institutions
NEW STUDENTS FROM SHARED GRADUATE PROGRAMS
Student CSHL Research Mentor Affiliation
Nila Banerjee
Michelle Carmell
Bidisha Chattopadhyaya
Brian Chen
Michelle Juarez
Jason Kinchen
Zaher Nahle
Thomas Pologruto
Irina Pugach
Ashish Saxena
Stephanie Shaw
Kathryn Tworkowski
Michael Zhang
Gregory Hannon
Z. Josh Huang
Karel Svoboda
Robert Martienssen
Marja Timmermans
Michael Hengartner
Scott Lowe
Karel Svoboda
Grigori Enikolopov
Nouria Hernandez
Adrian Krainer
William Tansey
George Mason University, School of Computational Sciences
SUNY Stony Brook, Genetics
SUNY Stony Brook, Neurobiology and Behavior
SUNY Stony Brook, Neurobiology and Behavior
SUNY Stony Brook, Genetics
SUNY Stony Brook, Molecular Genetics and Microbiology
SUNY Stony Brook, Physiology and Biophysics
Harvard University, Biophysics Program
SUNY Stony Brook, Neurobiology and Behavior
SUNY Stony Brook, Genetics
SUNY Stony Brook, Molecular and Cellular Biology
SUNY Stony Brook, Molecular and Cellular Biology
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Michelle Carmell, a student in the Genetics Program with SUNY
Stony Brook is carrying out her thesis research in Greg Hannon's
lab.
with Ph.D. degree-granting authority, most notably the State University of New York (SUNY) at Stony
Brook, have performed their doctoral research at Cold Spring Harbor Laboratory. The Laboratory
remains heavily involved in many shared graduate programs with SUNY Stony Brook. These programs
help make Long Island a vibrant environment for graduate studies. This year, we welcomed 12 new
students to Cold Spring Harbor Laboratory (see box).
Special Events
Alternative Careers in the Bioscience Industry
This year, we were most fortunate in being able to take advantage of the excellent series of seminars
on "Alternative Careers in the Bioscience Industry" that were hosted by the Center for Biotechnology
at SUNY Stony Brook. This seminar series explored the diverse career opportunities present in the bio-
science industry and was aimed at seniors and graduate students in engineering, life sciences, and
bioscience. It provided an opportunity for them to explore alternative career paths in industry outside
academia and featured key industry speakers from the various fields of corporate R&D, finance, busi-
ness development, regulatory affairs, and entrepreneurial ventures. Seminar titles included:
The Strategy Beyond the Science-Careers in Business Development
A Dollar and a Dream-Life as an Entrepreneur
$$ High Risk, High Returns $$"-Explore Exciting Career Opportunities in the Financial and
Commercial Development of Pharmaceutical and Biotechnology Ventures
Gavin Borden Lecture
The sixth Gavin Borden Visiting Fellow Lecture (so named after the energetic and charismatic publish-
er of The Molecular Biology of the Cell, who died in 1991 of cancer) was given by Douglas A. Melton,
Ph.D., of the Department of Molecular and Cellular Biology, Harvard University, and the Howard
Hughes Medical Institute. The lecture, entitled "Construction of the Pancreas," was followed by a
reception and dinner for the speaker with the graduate students. The next day Dr. Melton met with
graduate students for an informal discussion.
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Holiday Party
This year saw the start of what we expect to become an annual tradition-the Graduate Student
Holiday Party. An organizing committee made up of students Emily Bernstein, Ira Hall, Michelle Juarez,
Andy Samuelson, Yvette Seger, and Joe West worked relentlessly with Charles Prizzi, Director of
Special Events, and Lilian Gann to make this event happen (with only three weeks notice!). The party
included a D.J., Karaoke, and the first annual "Wheel of Science" faculty-student challenge. In true
graduate-student party tradition, the faculty were "roasted" in an evening filled with challenges, games,
quizzes, and much more! We all eagerly await the same fate next year.
Michelle Juarez, Yvette Seger, and Emily Bernstein in fluorescent wigs at the
Graduate Student Holiday Party.
Curriculum Development and Oversight
To develop a curriculum and for it to evolve and improve requires the effort of many people dedicated
to the success of the School. In this regard, the School is most fortunate to have a dedicated and wise
executive committee. The Watson School Executive Committee meets monthly to address the wide
range of issues involved in overseeing the program and the progress of the students. Issues the com-
mittee addresses are numerous and include:
Determining the roles of faculty in the program.
Overseeing the committees for admissions and qualifying examinations.
Monitoring graduate student progress.
Developing and monitoring the curriculum.
The faculty and students on the committee have been instrumental in the School's development.
The Executive Committee meetings are characterized by thoughtful and lively discussions of issues
important to the School. Its members have devoted considerable time and intellectual resources to the
program's development, for which I am most grateful.
We have also been particularly fortunate to have two student representatives, John Mignone repre-
senting SUNY Stony Brook students and Michelle Cilia representing Watson School students. I am
most thankful to John for helping us at a time when the Watson School did not yet exist and the impact
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the new school would have on the existing graduate student population was still unknown. He dis-
played loyalty and vision in his advice on how to make the transition successful and the Watson School
special. At the end of the year, two new student representatives replaced John and Michelle; Amy
Gaudy for the Watson School and Ajit Janardhan for SUNY Stony Brook. We look forward to working
with them over the course of the next year.
External Advisory Committee
In such an endeavor as establishing a new doctoral program, internal advice and guidance alone are
not sufficient and the School is most fortunate to have an outstanding external advisory committee led
by Keith Yamamoto. The Watson School External Advisory Committee showed its dedication to the
School by visiting the lab twice, once in January and the second time in July, during its inaugural year.
In January, the committee reviewed the first Fall Course term. A major observation of the Advisory
Committee was that we need to ensure that the students are learning concepts and principles and
integrating the information being presented. The committee was concerned that because of the inten-
sity of the fall term and the modular structure of the Scientific Reasoning and Logic core course, the
students might perform a "brain dump" at the end of each week and forget what they had learned
before moving on to the next week's assignments. These and other astute observations have been a
major impetus for the aforementioned changes to the Fall Course curriculum.
During the Committee's second visit, in addition to reviewing the spring curriculum and our
changes for this fall, they encouraged me to reduce my level of involvement in some of the clearly
successful components of the School to focus my energy on new challenges and opportunities that
will emerge in the future. With this advice in mind, in December, I stepped down from the School's
Admissions Committee and, at the Watson School Executive Committee's suggestion, handed over
the reins to Noun's Hernandez. At year's end, she, Janet Duffy, and the Committee had their work cut
out for them as there was more than a 50% increase in the number of applications received over the
previous year!
Michael Hengartner Announces His Imminent Departure
Not everything could be as we desired this year. We learned from one of the founders of the Watson
School curriculum, Michael Hengartner, that he would be leaving us early in 2001 for an endowed pro-
fessorship at the University of Zurich. Such news was most unwelcome, but it offered a chance to
reflect on how valuable the faculty have been in establishing a novel curriculum.
Michael joined the Laboratory staff in 1994, fresh from his doctoral studies with
Robert Horvitz at MIT. From the very beginning, it was evident that Michael was
one of our most enthusiastic, energetic, and smart colleagues. Immediately,
graduate students gravitated to his lab and in him I saw a future leader of the
Undergraduate Research Program, of which he became director in 1995. From
the start, Michael took an active interest in graduate education and became
heavily involved in the Genetics Program at SUNY Stony Brook, where he was
a part of its admissions and executive committees.
For me, Michael's most important contribution was in developing the
Watson School curriculum. He was a frequent attendee of the weekly roundtable
discussions in the fall of 1997 at which the essence of the curriculum was devel-
oped. He was particularly interested in teaching students scientific reasoning
and logic. Together with Scott Lowe, he developed the first exemplary problem
set of the Scientific Reasoning and Logic Core Course-of course, on his
favorite topic: apoptosisl-which was used to gain our accreditation from theMichael Hengartner
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New York State Education Department as a degree-granting institution. When we actually began to teach the
course, he naturally became the founding lead instructor. His teaching capabilities were an inspiration to us all
as he was consistently rated one of the best lecturers by the students. And yet, not only was he involved in a
course, however important it may have been, he was also a founding member of the Watson School Executive
Committee and the Admissions Committee. He will be sorely missed, and we can only hope that we will be able
to rely on him in new ways in the future.
A Heartfelt Thank You
The preparation of this annual report makes one reflect on how much the Watson School depends on so many
people for its success. The first and second classes of students have shown extreme loyalty to the new pro-
gram, offering much constructive advice as we try things for the very first time. The lean-but not mean!-School
administration has performed flawlessly. Without the devotion, intelligence, tact, care, and hard work of Lilian
Gann and Janet Duffy, the School would be nowhere near as successful as it has been. Where would the School
be without the financial support provided by David Luke's leadership and our many generous benefactors, or
without the sage advice of our external advisory committee led by Keith Yamamoto? The Laboratory's adminis-
tration led by Bruce Stillman and James Watson has supported the School at every step, while offering it the
opportunity to spread its wings. And it is a never-ending wonder to me that, at an institution known to attract
scientists for the freedom to pursue their research, there has been so much commitment and devotion by the
faculty to teaching, student mentoring, and developing new ideas for the curriculum. The School would pale in
comparison were it not for all that caring people have done for it, and for this I am most thankful.
April, 2001 Winship Herr
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SPRING CURRICULUM
Topics in Biology: Immunology
ARRANGED BY Lilian Gann
Jan Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship
The Fairchild Martindale Visiting Lectureship
The Lucy and Mark Ptashne Visiting Lectureship
The Michel David-Weill Visiting Lectureship
INSTRUCTOR Hidde Ploegh, Harvard Medical School
GUEST LECTURERS Diane Mathis, Jos lin Diabetes Center
Uli von Andrian, Harvard Medical School
TEACHING FELLOWS Margot Furman, Harvard Medical School
Ben Gewurz, Harvard Medical School
Made lon Maurice, Harvard Medical School
Each year, one or a team of invited instructors offer a 7-day course at the Banbury Conference Center
to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory faculty. The
course includes morning or evening lectures as well as afternoon sessions during which students read
assigned papers. For Spring 2000, the topic was immunology. This course introduced the elements of
the immune system, illustrating its unique characteristics as well as those it shares with other biological
systems. The course ran from Sunday to Sunday, February 20-27, and was organized and largely
taught by Hidde Ploegh. Two guests-Diane Mathis and Uli von Andrian-also lectured in the course,
and three teaching fellows participated in all aspects of the course. The course was highly rated by all
of the student participants, including course auditors.
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Back row (left to right): Hidde Ploegh,
Tomasz Swigut, Eric Gillitzer, Niraj Tolia
Middle row (left to right): Ahmet Den li,
Margot Furman, Ben Gewurz, Madelon
Maurice
Front row (left to right): Amy Gaudy,
Michelle Cilia, Takashi Odawara, Elizabeth
Thomas, Emiliano Rial Verde
Teaching Experience at the DNA Learning Center
INSTRUCTOR David A. Mick los
CO-INSTRUCTORS Scott Bronson
Trisha Maskiell
As science plays an increasing role in society, there is an increasing need for biologists to educate non-
scientists of all ages about biology. The Watson School of Biological Sciences doctoral program offers
its students unique teaching experiences through the Laboratory's DNA Learning Center, where stu-
dents teach laboratory courses. From these teaching experiences, they learn how to communicate
with nonbiologists and to inspire and educate creative young minds. The teaching module entailed
pairs of students teaching one morning a week for 12 weeks. During this time, the students had the
opportunity to teach both high school and middle school students. In the initial weeks, the course
instructors taught the students the didactic process-it was not until the fifth week that the students
taught on their own. At the end of the 12 weeks, the students were very excited about their teaching
experience.
Laboratory Rotations
MENTORS Hollis Cline
Grigori Enikolopov
Shiv Grewal
Gregory Hannon
Michael Hengartner
David Jackson
Leemor Joshua-Tor
Lincoln Stein
Bruce Stillman
Karel Svoboda
Michael Wig ler
Anthony Zador
Michael Zhang
The most important element of a doctoral education is learning to perform independent research that
leads to a unique contribution to human knowledge. After the fall course term, students participate in
laboratory rotations. These rotations provide students and faculty the opportunity to get to know each
other and to explore possibilities for doctoral thesis research. At the end of each rotation, students
make a short presentation of their studies to the other students and their rotation advisors. These talks
give students an opportunity to share their laboratory experiences and to learn how to give a scientific
presentation. With this latter goal in mind, the instructors of the Scientific Exposition and Ethics core
course attend the talks and give individual feedback to students on their presentations. This year, 13
CSHL faculty members (listed above) served as rotation mentors.
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FALL COURSE CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on
Scientific Reasoning and Logic
INSTRUCTORS Michael Hengartner (lead) David Helfman
Grigori Enikolopov Leemor Joshua-Tor
Gregory Hannon Scott Lowe
GUEST LECTURERS Alexander A.F. Gann
Bruce A. Futcher
David Jackson
Winship Herr
Adrian R. Krainer
Yuri Lazebnik
Robert Martienssen
Jacek Skowronski
David L. Spector
Arne Stenlund
Bruce Stillman
Nick Tonks
Linda Van Aelst
Michael Wig ler
Jan Witkowski
Rui-Ming Xu
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the Fall Course curriculum, students (1) acquired a broad base of knowledge
in the biological sciences, (2) learned the scientific method, and (3) learned how to think critically. This
course consisted of 12 weekly segments, each of which had a different theme. Each week, students
read an assigned set of research articles (generally five articles) and provided written answers to a prob-
lem set that guided them through two (or, on occasion, one) of the articles. Twice weekly, students
attended lectures related to the week's topic, which included concepts and experimental methods.
During the week, the students met to discuss the assigned papers not covered by the problem set
among themselves. At the end of each weekly segment, the students submitted their problem sets and
spent the evening discussing with faculty the articles not covered by the problem set. This year, the
course culminated with a final exam in the last week. Studying for the final exam gave the students the
opportunity to synthesize and integrate what they had learned over the course of the fall term. The
weekly topics were:
Week 1 Macromolecular Structure
Week 2 DNA Replication
Week 3 RNA Processing
Week 4 Protein Kinesis
Week 5 Signal Transduction
Week 6 Cell Cycle Regulation
Week 7 Cancer Genes
Week 8 Apoptosis
Week 10 Cell-Cell Communication
Week 11 Mobile Genetic Elements
Week 12 Development
Week 13 Final Exam
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The Norris and Henriette Darrell Core Course on
Scientific Exposition and Ethics
FUNDED IN PART BY The Edward H. Gerry Visiting Lectureship
The John P. and Rita M. Cleary Visiting Lectureship
The Martha F. Gerry Visiting Lectureship
The Susan T. and Charles E. Harris Visiting Lectureship
INSTRUCTORS William Tansey (lead)
Adrian R. KraMer
Jan Witkowski
GUEST INSTRUCTOR Winship Herr
GUEST LECTURER Terri Grodzicker
VISITING LECTURERS Robert P. Charrow, Esq., Crowell & Moring LLP
Maria Freire, Director, Office of Technology Transfer, NIH
Joe Palca, Senior Science Correspondent, National Public Radio
Nancy Wexler, Department of Psychiatry, Columbia University
This core course offered instruction about the fundamental elements of scientific exposition-writing
skills and public speaking-and ethics. The ability to communicate effectively and to appreciate the
intricacies of ethical issues are essential skills for biologists; both subjects were taught in a series of
example-based lectures and discussion groups. This year, the course took on a novel format in which
the course was organized around the scientific process, starting with how the ideas for an experiment
develop and covering execution of the experiment, presentation of the results at seminars and in pub-
lication, funding, and the implications of the experimental results on scientists and society. Asa part of
learning how to make oral presentations, together with the instructors, the students also critiqued for-
mal seminar presentations at the Laboratory. A primary objective of the course was for students to con-
sider exposition and ethics as an integral part of scientific research. An added benefit of this course was
that three of the visiting lecturers, Robert P. Charrow, Maria Freire, and Joe Palca, also lectured to the
entire Cold Spring Harbor Laboratory community.
Research Topics
ARRANGED BY Lilian Gann
David Hellman
This core course provided students with an in-depth introduction to the fields of research that the
Laboratory scientists investigate. Students and faculty attended a weekly Research Topics seminar, at
which faculty members presented their current research topics and methods of investigation each
Wednesday evening. The students learned how to approach important problems in biology. These
seminars, together with the annual fall in-house symposium, provide students with a basis for select-
ing laboratories in which to do rotations. The weekly speakers were:
Week 1 Ryuji Kobayashi, Andrew Neuwald, Rui-Ming Xu
Week 2 Leemor Joshua-Tor, Arne Stenlund, Bruce Stillman
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Week 3 David L. Spector, Michael Zhang
Week 4 Hollis Cline, David Jackson, Jacek Skowronski
Week 5 Linda Van Aelst, Jerry Yin, Yi Zhong
Week 6 Robert Lucito, William Tansey
Week 7 Shiv Grewal, Gregory Hannon, Tatsuya Hirano
Week 8 Masaaki Hamaguchi, Scott Lowe, Michael Wig ler
Week 9 Michael Hengartner, Nouria Hernandez, Adrian R. Krainer
Week 10 Winship Herr, Yuri Lazebnik, Lincoln Stein
Week 11 David Helfman, Karel Svoboda, Roberto Malinow
Week 12 Tim Tully, Z. Josh Huang
Week 13 W. Richard McCombie, Nicholas Tonks
Week 14 Dmitri Chklovskii, Zachary Mainen, Anthony Zador
SPECIALIZED DISCIPLINES COURSES
The Genome
FUNDED BY The George W., Jr. and Lucy Cutting Lectureship
The Quick & Reilly Lectureship
The George B. Rathmann Lectureship
INSTRUCTORS Robert Martienssen
W. Richard McCombie
Lincoln Stein
GUEST LECTURERS Robert Lucito
Vivek Mittal
Andrew Neuwald
Michael Wig ler
Jan Witkowski
Michael Zhang
VISITING LECTURER Benjamin Burr, Brookhaven National Laboratory
The first draft of the human genome sequence was completed this year, and the new science of
genomics promises to revolutionize biological concepts and approaches, making the computer as
essential a tool for research as the microcentrifuge and electrophoresis unit. With computer software,
scientists can digest the enormous amount of genetic information produced by the genome project,
and answer questions about evolution, model complex processes such as signal transduction and
gene regulation, and manage and organize experiments. This course provided essential background as
to how sequence and mapping information is generated and interpreted, the principles of microarray
and other functional strategies, and the history of the genome project. It also provided a practical intro-
duction to bioinformatics, including computational biology, biological data modeling, and laboratory
workflow management. Topics covered included genetic and physical mapping, DNA sequence acqui-
sition and interpretation, Web-based resources for genome data, gene modeling, and protein and DNA
sequence analysis, phylogenetic analysis, and functional genomics.
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Mechanisms of Transcriptional Regulation:
From E. coli to Elephants
FUNDED IN PART BY The Mary D. Lindsay Lectureship
INSTRUCTORS Winship Herr
William Tansey
GUEST LECTURERS Alexander A.F. Gann
Nouria Hernandez
Leemor Joshua-Tor
David L. Spector
This year, a draft of the complete sequence of the human genome has been determined, thus pre-
senting a complete set of instructions for human life. These instructions are read through the process
of gene transcription, and regulation of this process is central to the control of gene expression. This
course presented an integrated description of transcriptional regulation in prokaryotes and eukaryotes.
An underlying theme of the course was that, as postulated by Jacques Monod, what is true for E. coli
is true for elephants. The course was presented from both a historical perspective-to illustrate how
the ideas in the field developed-and a current perspective-to provide today's view of transcriptional
regulation in normal and diseased states.
Mechanisms of Synaptic Plasticity and Learning
FUNDED IN PART BY The Edward H. and Martha F. Gerry Lectureship
The Klingenstein Lectureship
INSTRUCTORS Hollis Cline
Roberto Malinow
Karel Svoboda
This course explored the cellular plasticity that underlies changes in brain function associated with
development and with learning and memory. The study of the development of the visual system shows
how organized topographic sensory projections develop in the central nervous system. Discussions of
research on the mammalian hippocampus using behavioral, cellular, and molecular approaches were
analyzed in order to describe the cellular basis of learning and memory in the adult brain. Ultimately,
students gained an understanding of neural plasticity in development and in learning and memory.
207
UNDERGRADUATE RESEARCH
Program Co-Directors: Michael Hengartner, Ph.D.
Leemor Joshua-Tor, Ph.D.
Program Administrator: Jane Reader
An important aspect of the summer program at Cold Spring Harbor Laboratory is the participation of
college undergraduate students in active research projects under the supervision of full-time laborato-
ry staff members. The program was initiated in 1959. Since that year, 552 students have participated
in the course, and many have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental princi-
ples of biology; (2) an increased awareness of experimental approaches to science; (3) a deeper under-
standing of the major issues in the fields of biochemistry, genetics, and molecular and cellular biology;
and (4) a personal acquaintance with research, research workers, and centers for study. The following
students, selected from 546 applicants, took part in the program:
Michelle A. Aaron, Clarion University
Sponsor: National Science Foundation
Advisor: Dr. Adrian Krainer
Exon definition and alternative splice site selection in AT-AC
intron splicing.
Sarah Addou, University College, London
Sponsor: Emanual Ax Fund
Advisor: Dr. Lincoln Stein
Genetic map display for ACeDB.
Bottom row, left to right: Sarah Hart, Despina Siolas, Ramya Rajagopalan, Michell Aaron, Daniela Cohen, Frederick
Tan, Maria Vichnevskaia
Middle row, left to right: Charles Kopec, Dougal Tervo, Kevin Vogeli, Sarah Addou, Doubles Weinstein, Trevor Yeung,
Eileen Wood
Top row, left to right: Mario Ezaguirre-Sierra, Tariq Ahmad, Michael Ryczko, Abullah Ozer, David Schlesinger, Ahmed
Elewa, Guillermo Munoz-Elias
Not pictured: Heather Cosel-Pieper, Natalia Caporale, Joan Hu, Sarah Archer-Evans, John D'Amore, Wisuwat
Songnuan
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Twig Ahmad, New York University
Sponsor: National Science Foundation
Advisor: Dr. Ryuji Kobayashi
Phosphorylation analysis of p62dok.
Sarah Archer-Evans, University of Texas
Sponsor: National Science Foundation
Advisor: Dr. David Jackson
Subcellular localization of fasciated ear2 in maize.
Natalia Caporale, University of Buenos Aires
Sponsor: Olney Fund
Advisor: Dr. Zachary Mainen
Individual recognition and its neuronal representation in the
olfactory bulb.
Daniela Cohen, Yale University
Sponsor: National Science Foundation
Advisor: Dr. Yi Zhong
Role of Notch in activity-dependent synaptic plasticity.
Heather Cosel-Pieper, New York University
Sponsor: The JM Foundation
Advisor: Dr. Scott Lowe
Toward an understanding of the cellular response to
chemotherapy.
John D'Amore, Harvard University
Sponsor: The JM Foundation
Advisor: Dr. Robert Malinow
The surface expression of NMDA receptors.
Ahmed Elewa, Cairo University
Sponsor: Garfield Fund
Advisor: Dr. Michael Hengartner
Measuring proliferation kinetics in the germ line of
Caenorhabditis elegans.
Sarah Hart, Cambridge University
Sponsor: Burroughs Wellcome
Advisor: Dr. William P. Tansey
Characterization of the F-box protein BAA7.
Joan Hu, Washington University
Sponsor: National Science Foundation
Advisor: Dr. Rui-Ming Xu
Toward the structural study of pre-mRNA splicing factors.
Mario Izaguirre-Sierra, National Autonomous University of
Mexico
Sponsors: Glass Fund & Libby Fund
Advisor: Dr. David Spector
Does actin play a role in nuclear structure?
Charles Kopec, Rutgers University
Sponsor: The JM Foundation
Advisor: Dr. Robert Martienssen
Expanding on a model of RA1s function in Zea mays.
Guillermo Munoz-Elias, Rutgers University
Sponsor: Frederica Von Stade Fund
Advisor: Hollis T. Cline
Lending ears to silent synapses: Regulation and expression of
calcium permeable AMPA receptors in the developing retino-
tectal system of Xenopus.
Abdullah Ozer, Bilkent University
Sponsor: Burroughs Wellcome Fund
Advisor: Dr. Yuri Lazebnik
Construction of single-chain antibodies against caspase-9,
caspase-7, and APAF-1.
Ramya Rajagopalan, Cornell University
Sponsor: Burroughs Wellcome
Advisor: Dr. W. Richard McCombie
Sequencing of a tomato BAC; analysis of promoter regions of
nodulin-like genes in Arabidopsis thaliana.
Michael Ryczko, Laurentian University
Sponsor: Bliss Memorial Fund
Advisor: Dr. Tim Tully
Adfl transcription factor and synapse formation in Drosophila
melonagaster.
David Schlesinger, Brigham Young University
Sponsor: Jephson Educational Trust
Advisor: Dr. Linda Van Aelst
Molecular characterization of oligophrenin-1.
Despina Siolas, St. John's University
Sponsor: National Science Foundation
Advisor: Dr. Gregory Hannon
Developing a procedure for creating a phenotype array using
RNA interference in Drosophila cells.
Wisuwat Songnuan, Duke University
Sponsor: Shakespeare Fund
Advisor: Dr. Marja Timmermans
Repression of homeobox genes by Rough Sheath2 in maize
lateral organ primordia.
Frederick Tan, Worcester Polytechnic Institute
Sponsor: Jephson Educational Trust, Read Fund
Advisor: Dr. Andrew Neuwald
Rapid sequence alignment against hidden Markov models.
Dougal (Gowan) Tervo, Oxford University
Sponsor: Burroughs Wellcome
Advisor: Dr. Anthony Zador
An electrophysiological and behavioral investigation of pitch in
the rat.
Maria Vichnevskaia, University of Bridgeport
Sponsor: Burroughs Wellcome Fund
Advisor: Dr. Michael Zhang
Identification of CREB targets in Drosophila melanogaster.
Kevin Vogeli, University of California, Berkeley
Sponsor: National Science Foundation
Advisor: Dr. Grigori Enikolopov
Role of nitric oxide signaling in early Xenopus development.
Douglas H. Weinstein, Duke University
Sponsor: The JM Foundation
Advisor: Dr. Leemor Joshua-Tor
Replication in the papillomavirus: A structural study.
Eileen Woo, Harvard University
Sponsor: National Science Foundation
Advisor: Dr. Bruce Stillman
Isolation and characterization of human Rad1, Rad9, and
Hus1: A putative PCNA-like complex.
Trevor M.-Y. Yeung, Clare College, Cambridge University
Sponsor: Burroughs Wellcome Fund
Advisor: Dr. David Helfman
An investigation into the importance of a 13-amino-acid
trigger sequence in mediating the dimerization of LMW
tropomyosin.
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NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to acquire
a greater knowledge and understanding of their environment. Through a series of specialized field cours-
es, younger students can engage in introductory programs such as Nature Bugs, Nature Detectives, and
Nature Discovery, and older students can enroll in more advanced programs such as Marine Biology and
Nature Photography.
During the summer of 2000, a total of 350 students participated in 27 courses within the program.
The classes were held outdoors, weather permitting, at the West Side School. The Laboratory has
equipped and maintains classroom and laboratory facilities as well as a darkroom at West Side School.
This facility is used as a base for the student's exploration of the local environment. Field classes are held
on Laboratory grounds, St. John's Preserve, Fire Island National Seashore, the Nature Conservancy,
Caumsett State Park, the Cold Spring Harbor Fish Hatchery and Aquarium, and other local preserves
and sanctuaries.
In addition to the three 2-week sessions, the Adventure Education course met on one Friday for a
12-mile canoe trip on the Nissequogue River to navigate and explore the waters of Long Island.
PROGRAM DIRECTOR: William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR: Sharon Bense, Cold Spring Harbor Laboratory
INSTRUCTORS: Alison Smith, B.S., Marine Science, University of Rhode Island
Michael Zarzicki, BA., English, Adephi University
Margot Gallowitsch, B.S., Biology, Fairfield University
Amy Friedank, B.S., Marine Science, Long Island University/Southampton College
Steve Gravano, School of Visual Arts, New York City
Patricia Grimaldi, B.S., Biology, SUNY at Stony Brook
COURSES
Nature Bugs (Kindergarten): Exploration, games, stories, and dramatics are used to introduce the young
child to a variety of natural habitats.
Nature Detectives (Grades 1-2): An introductory course in nature study, stressing interrelationships
between plants and animals. A variety of habitats are thoroughly explored.
Nature Discovery (Grades 1-2): Students continue their discovery of nature through activities and con-
cepts.
Ecology Explorers (Grades 3-4): Natural communities, food webs, and a succession of communities are
studied in this course. Students study the diversity of plant and animal forms native to the Cold Spring
Harbor Laboratory harbor area.
Frogs, Flippers, and Fins (Grades 3-4): Designed for younger students as an introduction to aquatic
ecosystems. Fresh water and marine habitats are explored.
Pebble Pups (Grades 3-4): Elementary geology for students interested in making a basic study of rocks
and minerals available on Long Island. Each student completes a rock and mineral collection. Dinosaurs
and fossils are featured themes in this course.
Freshwater Life (Grades 5-7): Students study the vertebrate, invertebrate, and plant life found in area
bogs, ponds, lakes, and streams.
Seashore Life (Grades 5-7): Children examine plant and animal life found below the tidemark. Fish,
marine worms, algae, shellfish, beach plants, and shore birds are studied.
Adventure Education (Grades 6-10): This course is a 12-mile canoe trip up and down the Nissequogue
River exploring the flora and fauna of the waterway.
Marine Biology (Grades 8-10): This course offers a more sophisticated study of plants and animals
native to the inner and outer harbors. This course provides field trip, dissection, microscope, and labora-
tory experiment experiences.
Nature Photography (Grades 8-10): Students take pictures and use the darkroom to learn techniques
of printing and developing. Photographic techniques relating to nature photography are emphasized.
Each student supplies their own camera and film; darkroom supplies are provided.
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ACADEMIC AFFAIRS
The Academic Program in 2000 brought scientists from all over the world to the Laboratory to teach, learn,
and communicate about the latest results and methodologies in a wide range of areas. The program this
year included 25 laboratory and lecture courses and 18 meetings, including the Cold Spring Harbor
Laboratory Symposium, which focused on Biological Responses to DNA Damage.
The course program ran from March through November and covered areas ranging from molecular
biology and biochemistry, genetics and genomics, and bioinformatics to structural biology and neuro-
biology. In the summer, 3-week laboratory courses were held, as well as lecture and workshop cours-
es at the Laboratory's Banbury Center. A series of 1- and 2-week courses continue to be held in the
spring and summer. Regardless of length and topic, the courses emphasize teaching the latest con-
cepts and techniques that can be immediately applied to the student's own research. The timeliness
and unique usefulness of the courses are reflected in the number and quality of the students who apply
to take them. For example, there were almost 300 applicants for the two bioinformatics courses that
were given in the fall. All of the courses were oversubscribed. The students who attended ranged from
graduate students and postdoctoral fellows to senior faculty. This unique mix of students made the
course labs a very lively place to be. Of course, the popularity of the courses depends, in large mea-
sure, on the wonderful instructors who come from around the world to teach them. Since the courses
extend from the morning until late into the evening, the instructors' energy and stamina as well as
expertise and knowledge are called into play. The course instructors, assistants, and lecturers are list-
ed in the Postgraduate Courses Section, and we are very grateful to them for their fabulous work.
The courses are supported by grants from the National Institutes of Health, the National Science
Foundation, the Howard Hughes Medical Institute, and the Grass Foundation. A variety of companies,
which are listed following the Postgraduate Courses Section, also lend valuable equipment and supplies.
A series of meetings and biotechnology workshops were held this year in the Grace Auditorium. The
highlight of the meetings season is always the Symposium, which was very exciting this year. This
heavily oversubscribed meeting, organized by Bruce Stillman, brought scientists from all over the world
to discuss their latest results in a rapidly moving area. Other oversubscribed meetings included those
on Translational Control, Genome Sequencing and Biology, and Zebrafish Development and Genetics.
In fact, we are saying farewell this year to the Zebrafish meeting, which was started here several years
ago and has now grown so much that it must seek a larger venue. The organizers, session chairs, and
session topics for the 2000 meetings are listed in the following pages.
One of the reasons that so many outstanding scientists are willing to teach courses and organize
meetings is the huge amount of skilled help that is provided by staff at the Laboratory. They include
Andrea Stephenson, the Course Registrar; Ed Campodonico, the Manager of Audiovisual Services; and
Barbara Zane, the Course Coordinator. Staff of the Meetings and Courses office handle an ever-increas-
ing and complex workload with efficiency, skill, and good humor. They include those listed above, as well
as Michael Glaessgen, Drew Mendelsohn, Mary Smith, Marge Stellabotte, and Jenna Williams. Housing
and front-desk services are provided by Nancy Weeks, the Head Concierge, and by Donna Dykemen
and Andrea Newell. Audiovisual services are ably provided by Ed Campodonico, William Dickerson,
John Parsons, and the part-time audiovisual staff. Staff from several other departments also do crucial
work for the courses and meetings, including Wendy Crowley, the Education Grants Manager; Cliff
Sutkevich and his staff, who set up and maintain course equipment; and Leigh Johnson in the Library,
who handles the book and journal needs of the courses. The Information Services Department, headed
by Jerry Latter, provides ever-increasing computer support for all of the courses and meetings.
Terri Grodzicker
Assistant Director for Academic Affairs
David Stewart
Director of Meetings and Courses
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65th COLD SPRING HARBOR SYMPOSIUM ON
QUANTITATIVE BIOLOGY
Biological Responses to DNA Damage
May 31-June 5 451 participants
ARRANGED BY Bruce Stillman, Cold Spring Harbor Laboratory
There are few times in science when all the planets align, allowing what were apparently different areas
of investigation to come together to present a new view of a field. Such appeared to be the case for
the varied fields that focused on the diverse aspects of the biological responses to DNA damage. DNA
repair, genotoxic stress, telomere maintenance, and cell division cycle checkpoint control were, not so
long ago, fields of research that did not obviously overlap. Now they are so intertwined that ignoring
developments in any one area would limit one's view of how cells respond to biological damage.
Indeed, Barbara McClintock's long-held notion that the genome can sense what is going on in its envi-
ronment does not now appear to be far from the truth. Moreover, understanding DNA damage control
is providing great insight into the mechanisms of cancer progression because cancer is a disease
caused by genome instability. Perhaps most surprisingly, genome damage controls are now intimately
tied into pathways that, when altered, cause premature aging of cells and when overexpressed, pro-
mote life extension. Combining these areas of research into a single symposium was too much of an
opportunity to pass by.
There has not been a Cold Spring Harbor Symposium devoted entirely to this topic, which is per-
haps surprising since Evelyn Witkin initiated studies with Milistav Demerec on ultraviolet-induced muta-
tions in bacteria at Cold Spring Harbor in 1944. This ultimately led to her major contributions to uncov-
ering the SOS response. Discussion of the nature of mutations and genetic damage was pervasive at
Cold Spring Harbor in the 1940s and 1950s due to the presence of Demerec, Max Delbruck, Salvador
"At the Picnic"
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Luria, and Barbara McClintock and can be traced to the 1941 Symposium on "Genes and
Chromosomes: Structure and Organization," which occurred long before the double helix was revealed.
We have come a long way in our understanding since then, and it was about time to correct the long
absence of this topic from these Symposia.
The Symposium started with a fascinating first night of introductory talks from Graham Walker,
Stephen El ledge, Elizabeth Blackburn, and Fred Alt. In all, the formal scientific program consisted of 67
oral presentations and a record 239 poster presentations, and the meeting attracted 451 participants
who packed the Grace Auditorium. I thank Errol Friedberg for agreeing to summarize the meeting and
writing such a marvelous and thoughtful summary for the Proceedings, matching the great summaries
of previous Symposia.
This meeting was funded in part by the National Cancer Institute, a branch of the National Institutes
of Health. In addition, financial help from the Corporate Sponsors, Affiliates, Associates, and
Contributors to our meetings program is essential for these symposia to remain a success, and we are
most grateful for their continued support. Corporate Sponsors include Amgen Inc.; AstraZeneca;
T. Lindahl, M. Kastan, R. Fishel, E. Friedberg
R. Rothstein, T. de Lange
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C. Greider, Gwendolyn Marie Comfort
E. Witkin, P. Hanawalt
J. Campbell, R. Kolodner, L. Guarente B. Stillman, J. Hoeijmakers
Aventis Pharma AG; BASF Bioresearch Corporation; BioVentures Inc.; Bristol-Myers Squibb Company;
Chiron Corporation; Chugai Research Institute for Molecular Medicine, Inc.; Diagnostic Products
Corporation; DuPont Pharmaceuticals Company; Forest Laboratories; Genentech, Inc.; Genetics
Institute; Glaxo Wellcome, Inc.; Hoffmann-La Roche Inc.; Johnson & Johnson; Kyowa Hakko Kogyo
Co., Ltd.; Eli Lilly and Company; Merck Research Laboratories; New England BioLabs, Inc.; Novartis
Pharma Research; OSI Pharmaceuticals, Inc.; Pall Corporation; Palmetto Partners, Ltd.; Parke-Davis
Pharmaceutical Research; PE Biosystems; Pfizer Inc.; Pharmacia & Upjohn, Inc.; Research Genetics,
Inc.; Schering-Plough Corporation; and SmithKline Beecham Pharmaceuticals. Plant Corporate
Associates include Monsanto Company; Novartis Agricultural Discovery; Pioneer Hi-Bred International,
Inc.; and Westvaco Corporation. We also thank our Foundation Associate, Albert B. Sabin Vaccine
Institute, Inc. at Georgetown University; our Corporate Affiliates, Affymetrix and Third Wave
Technologies, Inc.; and our Corporate Contributors, Alexis Corporation, Aquatic Habitats, Applied
Imaging, BD PharMingen, Biogen, Inc., CuraGen, Digital Gene Technologies, Inc., Double Twist, Inc.,
Dynal, Eppendorf 5 Prime-3 Prime, Gene Machines, Genetix, Ltd., Genomica, Incyte Genomics,
InforMax, Lexicon Genetics, Inc., Neomorphic, Promega Corporation, Proteome, Inc., Qiagen, R & D
Systems, Sequenom, Stress Gen Biotechnologies Corp., and ZymoGenetics, Inc.
T. Weinert, G. Wahl, A. Carr, E. Seeberg
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Targets and Molecules: The Science of Drug Discovery
March 8-10 107 participants
ARRANGED BY David Stewart, Cold Spring Harbor Laboratory
Bruce Stillman, Cold Spring Harbor Laboratory
Jan Witkowski, Cold Spring Harbor Laboratory
This special winter biotechnology conference on Targets and Molecules: The Science of Drug Discovery
was one of the scientific celebrations hosted by the Laboratory to welcome in the new millennium. The
conference was designed in part to reflect the interest of our industrial supporters, who have support-
ed the Banbury Conference and Grace Meeting programs for a number of years through the invaluable
Corporate Sponsor Program. The conference presented some of the most interesting and exciting
research in four major areas of drug discovery, specifically cancer, cardiovascular-related diseases,
infectious diseases, and neuroscience, together with a short session focused on controversial issues in
intellectual property facing the biotech/pharmaceutical industry. In addition, the conference opened and
closed with keynote addresses by Peter Colman on novel therapies for influenza, and by John Kozarich
on microorganisms and macroorganizations. This meeting was funded in part by the William Theodore
Dens low Foundation.
PROGRAM
Introduction
B. Stillman, Cold Spring Harbor Laboratory
Keynote Address
P. Colman, Biomolecular Research Institute, Parkville,
Australia
Cancer: Focus on Angiogenesis
Chairperson: S. Lowe, Cold Spring Harbor Laboratory
Round Table Discussion: Patent and Intellectual Property
Issues in Genomics, Targets, and Drug Discovery
Moderator: M. Freire, National Institutes of Health, Bethesda,
Maryland
Infectious Disease Targets
Chairperson: P Colman, Biomolecular Research Institute,
Parkyille, Australia
Neurodegenerative Diseases: Focus on Alzheimer's
Disease
Chairperson: R. Malinow, Cold Spring Harbor Laboratory
Neuroscience and Beyond: Targets and Molecules
Chairperson: H. Cline, Cold Spring Harbor Laboratory
Closing Address
J.W. Kozarich, Merck Research Laboratories
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M. Hoffman, D. Stewart
S. Xanthoudakis, L. Van Der Ploeg, J. Kozarich
F. Austin, E. Gimmi
Zebrafish Development ana uenetics
April 26-30 467 participants
ARRANGED BY Michael Brand, University of Heidelberg, Germany
Marnie Halpern, Carnegie Institution of Washington
John Kuwada, University of Michigan, Ann Arbor
Christine Thisse, IGBMC, France
Leonard Zon, HHMI/Children's Hospital
This fourth meeting on Zebrafish Development and Genetics consisted of more than 350 platform talks
and poster presentations and covered many of the most interesting areas of current zebrafish research.
Exciting sessions were held on Zebrafish as a Model for Human Disease, Cell Signaling, Early
Development, Tissue Patterning, Neural Crest, Organ Patterning, Sensory Organs, Sensory Processing
and Behavior, Neurobiology, and Evolution, with additional sessions on Technology and a special
Genomics Workshop and Poster session. Harold Varmus, former director of the National Institutes of
Health, delivered the keynote address. Progress was reported in using insertional mutagenesis to carry
out mutant screens, in the development of transposon-tagging methods, and in genomic analysis of
the zebrafish genome. The information presented confirmed the great promise of the zebrafish as a
model vertebrate for the study of developmental and physiological processes. The meeting clearly indi-
cated that molecular characterization of genes first identified from zebrafish mutant screens is adding
greatly to our knowledge of vertebrate development. More than 30 mutant genes were isolated as can-
didates, and about 10 positional cloning projects were discussed.
This meeting was funded in part by the National Institute of Child Health and Human Development;
National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National
Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Deafness and Other
Communication Disorders; National Institute of Environmental Health Sciences; National Institute on
Aging; and the National Human Genome Research Institute, branches of the National Institutes of
Health; and the National Science Foundation.
M. Brand, J. Kuwada, L. Zon, M. Halpern, C. Thisse
PROGRAM
The Zebrafish as a Model for Human Disease
Chairperson: I. Dawid, N/CHD, National Institutes of Health,
Bethesda, Maryland
Keynote Speaker
H. Varmus, Memorial Sloan-Kettering Cancer Center
Cell Signaling I
Chairperson: H. Takeda, National Institute of Genetics,
Mishima, Japan
Neurobiology I
Chairperson: C. Houart, University College London, United
Kingdom
Technology I
Chairperson: C. Thisse, Institute of Genetics and Molecular
Cellular Biology Strasbourg, France
Evolution
Chairperson: V. Prince, University of Chicago, Illinois
Early Development I
Chairperson: D. Kane, University of Rochester, New York
Sensory Processing and Behavior
Chairperson: K. Whitlock, Cornell University Ithaca, New York
Technology II
Chairperson: W. Talbot, Stanford
Medicine, California
Organ Patterning
Chairperson: L. Zon, Children's Hospital, Boston, Massachusetts
Neurobiology II
Chairperson: C.-B. Chien, University of Utah Medical Center,
Salt Lake City
Sensory Organs
Chairperson: M. Brand, University of Heidelberg, Germany
Community Meeting
Chairperson: J. Kuwada, University of Michigan, Ann Arbor
Early Development II
Chairperson: M. Hammerschmidt, Max-Planck Institute for
lmmunobiology, Freiburg, Germany
Tissue Patterning
Chairperson: I. Drummond, Massachusetts General Hospital,
Charlestown
Genomics Workshop
Moderator: S. Johnson, Washington University School of
Medicine, St. Louis, Missouri
Cell Signaling II
Chairperson: M. Halpern, Carnegie Institution of Washington,
Baltimore, Maryland
Neural Crest
Chairperson: R. Kelsh, University of Bath, United Kingdom
L. Steiner, N. Hopkins, B. Defrich
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D. Meyer, W. Talbot
Cancer Development, Diagnosis, and Therapies:
Implications for Pancreatic Cancer
May 2 111 participants
ARRANGED BY Ralph H. Hruban, Johns Hopkins Medical Institutions
Scott Lowe, Cold Spring Harbor Laboratory
A special 1-day conference on pancreatic cancer was jointly hosted by the Lustgarten Foundation for
Pancreatic Cancer Research and Cold Spring Harbor Laboratory. The Lustgarten Foundation is a char-
itable organization dedicated to improving the diagnosis and treatment of pancreatic cancer. The
Foundation has previously awarded several million dollars to support pancreatic cancer research and is
currently working with the National Cancer Institute to discuss strategies to improve public awareness
and funding of pancreatic cancer. The conference provided an overview of the current status of
research in pancreatic cancer and highlighted the use of mouse models, including disruption of TGF -jt
signaling in mice, novel strategies for generating mouse models of human cancers, and syndrome
modeling in mice. The conference also presented novel technologies for identifying cancer genes and
for microarray-based tumor diagnosis. Finally, novel anti-angiogenesis therapies were presented and
discussed. The conference featured an introduction by James D. Watson and talks by Patrick Brown,
Ronald DePinho, Ralph Hruban, Alfred Knudson, Jerry McMahon, Tak Mak, Joan Massague, Harold
Varmus, and Michael Wig ler.
PROGRAM
Opening Remarks
J.D. Watson, Cold Spring Harbor Laboratory
Introduction
R. Hruban, Johns Hopkins Medical Institutions
Session I: Technology and Models
Chairperson: S. Lowe, Cold Spring Harbor Laboratory
R. DePinho, Dana Farber Cancer Institute
H. Varmus, Memorial Sloan-Kettering Cancer Center
H. Varmus
J. Massague, Memorial Sloan-Kettering Cancer Center
P. Brown, Stanford University Medical Center
Session II: Targets and Biology
Chairperson: R. Hruban, Johns Hopkins Medical Institutions
J. McMahon, Sugen Inc., South San Francisco, California
M. Wigler, Cold Spring Harbor Laboratory
T. Mak, Ontario Cancer Institute
A. Knudson, Fox Chase Cancer Center
R. Hruban, S. Lowe
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Molecular Chaperones and the Heat Shock Response
May 3-7 366 participants
ARRANGED BY Elizabeth Craig, University of Wisconsin, Madison
Carol Gross, University of California, San Francisco
Arthur Horwich, HHMI/Yale University School of Medicine
The fifth biennial meeting on molecular chaperones and the heat shock response featured advances in
the areas of structure and mechanism of action of molecular chaperones; mechanisms of induction of
the stress response; and nature and mechanism of protein misfolding in disease. In the first area, fur-
ther advances were described for the classic heat shock proteins, the Hsp20, 60, 70, 90, and 100
classes, as well as for calnexin/calreticulin. A highlight was a session on quality control in the ER, deal-
ing with chaperone selectivity, the relation of oligosaccharide processing to folding and chaperone
recognition, and mechanisms of dislocation of misfolded proteins back to the cytosol for proteasomal
degradation. In the area of stress response, new understandings about signaling of ER stress to the
cytosol and nucleus were presented. The structure and action of a redox-regulated chaperone, Hsp33,
were presented. In the area of protein misfolding in disease, a number of talks dealt with recent obser-
vations about presenilin, a membrane protein of the secretory pathway involved in an inherited form of
Alzheimer's disease. It was biochemically isolated as part of a large complex, and evidence was pre-
sented that it exhibits y-secretase activity from two trans-membrane aspartates. Other talks dealt with
polyglutamine repeat disease and with the mechanism of prion formation. Conversion of yeast to a psi-
C. Gross, E. Craig, A. Horwich
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H. Scherer, H. Singh-Jasuja
plus state was reported to have been accomplished by physical transfer of in-vitro-converted material
into psi-minus cells.
This meeting was funded in part by the National Institute of Neurological Disorders and Stroke, a
branch of the National Institutes of Health; the National Science Foundation; the Alzheimer Association;
Bayer Corporation; HSP Research Institute; Merck & Co., Inc.; and Stress Gen Biotechnologies
Corporation.
PROGRAM
Diseases of Protein Misfolding
Chairperson: S. Prusiner, University of California, San
Francisco
Quality Control and Protein Trafficking
Chairperson: A. Helenius, Swiss Federal Institute of
Technology Zurich
Cellular Function of Chaperones
Chairperson: U. Hartl, Max-Planck Institute for Biochemistry,
Martinsried, Germany
Chaperone Function in Disease and Development
Chairperson: S. Radford, University of Leeds, United Kingdom
Regulation of the Stress Response
Chairperson: R. Morimoto, Northwestern University, Evanston,
Illinois
Chaperones and Proteolysis
Chairperson: S. Gottesman, National Cancer Institute,
Bethesda, Maryland
Chaperone Biochemistry and Protein Folding
Chairperson: D. Agard, University of California, San
Francisco
L. Bharadwaj, N. Ovsenek, G. Davies, S. Bharadwaj
W.R. Brown, M. Tytell
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Genome Sequencing and Biology
May 10-14 513 participants
ARRANGED BY Mark Boguski, National Center for Biotechnology Information
Stephen Brown, MRC Mouse Genome Centre, United Kingdom
Pui-Yan Kwok, Washington University
This meeting marked the 13th annual gathering of genome scientists in this setting. The past decade
or more has seen remarkable progress in the mapping and sequencing of the genomes of many "model
organisms," and there is now a strong indication that a "working draft" of the human genome sequence
is near completion. Phrases such as "functional genomics" and "post-genome biology" have become
common terms. Just over 500 people from around the world attended the meeting, with 298 abstracts
presented describing a broad array of topics relating to the analysis of genomes from a number of dif-
ferent organisms.
The session topics included areas such as biological insights from phylogenomics, mapping meth-
ods and technologies, functional genomics, computational genomics, and 21st century genetics. This
year's poster symposium featured the complete sequencing of human chromosomes 21 and 22 in
addition to the announcement by the public human genome project that 80% of the human genome
had been sequenced. Once again, projection-style, interactive computer demonstrations in Grace
Auditorium effectively highlighted the critical new bioinformatics tools being developed for storing, orga-
nizing, and analyzing genomic maps and sequences. There was also an ELSI (Ethical, Legal, and Social
Implications) panel discussion, chaired by Charmaine Royal of Howard University, which focused on
issues surrounding genetic enhancement.
The major themes of the meeting included the analysis of the complete Drosophila sequence and
the smallest human chromosomes, with the surprising observation that the number of genes in the
human might be as small as 30,000. Specific presentations continued to report major achievements
in the sequencing of model organisms and the human, the development of new technologies for genet-
P. Green, E. Green
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P.-Y. Kwok, S. Brown, M. Boguski
is analysis, and the use of microarrays for performing genome analysis. The now traditional Saturday
afternoon keynote talk was delivered by Francis Collins, director of the National Human Genome
Research Institute and head of the U.S. Human Genome Project.
This meeting was funded in part by the National Human Genome Research Institute, a branch of the
National Institutes of Health.
PROGRAM
Polymorphisms I: Discovery/Mapping/Scoring
Chairpersons: A.-C. Syvanen, Uppsala University Sweden;
L. Stein, Cold Spring Harbor Laboratory
Comparative Genomics I: Drosophila and Other Model
Organisms
Chairpersons: G. Rubin, Lawrence Berkeley National
Laboratory California; C. Venter, Cetera Genomics,
Rockville, Maryland
Bioinformatics I: Database Resources
Chairpersons: S. Sherry, NCBI, National Institutes of Health,
Bethesda, Maryland; J. Bouck, Baylor College of Medicine,
Houston, Texas
Comparative Genomics II: Plants
Chairpersons: D. Preuss, University of Chicago, Illinois;
S. Wessler, University of Georgia, Athens
Human Sequencing Poster Symposium
Chairpersons: J. Rogers, Sanger Centre, Cambridge, United
Kingdom; G. Schuler, NCBI, National Institutes of Health,
Bethesda, Maryland
Bioinformatics II: Software and Algorithms
Chairpersons: P. Green, University of Wisconsin, Madison;
P. Rodriguez-Tome, EMBL-EBI, Cambridge, United Kingdom
ELSI Panel Discussion: Genetic Enhancement-Ethical,
Legal, and Social Points to Consider
Moderator: C. Royal, Howard University Washington, D.C.
Comparative Genomics III: Mouse Genomics/Functional
Genomics I-Technologies and Infrastructure
Chairpersons: L. Stubbs, Lawrence Livermore National
Laboratory California; V Cheung, University of Pennsylvania,
Philadelphia
Polymorphisms II: Applications
Chairpersons: E. Lai, GlaxoWellcome, Research Triangle Park,
North Carolina; E. Ostrander, Fred Hutchinson Cancer
Research Center, Seattle, Washington
Bioinformatics III: Expression Technologies
Chairpersons: A. Robinson, EMBL-EBI, Cambridge, United
Kingdom; D. Gerhold, Merck & Co., Inc., West Point,
Pennsylvania
Keynote Speaker
F. Collins, National Human Genome Research Institute
Functional Genomics II: Applications
Chairpersons: J. Trent, National Institutes of Health, Bethesda,
Maryland; S. Rastan, SmithKline Beecham Pharmaceuticals,
Harlow, United Kingdom
B. Denother, L. Flagg, M. Hotic E. Mardis, D. Brown
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The Cell Cycle
May 17-21 353 participants
ARRANGED BY Fred Cross, The Rockefeller University
Stephen El ledge, Baylor College of Medicine
J. Wade Harper, Baylor College of Medicine
Jim Roberts, Fred Hutchinson Cancer Center
The sixth biennual Cell Cycle Meeting was held this year at Cold Spring Harbor Laboratory. This con-
ference is internationally recognized for its ability to bring together scientists who study cell cycle regu-
lation in eukaryotes ranging from yeast to humans. The meeting opened with an exciting plenary lec-
ture by Chuck Sherr, who spoke on how cell cycle research was providing new insights into cancer biol-
ogy as well as suggesting new approaches to cancer therapeutics. Diverse themes from previous years
received continued attention: the interaction of cell cycle control with developmental and cancer biolo-
gy; mechanisms of CDK activation by cyclins and by activating phosphorylation; and the mechanisms
of action of cell cycle checkpoints.
Research in proteolysis for both G1 /S and G2/M regulation in particular continues to receive intense
focus, with much progress reported. As in previous years, there was also emphasis on the long-stand-
ing problem of regulation of DNA replication in the cell cycle, its onset, and its restriction to once per
cell cycle. Neither problem has yet been solved, but there has been considerable progress in under-
standing both the ORC and MCM complexes and how their activities might be regulated. There was
also an extension of previous concepts derived from yeast studies to metazoans in the examination of
the coordination between growth and cell cycle progression in mammals and in flies. As in other years,
scientists studying cell cycle regulation in yeast, Xenopus, Drosophila, nematodes, and mammals were
well represented. Once again, the striking phylogenetic conservation of cell cycle regulatory mecha-
nisms was readily evident. The influence of mouse genetics becomes stronger each year and will like-
ly become a major component of this meeting in years to come.
S. El ledge, W. Harper, J. Roberts, F. Cross
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The cell cycle conference brought together 353 scientists for the presentation of 255 abstracts (74
talks, and 181 posters). It was another landmark meeting for the cell cycle field, and the participants all
continued to look forward to equally exciting meetings in future years.
This meeting was funded in part by the National Cancer Institute and the National Institute on Aging,
branches of the National Institutes of Health; and the National Science Foundation.
PROGRAM
CDK Regulation
Chairperson: D. Morgan, University of California, San
Francisco
Plenary Speaker
C. Sherr, St. Jude Children's Research Hospital
Special Lecture
P. Rao, University of Texas/M.D. Anderson Cancer
Center
Cell Cycle Entry/Exit
Chairperson: C. Lehner, University of Bayreuth, Germany
Replication I
Chairperson: T. Orr-Weaver, Whitehead Institute/MIT,
Cambridge, Massachusetts
Replication II
Chairperson: J. Diffley, Imperial Cancer Research Fund, South
Mimms, United Kingdom
Mitosis I
Chairperson: A. Amon, Massachusetts Institute of Technology
Cambridge
Mitosis II
Chairperson: D. Cleveland, University of California, San Diego
Controls
Chairperson: A. Hoyt, Johns Hopkins University Baltimore,
Maryland
Development
Chairperson: N. Dyson, Massachusetts General Hospital
Cancer Center, Charlestown
N. Kato, J. Kato, Y. Arata, K. Tomoda
M. Sanchet, J. Samuel
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Retroviruses
May 23-28 441 participants
ARRANGED BY Jonathan Stoye, National Institute for Medical Research, United Kingdom
John Young, University of Wisconsin-Madison Medical School
This was the 25th offering of the annual Cold Spring Harbor meeting, which began in 1975 as a meet-
ing on RNA Tumor Viruses and evolved into its current focus on Retroviruses in 1993. The 25th anniver-
sary was celebrated with special nightly keynote addresses by Harold Varmus on Retroviruses and
Cancer, John Coffin on Retroviruses and AIDS, and Robin Weiss on Retroviruses in the Lab and in the
Field. As always, among those presentations chosen from the openly submitted abstracts, many excit-
ing new findings in diverse areas of retrovirology were presented not only in traditionally strong areas
such as viral entry, reverse transcription, and integration, but also on a number of novel topics, includ-
ing a growing emphasis on understanding retrovirus interactions with host cell factors. Papers illustrat-
ing this trend included a description of the application of sophisticated microscopic techniques to
examine the association between incoming viruses and microtubules; the identification of localization
signals on a number of viral proteins and their interactions with cellular factors; the role of host factors
in viral RNA processing and export from the nucleus; and reports of the crucial role for ubiquitination in
viral assembly.
PROGRAM
Transcription/Splicing/Translation
Chairpersons: J. Dudley, University of Texas, Austin; A. Rice,
Baylor College of Medicine, Houston, Texas
RNA Export/Packaging
Chairpersons: K. Beemon, Johns Hopkins University,
Baltimore, Maryland; B. Felber, NCI-FCRDC, Frederick,
Maryland
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Assembly/Budding/Maturation
Chairpersons: E. Hunter, University of Alabama, Birmingham;
V. Vogt, Comes University Ithaca, New York
Env/Receptors/Entry
Chairpersons: D. Sanders, Purdue University, West Lafayette,
Indiana; M. Roth, Rutgers University, Piscataway, New
Jersey
L. Parent, K. Beemon, C. Hibbed, R. Garbitt
Keynote Address #1
H. Varmus: Retroviruses and Cancer
Reverse Transcription
Chairpersons: A. Telesnitsky, University of Michigan, Ann
Arbor; V. Prasad, Albert Einstein College of Medicine, Bronx,
New York
Keynote Address #2
J. Coffin: Retroviruses and AIDS
Accessory Genes
Chairpersons: E. Freed, NIAID, National Institutes of Health,
Bethesda, Maryland; B.M. Peterlin, University of California,
San Francisco
Keynote Address #3
R. Weiss: Retroviruses in the Lab and the Field
Vectors/Endogenous Retroviruses
Chairpersons: F.-L. Cosset, Ecole Normale Superieure,
Lyon, France; S. Russell, Mayo Foundation, Rochester,
Minnesota
Integration
Chairpersons: A.-M. Skalka, Fox Chase Cancer Center,
Philadelphia, Pennsylvania; M. Muesing, The Rockefeller
University New York, New York
Pathogenesis/Evolution
Chairpersons: K. Radke, University of California, Davis; R
Jolicoeur, Clinical Research Institute of Montreal, Canada
AntiviralsNaccines
Chairpersons: S. Hughes, NCI-FCRDC, Frederick, Maryland;
S. Le Grice, NCI-FCRDC, Frederick, Maryland
M. Roth, W.-S. Hu A. Viejo-Bordella, B. Blot, V. Blot
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New York Structural Biology Group
August 2 238 participants
ARRANGED BY Barry Honig, Columbia University, New York
Leemor Joshua-Tor, Cold Spring Harbor Laboratory
John Kuriyan, The Rockefeller University
The summer meeting of the New York Structural Biology Discussion Group was the third in day-long
meetings allowing structural biologists from all over the region to meet and discuss their latest results.
The meeting was open to structural biologists from different disciplines, including crystallographers,
spectroscopists, computational biologists, and biochemists, with more than 240 participants from
academia and industry from the tri-state area. The program featured nine talks and a poster session
and concluded with a beach barbecue, allowing a wonderful opportunity for informal interactions. This
meeting complements the bimonthly evening meetings of the group held at The Rockefeller University.
No registration was required and participants were encouraged to set up posters.
Financial support was provided by Hampton Research
Inc., Molecular Structure Corporation, Bruker AXS Inc.,
Protein Solutions Inc., Pfizer Inc., Hoffmann-La Roche Inc.,
and Merck Research Laboratories.
PROGRAM
Session I
Chairperson: B. Honig, Columbia University Medical School
J. Becker, Merck Research Laboratories
T Gaasterland, The Rockefeller University
D. Engelman, Yale University
E. Gouaux, Columbia University Medical School
D. Patel, Memorial Sloan-Kettering Institute
Session II
Chairperson: L. Shapiro, Mount Sinai School of Medicine
A. Palmer, Columbia University Medical School
V Rath, Pfizer Inc.
T. Lazaridis, City College New York
L. Joshua-Tor, Cold Spring Harbor Laboratory
Session II
Chairperson: A. Neuwald, Cold Spring Harbor Laboratory
D. Raleigh, SUNY Stony Brook
Y.-M. Chook, The Rockefeller University
J. Pandit, Pfizer
Session III
Chairperson: S. Roderick, Albert Einstein College of Medicine
S. Burley, The Rockefeller University
D. Cowburn, The Rockefeller University
P. Fitzgerald, Merck
B. Honig, Columbia University
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L. Joshua-Tor, L. Shapiro
B. Honig, A. Palmer, A.M. Pyle
S. Burley, L. Shapiro, C. Ojek
Cancer Genetics and Tumor Suppressor Genes
August 16-20 327 participants
ARRANGED BY Terri Grodzicker, Cold Spring Harbor Laboratory
Doug Hanahan, University of California, San Francisco
David Livingston, Dana Farber Cancer Institute
Scott Lowe, Cold Spring Harbor Laboratory
Bruce Ponder, University of Cambridge
Carol Prives, Columbia University
The third Cancer Genetics and Tumor Suppressor Genes meeting allowed scientists in different disci-
plines to discuss their latest results on different aspects of cancer cell biology and to have extensive
crosstalk concerning ideas and methodologies. The conference was attended by more than 325 sci-
entists meeting to present both talks and posters. Launched by a keynote address by Arnold Levine,
President of The Rockefeller University, the meeting covered an extensive range of work: from location
and nature of mutations in different tumors to properties of the p53 tumor suppressor gene. Many talks
dealt with growth control of cancer cells, and areas that received much attention included control of the
cell cycle, apoptosis, signaling transduction pathways, DNA repair, and
transcriptional regulation of and by tumor suppressor genes. Animal
models have provided much information about tumorigenesis, and more
than one session dealt with knock-out and transgenic mouse models. An
emphasis of many talks this year dealt with signaling to and regulation of
tumor suppressor gene activity. This meeting continued to be enthusias-
tically supported and all sessions found the lecture and poster halls
packed with extensive discussions and exchanges of information. The
meeting again featured a special session by
Tyler Jacks. NCI staff and scientists who served on institute panels
answered questions from the audience regarding NCI grants, policy, and
future directions.
This meeting was funded in part by the National Cancer Institute, a
branch of the National Institutes of Health.
D. Hanahan, D. Livingston, S. Lowe
T. de Lange
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PROGRAM
Mouse Models I
Chairpersons: L. Strong, University of Texas/M.D. Anderson
Cancer Center, Houston; D. Hanahan, University of
California, San Francisco
Keynote Address
A. Levine, The Rockefeller University New York, New York
Proliferation and DNA Damage Responses
Chairpersons: R. Fishel, Thomas Jefferson University
Philadelphia, Pennsylvania; T. de Lange, The Rockefeller
University New York, New York
Mortality and Apoptosis
Chairpersons: G. Evans, University of California, San
Francisco; T. Jacks, Massachusetts Institute of Technology
Cambridge
Regulation of Tumor Suppressor Gene Activity
Chairpersons: C. Sherr, St. Jude Children's Research
Hospital, Memphis, Tennessee; M. Oren, Weizmann Institute,
Rehovot, Israel
"NCI Listens"
Chairpersons: T.E. Jacks, Massachusetts Institute of
Technology; D.S. Singer, NCI, National Institutes of Health,
Bethesda, Maryland
Cancer Genetics/Genomics
Chairpersons: D. Housman, Massachusetts Institute of
Technology Cambridge; B. Ponder University of Cambridge,
United Kingdom
Signal Transduction/Animal Models II
Chairpersons; G. Vande Woude, Van Andel Research Institute,
Grand Rapids, Michigan; A. Berns, The Netherlands Cancer
Institute, Amsterdam
Gene Regulation
Chairpersons: E. Harlow, Massachusetts General Hospital,
Charlestown; J. Brugge, Harvard Medical School, Boston,
Massachusetts
C. Prives' lab at the wine & cheese party
M. Green, M. Green, L. Gann
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R. Nahta, A. Reddy
Molecular Genetics of Bacteria and Phages
August 22-27 219 participants
ARRANGED BY Tania Baker, Massachusetts Institute of Technology
Alan D. Grossman, Massachusetts Institute of Technology
Thomas Silhavy, Princeton University
The Molecular Genetics of Bacteria and Phages meeting continued to include exciting and high-quali-
ty research in prokaryotic molecular biology. Initiated as a forum for bacteriophage X. and T4 genetics,
it expanded to include other phages and then the molecular genetics of their bacterial host, Escherichia
coli. Now, many other bacteria and even archaebacterial phages are discussed, providing insights into
previously unanswerable questions. Surprising results were reported on the localization and rapid
movement of proteins involved in regulating cell division. Most remarkable is the movement of two pro-
teins from one cell pole to the other, on the time scale of approximately 20 seconds. There continued
to be strong representation from the bacterial transcription field, with several interesting sessions on
aspects of the structure and function of the transcription machinery and accessory proteins. Several
talks explored the interactions between pathogens and hosts and described mechanisms controlling
gene expression in pathogens. There were several presentations on genome sequence analysis and
using whole-genome sequences to explore evolutionary and functional relationships and to study gene
expression.
This meeting was funded in part by the National Science Foundation.
K. Schnetz, J. Sayers, G. Koudelka
T Baker, A. Grossman, T Silhavy
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PROGRAM
Cell Surfaces and Secretion
Chairperson: H. Shuman, Columbia University, New York,
New York
RNA Polymerase Structure, Function
Chairperson: R. Ebright, Howard Hughes Medical Institute,
Waksman Institute, Piscataway New Jersey
Cell Biology and Chromosome Partitioning
Chairperson: P. de Boer, Case Western Reserve University
School of Medicine, Cleveland, Ohio
Transcription Activators and Repressors
Chairperson: J. Roberts, Cornell University Ithaca, New York
Replication, Recombination, Transposition
Chairperson: R. Weisberg, NICHD, National Institutes of
Health, Bethesda, Maryland
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Growth and Environmental Stress
Chairperson: G. Storz, NICHD, National Institutes of Health,
Bethesda, Maryland
Pathogens and Symbionts
Chairperson: V. Miller, Washington University School of
Medicine, St. Louis, Missouri
Transcription Elongation and Termination
Chairperson: R. Landick, University of Wisconsin, Madison
Quorum Sensing and Signaling
Chairperson: B. Bassler, Princeton University New Jersey
Posttranscriptional Regulation
Chairperson: C. Squires, Tufts University School of Medicine,
Boston, Massachusetts
W. Szybalski, J. Wild
J. Roberts, S. Gottesman
Mouse Molecular Genetics
August 30-September 3 367 participants
ARRANGED BY Richard Behringer, The University of Texas/M.D. Anderson Cancer Center
Carmen Birchmeier, Max Delbruck Center, Germany
Maja Bucan, University of Pennsylvania
Richard Harvey, The Victor Chang Cardiac Research Institute, Australia
Held every other year at Cold Spring Harbor Laboratory, this meeting attracted more than 350 researchers
from across the globe. The meeting brings together a vast cadre of scientists with very diverse back-
grounds who are linked by the common thread of working with mouse mutants. Consequently, the scope
of the biology presented at the meeting is enormous, covering topics from early developmental decisions
in gastrulating embryos to the sleep patterns of mice.
Following a historically successful format, the meeting was organized into eight sessions each
arranged so that a session begins and ends with an invited senior researcher. Between these more in-
depth talks (which are selected to be of general interest), eight to nine speakers per session were
selected from the abstracts for more concise presentations. The meeting also included the presenta-
tion of several hundred posters in two afternoon sessions. In an attempt to highlight some of the con-
temporary approaches, two workshops on Comparative Sequence Analysis (Eric Green, discussion
leader) and Conditional Genetics (Richard Behringer and Andras Nagy, discussion leaders) were
arranged where several groups who are doing mutagenesis in the mouse came and presented their
approaches. Although concurrent with the poster sessions, these workshops were very well attended.
The mouse meeting has evolved over the years to have a stronger genetic and genomics empha-
sis, and this year invited presentations included detailed presentations on the state of the mouse EST
database, the importance of genetic background, etc. The meeting exemplified some of the special
E. Rubin, W. Birchmeier S. Sharan, R. Behringer K. Frazer, M. Bucan
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characteristics of the mouse genetics community: sharing of unpublished data and reagents (including
mice). Inevitably, this meeting is also a mouse dating service! Mice described in the meeting have found
their way to new homes to mate with other mutants to prove (or disprove) hypotheses developed dur-
ing interactions at Cold Spring Harbor.
This meeting was funded in part by the National Institute of Child Health and Human Development;
the National Human Genome Research Institute; the National Cancer Institute; the National Institute of
Mental Health; the National Institute on Deafness and Other Communication Disorders; the National
Institute of Dental and Craniofacial Research; and the National Institute of Arthritis and Musculoskeletal
and Skin Diseases, branches of the National Institutes of Health.
PROGRAM
Genetics
Chairperson: M. Justice, Baylor College of Medicine, Houston,
Texas
Genomics
Chairperson: E. Rubin, Lawrence Berkeley National
Laboratory California
Workshop on Comparative Sequence Analysis
Chairperson: E. Green, NHGRI, National Institutes of Health,
Bethesda, Maryland
Stem Cells and Regeneration
Chairperson: J. Rossant, Samuel Lunenfeld Research
Institute, Toronto, Canada
Signals and Receptors
Chairperson: P. Soriano, Fred Hutchinson Cancer Research
Center, Seattle, Washington
Workshop on Conditional Genetics
Chairpersons: R. Behringer, University of Texas/M.D.
Anderson Cancer Center, Houston; A. Nagy, Samuel
Lunenfeld Research Institute, Toronto, Canada
Models of Human Disease
Chairperson: M. Meisler, University of Michigan, Ann Arbor
Organogenesis
Chairperson: R. Harvey, Victor Chang Cardiac Research
Institute, Darlinghurst, Australia
Patterning
Chairperson: E. Lacy, Memorial Sloan-Kettering Cancer
Center, New York, New York
Neural Development
Chairperson: S. Pfaff, The Salk Institute, La Jolla, California
R. Harvey, V. Papaioannou
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S. O'Gorman, R. Kuhn
Translational Control
September 6-10 469 participants
ARRANGED BY Alan Hinnebusch, NICHD, National Institutes of Health
Michael Mathews, New Jersey Medical School, University of Medicine and Dentistry
Stuart Peitz, Robert Wood Johnson Medical School, University of Medicine and Dentistry
New Jersey
The 2000 Translational Control meeting attracted more than 450 participants from around the world
and included eight platform and three poster sessions that covered a record 403 abstracts.
The session on Translation Mechanisms began with the plenary lecture by Harry Noller on the strik-
ing X-ray crystal structure of the 70S ribosome in complexes with mRNA and tRNA fragments bound
to the A, P, and E sites. Other highlights included cryo-EM analysis of EF-G-dependent tRNA translo-
cation on the ribosome (Frank lab), the co-crystal structure of the elongation factor eEF1A:eEF1B com-
plex (Kinzy lab), and the structure of ribosome release factor RRF (Kaji lab). Provocative evidence for
translation in the nucleus was reported by Peter Cook.
In the second session, cell-cycle-regulated IRESs in the mRNAs for ODC, c-Myc (Sonenberg lab),
and p58 PITSLRE kinase, and another IRES activated by amino acid starvation (Hatzoglou), were
described. Jacquemin-Sablon reported that Unr protein is required in vivo for certain IRESs, and ITAF45
(aka murine proliferation-associated protein or Mpp1) was identified as a trans-acting factor required for
a particular picornavirus IRES (Hellen lab). Intriguing results suggested that cellular IRESs are com-
posed of short independently functioning modules that base pair with 18S rRNA (Edelman).
In the mRNA Turnover session, The Wilusz' and Peltz' labs described a decapping activity in He La
extracts stimulated by AU-rich elements (AREs) and the analysis of decapping and ARE-mediated
in yeast cell-free systems. Joan Steitz' lab reported that human homology of yeast UPF2 or UPF3
are sufficient to promote nonsense-mediated mRNA decay (NMD) when tethered 3' to a stop codon,
and biochemical evidence that NMD requires splicing-dependent remodeling of mRNP was provided
by Maquat and Moore. The Schoenberg lab reported that vigilin binding can selectively block cleavage
of vitellogenin, but not albumin, mRNA by PMR-1 endonuclease, and Schneider's group found that
ubiquitination of p37-AUF1 and proteosome activity are determinants of ARE-mRNA turnover.
A. Hinnebusch, S. Peitz, M. Mathews
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The Initiation session highlighted the role of Hsp27 in blocking translation during heat shock by dis-
sociating elF4F (Schneider) and discovery of a novel PABP-interacting protein (Paip2) that inhibits trans-
lation (Sonenberg). The eukaryotic IF2 homolog, eIF5B, was implicated in subunit joining (Hellen and
Pestova and Dever labs) and was shown to interact specifically with eIF1A (Hinnebusch and Dever
labs). Mutational analysis of elF5 by the Maitra and Proud labs suggests that it may function as a clas-
sical GTPase-activating protein (GAP) for elF2, and the catalytic center in eIF2B (the GEF for elF2) was
localized to the carboxyl terminus of its c-subunit (Pavitt). Finally, Pestova reported that 43S initiation
complexes can scan to a start codon in unstructured mRNA without ATP or the elF4 group of factors.
In the session on Regulatory Elements, Gal lie reported that HSP101 is a light-responsive regulator
of ferredoxin mRNA translation and stability. Mayfield showed that a chloroplast PAB stimulates trans-
lation and likely directs localization of mRNAs to the proper site of photosystem II assembly in chloro-
plasts. Expanded CUG repeats in the 3' UTR of the myotonin protein kinase gene were found to acti-
vate the elF2a kinase PKR and inhibit translation (Mathews). Genetic evidence was presented that S6
kinase mediates the amino acid control of TOP mRNA translation (Meyuhas), and Calkoven reported
that PKR and mTOR control the ratio of C/EBP isoform expression through an uORF. Finally, new
strategies were described to identify novel proteins that can regulate translation or stability of mRNAs
when tethered to the 3' UTR (Fields and Wickens), or to identify all of the in vivo mRNA targets of a
given RNA-binding protein (Keene).
The session on Phospho-Modulators from the Wek, Hinnebusch, Kaufman, and Ron labs showed
that the elF2a kinases GCN2 and PEK/PERK are activated separately by amino acid limitation and ER-
stress, that uncharged tRNA binding activates GCN2 by conformational rearrangement, that the ER-
lumenal domain of PERK mediates activation by unfolded proteins, and that elF2a phosphorylation
stimulates translation of uORF-containing mRNAs in mammalian cells, as in yeast. The heme-regulat-
ed elF2a kinase was shown to be important for controlling red blood cell size in mice (Chen). The elF2a
kinase PKR was found to have a novel function in splicing (Kaempfer), and the requirement for the
dsRNA-binding domain for activation of PKR was satisfied with a heterologous dimerization domain
(Dever).
A. Page, A. Murariu
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The session on Development Controls included a report by Richter et al. that phosphorylation of
CPEB by kinase Egf2 is crucial for cytoplasmic polyadenylation in Xenopus oocytes, and Wormington
showed that ARE elements enhance mRNA deadenylation by poly(A) ribonuclease. Hentze et al. found
that an hnRNP K +E1 repressor inhibits 15-LOX mRNA translation from the 3'UTR by blocking riboso-
mal subunit joining at the start codon. It was reported that Nanos and Pumilio mediate poly(A) tail
removal from hunchback mRNA via 3'UTR elements in addition to regulating translation (Lehmann).
Pumilio seems to regulate bicoid mRNA translation by interacting with something besides Nanos
(Gottlieb), and data from Gavis indicate that translational repression of Nanos mRNA by a 3' element
occurs at the elongation phase of translation. Wickens reported that Pumilio family members in C. ele-
gans are involved in multiple aspects of germ-line differentiation through varied interactions with Nanos
and CPEB homologs.
In the session on Viral Strategies, Poncet at al. reported that rotaviral NSP3 protein stimulates trans-
lation from the 3' end via interactions with eIF4G and that the activator of reinitiation from CaMV may
function by interacting with eIF3 and a ribosomal protein (Hohn lab). It was shown that adenovirus 100K
protein stimulates shunting on late mRNAs dependent on its tyrosine phosphorylation (Schneider). The
Wickner lab presented evidence that poly(A) is required in yeast primarily to counteract regulatory pro-
teins that inhibit translation of nonpolyadenylated viral mRNAs. Striking results from Sarnow et al. indi-
cated that cricket paralysis virus IRES directs translation initiation without an AUG codon, initiator tRNA,
or initiation factors. Antagonism of the antiviral function of PKR in phosphorylating elF2a was analyzed
for two proteins encoded by herpesvirus (Mohr), the E2 (Taylor et al.), and NS5A (Katze) proteins of
hepatitis C virus, and the E3L and K3L proteins of vaccinia virus (Jacobs).
PROGRAM
Translation Mechanisms
Chairperson: T.G. Kinzy, UMDNJ-Robert Wood Johnson
Medical School, Piscataway
Plenary Lecture
Chairperson: H.F. Noller, University of California, Santa Cruz
IRESs
Chairperson: C.U.T. Hellen, SUNY Health Science Center,
Brooklyn
mRNA Turnover
Chairperson: J. Wilusz, UMDNJ-New Jersey Medical School,
Newark
Initiation
Chairperson: P. Linder, University of Geneva, Switzerland
Regulatory Elements
Chairperson: M. Sachs, Oregon Graduate Institute, Portland
Phospho-Modulators
Chairperson: R. Wek, Indiana University School of Medicine,
Indianapolis
Developmental Controls
Chairperson: R. Lehmann, Skirball Institute, New York
University School of Medicine, New York
Viral Strategies
Chairperson: T. Hohn, Friedrich Miescher Institut, Basel,
Switzerland M. Ptushkina, P. Linder
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Dynamic Organization of Nuclear Function
September 13-17 284 participants
ARRANGED BY Thomas Cremer, Ludwig-Maximilians University, Germany
Robert D. Goldman, Northwestern University
Pamela Silver, Dana Farber Cancer Institute
David L. Spector, Cold Spring Harbor Laboratory
The Dynamic Organization of Nuclear Function meeting was a successful gathering of researchers from
a variety of different fields to discuss the relationship between nuclear structure and function. In the
opening session devoted to diseases, H.T. Orr discussed spinocerebellar ataxia type 1. This autosomal
dominant neurodegenerative disease results in the localization of a mutant protein ataxin-1 to the nucle-
us; transgenic mice expressing the mutant protein lacking a nuclear localization signal no longer devel-
op nuclear inclusions or ataxia, suggesting that the localization of this protein is important to disease.
X-linked Emery-Dreyfuss muscular dystrophy is also associated with a protein mislocalization. In this
case, of emerin, a lamin-binding protein normally found associated with the nuclear membrane that
relocalizes to the endoplasmic reticulum (K.L. Wilson). Other talks on myotonic dystrophy (TA. Cooper),
spinal muscular atrophy (L. Pellizzoni), various leukemias (E. Columbo), and other syndromes (Treacher
Collins, U.T. Meier), Werner and Bloom (N. Neff, H. Yan) all highlighted the close association of nuclear
structure to disease.
Numerous talks demonstrated the use of fluorescence recovery after photobleaching (FRAP) to
examine the dynamics of GFP-tagged nuclear proteins. G. Hager used glucocorticoid receptor (GR)
tagged with GFP and a cell line carrying a tandem array of GR-binding elements to monitor stable bind-
ing in living cells. FRAP showed that the hormone-occupied receptor exchanged rapidly between chro-
matin and the nucleoplasm, demonstrating that the interaction of regulatory proteins with target sites in
chromatin is much more dynamic than previously believed. T. Misteli
measured the residence time of histone H1 -GFP on chromatin; tricho-
statin A, an inhibitor of histone deacetylase and an inducer of chro-
matin remodeling, decreased the residence time. D. Hoogstraten
examined the relationship between transcription and the nucleotide
R. Goldman, P Silver, D. Spector, T. Cremer
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excision repair of lesions in DNA induced by UV light. UV-irradiation induced a transient and dose-
dependent immobilization of several components involved in XPA which presumably reflected the bind-
ing to a lesion. S. Huang examined the dynamics of several GFP-tagged nucleolar components (includ-
ing UBF, TBP, nucleolin, and fibrillarin) and found that the high mobility of UBF was not reduced when
transcription ceased during mitosis.
A variety of other approaches were also used to monitor nuclear dynamics. For example, A. Belmont
fused the GFP-/ac repressor to the wild-type estrogen receptor and expressed this construct in cells
bearing a tandem array of lac operator elements embedded in heterochromatin; the array now marked
by GFP unfolded, and estrogen addition partially recondensed it within 30 minutes. T. Pederson tracked
ribosome movements. Oligonucleotides complementary to rRNA and tagged with a caged fluorescein
were microinjected into cells where they concentrated in nucleoli. Upon uncaging, the hybridized
oligonucleotide could be followed as it moved to the cytoplasm with kinetics that were consistent with
diffusion.
Several studies advanced our understanding of structural proteins in the nucleus. T.P. Spann report-
ed that lamins may have an important structural role during transcription. Microinjecting lamin A bear-
ing an amino-terminal deletion reduced the incorporation of Br-UTP into nucleoplasmic RNA but had
no effect on RNA polymerase I activity. Actin was identified on the Balbiani ring pre-mRNP particles,
found in Chironomus, where it interacts with an hnRNP protein (P. Percipalle). A possible partner of
actin, a form of myosin 1 with an amino-terminal extension of 16 residues, was also identified; signifi-
cantly, myosin with this extension localized close to RNA polymerase II in nuclei, and antibodies direct-
ed against it blocked transcription in vitro (P. de Lanerolle).
PROGRAM
Nuclear Structure and Disease
Chairperson: H. Orr, University of Minnesota, Minneapolis
Dynamic Properties of the Nuclear Envelope/Lamina
Chairperson: K. Wilson, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Nuclear Transport
Chairperson: M. Rout, The Rockefeller University New York
New York
Genome Organization
Chairperson: A. Belmont, University of Illinois, Urbana
RNA Processing
Chairperson: T. Pederson, University of Massachusetts
Medical School, Worcester
Nucleoli and Other Inclusions
Chairperson: J. Gall, Carnegie Institution of Washington,
Baltimore, Maryland
Nuclear Assembly/Disassembly
Chairperson: D. Cleveland, University of California, San Diego
S. Polo, E. Fabre, B. Arcangioli
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Axon Guidance and Neural Plasticity
September 20-24 389 participants
ARRANGED BY Tobias Bonhoeffer, Max-Planck Institute of Neurobiology, Germany
Marc Tessier-Lavigne, HHMI/University of California, San Francisco
Larry Zipursky, HHMI/University of California, San Francisco
The remarkable feats of information processing performed by the human brain are determined by the
intricate network of connections between nerve cells (or neurons). The magnitude of the task involved
in wiring the nervous system is staggering. In adult humans, each of over a trillion neurons makes con-
nections with, on average, over a thousand target cells in an intricate circuit whose precise pattern is
essential for the proper functioning of the nervous system. How can this pattern be generated during
embryogenesis with the necessary precision and reliability? Neuronal connections form when each
developing neuron sends out an axon, tipped by a growth cone, which migrates through the embry-
onic environment to its synaptic targets, guided by attractive and repulsive proteins that instruct it to
migrate in particular directions. Once in their appropriate target regions, axons must seek out particu-
lar target cells with which to form synaptic connections. These connections are then further refined,
through the making and breaking of synaptic contacts, under the control of specific patterns of electri-
cal activity in the neurons and targets, until a highly tuned circuit is established.
In the past decade, our understanding of the mechanisms that control axon growth and guidance,
synaptogenesis, and the remodeling of neural circuits during development has progressed rapidly from
phenomenology to the identification of specific molecular control mechanisms. Progress has been
assisted by the finding that these mechanisms are highly conserved across evolution, so that both bio-
chemical approaches in vertebrates and genetic approaches in invertebrates (and increasingly, in ver-
tebrates as well) have led to mutually reinforcing discoveries that have helped fuel further advances.
As the pace of discovery has quickened, the field has grown enormously, making it more difficult for
scientists to keep abreast of new developments. To help facilitate communication in the field, a bienni-
M. Tessier-Lavigne, L. Zipursky, T. Bonhoeffer
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al CSH conference series on "Axon Guidance and Developmental Plasticity of the Nervous System" was
initiated in 1998. This year, the second of these meetings was held in September 2000, and involved
sessions devoted to particular stages in the assembly of the nervous system, with speakers chosen
from among the participants submitting abstracts by session chairs who are leaders in the field. Other
abstracts were presented as posters.
As for the first meeting, the response of the field to this conference was one of overwhelming enthu-
siasm. There were 365 registrants, 231 of whom submitted abstracts. 64 abstracts were selected for
talks, in eight sessions. Senior researchers, starting assistant professors, postdoctoral fellows, and
graduate students were are well represented. All the major areas of research in the field were covered,
as were all of the major approaches (cellular, physiological, anatomical, biochemical, and genetic). In
addition, there were two a keynote addresses. The first was by Dr. Tim Mitchison of Harvard Medical
School, and focused on basic mechanisms controlling the cytoskeleton. The second was by Dr. Patricia
Kuhl of the University of Washington and focused on mechanisms involved in language acquisition. The
meeting provided an important clearing house for ideas and approaches and helped scientists in the
field get the most up-to-date information, as well as enabling them to meet, to network, and to estab-
lish collaborations. From the uniformly enthusiastic comments of the participants, the intensity of the
oral and poster sessions, and the large crowds that stayed up late every night at the bar to discuss sci-
ence further, the meeting was deemed a great success.
This meeting was funded in part by the National Institute of Neurological Disorders and Stroke, a
branch of the National Institutes of Health; and the National Science Foundation.
PROGRAM
Plasticity I
Chairpersons: C. Shatz, Harvard Medical School, Boston,
Massachusetts; H. Cline, Cold Spring Harbor Laboratory
Guidance I: Ephrins and Netrins
Chairpersons: C. Goodman, University of California, Berkeley;
C. Holt, University of Cambridge, United Kingdom
Special Lecture I
T Mitchison, Harvard Medical School, Boston, Massachusetts
Cell Migration
Chairpersons: M.B. Hatten, The Rockefeller University New
York, New York; T Curran, St. Jude Children's Research
Hospital, Memphis, Tennessee
Guidance II: Semaphorins and Slits
Chairpersons: M.-M. Poo, University of California, San Diego;
J. Flanagan, Harvard Medical School, Boston, Massa-
chusetts
Targeting and Synaptogenesis
Chairpersons: J. Sanes, Washington University School of
Medicine, St. Louis, Missouri; M. Takeichi, Kyoto University
Japan
Guidance Ill
Chairpersons: R. Axel, Columbia University New York, New
York; F. Bonhoeffer, Max-Planck Institut fur Entwicklungs-
biologie, Tubingen, Germany
Plasticity II
Chairpersons: M. Bear, Brown University Providence, Rhode
Island; A. Doupe, University of California, San Francisco
Special Lecture II
P. Kuhl, University of Washington, Seattle
Guidance IV
Chairpersons: J. Raper, University of Pennsylvania School of
Medicine, Philadelphia; C. Bargmann, University of
California, San Francisco
D. Chklovskii, G. Goodhill
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Gene Therapy
September 25-29 236 participants
ARRANGED BY Jeffrey Leiden, Abbott Laboratories
Margaret Liu, Lafayette, California
Gary Nabel, National Institutes of Health
James Wilson, University of Pennsylvania
The Gene Therapy meeting was the fifth in the series of biyearly meetings. There has been an explo-
sion of interest and progress in the field and a growing conviction that truly beneficial clinical applica-
tions of gene transfer technologies will soon appear. Of the many meetings on gene therapy, the Cold
Spring Harbor meeting remains the only one with an abstract-driven format and therefore continues to
be the most accessible to the broad gene therapy community, including students, fellows, and junior
and senior investigators. Several sessions focused on developments in vector design and regulation of
gene expression, and one session examined emerging technologies including stem cells and tissue
engineering. A number of sessions addressed the immune system and disease models including hemo-
philia, hematopoietic and muscle disorders, cancer, AIDS and infectious diseases, and neurological,
metabolic, and cardiovascular disorders. Although results and progress in a number of ongoing clinical
trials were presented, the program of the meeting emphasized the molecular genetics and cell biology
issues underlying approaches to human gene therapy. A special panel discussion was convened to dis-
cuss ethical issues in the design of clinical trials and the practice of data safety monitoring.
The meeting was supported in part by a generous grant from the National Institute of Child Health
and Human Development, a branch of the National Institutes of Health.
J. Wilson, M. Liu
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PROGRAM
Disease Models I: Hematopoietic, Hemophilia, Muscle
Disorders
Chairperson: K. High, University of Pennsylvania School of
Medicine, Philadelphia
Gene Therapy for AIDS and Vaccination Approaches to
Infectious Diseases
Chairpersons: M. Liu, Lafayette, California; G. Nabel, National
Institutes of Health, Bethesda, Maryland
Immunity and Gene Transfer
Chairperson: J. Leiden, Abbott Laboratories, Abbott Park,
Illinois
Regulation of Gene Expresssion
Chairperson: H. Bujard, ZMBH, University Heidelberg,
Germany
Panel Discussion: Clinical Trial Design, Data Safety
Monitoring, and Bioethics
Genetic Approaches and Immunotherapy for Cancer and
Angiogenesis
Chairperson: J. Folkman, Children's Hospital/Harvard Medical
School, Boston, Massachusetts
Viral Vector Development and Regulation of Gene
Expression
Chairperson: I. Verma, Salk Institute, San Diego, California
New Technology, Stem Cells, and Tissue Engineering
Chairperson: J. Wilson, University of Pennsylvania,
Philadelphia
Disease Models II: Neurological, Metabolic, and
Cardiovascular
Chairperson: T. Friedmann, University of California, San Diego
W. Wybranietz, D. Henderson,
J. Bramson
"Gene Therapy-Surely you're joking"
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Germ Cells
October 5-8 204 participants
ARRANGED BY Geraldine Seydoux, Johns Hopkins University School of Medicine, Baltimore, Maryland
Chris Wylie, Children's Hospital Research Foundation, Cincinnati, Ohio
An essential requirement for sexual reproduction is the germ line-the immortal cell lineage that gener-
ates the male and female gametes. During the past few years, it has become apparent that many of
the fundamental developmental mechanisms required for the establishment and function of germ cells
have been conserved during evolution. The second Cold Spring Harbor Germ Cells meeting was orga-
nized with the goal of bringing together researchers who study germ line development in both verte-
brate and invertebrate systems, as well as plants, so that recent exciting advances in one field could
cross-fertilize the other. During the course of the meeting, researchers showed how nanos-related
genes regulate early germ cell development in organisms as diverse as Drosophila, Caenorhabditis ele-
gans, Xenopus, zebrafish, and planarians. The piwi gene family is
another family with evolutionarily conserved roles: A mouse
homolog was shown at the meeting to be essential for spermato-
genesis. A final highlight of the meeting was the unveiling of the
sequence of the human Y chromosome, whose repetitive struc-
ture appears to be at the root of many male infertility syndromes.
The next Germ Cells meeting will be held in the fall of 2002, with
David Page and Ruth Lehmann serving as the organizers.
This meeting was funded in part by the National Institute
of Child Health and Human Development, a branch of the
National Institutes of Health; the National Science Foundation;
Lalor; and the March of Dimes.C. Wylie, G. Seydoux
PROGRAM
The Early Germ Line
Chairpersons: S. Strome, Indiana University Bloomington; B.
Hogan, Vanderbilt University Medical Center, Nashville,
Tennessee
Regulation of Germ Cell Gene Expression
Chairpersons: T. Schedl, Washington University School of
Medicine, St. Louis, Missouri; S. Tilghman, Princeton
University, New Jersey
Oogenesis and Egg Polarity
Chairpersons: D. St. Johnson, Wellcome/CRC Institute,
Cambridge, United Kingdom; C. Wylie, University of
Minnesota Medical School, Minneapolis
Sperm Differentiation
Chairpersons: S. Wassarman, University of California, San
Diego; R. Braun, University of Washington School of
Medicine, Seattle
Fertilization and Gamete Function
Chairpersons: B. Wakimoto, University of Washington,
Seattle; R Wassarman, Mt. Sinai School of Medicine, New
York, New York
Meiosis
Chairpersons: T. Orr-Weaver, Massachusetts Institute of
Technology Cambridge; S. Hawley, University of California,
Davis
P. Wassarman, A. Mahowald
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Cold Spring Harbor Millennium Meeting on Human Origins
and Disease
October 25-29 167 participants
ARRANGED BY Michael Brown, Emory University School of Medicine
Aravinda Chakravarti, Case Western Reserve University
Luigi Cavalli-Sforza, Stanford University
Colin Renfrew, University of Cambridge
Christopher Stringer, Natural History Museum, London
Antonio Torroni, University of Rome "La Sapienza"
Douglas Wallace, Emory University School of Medicine
The third in a series of Cold Spring Harbor meetings focused on the evolution of modern human beings and
brought together fossil, linguistic, and substantial amounts of molecular genetic information in an attempt to
achieve a new synthesis in our understanding of human origins. New paleontological evidence was present-
ed that supports a recent "out-of Africa" origin for modern Homo sapiens, implying that modern humans
arose once in Africa between 100,000 and 150,000 years before present (YBP), migrated out-of-Africa in
perhaps two migrations, and replaced contemporaneous Homo erectus and Neanderthal individuals, further
supported by the recent comparison of Neanderthal and modern mitochondrial (mt) DNA sequences which
revealed a striking molecular discontinuity between archaic and modern humans.
Molecular anthropological studies of maternally inherited mtDNA and paternally inherited Y chromo-
somes were presented, indicating that Africa harbors both the greatest genetic diversity and the oldest lin-
eages, with the two complementary approaches yielding a remarkable consensus that modern humans
arose in Africa about 143-144,000 YBP. Molecular analyses of autosomal and X chromosome loci varia-
tion have proved more cumbersome, but work presented at the meeting clearly indicates the African pop-
ulations as being the oldest and the Native Americans, the youngest. However, in contrast to mtDNA and
Y chromosome studies, most of the genetic variation of the autosomes and X chromosome is shared
across all continents, and the coalescence time for the variation is much older. This discrepancy probably
reflects the higher effective population size and recombination of the autosomes as opposed to the mtDNA
and the Y chromosome. Even so, there is considerable information to be obtained from analysis of chor-
A. Chakravarti, D. Wallace, C. Renfrew, C. Stringer, L. Cavalli-Sforza, A. Torroni
245
mosomal loci, particularly using linkage disequilibrium coupled with high-throughput chromosomal
sequencing and single nucleotide polymorphism (SNP) analysis. Another promising source of historical
information within the autosomes are transposable elements: SINES and LINES. Analysis of recent Alu
SINE repeats is beginning to shed additional light on the radiation of higher primates and the recent dis-
persal of modern humans.
Besides being used to address global questions of human origins, molecular anthropology has permitted
novel approaches to the study of local population issues. These types of studies confirm that considerable
historical and migratory information can be deduced from our genes. What are needed now are new sources
of data and new analytical tools. High-throughput genomic sequencing, rapid genotyping of polymorphic
loci, and more reliable mathematical methods for analysis will be required to accurately extract the informa-
tion. Not only will such studies tell us much about human history, they will provide vital data on continent and
population-specific variation that will be important for localizing and cloning common disease genes.
PROGRAM
Overview of Human Origins
D.C. Wallace, Emory University School of Medicine, Atlanta,
Georgia
Global
Chairperson: L. Cavalli-Sforza, Stanford University Stanford
Global I
Chairperson: P. Underhill, Stanford University, Stanford
Global II
Chairperson: C. Stringer, Natural History Museum, London
Africa I
Chairperson: K. Kidd, Yale University Connecticut
Africa II
Chairperson: C. Renfrew, University of Cambridge, United
Kingdom
Asia I
Chairperson: M. Hammer, University of Arizona, Tucson
Asia II
Chairperson: J. Friedman, The Rockefeller University New York
Middle East-India
Chairperson: L. Jorde, University of Utah, Salt Lake City
Europe I
Chairperson: M. Brown, Emory University School of Medicine,
Atlanta, Georgia
Europe II
Chairperson: A. Torroni, University of Rome "La Sapienza,"
Italy
Americas
Chairperson: J. Renfrew, University of Cambridge, United
Kingdom
Gene and Environment-Common Disease
Chairperson: J. Felsenstein, University of Washington, Seattle
Analysis of Chromosomal Variation I
Chairperson: A. Clark, Pennsylvania State University
Philadelphia
Analysis of Chromosomal Variation II
Chairperson: A. Chakravarti, Case Western Reserve
University Cleveland, Ohio
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General Lecture I
Chairperson: T. Jenkins, S. Africa Institute of Medical
Research, Johannesburg
Lines and Sines
Chairperson: M.-C. King, University of Washington, Seattle
Evolutionary Genetics of Common Disease
Chairperson: A. Motulsky, University of Washington, Seattle
J.D. Watson, P. Tobias
J. Witkowski, N. Wade, M.-C. King
S. Patel, S. McBrearty
WINTER BIOTECHNOLOGY CONFERENCE
Therapeutic Opportunities in Neurodegenerative Diseases
November 30-December 3 126 participants
ARRANGED BY Sam Gandy, New York University
Harry Le Vine III, Pfizer Inc.
Marcy MacDonald, Massachusetts General Hospital/Harvard Medical School
As many as one-half of those aged 65 years or older will develop a debilitating degenerative disease of
the central nervous system, usually characterized by a decade or more of dependent living, accompa-
nied by progressive failure of cognitive function and/or coordinated movement. Although these illness-
es appear most commonly in the absence of obvious heretability or identifiable genetic mutations, it has
been possible during the past 20 years to discover risk-modifying DNA changes in some examples and
predictable causative changes in others. From these findings, transgenic technology has rapidly led to
the development of mouse, fruitfly, and nematode model systems that partially recapitulate the behav-
ioral abnormalities of the human diseases as well as some of the hallmark molecular and morphologi-
cal pathology of the conditions.
Rational biochemical and cell-based screens have generated lead compounds that show promise
in the living animal models. Most importantly, the animal models have enabled discovery of entirely
unanticipated therapeutic strategies (such as amyloid beta immunotherapy). In December 1999, some
of these rationally discovered compounds and unexpected immunotherapies entered Phase I clinical
trials. The progress of compounds and rational strategies from the animal model to the human clinical
trial, the design, results, and conclusions of trials, and the return to the animal model with questions
raised during human trials are the areas of particular emphasis for these biannual Winter Biotechnology
Meetings instituted in December 2000 with the explicit goal of facilitating the translation of "break-
through" science into effective medicines.
S. Gandy, M. MacDonald, H. Levine Ill J. Saffell, C. Masters
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For the 2000 meeting, seven 3- or 4-hour platform sessions were organized around common tech-
nological themes. Chairpersons, invited speakers, and speakers selected from submitted abstracts
were equally drawn from the academic and pharma sectors. Although the discussion of new, unpub-
lished data was emphasized, the group was tolerant of a wide range of intellectual property conven-
tions. Poster presentations were also encouraged: Posters were displayed throughout the Meeting, and
poster viewing was especially encouraged during the cocktail hours before the evening meals.
Topics in the 2000 meeting included protein aggregation inhibitors, protein processing enzymology
and pharmacology, gene transfer, stem cell transfer, immunotherapy, human genetics, design and inter-
pretation of genomic analyses in mammalian and lower systems, bioinformatics, mouse and fly models
of neurological disease, mechanisms of neurodegeneration, mitochondrial function and dysfunction,
programmed cell death, neurotrophins, and metabolic and hormonal influences on disease protein
metabolism in cell culture and living animal models, as well as in human clinical trials. Diseases consid-
ered at the 2000 meeting included Alzheimer's, Huntington's, spinocerebellar atrophies, ALS,
Parkinson's, tauopathies, and synucleinopathies.
PROGRAM
Aggregation and Anti-Aggregation
Chairperson: S. Priola, Rocky Mountain Laboratories, NIAID,
National Institutes of Health, Hamilton, Montana
Enzymology and Pharmacology of Alzheimer and Parkinson
Diseases
Chairperson: S. Sinha, Elan Pharmaceuticals, South San
Francisco, California
Mechanisms of Neurodegeneration and Cell Death
Chairperson: D. Choi, Washington University School of
Medicine, St. Louis, Missouri
Molecular Pathology and Pharmacology: Clinical
Correlations
Chairperson: M. Sano, Columbia University College of
Physicians & Surgeons, New York, New York
Infection, Inflammation, and Immunization: Pathogenesis
and Therapy
Chairperson: N. Mazarakis, Oxford BioMedica (UK) Ltd.,
United Kingdom
Genomic Approaches to Elucidation of Pathogenesis and to
Tailoring Therapy
Chairpersons: A. Califano, First Genetic Trust, Inc.; R.
Sherrington, Pfizer Global Research and Development,
Alameda, California
Polyglutamine Diseases, Tauopathies, and
Synucleinopathies
Chairperson: H. Zoghbi, Baylor College of Medicine, Houston,
Texas
P. Radel, S. McKinnon
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Arabidopsis Genomics
December 7-10 150 participants
ARRANGED BY Rob Martienssen, Cold Spring Harbor Laboratory
Michael Bevan, John lnnes Center, United Kingdom
This meeting served as the third in a series of biotechnology symposia aimed at bringing together those
groups sequencing and analyzing the genome of Arabidopsis thaliana with those attempting to deter-
mine the biological function of plant genes and other chromosomal sequences. The meeting just pre-
ceded the December 14th publication in the journal Nature of the complete A. thaliana genome by a
consortium of international groups, many of whom were able to present their latest data and interpre-
tation at the meeting. The meeting included an opening plenary talk on the completed Drosophila
melanogaster genome by Michael Ashburner, and a tribute by Ron Davis to De Lill Nasser, who togeth-
er with colleagues at the National Science Foundation spear-headed the international sequencing effort
in Arabidopsis (sadly, De Lill could not be at the meeting and passed away a few weeks later). Mike
Snyder gave a fascinating keynote talk on new tools for functional genomics in yeast. In all, the meet-
ing included two keynotes, 39 oral presentations, a functional genomics workshop, 43 posters, and
closing remarks by Steve Tanks ley. The auspicious timing of this meeting served to underscore the cel-
ebration for many of those involved in the international sequencing effort. The American Society of Plant
Physiology generously supported a champagne reception on December 9th to celebrate completion of
the first plant genome.
D. Preuss, M. Dilworth, R. Martienssen, E. Meyerowitz, J.D. Watson, H.-W. Mewes, W.R. McCombie, M. Bevan
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PROGRAM
Genome Analysis
Chairperson: E. Meyerowitz, California Institute of Technology,
Pasadena
Plenary Speaker
M. Ashburner, EMBL-EBI, Welcome Trust Genome Campus,
Hinxton, United Kindgom
Functional Genomics I
Chairperson: M. Bevan, John /noes Centre, Norwich, United
Kingdom
Plenary Speaker
M. Snyder, Yale University New Haven, Connecticut
Functional Genomics Workshop and Coordination Meeting
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
Functional Genomics II
Chairperson: M. Sussman, University of Wisconsin,
Madison
New Technologies
Chairperson: N. Fedoroff, Pennsylvania State University,
University Park
Genome Organization and Evolution
Chairperson: E. Richards, Washington University St. Louis,
Missouri
New Biological Insights From Genomics
Chairperson: G. JOrgens, University of TObingen,
Germany
M. Salanoubat, M. Bevan, S. Rounsley
V. Co lot, E. Heard, M. Ashburner
250
N. Fedoroff, T. Mitchell-Olds, M. Sussman
POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the
special need for training in interdisciplinary subjects that are either so new or so specialized that
they are not adequately treated by universities. Our aim is to provide intensive study in the most
recent developments and techniques in these subjects and to prepare students to enter directly
into research in a particular area. To ensure up-to-date coverage of current research work, we
bring together course faculty from many laboratories around the world and supplement this staff
with a series of seminar speakers.
Advanced Genome Sequence Analysis
March 15-28
INSTRUCTORS S. Clifton, Ph.D., Washington University School of Medicine, St. Louis, Missouri
E. Mardis, Ph.D., Washington University School of Medicine, St. Louis, Missouri
W.R. McCombie, Ph.D., Cold Spring Harbor Laboratory
J. McPherson, Ph.D., Washington University School of Medicine, St. Louis, Missouri
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ASSISTANTS M. de la Bastide, Cold Spring Harbor Laboratory
J. Eldred, Washington University School of Medicine, St. Louis, Missouri
M. Fitzgerald, Genome Therapeutics Corporation, Waltham, Massachusetts
E. Huang, Cold Spring Harbor Laboratory
D. Johnson, Washington University School of Medicine, St. Louis, Missouri
J. Kramer, Washington University School of Medicine, St. Louis, Missouri
M. Nhan, Washington University School of Medicine, St. Louis, Missouri
A. O'Shaughnessy, Cold Spring Harbor Laboratory
R. Preston, Cold Spring Harbor Laboratory
M. Rodriguez, Cold Spring Harbor Laboratory
R. Shah, Cold Spring Harbor Laboratory
L. Spiegel, Cold Spring Harbor Laboratory
This course focused on obtaining and analyzing genomic DNA sequence data. It also focused on large-
scale sequencing, presenting students with important information on the technical and project man-
agement aspects of genomic DNA sequencing projects as well as the computational analysis of the
sequence. This was achieved by carrying out a large-scale sequencing project during the class, with a
special emphasis on the technical nuances of large-scale sequencing. Increases in sequencing effi-
ciency now permit us to carry out the production phase of the student's sequencing project in less time.
As a result, the course increased its emphasis on two areas: the finishing process and the analysis of
DNA sequences (both computational and experimental). Last year's course included a module on
sequence-based polymorphism analysis. This year, the course expanded the polymorphism analysis to
include sequencing of regions from multiple individuals and additional SNP analysis. This curriculum
allowed students to learn advanced techniques and principles of genomic DNA sequence analysis, from
data generation to analysis of sequence variations in populations.
PARTICIPANTS
Brown, D., B.S., M.S., Research Genetics, Huntsville,
Alabama
Chan, D., B.S., M.Phil., Prince of Wale's Hospital (CUHK),
Hong Kong
Dubbelde, C., B.S., HHMI at Washington, St. Louis, Missouri
Eliana, G.-S., B.S., CIAT, Columbia
Garrigues, C., B.S., Molecular Dynamics, Sunnyvale,
California
Hauser, L., B.S., Ph.D., University of Tennessee/Oak Ridge
National Laboratory, Tennessee
Lee, Y.-S., B.A., Ph.D., College of Agriculature & Life
Sciences, Kangwon National University, South Korea
Liu, Y., B.M., M.S., Defence Medical Research Institute,
Singapore
SEMINARS
Green, E., NHGRI/National Institutes of Health, Bethesda,
Maryland: Mapping and sequencing a human chromosome:
How and why.
Hadd, A., Molecular Dynamics, Sunnyvale, California:
Nano Prep sequencing projects. Capillary electrophoresis:
Fundamental principles.
Hobert, 0., Columbia University, New York, New York: Using
the genome sequence to study neural development in C.
elegans.
Johnston, R., Incyte Microarray System, Fremont, California:
cDNA microarray technology.
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Lohi, H., M.Sc., Ph.D., University of Helinski, Finland
Nguyen, K., B.A., M.S., Tularik Inc., Green lawn, New York
Ohmen, J., B.S., Ph.D., Parke-Davis Laboratory for Molecular
Genetics, Alameda, California
Pennacchio, L., B.A., Ph.D., Lawrence Berkeley National
Laboratory, Berkeley, California
Struyf, F, M.D., Northwestern University Medical School,
Chicago, Illinois
Wiencis, A., B.S., M.A., Aventis Pharmaceuticals, Cambridge,
Massachusetts
Wilson, B., B.S., Ph.D., Jackson State University, Jackson,
Mississippi
Wing, R., A.B., Ph.D., Clemson University Genomics Institute,
Clemson, South Carolina
Kaul, S., The Institute for Genomic Research, Rockville,
Maryland: Arabidopsis genome.
Korf, I., Washington University School of Medicine, St. Louis,
Missouri: Human analysis.
Nickerson, D., Washington University School of Medicine, St.
Louis, Missouri: SNPs in candidate genes.
Watson, J.D., Cold Spring Harbor Laboratory: Thoughts on
DNA.
Wilson, R., Washington University School of Medicine, St.
Louis, Missouri: Sequencing the human genome.
Protein Purification and Characterization
April 5-18
INSTRUCTORS R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S.-H. Lin, University of Texas, Houston
S. Mische, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
ASSISTANTS: L. Anthony, University of Wisconsin, Madison
V. Bhaskar, University of California, Los Angeles
F. Gharandaghi, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut
E. Han, University of Texas, Houston
D. Meagher, The Rockefeller University, New York, New York
D. Phan, University of Texas, Houston
N. Thompson, University of Wisconsin, Madison
This course was intended for scientists who are not familiar with techniques of protein isolation and
characterization. It was a rigorous program that included laboratory work all day and a lecture with a
discussion session every evening. Each student became familiar with each of the major techniques in
protein purification by actually performing four separate isolations including (1) a regulatory protein from
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muscle tissue, (2) a sequence-specific DNA-binding protein, (3) a recombinant protein overexpressed
in E. coli, and (4) a membrane-bound receptor. A variety of bulk fractionation, electrophoretic, and
chromatographic techniques were used, including precipitation by salts, pH, and ionic polymers; ion
exchange, gel filtration, hydrophobic interaction, and reversed-phase chromatography; lectin affinity,
ligand affinity, oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel elec-
trophoresis and electroblotting; and high-performance liquid chromatography. Procedures were pre-
sented for solubilizing proteins from inclusion bodies and refolding them into active monomeric forms.
Methods of protein characterization were utilized including immunological and biochemical assays,
protein-protein interaction studies by far-Western analysis, peptide mapping, amino acid analysis, pro-
tein sequencing, and mass spectrometry. Emphasis was placed on strategies of protein purification
and characterization. Guest lecturers discussed protein structure, modification of proteins, method-
ologies for protein purification and characterization, and applications of protein biochemistry to cell and
molecular biology.
PARTICIPANTS
Birrell, G., B.S., Ph.D., Stanford University, California
Bonnal, S., B.S., Ph.D., National Institute of Health and
Medical Research, France
Duggan, L., B.S., Ph.D., Wistar Institute, Philadelphia,
Pennsylvania
Esumi, N., M.D., Ph.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Gutstein, H., A.B., M.D., University of Texas/M.D. Anderson
Cancer Center, Houston
Li, R., B.S., Ph.D., Children's Research Institute, Washington,
D.C.
Lopato, S., B.S., Ph.D., University of Vienna, Austria
Manogaran, A., B.S., Ph.D., Marquette University, Milwaukee,
Wisconsin
SEMINARS
Burgess, R., University of Wisconsin, Madison: Overview of
protein purification, immunoaffinity purtcation. Biochemical
studies of RNA polymerase/Sigma factor interactions.
Courey, A., University of California, Los Angeles: Protein-pro-
tein interactions in dorsal/ventral pattern formation in
Drosophila.
Guidotti, G., Harvard University, Cambridge, Massachusetts:
Membrane proteins and extracellular ATP.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Proteins in
3-D.
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Pollak, E., A.B., M.D., Children's Hospital of Philadelphia,
Pennsylvania
Ray, A., M.S., Ph.D., Cleveland Clinic Foundation, Ohio
Reddi, P., B.S., Ph.D., University of Virginia, Charlottesville
Reichert, A., Ph.D., Max-Planck Institute for Evolution/
Anthropology, Germany
Struffi, P., M.S., University of Michigan, East Lansing
Tiscornia, G., B.S., Ph.D., University of Wisconsin,
Madison
Ximenez-Fyvie, L., D.D.S., D.M.S., National University of
Mexico, Mexico
Zhang, H., B.M., Ph.D., Brigham and Women's Hospital,
Boston, Massachusetts
Kern, D., Brandeis University, Waltham, Massachusetts: Not
just structures: NMR studies of regulatory proteins in action.
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas: C-
CAM: A novel tumor suppressor with anti-angiogenesis
activity.
Mische, S., Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, Connecticut: Microanalytical protein preparation
and characterization.
Severinov, K., Waksman Institute, Rutgers, Piscataway, New
Jersey: Protein-protein interactions in bacterial transcription.
Cell and Developmental Biology of Xenopus
April 8-18
INSTRUCTORS P. Krieg, University of Arizona, Tucson
S. Moody, George Washington University Medical Center, Washington, D.C.
ASSISTANTS 0. Cleaver, Harvard University, Cambridge, Massachusetts
K. Kenyon, George Washington University, Washington, D.C.
P. Pandur, University of Ulm, Germany
A. Zorn, University of Cambridge/Wellcome CRC Institute, Cambridge, United Kingdom
The frog Xenopus is an important vertebrate model for studies of maternal factors, molecular mecha-
nisms of tissue inductions, and regulation of cell fate decisions. In addition, Xenopus oocytes and
embryos provide a powerful system in which to conduct a number of cell biological and gene regula-
tion assays. This course provided extensive laboratory exposure to the biology, manipulation, and use
of oocytes and embryos of Xenopus. The course consisted of intensive laboratory sessions, supple-
mented by daily lectures and demonstrations from experts in cellular, experimental. and molecular
development. Areas covered included (1) care of adults; (2) oocyte isolation and embryo production;
(3) stages of embryonic development and anatomy; (4) whole-mount in situ hybridization and immuno-
cytochemistry; (5) microinjection of eggs and oocytes with lineage tracers, DNA constructs, mRNA,
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and antisense oligonucleotides; (6) micromanipulation of embryos, including explant
and transplanta-
tion assays; (7) preparation of transgenic embryos; and (8) use of Xenopus tropicalis
for genetic analy-
ses. This course was suited for both investigators who had no previous
experience with Xenopus and
those who had worked with Xenopus and wished to learn new and cutting-edge
techniques. All par-
ticipants had current training in molecularbiology and some knowledge of developmental
biology.
PARTICIPANTS
Bosetti, A., B.S., San Raffaele Scientific Institute, Milano, Italy
Boyer, B., B.S., M.D., Ph.D., Centre National de la
Recherche Scientifique, Orsay, France
Drawbridge, J., B.S., Ph.D., Rider University, Lawrenceville,
New Jersey
Hamilton, F., B.Sc., University of Dundee, United Kingdom
Holley, C., B.S., Duke University, Durham, North Carolina
Kim, S.W., B.S., M.S., University of Texas/M.D. Anderson
Cancer Center, Houston
Luo, X., B.S., Ph.D., University of North Carolina, Chapel Hill
Marchant, J., B.A., M.A., Ph.D., University of California,
Irvine
Mullor, J., B.S., Ph.D., Skirball Institute, NewYork University
SEMINARS
Amaya, E., Cambridge University, United Kingdom: Intro-
duction to transgenic techniques.
Cleaver, 0., Harvard Medical School, Cambridge, Massa-
chusetts: Pancreas development.
De Simone, D., University of Virginia, Charlottesville: Regu-
lation of cell adhesion and morphogenesis in Xenopus.
Grainger, R., University of Virginia, Charlottesville:Xenopus
tropicalis: A new model for vertebrate developmental genet-
ics.
Gurdon, J., Cambridge University, United Kingdom: Mechan-
isms of perception of morphogen concentration.
Heasman, J., University of Minnesota, Minneapolis: Maternal
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Medical Center, New York, New York
Ogawa, M., B.M., Keio University, School of Medicine, Tokyo,
Japan
Otero, L., BA., D.Phil., University of Cambridge, United
Kingdom
Park, E.K., B.S., Ph.D., National Cancer Institute/Frederick
Cancer Research and Development Center, Maryland
Peng, Y., M.D., Ph.D., National Cancer Institute, Frederick,
Maryland
Seville, R., B.Sc., University of Warwick, Coventry, United
Kingdom
Vernon, A., B.S., University of Cambridge, United Kingdom
Warkman, A., B.Sc., University of Western Ontario, Canada
control of tissue specification.
Keller, R., University of Virginia, Charlottesville: Early embryon-
ic anatomy and morphogenesis of Xenopus.
King, M.L., University of Miami, Florida: Role of localized
maternal RNAs in Xenopus development.
Krieg, P., University of Arizona, Tucson: Cardiovascular devel-
opment.
Moody, S., George Washington University Medical Center,
Washington, D.C.: Introduction to early embryology. The
competence to form retina and amacrine cells.
Zorn, A., Wellcome Trust, Cambridge, United Kingdom:
Regulation of endoderm specification.
Genetic-Epidemiological Studies of Complex Diseases
June 7-13
INSTRUCTORS E. Squires-Wheeler, Columbia University College of Physicians & Surgeons,
New York, New York
N. Risch, Stanford University, California
This lecture course considered the many difficulties in studying the genetic basis of complex disorders,
such as diabetes, cardiovascular disease, cancer, Alzheimer's disease, schizophrenia, and epilepsy,
with a particular emphasis on neuropsychiatric conditions. We discussed genetic-epidemiologic study
designs, including family, twin, and adoption studies, as well as mode of inheritance analyses, and their
role in setting the framework for understanding the genetic and nongenetic components of a disease.
A major focus was the identification of specific gene effects using both linkage and association analy-
ses. We discussed the efficiency and robustness of different designs for such analysis. We also con-
sidered how evidence from genetic-epidemiologic studies informs both the design and interpretation of
molecular genetic studies. Recent discoveries of genes for both Mendelian and non-Mendelian dis-
eases guided the discussion of the various methodologic issues.
PARTICIPANTS
August, R, B.A., M.D., Cornell Medical College, New York, Bergson, C., B.S., Ph.D., Medical College of Georgia,
New York Augusta
Bai, Y., M.B., Ph.D., National Cancer Institute/NIH, Bethesda, Diaz, G., B.A., Ph.D., Mount Sinai School of Medicine, New
Maryland York, New York
257
Hall, M., B.Sc., Ph.D., Kings College, London, United
Kingdom
Heng, C.-K., B.S., Ph.D., National University of Singapore,
Singapore
Hsu, I., B.S., Ph.D., National Tsing Hua University, Hsinchu,
Taiwan, Republic of China
Hwa, K., B.S., Ph.D., Academia Sinica, Taipei, Taiwan,
Republic of China
Johansson, C., M.S., Karolinska Institutet, Stockholm,
Sweden
Lou, W.Y.W., B.S., Ph.D., Mount Sinai School of Medicine,
New York, New York
Loy, C., M.B., B.S., M.Med., University of Sydney/Garvin
Institute, Sydney, Australia
Malhotra, A., B.A., Ph.D., Hillside Hospital, Glen Oaks, New
York
Mar ler, J., A.B., M.D., National Institute of Neurological
Communicative Disorders and Stroke, Bethesda,
Maryland
Millwood, I., B.A., Ph.D., Imperial College of Medicine,
SEMINARS
Bressman, S., Beth Israel, New York, New York: Dystonia.
Kardia, S., University of Michigan, Ann Arbor: Candidate
genes in cardiovascular disease.
Keats, B., Louisiana State University Medical Center, New
Orleans: Mendelian principles and linkage analysis I.
Genetic disorders in the arcadian population.
Merikangas, K., Yale University School of Medicine, New
Haven, Connecticut: Further issues in genetic epidemiology.
Meyer, J., Millenium Pharmaceuticals, Cambridge, Massa-
chusetts: Biometrical genetics.
Myers, R., Stanford University School of Medicine, California:
Molecular technology and the genome project.
258
Middlesex, United Kingdom
Odeberg, J., M.S., Ph.D., Royal Institute of Technology,
Stockholm, Sweden
Peissel, B., M.D., Ph.D., National Cancer Institute, Milan,
Italy
Pennesi, G., M.D., Ph.D., National Institutes of Health,
Bethesda, Maryland
Rana, B., B.A., Ph.D., University of California, San Diego, La
Jolla
Scheinman, S., A.B., M.D., SUNY Health Science Center,
Syracuse, New York
Seielstad, M., B.S., Ph.D., Harvard School of Public Health,
Boston, Massachusetts
Van Belzen, M., M.Sc., University Medical Center Utrecht,
The Netherlands
Wager-Smith, K., B.S., M.A., The Scripps Research Institute,
La Jolla, California
Zhang, K., B.S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Ott, J., Columbia University College of Physicians &
Surgeons, New York, New York: Linkage analysis II.
Ottman, R., Columbia University School of Public Health,
New York, New York: First principles of genetic epidemiolo-
gy.
Risch, N., Stanford University, California: Autism.
Sandkuijl, L., Leiden University, Delft, The Netherlands:
Biopolar disorder.
Spielman, R., University of Pennsylvania School of Medicine,
Philadelphia: Polycystic ovary syndrome.
Witte, J., Case Western Reserve University, Cleveland, Ohio:
Family and non-family-based linkage disequilibrium studies.
Advanced Bacterial Genetics
June 7-27
INSTRUCTORS B. Bass ler, Princeton University, New Jersey
C. Manoil, University of Washington, Seattle
J. Slauch, University of Illinois, Urbana-Champaign
ASSISTANTS C. Ellermeier, University of Illinois, Urbana-Champaign
M. Miller, Princeton University, New Jersey
E. Round, University of Washington, Seattle
The laboratory course presented logic and methods used in the genetic dissection of complex biolog-
ical processes in bacteria. The methods presented included mutagenesis using transposons, mutator
strains, and chemical and physical mutagens; mapping mutations using genetic and physical tech-
niques; generation and analysis of gene fusions; molecular cloning; polymerase chain reaction;
Southern blot analysis; epitope insertion mutagenesis; and site-directed mutagenesis. A key compo-
nent of the course was the use of sophisticated genetic methods in the analysis of pathogenic and
"undomesticated" bacteria. Invited lecturers described the use of genetic approaches to study biolog-
ical processes in a variety of bacteria.
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PARTICIPANTS
Backhed, F., M.S., Karolinska Institutet, Stockholm, Sweden
Bakshi, S., B.Sc., M.Sc., University of Oxford, United
Kingdom
Georgellis, D., B.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Gueneau de Novoa, P., M.Sc., Ph.D., Institute Venezolano de
Investigaciones Cientifica, Altos de Pipe-Miranda, Venezuela
Kotton, Camille, B.A., M.D., Massachusetts General Hospital,
Boston
Levy, D., B.A., Ph.D., U.S. Food and Drug Administration,
Washington, D.C.
Madsen, E., B.A., Ph.D., Cornell University, Ithaca, New York
Ohl, M., B.S., M.D., University of Washington, Seattle
SEMINARS
Grossman, A., Massachusetts Institute of Technology,
Cambridge: Control of development by replication initiation
proteins in Bacillus subtilis.
Harriman, P., National Science Foundation, Arlington, Virginia:
Microbiology and genetics at the NSF.
Hughes, K., University of Washington, Seattle: Translation:
The grand unifying theory in type III secretion.
Jacobs, W., Albert Einstein College of Medicine, Bronx, New
York: The power of bacterial genetics: A 1914-D penny,
lotto, tuberculosis control, and beyond.
Kaplan, H., University of Texas Medical School, Houston:
Sensing and integration of multiple signals during
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Rosen, H., A.B., M.D., University of Washington, Seattle
Sambandamurthy, V, M.Sc., Ph.D., Albert Einstein College of
Medicine, Bronx, New York
Stockbauer, K., B.A., University of California, Los Angeles
Sturgill-Koszyck, S., B.S., Ph.D., University of Michigan, Ann
Arbor
Thomsen, L., M.S., The Royal Veterinary and Agricultural
University, Copenhagen, Denmark
Ting, C., BA., Ph.D., Massachusetts Institute of Technology,
Cambridge
Todd, W., B.A., Ph.D., LSU Agricultural Center and School of
Veterinary Medicine, Baton Rouge, Louisiana
Vanrompay, D., Ph.D., University of Gent, Belgium
Myxococcus multicellular development.
Lory, S., University of Washington, Seattle: DNA microarrays
as tools for studying host-pathogen interactions.
Metcalf, W., University of Illinois, Urbana: Genetic analysis of
methanogenesis in Methanosarcina species.
Miller, J., University of California, Los Angeles: Signal trans-
duction during the Bordetella infectious cycle.
Pogliano, K., University of California, San Diego, La Jolla:
Moving and fusing membranes during Bacillus subtilis
sporulation.
Roth, J., University of Utah, Salt Lake City: Adapative muta-
bility: Fact or artifact.
Molecular Embryology of the Mouse
June 7 -27
INSTRUCTORS A. Nagy, Mount Sinai Hospital, Toronto, Ontario, Canada
P. Tam, Children's Medical Research Institute, Wentworthville, Australia
CO-INSTRUCTORS S.-L. Ang, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Strasbourg,
France
A. Goss ler, Institut fur Molekularbiologie, Hannover, Germany
ASSISTANTS B. Davidson, Children's Medical Research Institute, Wentworthville, Australia
M. Gertsenstein, Samuel Lunenfeld Research Institute, Toronto, Ontario, Canada
This intensive laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse embryonic development. Laboratory components provided an intro-
duction into the technical aspects of working with and analyzing mouse embryos, and lectures provid-
ed the conceptual basis for contemporary research in mouse development. Experimental techniques
that were covered in the practicals included in vitro culture and manipulation of pre- and postimplan-
tation embryos; transgenesis by DNA microinjection; embryo transfer; establishment, culture, and
genetic manipulation of embryonic stem cells; production of chimeras by aggregation with and injec-
tion of embryonic stem cells; and the analysis of development by whole-mount in situ hybridization,
skeletal preparation, and transgene expression. The participating speakers were Siew-Lan Ang, Marisa
Bart° lame', Richard Behringer, Charles Emerson, Achim Goss ler, Brigid Hogan, Nancy Jenkins, Tom
Jessell, Alexandra Joyner, Monica Justice, Robin Lovell-Badge, Terry Magnuson, Anne McLaren, Peter
Mombaerts, Andras Nagy, Lee Niswander, Ginny Papaioannou, Janet Rossant, Austin Smith, Davor
Solter, Phil Soriano, Patrick Tam, and David Wilkinson.
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PARTICIPANTS
Bartsch, D., B.S., Ph.D., Columbia University, New York, New
York
Buchner, G., B.Sc., Guy's Hospital, London, United Kingdom
Chinoy, M., B.S., Ph.D., Pennsylvania State University,
Hershey
Hirschi, K., B.S., Ph.D., Baylor College of Medicine, Houston,
Texas
Lopez-Guisa, J., B.S., Ph.D., University of Washington
School of Medicine and Children's Hospital, Seattle
Lykke-Andersen, K., B.A., M.S., Yale University, New Haven,
Connecticut
Milewski, R., M.D., Ph.D., Yale University, New Haven,
Connecticut
SEMINARS
Ang, S.-I., Institut de Genetique et de Biologie Moleculaire et
Cellulaire, C.U. de Strasbourg, France: Head formation.
Bartolomei, M., University of Pennsylvania School Medicine,
Philadelphia: Genomic imprinting.
Behringer, R., University of Texas/M.D. Anderson Cancer
Center, Houston: Transgenesis. Reproductive organs.
Emerson, C., University of Pennsylvania School of Medicine,
Philadelphia: Signaling and transcriptional mechanisms
controlling skeletal myogenesis.
Goss ler, A., Institut fur Molekularbiologie, Hannover,
Germany: Somitogenesis.
Hogan, B., Vanderbilt University Medical Center/HHMI,
Nashville, Tennessee: BMP signaling, Forkhead genes, and
morphogenesis.
Jenkins, N., NCI-Frederick Cancer Research and Develop-
ment Center, Maryland: Mouse genetics.
Jessell, T., Columbia University, New York, New York:
Regionalization and cell-type specification.
Joyner, A., New York Medical Center/Skirball Institute of
Biology, New York, New York: Brain patterning.
Justice, M., Baylor College of Medicine, Houston, Texas:
ENU mutagenesis.
Lovell-Badge, R., MRC National Institute for Medical
Research, London, United Kingom: Mouse models and
experimental manipulation. Sox genes and cell fate deci-
sion. Sex determination.
Magnuson, T., Case Western Reserve University, Cleveland,
Ohio: Genetic analysis of development.
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Porse, B., M.S., Ph.D., University Hospital of Copenhagen,
Denmark
Tang, D., B.S., Ph.D., University College London, United
Kingdom
Van Hengel, J., M.S., Ph.D., University of Ghent, Belgium
Wang, B., B.S., Ph.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Yang-Yen, H.-F., B.S., Ph.D., Academia Sinica, Taiwan,
Republic of China
You, Y., B.S., Ph.D., Oak Ridge National Laboratory,
Tennessee
Zarach, J., B.S., Johns Hopkins University, Baltimore,
Maryland
McLaren, A., Wellcome/CRC Institute, Cambridge, United
Kindom: Germ cells.
Mombaerts, R, The Rockefeller University, New York, New
York: Analysis of olfactory function. Cloning by nuclear
transfer.
Nagy, A., Mount Sinai Hospital, Toronto, Ontario, Canada: ES
cells and the biology of chimeras. Gene targeting: Strategy
and technology.
Niswander, L., Memorial Sloan-Kettering Cancer Center, New
York, New York: Fgf signaling in vertebrate and invertebrate
development.
Papaioannou, G., Columbia University College of Physicians
& Surgeons, New York, New York: T-box genes.
Rossant, J., Mount Sinai Hospital, Toronto, Canada:
Extraembryonic tissues.
Smith, A., University of Edinburgh, United Kingdom:
Pluripotency and differentiation of embryonic stem cells.
Softer, D., Max-Planck Institut fur Immunbiologie, Freiburg,
Germany: Fertilization and preimplantation development.
Soriano, R, Fred Hutchinson Cancer Research Center,
Seattle, Washington: PDGF signaling. Gene trap.
Tam, R, Children's Medical Research Institute,
Wentworthville, Australia: Body patterning and early
organogenesis.
Wilkinson, D., MRC National Institute for Medical Research,
London, United Kingdom: In situ hybridization and Eph sig-
naling in patterning.
Physiological Approaches to Ion Channel Biology
June 7-27
INSTRUCTORS T. Otis, University of California, Los Angeles
A. Ribera, University of Colorado, Denver
L. Trussell, Oregon Health Sciences Center, Portland
CO-INSTRUCTORS L. Blair, Brown University, Providence, Rhode Island
G. Borst, Universiteit van Amsterdam, The Netherlands
ASSISTANTS S. Brenowitz Oregon Health Sciences Center, Portland
A. Linares, University of Colorado, Denver
V. Maubecin, Oregon Health Sciences Center, Portland
This intensive laboratory/lecture course introduced students to electrophysiological approaches for the
study of ion channels in their native environments. Hands-on exercises included patch-clamp record-
ing of ion channel activity in acutely isolated or cultured cells or neurons in brain slice preparations.
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Different recording configurations (e.g., extracellular, whole-cell, cell-free patches, and single channel)
were used. The advantages and disadvantages of each method and preparation were considered in
order to match experimental approaches to scientific questions. Similarly, various methods for lig-
and/drug application were demonstrated. A primary goal was to identify properties of ion channels that
allow neurons to carry out their unique physiological or systems-level roles. These properties were relat-
ed to information previously gained from molecular cloning and heterologous expression of ion chan-
nel genes. Areas of particular interest included channels that (1) were activated by the neurotransmit-
ter at central and peripheral synapses, (2) interacted with other channels to shape the response prop-
erties of neurons, (3) respond to neuromodulators with changes in functional properties, and (4) were
developmentally required and regulated. The research interests of guest lecturers complemented and
expanded this list. This course was intended for students with specific plans in applying these tech-
niques to a defined problem. Guest speakers included Bruce Bean, Leslie Blair, Gerard Borst, Sascha
Du Lac, Paul Fuchs, Elisabeth Glowtzki, Ruth Heidelberger, John Huguenard, Robert Malinow, Isabel
Mintz, Indira Raman, and Jim Surmeier.
PARTICIPANTS
Desai, R., M.Sc., Ph.D., Weizmann Institute of Science,
Rehovot, Israel
Fellin, T., Ph.D., University of Padua, Italy
Hardelin, J.-P., M.D., Pasteur Institute, Paris, France
Khan, F., F.Sc., M.D., Virginia Commonwealth University,
Richmond
Kim, G., B.S., M.S., University of Pittsburgh School of
Medicine, Pennsylvania
Klug, A., M.S., University of Texas, Austin
Leguen, I., B.Sc., Ph.D., Institut Nat'l de Recherche
SEMINARS
Bean, B., Harvard Medical School, Boston, Massachusetts:
Ionic mechanisms of spontaneous activity of central neu-
rons II, or spikes and the single channel.
Blair, L., Brown University, Providence, Rhode Island: Rapid
modulation of calcium channels by tyrosine phosphoryla-
tion.
Borst, G., Universiteit van Amsterdam, The Netherlands:
Physiology of a presynaptic terminal in the CNS, I.
Physiology of a presynaptic terminal in the CNS, II.
Du Lac, S., The Salk Institute, La Jolla, California: Cellular
mechanisms of eye movement control.
Fuchs, P., Johns Hopkins University Medical School,
Baltimore, Maryland: Hair cell physiology. A molecular
mechanism for electrical tuning. Efferent control of the
cochlea. Cholinergic inhibition of the cells.
Heidelberger, R., University of Texas/Houston Medical School,
Houston: Synaptic transmission in the retina.
Huguenard, J., Stanford University Medical School, Stanford,
California: Differential ion channel expression in neuronal
subclasses: Cellular and circuit consequences.
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Agronomique, Rennes, France
Li, Y., B.S., M.S., Ph.D., University of Illinois, Urbana-
Champaign
Nitabach, M., B.A., Ph.D., New York University, New York,
New York
Olofsdotter, K., M.S., Ph.D., Lund University, Sweden
Song, I., B.S., M.S., Postech, Pohang, Republic of Korea
Weissmann, A., B.A., Oregon Health Sciences University,
Portland
Malinow, R., Cold Spring Harbor Laboratory: Probing synap-
tic transmission and plasticity in hippocampal slices using
acute recombinant expression techniques.
Mintz, I., Boston University Medical Center, Massachusetts:
Patch-clamp and amperometric studies of dopamine den-
dritic release in the substantia nigra.
Otis, T., University of California, Los Angeles: Control of
metabotropic glutamate receptor signaling at the parallel
fiber synapse by a colocalized postsynaptic glutamate
transporter.
Raman, I., Northwestern University, Evanston, Illinois: Ionic
mechanisms of spontaneous activity of central neurons I.
Ribera, A., University of Colorado, Denver: Ion channel func-
tion in zebrafish behavioral mutants.
Surmeier, J., Northwestern University Medical School,
Chicago, Illinois: Dopaminergic modulation of ion channels.
Trussell, L., Oregon Health Sciences University, Portland:
Gating kinetics of glutamate receptor channels and synap-
tic function.
Computational Neuroscience: Vision
June 15-28
INSTRUCTORS E.J. Chichilnisky, The Salk Institute, La Jolla, California
P. Glimcher, New York University, New York, New York
E. Simoncelli, New York University, New York, New York
ASSISTANTS J. Gardner, University of California, San Francisco
G. Horwitz, The Salk Institute, La Jolla, California
Computational approaches to neuroscience have produced important advances in our understanding
of neural processing. Prominent successes have come in areas where strong inputs from neurobiolog-
ical, behavioral, and computational investigation can interact. The theme of the course was that an
understanding of the computational problems, the constraints on solutions to these problems, and the
range of possible solutions can help guide research in neuroscience. Through a combination of lectures
and hands-on experience in a computer laboratory, this intensive course examined color vision, spatial
pattern analysis, motion analysis, oculomotor function, attention, and decision making. Lecturers were
Edward Adelson, David Brainard, Marisa Carrasco, Eduardo Chichilnisky, Sascha Du Lac, Wilson
Geis ler, Paul Glimcher, David Heeger, J. Anthony Movshon, Andrew Parker, Fred Rieke, Michael
Shad len, Maggie Shiffrar, Eero Simoncelli, Larry Snyder, and Stefan Treue.
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PARTICIPANTS
Bayer, H., B.A., Ph.D., New York University, New York, New
York
Blaser, E., B.A., Ph.D., Rutgers University, Piscataway, New
Jersey
Bredfeldt, C., B.A., M.A., University of California, Los Angeles
Church land, A., B.A., Ph.D., University of California, San
Francisco
David, S., B.A., University of California, Berkeley
Di Carlo, J., B.S., M.D., Ph.D., HHMI/Baylor College of
Medicine, Houston, Texas
Grossman, E., B.A., Ph.D., Vanderbilt University, Nashville,
Tennessee
Huk, A., B.A., Stanford University, California
Lesmes, L., B.S., University of Southern California, Los
Angeles
Lipson, M., B.Sc., Ph.D., University of Oxford, United
Kingdom
Muller, J., B.S., Ph.D., Stanford University, California
SEMINARS
Adelson, E., Massachusetts Institute of Technology,
Cambridge: Elements of vision/lightness.
Brainard, D., University of California, Santa Barbara: Color
matching, cones, and context effects.
Carrasco, M., New York University, New York, New York:
Attention psychophysics.
Chichilnisky, E., The Salk Institute, La Jolla, California: Color
context effects/modeling. Retinal ganglion cell physiology
and white noise analysis.
Du Lac, S., The Salk Institute, La Jolla, California:
VOR/Saccades.
Geis ler, W., University of Texas, Austin: Pattern psychophysics.
Glimcher, R, New York University, New York, New York: Eye
movement. Parietal cortex.
Heeger, D., Stanford University, California: V1 modeling. fMRI
studies of pattern vision.
266
Murray, R., B.A., M.Phil., University of Toronto, Canada
Panerai, F., B.S., M.S., Ph.D., CNRS/College de France,
Paris, France
Pillow, J., B.A., New York University, New York, New York
Ress, D., B.S., Ph.D., Stanford University, California
Rowe, M., B.S.E., Ph.D., University of California, Santa
Barbara
Saenz, M., B.S., The Salk Institute, La Jolla, California
Schwartz, 0., B.S., M.S., New York University, New York,
New York
Sharon, D., B.S., M.S., Weizmann Institute, Rehovot, Israel
Uzzell, V., B.A., Ph.D., University of California, San Diego
Wolfe, U., B.A., Ph.D., New York University, New York, New
York
Yang, T., B.S., Baylor College of Medicine, Houston, Texas
Zenger, B., M.Sc., Ph.D., Stanford University, California
Zhao, R., B.S., M.S., Harvard Medical School, Cambridge,
Massachusetts
Movshon, J.A., New York University, New York, New York:
LGNN1 physiology. MT physiology.
Parker, A., University of Oxford, United Kingdom: MT and
perception.
Rieke, F, University of Washington, Seattle: Rods and photon
detection. RGC spike coding/information theory.
Shad len, M., University of Washington, Seattle: Frontal eye
fields.
Shiffrar, M., Rutgers University, Newark, New Jersey: Motion
psychophysics.
Simoncelli, E., New York University, New York, New York:
Statistical properties of visual images. Motion modeling.
Snyder, L., Washington University School of Medicine, St.
Louis, Missouri: Motor vs. decision.
Treue, S., University of Tubingen, Tubingen, Germany:
Attention physiology.
Making and Using DNA Microarrays
June 21-27
INSTRUCTORS J. DeRisi, University of California, San Francisco
V. lyer, Stanford University Medical Center, California
ASSISTANTS A. Alizadeh, Stanford University, California
H. Bennett, University of California, San Francisco
J. Boldrick, Stanford University, California
M. Diehn, Stanford University, California
C. Seidel, University of California, Berkeley
A DNA microarray is a simple, inexpensive, and versatile tool for experimental explorations of genome
structure, gene expression programs, gene function, and cell and organismal biology. In this hands-on
course, students were guided through the process of building a robot for printing DNA microarrays,
preparing DNA samples and slides to be used for printing microarrays, printing DNA microarrays,
designing and conducting experiments for analysis by DNA microarray hybridization, data analysis, dis-
play, and interpretation. Experimental applications covered in the course included systematic studies
of global gene expression programs, inferring gene function using microarrays, and genotyping and
measuring changes in gene copy number. Students who completed this course were able to set up
their own independent facility for printing and experimental use of DNA microarrays. Guest lecturers
presented the state of the art in new technology, experimental applications, and interpretation of large
genomic data sets.
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PARTICIPANTS
Allingham-Hawkins, D., B.Sc., Ph.D., North York General
Hospital, Toronto, Canada
Antoniou, E., B.S., Ph.D., University of Missouri, Columbia
Arctander, P., M.Sc., Ph.D., University of Copenhagen,
Denmark
Borsani, G., B.S., Ph.D., Telethon Institute of Genetics and
Medicine, Milano, Italy
Gaudy, M., B.S., Ph.D., Cornell Medical College at Burke
Research Institute, White Plains, New York
Dressman, H., B.S., Ph.D., Duke University Medical Center,
Durham, North Carolina
Ferrari, S., Ph.D.. University of Breads, Italy
Hensey, C., B.Sc., Ph.D., University College Dublin, Ireland
Huang, S., B.S., Ph.D., Memorial Sloan-Kettering Cancer
Center, New York, New York
SEMINARS
Alizadeh, A., Stanford University, California: Exploring expres-
sion variations in normal and malignant immune cells.
Basarsky, T., Axon Instruments, Inc., Foster City, California:
Image analysis.
Boldrick, J., Stanford University, California: Genomic respons-
es to infection.
Brown, P.O., Stanford University, California: The living
genome.
DeRisi, J., University of California, San Francisco: Introduction
to the microarrays course.
Diehn, M., Stanford University, California: Identifying mem-
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Hughes, K., B.A., Ph.D., Arizona State University, Phoenix
Kamdar, S., B.S., The Jackson Laboratory, Bar Harbor,
Maine
Mardis, E., B.S., Ph.D., Washington University School of
Medicine, St. Louis, Missouri
Myers, G., B.Sc., Ph.D., Walter & Eliza Hall Institute of
Medical Research, Melbourne, Australia
Rocap, G., Ph.D., Massachusetts Institute of Technology,
Cambridge
Satagopan, J., B.S., Ph.D., Memorial Sloan-Kettering Cancer
Center, New York, New York
Stetson, D., B.S., M.S., Massachusetts General Hospital,
Boston
Zhou, Y., Ph.D., University of British Columbia, Vancouver,
Canada
brane and secreted proteins using DNA microarrays.
Introduction to S.O.U.R.C.E.
Haab, B., Van Andel Research Institute, Grand Rapids,
Michigan: Protein arrays.
lyer, V, Stanford University, California: Mapping protein/DNA
interactions at the genomic level.
Kim, S., Stanford University, California: Whole genome C. e/e-
gans expression analysis.
Seidel, C., University of California, Berkeley: Introduction to
LINUX and PERL.
Arabidopsis Molecular Genetics
June 30-July 20
INSTRUCTORS K. Barton, University of Wisconsin, Madison
J. Bowman, University of California, Davis
U. Grossniklaus, University of Zurich, Switzerland
ASSISTANTS R. Joy, University of Wisconsin, Madison
D. Page, University of Zurich, Switzerland
F. Rodriguez, University of Wisconsin, Madison
This course provided an intensive overview of topics in plant growth, physiology, and development,
focusing on molecular genetic approaches to understand plant biology. It emphasized recent results
from Arabidopsis thaliana and other model plants and provided an introduction to current methods used
in Arabidopsis research. It was designed for scientists with experience in molecular techniques or in plant
biology who wish to work with Arabidopsis. The course consisted of a vigorous lecture series, a hands-
on laboratory, and informal discussions. Discussions of important topics in plant research were present-
ed by the instructors and by invited speakers. These seminars included plant morphology and anatomy;
gene dosage effects and epigenetic phenomena; cell biology (including calcium signaling, cell polarity,
and centromere behavior); plant development (including development of flowers, roots, meristems, and
leaves, male and female gametophytes, and embryos); floral induction; synthesis, function, and percep-
tion of hormones; bioinformatics tools available to the Arabidopsis community; and the potential of the
Arabidopsis genome project for accelerating Arabidopsis research. Speakers provided overviews of their
fields, followed by in-depth discussions of their own work. The laboratory sessions provided an intro-
duction to important techniques currently used in Arabidopsis research. These included studies of
Arabidopsis development, mutant analysis, in situ detection of RNA, histochemical staining, transient
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gene expression, applications of green fluorescent protein fusions, protein isolation and detection; mass
spectrometry, gene chip technology, QTL analysis, and techniques commonly used in genetic and phys-
ical mapping, and map-based cloning. The course also included several short workshops on important
themes in genetics. Speakers included Bonnie Bartel, Kathy Barton, David Baulcombe, Jim Birchler,
John Bowman, Barbara Butler, Kelly Dawe, Caroline Dean, Nancy Deng ler, Ueli Grossniklaus, Peter
Hepler, David Jackson, Jonathan Jones, Rich Jorgensen, Nancy Kerk, Joe Kieber, MaartenKoornneef,
Rob Last, Rob Martienssen, Peter Mc Court, Scott Peck, Tom Petersen, Bob Pruitt, KatrinaRamonell,
Eric Schaller, Ben Scheres, Sidney Shaw, David Spector, and Shu Hsing Wu.
PARTICIPANTS
Allen, G., B.Sc., Ph.D., University of California, San Diego
Coleman, C., B.S., Ph.D., Brigham Young University, Provo,
Utah
Co lot, V, Ph.D., John Innes Centre, Paris, France
Foreman, J., B.Sc., Ph.D., University of California, Davis
Friesner, J., B.S., University of California, Davis
Haswell, E., B.S., Ph.D., University of California, San
Francisco
Hoening, T., B.A., University of Wisconsin, Madison
Kaur, J., B.Sc., M.Sc., Centre for Cellular and Molecular
Biology, Hyderabad, India
Kanaoka, M., B.S., Ph.D., Kyoto University, Japan
SEMINARS
Bartel, B., Rice University, Houston, Texas: Synthesis and
metabolism of auxin in Arabidopsis.
Barton, K., University of Wisconsin, Madison: Formation of
the shoot apical meristem during embryogenesis.
Baulcombe, D., Sainsbury Laboratory, Norwich, United
Kingdom: Gene silencing.
Birch ler, J., University of Missouri, Columbia: Effects of vary-
ing gene dosage: Aneuploidy and polyploidy in maize.
Gene silencing in Drosophila.
Bowman, J., University of California, Davis: Floral develop-
ment.
Butler, B., Genetics Computer Group, Madison, Wisconsin:
Bioinformatics for Arabidopsis molecular geneticists.
Dawe, K., University of Georgia, Athens: Meiosis and cen-
tromere function in plants.
Dean, C., John Innes Centre, Norwich, United Kingdom:
Induction of flowering in Arabidopsis,
Deng ler, N., University of Toronto, Canada: The anatomy of
Arabidopsis.
Grossniklaus, U., University of Zurich, Switzerland: Female
gametophyte development.
Hepler, P., University of Massachusetts, Amherst: Calcium in
plant signaling.
Jackson, D., Cold Spring Harbor Laboratory: The shoot api-
cal meristem and protein movement.
Jones, J., Sainsbury Laboratory, Norwich, United Kingdom:
Plant pathogen interactions.
Jorgensen, R., University of California, Davis: Epigenetic
mechanisms in plants.
Kerk, N., Yale University, New Haven, Connecticut: Root
meristem initiation and organization.
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Kwon, M., B.S., M.S., Friedrich Miescher Institute, Basel,
Switzerland
McGinnis, K., B.S., Ph.D., Washington State University,
Pullman
Neuman, D., M.A., Ph.D., University of Nevada, Las Vegas
Reyes, J., B.A., Ph.D., Consejo Superior de Investigaciones
Cientificas, Sevilla, Spain
Rolland, F, M.S., Ph.D., University of Leuven, Belgium
Sera, T., B.S., Ph.D., Novartis Agriculural Discovery Institute,
Inc., San Diego, California
Vandenabeele, S., B.S., Ph.D., Flanders Interuniversity
Institute of Biotechnology, Gent, Belgium
Kieber, J., University of North Carolina, Chapel Hill: Molecular
genetics of cytokinins.
Koornneef, M., Wageningen Agricultural University,
Wageningen, The Netherlands: Analysis of quantitative
traits.
Last, R., Cereon Genomics LLC, Cambridge, Massachusetts:
Biochemical genetics.
Martienssen, R., Cold Spring Harbor Laboratory: Functional
genomics in Arabidopsis.
Mc Court, P., University of Toronto, Canada: Abscisic acid in
Arabidopsis growth and development.
Peck, S., Friedrich Miescher Institute, Switzerland: Use of
mass spectrometry in Arabidopsis.
Petersen, T., Iowa State University, Ames: Transposable ele-
ments.
Pruitt, B., Harvard University, Cambridge, Massachusetts:
Fertilization and the development of the male gametophyte.
Ramonell, K., Carnegie Institution of Washington, Stanford,
California: Gene chip technology.
Schaller, E., University of New Hampshire, Durham: The bio-
chemistry and molecular biology of ethylene action.
Scheres, B., Utrecht University, The Netherlands: Cell interac-
tions in the root apical meristem.
Shaw, S., Stanford University, California: Development of cel-
lular polarity in plants.
Spector, D., Cold Spring Harbor Laboratory: Microscopy.
Sussex, I., Yale University, New Haven, Connecticut: An intro-
duction to plant morphological diversity.
Wu, S.-H., Carnegie Institution of Washington, Stanford,
California: Gene chip technology.
Molecular Cloning of Neural Genes
June 30-July 20
INSTRUCTORS J. Boulter, University of California, Los Angeles
C. Du Lac, Harvard University, Cambridge, Massachusetts
C. Lai, The Scripps Research Institute, La Jolla, California
D. Lavery, Glaxo Wellcome Experimental Research, Lausanne, Switzerland
CO-INSTRUCTOR M. Schwab, The Scripps Research Institute, La Jolla, California
ASSISTANTS E. Fung, The Scripps Research Institute, La Jolla, California
H. Kong, New York University Medical Center, New York, New York
J. Rihel, Harvard University, Boston, Massachusetts
M. Samson, Harvard Medical School/HHMI, Boston, Massachusetts
T. Taketani, The Scripps Research Institute, La Jolla, California
I. Tietjen, Harvard University, Boston, Massachusetts
W. Walwyn, University of California, Los Angeles
This intensive laboratory and lecture course taught neuroscientists current approaches to molecular
neurobiology. The course consisted of daily lectures and laboratory exercises on the practice of mole-
cular neurobiology, with an emphasis on modern approaches to cloning and analyzing the expression
of neural genes. A series of evening research seminars by invited speakers focused on the ways in
which these molecular techniques have been successfully applied. In the past, evening seminar topics
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have included expression cloning, single-cell cloning, subtractive cDNA cloning strategies, and genet-
ic and mechanistic studies of neurologic disease, aquisition of cell identity, and axon guidance in the
developing nervous system. The laboratory portion of the course began with instruction in a series of
basic molecular biological techniques and rapidly advanced to more sophisticated methodologies.
Students learned to prepare genomic, phage, and plasmid DNAs and total and poly(A)* RNA and to
generate and screen cDNA libraries. Additional topics and methods covered included restriction map-
ping, agarose and polyacrylamide gel electrophoresis, Northern and Southern blotting, subcloning,
oligonucleotide primer design, a selection of PCR-based techniques, and the use of nucleotide and
protein sequence databases. Gene expression studies included the production of fusion proteins in
bacteria and mammalian cell transfection. The advanced techniques featured the construction of cDNA
libraries from single cells and the use of subtractive cDNA methods to clone genes expressed in limit-
ed populations of cells.
PARTICIPANTS
Adams, N., B.Sc, D.phil., The Rockfeller University, New York,
New York
Cantrell, Angela, B.S., Ph.D., University of Tennessee,
Memphis
Fernandes, J., B.Sc., Ph.D., Miami University, Oxford, Ohio
Kap lin, A., B.S., Ph.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Leamey, C., B.Sc., Ph.D., Sydney University, Australia
Mermelstein, P., B.S., Ph.D., Stanford University, California
Raman, C., B.S., Ph.D., University of California, Irvine
Rodriguez, C., B.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
SEMINARS
Barres, B., Stanford Medical School, California: Neuron-glial
interactions in the developing central nervous system.
Bettler, B., Novartis AG, Basel, Switzerland: Molecular
insights into GABA, receptor physiology.
Darnell, R., The Rockefeller University, New York, New York:
Molecular cloning of neural genes in pursuit of brain func-
tion: Nature's autoimmune approach and paraneoplastic
neuronal degenerations.
Du lac, C., Harvard University, Cambridge, Massachusetts:
Sensory coding of pheromone signals in mammals,
Julius, D., University of California, San Francisco: From pep-
pers to pain: The molecular biology of nociception.
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Shu, T.Z., M.D., Ph.D., University of Maryland, Baltimore
Stewart, A., B.A., Ph.D., George Washington University,
Washington, D.C.
Stotz, S., B.Sc., M.Sc., University of Calgary, Canada
Taylor, J., B.Sc., Ph.D., University of Oxford, United Kingdom
Unguez, G., B.S., Ph.D., New Mexico State University, Las
Cruces
Weiss, J., B.S., Ph.D., University of California, Irvine
Williams, S., B.A., Ph.D., Columbia University, New York, New
York
Zaki, R, B.S., University of California, Los Angeles
Lemke, G., Salk Institute, La Jolla, California: Genetic studies
of the role of EphA receptors in topographic mapping.
Sheng, M., Massachusetts General Hospital/HHMI, Boston:
Molecular organization of the postsynaptic specialization.
Silva, A., University of Calfornia Medical Center, Los Angeles:
You have cloned a neuronal gene: Now what?
Walsh, C., Beth Israel Deaconess Medical Center/Harvard
Medical School, Boston, Massachusetts: Mining the human
genome for genes that regulate cerebral cortical develop-
ment.
Weinmaster, G., University of California School of Medicine,
Los Angeles: Notch signal transduction in mammalian cells.
Neurobiology of Drosophila
June 30-July 20
INSTRUCTORS K. Broadie, University of Utah, Salt Lake City
S. De Belle, University of Nevada, Las Vegas
G. Tear, King's College, London, United Kingdom
ASSISTANTS B. But land, King's College, London, United Kingdom
M. Ginsburg, University of Nevada, Las Vegas
J. Rohrbough, University of Utah, Salt Lake City
This laboratory/lecture course was intended for researchers at all levels, from beginning graduate stu-
dents through established primary investigators, who want to use Drosophila as an experimental sys-
tem for nervous system investigation. The 3-week course was divided into the study of development,
physiology/function, and behavior. Daily seminars introduced the students to a variety of research top-
ics and developed those topics by including recent experimental contributions and outstanding ques-
tions in the field. Guest lecturers brought original preparations for viewing and discussion and direct
laboratory exercises and experiments in their area of interest. The course provided students with
hands-on experience using a variety of experimental preparations that are used in the investigation of
current neurobiological questions. The lectures and laboratories focused on both the development of
the nervous system and its role in controlling larval and adult behaviors. In addition to an exposure to
the molecular genetic approaches available in Drosophila, students learned a variety of techniques,
including embryo in situ hybridization, labeling of identified neurons, electrophysiological recording from
nerves and muscles, and the analysis of larval and adult behavior. Collectively, the course provided a
comprehensive and practical introduction to modern experimental methods for studying the Drosophila
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nervous system. The specific topics from this year's course included neurogenesis, axon pathfinding,
synaptogenesis, membrane excitability, synaptic function and plasticity, photoreception, mechanore-
ception, neural circuits, biological rhythms, courtship, learning and memory, and locomotor and flight
behaviors. Lecturers included Robert Anholt, Vanessa Auld, Kendal Broadie, Steven De Belle, Barry
Ganetzky, Ralph Greenspan, Volker Hartenstein, Charlotte Helfrich-Forster, Kei Ito, Maurice Kernan,
Rod Murphey, Kevin O'Dell, Diane O'Dowd, William Pak, Andreas Prokop, Dave Shepherd, Jim
Skeath, Roland Strauss, Guy Tear, and Tim Tully.
PARTICIPANTS
Ceriani, M., B.S., Ph.D., Scripps Research Institute, La Jolla,
California
Griffiths, R., B.Sc., University of Cambridge, United Kingdom
Keller, A., M.S., Universitat Wuerzburg, Germany
Latham, K., B.S., Ph.D., Oregon State University, Corvallis
Mao, T, B.S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Newport, J., B.A., Ph.D., University of California, San Diego
Nino, M., M.D., M.Sc., Baylor College of Medicine, Houston,
SEMINARS
Anholt, R., North Carolina State University, Raleigh: Odor recog-
nition and olfactory behavior in Drosophila melanogaster.
Auld, V. University of British Columbia, Vancouver, Canada:
Role of glia in neurodevelopment.
Broadie, K., University of Utah, Salt Lake City: Synaptic
development, function, and plasticity.
De Belle, S., University of Nevada, Las Vegas: Neuroanatomy
of memory in Drosophila.
Ganetzky, B., University of Wisconsin, Madison: Genetic
investigation of ion channels.
Greenspan, R.J., Neuroscience Institute, San Diego,
California: Fly sleep. Molecular genetics of natural variation
in behavior.
Hartenstein, V, University of California, Los Angeles:
Introduction to the embryo and patterning.
Helfrich-Forster, C., Universitat Tubingen, Germany: Circadian
rhythms in Drosophila: From molecules to neurons.
Ito, K., National Institute for Basic Biology, Aichi, Japan:
Neurogenesis of the larva and adult.
Kernan, M., SUNY, Stony Brook, New York:
Mechanoreception and hearing in Drosophila.
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Texas
Nordberg, E., B.S., University of Arizona, Tucson
Perazzona, B., B.S., Ph.D., Baylor College of Medicine,
Houston, Texas
Trotta, N., B.A., Lafayette College, Eastern, Pennsylvania
Verstreken, P, B.S., M.S., Baylor College of Medicine,
Houston, Texas
Zlatic, M., B.A., M.S., University of Cambridge, United
Kingdom
Murphey, R., University of Massachusetts, Amherst: Analysis
of Drosophila neural circuits.
O'Dell, K.M.C., University of Glasgow, United Kingdom:
Courtship and its neurbiological basis in Drosophila.
O'Dowd, D., University of California, Irvine: Ion channels and
Drosophila neuron culture.
Pak, W., Purdue University, West Lafayette, Indiana:
Mechanisms of phototransduction.
Prokop, A., Johannes Gutenberg-Universitaet Mainz,
Germany: Lineage tracing and the development of identity.
Shepherd, D., University of Southampton, United Kingdom:
Axonogenesis in the adult.
Skeath, J., Washington University School of Medicine, St.
Louis, Missouri: Early neurogenesis.
Strauss, R., Julius-Maximillians-Universitaet Wurzburg,
Germany: Central processing of motor behavior in
Drosophila.
Tear, G., King's College London School of Medicine, London,
United Kingdom: Axon guidance in the embryo/larva.
Tully, T, Cold Spring Harbor Laboratory: Genes, genes, and
more genes for memory.
Brain Development and Function
July 6-19
INSTRUCTORS R. McKay, National Institutes of Health, Bethesda, Maryland
M. Posner, Cornell Medical College, New York, New York
In this advanced lecture and discussion course on the development and function of the nervous sys-
tem, 17 participants with diverse geographical and intellectual backgrounds met for 2 weeks with lead-
ing neuroscience researchers. The lectures provided both a comprehensive introduction and a detailed
presentation of current research. There were many opportunities for interaction. This was an unusual
opportunity to review contemporary ideas about the brain with leading scientists. The speakers includ-
ed Richard As lin, Steve Burden, Susan Carey, Pietro De Camilli, Howard Eichenbaum, Charles Gilbert,
Steve Hillyard, Mary Kennedy, Jeff Lichtman, Roberto Malinow, Bruce Mc Ewen, Ron McKay, Michael
Meaney, Raja Parasuraman, Michael Posner, Marcus Raichle, Murray Sherman, David Silbersweig,
James Swanson, Kathleen Thomas, Tim Tully, and Mike Young.
The specific topics covered included neurogenetics, stem cell differentiation, cell and gene therapy,
axon guidance, synapse formation, synaptic plasticity, hippocampal function, neuroimaging methods,
human brain development, and aging. The goal was to provide a critical view of the different levels of
knowledge that are required for an integrated understanding of the brain.
275
PARTICIPANTS
Agerman, K., M.S., Karolinska Institutet, Stockholm, Sweden
Cecchi, C., Ph.D., DIBIT, San Raffaele Institute, Milan, Italy
Hoeppner, D., B.S., Ph.D., Cold Spring Harbor Laboratory
Hsieh, J., B.S., Carnegie Institution of Washington, Baltimore,
Maryland
Logvinova, A., B.S., M.D., Buck Center for Research in
Aging, Novato, California
Munno, D., B.A., University of Calgary, Alberta, Canada
Pedersen, K., M.Sc., Karolinska Institutet, Stockholm,
Sweden
Ramanan, N., B.S., M.S., National University of Singapore,
Singapore
Rodriguez, J., B.A., Ph.D., Centre Nat'l de la Recherche
SEMINARS
As lin, R., University of Rochester, New York: Development of
visually guided behavior.
Burden, S., New York University Medical Center, New York,
New York: The neuromuscular junction, the classic
synapse.
Carey, S., New York University, New York, New York: The
development of the infant mind.
De Camilli, P., Yale University, New Haven, Connecticut: The
cell biology of synapses.
Eichenbaum, H., Boston University, Massachusetts: Mid tem-
poral mechanisms in memory and amnesia.
Gilbert, C., The Rockefeller University, New York, New York:
Structure of the visual cortex.
Hillyard, S., University of California, San Diego, La Jolla:
Electrical and magnetic imaging.
Kennedy, M., California Institute of Technology, Pasadena:
Proteon complexes and synaptic function.
Lichtman, J., Washington University, St. Louis, Missouri:
Competition is all at the NMJ.
Malinow, R., Cold Spring Harbor Laboratory: Hippocampal
synaptic properties.
Mc Ewen, B., The Rockefeller University, New York, New
York: Stress mechanisms.
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Scientifique, Gif-sur-Yvette, France
Ryu, S., B.A., Ph.D., University of California, Berkeley
Saleh, M.-C., B.S., Institut Pasteur, Paris, France
Trus, M., B.A., Ph.D., Hebrew University, Jerusalem, Israel
Velasco, M., B.S., Ph.D., Universidad Nacional Autonoma de
Mexico, Mexico City
Verheijen, M., B.S., Ph.D., The Salk Institute, La Jolla,
California
Wolf, E., M.D., Ph.D., Karolinska Institutet, Stockholm,
Sweden
Yeo, E., B.A., B.S., Institute of Molecular and Cell Biology,
Singapore
McKay, R., National Institutes of Health, Bethesda, Maryland:
Reconstructing the brain.
Meaney, M., McGill University, Montreal, Quebec, Canada:
Development of stress mechanisms.
Parasuraman, R., The Catholic University of America,
Washington, D.C.: Aging and dementia.
Posner, M., Cornell Medical College, New York, New York:
Attentional networks and higher mental processes.
Raichle, M., Washington University School of Medicine, St.
Louis, Missouri: Neuroimaging history and current state.
Sherman, M., SUNY, Stony Brook, New York: Interactions
between thalamus and cortex in the visual system.
Silbersweig, D., Cornell University, New York, New York:
Imaging mechanisms in schizophrenia.
Swanson, J., Cornell Medical College, New York, New York:
Attention deficit disorder: Genes and neurosystems.
Thomas, K., Cornell University, New York, New York:
Development of implicit memory in humans.
Tully, T., Cold Spring Harbor Laboratory: The genetics of
learning in flies and mice.
Young, M., The Rockefeller University, New York, New York:
Molecules and rythmns.
Mouse Behavioral Analysis
July 7-20
INSTRUCTORS M. Fanselow, University of California, Los Angeles
M. Gallagher, Johns Hopkins University, Baltimore, Maryland
M. Mayford, University of California, San Diego, La Jolla
A. Silva, University of California Medical Center, Los Angeles
ASSISTANTS S. Anagnostaras, University of California School of Medicine, Los Angeles
R. Costa, University of California, Los Angeles
R. Bourtchuladze, Columbia University, New York, New York
This course was intended to provide a theoretical and experimental introduction to behavioral analysis
in the mouse, with a focus on learning and memory. It was specially designed for geneticists, molecu-
lar biologists, pharmacologists, and electrophysiologists with a need for a hands-on introduction to
behavioral analysis of the mouse. Additionally, the course covered the principles of using mutant mice
in behavioral studies, as well as the issues involved in integrating behavioral, neuroanatomical, neuro-
physiological, and molecular findings. Among the methods presented were the water maze, cued and
contextual fear conditioning, natural/ethologically relevant learning, open field behavior, and the rotor-
rod and other activity tests. In addition, there were demonstrations of several aspects of in vitro elec-
trophysiology (fields and whole-cell recordings of synaptic plasticity).
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PARTICIPANTS
Boerkoel, C., B.A., Ph.D., Baylor College of Medicine,
Houston, Texas
Fischbach, K., B.A., Ph.D., University of Texas, San Antonio
Halldner, L., M.D., Karolinska Institutet, Stockholm, Sweden
Israely, I., B.S., Ph.D., University of California, Los Angeles
Liljelund, F:, B.Sc., Ph.D., Aston University, Birmingham,
United Kingdom
McGlone, J., B.S., Ph.D., Texas Technology University,
Lubbock
McHugh, T., B.A., Massachusetts Institute of Technology,
SEMINARS
Amaral, D., University of California, Davis: Functional neu-
roanatomy of the hippocampal formation.
Chapman, P., Memorial Sloan-Kettering Cancer Center, New
York, New York: Animal models of Alzheimer's.
Eichenbaum, H., Boston University, Massachusetts: Mapping
brain function in cognitive neuroscience: From humans to
animal models.
Fanselow, M., University of California, Los Angeles: Animal
behavior from an ethological and evolutionary view.
Holland, P., Duke University, Durham, North Carolina:
Learning processes and behavioral paradigms.
Laroche, S., CNRS-Universite de Paris-Sud, Orsay, France:
LTP and learning in the hippocampus and neocortex.
Lione, L., University Forvie Site, Cambridge, United Kingdom:
Motor and sensorimotor functions in rodents.
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Cambridge
Peters, M., M.Sc., Ph.D., University College London, United
Kingdom
Shumyatsky, G., M.S., Ph.D., Columbia University College of
Physicians & Surgeons, New York, New York
Speca, D., B.A., Ph.D., University of California, Berkeley
Van Herpen, E., M.Sc., Erasmus University, Rotterdam, The
Netherlands
Vogt, T., M.S., Ph.D., Princeton University, New Jersey
Mainen, Z., Cold Spring Harbor Laboratory: Neural plasticity
in mammalian brain.
Mauk, M., University of Texas Medical School, Houston:
Cerebellar learning.
Mayford, M., University of California, San Diego: Inducible
genetic approaches to learning and memory.
Montague, R., Baylor College of Medicine, Houston, Texas:
Computational models of brain function.
Muller, B., SUNY Health Science Center, Brooklyn, New York:
Place field recording in the mouse.
Silva, A., University of California Medical Center, Los Angeles:
Genetics and the study of cellular neurosystems.
Tonegawa, S., Massachusetts Institute of Technology,
Cambridge: Genetics of plasticity.
Molecular Mechanisms of Human Neurological Diseases
July 21-27
INSTRUCTORS A. Aguzzi, University Hospital of Zurich, Switzerland
S. Gandy, New York University, Orangeburg, New York
J. Hardy, Mayo Clinic Jacksonville, Florida
How and why do neurons die in specific human neurological disorders? What are the molecular and
biochemical manifestations of specific genetic lesions in neurodegenerative disorders? Do different
pathological deaths share common mechanisms? What practical treatments are contemplated? This
lecture course explored possible answers to these important questions. Recent advances in neuroge-
netics and in molecular and cell biology have begun to shed light on the mechanisms that underlie ner-
vous system injury in disease states such as Alzheimer's disease, Parkinson's disease, frontotemporal
dementia, amyotrophic lateral sclerosis, prion diseases, and polyglutamine repeat disorders. Taking
advantage of small class size and extensive discussion, invited faculty lecturers examined critical issues
in their areas of expertise. Overviews were provided and course participants did not have to be famil-
iar with neurological diseases. The course focused principally on the specific hypotheses and
approaches driving current research. Emphasis was placed on the highly dynamic interface between
basic and clinical investigation, including the interdependence of clinical research and disease model
development, and the value of disease research in understanding the function of the normal nervous
system. Participating lecturers were A. Aguzzi, D. Borchelt, D. Cleveland, S. Gandy, J. Ghiso, R.
Glockshuber, J. Hardy, D. Holtzman, E. Koo, V. Lee, M. MacDonald, J. Morris, H. Orr, D. Tag le, R. Tanzi,
and J. Trojanowski.
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PARTICIPANTS
Behrens, A., B.S., Ph.D., Institute of Neuropathology, Zurich,
Switzerland
Costa, J., B.S., Ph.D., Institute de Tecnologia, Oeiras,
Portugal
Coulombe, N., B.S., M.S., Merck Forsst & Co., Quebec,
Canada
Gao, W., M.D., Ph.D., Veteran Affairs, Beford, Massachusetts
Haberman, R., B.S., Ph.D., University of North Carolina,
Chapel Hill
Holm, P, B.S., M.S., Karolinska Institutet, Stockholm,
Sweden
Johansson, C., BA., D.D.S., Karolinska Institutet, Stockholm,
Sweden
Jonsson, A., B.Sc., M.Sc., Umea University Hospital,
Sweden
Lashuel, H., B.S., Ph.D., The Picower Institute for Medical
Research, Manhasset, New York
Lau, L.-E, M.phil., Ph.D., Pfizer, Inc., Groton, Connecticut
Lawson, V., B.S., Ph.D., NIAID/National Institutes of Health,
Hamilton, Montana
Liscic, R., B.S., Ph.D., Institut for Medical Research, Zagreb,
SEMINARS
Aguzzi, A., University Hospital of Zurich, Switzerland:
Immunopathology of prion disease.
Ahlijanian, M., Pfizer, Inc., Groton, Connecticut: cdk5 in
tauopathies.
Bates, G., Guy's, King's and Thomas's School of Medicine,
King's College, London, United Kingdom: Trinucleotide
repeat diseases.
Eidelberg, D., North Shore University Hospital, Manhasset,
New York: Clinical and structural basis of Parkinson's dis-
ease.
Friedlander, R., Harvard Medical School, Charlestown,
Massachusetts: Programmed cell death in neurodegenera-
tive disease.
Gandy, S., New York University, Orangeburg, New York:
Molecular and regulatory bases for Ap generation.
Ghiso, J., New York University Medical Center, New York,
New York: Amyloidosis and familial British dementia.
Hardy, J., Mayo Clinic, Jacksonville, Florida: Overview of neu-
rogenetic basis of neurodegenerative disease.
Holtzman, D., Washington University School of Medicine, St.
Louis, Missouri: Role of apoE in Alzheimer's disease.
Hutton, M., Mayo Clinic, Jacksonville, Florida: Genetics and
Croatia
Liu, X.F., B.S., Ph.D., AstraZeneca, Worcester,
Massachusetts
Mar ler, J., A.B., M.D., NINDS/National Institutes of Health,
Bethesda, Maryland
Momma, S., M.S., Karolinska Institutet, Stockholm, Sweden
Mullen, C., B.S., Biogen, Inc., Cambridge, Massachusetts
Murphy, D., B.A., Ph.D., NINDS/National Institutes of Health,
Rockville, Maryland
Neocleous, V, B.S., Ph.D., Cyprus Institute of Neurology and
Genetics, Nicosia, Cyprus
Rosso, S., M.D., University Hospital Rotterdam, Dijkzigt, The
Netherlands
Sandhu, J., B.Sc., Ph.D., National Research Council of
Canada, Ottawa
Schenone, A., M.D., University of Genova, Italy
Srivatsan Ayyangar, M., B.S., Ph.D., University of Kentucky
College of Medicine, Lexington
Stanford, P, B.Sc., Ph.D., Garvan Institute of Medical
Research, Sydney, Australia
Tseng, H.-C., B.S., Ph.D., Iowa State University, Ames
transgenesis of tauopathies.
Lee, V., University of Pennsylvania School of Medicine,
Philadelphia: Molecular pathology and biochemistry of
tauopathies.
Li-Huei, T., Harvard Medical School/HHMI, Boston,
Massachusetts: Role of CDK5 in neurodegeneration.
Lingappa, V, University of California, San Francisco: Cell and
structural biology of prion disease.
Morris, J., Washington University, St. Louis, Missouri: Clinico-
pathological correlations in cognitive impairment and
Alzheimer's disease.
Price, D., Johns Hopkins University, Baltimore, Maryland:
Overview of molecular neuropathology of neurodegenera-
tion.
Selkoe, D., Harvard Medical School, Boston, Massachusetts:
Genotype-phenotype relationships in Alzheimer's disease;
the biology of the presenilins/gamma secretases.
Trojanowski, J., University of Pennsylvania School of
Medicine, Philadelphia: Synucleinopathies.
Vassar, R., Amgen, Inc., Thousand Oaks, California: BACE
and b-secretase processing of APP: Therapeutic implica-
tions for Alzheimer's disease.
C. elegans
July 25-August 14
INSTRUCTORS M. Hengartner, Cold Spring Harbor Laboratory
E. Jorgensen, University of Utah, Salt Lake City
R. Korswagen, University Hospital Utrecht, The Netherlands
R. Plasterk, Netherlands Cancer Institute, Amsterdam, The Netherlands
ASSISTANTS M. Hammarlund, University of Utah, Salt Lake City
S. Milstein, Cold Spring Harbor Laboratory
S. Tharin, Cold Spring Harbor Laboratory
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans Genome
Project. The course was suited both for those who have a current training in molecular biology and
some knowledge of genetics, but have no experience with C. elegans, and students with some prior
worm experience who wished to expand their repertoire of expertise. The following topics were cov-
ered both in the laboratory and by lectures from experts in the field: worm pushing, C. elegans data-
bases and worm bioinformatics, anatomy and development, forward genetics, chemical and transpo-
son mutagenesis, generation of transgenic animals, expression pattern analysis, reverse genetics, con-
struction and screening of deletion libraries, and RNA inactivation. The course was designed to impart
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sufficient training to students in the most important attributes of the C. elegans system to enable stu-
dents to embark on their own research projects after returning to their home institutions
PARTICIPANTS
Boulton, S., B.Sc., Ph.D., Massachusetts General Hospital
Cancer Center, Charlestown
Drescher, R., M.S., Aventis Research & Technologies,
Frankfurt, Germany
Fingerle-Rowson, G., M.D., The Picower Institute for Medical
Research, Manhasset, New York
Haklai Topper, L., B.Sc., M.Sc., The Weizmann Institute of
Science, Rehovot, Israel
Hudson, M., B.Sc., Ph.D., Oregon Health Sciences
University, Portland
Kinnunen, T., M.Sc., Ph.D., University of Birmingham, United
Kingdom
Martinez-Torres, A., B.S., M.S., University of California, Irvine
Mc New, J., B.S., Ph.D., Memorial Sloan-Kettering Cancer
Center, New York, New York
SEMINARS
Ahringer, J., University of Cambridge, United Kingdom:
Embryonic development; RNAi.
Avery, L., University of Texas Southwestern Medical Center,
Dallas: Nematode excitable cell function.
Barstead, R., Washington University School of Medicine, St.
Louis, Missouri: Muscle biology; gene knockouts.
Chisholm, A., University of California, Santa Cruz: Genetics of
C. elegans morphogenesis.
Emmons, S., Albert Einstein College of Medicine, Bronx, New
York: The male.
Fitch, D., Wayne State University School of Medicine, Detroit,
Michigan: Evolution of nematodes.
Hengartner, M., Cold Spring Harbor Laboratory: Programmed
cell death; suppression genetics.
Hodgkin, J., University of Cambridge, United Kingdom: Sex
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Palmitessa, A., B.S., Ph.D., Thomas Jefferson University,
Philadelphia, Pennsylvania
Pasierbek, P., B.S., M.S., University of Vienna, Austria
Rolls, M., B.S., Harvard Medical School, Boston,
Massachusetts
Scott, J., B.S., Ph.D., University of Hawaii, Hilo
Siomos, M., B.Sc., Ph.D., Institute of Molecular Pathology,
Vienna, Austria
Taschner, P., M.Sc., Ph.D., Leiden University, The
Netherlands
Van Berkel, W., B.Sc., M.Sc., Utrecht University, The
Netherlands
Walhout, A., Ph.D., Dana Farber Cancer Institute, Boston,
Massachusetts
determination and bacterial infection in C. elegans.
Jorgensen, E., University of Utah, Salt Lake City: Synaptic
transmission forward genetics.
Korswagen, R., University Hospital Utrecht, The Netherlands:
Wnt pathways.
Plasterk, R., Netherlands Cancer Institute, Amsterdam, The
Netherlands: mut-7 and regulation of transposition of trans-
posons.
Stein, L., Cold Spring Harbor Laboratory: The C. elegans
genome ACeDB.
Sternberg, P., California Institute of Technology, Pasadena:
Development of the vulva.
Thomas, J., University of Washington, Seattle: Defecation
and Cam kinase.
Eukaryotic Gene Expression
July 25-August 14
INSTRUCTORS B. Dynlacht, Harvard University, Cambridge, Massachusetts
G. Gill, Harvard Medical School, Boston, Massachusetts
J. Goodrich, University of Colorado, Boulder
J. Lees, Massachusetts Institute of Technology, Cambridge
ASSISTANTS T. Bolger, Harvard Medical School, Boston, Massachusetts
H. Ferguson, University of Colorado, Boulder
J. Rayman, Harvard University, Cambridge, Massachusetts
J. Trimarchi, Massachusetts Institute of Technology, Cambridge
This course was designed for students, postdocs, and principal investigators who have recently ven-
tured into the dynamic area of gene regulation. The course focused on state-of-the-art strategies and
techniques employed in the field. Students made nuclear extracts, performed in vitro transcription, and
measured RNA levels using primer extension. Emphasis was placed on biochemical studies of protein-
DNA and protein-protein interactions. Detailed characterizations of the DNA-binding properties of site-
specific transcription factors were carried out using electrophoretic mobility shift and DNase I foot-
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printing assays. These assays were used to study protein-DNA interactions in crude extracts and using
recombinant proteins. Both coimmunoprecipitation and yeast two-hybrid methods were employed to
investigate protein-protein interactions with the general transcription machinery. During the past few
years, the gene regulation field has begun to emphasize the importance of in vivo approaches to study-
ing protein-DNA and protein-protein interactions. Students were therefore exposed to the chromatin
immunoprecipitation technique. Experience with basic recombinant DNA techniques was a prerequi-
site for admission to this course. Lectures by the instructors covered the current status of the gene
expression field, theoretical aspects of the methodology, and broader issues regarding strategies for
investigating the regulation of gene expression in eukaryotes. Guest lecturers discussed contemporary
problems in eukaryotic gene regulation and technical approaches to their solution. The speakers
included David Allis, Laura Attardi, Keith Blackwell, Steve Buratowski, Steve Burley, Ken Buts, Mike
Carey, Brian Dynlacht, Grace Gill, Jim Goodrich, Caroline Hill, Kathy Jones, Leemor Joshua-Tor, Jackie
Lees, Bob Roeder, Dimitris Thanos, Marc Timmers, and Jerry Workman.
PARTICIPANTS
Asp, P., B.S., M.S., Massachusetts Institute of Technology,
Cambridge
Borrego, F., B.S., Ph.D., NIAID/National Institutes of Health,
Rockville, Maryland
Dangond, F., B.A., M.D., Brigham and Women's Hospital,
Boston, Massachusetts
Diehl, S., B.S., University of Vermont, Burlington
Fitzpatrick, G., B.S., Roswell Park Cancer Institute, Buffalo,
New York
Giagtzoglou, N., B.S., M.S., University of Crete, Heraklion,
Greece
Hansson, A., B.S., M.S., Lund University, Malmo, Sweden
Haronen, R., B.S., M.S., University of Helsinki, Finland
SEMINARS
Allis, D., University of Virginia, Charlottesville: Linking histone
modifications to gene activity and more.
Attardi, L., Massachusetts Institute of Technology,
Cambridge: Identification of apoptosis-specific p53 target
genes.
Blackwell, K., Harvard Medical School, Boston, Massa-
chusetts: Mechanisms of developmental gene regulation in
C. elegans.
Buratowski, S., Harvard Medical School, Boston, Massa-
chusetts: Connecting transcription to chromatin and mRNA
processing.
Burley, S., The Rockefeller University, New York, New York:
Structural biology of eukaryotic transcriptional regulation.
Carey, M., University of California School of Medicine, Los
Angeles: Enhanceosome assembly and function.
Dynlacht, B., Harvard University, Cambridge, Massachusetts:
Transcriptional regulation during the mammalian cell cycle.
Gill, G., Harvard Medical School, Boston, Massachusetts:
Transcriptional regulation in the nervous system.
Goodrich, J., University of Colorado, Boulder: Mechanisms of
human RNA polymerase II transcription.
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Jones, G., B.S., Ph.D., University of Kentucky, Lexington
Kim, D., B.S., Ph.D., Chicago Medical School, North
Chicago, Illinois
Knight, J., B.A., Oxford University, United Kingdom
Maestro, R., B.S., Ph.D., Centro di Riferimento Oncologico,
Aviano, Italy
Millevoi, S., B.S., Ph.D., Centre National de la Recherche
Scientifique, Toulouse, France
Petersen, R., B.S., M.S., University of Illinois, Urbana-
Champaign
Srivastava, M., B.Sc., Ph.D., NICHD/National Institutes of
Health, Bethesda, Maryland
Yang, T, M.S., Ph.D., Ohio State University, Columbus
Hill, C., Imperial Cancer Research Fund, London, United
Kingdom: TGF-p signaling and regulation of transcription.
Jones, K., The Salk Institute for Biological Studies, La Jolla,
California: Regulation of HIV transcription.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Transcription
factors in 3D.
Lees, J., Massachusetts Institute of Technology, Cambridge:
The in vivo of the E2F transcription factors.
Powers, T., University of California, Davis: Exploring gene
expression during nitrogen utilization in yeast.
Roeder, R., The Rockefeller University, New York, New York:
Role of general and gene-specific coactivators in transcrip-
tional regulation.
Thanos, D., Columbia University, New York, New York:
Activation and attenuation of transcription by the IFN-p
enhanceosome.
Timmers, M., Utrecht University, The Netherlands: Basal tran-
scription by RNA polymerase II.
Workman, J., Pennsylvania State University, University Park:
Transcription regulation by SWI/SNF and HAT complexes.
Imaging Structure and Function in the Nervous System
July 25-August 14
INSTRUCTORS K. Delaney, Simon Fraser University, Burnaby, Canada
V. Murthy, Harvard University, Cambridge, Massachusetts
K. Svoboda, Cold Spring Harbor Laboratory
ASSISTANTS J. Dantzker, The Salk Institute, La Jolla, California
B. Hall, Simon Fraser University, Burnaby, Canada
Z. Li, Harvard University, Cambridge, Massachusetts
M. Maravall, Cold Spring Harbor Laboratory
Advances in light microscopy and digital image processing and the development of a variety of pow-
erful fluorescent probes present expanding opportunities for investigating the nervous system, from
synaptic spines to networks in the brain. This intensive laboratory and lecture course provided partici-
pants with the theoretical and practical knowledge to utilize emerging imaging technologies. The pri-
mary emphasis of the course was on vital light microscopy. Students learned the principles of light
microscopy, as well as use of different types of electronic cameras, laser-scanning systems, function-
al fluorophores, delivery techniques, and digital image-processing software. In addition to transmitted
light microscopy for viewing cellular motility, the course examined a variety of molecular probes of cell
function, including calcium-sensitive dyes, voltage-sensitive dyes, photo-activated ("caged") corn-
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pounds, and exocytosis tracers. Issues arising in the combination of imaging with electrophysiological
methods were covered. Particular weight was given to multiphoton laser scanning microscopy and to
newly available biological fluorophores, especially green fluorescent protein (GFP) and its variants. A
spectrum of neural and cell biological systems was used, including living animals, brain slices, and cul-
tured cells. Applicants had a strong background in the neurosciences and in cell biology. Lecturers
included W. Almers, C. Aoki, William Betz, Holly Cline, Jami Dantzker, Richard Day, Kerry Delaney,
Winfried Denk, Joseph Fetcho, Paul Forscher, J. Fujimoto, Amiram Grinvald, Ernst Keller, Delaney
Kerry, Fred Lanni, Lew Loew, Tobias Meyer, B. Moomaw, Venkatesh Murthy, M. Nonet, Tim Ryan,
Bernado Sabatini, Karel Svoboda, Roger Tsien, Samuel Wang, and Shimon Weiss.
PARTICIPANTS
Castonguay, A., B.S., Ph.D., University de Montreal, Quebec,
Canada
Das, T, B.A., University of Cambridge, United Kingdom
Golding, N., B.S., Ph.D., Northwestern University, Evanston,
Illinois
Lezcano, N., M.A., Ph.D., Medical College of Georgia,
Augusta
Louissaint, Jr., A., B.A., M.A., Weill Medical College of Cornell
University, New York, New York
Prescott, S., B.Sc., M.D., McGill University, Montreal,
SEMINARS
Almers, W., Vollum Institute, Portland, Oregon: Vesicle imag-
ing, TIRE.
Aoki, C., New York University, New York, New York: Electron
microscopy. Applications of electron microscopy.
Betz, W., University of Colorado, Denver: FM-143 imaging.
Cline, H., Cold Spring Harbor Laboratory: In vivo imaging of
development in Xenopus.
Dantzker, J., Salk Institute, La Jolla, California: Uncaging to
study neural circuits.
Day, R., University of Virginia, Charlottesville: Basics of GFP.
FRET microscopy.
Delaney, K., Simon Fraser University, Burnaby, Canada: Ca"
imaging applications.
Denk, W., Max-Planck Institute for Medical Research,
Heidelberg, Germany: Two-photon 1. Two-photon 2. Two-
photon applications.
Fetcho, J., SUNY, Stony Brook, New York: In vivo imaging in
zebrafish.
Forscher, P., Yale University, New Haven, Connecticut:
Phase and DIC microscopy. Video DIC and time-
lapse.
Fujimoto, J., Massachusetts Institute of Technology,
Cambridge: Optical coherence tomography. Applications of
optical coherence tomography.
Grinvald, A., Weizmann Institute of Science, Rehovot, Israel:
Intrinsic signal and voltage sensitive dyes in vivo.
Keller, E., Carl Zeiss, Inc., Thornwood, New York: Basics of
microscopy; image formation. Basics on microscopy.
Quebec, Canada
Ratte, S., B.Sc., Ph.D., University of Birmingham, United
Kingdom
Scheiffele, P., Ph.D., University of California, Berkeley
Snyder, E., B.A., Ph.D., Brown University, Providence, Rhode
Island
Tao, H., B.S., M.S., Ohio University, Athens
Wang, C.-T, B.S., M.S., University of Wisconsin, Madison
Zelles, T., M.D., Ph.D., Institute of Experimental Medicine,
Hungarian Academy of Scicience, Budapest, Hungary
Kerry, D., Simon Fraser University, Burnaby, Canada: Ca'
imaging.
Lanni, F, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Fluorescence. Fluorescence microscopy.
Loew, L., University of Connecticut Health Center,
Farmington: Voltage sensitive dyes. Voltage-sensitive dyes
and harmonic imaging.
Meyer, T., Duke University Medical Center, Durham, North
Carolina: Imaging intracellular signaling using GFP.
Moomaw, B., Hamamatsu Photonic Systems, Bridgewater,
New Jersey: CCD cameras.
Murthy, V, Harvard University, Cambridge, Massachusetts:
Imaging secretion.
Nonet, M., Washington University, St. Louis, Missouri:
Imaging synaptogenesis in C. elegans using GFP.
Ryan, T., Cornell University Medical College, New York, New
York: Vesicle imaging, Phluorins.
Sabatini, B., Cold Spring Harbor Laboratory: Quantitative
two-photon imaging in small compartments.
Svoboda, K., Cold Spring Harbor Laboratory: Basic optics. In
vivo imaging in mammalian neocortex.
Tsien, R., University of California, San Diego, La Jolla:
Functional probes 1. Functional probes 2. Functional imag-
ing.
Wang, S., Princeton University, New Jersey: Uncaging.
Cages.
Weiss, S., Lawrence Berkeley National Laboratory, Berkeley,
California: 0-dots; single molecules; near-field.
Yeast Genetics
July 25-August 14
INSTRUCTORS D. Burke, University of Virginia, Charlottesville
0. Cohen-Fix, National Institutes of Health, Bethesda, Maryland
D. Dawson, Tufts University, Boston, Massachusetts
T. Stearns, Stanford University, California
ASSISTANTS Z. Hiloti, National Institutes of Health, Bethesda, Maryland
R. Kamieniecki, Tufts University, Boston, Massachusetts
M. Mc Cleland, University of Virginia, Charlottesville
This was a modern, state-of-the-art laboratory course designed to teach the students the full repertoire
of genetic approaches needed to dissect complex problems in the yeast Saccharomyces cerevisiae.
Combinations of classical genetic approaches were emphasized, including the isolation and charac-
terization of mutants, tetrad analysis, complementation, and mitotic recombination. Molecular genetic
techniques were emphasized, including various types of yeast transformations, gene replacement with
plasmids and PCR, construction and analysis of gene fusions, and generation of mutations in cloned
genes. Students used classical and molecular approaches to gain experience in identifying and inter-
preting various kinds of genetic interactions including suppression and synthetic lethality. Students
were immersed in yeast genomics and performed and interpreted experiments with DNA arrays.
Students gained first-hand experience in modern cytological approaches such as epitope tagging and
imaging yeast cells using indirect immunofluorescence, GFP-protein fusions, and a variety of fluores-
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cent indicators for various subcellular organelles. Lectures on fundamental aspects of yeast genetics
were presented along with seminars given by outside speakers on topics of current interest.
Participating speakers included J. Konopka, A. Amon, A. Hopper, B. Futcher, M. Lichten, T. Weinert,
D. Roof, P Meluh, D. Pellman, G. Fink, M. Snyder, V. Lundbald, J. Boeke, and M. Winey.
PARTICIPANTS
Aguilaniu, H., M.S., Ph.D., Chalmers University, Gothenburg,
Sweden
Boutonnet, C., B.S., Ph.D., INSERM, Toulouse, France
Caste Ili, L., B.A., Commonwealth and Scientific Industrial
Research Organization, Parkville, Australia
Chang, W.-H., M.S., Ph.D., Stanford University School of
Medicine, California
Debburman, S., B.A., Ph.D., Kalamazoo College, Michigan
Fehrenbacher, K., B.S., Columbia University, New York, New
York
Goddard, M., B.Sc., Ph.D., University of London, Ascot,
United Kingdom
Gunjan, A., B.S., Ph.D., Imperial Cancer Research Fund,
SEMINARS
Amon, A., Massachusetts Institute of Technology,
Cambridge: Exit from mitosis in yeast.
Biggins, S., Fred Hutchinson Cancer Research Institute,
Seattle, Washington: 1p11 and chromosome segregation.
Cyert, M., Stanford University, California: Calcium regulation
in yeast.
Fox, T, Cornell University, Ithaca, New York: Mitochondrial
genetics and biogenesis.
Hollingsworth, N., SUNY, Stony Brook, New York: Protein-
protein interactions essential for meiosis in yeast.
Kamakaka, R., National Institute of Child Health and Human
Development, Bethesda, Maryland: Sir1 and transcriptional
silencing at HMR.
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Harts, United Kingdom
Hoss, M., Ph.D., Institut Suisse de Recherche Experimental
sur la Cancer, Epalinges, Switzerland
Jiang, M., B.S., Ph.D., University of California, Los Angeles
Lewis, M., B.A., Ph.D., University of Texas, Austin
Lin, W., D.E.A., Institut Curie, Paris, France
Luke, B., B.Sc., M.S., Queen's University, Kingston, Canada
McCarty, G., B.S., University of Maryland, Baltimore
Moreira dos Santos, M.M., B.S., M.S., Technical University of
Denmark, Denmark
Tyler, J., B.Sc., Ph.D., University of California, San Diego, La
Jolla
Klar, A., National Cancer Institute, Frederick, Maryland:
Mating-type switching in yeast.
Lew, D., Duke University, Durham, North Carolina: The mor-
phogenesis checkpoint.
Pringle, J., University of North Carolina, Chapel Hill: On
selecting an axis of polarization: Bud-site section in S. cere-
visiae.
Sclafani, R., University of Colorado Health Sciences, Denver:
Using yeast genetics to study DNA replication.
Shaw, J., University of Utah, Salt Lake City: Fission and
fusion among yeast mitochondria.
Smith, M., University of Virginia, Charlottesville: Novel his-
tones, novel functions.
Yeast Genetics Course Millennium Reunion
August 11-13
ARRANGED BY Dan Burke, University of Virginia, Charlottesville
David Stewart, Cold Spring Harbor Laboratory
The Cold Spring Harbor Yeast Genetics course began in 1970 and was taught for a total of 17 years
by Gerald Fink and Fred Sherman. Successive cadres of instructors have taken up the challenge to
teach the yeast course every summer since then. To celebrate 30 years of yeast genetics, a millenni-
um celebration was held on the last weekend of the 2000 yeast genetics course. Invitations were
issued to former instructors and past students still active in the field of yeast genetics and biology. The
weekend featured a fascinating combination of scientific stories past and present, with ample time for
reminiscences of every kind, and provided an opportunity for old friends and colleagues to catch up
(and run in the famous Plate Race together). It also afforded the students in the 2000 course a chance
to meet many of the famous alumni from the course who have contributed so much over the years to
the field of yeast genetics and biology. Reunion participants included:
Alison Adams
David Botstein
James Broach
Judith Campbell
Scott Clark
Nancy Du
Nicholas Edgington
Francisco Ferrezuelo
Gerald Fink
Rosalie Fink
Brigitte Gallwitz
Dieter Gallwitz
Ira Herskowitz
Jim Hicks
Philip Hieter
Jun Horiuchi
Alexander Johnson
Chris Kaiser
Amar Klar
Christopher Lawrence
Susan Michaelis
Thomas Petes
Peter Philippsen
Mark Rose
Elena Rustchenko
Randy Schekman
Arndt Schmitz
Fred Sherman
Pamela Silver
Gerry Smith
George Sprague
Jeremy Thorner
Reed Wickner
The reunion, held at Bush Auditorium, featured the following program:
Friday August 11
8:00 pm Opening Remarks: James Watson
Introduction: Terri Grodzicker
Fred Sherman, Gerry Fink
Saturday August 12
9:00 am Session Chair: Tim Stearns
David Botstein, Ira Herskowitz,
Thomas Petes
11.00 am Session Chair: Orna Cohen-Fix
Jeremy Thorner, Peter Phillipsen
1:30 pm Session Chair: Dean Dawson
Amar Klar, Pam Silver, Chris Kaiser
3:30 pm Session Chair: Dan Burke
Phil Hieter, Mark Rose
4.30 pm Closing Remarks: Bruce Stillman
5:00 pm Plate Race
6:00 pm Cocktails & Banquet
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J. Hicks, J.D. Watson, A. Klar, J. Strathern
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G. Fink, T. Grodzicker
S. Michaelis, I. Herskowitz, P. Silver
"The veteran's get ready"
C. Kaiser, T. Stearns
Start of the race (veteran's team led by Mark Rose on the right)
Advanced Drosophila Genetics
July 31-August 13
INSTRUCTORS M. Ashburner, EMBL-EBI, Cambridge, United Kingdom
S. Hawley, University of California, Davis
This intensive seminar course provided an introduction to the theory and practice of methods used to
manipulate the Drosophila genome. It was suitable for graduate students and researchers, with some
experience with Drosophila, who were interested in expanding their knowledge of the wide range of
genetic techniques now available for use with this organism. Topics included chromosome mechanics,
the design and execution of genetic screens, and the use of transposable elements as genetic tools.
This year was the year of the fly genome, and its impact on genetic analysis was a particular focus of
the course.
PARTICIPANTS
Barcelo, H., B.S., Ph.D., North Dakota State University, Fargo
Champion, M., B.S., Ph.D., University of California, Davis
Gallio, M., M.S., Karolinska Institutet, Huddinge, Sweden
Gilbert, M., B.S., Ph.D., SUNY, Stony Brook, New York
Haywood, A., B.Sc., M.Sc., Memorial University of New
Found land, New Zealand
Hendricks, J., B.S., Ph.D., University of Pennsylvania,
Philadelphia
Jones, C., B.S., Emory University, Atlanta, Georgia
Lau, G., B.S., Ph.D., Massachusetts General Hospital,
Boston
Paddy, M., B.S., Ph.D., University of California, Davis
Rattner, B., B.S., Ph.D., Tufts University, Medford,
Massachusetts
Ribeiro, C., dipl. Phil. II, Biozentrum der Universitaet Basel,
Switzerland
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Serpe, M., M.S., Ph.D., University of Minnesota, Minneapolis
Shilkova, 0., B.S., M.S., St. Petersburg State University,
Russia
Singh, S., M.Sc., Ph.D., SUNY, Buffalo, New York
Ting, C.-T., B.S., Ph.D., University of Chicago, Illinois
SEMINARS
Ashburner, M., EMBL-EBI, Cambridge, United Kingdom:
Introduction to Drosophila biology, phylogeny. Fly Base:
Where to find information. Chromosomes, cytogenetics,
chromosome aberrations, mapping (genetic and cytogenet-
ic).
Ashburner, M., EMBL-EBI, Cambridge, United Kingdom, and
S.R. Hawley, University of California, Davis: Summing up.
Burtis, K., University of California, Davis: DNA microarrays in
Drosophila.
Cline, T., University of California, Berkeley: Alternative to brute
force: Selective and sensitized genetic screens and their use
in the genetic dissection of Drosophila sex determination.
Golic, K., University of Utah, Seattle, Washington: Mosaic sys-
tems; FRT/FLP.
Hawley, S.R., University of California, Davis: Genetics of meio-
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Walker, D., B.A., Ph.D., University of Utah, Salt Lake City
Weber, F., B.S., Ph.D., The Scripps Research Institute, San
Diego, California
Wolf-Watz, H., M.S., Ph.D., University of Stockholm, Sweden
Yildiz, 0., B.S., University of North Carolina, Chapel Hill
sis; methods of study and exploitation.
Heberlein, U., University of California, San Francisco:
Neurogenetics and behavior.
Karpen, G., The Salk Institute, La Jolla, California:
Heterochromatin, centromeres, and telomeres.
Lehmann, R., Skirball Institute, HHMI, New York, New York:
Genetic screens for mutations affecting embryogenesis
(including maternal effect mutations): Methods for their
analysis.
Rorth, P., Carnegie Institute of Washington, Baltimore,
Maryland: P-element technologies/gain-of-function genetics.
Rubin, G., HHMI/University of California, Berkeley: The fly
genome.
Sullivan, B., University of California, San Francisco: Cell biolo-
gy.
Bioinformatics: Writing Software for Genome Research
October 11-24
INSTRUCTORS S. Rozen, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
L. Stein, Cold Spring Harbor Laboratory
ASSISTANTS R. Halgren, Michigan State University, East Lansing
J. Kissinger, University of Pennsylvania, Philadelphia
C. Mungall, Berkeley Drosophila Genome Project, Berkeley, California
The desktop computer is rapidly becoming an indispensable tool in the biologist's tool chest. The suc-
cess of the Human Genome Project has created an explosion of information: billions of bits of biolog-
ical information stashed electronically in databases around the globe just waiting for the right key to
unlock them. New technologies such as DNA microarrays and high-throughput genotyping are creat-
ing an information overload that the traditional laboratory notebook cannot handle. To exploit the infor-
mation revolution in biology, biologists must move beyond canned Web interfaces and Excel spread-
sheets. They must take charge of the data by creating their own software to fetch, manage, and inte-
grate it.
The goal of this course was to provide biologists with the tools needed to deal with this changing
landscape. Designed for students and researchers with little prior knowledge of programming, this 2-
week course taught the fundamentals of the Unix operating system, Pen scripting, dynamic Web page
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development with the CGI protocol, and database design. The course combined formal lectures with
hands-on experience in which students worked to solve a series of problem sets drawn from common
scenarios in biological data acquisition, integration, and laboratory workflow management. For their
final projects, students posed problems using their own data and worked with each other and the fac-
ulty to solve them.
PARTICIPANTS
Buck, G., B.S., Ph.D., Virginia Commonwealth University,
Richmond
Burnside, J., B.S., Ph.D., University of Delaware, Newark
Ebersberger, I., B.S., Max-Planck Institute for Evolutionary
Anthropology, Leipzig, Germany
Eichler, E., B.S., Ph.D., Case Western Reserve University,
Cleveland, Ohio
Farrer, M., B.S., Ph.D., Mayo Clinic, Jacksonville, Florida
Ferrezuelo, F., B.S., Ph.D., Cold Spring Harbor Laboratory
Gerton, J., B.A., Ph.D., University of California, San Francisco
Gunsalus, K., B.A., Ph.D., Cornell University, Ithaca, New
York
Haqq, C., B.S., Ph.D., University of California, San Francisco
Hazard, S., B.S., M.S., Ph.D., Medical University of South
Carolina, Charleston
Li, M., B.S., Ph.D., Bristol Myers Squibb, Princeton, New
Jersey
Martell, R., B.A., M.B.A., National Institutes of Health,
Bethesda, Maryland
Mayer, L., B.S., Ph.D., Centers for Disease Control, Atlanta,
Georgia
SEMINARS
Bader, J., CuraGen Corporation, New Haven, Connecticut:
Analysis of expression data.
Birney, E., EMBL-EBI, Hinxton, United Kingdom: Writing perl
modules. The ensemble genome database.
Burge, C., Massachusetts Institute of Technology, Cambridge:
Computational gene finding.
Chervitz, S., Neomorphics, Inc., Berkeley, California: Writing
perl modules. The ensemble genome databases.
Hughey, R., University of California, Santa Cruz: HMMs.
Marth, G., National Center for Biotechnology Information,
Bethesda, Maryland: Sequence analysis pipeline: Lashing
294
McPherson, J., B.Sc., Ph.D., Washington University, St.
Louis, Missouri
Nickerson, E., B.S., Ph.D., Baylor College of Medicine,
Houston, Texas
Reboul, J., M.S., Ph.D., Dana Farber Cancer Institute,
Boston, Massachusetts
Rowen, L., BA., Ph.D., Institute for Systems Biology, Seattle,
Washington
Rutherford, R., B.A., Ph.D., University of California/HHMI,
San Francisco
Scherer, S., BA., Ph.D., Baylor College of Medicine,
Houston, Texas
Shoulders, C., BA., D.Phil., MRC, Imperial College School of
Medicine, London, United Kingdom
True, H., B.S., Ph.D., University of Chicago, Illinois
Ware, D., B.S., Ohio State University ABRC, Columbus
West, J., B.S., Cold Spring Harbor Laboratory
Whetzel, T., B.S., Ph.D., University of Pennsylvania School of
Medicine, Philadelphia
Yang, U.-C., B.S., Ph.D., National Yang-Ming University,
Taiwan
everything together with perl.
Pearson, B., University of Virginia, Charlottesville: Sequence
similarity.
Peitzsch, R., Pfizer, Inc., Groton, Connecticut: SQL.
SQLJDatabases.
Rebhan, M., AstraZeneca, Inc., Cambridge, Massachusetts:
Web usability.
Slonim, D., Whitehead Institute, Cambridge, Massachusetts:
Analysis of expression data.
Young, P., SmithKline Beecham Pharmaceuticals, King of
Prussia, Pennsylvania: Gene expression databases.
Gene Isolation: Advanced Methods in Positional Cloning
October 11-24
INSTRUCTORS C. Amemiya, Boston University School of Medicine, Massachusetts
H. Jacob, Medical College of Wisconsin, Milwaukee
G. Silverman, Children's Hospital/Harvard Medical School, Boston, Massachusetts
F. Spencer, Johns Hopkins University School of Medicine, Baltimore, Maryland
ASSISTANTS D. Askew, Harvard Medical School, Boston, Massachusetts
L. Roden, University of Warwick, Coventry, United Kingdom
S. Twigger, Medical College of Wisconsin, Milwaukee
Classical positional cloning strategies have relied on the use of genetic mapping studies to localize the
gene and physical mapping reagents to clone the candidates. The completion of major sequencing
efforts promised to alter this paradigm by providing the identity and syntenic relationships of all the
genes. This laboratory-based course was designed to assist in the physical isolation of novel genes,
including well-mapped disease-related genes and QTLs, using all available assets including physical
mapping tools and sequenced genomes. Principal procedures included physical mapping by contig
construction using YACs and BACs, STS-content mapping, DNA fingerprinting, pulsed-field gel elec-
trophoresis, and end-rescue. Methods for converting YAC contigs to sequence-ready BAC contigs
were also illustrated. Procedures using the yeast as a host organism for YAC analysis and manipula-
tion were covered. These techniques included YAC transfer between strains to facilitate purification of
pure clone DNA, and fragmentation and retrofitting strategies for modifying clones prior to their intro-
duction into cell lines or ES cells. Modification of BACs by recombination cloning methodologies were
also emphasized. Methods used for the cloning of genes from large cloned DNA segments such as
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cDNA selection or exon trapping were compared to gene-identification computer algorithms used for
searching genomic DNA sequence databases. Bioinformatics sessions emphasizing end-user applica-
tions, comparative genomic analysis, and database mining were incorporated into multiple problem
solving sessions. Recombinational cloning of disease-related loci using BACs and YACs were used as
a means to circumvent conventional library construction and cloning techniques. Studies in mutation-
al analysis were also included. The laboratory-based component was supplemented by lectures from
prominent investigators who had pioneered the development and application of techniques utilized in
the course. All participants presented a synopsis of their work. These brief presentations served as a
means to discuss positional cloning strategies in the context of real research projects. Due to conser-
vation of genomic sequence across a diversity of species, investigators engaged in projects outside
mainstream sequencing projects were also encouraged to apply.
PARTICIPANTS
Conway, G., B.S., Ph.D., NASA Ames Research Center,
Moffett Field, California
Culp, D., B.S., Ph.D., University of Rochester, New York
Doucet, J., B.S., Ph.D., Nichols State University, Thibodaux,
California
D'Souza, J., M.Sc., Ph.D., IMA, National University of
Singapore, Singapore
Geiger, H., B.S., Ph.D., University of Kentucky, Lexington
Hasham, S., M.S., B.S., University of Texas, Houston
Johannesson, M., B.S., M.S., Lund University, Sweden
Knapik, E., M.D., GSF-National Research Center, Munich,
Germany
SEMINARS
Amemiya, C., Boston University, Massachusetts: Applications
of large-insert cloning for studies on the evolution and
development of the vertebrate immune system and of the
HOX gene system.
Baxevanis, A., National Institutes of Health, Bethesda,
Maryland: Bioinformatics II: Gene prediction. Bioinformatics
III: Protein prediction.
Birren, B., Whitehead Center for Genome Research, MIT,
Cambridge, Massachusetts: From genome to clones and
BAC again.
Dewar, K., Whitehead Center for Genome Research, MIT,
Cambridge, Massachusetts: Comparative genomic
sequencing.
Green, E., National Institutes of Health, Bethesda, Maryland:
Mapping and sequencing mammalian chromosomes: How
and why?
Hengartner, M., Cold Spring Harbor Laboratory: Positional
cloning in C. elegans.
Jacobs, H., Medical College of Wisconsin, Milwaukee: From
QTL to gene using comparative genomics, bioinformatics,
and SNPS I. From QTL to gene using comparative
genomics, bioinformatics, and SNPS II.
Kwiatkowski, D., Harvard Medical School, Brigham and
Women's Hospital, Boston, Massachusetts: Methods for
mutations/SNP detections: HD Gels, SSCP, DGGE,
DHPLC.
Matise, T, Rutgers University, Piscataway, New Jersey:
Bioinformatics I: Mapping.
Meltzer, P., National Institutes of Health, Bethesda, Maryland:
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Li, W.-D., M.D., Ph.D., University of Pennsylvania,
Philadelphia
Magnusson, V. B.S., Ph.D., Uppsala University, Sweden
Pereira, L.F., B.S., Ph.D., Londrina, Brazil
Riba, L., B.S., M.S., Natinonal University of Mexico, Mexico
Silahtaroglu, A., M.Sc., Ph.D., University of Copenhagen,
Denmark
Vanavichit, A., M.S., Ph.D., Kasetsart University, Nakorn
Pathom, Thailand
Von Tell, D., M.S., Ph.D., Karolinska Institutet, Stockholm,
Sweden
Gene expression profiling with cDNA microarrays.
Reeves, R., Johns Hopkins University School of Medicine,
Baltimore, Maryland: Understanding Down syndrome as a
(VERY) complex genetic disorder.
Roden, L., University of Warwick, Coventry, United Kingdom:
Circadian rhythms: Photoperiodism and the search for
"clock" genes in Arabidopsis.
Roe, B., University of Oklahoma, Norman: The Human
Genome Project: So many bases, so little time-A view
from the trenches.
Rubin, E., University of California, Berkeley: Sifting sequence
for function: Exploiting the mouse.
Satish, P., Johnson & Johnson, Skillman, New Jersey: cDNA
selection I. cDNA selection II.
Silverman, G., Harvard Medical School, Children's Hospital,
Boston, Massachusetts: Delineation of the serpin super-
family by comparative genomics.
Spencer, F., Johns Hopkins University School of Medicine,
Baltimore, Maryland: Chromosome segregation in yeast.
Stewart, F., EMBL, Heidelberg, Germany: ET cloning.
Trask, B., Fred Hutchinson Cancer Research Center, Seattle,
Washington: Fluorescence in situ hybridization (FISH) and
genome analysis.
Twigger, S., Medical College of Wisconsin, Milwaukee:
Bioinformatics: It's not just for geeks. Practical ways to start
using bioinformatics in the lab.
Williams, S., Smith College, Southampton, Massachusetts:
Filarial genome project.
Macromolecular Crystallography
October 11-24
INSTRUCTORS W. Furey, V.A. Medical Center, Pittsburgh, Pennsylvania
G. Gilliland, National Institute of Standards & Technology, Rockville, Maryland
A. McPherson, University of California, Irvine
J. Pflugrath, Molecular Structure Corporation, The Woodlands, Texas
ASSISTANT S. Chu, National Institute of Standards & Technology, Rockville, Maryland
Crystallography and X-ray diffraction yielded a wealth of structural information unobtainable through
other methods. This intensived laboratory/computational course focused on the major techniques used
to determine the three-dimensional structures of macromolecules. It was designed for scientists with a
working knowledge of protein structure and function, but who are new to macromolecular crystallogra-
phy. Topics covered included crystallization (proteins, nucleic acids, and complexes), crystal character-
ization, X-ray sources and optics, synchrotrons, crystal freezing, data collection, data reduction, multi-
ple isomorphous replacement, multiwavelength anomalous dispersion phase determination, solvent flat-
tening, molecular replacement and averaging, electron density interpretation, structure refinement, mol-
ecular graphics, noncrystallographic summary, simulated annealing, and coordinate deposition.
Participants learned through extensive hands-on experiments. They crystallized and determined a pro-
tein structure, along with lectures on the theory and informal discussions behind the techniques.
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Participating lecturers were Paul Adams, William Furey, Gary Gilliland, Wayne Hendrickson, Andrew
Howard, Li-Wei Hung, Morten Kjeldgaard, Alexander McPherson, Jorge Navaza, Anastassis Perrakis,
James Pflugrath, David Richardson, Jane Richardson, Robert Sweet, and Dale Tronrud.
PARTICIPANTS
Bezprozvanny, L., M.S., Ph.D., University of Texas South-
western Medical Center, Dallas
Campos, A., B.S., Ph.D., University of Illinois, Chicago
Chaves, S., B.S., Ph.D., The Rockefeller University, New
York, New York
Cullen, D., B.S., Ph.D., Connecticut College, New London
Gariani, T., B.Sc., Ph.D., Umea University, Sweden
Ghirlanda, G., Ph.D., University of Pennsylvania, Philadelphia
Mancini, E., M.S., Ph.D., European Molecular Biology
Laboratory, Heidelberg, Germany
Margulies, D., Ph.D., National Institutes of Health, Bethesda,
Maryland
Maynes, J., B.Sc., Ph.D., University of Alberta, Edmonton,
SEMINARS
Furey, W., V.A. Medical Center, Pittsburgh, Pennsylvania:
Direct methods and many site Se-Met MAD problems: An
example.
Gilliland, G., National Institute of Standards & Technology,
Gaithersburg, Maryland: Structural genomics: High-
throughput crystallization.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Origin recog-
nition by a replication initiation factor: The DNA-binding
domain of El from papillomarvirus.
Kjeldgaard, M., University of Aarhus, Denmark:
BirdBuilder/Birdwash: A multipurpose programming envi-
ronment for macromolecular crystallography.
McPherson, A., University of California, Irvine: Probing crystal
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Canada
Morin, P., B.S., Ph.D., Dupont Pharmaceuticals, Wilmington,
Delaware
No Ilert, P., Ph.D., University of California, San Francisco
Nymalm, Y., M.S., Abo Akademi University, Turku, Finland
Plotnikov, A., M.S., Ph.D., New York University School of
Medicine, New York, New York
Sickmier, A., B.S., Ph.D., St. Jude Children's Research
Hospital, Memphis, Tennessee
Stine, J., BA., Ph.D., University of Texas Health Science
Center, San Antonio
Weeks, K., B.A., Ph.D., University of North Carolina, Chapel
Hill
defect with atomic force microscopy.
Navaza, J., Universite Paris Sud, Chatenay-Malabry, France:
Fitting molecular structures into EM 3D reconstructions:
Application to helical and icosahedral reconstruction of the
rotavirus VP6 protein.
Perrakis, A., EMBL Grenoble, France: Function and structure
of the MutS DNA mismatch repair protein.
Ramikrishnan, V. MRC Laboratory of Molecular Biology,
Cambridge, United Kingdom: Insights from the atomic res-
olution structure of the 30S ribosomal subunit.
Richardson, D. and Richardson, J., Duke University Medical
Center, Durham, North Carolina: The importance of packing
hydrogens for improved fitting and refinement.
Immunocytochemistry, In Situ Hybridization, and Live Cell Imaging
October 18-31
INSTRUCTORS J. Murray, University of Pennsylvania School of Medicine, Philadelphia
T. Ried, National Cancer Institute/NIH, Bethesda, Maryland
D. Spector, Cold Spring Harbor Laboratory
J. Swedlow, University of Dundee, United Kingdom
ASSISTANTS A. Binnie, Oxford University, United Kingdom
M. Difilippantonio, National Cancer Institute/NIH, Bethesda, Maryland
T. Howard, Cold Spring Harbor Laboratory
M. Platani, University of Dundee, United Kingdom
This course focused on specialized techniques in microscopy related to localizing DNA, RNA, and pro-
teins in fixed mammalian cells as well as protein dynamics in living cells. The course emphasized the
use of the latest equipment and techniques in epifluorescence microscopy, confocal laser-scanning
microscopy, digital image processing, and live-cell imaging. The aims of the course were designed to
provide state-of-the-art technology and scientific expertise in the use of microscopic applications to
address basic questions in cellular and molecular biology. The course was designed for the molecular
biologist who was in need of microscopic approaches and for the cell biologist who was not familiar
with the practical application of the advanced techniques presented in the course. Among the meth-
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ods presented were the preparation of tagged nucleic acid probes, fixation methods, detection of mul-
tiple DNA sequences in single nuclei or chromosome spreads, comparative genomic hybridization, cel-
lular localization of RNA, localization of nucleic acids and proteins in the same cells, use of a variety of
reporter molecules and nonantibody fluorescent tags, indirect antibody labeling, detection of multiple
proteins in a single cell, and the use of GFP variants to study protein localization and dynamics. In each
method, several experimental protocols were presented, allowing the students to assess the relative
merits of each and to relate them to their own research. Students were encouraged to bring nucleic
acid or antibody probes to the course which were used in addition to those provided by the instruc-
tors. The laboratory portion of the course was supplemented by invited lecturers who presented up-
to-the-minute reports on current methods and research using the techniques presented in the course.
PARTICIPANTS
Bhuiyan, H., B.S., M.S., Stockholm University, Sweden
Bratu, D., B.A., M.A., New York University, New York, New
York
Brown, A., A.B., M.D., Massachusetts General Hospital, E.
Charlestown
Chin, S.-F., B.Sc., Ph.D., University of Cambridge, United
Kingdom
Di Tomaso, E., B.Sc., Ph.D., Massachusetts General
Hospital/Harvard Medical School, Boston
Dredge, K., B.Sc., The Rockefeller University, New York, New
York
Du, J., B.S., Ph.D., Cold Spring Harbor Laboratory
Kiesslich, A., B.S., Institute for Molecular Biotechnologie,
Jena, Germany
Moore, Y., M.S., Ph.D., University of Texas Southwestern
SEMINARS
Dernburg, A., Stanford University School of Medicine,
California: Chromosome FISH.
Ells, R., University of Heidelberg, Germany: Time-resolved
analysis and visualization of dynamic processes in living
cells.
Huang, S., Northwestern University Medical School, Chicago,
Illinois: Fluorescence in situ hybridization to localize RNA.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Basic introduction to light and fluorescence
microscopy. Principles of confocal microscopy and decon-
volution techniques.
Ried, T., National Cancer Institute/NIH, Bethesda, Maryland:
Mechanisms and consequences of chromosomal aberra-
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Medical Center, Dallas
Morris, L., M.S., Ph.D., University of Cambridge, United
Kingdom
Ott, I., B.S., M.D., Deutsches Herzzentrum der Technischen
Universitat, Munchen, Germany
Pfeifer, C., B.S., M.S., The Royal Veterinary and Agricultural
University, Copenhagen, Denmark
Sampson, N., B.Sc., Ph.D., University of Nottingham, United
Kingdom
Schelhaas, M., M.Sc., Max-Planck Institute for Neurological
Research, Koln, Germany
Trevino, C., B.S., Ph.D., University of Mexico, Cuernavaca
Wood, S., B.Sc., Ph.D., Weill Medical College of Cornell
University, New York, New York
tions in cancer cells.
Singer, R., Albert Einstein College of Medicine, Bronx, New
York: Cytoplasmic organization of mRNA.
Spector, D., Cold Spring Harbor Laboratory: Immunocyto-
chemistry.
Spring, K., National Heart, Lung, and Blood Institute/NIH,
Bethesda, Maryland: Light sources and cameras.
Yasuda, R., Keio University, Yokohama, Japan: Single-mole-
cule fluorescence imaging of FI-ATPase.
Zipfel, W., Cornell University, Ithaca, New York: GFP/multi-
photon microscopy and correlation fluorescence spec-
troscopy.
Computational Genomics
October 26-31
INSTRUCTORS W.R. Pearson, University of Virginia, Charlottesville
R.F. Smith, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania
Beyond BLAST and FASTA. This course presented a comprehensive overview of the theory and prac-
tice of computational methods for gene identification and characterization from DNA sequence data.
The course focused on approaches for extracting the maximum amount of information from protein
and DNA sequence similarity through sequence database searches, statistical analysis, and multiple
sequence alignment. Additional topics included gene recognition (exon/intron prediction), identifying
signals in unaligned sequences, and integration of genetic and sequence information in biological data-
bases. The course combined lectures with hands-on exercises; students were encouraged to pose
challenging sequence analysis problems using their own data. The course maked extensive use of local
VVVVW pages to present problem sets and the computing tools to solve them. Students used Windows
and Mac workstations attached to a UNIX server; participants had experience with and were comfort-
able using the Unix operating system and a Unix text editor. The course was designed for biologists
seeking advanced training in biological sequence analysis, computational biology core resource direc-
tors and staff, and for scientists in other disciplines, such as computer science, who wish to survey
current research problems in biological sequence analysis.
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PARTICIPANTS
Ahrens, C., B.S., Ph.D., GPC Biotech AG, Munich, Germany
Bal, H., M.S., Ph.D., Cold Spring Harbor Laboratory
Burchett, S., B.S., Ph.D., Yale University School of Medicine,
New Haven, Connecticut
Chen, R., B.S., Ph.D., Baylor College of Medicine, Houston,
Texas
Chinwalla, A., B.S., M.S., Washington University School of
Medicine, St. Louis, Missouri
Chu, M.-L., B.S., Ph.D., Thomas Jefferson University,
Philadelphia, Pennsylvania
Coleman, D., B.A., D.Phil., Princeton University, New Jersey
Cortes, D.-F., B.Sc., International Center for Tropical
Agriculture CIAT, Cali, Columbia
Crignon, I., B.S., Ph.D., Novartis Pharma AG, Basel,
Switzerland
Di Rienzo, A., B.S., Ph.D., University of Chicago, Illinois
Garnhart, N., B.M., University of New Hampshire, Durham
Gattu, M., B.S., Ph.D., Smithkline Beecham, King of Prussia,
Pennsylvania
Goodman, M., B.S. Ph.D., Wittenberg University, Springfield,
Ohio
SEMINARS
Altschul, S., National Institutes of Health, Bethesda,
Maryland: Statistics of sequence similarity scores. Statistics
of patterns and profiles.
Cherry, M., Stanford University, California: Genome databas-
es and genome informatics. The gene ontology project.
Gaasterland, T., The Rockefeller University, New York, New
York: The whole genome perspective.
Henikoff, S., Fred Hutchinson Cancer Research Center,
Seattle, Washington: Protein family databases. Blocks-
based methods for finding distant relationships.
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Joubert, F., B.Sc., Ph.D., University of Pretoria, South Africa
Lin, D., B.S., Ph.D., Brookhaven National Laboratory, Upton,
New York
Lopez-Jimenez, N., B.A., Ph.D., National Institutes of Health,
Rockville, Maryland
Lue, N., B.S., M.D., Ph.D., Cornell University, New York, New
York
Martin, S., B.S., M.S., National Resources Canada,
Fredericton, Canada
McMahan, L., B.A., M.S., Montclair State University,
Bloomfield, New Jersey
Schmidt, T., B.S., Ph.D., Michigan State University, East
Lansing
Stajich, J., B.S., Duke University Medical Center, Durham,
North Carolina
Temple, B., B.S., Ph.D., University of North Carolina, Chapel
Hill
Zhang, L., B.S., University of California, Irvine
Zhang, Y., B.S., M.A., Fox Chase Cancer Center,
Philadelphia, Pennsylvania
Pearson, W., University of Virginia, Charlottesville:
Introduction and overview. Protein evolution-biology.
Algorithms for pairwise sequence comparison. Multiple
sequence comparison with hidden Markov models.
Stormo, G., Washington University Medical School, St. Louis,
Missouri: Identifying sites in unaligned sequences.
Smith, R., Bioinformatics, King of Prussia, Pennsylvania:
Panel discussion/review: Blocks, HMMs, and motifs-Which
tool when? Introduction to multiple sequence comparison.
Phage Display of Combinatorial Antibody Libraries
November 7-20
INSTRUCTORS C.F. Barbas, The Scripps Research Institute, La Jolla, California
D.L. Siegel, University of Pennsylvania Medical Center, Philadelphia
G.J. Silverman, University of California, San Diego, La Jolla
ASSISTANTS R. Fuller, The Scripps Research Institute, La Jolla, California
C. Goodyear, University of California, San Diego, La Jolla
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This intensive laboratory/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and selection of desired antibodies from the library. Students learned the theoretical and prac-
tical aspects of constructing combinatorial libraries from immune and nonimmune sources as well as
the construction of synthetic antibody libraries. Antibodies were selected from the library by panning.
Production, purification, and characterization of Fab fragments expressed in E. coli were also covered.
The lecture series, presented by a number of invited speakers, emphasized the PCR of
immunoglobulin genes, the biology of filamentous phage and the utility of surface expression libraries,
expression of antibodies in E. coli and mammalian cells, antibody structure and function, catalytic anti-
bodies, directed protein evolution, retroviral and cell display libraries, the immunobiology of antibody
activity, and recent results on the use of antibodies in therapy. The theory and practical implications for
selection from phage displayed libraries of random peptides, cDNA products, and semisynthetic pro-
teins were also explored.
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PARTICIPANTS
Azzazy, H., Ph.D., University of Maryland School of Medicine,
Baltimore
Coronella, J., Ph.D., University of Arizona, Tucson
Crawford, J., Ph.D., Paradigm Genetics, Inc., Research
Triangle Park, North Carolina
Drier, E., Ph.D., Cold Spring Harbor Labortory
Enright, J., Ph.D., Dyax Corp., Cambridge, Massachusetts
Eroglu, C., B.S., M.S., European Molecular Biology
Laboratory, Heidelberg, Germany
Evans, T., M.D., University of Rochester, New York
Hopf, C., Ph.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
James, W., Ph.D., Intergen Corporation, Gaithersburg,
Maryland
SEMINARS
Arap, W., University of Texas, M.D. Anderson Cancer Center,
Houston: In vivo panning.
Lowan, H., Genentech, Inc., S. San Francisco, California:
SAR of peptides using phage.
McHeyzer-Williams, M., Duke University Medical Center,
Durham, North Carolina: Immunobiology of T-B cell
responses.
Nolan, G., Stanford University School of Medicine, California:
Retroviral libraries.
The Laboratory would like to acknowledge the generosity
reagents to the various courses:
5 Prime-3 Prime
ALA Scientific Instruments, Inc.
Agilent Technologies, Inc.
Ambion
Amersham Pharmacia Bio-
tech, Inc.
A.M.P.I.
Amresco
Applied Precision Inc.
Applied Scientific Instrumen-
tation, Inc.
Astro-Med
Axon Instruments
Becton Dickinson Labware
Bioptechs
Bio-Rad Laboratories
BioVision Technologies
Boehringer Mannheim Corp.
Brinkmann Instruments
Calbiochem-Novabiochem
Carl Zeiss, Inc.
Cell & Molecular Technologies,
Inc.
Chroma Technology Corp.
Codonics Inc.
Coherent Laser
Cora Styles Needles and
Blocks
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Corning Costar Corp.
Corning Inc.
Dagan Corp.
David Kopf Instruments
Delaware Diamond Knives
Denville Scientific Inc.
Diagnostic Instruments,
Inc.
Drummond Scientific Co.
DuPont NEN
Dynal
Dynex
E.Y. Laborotories, Inc.
Eastman Kodak Co.
Epicentre Technologies
Eppendorf Scientific
Fisher Scientific
FMC Corp.
Fotodyne
General Valve
Gibco/Life Technologies
HVS Image Ltd
Hamamatsu Photonic
Systems
Hampton Research
Harvard Apparatus, Inc.
Hitachi Denski America LTD.
Improvision Inc.
Mahler, E., B.S., Institute for Genetic Engineering and
Molecular Biology Research, Capital Federal, Argentina
Maranhao, A., M.S., B.S., Universidade de Braseilia, Braseila,
Brazil
Messmer, B., Ph.D., North Shore University Hospital,
Manhasset, New York
Neethling, F., Ph.D., Oklahoma State University, Stillwater
Panousis, C., Ph.D., Ludwig Institute for Cancer Research,
Melbourne, Victoria, Australia
Sehgal, D., Ph.D., National Institutes of Health, Bethesda,
Maryland
Xiao, H., Ph.D., National Institutes of Health, Bethesda,
Maryland
Noren, C., New England Biolabs, Beverly, Massachusetts:
Phage peptide libraries: The PhD for peptides.
Rader, C., The Scripps Research Institute, La Jolla, California:
Antibody humanization with phage display.
Webster, R., Duke Univeresity, Durham, North Carolina: The
biology of filamentous phage.
Wilson, I., The Scripps Research Institute, La Jolla, California:
Structural biology of the immune system.
of the following companies who loaned equipment and
Improvision-Image Processing
and Vision Co. Ltd.
Instrutech
Invitrogen Corp.
Jackson Immunoresearch
Laboratories
Jouan, Inc.
Leica Microsystems, Inc.
Med Associates
Micro Video Instruments
Millipore
MJ Research, Inc.
Modulation Optics, Inc.
Molecular Devices Corp.
Molecular Dynamics
Molecular Probes
Nalge Nunc International
Narishige International USA,
Inc.
NEN Life Science Products
New England Biolabs
Nikon Inc.
Novagen
Novex
Olympus America, Inc.
Operon Technologies Inc.
Optronics Engineering
Pel-Freez Biologicals
Perkin-Elmer Applied
Biosystems
PerSeptive Biosystems
Polysciences
Promega Corp.
Qiagen Inc.
Robbins Scientific Corp.
Roper Scientific
SD Instruments
Santa Cruz Biotechnology Inc.
Savant Instruments
Scanalytics Inc.
Schleicher & Schuell
Sigma-Aldrich
Sony Medical Systems
Specialty Media
Spectra-Physics Lasers, Inc.
Statsoft
Stratagene
Sutter Instruments
Technical Manufacturing Corp.
The Math Works Inc.
Universal Imaging Corp.
Upstate Biotechnology Inc.
Vector Laboratories
Vincent Associates
VWR Scientific Products
Warner Instruments
SEMINARS
Invited Speaker Program
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
latest findings on a weekly basis. These seminars keep the CSHL staff current on the latest develop-
ments and broaden their perspectives. Graduate students and postdoctoral fellows meet with the sem-
inar speakers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas
in an informal setting.
January
Dr. Rakesh Jain, Harvard University. A journey inside the world
of solid tumors. (Host: Michael Hengartner)
Dr. Sandra Schmid, Scripps Research Institute. Dynamin: A
master regulator of receptor-mediated endocytosis. (Host:
Linda Van Aelst)
Dr. Nancy Hopkins, Massachusetts Institute of Technology.
Large-scale insertional mutagenesis screen in zebrafish.
(Host: Terri Grodzicker)
Dr. Joan Massague, Memorial Sloan-Kettering Cancer Center.
The TGF-13/SMAD signaling system. (Host: Nick Tonks)
Dr. Larry Zipursky, University of California, Los Angeles School
of Medicine. Axon guidance and targeting in the Drosophila
visual system. (Host: Hollis Cline)
February
Dr. Tyler Jacks, HHMI/Massachusetts Institute of Technology,
Department of Biology. Modeling cancer in the mouse.
(Host: Scott Lowe)
Dr. Cori Bargmann, HHMI/University of California, San
Francisco. Signaling pathways in olfaction and olfactory
development. (Host: Terri Grodzicker)
Dr. Carol Prives, Columbia University. The p53 tumor suppres-
sor protein. (Host: Terri Grodzicker)
Dr. Eric Gouaux, Columbia University. Structure and function
of glutamate receptors. (Host: Leemor Joshua-Tor)
March
Dr. Andrew Belmont, University of Illinois, Urbana-Champaign.
Large-scale chromatin structure and dynamics. (Host:
Tatsuya Hirano)
Dr. Richard Losick, Harvard University. Asymmetry and cell
fate. (Host: Terri Grodzicker)
Dr. Harold Noller, University of California, Santa Cruz. X-ray
structure of functional complexes of the 70s ribosome.
(Host: Winship Herr)
Dr. Stephen J. [Hedge, Baylor College of Medicine. The DNA
damage response in mammals. (Host: Terri Grodzicker)
April
Dr. Doug Rees, HHMI/California Institute of Technology.
Structural studies of a gated mechanosensitive channel.
(Host: Leemor Joshua-Tor)
Dr. Elaine Fuchs, University of Chicago. Beauty is skin deep:
Mechanisms of growth and differentiation in the skin. (Host:
David Spector)
October
Dr. Sandra Schmid, Scripps Research Institute. Dynamin
collars: More than meets the eye. (Host: Linda Van
Dr. Peter Mombaerts, The Rockefeller University. Targeting
olfaction. (Host: Zach Mainen)
November
Dr. Jackie Lees, Center for Cancer Research, Massachusetts
Institute of Technology. Role of the E2F transcription factors:
Proliferation or differentiation? (Host: Bruce Stillman)
Dr. Phil Benfey, New York University. Radial patterning in
Arabidopsis: Signaling inside out. (Host: David
Jackson)
Dr. Rick Fishel, Thomas Jefferson University, Kimmel Cancer
Institute. Mismatch repair and cancer: The mechanics of a
molecular switch. (Host: Scott Lowe)
December
Dr. Nancy Kanwisher, Massachusetts Institute of Technology.
Functional MRI investigations of human cortex: People,
places, and things. (Host: Zach Mainen)
Dr Larry Katz, Duke University Medical Center. Functional
architecture of mammalian olfaction. (Host: Dmitri
Chklovskii)
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In-House Seminar Program
Cold Spring Harbor In-House Seminars were initiated to provide a semiformal avenue for communica-
tion between the various research groups at the Laboratory. They are particularly useful for research
personnel who have recently joined the Laboratory. The seminars also afford a necessaryopportunity
for the graduate students and postgraduate staff to develop their skills in organizing, presenting, and
defending their research.
January
Michael Wig ler: Measuring gene copy fluctuations with
microarrays.
Julius Zhu (Malinow Laboratory): Gluamate receptor trafficking
and formation of functional synapses during early development.
Richard McCombie: Plant genome analysis.
Tohru Mizushima (Stillman Laboratory): Biochemical analysis
of initiation of DNA replication in eukaryotic cells.
February
Nouria Hernandez: Assembly of RNA polymerase II and Ill
transcription initiation complexes.
Dan Vaughn (Joshua-Tor Laboratory): The Apaf-1 CARD
structure: A Greek key to death-fold signaling in apoptosis.
Dan Hoeppner (Hengartner Laboratory): Breaking the pathway
to programmed cell death in C. elegans.
Alex Rai (Helfman Laboratory): Snapin is a ubiquitously expressed
phosphoprotein involved in intracellular vesicle transport.
March
Karel Svoboda: Experience-dependent plasticity in the neo-
cortex.
Scott Hammond (Harmon Laboratory): Some studies on the
mechanism of RNA interference.
Patrick Reilly (Herr Laboratory): Herpes simplex virus-host cell
interactions: Targeting the cell cycle.
Scott Lowe: p53 action in apoptosis and senescence.
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April
Grigori Enikolopov: Stem cells, nitric oxide, and differentiation.
Junjiro Horiuchi (Yin Laboratory): Phosphorylation regulates
CREB activity at multiple steps: Possible implications for
memory formation.
October
Jacek Skowronski: Nef functions and AIDS.
Jannik Andersen (Tonks Laboratory): Molecular basis for
recognition and dephosphorylation of the activation segment
of the insulin receptor by protein tyrosine phosphatase 1B.
November
David Spector: Visualization of gene activity in living cells.
Laura Schramm (Hernandez Laboratory): Different human TFII-
IB activities direct RNA polymerase Ill transcription from the
TATA-containing and TATA-less promoters.
December
Ana Losada (Hirano Laboratory): Sister chromatid cohesion in
vertebrate cells.
Luca Cartegni (Krainer Laboratory): Haystacks, needles, and
genetic diseases: Designing chimeric molecules that pro-
mote exon inclusion.
Yi Zhong: A fly model of Alzheimer's disease? Insights from
studies of presenilin function.
BANBURY CENTER

BANBURY CENTER
DIRECTOR'S REPORT
In 2000, there were 25 meetings at Banbury Center, exceeding by two the 1999 record. Laboratory
staff used Banbury Center for 11 meetings, and a notable addition to the Banbury schedule was the
first of the Topics in Biology courses of the Watson School of Biological Sciences. There were the usual
five Summer Courses, and we made the Center available to community groups on seven occasions.
More than 700 visitors came to Banbury in 2000, and the geographical distribution of the partici-
pants was much the same as in previous years; 80% of participants came from the United States, and
although New York, California, and Massachusetts accounted for 44% of the participants, 39 U.S.
states were represented. There were 95 participants from Europe, the majority coming from the United
Kingdom.
Eugenics on the Web
This, a joint project between the DNA Learning Center and Banbury Center, completed its first stage
in January, 2000. Our Advisory Board came to Banbury to review and approve the final version of the
site before we went to the National Human Genome Research Institute for authority to release it to the
public. The Advisory Board was, as always, constructively critical and made valuable suggestions. They
approved the site, and we presented them with a certificate thanking them for their help. We have
obtained a second round of funding to expand the site further, by increasing the number of images and
by extending it to include European eugenics.
Neuroscience
A significant feature of the 2000 program was the large number of neuroscience meetings. This came
about partly by chance, but it also reflects the increasing role that neuroscience now has in the research
life of Cold Spring Harbor Laboratory. Banbury Center is well known in the worlds of molecular biolo-
gy, molecular genetics, and human genetics, and I hope that neuroscience meetings like those held
this year will establish the Center's reputation in the neuroscience world as well.
The Structure, Mechanism, and Function of CaMKII meeting was organized by Hollis Cline (Cold
Spring Harbor Laboratory) and John E. Lisman (Brandeis University) and funded by the Marie H.
Robertson Memorial Fund. CaMKII is an enzyme that acts as a molecular switch at synapses, and it
may have a key role in synaptic plasticity and memory. Interfering with CaMKII function disrupts devel-
opmental processes and learning itself, making CaMKII a leading candidate as the molecular storage
molecule for memory. Participants in this meeting study CaMKII from a variety of perspectives: its mol-
ecular structure and intramolecular reactions, its presynaptic and postsynaptic targets, and its activi-
ties at the synapse. The goal of the meeting was to examine how these properties might account for
its role in memory.
Toward Animal Models of Attention and Consciousness, organized by Christof Koch (California
Institute of Technology) and Anthony Zador (Cold Spring Harbor Laboratory) and funded by The Swartz
Initiative for Computational Neuroscience, dealt with the fascinating topics of visual selective attention
and visual consciousness. These have been treated within the realm of philosophy, but new molecular
and imaging tools have led many to argue that consciousness can now be approached in an empiri-
cal and reductionist manner. This meeting brought together neuroscientists who are undertaking this
task through electrophysiological and functional MRI analyses of the visual system, studies of the visu-
al psychophysics of attention, and the development of animal model systems to study consciousness.
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Meier House provides accommodations for meeting participants at Banbury Center.
Sebastian Seung (Massachusetts Institute of Technology) and David Tank (Bell Laboratories, Lucent
Technologies) organized the meeting Persistent Neural Activity, funded by grants from the Alfred P.
Sloan Foundation and The Swartz Initiative for Computational Neuroscience. "Persistent neural activi-
ty" is evoked by a short sensory stimulus, but the response persists for as long as many seconds and
is believed to be involved in establishing short-term memory. This meeting was designed to examine
the question: By what physiological mechanisms does a transient input cause a persistent change in
neural activity? New findings, both physiological and theoretical, made this the right time to bring
together researchers using different techniques, different animals, and different models to survey the
field and identify emerging questions for further research.
The idea of neural networks and their application in computing began in the mid 1980s. Neural
Networks and Cognition was organized by Anthony Zador (Cold Spring Harbor Laboratory), Zachary
Mainen (Cold Spring Harbor Laboratory), and Alex Pouget (University of Rochester) to discuss the cur-
rent theories of network-level computation in the brain. The organizers brought together researchers in
statistical learning theory, cognitive neuroscience, and other relevant areas. The meeting was funded by
Handspring Inc., and we were very pleased that Jeff Hawkins-developer of the neural network-based
handwriting recognition system for the Palm Pilot and cofounder of Handspring Inc.-participated.
Natural Stimulus Statistics was organized by Simon Laughlin (University of Cambridge) and Pamela
Reinagel (Harvard Medical School) and funded by the Cold Spring Harbor Laboratory Corporate
Sponsor Program. Sensory neurons receive signals from the external world and transmit information
about them to the brain. It has been suggested that a major function of the sensory neurons is to
remove unnecessary information; optimal neural codes would enable peripheral cells to send vastly
more information to the brain. The meeting brought together an eclectic group of scientists with back-
grounds in physics, mathematics, and neurophysiology, with the goal of drawing up a list of key prob-
lems that need immediate attention.
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Studies on the molecular basis of learning and memory in vivo are making use of mice with muta-
tions in specific genes. But to do these studies properly requires careful and standardized assess-
ments of behavior, especially if correlates are to be established with human clinical conditions. Mouse
Behavioral Phenotyping was supported by the National Institute for Mental Health to provide an oppor-
tunity for investigators being funded under a new program to meet and discuss their findings.
Organized by Michela Gallagher (Johns Hopkins University), the meeting was intended to assist exist-
ing collaborations and to promote further collaborative activities.
A large inter-institutional project is being planned for research on Signaling Network ControlCell
Interactions. To be funded by the National Institutes of Health, the project involves several institutes,
including Cold Spring Harbor Laboratory, scattered throughout the country. A planning meeting for the
project was organized by Ravi lyengar (Mount Sinai School of Medicine), and key investigators came
to Banbury for 2 days of very hard work, away from the distractions at their own institutions.
Biological Studies
Ten years ago, Irwin Fridovich (Duke University) and John G. Scandalios (North Carolina State
University) organized a meeting on free oxygen radicals. In 2000, they returned and organized a meet-
ing on the Molecular Biology of Oxidative Stress, funded by the Cold Spring Harbor Laboratory
Corporate Sponsor Program. The main change in the intervening period has been the application of
molecular approaches, with the cloning and characterization of many of the antioxidant defense genes,
together with the elucidation of stress response triggers and pathways. An interdisciplinary group of
experts concerned with the basic molecular biology and genetics of oxidative stress came to Banbury
to discuss common mechanisms operating across evolutionary lines and to set future research goals.
We have come some way since Bishop Wilberforce asked T.H. Huxley whether it was on his grand-
father's or his grandmother's side that ape ancestry was to be found. But quite what that ape ances-
try is-what the genetic relationships are between the great apes, and how these are reflected in dif-
ferences in phenotypes-is still uncertain. Great Apes: Phenotypes and Genotypes was organized by
Aravinda Chakravarti (Case Western Reserve University), Svante Paabo (Max-Planck Institute for
Evolutionary Anthropology), and Jan Witkowski (Cold Spring Harbor Laboratory) and funded by the
Cold Spring Harbor Laboratory Corporate Sponsor Program. The meeting reviewed phenotypic differ-
ences between the great apes and what is known currently of the genetic and genomic differences
between these species and discussed the feasibility of an ape genome project.
Apoptosis is a conserved program used by organisms to get rid of cells that are in excess, in the
way, or potentially dangerous. Although cell killing is being studied in detail, far less is known of the
subsequent steps of Getting Rid of the Bodies. Organized by Giovanna Chimini (INSERM-CNRS,
Marseille, France) and Michael Hengartner (Cold Spring Harbor Laboratory), this meeting examined
questions such as: What are the "eat-me" signals, and how are these signals generated by the apop-
totic cells? What are the "eat-me" receptors, and what are the signaling pathways downstream from
them? What is different between an apoptotic and a necrotic cell corpse? The meeting was funded by
the Cold Spring Harbor Laboratory Corporate Sponsor Program.
Two meetings were an interesting combination of fundamental research and applied biology.
Mammalian Cloning: Biology and Practice was held 3 years after the cloning of Dolly to review critically
the current status of cloning of cows, pigs, mice, and goats. Organized by Neal First (University of
Wisconsin), Peter Mombaerts (The Rockefeller University), and Jan Witkowski (Cold Spring Harbor
Laboratory), the meeting was funded by the Alfred P. Sloan Foundation. Questions examined includ-
ed: Why is it that there is such a high failure rate? What is known of the biology underlying mammalian
cloning? What can the biology tell us about the best strategies for cloning? Participants came from
academic institutions and from companies, and included pioneers of mammalian cloning, Steen
Willadsen, Ian Wilmut, and Keith Campbell.
The second of these two meetings was RNA Silencing: Functions, Mechanisms, and Applications,
organized by David Baulcombe (John Innes Centre) and Greg Hannon (Cold Spring Harbor Laboratory)
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and funded by the Cold Spring Harbor Laboratory Corporate Sponsor Program. RNA silencing is a
remarkable phenomenon in which overexpression of an RNA can suppress expression of a gene.
Originally discovered in plants, it has become clear that the phenomenon is ubiquitous in eukaryotes.
This was the first meeting that made a deliberate effort to assemble researchers working on different
aspects of RNA silencing in different organisms. This was an especially timely topic, producing a most
interesting and lively meeting.
Regulation and Function of Heat Shock Proteins was a meeting organized by Betty Craig (University
of Wisconsin), Carol Gross (University of California, San Francisco), and Rick Morimoto (Northwestern
University) for friends and colleagues of Professor Takashi Yura. Professor Yura, who made significant
contributions to the field, will be retiring from the HSP Institute in 2001. It was fitting that his retirement
was marked by holding a scientific meeting that covered topics such as protein folding and the regu-
lation of the heat shock response.
Plant Biology
Plants were featured in a number of meetings, but two meetings in 2000 were largely devoted to plant
science. For example, although sugar production through photosynthesis is the most important activ-
ity in plant life, sugars have vital roles in all organisms. Mark Johnston (Washington University Medical
School), Jenn Sheen (Massachusetts General Hospital), and Mark Stitt (University of Heidelberg) orga-
nized the meeting Sugar Sensing and Signaling in Plants and Other Organisms, funded by the Cold
Spring Harbor Laboratory Corporate Sponsor Program. The purpose of the meeting was to highlight
recent advances in our understanding of the molecular mechanisms underlying sugar sensing and sig-
naling. Although the meeting focused on plants, research on other organisms-bacteria, yeast, mam-
mals-was included. As with RNA Silencing, this was the first meeting to include such a diverse set of
researches on sugar sensing.
Robertson House also provides housing accommodations at Banbury Center.
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One of the great triumphs of the genome world came in December when the complete sequence
of Arabidopsis thaliana was published. David Luke III (former Chairman of the Laboratory's Board of
Trustees) and Westvaco, Inc. have long been supporters of the Arabidopsis genome project, and it was
a particular pleasure that Mr. Luke attended the meeting The Application of Arabidopsis Genomics to
Forestry and Other Complex Plant Systems, held the week before the sequence was published. The
meeting was organized by Robert Martienssen (Cold Spring Harbor Laboratory) and Ronald Sederoff
(North Carolina State University) and funded by the Cold Spring Harbor Laboratory Corporate Sponsor
Program. Although completion of the Arabidopsis genome sequence promises to revolutionize the
study of all plants, its application to the biology of complex plant genomes-such as those of forest
trees-remains a significant challenge. This meeting took up this challenge and concluded with a dis-
cussion of the benefits that would come from sequencing a tree genome.
Bioinformatics
Having large amounts of sequence data will not be helpful if the information cannot be integrated into
the existing body of biological knowledge. The Gene Ontology (GO) Consortium has recognized that a
major obstacle to such biology-wide integration of information is the absence of a unified vocabulary
that is recognized across the databases devoted to particular organisms. The GO is attempting to
derive such a vocabulary and nomenclature. Michael Ashburner (European Bioinformatics Institute,
Cambridge) organized Gene Ontology Annotation and the Human Genome, a small but very intensive
workshop to discuss how to extend the GO concept to the human genome.
Human Genetic Disorders
Banbury Center continued its 17-year tradition of having meetings on human genetic disorders. The
first in 2000 was on Therapeutic Approaches in Mouse Models of ALS, organized by M. Flint Beal (Weill
Medical College, Cornell University) and Don W. Cleveland (University of California, San Diego). Mouse
models of human genetic disorders are important for exploring the molecular pathology of diseases and
for developing therapies, and this meeting focused on current strategies for testing therapeutic
approaches in mouse models of amyotrophic lateral sclerosis (ALS) and other human neurodegenera-
tive diseases. Topics that were covered included a survey of available models, potential therapeutic
agents, and methods of drug delivery. The meeting was funded by the Amyotrophic Lateral Sclerosis
Association.
A most significant advance in understanding the Fragile X syndrome came with the identification of the
protein, FMRP. The title of the meeting FMRP: What Does It Do? described exactly the goals of the meet-
ing organized by William Greenough (University of Illinois) and David Nelson (Baylor College of Medicine)
and funded by the FRAXA Research Foundation. There are fascinating reports of the localization of FMRP
to the dendrites of neurons, suggesting that the absence of FMRP leads to impaired communications
between neurons, which leads to mental retardation. As there is now a broad range of scientific expertise
involved in research on Fragile X-biochemistry, molecular biology, neuroimaging, and behavior-the
meeting provided a forum for scientists working in these different areas to meet and interact.
Pathogens
In 1991, Banbury Center held its first meeting on Lyme Disease. At that time, Lyme Disease counted
as a newly emerging pathogen, the causative agent (the spirochaete Borrelia burgdofen) having been
identified in the early 1980s. The West Nile virus, another previously unknown pathogen, appeared in
the New York area in 1999. So, the meeting Strategies for Identification and Characterization of
Unknown Pathogens, organized by Benjamin Luft (SUNY, Stony Brook), Steven Schutzer (UMDNJ/New
Jersey Medical School), and Suzanne Vernon (Centers for Disease Control) and funded by the Centers
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for Disease Control, was very timely. The meeting brought together scientists from diverse backgrounds
including evolutionary and molecular biology, biochemistry, immunology, epidemiology, and infectious
diseases to discuss the utilization of leading-edge biotechnology for the recognition of novel
pathogens.
Newly emerging pathogens afflict not only human beings, but also livestock and crops. The
Agricultural Research Service of the USDA funded a discussion meeting, Meeting the Challenge of
Infectious Diseases in the 21st Century (organized by Roger Breeze, USDA), to help define a national
capacity and strategy for dealing with unresolved issues in infectious diseases of animals and plants
and to prepare for meeting all new and emerging threats, of which biological terrorism is the latest. The
meeting focused on science rather than policy, considering, for example, the potential impact of micro-
bial and host genomic information.
Vaccines
One of the most effective ways of combating pathogens is through vaccination, but vaccines with a lim-
ited market will not be developed by industry. Social Venture Capital for Neglected Vaccines: Creating
Successful Alliances explored alternative sources of funding for vaccine development. The organizer was
Melinda Moree (PATH/Malaria Vaccine Initiative), with co-chairs Regina Rabinovich (PATH/Malaria
Vaccine Initiative) and Philip K. Russell (The Albert B. Sabin Vaccine Institute). The meeting was funded
by the Albert B. Sabin Vaccine Institute, Inc., through a grant from the Bill and Melinda Gates Foundation.
It was expected that the discussions would assist public sector vaccine programs by developing strate-
gies for managing partnerships with industry and dealing with intellectual property and other contractu-
al commitments to assure the availability of neglected vaccines for the developing world.
The J.P. Morgan and Cold Spring Harbor Laboratory Executives' Meeting
This was the 15th in the series of meetings for senior executives in the pharmaceutical, biotechnology,
and financial worlds, and for the seventh year, we are very grateful to Sandy Warner and David Deming
of J.P. Morgan, Inc., for their continuing support. These meetings are always remarkable occasions, but
this year's meeting was exceptional even by past standards. Entitled Human Intelligence and
Consciousness, we drew upon an wonderful roster of speakers. Oliver Sacks began the meeting by
describing extraordinary autistic savants. Other speakers were Howard Gardner, Irene Pepperberg,
Charles Murray, Stephen Pinker, Vilayanur Ramachandran, and Rodney Brooks.
The President's Council Meeting
Although most activities associated with James Watson's President's Council meeting take place on
the main campus, the opening talk is held at Banbury and is followed by dinner at Robertson House.
The topic for this year's meeting was The Dog and Its Genetics: Breeds, Evolution & Behavior, an
unbeatable combination of cutting-edge genetic research and humanity's closest friend. Our speaker
on Friday evening was Roger Caras, known for his encyclopedic knowledge of dogs that he puts to
good use in his role of Master of Ceremonies at the annual Westminster Club Show. Sitting on a stool
like a story teller, Mr. Caras gave a spell-binding talk on the special relationship between human beings
and animals, especially dogs.
Watson School of Biological Sciences-Topics in Biology
The Watson School of Biological Sciences has a faculty with remarkably diverse interests, but there are
some areas of biology in which we are lacking deep expertise. To ensure that our students receive
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instruction in these areas, we have instituted a special Topics in Biology course, to be held each spring
at the Banbury Center. The students are taken away from the laboratory bench, enabling them to
devote themselves to a concentrated program. For 2000, the selected topic was immunology, and we
were very fortunate to have Hidde Ploegh from Harvard Medical School come to teach the week-long
course. Hidde is an inspiring teacher, and the course was a success beyond our already high expec-
tations. The topic for 2001 is Evolution.
Other Meetings
Several Laboratory science groups came to Banbury for review and planning meetings, as did the DNA
Learning Center and the Cold Spring Harbor Laboratory Press. As usual, we made the Center avail-
able to a small number of local community groups, notably Lloyd Harbor Village, Cold Spring Harbor
School District, and Holiday House.
Funding
The Banbury Center and the scientists who participated in meetings here are very grateful for the gen-
erosity of all those institutions that provided support for the Banbury program. Foremost among these
was the Cold Spring Harbor Laboratory Corporate Sponsor Program, which provided funds for six
meetings. Federal funding came from five of the National Institutes of Health (NHGRI, NICHHD,
NIGMS, NIMH, NIDCD); the Centers for Disease Control; and the Agricultural Research Service (United
States Department of Agriculture). Nonfederal support came from the ALS Association; the FRAXA
Research Foundation; Handspring Inc.; the Marie H. Robertson Memorial Fund for Neurobiology; the
Albert B. Sabin Vaccine Institute; the Alfred P. Sloan Foundation; and The Swartz Initiative for
Computational Neuroscience.
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Once again, Banbury could not have had such a successful year without the invaluable contributions
of Bea To liver, Ellie Sidorenko, and Katya Davey to the operation of the Center. The Meetings Office
has worked with us on the increasingly difficult task of interleaving the Grace Auditorium and Banbury
Center meetings, the Audiovisual Department has kept presentations running smoothly, and House-
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estate looking beautiful, contributing to the special ambience of the Center. Finally, the meetings
depend on the enthusiasm and work of the organizers and the contributions made by all participants.
Jan Witkowski
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MEETINGS
Fourth Meeting of the Editorial Advisory Panel: Digital Image
Archive on the American Eugenics Movement
January 28-30
FUNDED BY National Human Genome Research Institute, NIH
ARRANGED BY D. Mick los, DNA Learning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1 SESSION 3
J.A. Witkowski, Banbury Center, Cold Spring Harbor Labora-
tory: Welcome, general instructions, and hospitality.
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory: Workshop objectives and other matters.
S. Lauter and M. Christensen, DNA Learning Center, Cold
Spring Harbor Laboratory: Introduction to the new inter-
face.
Computer Work: Reactions to the site and review images in
assigned topics.
SESSION 2
Review topic narratives, draft new topic narratives, and draft
essay on "European connections."
Discuss NIH restriction on images.
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Finalize list of essential items to be completed before open-
ing the site and those that can be completed after opening
the site.
Resolutions concerning NIH restriction and opening the site.
Future developments.
S. Lauter, M. Christensen, G. Allen, D. Mick los
Therapeutic Approaches in Mouse Models of ALS
February 13-16
FUNDED BY Amyotrophic Lateral Sclerosis Association
ARRANGED BY M.F. Beal, Weill Medical College, Cornell University, New York
D.W. Cleveland, University of California, San Diego
Introduction:
R.V. Abendroth, The ALS Association, Milwaukee, Wisconsin
SESSION 1: Pathogenesis of ALS
Chairperson: M.F. Beal, Weill Medical College,Cornell University,
R.H. Brown, Massachusetts General Hospital, Charlestown:
Overview of theories of mechanisms of disease.
D.W. Cleveland, Ludwig Institute for Cancer Research,
University of California, San Diego: Mechanisms of neuronal
death in ALS: Axonal strangulation, catalysis by copper,
protein aggregates, and chronic caspase activation.
M. Gurney, Pharmacia & Upjohn, Kalamazoo, Michigan:
Gene expression profiling in FALS transgenic mice.
New York
J.A. Johnston, Pharmacia & Upjohn, Kalamazoo, Michigan:
Aggregation of mutant SOD1 is an early event in the patho-
genesis of ALS motoneuron disease.
D.R. Borchelt, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Studies in transgenic mice.
J. Rothstein, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Overview of therapeutics in mice and
men.
SESSION 2: Therapeutics in ALS Mice I
Chairperson: D.W. Cleveland, Ludwig Institute for Cancer Research, University of
California, San Diego
S.E. Przedborski, Columbia University, New York: Programmed
cell death in ALS.
J.P. Crow, University of Alabama at Birmingham: Pharma-
cologic intervention at onset: Intercepting the mediators of
toxicity?
R.M. Friedlander, Brigham and Women's Hospital, Boston,
Massachusetts: Caspase inhibition in the treatment of
ALS.
M.F. Beal, Weill Medical College, Cornell University, New
York: Therapeutics with creatine.
S.H. Appel, Baylor College of Medicine, Houston, Texas:
Calcium alteration in motor neuron injury: Protective effects
of parvalbumin.
E.Y. Snyder, Children's Hospital, Harvard Medical School,
Boston, Massachusetts: Potential role of neural stem cells
in motoneuron disease.
A. McMahon, D. Cleveland
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SESSION 3: Therapeutics in ALS Mice II
Chairperson: R.H. Brown, Massachusetts General Hospital, Charlestown
L.A. Shinobu, Massachusetts General Hospital, Boston:
Does overexpression of heat shock protein 70 alter the nat-
ural history of the G93A mouse model of ALS?
SESSION 4: Approaches Beyond ALS I
Chairperson: R.H. Brown, Massachusetts General Hospital, Charlestown
J. Morton, University of Cambridge, United Kingdom: How
good is the medicine?: Measuring clinical improvements in
mice.
G.A. Cox, The Jackson Laboratory, Bar Harbor, Maine:
Tissue-specific transgenic rescue in the neuromuscular
degeneration (nmd) mouse.
SESSION 5: Approaches Beyond ALS II
Chairperson: A.P. McMahon, Harvard University, Cambridge,
H. Mitsumoto, ALS Center, Columbia-Presbyterian Medical
Center, New York, New York: An approach in a natural
motor neuron disease (VVobbler mouse).
K. Duff, Nathan Kline Institute, Orangeburg, New York: MRI
as a tool in the assessment of transgenic models of neu-
rodegenerative disease.
S.M. Hersch, Emory University School of Medicine, Atlanta,
Georgia: Neuropathology in Huntington's disease trans-
genic models.
N.L. Heintz, HHMI, The Rockefeller University, New York: A
novel pathway for glutamate receptor-mediated neurore-
generation.
M. Beaulieu, Montreal General Hospital Research Institute,
Canada: Transgenic mice overexpressing peripherin: A new
mouse model of motor neuron disease.
Massachusetts
SESSION 6: Oxidative Injury and Copper Metabolism
Chairperson: S.H. Appel, Baylor College of Medicine, Houston,
A.G. Kato, Centre Medical Universitaire, Geneva, Switzerland:
Overview of the pmn mouse model for studies on ALS.
M. Cudkowicz, Massachusetts General Hospital, Boston:
Effects of altered levels of GSHPx in the ALS on disease
phenotype in the ALS mouse model (and other therapeutic
studies).
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W.T. Dauer, Neurological Institute of New York, New York:
Regulatable animal models of neurological disease.
P. Wong, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Neurodegenerative disease: Lessons
from transgenic models.
T Williamson, Trophos S.A., Marseille, France: Purified neu-
ronal cultures from mouse models: High-throughput
screening on the cells at risk.
Texas
Z. Xu, University of Massachusetts Medical School,
Worcester: Therapeutic effects of creatine and SOD1 cata-
lase mimetics in a mouse model of ALS.
R.J. Ferrante, Bedford VA Medical Center, Massachusetts:
Mechanisms of neurodegeneration and therapeutic inter-
vention in ALS.
Molecular Biology of Oxidative Stress
March 5-8
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J.G. Scandalios, North Carolina State University, Raleigh
I. Fridovich, Duke University Medical Center, Durham, North Carolina
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
J.G. Scandalios, North Carolina State University, Raleigh
SESSION 1: Antioxidant Gene Structure, Regulation, and Expression (Prokaryotes)
Chairperson: D. Touati, Institut Jacques Monod, Paris, France
S.S. Wallace, University of Vermont, Burlington: Repair of Carolina: Sugars as target for 02.
oxidative DNA base lesions. J. Imlay, University of Illinois, Urbana: Genetics and physiol-
D. Touati, Institut Jacques Monod, Paris, France: Bacterial ogy of iron-sulfur-cluster damage and repair in E. coll.
superoxide dismutases. I. Fita, CID, Council of Higher Scientific Investigation,
P.C. Loewen, University of Manitoba, Canada: Structure and Barcelona, Spain: Structure-function relationships of heme
function of bacterial catalases. catalases.
I. Fridovich, Duke University Medical Center, Durham, North
SESSION 2: Antioxidant Gene Structure, Regulation, and Expression (Eukaryotes)
Chairperson: I. Fridovich, Duke University Medical Center, Durham, North Carolina
E.B. Gra Ila, University of California, Los Angeles: Iron and
oxidative stress in yeast.
J.L. Pinkham, University of Massachusetts, Amherst: A single
site in the promoter of the yeast SOD2 gene mediates
stress and heme-regulated transcription.
J.G. Scandalios, North Carolina State University, Raleigh:
Antioxidant genes: Structure, regulation, and expression in
response to oxidative stress.
W. Orr, D. Touati, N. Cole, J. Scandalios
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H. Ruis, Institute of Biochemistry and Molecular Cell
Biology, Vienna, Austria: Nuclear protein transport in
stress signaling from the cellular environment to the nucle-
us.
L.M. Guan, North Carolina State University, Raleigh:
Regulation of maize antioxidant catalase genes in response
to environmental stress.
A.J. Slusarenko, Institut fuer Biologie III, Aachen, Germany:
Role of reactive oxygen intermediates in the resistance of
Arabidopsis to infection.
SESSION 3: Signal Perception and Transcriptional Regulation
Chairperson: J.G. Scandalios, North Carolina State University, Raleigh
G. Storz, NICHD, NIH, Bethesda, Maryland: The redox-sensi-
tive OxyR transcription factor.
S.W. Ryter, University of Southern Illinois School of Medicine,
Springfield: Heme metabolism and oxidative stress.
R. Kahl, University of Dusseldorf, Germany: Regulation of
antioxidant enzymes.
F.C. Fang, University of Colorado Health Sciences Center,
Denver: Subversion of the NADPH phagocyte oxidase by
Salmonella.
C. Richter, ETH Zentrum, Zurich, Switzerland: Nitric oxide
and peroxynitrite in mitochondria.
N. Smirnoff, University of Exeter, United Kingdom: The
metabolism and function of ascorbic acid in plants.
A. Puga, University of Cincinnati Medical Center, Ohio: The
Aryl hydrocarbon receptor: An environmental sensor that
signals oxidative stress and cell cycle arrest.
SESSION 4: Oxidative Stress and the Aging Process
Chairperson: N.J. Holbrook, National Institute on Aging, NIH, Baltimore, Maryland
N.J. Holbrook, National Institute on Aging, NIH, Baltimore,
Maryland: Signaling pathways activated by oxidative stress:
Links to cell survival and aging.
W.C. Orr, Southern Methodist University, Dallas, Texas:
Regulation of antioxidant gene expression in
SESSION 5: Biomedical Aspects of Oxidative Stress
Chairperson: S.S. Wallace, University of Vermont, Burlington
M.D. Jacobson, Millennium Pharmaceuticals, Inc., Cam-
bridge, Massachusetts: Role of ROS in cell death.
M.A. Beck, University of North Carolina, Chapel Hill: Influence
of oxidative stress on viral pathogenicity: Changes in the
viral genome.
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Drosophila.
G. Pastori, IACR-Rothamsted, Hertfordshire, United Kingdom:
ROS and plant senescence.
R. Levine, National Heart, Lung, and Blood Institute, NIH,
Bethesda, Maryland: Methionine oxidation.
D. St. Clair, University of Kentucky, Louisville: Transcriptional
regulation of the human MnSOD gene.
S.J. Chanock, National Cancer Institute, NIH, Gaithersburg,
Maryland: Genetic polymorphisms and functional/biological
implications of oxidative stress.
Mammalian Cloning: Biology and Practice
March 12-15
FUNDED BY Alfred P. Sloan Foundation
ARRANGED BY N.L. First, University of Wisconsin, Madison
P. Mombaerts, The Rockefeller University, New York
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction and Overview:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
I. Wilmut, Geron-BioMed, Midlothian, United Kingdom
SESSION 1: Biology of Early Development
Chairperson: R. Lovell-Badge, National Institute for Medical Research, London, United
Kingdom
B. Knowles, The Jackson Laboratory, Bar Harbor, Maine:
Nuclear reprogramming: Molecular mechanisms controlling
the oocyte to embryo transition.
M.A. Surani, University of Cambridge, United Kingdom: Germ
line, stem cells, and genomic imprinting.
A.P. Wolffe, National Institute of Child Health & Human
Development, Bethesda, Maryland: The biochemical basis
of nuclear reprogramming.
SESSION 2: Cloning of Rodents I
Chairperson: P. Mombaerts, The Rockefeller University, New York
T Wakayama, The Rockefeller University, New York: Cloning
mice.
R. Jaenisch, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Methylation, imprinting, and
K.E. Latham, Temple University School of Medicine,
Philadelphia, Pennsylvania: Transcriptional responses of
nuclei to 1-cell cytoplasm.
R.M. Schultz, University of Pennsylvania, Philadelphia:
Differential effects of culture on imprinted gene expression
in the preimplantation mouse embryo: Implications for
cloning of mammals.
nuclear cloning.
P.M. lannaccone, Northwestern University Medical School,
Chicago, Illinois: Rat blastocyst formation following nuclear
transfer to adult or fetal nuclei.
H. Nagashima, I. Wilmut, H. Varmus
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SESSION 3: Societal Issues
Chairperson: P. Mombaerts, The Rockefeller University, New York
L.M. Silver, Princeton University, New Jersey: Cloning:
Implications for human reproduction.
SESSION 4: Cloning of Rodents II
Chairperson: N.L. First, University of Wisconsin, Madison
E. Overstrom, Tufts University School of Veterinary Medicine,
North Grafton, Massachusetts: Modified oocyte activation
and enucleation paradigms enhance mammalian cloning
efficiency.
SESSION 5: Cloning of Cattle
Chairperson: N.L. First, University of Wisconsin, Madison
J.M. Robl, University of Massachusetts, Amherst: Factors
influencing variability in cloning success.
M.D. Bishop, Infigen, Inc., De Forest, Wisconsin: Cloning,
reprogramming, and rearing.
M.E. Westhusin, Texas A&M University, College Station:
Characterization of developmental abnormalities in embryos
and fetuses produced by nuclear transfer/cloning.
SESSION 6: Cloning of Sheep and Pigs
Chairperson: N. Zinder, The Rockefeller University, New York
A. Colman, PPI Therapeutics plc, Edinburgh, United
Kingdom: Successful gene targeting in livestock.
K.H. Campbell, University of Nottingham, Leicestershire,
United Kingdom: Donor cell cycle stages: Successes and
problems.
SESSION 7: Philosophical Issues
Chairperson: P. Mombaerts, The Rockefeller University, New York
J. Burley, Queen's College, Oxford, United Kingdom: Is
human cloning morally permissible?
SESSION 8: Manipulation of Primate Embryos
Chairperson: H.E. Varmus, National Institutes of Health, Bethesda,
D.P. Wolf, Oregon Regional Primate Research Center, Beaver-
ton: Cloning by nuclear transfer and blastomere separation
in rhesus macaques.
G.E. Schatten, Oregon Regional Primate Research Center,
Beaverton: Cloned, transgenic, and stem-cell-derived non-
human primates as human disease models.
J. Cohen, Saint Barnabas Medical Center, Livingston, New
Jersey: Role of mitochondria in human embryos and after
cytoplasmic transplantation.
J.A. Thomson, University of Wisconsin, Madison: Human ES
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Y. Tsunoda, Kinki University, Nara, Japan: In vitro and in vivo
development of nuclear transferred bovine oocytes receiv-
ing somatic cells from various tissues of adults, newborns,
and fetuses.
X. Yang, University of Connecticut, Storrs: Cloning adult
cows and bulls: Biological factors.
H. Nagashima, Meiji University, Tokyo, Japan: Pig cloning by
the Honolulu method.
R.S. Prather, University of Missouri, Columbia: Nuclear trans-
fer in pigs.
Maryland
cells: The problem of graft rejection.
J.B. Cibelli, Advanced Cell Technology, Worcester, Massa-
chusetts: Lifespan extension of primary cells by somatic
cell cloning in cattle.
P. Mombaerts, The Rockefeller University, New York, and N.L.
First, University of Wisconsin, Madison: Concluding discus-
sion and summary.
S.M. Willadsen, Saint Barnabas Medical Center, Livingston,
New Jersey: Concluding remarks.
Great Apes: Phenotypes and Genotypes
March 19-22
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY A. Chakravarti, Case Western Reserve University, Cleveland, Ohio
S. Paabo, Max-Planck Institute for Evolutionary Anthropology, Leipzig, Germany
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
S. Paabo, Max-Planck Institute for Evolutionary Anthropology, Leipzig, Germany
SESSION 1: Neural Phenotypes
Chairperson: S. Paabo, Max-Planck Institute for Evolutionary Anthropology, Leipzig, Germany
P. Rakic, Yale University School of Medicine, New Haven,
Connecticut: Evolution of neocortical expansion in primates.
J.K. Billing, Emory University, Atlanta, Georgia: What's unique
about the human brain? Comparative neuroimaging studies
of anthropoid primates.
K. Semendeferi, University of California, San Diego, La Jolla:
Hominoid neural specializations.
SESSION 2: Chromosomal Phenotypes
Chairperson: A. Varki, University of California, San Diego
E.E. Eichler, Case Western Reserve University, Cleveland,
Ohio: The paralogous nature of the hominoid genome:
Novel patterns of primate gene evolution.
M. Rocchi, Istituto di Genetica, Bari, Italy: Primate genome
plasticity: A cytogenetic point of view.
D.L. Nelson, Baylor College of Medicine, Houston, Texas:
S. Rice, Yale University, New Haven, Connecticut: Dis-
tinguishing novelty from heterochrony in primate brain evolu-
tion.
B.T. Shea, Northwestern University, Chicago, Illinois:
Heterochrony and phenotypic variation among the large
bodied hominoids.
Defining chromosome rearrangements amongst the great
apes: Sequence at a chromosome 12 pericentric inver-
sion.
M. Pagel, University of Reading, United Kingdom: LINE-1 ele-
ments and genome organization: Ancient genome-wide
infections.
A. Motulsky, M.-C. King, M. Goodman
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SESSION 3: Molecular Evolution
Chairperson: D.L. Nelson, Baylor College of Medicine, Houston
M. Goodman, Wayne State University School of Medicine,
Detroit, Michigan: Comparative primate genomics: A search
for positively selected mutations in humankind's evolutionary
history.
S. Paabo, Max-Planck Institute for Evolutionary Anthropology,
Leipzig, Germany: Molecular approaches to comparing
humans and apes.
A. Varki, University of California, San Diego: Studies of
SESSION 4: Population Genetics
Chairperson: M.-C. King, University of Washington, Seattle
E.B. Hey, Rutgers University, Piscataway, New Jersey: Com-
parative population genetics of humans and great apes.
R Oefner, Stanford University, Palo Alto, California: Compara-
tive analysis of autosomal and Y chromosome genes in
human and great apes.
SESSION 5: General Issues
Chairperson: A.G. Motulsky, University of Washington School
W.-H. Li, University of Chicago, Illinois: How different are
human, chimp, and gorilla genomes?
N. Saitou, National Institute of Genetics, Mishima, Japan:
Silver: Ape genome sequencing project.
S. Rozen, Whitehead Institute for Biomedical Research,
, Texas
humans as great ape "knockouts" for CMP-sialic acid
hydroxylase.
P.A. Morin, Max-Planck Institute for Evolutionary Anthropology,
Leipzig, Germany: Chimp SNPs from CATS: Beginning a
chimpanzee SNP map.
J. Lenz, Albert Einstein College of Medicine, Bronx, New
York: HERV-K, the replicating, germ line retrovirus of homi-
noids.
A. Smit, University of Washington, Seattle: Repeat elements
predating ape evolution.
A. Eyre-Walker, University of Sussex, Brighton, United
Kingdom: Deleterious mutation rates in humans, great
apes, and other animals.
of Medicine, Seattle
Cambridge, Massachusetts: Sequence of the human
Y chromosome: Genes, gene families, and pheno-
types.
M.-C. King, University of Washington, Seattle: The conse-
quences of being a hastily made-over ape.
General Discussion:
Co-Chairpersons: S. Brenner, The Molecular Sciences Institute, Inc. Berkeley, California,
and A.G. Motu !sky, University of Washington School of Medicine, Seattle
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Strategies for Identification and Characterization
of Unknown Pathogens
April 2-5
FUNDED BY
ARRANGED BY
National Center for Infectious Diseases, Centers for Disease Control
Prevention, with additional support from Aventes Pharma AG
B.J. Luft, State University of New York, Stony Brook
S.E. Schutzer, UMDNJ/New Jersey Medical School, Newark
S. Vernon, Centers for Disease Control & Prevention, Atlanta, Georgia
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
S. Vernon, Centers for Disease Control & Prevention, Atlanta, Georgia
SESSION 1: Success Stories/Lessons Learned
Co-Chairpersons: B.J. Luft, State University of New York, Stony Brook, and
R. Breeze, U.S. Department of Agriculture, Athens, Georgia
D.H. Persing, Corixa Corporation, Seattle, Washington:
Detection of novel pathogen-specific nucleic acids in
human cancers and chronic inflammatory diseases.
G.H. Cassell, Eli Lilly and Company, Indianapolis, Indiana:
Role of infection in chronic lung disease and arthritis.
S.B. Fisher-Hoch, Laboratoire Jean Merieux, Lyon, France:
Ecology and epidemiology of emerging diseases.
M. Koopmans, Laboratory of Infectious Diseases, Bilthoven,
The Netherlands: Animal pathogens infecting humans.
R.L. Berkelman, Emory University, Atlanta, Georgia: Emerging
infectious diseases: A historical perspective.
J. Ellner, Case Western Reserve University, Cleveland, Ohio:
How the epidemic of HIV infection changed the face of
tuberculosis.
E.R. Unger, Centers for Disease Control & Prevention,
Atlanta, Georgia: The sample as a window on disease:
Problems in the absence of lesion.
M. Koopmans, S. Vernon
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SESSION 2: Nervous System as a Target and Sampling Site
Co-Chairpersons: S. Cook, UMDNJ/New Jersey Medical School, Newark, and
J.L. Benach, State University of New York, Stony Brook
P.K. Coyle, State University of New York, Stony Brook: Infec-
tious versus autoimmune causes.
J. Wages, Etiogen Pharmaceuticals, Inc., Mountain View,
California: Applying viral sequence tags to hunting for
viruses.
W.I. Lipkin, University of California, Irvine: Lessons from
Borna, Kawasaki, and West Nile. A retrospective analysis
and algorithm for future work.
R.S. Fujinami, University of Utah School of Medicine, Salt
Lake City: Virus can silently prime for autoimmune disease
which can be triggered by infection.
M. Sha, Ciphergen Biosystems, Inc., Palo Alto, California:
Detection and identification of protein biomarkers in patho-
genic and other diseases.
S.E. Schutzer, UMDNJ/New Jersey Medical School, Newark:
Identification of infections by protein microchip analysis.
SESSION 3: Factors Implicating Infectious Etiology
Co-Chairpersons: A. Steinberg, Mitretek Systems, McLean, Virginia, and
R.J. Dattwyler, State University of New York, Stony Brook
W.C. Reeves, Centers for Disease Control & Prevention,
Atlanta, Georgia: Epidemiology as a tool to identify infec-
tious agents.
J.W. Casey, Cornell University, Ithaca, New York: Identification
of new retroviruses and herpesviruses associated with neo-
plasias in aquatic animals.
D.N. Frank, University of Colorado, Boulder: rRNA-based
community analysis of human inflammatory diseases of
uncertain etiology.
G.P. Smith, University of Missouri, Columbia: Mimics of
pathogen epitopes obtained without knowledge of the
pathogen.
D.L. Rock, USDA Agricultural Research Service, Greenport,
New York: Functional genomics of microbial threat agents.
SESSION 4: Successful Molecular Methods for Identification of Unknown Pathogens
Co-Chairpersons: B.J. Luft, State University of New York, Stony Brook, and
W.C. Reeves, Centers for Disease Control & Prevention, Atlanta, Georgia
A.B. Pardee, Dana-Farber Cancer Institute, Boston, Massa- and previously identified infectious agents.
chusetts: Identification of pathogens by RT-PCR methods. W.A. Bryden, Johns Hopkins University, Laurel, Maryland:
J.J. Dunn, Brookhaven National Laboratory, Upton, New MALDI-TOF mass spectrometry for biodetection and
York: SAGE-type protocol for identifying pathogens. pathogen identification.
P.A. Demirev, University of Maryland, College Park: E.S. Raveche, UMDNJ/New Jersey Medical School, Newark:
Identification of microorganisms by mass spectrometry and Antisense strategies in disease.
proteome. M.A. Hollis, Massachusetts Institute of Technology, Lexington:
P.J. Jackson, Los Alamos National Laboratory, New Mexico: B-cell-based identification sensor.
Phylogenetic methods of detecting and characterizing new
SESSION 5: Novel Molecular Approaches to Identify Pathogens
Co-Chairpersons: S. Vernon, Centers for Disease Control & Prevention, Atlanta, Georgia,
and S.E. Schutzer, UMDNJ/New Jersey Medical School, Newark
B. Kreider, Phylos, Inc., Lexington, Massachusetts: Utilization fingerprints of normal and malignant immune cells.
of PROfusionTM technology for the creation of highly sensi- J. Boldrick, HHMI, Stanford University Medical School,
tive detectors. California: Exploring host responses to infection using cDNA
D.H. Farkas, Clinical Micro Sensors, Inc., Pasadena, Califor- microarrays.
nia: Bioelectronic detection of nucleic acids. S. Salzberg, The Institute for Genomic Research, Rockville,
A. Alizadeh, HHMI, Stanford University Medical School, Cali- Maryland: Computational methods for detecting unusual
fornia: Genome-wide expression profiling reveals molecular DNA sequences.
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RNA Silencing: Functions, Mechanisms, and Applications
April 9-12
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY D.C. Baulcombe, John Innes Centre, Norwich, United Kingdom
G. Hannon, Cold Spring Harbor Laboratory
Introduction and Overview:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D.C. Baulcombe, John Innes Centre, Norwich, United Kingdom
SESSION 1: RNA Silencing in Diverse Systems
Chairperson: D.C. Baulcombe, John Innes Centre, Norwich, United Kingdom
E. Ul lu, Yale University School of Medicine, New Haven,
Connecticut: Insights into the mechanism of RNAi in try-
panosomes.
L. Timmons, Carnegie Institution of Washington, Baltimore,
Maryland: RNAi in C. elegans.
R. Carthew, University of Pittsburgh, Pennsylvania: RNA in
Drosophila melanogaster.
M. Zernicka-Goetz, Wellcome/CRC Institute, Cambridge,
United Kingdom: Specific interference with gene function by
dsRNA in early mouse development.
SESSION 2: Spread and Maintenance of RNA Silencing
Chairperson: J.A. Birch ler, University of Missouri, Columbia
A. Grishok, University of Massachusetts Medical Center,
Worcester: Inheritance of RNA-induced gene silencing in C.
elegans.
W.J. Lucas, University of California, Davis: Phloem long-dis-
RM. Waterhouse, CSIRO Plant Industry, Canberra, Australia:
PTGS in plants is very efficiently induced by hairpin RNA
and independent of methylation.
A.J. Mau le, John Innes Centre, Norwich, United Kingdom:
How low can you get? Size restraints on virus-induced
gene silencing.
R. Jorgensen, University of Arizona, Tucson: Genetic determi-
nants of patterns of cosuppression of pigment genes in
petunia flowers.
tance translocation of RNA: Mechanisms and functions.
M. Kiebler, Max-Planck Institut fur Entwicklungsbiologie,
Tubingen, Germany: Insights into mRNA transport and local
translation in the mammalian nervous system.
L Timmons, A. Grishok
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SESSION 3: dsRNA and Transcriptional Silencing
Chairperson: P.M. Waterhouse, CSIRO Plant Industry, Canberra, Australia
J.A. Birch ler, University of Missouri, Columbia: Transcriptional
and posttranscriptional silencing of dispersed transgenes in
Drosophila.
M. Matzke, Institute of Molecular Biology, Salzburg,
Austria: RNA-directed methylation of plant promoter
sequences.
M. Wassenegger, Fraunhofer Institut, Martinsried, Germany:
RNA-directed RNA methylation.
SESSION 4: Biochemical and Molecular Approaches to Mechanism
Chairperson: E. Ul lu, Yale University School of Medicine, New Haven, Connecticut
V.B. Vance, University of South Carolina, Columbia: A calmod-
ulin-related protein suppresses posttranscriptional gene
silencing in plants.
J.M. Kooter, Institute for Molecular Biological Sciences,
Amsterdam, The Netherlands: Gene silencing in petunia by
inverted repeats involves double-stranded RNAs and is
associated with the production of small sense and anti-
sense RNAs.
B.L. Bass, HHMI, University of Utah, Salt Lake City:
Adenosine deaminases that act on RNA and their double-
stranded RNA substrates.
SESSION 5: Genetical Approaches to Mechanism
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
M.B. Mathews, UMDNJ/New Jersey Medical School, Newark:
Human dsRNa-binding proteins.
H. Cerutti, University of Nebraska, Lincoln: Posttranscriptional
silencing of transgenes and transposons in a green alga:
Role of an RNA helicase.
J.-B. Morel, Laboratorire de Biologie Cellulaire, Versailles,
France: Characterization of Arabidopsis SGS genes involved in
SESSION 6: Biological Roles of RNA Silencing
Chairperson: G. Hannon, Cold Spring Harbor Laboratory
J. Carrington, Washington State University, Pullman: Viruses
and RNA silencing: Stealth and sabotage.
S.-W. Ding, Institute of Molecular Agrobiology, Singapore:
Silencing suppression by a nuclear protein.
S. Jensen, Institute Gustave Roussy, Villejuif, France:
Cosuppression of transposable elements in Drosophila.
H. Lin, Duke University Medical Center, Durham, North
S.M. Freier, ISIS Pharmaceuticals, Inc., Carlsbad, California:
Mechanisms for regulation of mRNA expression in mam-
malian cells using synthetic oligonucleotides.
G. Hannon, Cold Spring Harbor Laboratory: Mechanistic
studies of posttranscriptional gene silencing.
P. Zamore, University of Massachusetts, Worcester: RNAi:
dsRNA directs the ATP-dependent cleavage of mRNA at
21-23-nucleotide intervals.
P. Green, Michigan State University, East Lansing: Determi-
nants of mRNA stability in Arabidopsis.
posttranscriptional (trans) gene silencing and virus resistance.
R.H. Plasterk, The Netherlands Cancer Institute, Amsterdam:
Genetic links between mechanisms for transposon silenc-
ing, RNAi, and cosuppression in C. elegans.
D.C. Baulcombe, John Innes Centre, Norwich, United
Kingdom: Genetic and biochemical dissection of RNA
silencing in Arabidopsis.
Carolina: Role of piwi family genes in stem cell division and
germ line development.
E.M. Maine, Syracuse University, New York: A possible func-
tion for RNA silencing in development of the C. elegans
germ line.
R. Martienssen, Cold Spring Harbor Laboratory: Argonauts
genetics in Arabidopsis and yeast.
SESSION 7: Overview
Chairpersons: G. Hannon, Cold Spring Harbor Laboratory; and D.M. Glover, University of
Cambridge, United Kingdom
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FMRP: What Does It Do?
April 16-19
FUNDED BY FRAXA Research Foundation, with additional support from the
National Institute of Child Health and Human Development, NIH,
and National Institute of Mental Heath, NIH
ARRANGED BY W.T. Greenough, University of Illinois, Urbana
D.L. Nelson, Baylor College of Medicine, Houston
Introduction and Overview:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory: Introduction.
W.T. Greenough, University of Illinois, Urbana: Fragile X syndrome: Neural and behavioral characteristics.
D.L. Nelson, Baylor College of Medicine, Houston, Texas: Fragile X syndrome: Molecular and genetic characteristics.
SESSION 1: Fragile X Mental Retardation Protein: Insights into Neuronal Plasticity
Chairperson: D.L. Nelson, Baylor College of Medicine, Houston, Texas
J. Eberwine, University of Pennsylvania Medical School, tein synthesis and FMRP.
Philadelphia: Single-cell molecular biology insights into den- C. Bagni, Universita' di Roma, Tor Vergata, Roma, Italy:
dritic functioning and human disease. Study of FMR1 mRNA localization and translation at the
W.T. Greenough, University of Illinois, Urbana: Synaptic pro- synapses.
SESSION 2: Characterization of FMRP: Genetics and Expression
Chairperson: S.T. Warren, HHMI, Emory University School of Medicine, Atlanta, Georgia
D.L. Nelson, Baylor College of Medicine, Houston, Texas:
Consequences of altered FMRP expression in mice and
flies.
D. Reines, Emory University School of Medicine, Atlanta,
Georgia: Chromatin structure and the silent FMR1 locus in
patients.
S. Adinolfi, National Institute of Medical Research, London,
United Kingdom: Dissecting Fragile X mental retardation
E. Kandel, J. Yin, D. Nelson, S. Warren
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protein (FMRP) in its structural and functional domains.
R.P. Bauchwitz, Columbia University, New York: Analysis of
human FMR1 transgenic and fmr1(tm1Cgr) knockout mice.
E.W. Khandjian, Laval University, Quebec, Canada: Complex
SESSION 3: Transport and Translational Regulation
Chairperson: R.B. Darnell, The Rockefeller University, New York
A. Tartakoff, Case Western Reserve University, Cleveland, Ohio:
Nucleocytoplasmic transport of RNA-binding proteins.
G.J. Bassell, Albert Einstein University, Bronx, New York:
Mechanisms of mRNA targeting to neuronal dendrites and
spines.
J. Esteban, Cold Spring Harbor Laboratory: Driving AMPA
SESSION 4: Functional Aspects of FMRP
Chairperson: W.T. Greenough, University of Illinois, Urbana
M. Segal, The Weizmann Institute, Rehovot, Israel: FMRP
involvement in formation of synapses among cultured hip-
pocampal neurons.
E. Nimchinsky, Cold Spring Harbor Laboratory: Dendritic
development in FMR1 knockout mice.
R.B. Darnell, Rockefeller University, New York: Identification of
high-affinity RNA ligands for the KH-type neuronal RNA-
binding proteins Nova and FMRP.
SESSION 5: The Fragile X Syndrome and Mouse Models
Chairperson: I.J. Weiler, University of Illinois, Urbana-Champaign
L. Crnic, University of Colorado Health Sciences Center,
Denver: Startle responses in Fragile X mice.
R. Denman, New York State Institute for Basic Research,
Staten Island: The ligands of FMRP: Toward an understand-
ing of Fragile X syndrome.
F Tassone, University of Colorado School of Medicine, Denver:
FMR1 mRNA and protein expression.
W.T. Brown, New York State Institute for Basic Research,
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expression of the Fragile-X-related 1 gene in mammals.
A.T. Hoogeveen, Erasmus University Medical School,
Rotterdam, The Netherlands: FMRP and the Fragile-X-relat-
ed proteins (FXR1P and FXR2P).
receptors into synapses.
B. Bardoni, CNRS/INSERM, Illkirch, France: Novel FMRP
interacting proteins.
A.J. Scheetz, Yale University, New Haven, Connecticut:
Cytoskeletal dynamics and translational control at develop-
ing synapses.
J.R. Fallon, Brown University, Providence, Rhode Island: CPEB-
mediated cytoplasmic polyadenylation: A mechanism for
experience-dependent local mRNA translation at synapses.
E.R. Kandel, HHMI, Columbia University, New York: Role of
local protein synthesis in synapse-specific facilitation.
S.T. Warren, HHMI, Emory University School of Medicine,
Atlanta, Georgia: Biochemical and neurobiological aspects
of FMRP function.
Staten Island: Modifier genes and the Fragile X syndrome.
R.E. Paylor, Baylor College of Medicine, Houston, Texas:
Behavioral characterization of fmrl and fmr2 mutant
mice.
M. Toth, Cornell University Medical College, New York:
Abnormal processing of auditory stimuli and audiogenic
seizures of FMRP knockout mice.
Regulation and Function of Heat Shock Proteins
May 2-3
ARRANGED BY E. Craig, University of Wisconsin, Madison
C. Gross, University of California, San Francisco
R.I. Morimoto, Northwestern University, Evanston, Illinois
SESSION 1
Chairperson: C.A. Gross, University of California, San Francisco
R.I. Morimoto, Northwestern University, Evanston, Illinois: The
stress of misfolded proteins.
E.A. Craig, University of Wisconsin, Madison: Multiple
SESSION 2
Chairperson: L.E. Hightower, University of Connecticut, Storrs
Hsp70s: Clues regarding specialization.
K. Mori, Kyoto University, Japan: Analysis of the unfolded
protein response.
K. Nagata, Kyoto University, Japan: Substrate recognition by its eight different subunits in mammalian cells.
HSP47 and its possible functions in the collagen biosynthe- B. Bukau, University of Freiburg, Germany: The E coil heat
sis. shock response.
H. Kubota, Kyoto, Japan: Cytosolic chaperone in CCT and T Yura, Kyoto University, Japan: Slides
SESSION 3
Chairperson: K. Nagata, Kyoto University, Japan
S. Wickner, National Cancer Institute, NIH, Bethesda, Mary- and reverse movement of proteins across the E. coif mem-
land: Protein recognition and unfolding by CIpA and degra- brave.
dation by CIpAP. A.D. Grossman, Massachusetts Institute of Technology,
K. Ito, Kyoto University, Japan: Machinery for the forward Cambridge: DNA replication, cell cycle, and development.
SESSION 4
Chairperson: K. Mori, Kyoto University, Japan
C.A. Gross, University of California, San Francisco: Role of
032 in the heat shock response.
T Yura, Kyoto University, Japan: Heat shock response in
bacteria: Recollection.
L.E. Hightower, University of Connecticut, Storrs: Bacterium
meets mammal: A greeting from the heat shock response.
331
Toward Animal Models of Attention and Consciousness
May 14-17
FUNDED BY The Swartz Initiative for Computational Neuroscience
ARRANGED BY C. Koch, California Institute of Technology, Pasadena
A.M. Zador, Cold Spring Harbor Laboratory
SESSION 1
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: Introductory remarks.
C. Koch, California Institute of Technology, Pasadena: A
framework for discovering the neuronal basis of conscious-
ness.
D.J. Heeger, Stanford University, California: Attentional modu-
lation and stimulus-evoked activity in human primary visual
cortex.
SESSION 2
G. Tononi, The Neurosciences Institute, San Diego, California:
Consciousness and complexity.
C. Brody, New York University, New York: The "unified per-
cept" hypothesis and its quantitative neurophysiological
consequences.
E.K. Miller, Massachusetts Institute of Technology, Cambridge:
Executive function: The neural basis of cognitive control.
332
G.E. Rees, California Institute of Technology, Pasadena: Linking
visual attention and awareness with functional MRI.
D.A. Leopold, Max-Planck Institute for Biological Cybernetics,
Tubingen, Germany: Neural correlates of multistable visual
perception.
S.L. Macknik, Harvard Medical School, Boston,
Massachusetts: The visibility and invisibility of spatiotempo-
ral edges in the primate visual system,
V.A.F. Lamme, Academical Medical Center, Amsterdam,
The Netherlands: Neural correlates of visual awareness in
Vi.
J.D. Schell, Vanderbilt University, Nashville, Tennessee:
Antecedents and correlates of visual attention and aware-
ness in prefrontal cortex.
D. Heeger, J. Reynolds, M. Sherman
SESSION 3
S.M. Sherman, State University of New York, Stony Brook:
Don't forget the thalamus.
C.D. Gilbert, The Rockefeller University, New York: Attention
and learning in the primary visual cortex.
P.R. Adams, State University of New York, Stony Brook: Neo-
cortical plasticity control, thalamic bursting, and awareness.
SESSION 4
Y. Miyashita, University of Tokyo School of Medicine, Japan:
Top-down activation of higher-order visual representations.
N.G. Kanwisher, Massachusetts Institute of Technology, Cam-
bridge: Mechanisms of attention in human visual cortex.
I. Fried, University of California Los Angeles School of
Medicine: Single-unit recordings in the human temporal
lobe during encoding and retrieval of visual stimuli.
L.R. Squire, University of California, San Diego: Conscious
and nonconscious memory systems.
A.C. Nobre, University of Oxford, United Kingdom: Brain-
imaging/ERP studies of attention or flexible modu-
lation of sensor/motor processing by selective
expectancies.
J.H. Reynolds, National Institute of Mental Health, NIH,
A.K. Engel, Max-Planck-Institute for Brain Research,
Frankfurt, Germany: The possible role of temporal binding
for consciousness.
A.M. Zador, Cold Spring Harbor Laboratory: Is the simuncu-
lus just watching TV?
Bethesda, Maryland: Visual salience, competition, and
selective attention.
J. Braun, California Institute of Technology, Pasadena: Neural
basis of "early" selection.
A. Pouget, University of Rochester, New York: Statistical con-
straints on theories of attention.
M.A. Goodale, University of Western Ontario, Canada:
Dissociations between conscious visual perception and the
visual control of action in neurological patients and normal
observers.
C. Koch, California Institute of Technology, Pasadena: Wrap
Up.
Discussion: Toward Animal Models of Consciousness
Front view of Banbury Conference Center.
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Mouse Behavioral Phenotyping
August 27-30
FUNDED BY National Institute of Mental Health, NIH
ARRANGED BY M. Gallagher, Johns Hopkins University, Baltimore, Maryland
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
M. Gallagher, Johns Hopkins University, Baltimore, Maryland
SESSION 1
Chairperson: J.L. Noebels, Baylor College of Medicine, Houston,
Y. Benjamini, Tel Aviv University, Israel: Controlling the false
discovery rate in behavior research.
W.A. Falls, University of Vermont, Burlington: Screening for
sensory, motor, learning, and anxiety phenotypes in mice
using startle reflex methodology.
SESSION 2
Chairperson: W.A. Falls, University of Vermont, Burlington
J.I. Glendinning, Columbia University, New York: High-
throughput screens for assessing taste sensitivity in
mice.
Texas
W.N. Frankel, The Jackson Laboratory, Bar Harbor, Maine:
Assessment of electroconvulsive seizure thresholds of
mouse strains.
M. Gallagher, Johns Hopkins University, Baltimore, Maryland:
Learning and memory assessments in mice.
I. Golani, Tel Aviv University, Israel: Computerized visualiza-
tion, algorithmic definition, and measurement of mouse
exploratory behavior.
J. Noebels, Y. Benjamini
SESSION 3
Chairperson: B.M. Slotnick, American University, Washington, D.C.
T.A. Jones, University of Missouri, Columbia: Balance behav-
iors and vestibular function in four mutant strains (B6 inbred
background).
D. Goldowitz, University of Tennessee, Memphis:
Structure and function: Histological phenotyping of the
nervous system.
G.K. Martin, University of Miami, Florida: Distortion-product
otoacoustic emissions in mouse models of susceptibility to
aging and noise.
SESSION 4
Chairperson: P.C. Holland, Duke University, Durham, North Carolina
J.L. Noebels, Baylor College of Medicine, Houston, Texas:
Mutational analysis of brain rhythms and cortical excitability.
B.F. O'Hara, Stanford University, California: A high through-
put piezoelectric system for monitoring sleep and wake.
R.E. Paylor, Baylor College of Medicine, Houston, Texas:
Organismic and experiential factors influencing the behav-
ioral characterization of inbred mice.
E. Pugh, University of Pennsylvania, Philadelphia: Phenotyping
the mouse visual system.
SESSION 5
Chairperson: R.E. Pay lor, Baylor College of Medicine, Houston, Texas
B.M. Slotnick, American University, Washington, D.C.: Mouse R.W. Williams, University of Tennessee, Memphis: Efficient
olfaction assessed using conditioned avoidance and by mapping of neuroanatomical and behavioral QTLs with sub-
olfactometry. centimorgan prevision using 5000 isogenic RIX lines.
M.G. Tordoff, Monell Chemical Senses Center, Philadelphia,
Pennsylvania: Use of the two-bottle choice test to assess Summary and Future Plans
mouse taste preferences.
Overhead slide projection presentation.
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Neural Networks and Cognition
September 10-13
FUNDED BY
ARRANGED BY
Handspring Inc.
A.M. Zador, Cold Spring Harbor Laboratory
Z.F. Mainen, Cold Spring Harbor Laboratory
A. Pouget, University of Rochester, New York
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: A. Pouget, University of Rochester, New York
A.M. Zador, Cold Spring Harbor Laboratory: Dynamic com-
putation in the cortex: The cocktail party problem.
M.J. Tarr, Brown University, Providence, Rhode Island:
Cortical brain networks automatized by expertise.
R.S. Zemel, University of Arizona, Tucson: Bayesian inference
using population codes.
J. Tenenbaum, Stanford University, California: Bayesian infer-
SESSION 2
Chairperson: Z.F. Mainen, Cold Spring Harbor Laboratory
J.C. Hawkins, Handspring Inc., Mountain View, California:
Neural networks and cognition.
P. Kanerva, Swedish Institute of Computer Science, Kista,
Sweden: Stochastic pattern computing as a model of com-
puting by the brain.
J. Kristoferson, Swedish Institute of Computer Science, Kista,
Sweden: On different latent semantic techniques to construct
high-dimensional distributed representations of words in large
corpora.
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ence in human cognition.
M. Mozer, University of Colorado, Boulder: Temporal dynam-
ics of information transmission in a Bayesian cognitive archi-
tecture.
Y. Weiss, University of California, Berkeley: Bayesian inference
in distributed networks: From psychophysics to error-cor-
recting codes.
G. Sjodin, Swedish Institute of Computer Science, Kista,
Sweden: Raising the abstraction level and finding seman-
tic/syntactic concepts in large corpora by using latent
semantic techniques.
B.A. Pearlmutter, University of New Mexico, Albuquerque:
Independent components analysis.
S. Roweis, University College London, United Kingdom:
Unsupervised learning of nonlinear manifolds.
P. Latham, A. Koulakov, Z. Mainen
SESSION 3
Chairperson: D. Chklovskii, Cold Spring Harbor Laboratory
J.J. Hopfield, Princeton University, New Jersey: Large N rep-
resentations, algorithms, and dynamics.
P. Latham, University of California, Los Angeles: Attractors in
realistic neuronal networks: Can they exist?
A. Koulakov, Salk Institute, La Jolla, California: A sandpile
model of neural integrator.
P. Dayan, University College, London, United Kingdom:
Statistical model of attention and conditioning.
Z. Li, University College, London, United Kingdom: Vision in
VI, a network model for the theory of pre-attentive vision.
T. Hely, The Santa Fe Institute, New Mexico: Role of feedback
in information processing in the brain.
SESSION 4
Chairperson: B.W. Mel, University of Southern California, Los Angeles
B.W. Mel, University of Southern California, Los Angeles:
Dendrites may be why you're so smart.
D. Chklovskii, Cold Spring Harbor Laboratory: Wire length
minimization is a powerful tool for uncovering brain cir-
cuits.
B. Olshausen, University of California, Davis: Sparse coding
of images in space and time.
SESSION 5
Chairperson: A.M. Zador, Cold Spring Harbor Laboratory
D. Wilishaw, University of Edinburgh, United Kingdom: Role of
the subthalamic nucleus in the basal ganglia.
E. Todorov, University College London, United Kingdom:
Constraints on neural processing in the motor system
N. Tishby, The Hebrew University, Jerusalem, Israel: Analysis
of neural codes via the information bottleneck method.
A.V.M. Herz, Homboldt University, Berlin, Germany: Interplay
of firing rates, firing times, and adaptation.
A. Pouget, University of Rochester, New York: Efficient
computation and cue integration with population codes.
imposed by properties of the motor periphery.
D.D. Lee, Bell Laboratories, Murray Hill, New Jersey: Making
a robotic dog see and hear.
E. Ziff, J. Lisman
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Structure, Mechanism, and Function of CaMKII
September 17-20
FUNDED BY Marie H. Robertson Memorial Fund for Neurobiology
ARRANGED BY H. Cline, Cold Spring Harbor Laboratory
J.E. Lisman, Brandeis University, Waltham, Massachusetts
SESSION 1
Chairperson: A. Nairn, The Rockefeller University, New York
A. Nairn, The Rockefeller University, New York: CaM kinase:
Structure and mechanism.
N. Waxham, University of Texas Health Science Center,
Houston: The three-dimensional structure of CaMKII reveals
its unique subunit organization.
SESSION 2
Chairperson: S. Halpain, The Scripps Research Institute, La Jolla, California
S. Halpain, The Scripps Research Institute, La Jolla, California: Stroke, NIH, Bethesda, Maryland: Distribution of CaMKII at
Multifunctional MAP2 as a target of multifunctional CaMKII. the postsynaptic density (at rest and during activity).
T Meyer, Duke University Medical Center, Durham, North A. Dosemeci, Marine Biological Laboratory, Woods Hole,
Carolina: Molecular memory by translocation priming and Massachusetts: CaMKII clustering: Mechanism and func-
postsynaptic trapping of CaMKII. tion.
T.S. Reese, National Institute of Neurological Disorders and
SESSION 3
Chairperson: M.H. Sheng, Massachusetts General Hospital, Boston
M.H. Sheng, Massachusetts General Hospital, Boston:
Phosphorylation of PSD proteins by CaMKII.
M.B. Kennedy, California Institute of Technology, Pasadena:
Postsynaptic targets for phosphorylation by CaMKII.
R.J. Colbran, Vanderbilt University School of Medicine,
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Nashville, Tennessee: Mechanisms of CaMKII association
with postsynaptic densities.
J.W. Hell, University of Wisconsin, Madison: Regulation and
physiological significance of the interaction between CaMKII
and the NMDA receptor.
A. Dosemeci, S. Halpain
SESSION 4
Chairperson: H. Schulman, Stanford University School of Medicine, California
H. Schulman, Stanford University School of Medicine,
California: Activity-dependent targeting and autophosphory-
lation both switch the functional state of CaMKII.
SESSION 5
Chairperson: R.A. Nicoll, University of California, San Francisco
J.E. Lisman, Brandeis University, Waltham, Massachusetts:
New mechanisms for PSD CaMKII as a memory element.
T.R. Soder ling, Oregon Health Sciences University, Portland, plasticity.
Oregon: Regulation of AMPA-Rs by CaMKII in LTP. R. Nicoll, University of California, San Francisco: Role of
R. Malinow, Cold Spring Harbor Laboratory: CaMKII controls CaMKII in Ca channel and non-NMDA receptor-dependent
synaptic delivery of GluR1. synaptic plasticity.
R.L. Huganir, HHMI, Johns Hopkins University, Baltimore, K. Fukunaga, Kumamoto University School of Medicine, Japan:
Maryland: Regulation of AMPA receptors and synaptic Molecular targets of CaMKII involved in the hippocampal LTP.
SESSION 6
Chairperson: J.E. Lisman, Brandeis University, Waltham, Massachusetts
E.M. Landau, Mt. Sinai School of Medicine, New York:
Regulation of CaMKII activity in transmitter-dependent LTP.
R.H. Kramer, University of Miami School of Medicine, Florida:
Role of CaMKII in long-term plasticity of cyclic nucleotide
metabolism revealed with the "patch-cramming" technique.
N. Otmakhov, Brandeis University, Waltham, Massa-chusetts:
Is persistent activity of calcium/calmodulin-dependent
SESSION 7
Chairperson: H. Cline, Cold Spring Harbor Laboratory
K. Fox, Cardiff University, Wales: Role of CaMKII in plasticity
in vivo.
J.R. Fallon, Brown University, Providence, Rhode Island:
Regulation of CaMKII translation at synapses.
M. Constantine-Paton, Massachusetts Institute of Technol-
kinase required for the maintenance of LTP?
L.C. Griffith, Brandeis University, Waltham, Massachusetts:
Genetic manipulation of CaMKII and its targets.
A.J. Silva, University of California, Los Angeles: CaMKII's role
in short-term plasticity, LTP, and memory.
M.R. Mayford, University of California, La Jolla: CaMKII func-
tion in dendrites and during development.
ogy, Cambridge: NMDAR control of CaMKII during nervous
system development.
H. Cline, Cold Spring Harbor Laboratory: CaMKII mediates
maturation of the visual system in vivo.
T. Reese, M. Kennedy, S. Halpain
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Persistent Neural Activity
October 1-4
FUNDED BY Alfred P. Sloan Foundation and The Swartz Initiative for
Computational Neuroscience
ARRANGED BY H.S. Seung, Massachusetts Institute of Technology, Cambridge
D.W. Tank, Bell Laboratories, Lucent Technologies, Murray Hill, New Jersey
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: C. Brody, New York University, New York
P.S. Goldman-Rakic, Yale University School of Medicine, New
Haven, Connecticut: Prefrontal microcircuits and the tem-
poral dynamics of working memory.
M. D'Esposito, University of California, Berkeley: Toward
understanding the role of prefrontal cortex in working mem-
ory: Evidence from functional MRI.
X.-J. Wang, Brandeis University, Waltham, Massachusetts:
Synaptic and cellular mechanisms of working memory:
Stable persistent activity and NMDA receptors.
M. Bodner, University of California, Los Angeles: Cortical
attractors in working memory.
D. Durstewitz, Salk Institute for Biological Studies, La Jolla,
California: Modulatory control of and transitions in working
memory.
SESSION 2
Chairperson: P.S. Goldman-Rakic, Yale University School of Medicine, New Haven,
Connecticut
R.A. Andersen, California Institute of Technology, Pasadena:
The nature of delay activity in the posterior parietal cortex.
P.W. Mitra, Lucent Technologies, Murray Hill, New Jersey:
Tuned temporal structure in neural activity during working
memory.
E. Zohary, Hebrew University, Jerusalem, Israel: Strategies of
visual memory: Behavioral, neuronal, and computational
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perspectives.
M. Griniasty, Intel Cellular Communication Division, Givat
Shmuel, Israel: Correlations between patterns of persistent
neural activity and the Hopfield model.
J.E. Lisman, Brandeis University, Waltham, Massachusetts:
Mechanisms of multi-item working memory.
Posters:
A. Koulakov, Salk Institute, La Jolla, California: A sandpile model of neural integrator.
A. Renart, Brandeis University, Waltham, Massachusetts: Low rate and highly variable persis-
tent activity in a micro-columnar LIF network model.
B. Pesaran, California Institute of Technology, Pasadena: Spectral measures of temporal
structure in neuronal activity.
SESSION 3
Chairperson: J.E. Lisman, Brandeis University, Waltham, Massachusetts
C. Brody, New York University, New York: Single and multi-
electrode recordings in primate prefrontal cortex during
parametric working memory tasks.
H.I. Sompolinsky, The Hebrew University, Jerusalem, Israel:
Balanced states and multiple attractors in cortical networks.
G.B. Ermentrout, University of Pittsburgh, Pennsylvania:
Mechanisms underlying maintained activity.
SESSION 4
Chairperson: M.N. Shad len, University of Washington, Seattle
C.R. Gallistel, Rutgers University, Piscataway, New Jersey:
Various behaviors that appear to require integration with
respect to time.
C. Kaneko, University of Washington, Seattle: Neural integra-
tion in the oculomotor system of the alert monkey.
H.S. Seung, Massachusetts Institute of Technology,
Cambridge: Recurrent network models of the oculomotor
integrator.
D.W. Tank, Lucent Technologies, Murray Hill, New Jersey:
SESSION 5
Chairperson: R.A. Andersen, California Institute of Technology,
J.S. Taube, Dartmouth College, Hanover, New Hampshire:
Persistent neural activity in the head-direction cell network.
K. Zhang, The Salk Institute, La Jolla, California: Attractor
theories of the head-direction system: Necessary features
and difficulties.
B.L. Mc Naughton, University of Arizona, Tucson: Continuous
S. Wise, National Institutes of Health, Bethesda, Maryland:
Empirical dissociation of confounded spatial variables in
instructed-delay tasks: Attention vs. memory vs. gaze vs.
intention vs. cue vs. target.
W. Schultz, University Fribourg, Switzerland: Predictive coding
of behavioral outcomes in primate basal ganglia and frontal
cortex.
Persistent activity in a goldfish oculomotor neural
integrator.
R. Baker, New York University School of Medicine, New York:
Neural basis and function of eye velocity storage.
E.E. Fetz, University Washington School of Medicine, Seattle:
Neural mechanisms mediating persistent activity in primate
motorcortical and spinal circuits.
J.J. Hopfeld, Princeton University, New Jersey: What is a
moment? "Cortical" sensory integration over a brief interval.
Pasadena
and discontinuous attractor dynamics in the hippocampus.
D.S. Touretzky, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Attractor maps in the rodent hippocampus.
D.A. McCormick, Yale University School of Medicine, New
Haven, Connecticut: Cellular basis for recurrent and rhyth-
mic spontaneous activity in the cerebral cortex.
SESSION 6
Chairperson: S. Wise, National Institutes of Health, Bethesda, Maryland
M.N. Shad len, University of Washington, Seattle: Neural integra-
tion in the parietal cortex: Accumulating the evidence.
C. Chow, University of Pittsburgh, Pennsylvania: A spiking
neuron model of binocular rivalry.
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Social Venture Capital for Neglected Vaccines:
Creating Successful Alliances
October 10-12
FUNDED BY Albert B. Sabin Vaccine Institute, Inc., through a grant from the
Bill and Melinda Gates Foundation
ARRANGED BY M. Moree, PATH/Malaria Vaccine Initiative, Seattle, Washington
R. Rabinovich, PATH/Malaria Vaccine Initiative, Rockville, Maryland
P.K. Russell, Albert B. Sabin Vaccine Institute, Inc., New Canaan, Connecticut
Introduction and Charge to the Conference:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
H.R. Shepherd, Albert B. Sabin Vaccine Institute, New Canaan, Connecticut
P.K. Russell, Albert B. Sabin Vaccine Institute, Inc., New Canaan, Connecticut
R. Rabinovich, PATH/Malaria Vaccine Initiative, Rockville, Maryland
SESSION 1: Perspectives on the Development of Neglected Vaccines
M. Moree, PATH/Malaria Vaccine Initiative, Seattle,
Washington: Public sector.
L.K. Gordon, OraVax Inc., Cambridge, Massachusetts:
Industry.
SESSION 2: Mechanisms for Public-Private Partnerships
H. Kett ler, Office of Health Economics, London, United
Kingdom: Narrowing the gap between provision and need
for vaccines in developing countries.
C. Elias, PATH/Malaria Vaccine Initiative, Seattle, Washington:
Public-private partnerships for contraceptives and microbi-
cides.
SESSION 3: Alliance Management
M. McDade, Corixa Corporation, Seattle, Washington: Industry.
L. Nelsen, Massachusetts Institute of Technology,
Cambridge, Massachusetts: Academia.
SESSION 4: Commitments to Ensure Availability and
Accessibility of Vaccines for Developing Country Markets
P. Young, Alpha Vax, Durham, North Carolina: Biotech.
L. Barreto, Aventis Pasteur, Lyon, France: Pharma.
R.P. Eddy, U.S. Mission to the United Nations, New York:
News from the White House.
J.-F. Martin, Parteurop S.A., Lyon, France: The Global
Children's Vaccine Fund.
SESSION 5: What should be done to move the development of
neglected vaccines forward? How do we form better partnerships?
Chairperson: R. Rabinovich, PATH/Malaria Vaccine Initiative,
Rockville, Maryland
PANEL:
R.J. Saldarini, Mahwah, New Jersey
C. McFadden, Dewey Ballantine, Washington, D.C.
C. Nacy, Sequella, Inc., Rockville, Maryland
T Lakavage, SmithKline Beecham Biologicals, Rixensart, Belgium
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J.V. Scott, New York University, New York: Academia.
S.M. Ferguson, Office of Technology Transfer, National
Institutes of Health, Rockville, Maryland: Government.
A. Batson, W. Koff, T. Elliott
Meeting the Challenge of Infectious Diseases in the 21st Century
October 15-18
FUNDED BY Agricultural Research Service, U.S. Department of Agriculture
ARRANGED BY R. Breeze, U.S. Department of Agriculture, Athens, Georgia
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
R. Breeze, U.S. Department of Agriculture, Athens, Georgia
SESSION 1: Microbial Genomics and Pathogenesis
D.L. Rock, USDA Agricultural Research Service, Greenport,
New York: Functional genomics of viruses.
L.W.J. Bail lie, Defence Evaluation Research Agency, Salis-
bury, United Kingdom: Functional genomics of bacteria.
R. Dean, North Carolina State University, Raleigh: Functional
genomics of fungi.
B. Sobral, Virginia Polytechnic Institute & State University,
Blacksburg: Role of bioinformatics in biosafety.
SESSION 2: Pathogenesis, Prevention, and Control of Infectious Diseases:
The Next 10 Years: Plants
S. Leath, North Carolina State University, Raleigh: Improving
disease resistance of crops through breeding and
genomics.
E. Buckler, North Carolina State University, Raleigh: Structural
and functional genomics of complex traits in field crops.
N.C. Kistler, University of Minnesota, St. Paul: Fungal plant
pathogenicity: Future directions.
S.A. Lommel, North Carolina State University, Raleigh: Plant
virus pathogenicity: State of the art and future directions.
R.P. Niedz, U.S. Horticultural Research Laboratory, Ft. Pierce,
Florida: Woody perennials: Biological considerations and
genomic applications.
SESSION 3: Pathogenesis, Prevention, and Control of Infectious Diseases:
The Next 10 Years: Animals
W. Laegreid, USDA Agricultural Research Service, Clay
Center, Nebraska: Functional genomics and disease control
in livestock.
G. Letchworth, USDA Agricultural Research Service,
ABADRL, Laramie, Wyoming: Functional genomics of
pathogen infection, replication, survival, and transmittal in
vectors: Ideas for disease intervention.
M. Jutila, Montana State University, Bozeman: Analysis of
bovine y/5 T cells: Gene expression and function.
T.J. Leighton, University of California, Berkeley: Anthrax:
Solving pathobiology problems with genomic informa-
tion.
D. Knowles, ARS-USDA, Washington State University,
Pullman: Anaplasma marginate: Efficient use of a small
genome to generate antigenic diversity.
B.J. Luft, State University of New York, Stony Brook: Rational
vaccine design.
J.J. Dunn and S. Swaminathan, Brookhaven National
Laboratory, Upton, New York: OspC of Borre lia burgdorferi:
Clues to biochemical function from genomics and structural
analysis.
J.N. Mac Lachlan, University of California, Davis: New and
emerging virus diseases: What horses can tell us.
D.E. Swayne, USDA Agricultural Research Service, Athens,
Georgia: Viral ecology and pathogenesis in future diagnosis
and control of avian influenza.
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SESSION 4: Detection, Identification, Forensics, and Diagnosis I
W.A. Bryden, Johns Hopkins University, Laurel, Maryland and
J. Jackman, Johns Hopkins University, Laurel, Maryland:
MALDI-TOF mass spectrometry for biodetection and
pathogen identification,
P. Keim, Northern Arizona University, Flagstaff: High-resolution
SESSION 5: Detection, Identification, Forensics, and Diagnosis II
T.J. Leighton, University of California, Berkeley: Ab initio con-
struction of definitive anthrax group diagnostic reagents.
W.I. Lipkin, University of California, Irvine: Pathogen discov-
ery: From Borna to West Nile and beyond.
K. Lohman, AFIERA, San Antonio, Texas: Rapid identification
of pathogens from clinical specimens using real-time fluo-
rescent PCR.
J. Mullet, Texas A&M University, College Station: Use of
remote sensing and satellite imaging in conjunction
pathogen typing: Epidemiological implications.
Interim Discussion:
Chairperson: R. Breeze, U.S. Department of Agriculture,
Athens, Georgia
with DNA diagnostics for early detection of plant
pathogens.
S.E. Schutzer, UMDNJ/New Jersey Medical School, Newark:
Detection of the unknown pathogen: Methods and
approach.
Summing Up:
Chairperson: R. Breeze, U.S. Department of Agriculture,
Athens, Georgia
Slide presentation during a meeting.
J.P. Morgan & Co., Incorporated/Cold Spring Harbor Laboratory
Executive Conference on Human Intelligence and Consciousness
October 19-21
ARRANGED BY J.D. Watson, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
J.D. Watson, Cold Spring Harbor Laboratory: Welcoming
remarks.
0. Sacks, Department of Neurology, Albert Einstein College
of Medicine, Bronx, New York: Prodigies.
SESSION 2
H. Gardner, Harvard University Graduate School of
Education, Cambridge, Massachusetts: How much of
intelligence is in the brain?
I. Pepperberg, University of Arizona, Tucson: Cognitive and
communicative abilities of Alex the Grey Parrot.
SESSION 3
C. Murray, American Enterprise Institute for Public Policy
Research, Washington, D.C.: The intersection of intelli-
gence and policy: Two approaching problems.
SESSION 4
Z.F. Mainen, Cold Spring Harbor Laboratory: Olfaction: A
complex sensory function.
A.M. Zador, Cold Spring Harbor Laboratory: Selective hear-
ing: The "cocktail party problem."
SESSION 5
S. Pinker, Brain and Cognitive Sciences, Massachusetts
Institute of Technology, Cambridge: Words and rules: The
ingredients of language.
V.S. Ramachandran, University of California, San Diego:
What neurology can tell us about human nature, synethe-
sia, and the meaning of art.
R.A. Brooks, Artificial Intelligence Laboratory, Massachusetts
Institute of Technology, Cambridge: Building intelligent
sociable machines: Understanding human intelligence.
Discussion and Closing Remarks:
J.D. Watson, Cold Spring Harbor Laboratory
J.D. Watson, C. Murray
A. Berry, J. Hawkins
R. Brooks, H. Gardner, D. Pakianathan
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Natural Stimulus Statistics
October 22-25
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY S. Laughlin, University of Cambridge, United Kingdom
P. Reinagel, Harvard Medical School, Boston, Massachusetts
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
S. Laughlin, University of Cambridge, United Kingdom,
P. Reinagel, Harvard Medical School, Boston, Massachusetts
SESSION 1
Chairperson: D.L. Donoho, Stanford University, California
W. Bialek, NEC Research Institute, Inc., Princeton, New
Jersey: Finding relevant features in natural signals.
H. Barlow, University of Cambridge, United Kingdom: Help
and hindrance from redundancy.
D. Mumford, Brown University, Providence, Rhode Island:
Searching for an explicit stochastic model for natural scene
SESSION 2
Chairperson: S. Laughlin, University of Cambridge, United Kingdom
Y. Gousseau, CNRS-ENS Cachan, France: Morphological
statistics of natural images.
E. Simoncelli, New York University, New York: Image statis-
tics, Gaussian scale mixture models, and divisive normal-
ization.
D.W. Dong, Florida Atlantic University, Boca Raton: Eye
movements and spatiotemporal input statistics during free-
viewing natural time-varying images.
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image patches.
B. Olshausen, University of California, Davis: Sparse coding of
natural images: Space, time, and color.
D. Tolhurst, University of Cambridge, United Kingdom: Measur-
ing sparse coding: Definitions and confusions.
K. Kording, Institute for Neuroinformatik, Zurich, Switzerland:
What a cat sees and what algorithms can learn from this.
R. Kern, Universitat Bielefeld, Germany: Representation of
behaviorally generated optic flow in a fly visual interneuron.
R. de Ruyter, NEC Research Institute, Inc., Princeton, New
Jersey: Motion detection in the wild: Natural stimuli and
information transmission in a blowfly motion-sensitive neu-
ron.
B. Olshausen, H. Barlow, W. Geis ler
SESSION 3
Chairperson: M. Meister, Harvard University, Cambridge, Massachusetts
A. Fairhall, NEC Research Institute, Inc., Princeton, New
Jersey: Olfaction from the point of view of physics.
F. Grasso, Boston University Marine Program, Woods Hole,
Massachusetts: Olfaction, turbulence, and odor plumes:
Structure from concentration dynamics.
G. Laurent, California Institute of Technology, Pasadena:
Reformatting and optimization of odor representations in
SESSION 4
Chairperson: D.J. Field, Cornell University, Ithaca, New York
F. Theunissen, University of California, Berkeley: Analyzing
auditory neurons with natural and synthetic sounds.
K. Sen, University of California, San Francisco: Hierarchical
processing of natural sounds in the songbird auditory fore-
brain.
E. Nelken, Hebrew University-Hadassah Medical School,
Jerusalem, Israel: Coding of foregrounds and backgrounds
SESSION 5
Chairperson: D. Osorio, University of Sussex, Brighton, United
W.S. Geisier, University of Texas, Austin: Perceptual grouping
and the Bayesian co-occurrence statistics of features in
natural images.
J. Malik, University of California, Berkeley: Ecological statis-
tics of Gestalt grouping factors.
the zebrafish olfactory bulb.
M.S. Lewicki, Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Learning efficient codes for natural scenes
and sounds: A principle for sensory coding.
P. Penev, The Rockefeller University, New York: Factorial
transmission of time-varying natural stimuli with sparse,
interacting unitary events: Spiking for speech and movies.
in auditory scenes.
P. Reinagel, Harvard Medical School, Boston, Massachusetts:
Coding of temporal visual information by LGN neurons.
Y. Dan, University of California, Berkeley: Analysis of visual
coding in the LGN and
J.L. Gallant, University of California, Berkeley: Using natural
scenes to reveal coding properties in visual cortex.
Kingdom
M. Vorobyev, University of Maryland, Baltimore: Color coding
of signals and backgrounds.
E.H. Adelson, Massachusetts Institute of Technology,
Cambridge: Statistical aspects of lightness estimation.
D. Field, E. Simoncelli
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Sugar Sensing and Signaling in Plants and Other Organisms
October 29-November 1
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY M. Johnston, Washington University Medical School, St. Louis, Missouri
J. Sheen, Massachusetts General Hospital, Boston
M. Stitt, University of Heidelberg, Germany
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Transporter Proteins, GPCR, and Protein Kinases in Glucose Signaling
Chairperson: M. Johnston, Washington University Medical School, St. Louis, Missouri
M. Johnston, Washington University Medical School, St. Louis,
Missouri: Metabolic and receptor-mediated glucose signals
regulate gene expression in yeast by different mechanisms.
S. Ozcan, University of Kentucky College of Medicine,
Lexington: Regulation of gene expression by glucose in
yeast and in mammalian cells.
M. Carlson, Columbia University, New York: Snf1 protein
kinase and glucose signaling in yeast.
G. Hardie, University of Dundee, United Kingdom:
SNF1/AMP-activated protein kinases: Highly conserved
kinase cascades involved in sugar sensing in plants, ani-
mals, and yeast.
J. Thevelein, Catholic University of Louvain, Belgium: Both a
G-protein-coupled receptor system and glucose phosphory-
lation are required for glucose activation of the cAMP-PKA
pathway in yeast.
SESSION 2: Glucose, Mannose, and Sucrose Sensing and Signaling in Plants I
Chairperson: K.E. Koch, University of Florida, Gainesville
C. MacKintosh, University of Dundee, United Kingdom:
14-3-3s regulate the global cleavage of their diverse
binding partners in sugar-starved Arabidopsis cells.
U. Wobus, Institute Pflanzenetik and Kulturpflanzenforschung,
Gatersleben, Germany: Sugar gradients, sugar metabolism,
and sugar sensing in developing plants seeds.
K.E. Koch, University of Florida, Gainesville: A central role for
sucrose metabolism in sugar signaling: A whole plant con-
text.
I. Graham, University of York, Sand Hutton, United Kingdom:
Why is trehalose metabolism essential for Arabidopsis seed
development?
T Roitsch, University of Regensburg, Germany:
Differential regulation of source and sink metabolism by
sugars.
D.R. Bush, University of Illinois, Urbana: Sucrose signaling
and phloem loading.
J.-C. Jang, Ohio State University, Columbus: Signal trans-
duction of glucose-regulated cell expansion.
M. Bevan, John Innes Centre, Norwich, United Kingdom:
Genetic analysis of sucrose-mediated transcription of
genes encoding enzymes of starch biosynthesis.
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M. Bevan
SESSION 3: Glucose, Mannose, and Sucrose Sensing and Signaling in Plants II
Chairperson: W.-B. Frommer, University of Tubingen, Germany
S.C. Huber, North Carolina State University, Raleigh: Sucrose
synthase and SNF-I -related protein kinases: New compo-
nents of sugar sensing in plants?
W.-B. Frommer, University of Tubingen, Germany: Sucrose
transporters and sugar sensing.
P.S. Chourey, University of Florida, Gainesville: Mannose
induces global gene repression in maize through a signaling
pathway that is independent from sugar depletion.
SESSION 4: Glucose and Galactose Sensing and Signaling in Yeast/Mammals
Chairperson: M. Carlson, Columbia University, New York
C. Michels, Queens College of CUNY, Flushing, New York:
Maltose sensing and signaling in Saccharomyces and its
glucose regulation.
J.E. Hopper, Pennsylvania State University, Hershey: The
Gal3p-Ga180p-Gal4p transcription switch of the yeast,
Saccharomyces cerevisiae: A galactose-sensing switch.
SESSION 5: Glucokinases and Hexokinases
Chairperson: J. Sheen, Massachusetts General Hospital, Boston
M.A. Magnuson, Vanderbilt University School of Medicine,
Nashville, Tennessee: Glucokinase: Role as glucose signal
mediator in mammals.
D. Granot, Agricultural Research Organization, Bet Dagan,
SESSION 6: Sugar and Hormones and Nitrogens
Chairperson: G. Coruzzi, New York University, New York
S.C. Smeekens, University of Utrecht, The Netherlands:
Interactions between sugar and hormonal signaling path-
ways in plants.
P. Leon, Institute de Biotechnologia, UNAM, Morelos, Mexico:
Sugar sensing and signaling in plants and other organisms.
D.R. Bush, University of Illinois, Urbana: Sucrose signaling in
C. Hoffman, Boston College, Chestnut Hill, Massachusetts:
Glucose detection and adenylate cyclase activation in fis-
sion yeast.
W. Heideman, University of Wisconsin, Madison: Trying to
connect the effects of glucose on growth with effects on the
cell cycle in yeast.
Israel: Comparative roles of hexokinase and fructokinase in
tomato sugar sensing.
J. Sheen, Massachusetts General Hospital, Boston: Plant
hexokinases: Novel features and functions.
phloem loading.
A. Krapp, University of Heidelberg, Germany: Metabolic sig-
naling in C/N interaction.
G. Coruzzi, New York University, New York: Sugar signaling
and C:N regulation of amino acid biosynthesis in
Arabidopsis.
M. Magnuson, K. Koch
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Getting Rid of the Bodies
November 12-15
FUNDED BY
ARRANGED BY G. Chimini, INSERM-CNRS, Marseille, France
M. Hengartner, Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory Corporate Sponsor Program
Introduction:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Membrane Events
Chairperson: J. Savill, Royal Infirmary, Edinburgh, United Kingdom
J. Borst, The Netherlands Cancer Institute, Amsterdam:
Mechanism and relevance of sphingomyelin hydrolysis dur-
ing apoptosis.
P. Williamson, Amherst College, Massachusetts: Phospho-
lipid scramblase activation in apoptotic lymphocytes.
C.J. Fielding, University of California, San Francisco:
SESSION 2: Apoptotic Receptors and Downstream Signaling
Chairperson: M. Hengartner, Cold Spring Harbor Laboratory
V.A. Fadok, National Jewish Medical and Research Center,
Denver, Colorado: Engagement of a new receptor for phos-
phatidylserine is required for engulfment of apoptotic cells
by phagocytes.
G. Matsushima, University of North Carolina, Chapel Hill:
Role of Mer in macrophages and autoimmunity.
C.D. Gregory, University of Nottingham Medical School,
United Kingdom: Role of CD14 in apoptotic-cell clearance.
S.C. Finnemann, Weill Medical College of Cornell University,
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Modification of cell surface phospholipids.
G. Chimini, INSERM-CNRS de Marseille Luminy, France:
Membrane lipid architecture and competence to engulf.
R.A. Schlegel, Pennsylvania State University, University Park:
Necessity and sufficiency of loss of phospholipid asymmetry
by target cells and macrophages for phagocytosis.
New York: Focal adhesion kinase dynamics during al 35
integrin-dependent photoreceptor
nal pigment epithelium.
K. Ravichandran, University of Virginia, Charlottesville: Role for
Crkll and lipid raft domains in engulfment of apoptotic cells.
M.L. Albert, The Rockefeller University, New York: Vivir La
Muerte: The avB5 integrin recruits the CrklI/DOCK 180 mol-
ecular switch for phagocytosis of apoptotic cells.
N. Franc, P. Williamson, G. Chimini
SESSION 3: Modulation of Phagocytosis
Chairperson: C.D. Gregory, University of Nottingham Medical School
S. Gallucci, National Institutes of Allergy and Infectious
Diseases, NIH, Bethesda, Maryland: Induction of
apoptosis in dendritic cells by an exogenous danger
signal.
G. Randolph, Mt. Sinai School of Medicine, New York:
Differentiation of monocytes into migratory dendritic cells
SESSION 4: Invertebrate Systems
Chairperson: S. Nagata, Osaka University Medical School, Japan
M. Hengartner, Cold Spring Harbor Laboratory: Engulfment
genes cooperate with ced-3 to promote apoptosis in C.
elegans.
Z. Zhou, Massachusetts Institute of Technology, Cambridge:
C. elegans CED-1 is a transmembrane receptor that recog-
nizes cell corpses and initiates their engulfment.
M.A. Driscoll, Rutgers, State University of New Jersey,
SESSION 5: In Vivo Models
Chairperson: G. Chimini, INSERM-CNRS, Marseille, France
J. Savill, Royal Infirmary, Edinburgh, United Kingdom:
Comparison of clearance in vitro and in vivo.
M. Botto, Imperial College School of Medicine, London,
United Kingdom: Complement, apoptosis, and autoimmu-
city.
P.R. Martin, University College London, United Kingdom:
Points for Discussion
Chairperson: M. Hengartner, Cold Spring Harbor Laboratory
Universality of the Apoptotic Process
Diseases and Apoptosis
Other Points
I.
D
, United Kingdom
after delivery of a phagocytic stimulus.
Dransfield, University of Edinburgh Medical School, United
Kingdom: Regulation of macrophage capacity for phagocy-
tosis of apoptotic cells.
. Mevorach, Tel Aviv Medical Center, Israel: Getting rid of the
bodies: The milieu determines patterns of uptake.
Piscataway: A monopoly of undertakers: A common set of
genes mediate the removal of both apoptotic and necrotic
cellcorpses in C. elegans.
N.C. Franc, Massachusetts General Hospital, East
Charlestown: Phagocytosis of apoptotic cells by Drosophila
(getting rid of the bodies and fly away).
Clearance of apoptotic debris in macrophageless PPU.1 KO
mice.
S. Nagata, Osaka University Medical School, Japan: DNA
fragmentation by phagocytes and its abnormality.
G. Bokoch, The Scripps Research Institute, La Jolla,
California: Macropinocytosis.
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Signaling Network Control-Cell Interactions: Phase II Meeting
November 27-29
FUNDED BY
ARRANGED BY R. lyengar, Mount Sinai School of Medicine, New York
National Institute of General Medical Sciences, NIH
Overview:
R. lyengar, Mount Sinai School of Medicine, New York
Opening:
Comments by Bridging Grant Clusters Leaders
Open Discussion (Data Exchange)
Break Out Sessions for the five Bridging Grant Clusters I
Report back of the Break Out Sessions (Integration I)
Break Out Sessions for the five Bridging Grant Clusters II
(Members participating in two Bridging Grant Clusters can
switch groups in the two sessions)
Report back of the Break Out Sessions (Integration II)
Talks:
B. Ray, Science, Washington, D.C.
J.D. Scott, Oregon Health Sciences University, Portland,
Oregon
R.W. Tsien, Stanford University School of Medicine,
California
Role of the Facilities
Discussion Leaders:
H.E. Hamm, Northwestern University Medical School,
Chicago, Illinois
H. Weinstein, Mount Sinai School of Medicine, New York
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RALs and Their Relationships to Bridging Grant
Clusters
Discussion Leaders:
M.P. Sheetz, Columbia University, New York
T.C. Sudhof, University of Texsas Southwestern Medical
Center, Dallas
Open Discussion (Integration III and Data Exchange)
Talks:
G. Mandel, HHMI, State University of New York, Stony
Brook
K. Svoboda, Cold Spring Harbor Laboratory
Project Organization and Administration
Discussion Leaders:
R. Goodman, Oregon Health Sciences University, Portland
M.P. Sheetz, Columbia University, New York
Topics:
Administrative and Project Management Plans
Administrative Facility
Education and Data Dissemination
Phase II Grant Organization
Writing and Internal Review Assignments
Back view of Banbury Conference Center.
The Application of Arabidopsis Genomics to Forestry and
Other Complex Plant Systems
December 4-7
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY R. Martienssen, Cold Spring Harbor Laboratory
R.R. Sederoff, North Carolina State University, Raleigh
SESSION 1: Comparative Genomics I
R. Martienssen, Cold Spring Harbor Laboratory: The
Arabidopsis genome.
D.B. Neale, University of California, Davis: Comparative
genetic mapping in pine.
S.H. Strauss, Oregon State University, Corvallis: Poplar as a
tool for functional genomics of trees.
SESSION 2: Comparative Xylogenesis I
M. McCann, John lnnes Centre, Norwich, United Kingdom:
Analysis of gene expression patterns as mesophyll cells of
Zinnia elegans trans-differentiate to tracheary elements.
A. Jones, University of North Carolina, Chapel Hill: Signal
transduction pathways in plant cell elongation, division, and
differentiation.
A. Groover, University of California, Davis: Dissecting vascular
G. Sandberg, Swedish University of Agricultural Sciences,
Umea, Sweden: Arabidopsis: A necessity for the success of
the Swedish poplar functional genomics program.
R.J. Kodrzycki, Westvaco Corporation, Summerville, South
Carolina: Functional genomics in forest trees: An industry
perspective.
development in herbaceous and woody plants using gene
traps.
D. Horvath, USDA/ARS/BRL, Fargo, North Dakota: Use of
Arabidopsis microarrays for study of heterologous systems.
S. Lev-Yadun, University of Haifa at Oranim, Tivon, Israel:
Wood and fiber formation in Arabidopsis.
D. Luke, R. Sederoff
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SESSION 3: Comparative Genomics II
V. Irish, Yale University, New Haven, Connecticut: Evolution of
floral developmental mechanisms.
S. Tingey, DuPont Company, Newark, Delaware: Com-
parative genomics between E grandis and A. thaliana,
0. sativa, and Z. mays.
T. Mitchell-Olds, Max-Planck Institute for Chemical Ecology,
Jena, Germany: Quantitative genetics and comparative
genomics of Arabidopsis.
C. Loopstra, Texas A&M University, College Station:
Arabinogalactan proteins and wood development: The
Arabidopsis genome.
SESSION 4: Discussion of Policy Issues
Chairperson: R.R. Sederoff, North Carolina State University, Raleigh
SESSION 5: Comparative Xylogenesis II
E. Beers, Virginia Polytechnic Institute & State
University, Blacksburg: Arabidopsis as a model for the
study of protease function in vascular tissues.
S. Wyatt, Ohio University, Athens: Reaction wood and
Arabidopsis: A developing model.
SESSION 6: Woody Plant Systems
W. Boerjan, University of Gent, Belgium: Mapping and genet-
ic engineering in Populus.
R. Alscher, Virginia Polytechnic Institute & State University,
Blacksburg: Toward understanding stress response mecha-
nism in loblolly pine: A systems approach.
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B.R. Franke, Purdue University, West Lafayette, Indiana:
Lignin engineering with P450s.
M. Campbell, University of Oxford, United Kingdom: The
developmental control of lignification.
R.R. Sederoff, North Carolina State University, Raleigh: The
pine genome project: Comparative genomics.
J.E. Carlson, Pennsylvania State University, University Park:
Environmental genomics and hardwood forests.
Robertson House
Gene Ontology Annotation and the Human Genome
December 10-12
ARRANGED BY M. Ashburner, University of Cambridge, United Kingdom
SESSION 1: Presentations from the Gene Ontology
Consortium
M. Ashburner, University of Cambridge, United
Kingdom
J. Blake, The Jackson Laboratory, Bar Harbor, Maine
S. Lewis, University of California, Berkeley
SESSION 2: Presentations from Other Public Domain
Groups
R. Apweiler, European Bioinformatics Institute, Cambridge,
United Kingdom
M. Clamp, Sanger Centre, Cambridge, United
Kingdom
D. Maglott, National Center for Biotechnology Information,
Bethesda, Maryland
S. Povey, University College London, United Kingdom
SESSION 3: Presentations from Companies
K. Roberg-Perez, Proteome, Inc., Beverly, Massachusetts
R. Mural, Celera Genomic Research, Rockville, Maryland
D. Gietzen, Incyte Pharmaceuticals, Inc., Palo Alto, California
A. Kasarskis, Double Twist Inc., Oakland, California
K. Fasman, AstraZeneca Inc., Waltham, Massachusetts
SESSION 4: General Discussion
L. Brooks, National Human Genome Research Institute,
Bethesda, Maryland
J. Cherry, Stanford University School, Palo Alto, California
J. Eppig, The Jackson Laboratory, Bar Harbor, Maine
D. Hill, The Jackson Laboratory, Bar Harbor, Maine
M. Ringwald, The Jackson Laboratory, Bar Harbor, Maine
L. Stein, Cold Spring Harbor Laboratory, New York
P. Thomas, Celera Genomic Research, Rockville, Maryland
J. Wortman, Celera Genomic Research, Rockville, Maryland
S. Lewis, M. Ashburner
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We stand at the threshold of a new century with the whole human genome stretched out before us.
Messages from science and the popular media suggest a world of seemingly limitless opportunities to
improve human health and productivity. Yet, at the turn of the last century, science and society faced
a similar rush to exploit human genetics. The story of eugenics-humankind's first venture into a "gene
age"-holds a cautionary lesson for our current preoccupation with genes.
Eugenics was the effort to apply principles of genetics to improve the human race. Most people
equate eugenics with the atrocities committed for the sake of racial purity in Nazi Germany. Most are
unaware of the "positive" eugenics movement, exemplified in England, which advocated voluntary
efforts by families to improve their own heredity. Fewer still realize that a coercive, "negative" eugenics
movement flourished in the United States, that it involved numerous prominent scientists and civic lead-
ers, and that it made its intellectual home at the forerunner of the now prestigious Cold Spring Harbor
Laboratory.
During the first decade of the 20th century, eugenics was organized as a scientific field by the con-
fluence of Mendelian genetics and experimental breeding. This synthesis was embodied by Charles
Benedict Davenport, who is considered the father of the American eugenics movement. When Charles
Davenport arrived at Cold Spring Harbor in 1898, he assumed the directorship of The Biological
Laboratory, a progressive, if somewhat sleepy, "summer camp" for the study of evolution. Founded in
1890, The Biological Laboratory at Cold Spring Harbor followed in the footsteps of the Marine Biological
Laboratory at Woods Hole, Massachusetts (1888). Both had been established in the tradition of sea-
side biological stations founded along the European coastlines following the publication of Darwin's
Origin of Species. The intersection of land and water was thought to be the ideal place to study how
organisms had evolved and adapted to fill a multitude of aquatic, semi-aquatic, and terrestrial niches.
Although he had been trained in the classic observation methods of zoology and comparative mor-
phology, Davenport became interested in the new movement that sought to directly recreate evolution
in the laboratory. He and a number of other biologists, including Thomas Hunt Morgan, believed that
controlled breeding experiments with plants and animals would yield new insight into evolutionary
processes. Davenport gained the ear of the board of the Carnegie Institution of Washington, one of
several philanthropies formed under Andrew Carnegie's will to disburse the proceeds of the divestiture
of his steel holdings. From them, Davenport secured funding to establish a Station for Experimental
Evolution at Cold Spring Harbor.
The dedication of the Station's first building, in 1904, offered a prediction about the future of exper-
imental evolution-the keynote speech was delivered by Hugo de Vries, one of three researchers who
had recently rediscovered Mendel's laws of genetics. Davenport populated the Station with like-mind-
ed researchers, who made agricultural plants and animals their research subjects. The Station took on
the aspect of a farm with chicken coops, goat sheds, Manx cats and canaries, and fields of corn and
jimsonweed. Many of the researchers at the Station for Experimental Evolution embraced Mendel's
laws, and the shorthand popularized by Reginald Punnet, as a means to follow traits through their
experimental crosses. For many, the intricacies of genetics eventually subsumed the experimental
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The Station for Experimental Evolution, circa 1908. This view from Blackford lawn look-
ing toward Route 25A includes the Carnegie Library beyond the chicken coops. Image
source: Harry H. Laughlin Archives, Truman State University.
study of evolution, and in 1920, the Station for Experimental Evolution was quietly renamed the
Carnegie Department of Genetics. Thus, the experimental evolutionists had become the first genera-
tion of geneticists.
Several years later, Davenport was introduced to Mrs. E.H. Harriman, by way of her daughter, who
had taken a summer course at The Biological Laboratory. Mrs. Harriman was the widow of the railroad
magnate who had founded the New York Central Railroad and its Grand Central Station in Manhattan.
Davenport convinced Mrs. Harriman to contribute $10,000 to establish a Eugenics Record Office
(ERO) on property adjacent to the Station for Experimental Evolution, and she later provided a
$300,000 endowment.
Davenport recruited Harry Laughlin, a person with whom he shared an interest in chicken breeding,
as superintendent of the ERO. Davenport's little book, Eugenics: The Science of Human Improvement
by Better Breeding, illustrates how eugenicists sought to transfer lessons from agriculture to human
beings. With almost religious zeal, Davenport and Laughlin set out to popularize eugenics. A series of
ERO bulletins, including Davenport's Trait Book and How to Make a Eugenical Family Study, helped to
standardize methods and nomenclature for pedigree studies. Eugenical News, published by the ERO
from 1920 through 1938, was the dominant mouthpiece for the racist and anti-immigration agenda of
eugenics research. The ERO also published a number of forms that facilitated data collection. Many
families proudly submitted their pedigrees of intellectual/artistic achievement, while others sought
advice on the eugenic fitness of proposed marriages. Budding eugenics researchers convened at Cold
Spring Harbor each summer to learn how to conduct field work-interviewing subjects, taking med-
ical histories, and constructing pedigrees. During its years of operation, 1910-1939, the ERO amassed
hundreds of thousands of family records, pedigrees, and articles on eugenics.
Eugenics arose during the progressive era that followed in the wake of the industrial revolution,
when the fruits of science and technology were improving many aspects of life. A growing middle
class of professional managers believed that scientific progress offered the possibility of rational cures
for social ills. At the same time, eugenicists advanced the notion that bad genes lay at the root of age-
old social problems, including poverty, crime, prostitution, and insanity. They warned that bad
genes-especially those purportedly entering the country with immigrants from southern and eastern
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Europe-threatened to pollute the predominately Anglo "foundation stock" of America. "Data" col-
lected by eugenicists begged an obvious question: Why build more insane asylums, poorhouses, and
prisons, when the underlying problem-bad genes-could be halted by controlling human reproduc-
tion? This progressive slant appealed to many educated Americans, who also accepted the
Malthusian notion that the human species required some sort of pruning to maintain its health.
American eugenics was thus transformed, by degrees, from an agricultural experiment to a popular
program in social engineering. Flawed eugenic data provided a supposedly scientific basis for social
legislation to separate racial and ethnic groups, restrict immigration from southern and eastern Europe,
and sterilize people considered "genetically unfit." The 1927 decision of the United States Supreme
Court, Buck v. Bell, upheld the constitutionality of eugenic sterilization and signaled the nadir of
American civil liberty. By the 1930s, the Nazis applauded the scientific use of eugenic sterilization and
based their own sterilization laws on a model provided by the ERO's Harry Laughlin.
Although scientific opposition to eugenics mounted in the United States during the 1930s, it did lit-
tle to dampen public enthusiasm. Many sophisticated geneticists, including some whose data refuted
key eugenic tenets, were ambivalent and supported some type of eugenic program at one point or
another. Only growing public knowledge of the Nazi's horrific "final solution" to achieve racial purity led
to a wholesale abandonment of popular eugenics, and the ERO was closed in December 1939.
The eugenicists sought an exclusively genetic explanation of human development, neglecting the
important contributions of the environment. They managed to inculcate this belief into a whole gener-
ation of educated Americans. This is perhaps the greatest danger of modern genetics-that genes
once again will be misconstrued as the sole determinants of human life. Genetic determinism is implic-
it in the Human Genome Project's objective to identity genes involved in human health. The search for
disease genes, prima facie, entails value judgments about what is normal versus abnormal. The social
and legal acceptance of such judgments may create a pressure for genetic conformity that is difficult
to predict today. What will it be like when we have a precise catalog of all the good, bad, and middling
genes, and the wherewithal to determine who has which? In the face of such knowledge, will society
continue to acquiesce to those who prefer to let nature take its course?
The real lesson of eugenics is that it was practiced by well-intentioned persons and bigots alike, and,
short of the most obvious excesses, there was often no sharp line between them. Certainly forms of
behavior that pass for eugenics are with us today. The killing fields of Cambodia, Central Africa, and the
Balkans differ only in method and degree from the Nazi regime of
"negative eugenics." Viewed in the cold light of racial and ethnic
cleansings, it may seem clear to some that strict, and amoral,
adherence to scientific data will protect us from future abuses of
genetics. In this sense, the cleansing of the human genome of
disease genes can be viewed as merely antiseptic. However, the
past tells us that assumptions about human genetics are rarely
value-neutral-many of the first crop of human geneticists loaded
their data and models with their own aspirations for society.
We chuckle at eugenicists' pedigrees of musical talent,
lack of moral control, and criminal tendencies. Yet today, molec-
ular geneticists are actively searching for genes involved in per-
fect pitch, sexual orientation, aggression, and other constructs of
human behavior. Every parent's longing for healthy, happy chil-
dren, who can continue the flow of their family heritage, is an
expression of the best aspirations of "positive eugenics." In the
context of in vitro fertilization, what parent would not choose to
implant the embryo whose gene combination favors intelligence
and creativity? Therefore, rather than dismissing eugenics out of
hand, it is far better that each of us attempts to discover where
we, and the technologies that we are using, stand in its continu-
um. Then we can guard against slipping too far.
Harry Laughlin and Charles
Davenport outside the Eugenics
Record Office (ERO). Image source
Harry H. Laughlin Archives, Truman
State University.
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Launch of the Image Archive on the American Eugenics Movement
With these ideas in mind, in 1998 we embarked on a major project to collect archival materials on the
American eugenics movement and publish them on the World Wide Web (WWW). On February 11, we
launched the Image Archive on the American Eugenics Movement, as the second major content site
at the DNALC's WWW Site. The project is funded by a grant from the Ethical, Legal, and Social
Issues(ELSO Program of the National Human Genome Research Institute.
With more than 1200 images and documents, the Eugenics Archive provides students, teachers,
scholars, and the interested public with an extraordinary window into a "hidden" chapter of history. We
hope that the opportunity to revisit this period will stimulate people to think critically about our current
involvement in human genetics. By providing access to the eugenicists' own words and "data," we hope
to challenge visitors to assume the role of historian/researcher. By focusing primarily on visual docu-
ments, we hope to engage young people and others who would not normally access a scholarly collec-
tion.
When we were conceptualizing the project, we wanted to develop a resource that could stimulate
independent thinking about eugenics without espousing a "correct" interpretation of the materials.
Although there was consensus that it is important to make the materials available for public scrutiny,
there was also grave concern that they might be misinterpreted as "proven science" and therefore be
misused to support racist views. Thus, we were challenged to assist users in understanding the his-
torical, social, political, and ethical context in which the American eugenics movement developed,
flourished, and finally collapsed. Context is built into the Archive on two levels. First, users are encour-
aged to enter the Site through a series of virtual exhibits, which introduce the key events, persons, and
social conditions that contributed to the development of eugenics. Second, all images are sorted into
more than 20 topic areas. Browsing by topic or searching by keyword returns a set of related images
with extended captions. The topic captions are designed to help the user understand relationships
among images and the relationship of the image to the eugenics movement and society. Both levels
were developed in collaboration with several leading historians of eugenics. At each level, users are
reminded that the vast majority of what was presented as scientific "fact" by eugenicists was funda-
mentally flawed and has been discredited by modern research standards.
The very act of publishing eugenic materials on the Internet set precedents for other projects deal-
ing with the release of sensitive documents via the Internet. The documents were drawn from four
major archives: the American Philosophical Society Library, Rockefeller University Archive Center,
Truman State University Archives, and Cold Spring Harbor Laboratory Research Archives. At the start
of the project, each archive had concerns about the large-scale publication of eugenic materials, and
none had policies governing the release of their materials over the Internet. Thus, we were challenged
to develop guidelines for online publication, educational "fair use" of documents, and privacy protec-
tions for subjects of the Archive. These policies were developed by consensus during 6 days of work-
shop sessions by a 15-member advisory panel:
Garland Allen, Washington University, St. Louis,
Missouri
Elof Carlson, SUNY, Stony Brook, New York
Pat Colbert-Cormier, Lafayette High School, Louisiana
Nancy Fisher, Regence Blue Cross, Seattle, Washington
Henry Friedlander, City University of New York, New
York
Daniel Kev les, California Institute of Technology,
Pasadena
Philip Kitcher, University of California, San Diego
Martin Levitt, American Philosophical Society,
Philadelphia, Pennsylvania
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Paul Lombardo, University of Virginia, Charlottesville
Nancy Press, Oregon Health Sciences University,
Portland
Philip Reilly, Shriver Center for Mental Retardation,
Waltham, Massachusetts
Pat Ryan, Carolina Biological Supply Company,
Burlington, North Carolina
Marsha Saxton, World Institute on Disability, San
Francisco, California
Steven Selden, University of Maryland, College Park
Terry Sharrer, National Museum of American History,
Washington, D.C.
Completion of DNA from the Beginning
In the fall, we completed a 3-year project to publish an online "primer" on genetics, DNA from the
Beginning (DNAFTB). Funded through a grant from the Josiah Macy, Jr. Foundation, DNAFTB is one of
the most content-rich and innovative Web Sites on the WWW. Aimed at a high school audience, the Site
is popular with genetics teachers, but also with regular folks who are interested in keeping up with today's
news stories on cloning and genetic engineering. More than 750,000 people viewed DNAFTB in 2000,
and it accounts for about 60% of the visits to the DNALC WVVW Site. DNAFTB's media-rich elements
were designed to operate over fast Internet connections (such as T1, cable modem, and DSL), so in
2001, we will offer a CD version that will play quickly in situations with slow, or no, Internet connectivity.
The 41 chapters cover concepts a person needs to know to understand what is going on in biolo-
gy today, from Mendelian genetics to the structure of DNA to techniques used to make "knock-out"
mice. Central to each chapter is an animation in which researchers describe how they did key experi-
ments that contributed to understanding the concept. The animation helps viewers visualize molecular
events and dynamic interactions that are difficult to portray in static diagrams. Video clips and a gallery
of personal photographs bring home the fact that scientists are real people with whom anyone can
identify. The work of more than 80 scientists is highlighted in animations and interviews, including 25
Nobel Laureates (*) and 11 past and present CSHL scientists (+):
Garland Allen Charles Davenport+ Edward Lewis" Thomas Sargent
Oswald Avery Igor Dawid Scott Lowe+ Brian Sauer
David Baltimore" Hugo de Vries Maclyn McCarty Theodor Schwann
George Beadle" Walther Flemming Barbara McClintock*" Jane Setlow
Seymour Benzer Stephen Fodor Richard McCombie+ Richard Setlow
Michael Bishop* Rosalind Franklin Gregor Mendel Philip Sharp*
Theodor Boveri Raymond Geste land Matthew Meselson George Shull'
Herbert Boyer Walter Gilbert* Freidrich Miescher Frank Stahl
Sydney Brenner Doug Hanahan+ Stanley Miller Nettie Stevens
Roy Britten Leland Hartwell Jacques Monad* Alfred Sturtevant
Patrick Brown Michael Hengartner+ Thomas Hunt Morgan" Howard Temin"
Leigh Burgoyne Alfred Hershey" Hermann Muller* Harold Varmus*
Mario Capecchi Dean Hewish Marshall Nirenberg* J. Craig Venter
Elof Carlson Mahlon Hoagland Christiane Nusslein-Volhard" Erich von Tschermak-Seysenegg
Thomas Cech" Robert Horvitz Robert Olby Ivan Wallin
Erwin Chargaff Francois Jacob* Svante Paabo James Watson"+
Stanley Cohen Arthur Kornberg" Reginald Punnett Eric Wieschaus"
Francis Collins Roger Kornberg Richard Roberts`+ Michael Wigler
Carl Correns Phil Leder Stanley Rupert Maurice Wilkins"
Francis Crick* Joshua Lederberg" Frederick Sanger* Paul Zamecnik
James Darnell Phoebus Levene
UNCLE DARWIN SAYS
I WANT YC
TO VOTE FOY
DNAFRTZ BEGIN]
tattp: / /vector . cshl . or
Postcards were mailed in
spring and winter 2000 to
promote DNA from the
Beginning. The Uncle
Darwin postcard was also
used to solicit votes for the
Webby Awards (discussed
on the following page).
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Webby Nominations and Renewed Funding for the BioMedia Group
The success of the DNALC's Internet publishing ventures was affirmed in April when members of the
BioMedia group traveled to San Francisco to attend the 2000 Webby Awards, which are billed as the
online Oscars. DNA from the Beginning was a finalist in the education category, and the DNALC por-
tal site, Gene Almanac, was a finalist in the science category. We also received continuation funding
for our two major content projects. Image Archive on the American Eugenics Movement received a
three-year continuation from the National Human Genome Research Institute, bringing five-year fund-
ing to $1,160,000. The Josiah Macy, Jr. Foundation approved a two-year continuation for DNA from
the Beginning, bringing five-year contributions to $1,370,000. These renewals continue the BioMedia
group's healthy financial situation and will allow us to be in full operation when we occupy our new
BioMedia addition in 2001.
Macy funding will be used to develop Your Genes, Your Health (YGYH) as a companion to the exist-
ing site, DNA from the Beginning. YGYH will be a multimedia guide on genetic disorders for which
causative genes have been identified and for which new diagnostics are available and rational treat-
ments imminent. The site is specifically targeted at patients and families who are urgently looking for
understandable information about a specific genetic disorder. These people are motivated to under-
stand the meaning (the biology) behind the medical jargon they have read about or heard from a physi-
cian. The site will contain a number of resources that can help families participate more effectively in
the care of a loved one:
Animations to help visualize the unseen world of genes and molecules.
Interviews with researchers and patients to provide insiders' perspectives on genetic disorders.
Links to current news articles, support groups, and clinical trials to provide up-to-the-minute infor-
mation on treatment options.
To make the site as responsive as possible to the needs of consumers, in December we convened a
focus group of representatives from 10 genetic disorder foundations and support groups. We will con-
tinue to enlist the help of disorder-specific foundations and support groups to put us in touch with
experts and families to interview for the VVVVVV site and to review content prior to public release. By the
end of the year, we were well on the way to producing the first module-on Fragile X Syndrome. By
fall 2002, we expect to have published modules on 15 of the most common and most severe disor-
ders for which genes have been identified (or are expected to be identified soon): Alzheimer, cystic
fibrosis, Down syndrome, hemochromatosis, hemophilia, Huntington, Lou Gehrig, Marian, muscular
dystrophy, neurofibromatosis, Parkinson, phenylketonuria, sickle cell anemia, and Tay-Sachs.
Vector Net Portable Computer Laboratory
By year's end, we completed development of Vector Net, a portable computer laboratory designed as
the centerpiece of a pre-college science education grant from the Howard Hughes Medical Institute.
Vector Net was developed in response to problems we experienced conducting computer labs at insti-
tutions in the United States and abroad over several years, including lack of fast Internet service, local
network unreliability, security provisions, nonuniform hardware setups, and software misconfigurations.
The stand-alone system provides all computer hardware and software needed to deliver high-quality
bioinformatics instruction at any location, regardless of existing computer infrastructure.
The Vector Net Laboratory consists of 12 participant notebook computers, network server-in-a-box,
wireless router, wireless intranet transceivers, and video projector. The system can operate entirely from
DNALC VVVVW Sites and Genbank subdatabases stored on the network server, or the router can pro-
vide centralized Internet access via a single T1, cable modem, or DSL connection. This equipment is
packed in two wheeled containers, which can be shipped or carried as luggage to any site in the
United States. Host institutions for Vector Net need only provide a classroom or seminar room with
tables, power points, and (optionally) a fast Internet line.
We also completed development of the key Internet resources that will be used in the program's
student and teacher components: three Bioservers and the Genetics Origins meta-site. Allele Server
allows students to tabulate student Alu insertion data and compare two populations by contingency
chi-square, genetic drift, and genetic distance. Sequence Server allows students to compare DNA
sequences through multiple sequence alignments and construction of phylogenetic trees. Both
servers have facilities to allow students to enter their own polymorphism data and to compare their
data with world reference populations. Simulation Server allows students to model genetic changes
over time, simulating the same conditions in 100 or more test populations concurrently. Genetic
Origins contains all resources to support student experiments with two polymorphisms-an Alu inser-
tion and mitochondrial sequence variations. This "super site" includes laboratory protocols, reagent
recipes, supporting animations, guided use of Bioservers, and video interviews with molecular anthro-
pologists.
Vector Net functioned without major difficulties during the initial rotation at John F. Kennedy High
School (Bronx), where 128 8th- and 9th-grade students used the portable lab to access the Image
Archive on the American Eugenics Movement and DNA from the Beginning. The Allele Server was also
used to analyze student DNA types for the Alu insertion polymorphism PV92. One teacher reported that
working at the Allele Server site really helped students understand the difficult concept of genetic equi-
librium in populations. Additional rotations for the 2000-2001 academic year have been planned in col-
laboration with the Gateway to Higher Education Program of Mt. Sinai School of Medicine and include
the following schools: Benjamin Cardozo High School (Queens), Brooklyn Technical High School,
Lafayette High School (Brooklyn), Life Sciences Secondary School (Manhattan), Queens Gateway to
Health Sciences High School, Science Skill Center (Brooklyn), Bayard Bustin High School for the
Humanities (Manhattan), and Stevenson High School (Bronx).
Initially, we had the entire setup returned for maintenance and server updating at the DNALC.
However, in the future we intend to do most maintenance on site. Future rotations will be made easier
by the purchase of a second server, which will allow us to provide each school with an up-to-date mir-
ror of the DNALC VVVVW site. The equipment set will be transferred directly between schools. In a sin-
gle visit to the receiving school, a DNALC staff member will swap the old server for an updated one,
run equipment checks, and train participating staff.
During the next several academic years, the Vector Net Laboratory will continue to be rotated among
New York City Public Schools. However, beginning in summer 2001, the Vector Net Laboratory will take
on an additional life. During the summer, Vector Net will provide the infrastructure for administering
week-long workshops on bioinformatics for biology teachers at sites held around the United States. In
the 1980s and 1990s, the Vector DNA Science Workshop brought the methods of bacterial molecular
genetics to teachers around the country. Now, the Vector Net Bioinformatics Workshop aims to help
faculty extend their expertise to human molecular genetics and genomic biology.
We Prepare to Occupy a New Facility
Despite wet conditions during much of the summer, construction of the Bio Media addition progressed
with amazing speed. The completion of this 8000-square-foot structure in spring 2001 will double the
size of our facility and will provide the physical infrastructure needed to substantially increase the
DNALC's impact on modern biology education.
By year's end, it was easy to visualize the future life of the new structure. The exterior brick façade
and Georgian details blend perfectly with the existing building. One immediately grasps the cleverness
of the design, which nestles the structure into the hillside such that the second-floor offices open direct-
ly onto the woody glade. Prominent on the lower level is the large space that will be occupied by a new
teaching laboratory-directly in line with two other labs in our existing building. One can sense that the
octagonal computer lab, centered on the main entrance to the addition, will become the symbolic heart
of the building. This striking space, with two tiers of glass-countered work spaces, will emphasize that
the business of understanding the trove of data from the Human Genome Project has, indeed, trans-
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Clockwise from upper left: view of the BioMedia Addition from the west parking lot; the Bio Media Computer
Laboratory; the genetics laboratory; and the suite of offices and conference area on the upper level. Images taken
in December 2000.
formed biology into an information science. Like the best of today's genome biologists, students will
have the opportunity to move effortlessly between biochemical manipulations of DNA and computer
manipulations of the information stored in that DNA.
A large central gallery will nearly double the size of adjacent galleries in the existing building. Here,
working in collaboration with curators from the American Museum of Natural History and the
Smithsonian Institution, we will install entirely new exhibits on the Human Genome Project. A mini-DNA
sequencing laboratory, where high school interns prepare and sequence DNA samples submitted from
students around the country, will greet visitors entering this exhibition. One module will use the Old
Order Amish as a case study-both of using distinct population groups to track down disease genes
and as a metaphor for our rush into the "gene age." Although this anachronistic group appears to be
stuck in the 19th century, they accept modern genetic medicine and are even preparing to participate
in gene therapy trials. Another module will highlight CSHL's effort to sequence plant genomes: the
model plant Arabidopsis and the important staple, rice. A module on the American eugenics move-
ment, drawn from the evocative materials at our WVVVV site, will highlight lessons that can be learned
from the misuse of genetics in the first part of the 20th century.
The entire upper level of the addition will be the home of the Bio Media group, our Internet publish-
ing venture that focuses on providing authoritative, multimedia content on genetics. The loft-like space
includes editorial offices and multimedia editing suites to support five major VVWW sites in the DNALC
portfolio. A video studio will allow us to expand into broadband communications and to further exploit
CSHL's position as a gathering place for the world of molecular genetics. Here, we will interview lead-
ing scientists for use on our WVVW sites and, potentially, for cable distribution.
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We Become the First Science Center to Perform On-Site DNA Sequencing
During the past 2 years, we have developed a relatively simple system to allow students to obtain and
work with their own DNA sequences. Using a kit developed by the DNALC and distributed by 3
Carolina Biological Supply Company, students isolate DNA from hair roots or cheek cells, then mix their
DNA with freeze-dried PCR reagents to amplify (enrich) a highly variable region of their mitochondrial
genome. The amplified samples are then mailed to the DNALC, where high school interns perform the
final DNA sequencing reactions.
The DNA sequences are placed in the Sequence Server database at our VVWW Site, where they can
be used to perform a number of analyses, including evolutionary comparisons with DNA from ancient
humans and Neanderthals. The sequencer is currently set up on a Plexiglas-enclosed lab bench in our
main exhibit hall, but will become a larger Visible Sequencing Laboratory as part of the major new
exhibit on the Human Genome Project.
Initially, the actual sequencing was done in Dick McCombie's lab on the main campus, but in the
spring we moved the sequencing to the DNALC. This was made possible by the gift of a new 377 DNA
Sequencer, valued at $130,000, arranged by our good friend Frank Stephenson, head of technical
training at Applied Biosystems. During the year, we processed 1140 samples submitted by 36 high
schools, 15 universities/colleges, and 6 community colleges throughout the country. In addition, a
switch to "big dye" chemistry substantially improved results. We are grateful for the help that we have
received from the CSHL Genome Sequencing Center and Applied Biosystems, which has enabled us
to prove the feasibility of providing a centralized sequencing facility for educational purposes.
In addition to our national program, we began offering DNA sequencing on the "menu" of lab field
trips offered to students from local school districts. Students isolate and amplify their own mitochon-
drial DNA. After confirming polymerase chain reaction (PCR) success by electrophoresing samples in
an agarose gel, students set up sequencing reactions using their own templates. Students and teach-
ers are also introduced to the ABI 377 sequencer and to online sequence analysis tools available at the
DNALC VVVVW site. After returning to school, the student samples are sequenced, and their sequence
data are posted in the Sequence Server database.
During the year, we continued our collaboration with Rob De Salle, head of the molecular biotech-
nology laboratory at the American Museum of Natural History in New York. Rob was curator of the high-
ly successful exhibit "Outbreak" (1999) and is curator of the forthcoming exhibit, "The Genomic
Revolution" (2001). With advice from the DNALC, Rob has included a teaching lab and DNA sequencer
as integral parts of the exhibit. He plans to replicate our mitochondrial DNA sequencing program for
field trips by New York City students visiting the museum's genome exhibit.
Instructional Programs Continue to Grow
The year proved to be a trying one for the DNALC staff. There was not a trace of unhappiness when
mechanical preparations for the BioMedia addition necessitated moving everyone out of our dreary
basement offices. We retasked exhibit space as a temporary office for the instructional staff, but there
was no room at all for the BioMedia group, which ended up in very nice quarters in Williams House on
the main CSHL campus. The retrenching of exhibit spaces and general overcrowding meant that over-
all visitation held steady at the 1999 level of 30,200. Miraculously, however, a record 21,750 students
and teachers participated in hands-on labs and workshops.
During the spring, we wrapped up a successful workshop series sponsored by the Ethical, Legal,
and Social Issues (ELSI) Program of the Department of Energy's Human Genome Initiative. The Science
& Issues of Human DNA Polymorphisms introduced high school faculty to our hands-on experiments
and computer software for the classroom analysis of human DNA. The final workshops were held at
the Mailman Center for Child Development, University of Miami School of Medicine, and Austin
Community College. During the summer, we concluded the National Science Foundation-sponsored
program, Genomic Biology, with workshops held in Oklahoma, Utah, California, and New York.
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Staff and Interns
Although several staff members departed during the year, there was a net growth of two positions in the
DNALC staff in anticipation of expanded laboratory and Internet programs in the BioMedia addition.
In March, we were saddened to learn that Matt Christensen was leaving the BioMedia group to start
a programming job in Chicago at unext.com. Matt was not just any programmer-he was a program-
mer with a passion for biology and bioinformatics. In addition to building our web site from scratch, he
constructed a user-friendly interface for the bioinformatics tools that are found elsewhere on the Web
but are tricky for high school students to navigate. Matt is currently enjoying the city life in Chicago, but
his car has taken a beating in the 20-inch snow and 20-inch potholes.
Trish Maskiell (formerly Harrison) left us for New Hampshire when her husband got a new job. Trish
started at the DNALC as a middle school teacher in 1997 and was promoted to Education Coordinator
in 1998. Under Trish's management, enrollment in middle school programs increased and relationships
with outside school districts solidified. Inside the classroom, Trish introduced the glowing genes lab
and live C. e /egans to young students. Kids loved Trish's mild-mannered teaching style and the analo-
gies she came up with to help them understand genetics. Although she planned on becoming a stay-
at-home mom in New Hampshire, rumors have it that she is back to coordinating, this time for a dis-
trict-wide after-school program.
About the same time Trish left, we also said goodbye to Martha Mullally, a middle school teacher
since 1998. Martha brought the middle school group her unique lab experience and successfully trans-
lated it for her students. One outside teacher said it best when she exclaimed, "I just love watching her
teach! She's like a mad scientist!" Martha returned to her native Canada to start a 1-year education
program at the University of Ottawa that will lead to a Canadian teaching certificate.
Veronique Bourdeau joined us in June to teach high school classes and develop new labs for the
students. Vero recently received her Ph.D. in biochemistry from her hometown school, the University
of Montreal, but grew up wanting to become a teacher. As luck would have it, her husband's work
brought her to Cold Spring Harbor, and now she combines her research and teaching skills for us.
Two new middle school instructors also joined us this past summer, Elna Carrasco and Maureen
Cowan. Elna knew she wanted an adventurous career in science after watching "Raiders of the Lost
Ark." In love with the 70-foot Apatosaurus at the American Museum of Natural History since she was
five, Elna searched for dinosaur fossils in Montana as part of her work for a degree in earth and space
science from SUNY, Stony Brook. At the DNALC, she combines her interests in evolution and theater
by performing/teaching the "Story of a Gene" to 5th through 8th graders.
Maureen Cowan had a teaching career in the back of her mind since high school, but it never real-
ly clicked until a friend complimented her presentation in a college genetics course. After graduating
from Villanova in 1998 with a B.S. in biology, she came to Jerry Yin's lab at Cold Spring Harbor to study
fruit fly behavior and worked at night on her master's degree in Secondary Education. Maureen brings
her excitement about genetics into the classroom and is an excellent teacher.
"Jack-of-all-trades," Uwe Hilgert, joined the BioMedia group in November. Uwe (pronounced oov-
eh) did his Ph.D. work at the Max-Planck Institute in Cologne, Germany, and post-doc work at the
University of Arizona in Tucson. Engrossed with pathogenic fungi, Uwe was nevertheless drawn out of
the lab one day to talk with an elementary school class, and the experience changed him forever. Since
then, Uwe has helped develop science modules with teachers, taught molecular biology to senior citi-
zens, and dabbled in the use of computers in teaching. At the DNALC, he is currently updating our
bioinformatics tools and working with teachers to bring these tools to underprivileged schools in New
York City.
Vin Torti joined us at the beginning of the year as the DNALC's own development officer. Vin spent
15 years teaching philosophy and raising money at Xaverian High School in Brooklyn before joining the
development office at Cold Spring Harbor Laboratory. He enthusiastically combines his love of teach-
ing with his love of raising money to make sure we can keep bringing the best genetics education to
Long Island, New York City, and the world.
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New employees, from
left to right: Maureen
Cowan, Uwe Hilgert,
Elna Carrasco, and
Veronique Bourdeau.
The DNALC's staff of high school interns continues to be a vital part of the daily "runnings" of the
educational department. Interns prepare equipment and reagents for on-site and off-site lessons and,
in the process, learn standard scientific techniques such as microbiological care and culturing, prepar-
ing and diluting solutions, restricting and ligating DNA, analyzing and sequencing DNA, and transform-
ing cells. They experiment with many of the protocols when we reevaluate and upgrade the lessons.
Currently, our veteran interns are Rebecca Shoer (Syosset High School), Caroline Lau (Syosset High
School), Daniel Goldberg (Half Hollow Hills East High School), Yan Huang (Harborfields High School),
and Janice Lee (Oyster Bay High School), and we welcomed newcomers Jordan Komisaro (Long
Beach High School), Jared Winoker (Syosset High School), Benjamin Blond (Long Island School for the
Gifted), and Marie Mizuno (Cold Spring Harbor High School).
After several years, many of our interns find their DNALC experience useful when they leave us for
college or other jobs. Ken Mizuno, an intern for the past 2 years, headed for Carnegie Mellon University
where he majors in computational biology and minors in computer science. Gina Conenello, an intern
of 3 years, supervised the high school interns during the summer workshops and then left to attend
Bucknell University, where she majors in biochemistry and cell biology. Greg Bautista left to attend
Colgate University. Rebecca Yee, a Wellesley College student, returned during the summer to lead the
middle school interns through the workshop season. Adam Frange (VVantagh High School) left his
internship to begin an apprenticeship with Dr. Huifu Guo in CSHL's Beckman Laboratory.
In addition to their regular duties, many interns conduct independent research projects under the
advisement of Scott Bronson. Caroline Lau and Daniel Goldberg received High Honors from the Long
Island Science Congress for their research accomplished at the DNALC. Dan Goldberg's project
focused on the effects of NF-1 genes in Drosophila melanogaster after heat shock response. Caroline
Lau studied the population genetics of Long Island's native brook trout. Janice Lee is currently
researching techniques in plant PCR. Rebecca Shoer is developing techniques in gene transfer of
Hydra and Jordan Komisaro has already begun developing the tobacco mosaic virus as a classroom
tool in plant research.
After 6 years, the DNALC said goodbye to Jermel Watkins. Jermel was head intern for many years,
assisting instructors and interns alike. Presently, Jermel is working at SUNY, Stony Brook where he is
investigating the genes associated with microglial activation in the brain when exposed to glutamate
and LPS. We will miss him.
The BioMedia group continues to be extremely fortunate in their choice of high school and college
interns. High school interns in 2000 were Tracy Mak, Syosset High School, and Felix Hu, Northport
High School. The summer college interns were Sheila Vyas, Wellesley College, and Joshua Cohen,
University of Washington.
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2000 Workshops, Meetings, and Collaborations
January 28-30 National Human Genome Research Institute ELSI Project, Eugenics Image Archive,
Editorial Advisory Panel Meeting, Banbury Center
February 11 DNA from the Beginning interviews, Dr. Richard Set low and Dr. Jane Set low, Brookhaven
National Laboratory
February 11 DNA from the Beginning interview, Dr. Elof Carlson, State University of New York, Stony
Brook
February 17-20 American Association for the Advancement of Science Annual Meeting, Washington D.C.
February 27-March 2 Department of Energy Contractor-Grantee Meeting, Santa Fe, New Mexico
March 7 DNA from the Beginning interview, Dr. Richard McCombie, CSHL
March 16 Site visit by Steve Israel, Huntington Town Board Councilman, and Beverly Wayne, Institute
on Holocaust and Law
National Institute of Social Sciences Issues Discussion Group, New York, New York
March 20 Loomis Chaffee Convocation, Windsor, Connecticut
March 22 Huntington Township Chamber of Commerce Economic Summit II Meeting, Huntington, New York
Gateway to Higher Education Planning Meeting, Mount Sinai School of Medicine, New
York, New York
March 26-30 BI02000 International Meeting & Exhibition, Boston Massachusetts
March 29 National Human Genome Research Institute ELSI Review Panel, Bethesda, Maryland
March 31 Educational Advisory Board Meeting on the Human Genome Exhibit, American Museum of
Natural History, New York, New York
April 3-5 Department of Energy ELSI Workshop, The Science and Issues of Human DNA Polymor-
phisms, The Mailman Center for Child Development, University of Miami School of
Medicine, Florida
April 6 Laboratory for National Institute of Science, Beta Kappa Chi, Nashville, Tennessee
April 6-9 National Science Teachers Association Annual Meeting, Orlando, Florida
April 7-9 Department of Energy ELSI Workshop, The Science and Issues of Human DNA
Polymorphisms, Austin Community College, Rio Grande Campus, Texas
April 11 Hutton House lecture, Long Island University, Brookville, New York
April 17 Great Moments in DNA Science Honors Students Seminar, CSHL
April 18 Hutton House lecture and laboratory, Long Island University, Brookville, New York
April 20 Site visit by Dr. June Osborn, Josiah Macy, Jr. Foundation, New York, New York and David
Luke, Cold Spring Harbor Laboratory Board of Trustees
April 21 Seminar on Eugenics, Anne Arundel Community College, Arnold, Maryland
April 22 Laboratory for Rampart and Sierra High Schools, Colorado Springs, Colorado
April 25 Hutton House lecture, Long Island University, Brookville, New York
May 3 National Institute of Social Sciences Award Luncheon, Harvard Club, New York, New York
May 8 Great Moments in DNA Science Honors Students Seminar
May 11 Webby Awards, San Francisco, California
May 12 DNA from the Beginning interview, Dr. James Cleaver, University of California, San Francisco
May 12 DNA from the Beginning interview, Dr. Stanley Prusiner, University of California, San Francisco
May 22 Site visit by Carolyn Gusoff, Channel 4 News
May 22 Great Moments in DNA Science Honors Students Seminar
June 1 Site visit to Clinic for Special Children, Strasbourg, Pennsylvania
June 2 Site visit by Christopher Perez, Pfizer Foundation, New York, New York
June 5-10 National Science Foundation Workshop, Genomic Biology, Oklahoma City Community
College, Oklahoma
June 16 Site visit by Frank Stephenson, Applied Biosystems, Foster City, California
June 19-24 National Science Foundation Workshop, Genomic Biology, Eccles Institute of Human
Genetics, University of Utah, Salt Lake City
June 26-30 Fun With DNA Workshop, DNALC
DNA Science Workshop, DNALC
June 26-July 7 Genomic Biology & PCR Minority Workshop, Central Islip High School, New York
June 28 Interview by Lea Tyrrell, Channel 12 News .
June 30 Interview by Roland Pease, BBC worldwide
July 5 DNA from the Beginning interview, Dr. James Darnell, Rockefeller University, New York
July 10-15 National Science Foundation Workshop, Genomic Biology, California State University,
Fullerton
July 10-15 Fun With DNA Minority Workshop, PS 38, Rosedale, New York
World of Enzymes Workshop, DNALC
DNA Science Minority Workshop, Brooklyn Technical High School, New York
DNA Science Workshop, DNALC
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July 17-21 Fun With DNA Workshop, DNALC
DNA Science Minority Workshop, John F. Kennedy High School, Bronx, New York
July 17-22 National Science Foundation Workshop, Genomic Biology, DNALC
July 24-28 Fun With DNA Workshop, DNALC
DNA Science Minority Workshop, Brooklyn Technical High School, New York
DNA Science Workshop, DNALC
July 31-August 4 Fun With DNA Workshop, DNALC
Genomic Biology & PCR Workshop, DNALC
August 4 Site visit by Alan Aida, Scientific American Frontiers
August 7-10 World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
August 14-18 Fun With DNA Workshop, DNALC
DNA Science Workshop, DNALC
August 15 National Human Genome Research Institute ELSI Project, Eugenics Image Archive, collec-
tion visit to Museum of the City of New York
National Human Genome Research Institute ELSI Project, Eugenics Image Archive, collec-
tion visit to American Museum of Natural History
August 21-25 Fun With DNA Workshop, DNALC
Genetic Horizons Workshop, DNALC
Genomic Biology & PCR Workshop, DNALC
August 28 Site visit by Dr. Nicholas Chiorazzi and Dr. Bette Steinberg, North Shore-Long Island
Jewish Research Institute, Manhasset, New York
August 28-31 World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
September 7 Site visit by Rob De Salle, American Museum of Natural History, New York, New York
September 9 Macmillan Genetics Encyclopedia Editorial Board Meeting, New York, New York
September 15 DNA from the Beginning interview, Dr. Michael Wig ler, CSHL
September 18 DNA from the Beginning interview, Dr. Michael Hengartner, CSHL
September 19 Site visit by Dr. Frederick Volp, Cold Spring Harbor School District, New York
September 20 DNA from the Beginning interview, Dr. Eric Wieschaus, Princeton University, New Jersey
September 22 DNA from the Beginning interview, Dr. Scott Lowe, Cold Spring Harbor Laboratory, New York
September 24-25 American Association for the Advancement of Science-American Physiological Society
Meeting, Warrenton, Virginia
September 28-29 National Human Genome Research Institute ELSI Project, Eugenics Image Archive, collec-
tion visit to State University of New York, Albany
October 3 Site visit by the Cosmopolitan Club, New York, New York
October 10-12 Howard Hughes Medical Institute Program Directors Meeting, Chevy Chase, Maryland
October 11 Site visit to Clemson University, Clemson, South Carolina
October 14-17 Association of Science-Technology Centers Conference, Cleveland, Ohio
October 16 Site visit by Philip Palmedo, Steven Barry, and Jerry Sandler, The Long Island Museum of
Science & Technology, Garden City, New York
Site visit by Stephen Speer, CSIRO Discovery, Canberra, Australia
October 25-28 National Association of Biology Teachers Annual Meeting, Orlando, Florida
October 27-28 National Science Foundation Program Directors Meeting, Washington D.C.
November 3-5 Department of Energy Meeting, Science Education on the Internet, Salt Lake City, Utah
November 7 Site visit to North Shore-Long Island Jewish Research Institute, Manhasset, New York
November 9 Howard Hughes Medical Institute City Genes meeting, CSHL
November 10 Site visit by Dr. Harold Cheatham and Dr. Jerry Trapnell, Clemson University, Clemson,
South Carolina
November 13 EAB presentation, DNALC
November 21 Site visit to American Museum of Natural History, New York, New York
November 22 Site visit by Dr. John Reiher, The Center for Occupational Research and Development, Waco, Texas
November 29 Presentation for faculty and parents, Green Vale School, Glen Head, New York
December 4 National Institute of Social Sciences Gold Medal Award Dinner, Union Club, New York, New York
December 5 National Human Genome Research Institute ELSI Project, Eugenics Image Archive, collec-
tion visit to Ellis Island, New York
December 13 Site visit by Anne Dhanaraj, Singapore Science Centre
December 15 National Human Genome Research Institute ELSI Project, Your Genes, Your Health
Planning Meeting, Banbury Center
December 19 DNA from the Beginning interview, Dr. Walter Gilbert, Harvard University, Cambridge,
Massachusetts
December 21 Site visit by Lisa Darma and Lawrence Wallace, Carolina Biological Supply Company,
Burlington, North Carolina
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Sites of Major Faculty Workshops 1985-2000
Key: High School College Middle School
ALABAMA University of Alabama, Tuscaloosa 1987-1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA Foothill College, Los Altos Hills 1997
University of California, Davis 1986
San Francisco State University 1991
University of California, Northridge 1993
Canada College, Redwood City 1997
Pierce College, Los Angeles 1998
California Lutheran University, Thousand Oaks 1999
Laney College, Oakland 1999
California State University, Fullerton 2000
COLORADO Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
DISTRICT OF COLUMBIA Howard University 1992,1996
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
University of Miami School of Medicine 2000
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991,1996
Morehouse College, Atlanta 1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986,1987
University of Chicago 1992,1997
INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
MASSACHUSETTS Beverly High School 1986
City Lab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Boston University 1994,1996
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990,1991
MISSOURI Washington University, St. Louis 1989
Washington University, St. Louis 1997
NEW HAMPSHIRE St. Paul's School, Concord 1986,1987
New Hampshire Community Technical College, Portsmouth 1999
NEVADA University of Nevada, Reno 1992
NEW YORK Albany High School 1987
Bronx High School of Science 1987
Columbia University, New York 1993
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Cold Spring Harbor High School 1985,1987
DeWitt Middle School, Ithaca 1991,1993
DNA Learning Center 1988-1995
DNA Learning Center 1990,1992,
1995, 2000
DNA Learning Center 1990-1992
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987-1990
Titusville Middle School, Poughkeepsie 1991,1993
Wheatley School, Old Westbury 1985
U.S. Military Academy, West Point 1996
Stuyvesant High School, New York 1998-1999
NORTH CAROLINA North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA School of Science and Mathematics, Oklahoma City 1994
Oklahoma City Community College 2000
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
University of Texas, Austin 1999
Austin Community College-Rio Grande Campus 2000
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998
University of Utah, Salt Lake City 2000
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
WASHINGTON University of Washington, Seattle 1993,1998
Fred Hutchinson Cancer Research Center, Seattle 1999
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986,1987
University of Wisconsin, Madison 1988,1989
Madison Area Technical College 1999
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
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2000 PUBLICATIONS
LABORATORY MANUALS We Can Sleep Later: Alfred D. Hershey and the Origins of
Molecular Biology
Molecular Cloning: A Laboratory Manual, Third Edition Franklin W. Stahl (ed.)
Joseph Sambrook and David W. Russell
Abraham Lincoln's DNA and Other Adventures in Genetics
Phage Display: A Laboratory Manual Philip R. Reilly
Carlos F. Barbas III, Dennis R. Burton, Jamie K. Scott, and
Gregg J. Silverman
Methods in Yeast Genetics 2000
Dan Burke, Dean Dawson, and Tim Stearns
Drosophila Protocols
William Sullivan, Michael Ashburner, and R. Scott Hawley
CSHL MONOGRAPH SERIES
Translational Control of Gene Expression
Nahum Sonenberg, John W.B. Hershey, and Michael B.
Mathews (eds.)
SYMPOSIUM
Signaling and Gene Expression in the Immune System
Cold Spring Harbor Symposia on Quantitative Biology,
Volume LXIV
OTHER TITLES
A Passion for DNA: Genes, Genomes, and Society
James D. Watson
The Coiled Spring: How Life Begins
Ethan Bier
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Dorothy Hodgkin: A Life (U.S. edition)
Georgina Ferry
Landmark Papers in Cell Biology: Selected Research Articles
Celebrating Forty Years in The American Society for Cell
Biology
Joseph G. Gall and J. Richard McIntosh (eds.)
JOURNALS
Genes & Development (Volume 14, 24 issues)
T Grodzicker and D. Solter (eds.)
Genome Research (Volume 10, 12 issues)
A. Chakravarti, R. Gibbs, E. Green, R. Myers, M. Boguski, and
L. Goodman (eds.)
Learning & Memory (Volume 8, 6 issues)
J.H. Byrne (ed.)
OTHER
CSHL Annual Report 1999
Banbury Center Annual Report 1999
Administration and Financial Annual Report 1999
COLD SPRING HARBOR LABORATORY PRESS
Publishing at the Laboratory made important advances in 2000. The scope of the book program was
broadened and its sales support was strengthened through contracts with major booksellers in the
United States and the creation of a European sales team centered in Oxford. Advance orders for the
new edition of the celebrated laboratory Molecular Cloning were strong. There was significant growth
in institutional journal subscriptions and journal advertising sales. And solid progress was made in
Internet-based publishing and marketing. As a result, the financial results for the year were very satis-
factory. Revenue rose by 35% and the net operating excess by 56%.
Books for Scientists
Nine new books were published for the use of scientists at the graduate student level and beyond. The
most eagerly anticipated was a new edition of the laboratory manual that can be said to have changed
biology. Molecular Cloning: A Laboratory Manual was first published in 1982. It contained technical wis-
dom distilled by Tom Maniatis, Ed Fritsch, and Joe Sambrook from their 2 years of teaching a course
in recombinant DNA technology. Joe recalled recently that in the course's first year, none of the tech-
niques worked, and students learned the hard way that experimental science was unpredictable. The
methods then were new and known to just a few pioneers, but their power was clear and scientists
were eager to learn them. In the Laboratory's Annual Report for 1982, Jim Watson gleefully reported
that the demand was so strong it seemed possible that the manual would sell as many as 25,000
copies. Two editions and more than 150,000 copies later, the manual has become the definitive work
of reference in its field and can be seen as an important catalyst in the transformation of many biolog-
ical disciplines from the descriptive to the analytical.
For the third edition, written by Joe Sambrook and David Russell, with associate authors Nina Irwin
and Kaaren Janssen, Molecular Cloning was handsomely redesigned in two colors, bound as a clas-
sic book, rather than a manual, and published in a new and compelling print and on-line combination.
To be truly useful, scientific information now must be networked, so purchasers of the book are given
access to a private Web Site from which they can print protocols for bench use, link to reference data
bases, take part in discussions about methods of interest, and receive new and updated information.
Thanks to a vigorous marketing and sales campaign, advance orders for Molecular Cloning were
strong, and the book was published to great enthusiasm in December. As in 1982, we believe that its
prospects are good.
Three other laboratory manuals were published this year, more narrowly focused but written with
the authority of experienced teachers and investigators. Phage Display: A Laboratory Manual and
Methods in Yeast Genetics 2000 both emerged from long-standing courses at the Laboratory.
Drosophila Protocols broadened and updated the scope of Michael Ashburner's classic book of meth-
ods for work on fruit flies. Our two major book series were extended, with the addition of the valuable
monograph Translational Control of Gene Expression and publication of the 64th Annual Symposium
volume Signaling and Gene Expression in the Immune System.
The professional list was completed by three unusual books. In a collaboration with the American
Society of Cell Biology, to mark its 40th anniversary, we published Landmark Papers in Cell Biology, a
selection of classic research papers published since the Society's foundation that was greeted warm-
ly by college teachers and investigators alike. And we were delighted with the appearance of The
Coiled Spring: How Life Begins, an elegant account of embryonic development by Ethan Bier in a
beautifully designed and illustrated volume of remarkable breadth. Finally, we were proud to produce a
tribute to one of the giants of science at Cold Spring Harbor, Alfred Hershey. A series of essays by col-
leagues, collaborators, and friends, We Can Sleep Later portrays a man who was not easy to know but
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commanded immense respect for his intelligence, insight, and diligence-a consummate scientist and
a leading architect of the new discipline of molecular biology in the 1940s and 1950s.
Sales to scientists were also strongly supported by the backlist of established books, particularly
At the Bench, Using Antibodies, and Transcriptional Regulation in Eukaryotes.
Books for the Public
The steady sales of our 1992 re-issue of the classic history of molecular biology-Horace Judson's The
Eighth Day of Creation-and Max Perutz's essay collection I Wish I'd Made You Angry Earlier have
encouraged us to believe that we can find an audience for interesting science among curious but non-
specialist readers. Jim Watson is a proven master of such prose, and we were fortunate to have the
opportunity to anthologize some of the essays he has written in the past 20 years for a variety of pur-
poses and publications. With a sparkling introduction by Walter Gratzer, A Passion for DNA was pub-
lished in March and simultaneously in Europe by Oxford University Press. Assisted by the author's will-
ingness to make media and bookstore appearances as he traveled the country, the book sold very well
and attracted excellent reviews. During the year, agreements were made for its translation into five lan-
guages.
This title was the first of three new general interest titles to be published this year, and publicity
through press releases, book signings, and media coverage was arranged to promote them. Abraham
Lincoln's DNA and Other Adventures in Genetics, by the distinguished scientist and attorney Philip
Reilly, proved to be very popular and attracted favorable press comment. The United States edition of
the biography Dorothy Hodgkin: A Life was also published, and its British author Georgina Ferry visit-
ed Cold Spring Harbor in December to give a talk and sign books. The success of these titles is
encouraging us to seek opportunities to publish similar books for a general audience.
Books for Students
The development of undergraduate textbooks is a lengthy process, involving authors, editors, and
artists in several years of work before anything is produced. The undergraduate textbook program ini-
tiated in 1999 moved closer to fruition this year, and the number of books being developed increased
sharply. Recognizing the special expertise and deep pockets required to ensure the widespread adop-
tion of textbooks for course teaching, our strategy is to co-publish these books with larger, commer-
cial partners that have proved themselves in the markets concerned. In 2000, three co-publication con-
tracts were either signed or brought to final draft. The first book to be published will be the volume on
gene regulation being written by Mark Ptashne and Alex Gann, the textbook program's senior editor,
that is scheduled for 2001. Other titles to appear in 2002 and 2003 will include the fifth edition of Jim
Watson's classic text Molecular Biology of the Gene, with authors from Harvard, Berkeley, MIT, and
Cold Spring Harbor.
In the development of all of these projects, the writing center at the Meier House has proved to be
an extraordinary asset, and more than a dozen authors have spent productive and pleasant periods in
residence during the year.
Books On-line
The Web Site for Cold Spring Harbor Laboratory Press, CSHLPress.com, was redesigned and rebuilt
during the latter months of 2000, for release early the next year. The Site provides sophisticated e-com-
merce for books and journals, a dynamic home page that assists targeted promotional activities, and
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software for communicating directly with purchasers. In 2000, on-line purchasing rose to account for
6% of book sales. The redesigned Site will enhance the development of this marketing channel.
Like the manual Molecular Cloning, the advanced textbook Bioinformatics: Sequence and Genome
Analysis, to be published early in 2001, will have an associated Web Site, BioinformaticsOnline.org, that
will be accessible only to book purchasers. The Site will provide live links to the software and other
resources described in the book and will be continually updated. Sponsorship and advertising support
for the Site are in discussion.
During the year, there was continuous appraisal of the opportunities for book publishing offered by
emerging electronic technologies. Contracts were signed with NetLibrary.com for the conversion of
back volumes of the series Cancer Surveys into e-books that can be read by library patrons. Work con-
tinued at the National Center for Biotechnology Information on the creation of on-line editions of the
books Retroviruses and C. elegans IL There is not yet a consensus on the best file formats for elec-
tronic books, or the best device on which to read them. Nevertheless if the market for e-books does
catch fire, it is likely to happen first in academic circles, and we want to be prepared.
Journal Publishing
All three of our journals had a successful year, gaining institutional subscriptions at a rate of 2-10%,
receiving more submitted manuscripts than ever, and achieving a level of advertising sales higher even
than last year's record-breaking total. These results were particularly satisfying under business condi-
tions that resulted in an industry-wide average decline of science journal subscriptions by 5%.
The journals' impact factors continued to be satisfactory. Genes & Development's impact factor
rose to 19.22, ranking it among the top ten journals in all biology.
On-line full-text access to the current year's issues of Cold Spring Harbor journals remained avail-
able only with a print subscription. Issues older than 12 months were made accessible free of charge
on-line. More than 70% of subscribers made use of the electronic edition in 2000. The possibility of
introducing site licenses for on-line-only access next year was opened in discussion with academic
institutions, library consortia, and companies worldwide.
Throughout the year, preparations were made for the transition of Protein Science to publication by
Cold Spring Harbor in 2001. The journal, owned by The Protein Society, was elegantly redesigned, and
a complementary Web Site was built in collaboration with our electronic publishing partner, The
High Wire Press of Stanford University Library. After much detailed effort to engineer a smooth transi-
tion of manuscript submission and subscription handling, the first issue of the journal to be published
by Cold Spring Harbor, dated January 2001, appeared on schedule in December. Editorially, the jour-
nal will begin now to expand its scope to include reviews, commentaries, meeting reports, and papers
from the emerging field of proteomics.
At the suggestion of Mr. and Mrs. Takemori, owners and publishers of Newton, a lavishly illustrat-
ed science magazine with a mass audience in Japan, Spain, and Italy, an unusual collaboration was ini-
tiated in 2000. Twelve lengthy articles on aspects of biology were commissioned from freelance science
writers and edited for publication in the magazine by our journal editors Laurie Goodman and Emily
Huang. Newton assigned to the project a team of very talented illustrators, whose computer graphics
brought to vibrant life the science described in the articles. The finished articles are visually striking,
broadly educational, and their re-publication in book form is now being considered.
Sales, Marketing, and Distribution
Promotional activities in 2000 included direct mail, meeting exhibits, and advertising in print publica-
tions and on-line. We attended 11 professional meetings, displaying new and established books in such
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numbers that a double-wide exhibit booth has now become a standard necessity. Valuable use was
made of the conferences at the Laboratory to draw scientists' attention to our new publications.
As part of our increasingly vigorous sales strategy, visits were made to the Tokyo (April), London
(March), Beijing (August), and Frankfurt (October) Book Fairs, where extensive contacts were made
with potential distributors and translators of our books. The previous year's efforts to establish a sales
presence in Europe culminated in the establishment of CSHL Press U.K., a warehouse and order-pro-
cessing facility in Oxford where orders can be taken in pounds sterling and goods shipped to book
stores and academic institutions more quickly than is possible from the United States. To support the
expansion of sales efforts in Europe, a group of experienced commission sales representatives was
appointed to cover several countries and has rapidly become most effective.
Staff
The staff members of the Press (as of December 2000) are listed at the end of this volume. It is a plea-
sure to acknowledge the dedication and high standards they bring to their duties.
In 2000, we welcomed several new members to the staff: Kathryn Fitzpatrick as Marketing
Manager; Dawn Canfora as Journal Secretary; Heather Cosel-Pieper as Editorial Intern; Arlen
Feldwick-Jones as Production Assistant; Anne Wenzel as Copy Editor; Geraldine Jaitin, Joan
Pepperman, Mary Saba la, and Kathleen Watras as Fulfillment Assistants; Katya Gurbeloshvili as Sales
Assistant; and Christopher Vacca as Warehouse Assistant.
With a staff roster of 50, located at three sites within the Laboratory and one nearby at Plainview,
and with three staff members working from home offices in San Diego, California; Guildford,
Connecticut; and Questa, New Mexico, CSHL Press has become a larger and more complex organi-
zation to manage. I am therefore particularly grateful for the intelligence, efficiency, and attention to
detail of my assistant Liz Powers and the senior staff: Jan Argentine, Editorial Development Manager;
Ingrid Benirschke, Marketing Manager; Kathryn Fitzpatrick, Marketing Manager; Marcie Ebenstein,
Advertising Manager; Nancy Hodson, Business Manager; Guy Keyes, Sales and Fulfillment Manager;
Denise Weiss, Production Manager; and the editors of our journals, Terri Grodzicker at Genes &
Development and Laurie Goodman at Genome Research.
John R. Inglis
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FINANCIAL STATEMENTS
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
December 31, 2000 and 1999
Assets: 2000 1999
Cash and cash equivalents $ 27,456,990 34,830,286
Accounts receivable:
Publications 2,187,811 837,564
Other 937,537 333,310
Grants receivable 3,652,363 2,759,349
Contributions receivable 8,130,610 4,878,895
Publications inventory 2,327,313 2,138,874
Prepaid expenses and other assets 1,691,542 1,321,313
Investments 208,166,091 203,853,845
Investment in employee residences 3,047,429 2,751,580
Land, buildings, and equipment:
Land and land improvements 14,157,625 12,614,303
Buildings 84,495,326 80,460,206
Furniture, fixtures and equipment 7,907,387 5,427,259
Laboratory equipment 14,606,551 12,405,968
Library books and periodicals 365,630 365,630
Construction in progress 15,899,784 4,514,827
137,432,303 115,788,193
Less accumulated depreciation and amortization (38,108,559) (34,481,784)
Land, buildings, and equipment (net) 99,323,744 81,306,409
Total assets $ 356,921,430 335,011,425
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $ 7,928,869 4,840,651
Notes payable 227,932 251,918
Bonds payable 45,200,000 45,200,000
Deferred revenue 2,695,061 2,878,365
Total liabilities 56,051,862 53,170,934
Net assets:
Unrestricted
General operating 13,903,989 13,408,682
Designated by board for:
Research programs 2,197,000 1,900,000
Endowment 107,942,756 99,533,294
Net investment in plant 53,895,812 46,536,091
Total unrestricted 177,939,557 161,378,067
Temporarily restricted 9,796,302 8,587,520
Permanently restricted 113,133,709 111,874,904
Total net assets 300,869,568 281,840,491
Total liabilities and net assets $ 356,921,430 335,011,425
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2000
With comparative totals for the year ended December 31, 1999
Unrestricted
Temporarily
Restricted
Permanently
Restricted
2000
Total
1999
Total
Revenue, gains, and other support:
Public support (contributions and
nongovernment grant awards) $ 9,489,893 9,687,797 5,625,670 24,803,360 23,878,182
Government grant awards 20,097,385 20,097,385 17,658,439
Indirect cost allowances 12,885,076 12,885,077 11,377,795
Other revenue:
Program fees 2,551,373 2,551,373 2,385,687
Rental income 374,757 374,757 358,934
Publications sales 8,683,809 8,683,809 6,400,303
Dining services 2,616,113 2,616,113 2,445,184
Rooms and apartments 1,985,658 1,985,658 1,865,047
Royalty and licensing fees 1,093,573 1,093,573 606,691
Realized gain on sale of
investments (net) 23,856,792 2,604,143 26,460,935 6,519,465
Investment income (interest
and dividends) 8,132,622 8,132,622 6,967,857
Miscellaneous 173,074 173,074 146,841
Total other revenue 49,467,771 2,604,143 52,071,914 27,696,009
Net assets released from restrictions 8,479,015 (8,479,015) -
Total revenue, gains, and other support 100,419,140 1,208,782 8,229,813 109,857,735 80,610,425
Expenses:
Research 35,923,808 35,923,808 31,454,215
Educational programs 9,801,786 9,801,786 9,153,276
Publications 8,281,363 8,281,363 6,159,371
Banbury Center conferences 1,165,989 1,165,989 1,111,921
DNA Learning Center programs 1,105,658 1,105,658 1,059,168
General and administrative 9,252,253 - 9,252,253 7,767,286
Dining services 3,635,324 - 3,635,324 3,117,043
Total expenses 69,166,181 69,166,181 59,822,280
Increase in net assets from operations 31,252,959 1,208,782 8,229,813 40,691,554 20,788,145
Other changes in net assets
Net unrealized (loss) gain on fair value
of investments (14,691,469) (6,971,008) (21,662,477) 39,572,760
Increase in net assets before
extraordinary item 16,561,490 1,208,782 1,258,805 19,029,077 60,360,905
Extraordinary item (loss on
refinancing of debt) (598,061)
Increase in net assets 16,561,490 1,208,782 1,258,805 19,029,077 59,762,844
Net assets at beginning of year 161,378,067 8,587,520 111,874,904 281,840,491 222,077,647
Net assets at end of year $ 177,939,557 9,796,302 113,133,709 300,869,568 281,840,491
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CONSOLIDATED STATEMENTS OF CASH FLOWS
Years ended December 31, 2000 and 1999
2000 1999
Cash flows from operating activities:
Increase in net assets $ 19,029,077 59,762,844
Adjustments to reconcile increase in net assets to net cash provided by
operating activities:
Depreciation and amortization 3,974,311 3,526,229
Extraordinary item (loss on refinancing of debt) 598,061
Net appreciation in fair value of investments (4,798,458) (46,092,225)
Contributions restricted for long-term investment (9,350,612) (10,043,571)
Changes in assets and liabilities:
Increase in accounts receivable (1,954,474) (215,871)
Increase in grants receivable (893,014) (374,642)
Increase in contributions receivable (3,600,936) (1,903,687)
Increase in publications inventory (188,439) (215,090)
(Increase)decrease in prepaid expenses and other assets (370,229) 140,163
Increase in accounts payable and accrued expenses 3,088,218 2,030,863
Decrease in deferred revenue (183,304) (480,357)
Net cash provided by operating activities 4,752,140 6,732,717
Cash flows from investing activities:
Capital expenditures (21,991,646) (12,545,862)
Proceeds from sales and maturities of investments 71,313,900 70,618,250
Purchases of investments (70,827,688) (70,270,898)
Net change in investments in employee residences (295,849) (287,320)
Net cash used in investing activities (21,801,283) (12,485,830)
Cash flows from financing activities:
Permanently restricted contributions 5,625,670 6,291,765
Contributions restricted for investment in land, buildings, and equipment 3,724,942 3,751,806
Decrease(increase) in contributions receivable 349,221 (317,460)
Repayment of bonds payable (27,000,000)
Issuance of bonds payable 42,200,000
Deferred financing costs incurred (576,994)
Repayment of notes payable (23,986) (24,245)
Net cash provided by financing activities 9,675,847 24,324,872
Net (decrease)increase in cash and cash equivalents (7,373,296) 18,571,759
Cash and cash equivalents at beginning of year 34,830,286 16,258,527
Cash and cash equivalents at end of year $ 27,456,990 34,830,286
Supplemental disclosures:
Interest paid $ 2,063,031 1,494,414
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COMPARATIVE OPERATING HISTORY 1996-2000
(Dollars in Thousands)
1996 1997 1998 1999 2000
Revenue:
Main Lab:
Grants & contracts $ 20,879 22,743 24,025 27,397 31,027
Indirect cost reimbursement 9,704 9,910 11,054 11,207 12,718
Other 7,859 8,472 9,441 9,426 10,618
CSHL Press 4,805 5,238 6,341 6,400 8,684
Banbury Center 1,214 1,495 1,444 1,848 1,856
DNA Learning Center 754 875 1,334 1,392 1,471
Total income 45,215 48,733 53,639 57,670 66,374
Expenses:
Main Lab:
Research & training 20,879 22,743 24,025 27,397 31,027
Operation & maintenance of plant 5,446 5,274 5,549 5,765 6,589
General & administrative 3,438 3,625 3,378 3,844 6,162
Other 5,367 5,759 7,328 7,863 7,075
CSHL Press 5,032 5,320 6,141 6,077 8,186
Banbury Center 1,225 1,437 1,321 1,614 1,702
DNA Learning Center 781 887 1,228 1,280 1,362
Total expenses, excluding depreciation 42,168 45,045 48,970 53,840 62,103
Excess before depreciation, amortization
and release of designated funds 3,047 3,688 4,669 3,830 4,271
Depreciation and amortization (2,988) (3,371) (3,443) (3,526) (3,974)
Designation of funds (1) - (750) (297)
Net operating excess $ 59 317 476 304 1,244
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(1) Funds designated to underwrite future direct and indirect expenses of the neuroscience, imaging, computational neuroscience and other research programs.
Auxiliary Activities
22.0%
Corporate Contributions
and Grants Interest and
3.7% Miscellaneous
COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31, 2000
1.0% Royalty and Licensing
Fees
4.4%
Federal Grants
39.9%
Foundation and Private
Contributions and
Grants
21.2%
Endowments and Board
Designated Funds
7.8%
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the DNA Learning Center receive a substantial
portion of their funding through grants from the Federal Government and through grants, capital gifts,
and annual contributions from private foundations, corporations, and individuals. The following section
summarizes funding that occurred during 2000.
GRANTS January 1, 2000-December 31, 2000
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2000 Funding*
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Dr. Herr 1/92-12/01 $ 4,206,852
Dr. Stillman 8/90-7/05 3,473,216
Research Support Dr. Cline 12/99-11/04 438,640
Dr. Cline 3/98-2/01 284,918
Dr. Enikolopov 8/99-5/04 325,299
Dr. Enikolopov 9/94-11/03 392,359
Dr. Futcher 4/93-3/01 283,628
Dr Grewal 3/00-2/05 281,847
Dr. Hannon 9/00-8/05 283,333
Dr. Helfman 9/99-8/04 374,872
Dr. Hengartner 5/00-4/04 291,355
Dr. Hernandez 7/00-6/04 200,101
Dr. Hirano 5/96-4/01 328,964
Dr. Joshua-Tor 12/01-11/04 288,523
Dr. Krainer 7/89-6/02 438,566
Dr. Lowe 7/99-6/04 315,853
Dr. Malinow 5/00-4/05 504,941
Dr. Malinow 4/95-3/03 429,090
Dr. McCombie 1/99-12/03 877,686
Dr. McCombie 9/99-9/02 1,499,223
Dr. Neuwald 10/98-8/01 344,771
Dr. Skowronski 4/98-3/03 473,529
Dr. Spector 4/90-3/03 477,968
Dr. Stillman 6/00-5/04 517,992
Dr. Svoboda 12/98-11/03 368,943
Dr. Tonks 8/91-3/01 536,041
Dr. Tonks 5/97-4/01 299,173
Dr. Tully 4/94-3/02 352,460
Dr. Tully 10/00-9/03 567,290
Dr. Van Aelst 12/97-11/01 381,829
Dr. Wigier 7/98-4/02 910,736
Dr. Wig ler 9/00-7/03 750,111
Dr. Xu 1/98-12/02 294,209
Dr. Yin 9/99-4/02 355,953
Dr. Zhang 9/00-8/03 416,667
Dr. Zhang 8/00-7/03 300,150
Dr. Zhong 6/00-5/04 291,813
*New Grants Awarded in 2000
*Includes Direct & Indirect Cost
386
Grantor Program/Principal Investigator Duration of Grant 2000 Funding*
Fellowships Dr. Sacco-Bubulya 7/00-1/02 32,416
Dr. Groover 5/99-4/01 14,569
Dr. Haas 7/98-6/01 39,232
Dr. Hofmann 12/00-12/02 34,832
Dr. Horiuchi 10/98-9/00 36,700
Dr. Nimchinsky 9/98-8/01 40,936
Dr. Ruthazer 3/99-2/02 39,232
Training Support Training in Cancer Cell Biology and 7/94-12/03 305,184
Tumor Virology
Course Support Cancer Research Center Workshops 4/92-3/05 280,319
Neurobiology Short-term Training 5/82-4/01 159,099
Analysis of Large DNA Molecules 4/91-3/01 67,224
Computational Genomics 9/91-8/01 93,149
In Situ Hybridization and Immunocyto-
chemistry
7/98-6/03 86,396
Automated Genome Sequencing 4/95-3/01 93,087
Molecular Biology and Development of 4/96-3/01 18,000
Xenopus laevis
C. elegans 8/98-6/01 41,243
Macromolecular Crystallography 9/00-8/01 48,359 *
Meeting Support Genome Mapping and Sequencing 4/90-3/02 35,947
65th CSHL Symposium: Biological Responses
to DNA Damage
6/98-5/01 10,000
Zebrafish Development and Genetics 4/00-3/03 18,270
Axon Guidance and Neural Plasticity 6/00-5/01 20,000
Cancer Genetics and Tumor Suppressor Genes 8/00-7/05 15,000
Mouse Molecular Genetics 8/00-7/05 16,500
Germ Cells 9/00-8/01 6,000
Gene Therapy 8/00-8/01 6,000
Molecular Chaperones and Heat Shock 3/00-2/01 8,000
Response
NATIONAL SCIENCE FOUNDATION
Cooperative Agreement Dr. McCombie 2/99-1/02 1,068,426
Research Support Dr. Cline 5/99-8/03 115,000
Dr. Helfman 2/99-1/03 108,590
Dr. Jackson 2/98-1/01 100,000
Dr. Martienssen 11/98-10/01 559,979
Training Support URPs 6/00-5/03 56,920
Course Support Advanced Bacterial Genetics 5/99-4/02 77,264
Arabidopsis Molecular Genetics 4/00-3/03 63,500
Early Development of Xenopus laevis 9/98-8/02 20,674
Computational Neuroscience: Vision 8/00-7/02 18,135
Meeting Support Zebrafish Development and Genetics 4/00-3/01 9,781 *
Cell Cycle 5/00-4/01 8,000 *
Molecular Genetics 7/00-6/01 10,000 *
Early Development of Xenopus laevis 9/00-8/01 19,980 *
Axon Guidance and Neural Plasticity 9/00-8/01 7,000 *
Germ Cells 9/00-8/01 12,840 *
Molecular Genetics 7/00-6/01 10,000 *
*New Grants Awarded in 2000
*Includes Direct & Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 2000 Funding*
DEPARTMENT OF ENERGY
Research Support Dr. Martienssen 8/91-2/01 102,000
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Martienssen 12/00-11/01 72,000 *
Drs. McCombie/Martienssen 7/98-8/01 95,100
Dr. Jackson 9/99-8/01 105,000
Dr Stein 9/00-8/04 515,097 *
Dr. Stein 9/00-8/02 336,939 *
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 6/00-5/03 126,000 *
Dr. Helfman 7/99-6/02 117,600
Dr. Van Aelst 7/99-6/02 117,600
Dr. Zhong 9/99-8/02 240,793
Fellowship Support Dr. Hamaguchi 4/00-3/04 59,000 *
Dr. Hannon 6/00-5/01 59,000 *
Dr Jin 5/99-5/02 42,000
Dr. Mendez 7/99-6/02 42,000
Dr. Saitoh 1/01-12/03 48,191 *
Dr. Samuelson 6/98-5/01 21,500
MISCELLANEOUS GRANTS
Research Support
Alzheimer's Association Dr. Barria 8/99-7/01 40,000
Dr. Malinow 8/99-7/01 60,000
American Cancer Society Dr. Wig ler, Professorship 1986-2012 50,000
Dr. Wig ler, Supply Allowance 2000 10,000
Dr. Lowe 7/99-6/02 150,000
Dr. Joshua-Tor 7/99-6/02 125,000
Andrew's Buddies Corporation Dr. Krainer 1/00-12/01 40,000 *
Michael Scott Barish Human Dr. Wig ler 2000 205,000 *
Cancer Grant sponsored by the
1 in 9: The Long Island Breast
Cancer Action Coalition
The Louis Berkowitz Family Dr. Lazebnik 2000 23,000 *
Foundation, Inc.
Breast Cancer Research Dr. Wig ler 10/00-9/01 1,000,000 *
Foundation
Llewellyn Burchell Charitable Dr. Lazebnik 12/00-11/01 20,000 *
Trust
Dr. and Mrs. Burke A. Cunha Gift Dr. Van Aelst 2000 1,000 *
Davenport Family Foundation Cancer Research Programs 1/00-12/00 325,000 *
Devgen N.V. Dr. Hengartner 4/98-3/01 200,000
W.H. Donner Foundation Dr. Lazebnik 9/00-8/01 45,000 *
The Fraxa Foundation Dr. Svoboda 6/99-6/01 44,000 *
Joseph Flaherty Gift Dr. Wig ler 2000 500 *
Genetica Dr. Hannon 11/00-10/01 133,652 *
Thomas S.T. Gimbel and Utrophin Medical Research Project 2000 12,500 *
Lesley B. Gimbel Gift
*New Grants Awarded in 2000
*Includes Direct & Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 2000 Funding*
Huntington Breast Cancer Action Dr. Wig ler 2000 25,000 *
Coalition
Human Frontier Science Program Dr. Hirano 7/98-6/01 55,000
Organization (HFSP) Dr. Svoboda 9/98-8/01 67,947
Dr. Tully 8/99-8/02 46,670
Illinois Neurofibromatosis Dr. Van Aelst 2000 10,000 *
Edward and Patricia Karsch Fund Dr. Lazebnik 2000 500 *
Long Island Foundation for the Dr. Wig ler 2000 8,000 *
Elimination of Breast Cancer
Long Islanders Against Breast Dr. Wig ler 2000 5,515 *
Cancer
Long Beach Breast Cancer Dr. Wig ler 2000 2,500
Coalition
Manhasset Women's Coalition Dr Wig ler 2000 25,000 *
Against Breast Cancer
Louis Morin Charitable Trust Dr. Dubnau 2000 45,740
Dr. Joshua-Tor 2000 79,260
March of Dimes Dr. Hengartner 6/99-5/00 54,402
Elizabeth McFarland Breast Dr. Wig ler 9/00-8/01 58,486
Cancer Research Grant
G. Harold and Leila Y. Mathers Dr. Svoboda 3/99-2/02 290,140
Charitable Foundation
The Maxfield Foundation Dr. Lazebnik 12/00-11/01 10,000
Monsanto, Inc.-Plant Dr. Martienssen 1/98-8/00 202,500
Consortium Program
Neurofibromatosis Foundation
of Arizona
Dr. Van Aelst 9/99-8/00 10,000 *
Neurofibromatosis, Inc., Dr. Van Aelst 9/99-8/00 10,000 *
Massachusetts Bay Area
Neurofibromatosis Foundation- Dr. Zhong 7/00-6/01 75,000 *
Illinois and Massachusetts
Bay Chapters
NIH/Cal Tech Consortium Agreement Dr. Stein 9/00-6/03 268,074 "
NIH/Nanoprobes, Inc. Dr. Spector 4/99-3/01 31,263
Consortium Agreement
NIH/Sloan Kettering Consortium Dr. Wig ler 9/95-8/01 333,333
Agreement
NIH/Sloan Kettering Consortium Drs. TonksNan Aelst 8/97-5/01 471,211
Agreement
NIH/University of Pennsylvania Dr. Yin 10/97-9/01 100,000
Consortium Agreement
NIH/VVashington University Dr. Stein 3/99-2/03 36,123
Consortium Agreement Dr. Stein 9/99-11/01 138,141
Dr. Stein 9/99-9/02 10,105
Mr and Mrs. Edmond Nouri Dr. Tully 4/00-3/03 41,795 *
Novartis-Plant Consortium Dr. Martienssen 1/98-12/02 135,000
Program
NSF/Clemson Consortium Dr. McCombie 10/99-9/02 323,000
Agreement
NSF/Rutgers University Drs. Spector/Martienssen/McCombie 10/00-9/05 463,472 *
Consortium Agreement
NSF/University of Wisconsin Dr. Martienssen 9/00-8/05 210,653 *
Consortium Agreement
Offin Charitable Trust Dr. Lazebnik 12/00-11/01 25,000 *
Michael Rankowitz and Shelia Dr. Zhong 2000 25,000 *
Heffron
Rap Publishing Dr. Lazebnik 2000 508 *
*New Grants Awarded in 2000
*Includes Direct & Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 2000 Funding*
Fannie E. Rippel Foundation Equipment: Advanced Neuroscience 2000 355,000 *
Imaging Center
Robin and Enrique Senior Utrophin Medical Research Project 2000 5,000 *
Philanthropic Fund
Seraph Foundation Dr. Enikolopov 11/00-4/01 54,000 *
Dr. Huang 11/00-4/01 25,000 *
Dr. Lazebnik 1/00-12/00 23,000 *
Sewanhaka Central High School Dr. Wig ler 2000 200 *
Dr. Jeffrey B. Shellan Gift Dr. Wig ler 2000 500 *
Alfred P. Sloan Foundation Dr. Watson 4/00-12/00 45,000 *
SNP Consortium Dr. Stein 4/99-9/01 656,877
Dr. Stein 11/99-9/01 131,299
Ambassador Felix Schnyder Dr Lowe 1/00-12/00 15,000 *
Memorial Fund, administered by
The Lauri Strauss Leukemia
Foundation
St. Giles Foundation Drs. Wigler/Hatchwell 8/00-1/01 178,677
Sungene Plant Consortium Program Dr. Martienssen 7/00-6/01 135,000
Texas Neurofibromatosis Foundation Dr. Van Aelst 2000 10,000
Tularik, Inc. Dr. Wig ler 10/97-10/03 660,000
U.S.D.A./Clemson Consortium Dr. McCombie 10/99-9/02 323,000
Agreement
West Islip Breast Cancer Dr. Wig ler 2000 5,000
Coalition for L.I., Inc.
Westvaco-Plant Consortium Program Dr. Martienssen 1/99-12/02 135,000
Zeneca Ltd.-Plant Consortium Dr. Martienssen 7/99-7/03 135,000
Program
The Whitaker Foundation Dr. Svoboda 6/98-7/01 46,750
Donnamarie Zuzzolo Gift Dr. Wig ler 2000 50 *
Fellowships
Rita Allen Foundation Dr. Lowe 9/99-8/02 50,000
Dr. Hannon 10/00-9/03 50,000
Alzheimer's Association Dr. Esteban 8/99-7/01 40,000
American Cancer Society Dr. Drier 7/99-6/02 32,000
Dr. Hastings 1/00-12/02 30,000 *
Dr. Saitoh 4/00-12/00 34,000
Arnold and Mabel Beckman Watson School of Biological Sciences 9/00-8/05 250,000 *
Foundation
Burroughs Wellcome Fund Dr. Mainen 9/97-8/00 115,500
Canadian Insitutes of Health Dr. Querido 8/99-7/02 35,000
Research (CIHR)
Cancer Research Fund-Damon Dr. Z. Zhang 6/99-5/02 42,500
Runyon Walter Winchell
CSHL Association Fellowship and Start up Fund support 2000 205,821 *
Danish Academy of Technical Sciences Drs. Tonks/Andersen 2000 13,510 *
Demerec-Kaufman-Hollander Dr. Grewal 1/00-12/00 5,971 *
Fellowship
Deutsche Forschungsgemeinschaft Dr. Schmitz 6/99-5/01 28,000
(DFG)
The Ellison Medical Foundation Dr. Grewal 9/99-9/01 50,000
Engelhorn Scholars Program Funded
by European Foundation for the
Watson School of Biological Sciences 2000 104,200 *
Advancement of Medicine
The Eppley Foundation for Research Dr. Huang 9/00-8/01 22,000 *
Johns Hopkins/Ellison Foundation Dr. Kass-Eisler 11/99-10/00 70,635 *
"New Grants Awarded in 2000
+Includes Direct & Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 2000 Funding*
Joseph G. Goldring Foundation Dr. Stillman 7/99-6/00 60,000
Helen Hoffritz Foundation Dr. Cline 12/97-12/00 30,000
Howard Hughes Medical Institute Watson School of Biological Sciences 9/00-8/01 133,000
Graduate Student Support 6/99-5/04 64,200
Human Frontier Science Program Dr. Davenne 5/00-4/02 35,000
Organization (HFSPO) Dr. Nakayama 4/00-3/02 42,000
Dr. de Stanchina 1/00-12/02 36,000
Irving A. Hansen Memorial Foundation Dr. Tonks 2000 10,000
Japan Society for the Promotion
of Science (JSPS)
Dr. Fukada 4/00-3/02 51,000
Cynthia Jay Gift Dr. Cline 11/00-12/00 3,600 *
Sidney Kimmel Foundation Dr. Tansey 7/99-6/01 100,000
Esther A. and Joseph Dr. Svoboda 7/98-6/01 40,000
Klingenstein Fund, Inc.
Charles Henry Leach II Foundation Dr. Enikolopov 1/97-12/01 25,000
Lehrman Institute Dr. Svoboda 4/00-3/03 53,000
Dr. Watson Archives 4/00-3/03 72,000
The Leukemia and Lymphoma Dr. Duelli 12/00-12/03 35,000
Society Special Fellow Award Dr. Julien 7/99-6/02 33,250
Dr. Pendergrast 7/98-6/01 39,700
Dr. Schmitt 7/00-6/03 42,000
Dr. Shibahara 7/00-6/01 45,000
Dr. Soengas 7/99-6/02 39,700
Life Science Research Foundation Dr. Vollbrecht 6/99-5/02 42,000
Ministerio de Educacion y Cultura Dr. Cantallops 5/99-4/01 17,694
NARSAD Dr. Esteban 7/99-6/00 30,000
Dr. Zhu 7/00-6/01 30,000
Pew Charitable Trust Dr. Hannon 7/97-6/01 60,000
Dr. Svoboda 7/98-6/02 60,000
Rockefeller Foundation Dr. Vanavicht 11/99-10/01 11,674
Roche Foundation Fellowship Dr. Duelli 1/00-12/00 20,880
Schwarz Foundation Drs. Svoboda/Maravall 2000 25,000
Schwarz Foundation Initiative for Computational Neuroscience 1/00-12/00 48,050
Searle Scholars Program Dr. Grossniklaus 7/98-6/01 60,000
Andrew Seligson Memorial Fellowship Fellowship Support 2000 35,000
Alfred P. Sloan Foundation Dr. Zador 9/00-9/02 20,000
Spanish Dept. of Education and Dr. Maravall 7/00-12/01 11,270
Science (Ministerio de
Educacion y Ciencia)
Tularik, Inc. Fellowship Support 1/98-12/03 200,000
The V Foundation Dr. Myers 8/99-7/01 50,000
Dr. Hamaguchi 4/00-3/02 50,000 *
Helen Hay Whitney Foundation Dr. Sabatini 4/99-3/02 37,000
Dr. Zito 7/00-6/03 35,000 *
Course Support
Grass Foundation Scholarships 2000 15,000 *
Howard Hughes Medical Institute Advanced Neurobiology Courses 2000 330,000 *
Meeting Support
Hampton Research Crystallography Workshop 2000 1000 *
Hoffmann-LaRoche, Inc. Crystallography Workshop 2000 1000 *
MSC Molecular Structure Corp. Crystallography Workshop 2000 1000 *
Merck Research Laboratories Crystallography Workshop 2000 1000 *
Pfizer Crystallography Workshop 2000 750 *
Protein Solutions, Inc Crystallography Workshop 2000 500 *
*New Grants Awarded in 2000
*Includes Direct & Indirect Cost
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BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant 1999 Funding*
FEDERAL SUPPORT
CDC-National Center for
Infectious Diseases
NIH-National Human Genome
Research Institute
NIH-National Institute of Child
Health and Human Development
NIH-National Institute of General
Medical Sciences (through a grant
to Mount Sinai School of Medicine)
NIH-National Institute of Mental
Health
NIH-National Institute of Mental
Health
USDA-Agricultural Research Service
NONFEDERAL SUPPORT
Meeting Support
ALS Association
FRAM Research Foundation
Handspring Inc.
Marie H. Robertson Memorial Fund
for Neurobiology
Albert B. Sabin Vaccine Institute,
Inc. (through a grant from the
Bill & Melinda Gates Foundation)
Alfred P. Sloan Foundation
Alfred P. Sloan Foundation
(through a grant to Massachusetts
Institute of Technology)
The Swartz Initiative for Computational
Neuroscience
The Swartz Initiative for Computational
Neuroscience
*New Grants Awarded in 2000
-Includes Direct & Indirect Cost
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Strategies for Identification and
Characterization of Unknown
Pathogens
Digital Image Archive on the American
Eugenics Movement Editorial
Advisory Panel Workshops
FMRP: What Does It Do?
Signaling Network Control-Cell
Interactions: Phase II Planning
FMRP: What Does It Do?
Mouse Behavioral Phenotyping
Meeting the Challenge of Infectious
Diseases in the 21st Century
Therapeutic Approaches in Mouse
Models of ALS
FMRP: What Does It Do?
Neural Networks and Cognition
Structure, Mechanism, and Function
of CaMKII
Social Venture Capital for Neglected
Vaccines: Creating Successful Alliances
Mammalian Cloning: Biology and
Practice
Persistent Neural Activity
Persistent Neural Activity
Toward Animal Models of Attention
and Consciousness
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
2000
$ 44,500 *
9,122
10,000 *
24,219 *
10,000 *
25,000 *
43,406 *
36,167 *
20,975 *
25,000 *
20,000
23,551 *
40,180 *
30,000 *
17,565 *
2000 36,772 *
DNA LEARNING CENTER
Grantor Program/Principal Investigator Duration of Grant 2000 Funding'
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
ELSI Research Program
NATIONAL SCIENCE FOUNDATION
DEPARTMENT OF ENERGY
NONFEDERAL GRANTS
Howard Hughes Medical Institute
Josiah Macy, Jr. Foundation
Creation of a Digital Image Archive on the
American Eugenics Movement
A Partnership to Develop Advanced
Technology Units on Genomic Biology
The Science and Issues of Human DNA
Polymorphisms: An ELSI Training Program
for High School Biology Teachers
Precollege Science Education Initiative
for Biomedical Research Institutions
DNA from the Beginning
3/98-3/01
8/97-7/01
1/97-9/01
$ 201,289
166,270
62,642
7/94-8/01 66,732
10/97-9/01 297,484
The following schools each awarded a grant for the Genetics as a Model for Whole Learning Program:
Bethpage Union Free School District $ 1,050 Locust Valley Central School District 15,175
Commack Union Free School District 125 Mamaroneck Union Free School District 1,625
Community School District #29 33,375 Massapequa Union Free School District 1,425
East Meadow Union Free School District 4,065 Northport-East Northport Union Free School District 5,600
Farmingdale Union Free School District 1,995 Old Westbury School of the Holy Child 1,650
Garden City Public School 6,005 Oyster Bay-East Norwich Central School District 2,770
Great Neck Union Free School District 5,200 Plainedge Union Free School District 1,075
Green Vale School 2,800 Port Washington Union Free School District 6,770
Half Hollow Hills Central School District 6,375 Rockville Center Union Free School District 4,525
Harborfields Central School District 8,785 St. Dominic Elementary School 5,650
Jericho Union Free School District 5,500 Syosset Central School District 22,100
Lawrence Union Free School District 3,640
The following schools each awarded a grant for Curriculum Study:
Commack Union Free School District $1,100 Massapequa Union Free School District 2,200
East Woods School 1,100 Oceanside Union Free School District 1,100
Elwood Union Free School District 2,200 Oyster Bay-East Norwich Central School District 2,200
Friends Academy 2,200 Plainview-Old Bethpage Central School District 1,100
Garden City Union Free School District 1,100 Port ledge School 1,100
Green Vale School 1,100 Port Washington Union Free School District 1,100
Half Hollow Hills Central School District 1,100 Ramaz School 2,200
Harborfields Central School District 1,100 Roslyn Union Free School District 1,100
Herricks Union Free School District 1,100 Sachem Central School District 1,100
Island Trees Union Free School District 1,100 South Huntington Union Free School District 1,100
Jericho Union Free School District 1,100 Syosset Central School District 1,100
Locust Valley Central School District 1,100 West Hempstead Union Free School District 1,100
Long Beach City School District 2,200
393
We wish to express the genuine gratitude of the trustees, administration, and most especial-
ly the scientists of Cold Spring Harbor Laboratory for the generous financial support of those
persons, corporations, and foundations whose names appear on the following pages of the
Annual Report.
Richard L. Cosnotti, Chief Development Officer
Cold Spring Harbor Laboratory is a nonprofit research and educational institution chartered
by the University of the State of New York. Less than half of the Laboratory's annual revenues
are derived from Federal grants and contracts, and thus, we rely heavily on support from the
private sector: foundations, corporations, and individuals. Contributions from the private sec-
tor are tax exempt under the provisions of Section 501(c)(3) of the Internal Revenue Code. In
addition, the Laboratory is designated a "public charity" and, therefore, is enabled to receive
funds resulting from the termination of "private foundations."
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of Money can be made directly to Cold Spring Harbor Laboratory.
Securities: Stock certificates may be reassigned directly or transferred through your broker.
Appreciated securities should be given outright, which will avoid capital gains taxes on the
appreciated value. Securities that have decreased in value should be sold, and the proceeds
donated. In this way, a donor will receive a deduction for both the loss and the charitable
contribution.
Life Insurance: You may designate the Laboratory as the beneficiary of an existing or new
policy, or irrevocably assign ownership of the policy. There are estate tax benefits in either
case. If ownership is assigned, there is an immediate tax deduction.
Pooled Income Funds: Combine gifts from a number of donors in a pool for attractive
investment and tax purposes.
Appreciated Real Estate or Personal Property: Sizable tax benefits can result from such
donations; the Laboratory can use some in its program and can sell others.
Charitable Remainder Trusts can be structured to suit the donor's specific desires as to
extent, timing, and tax needs.
Bequests: Most wills probably need to be updated. Designating Cold Spring Harbor
Laboratory as beneficiary ensures that a bequest will be utilized as specified.
Conversion of Private Foundation to "Public" Status on Termination: This may be
done by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets
of the private foundation are accounted for as a separate fund and used for the purposes
specified by the donor. Alternatively, the private foundation can be established as a sup-
porting organization of Cold Spring Harbor Laboratory.
Matching Gifts: Many employers will match gifts to Cold Spring Harbor Laboratory and/or
the Watson School of Biological Sciences. Please check with your employer to augment
your gift.
For additional information, please contact the Chief Development Officer, Cold Spring Harbor Laboratory,
One Bungtown Road, Post Office Box 100, Cold Spring Harbor, NY 11724, 516-367-8840.
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CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 2000-December 31, 2000
Contributions of $5,000 and above, exclusive of Annual Fund
In 2000, Cold Spring Harbor Laboratory received significant support in the form of capital and program
contributions from individuals, foundations, and corporations.
Rita Allen Foundation, Inc.
The Michael Scott Barish Memorial Grant sponsored by
1 in 9: The Long Island Breast Cancer Action Coalition
Andrew's Buddies Corporation
Anonymous
Arrow Electronics
Louis Berkowitz Family Foundation, Inc.
The Breast Cancer Research Foundation
Llewellyn Burchell Charitable Trust
Arthur and Barbara Crocker Charitable Trust
The Ira W. De Camp Foundation
Devgen N.V.
Oliver S. & Jennie R. Donaldson Charitable Trust
William H. Donner Foundation
Ellison Medical Foundation
The Eppley Foundation for Research
Lawrence Flinn, Jr. Charitable Trust
Fraxa Research Foundation
Samuel Freeman Charitable Trust
Bernard F. and Alva B. Gimbel Foundation
Goldring Family Foundation
Irving A. Hansen Memorial Foundation
The Helen Hoffritz Foundation
Huntington Breast Cancer Action Coalition
Illinois Neurofibromatosis, Inc.
Sidney Kimmel Foundation for Cancer Research
The Esther A. and Joseph Klingenstein Fund, Inc.
Charles Henry Leach II Foundation
The Lehrman Institute
Mrs. Joy Levy
Long Island Foundation for the Elimination of Breast
Cancer
Long Islanders Against Breast Cancer (L.I.A.B.C.)
Mr. and Mrs. David L. Luke III
Marks Family Foundation
G. Harold & Leila Y. Mathers Charitable Foundation
The Maxfield Foundation
momminvpTotal
Breast Cancer Awareness Day in memory of
Elizabeth McFarland
Monsanto, Inc.
Louis Morin Charitable Trust
NARSAD
Neurofibromatosis of Arizona
Neurofibromatosis, Inc. Mass Bay Area
Mr. and Mrs. Edmond J. Nouri
Novartis
Offin Charitable Trust
Pew Charitable Trust
William E. and Maude S. Pritchard Charitable
Trust
Michael L. Rankowitz and Sheila Heffron
John R. Reese
Fannie E. Rippel Foundation
The Rockefeller Foundation
Mr. and Mrs. Jerry Saslow
Mr. and Mrs. Alan Seligson
Robin and Enrique Senior Philanthropic Fund
The Seraph Foundation
Alfred P. Sloan Foundation
SNP Consortium
St. Giles Foundation
Laurie Strauss Leukemia Foundation
Sun Gene GmbH & Co.
Swartz Initiative for Computational Neuroscience
Texas Neurofibromatosis Foundation
Tularik, Inc.
Mary G. Turner
The V Foundation
Dr. and Mrs. James D. Watson
West Islip Breast Cancer Coalition
Westvaco
The Whitaker Foundation
Helen Hay Whitney Foundation
Zeneca, Ltd.
$10,359,907
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
CAPITAL CAMPAIGN
January 1, 2000-December 31, 2000
Contributions of $10,000 and above, exclusive of Annual Fund
The Watson School of Biological Sciences at Cold Spring Harbor Laboratory was established for the
purpose of granting the Ph.D. degree. In its second year, the Watson School matriculated 9 addition-
al students bringing the total number to 15. In 2000, the laboratory received significant support from
individuals, foundations, trusts, and corporations.
Arnold and Mabel Beckman Arnold and Mabel Beckman Foundation
Graduate Studentship
Core Course
Dean's Chair
Faculty Lectureships
Fellowships
Knight House
Pall Fund
Visiting Lectureships
Watson Fund
Total
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Arnold and Mabel Beckman Foundation
Mr. Nicholas C. Forstmann
Mr. and Mrs. Leslie C. Quick, Jr.
Lita Annenberg Hazen Foundation
Annenberg Foundation
The Esther A. and Joseph Klingenstein Fund, Inc.
Mrs. Mary D. Lindsay
Quick & Reilly Group, Inc.
Dr. George B. Rathmann
Bristol-Myers Squibb Company
The Charles A. Dana Foundation
European Foundation for the Advancement
of Medicine
Mr. Alan Goldberg
Mrs. Gertrude W. Conner
Mr. Edward Giles
J.P. Morgan and Co. Inc.
Alan B. Slifka Foundation, Inc.
The Michel David-Weill Foundation
Fairchild Martindale Foundation
Mr. and Mrs. Charles E. Harris
Dr. Daniel E. Koshland, Jr.
Dr. and Mrs. Mark A. Ptashne
Biogen, Inc.
Mrs. John H. Livingston
Dr. and Mrs. Walter C. Meier
Dr. Michael Wig ler
Dr. Mark J. Zoller
$14,794,970
The Florence Gould Foundation
Mr. and Mrs. David H. Koch
Mr. Robert D. Lindsay
Mr. and Mrs. David L. Luke III
The Miller Family Foundation
ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
The Corporate Sponsor Program continues to be an essential factor in the overall success of the
Laboratory's meetings programs, for meetings held in Grace Auditorium on the main Laboratory cam-
pus and at Banbury Center. The funding provided by the Program enables us to plan ahead for the fol-
lowing year's meetings, and we are able to use it to select new and unusual topics. However, the wave
of mergers in the pharmaceutical and biotechnology industries is severely reducing the pool of com-
panies that we can approach, and we are therefore evermore grateful to the 38 corporate sponsors
and affiliates who joined us in 2000 and are listed below.
The Corporate Affiliates and Contributors Program began in 1999 with the expectation that smaller
biotechnology companies which must, necessarily, devote their resources to research might neverthe-
less find it useful to have some of the benefits of the Corporate Sponsor Program.
The members of the Program receive special privileges in acknowledgment of their contributions. We
waive all on-site fees for eight representatives of each company at our meetings. The number of meet-
ings has increased, so that in 2000, no fewer than 17 meetings took place in Grace Auditorium. Three
scientists from member corporations may attend meetings at Banbury Center, where attendance is oth-
erwise only by invitation of the organizers. Corporate Sponsors receive gratis copies of Cold Spring
Harbor Laboratory Press publications, including the journals Genes and Development, Learning and
Memory, Genome Research, and Protein Science. We acknowledge our Sponsors in all relevant pub-
lications, including the books of abstracts given to each of the 7000 participants who come to the meet-
ings each year. The names of the sponsoring companies are listed on the poster describing the meet-
ings; this is mailed to approximately 17,000 scientists throughout the world. In addition, the companies
are listed on the Cold Spring Harbor Laboratory Web Site, on the Meetings and Banbury Center pages.
COLD SPRING HARBOR LABORATORY CORPORATE SPONSORS
Amgen Inc.
AstraZeneca
Aventis Pharma AG
BASF Bioresearch Corporation
BioVentures, Inc.
Bristol-Myers Squibb Company
Chiron Corporation
Chugai Research Institute for Molecular
Medicine, Inc.
Diagnostic Products Corporation
DuPont Pharmaceuticals Company
PLANT CORPORATE ASSOCIATES
Monsanto Company
Novartis Agricultural Discovery Institute
Pioneer Hi-Bred International, Inc.
Westvaco Corporation
Forest Laboratories, Inc.
Genentech, Inc.
Genetics Institute
Glaxo Wellcome Inc.
Hoffmann-La Roche Inc.
Johnson & Johnson
Kyowa Hakko Kogyo Co., Ltd.
Eli Lilly and Company
Merck Research Laboratories
New England BioLabs, Inc.
Novartis Pharma Research
FOUNDATIONS
Albert B. Sabin Vaccine Institute, Inc.
CORPORATE AFFILIATES AND CONTRIBUTORS
Affymetrix, Inc.
Alexis Biochemical Corp.
Applied Imaging
Biogen, Inc.
CuraGen Corporation
Digital Gene Technologies, Inc,
Double Twist, Inc.
Dynal, Inc.
Total
Eppendorf - 5 Prime, Inc.
Genetix Limited
Genome Systems, Inc.
Genomic Instrumentation Ser.
Genomica Corporation
Inform., Inc,
Lexicon Genetics, Inc.
$1,043,000
OSI Pharmaceuticals, Inc.
Pall Corporation
Palmetto Partners, Ltd.
Parke-Davis Pharmaceutical Research
PE Biosystems
Pfizer Inc.
Pharmacia & Upjohn, Inc.
Research Genetics, Inc.
Schering-Plough Corporation
SmithKline Beecham Pharmaceuticals
PharMingen
Proteome, Inc.
Qiagen GMBH
Research & Diagnostic Systems, Inc.
Stressgen
Third Wave Technologies, Inc.
Zymo Genetics
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DNALC Corporate Advisory Board Annual Fund
The Corporate Advisory Board, established in 1992, serves the DNA Learning Center as a liaison to
the corporate community and assists in securing unrestricted dollars for annual support. As a means
of raising awareness, the Board conducts the annual CSHL Golf Tournament as well as the Annual
Fund. The proceeds benefit the DNA Learning Center and the Partners for the Future program. The
Partners program teaches principles and methods of basic scientific research to eight Long Island high
school seniors, who work with scientists 10 hours per week after school, from October through March.
Chairman: John J. Leahy, Citibank Private Bank
Michael Aboff, Aboff's Inc.
Andrew D. Ackerman, Chase Manhattan Bank
Brett Ashley, Cole Communications
Rocco S. Barrese, Esq., Dilworth and Barrese
Howard M. Blankman, The Blankman Group
Jane S. Block, Pall Corporation
Thomas J. Calabrese, Daniel Gale Agency
Richard A. Catalano, KPMG, LLP
Edward A. Chernoff, Motors and Armatures,
Inc.
Paul Czeladnicki, Rivkin, Radler and Kremer
Robert Diller, Brinkmann Instruments
Candido E. Fuentes-Felix, M.D., F.A.C.S.
ANNUAL FUND CONTRIBUTORS
GENOME SUPPORTERS
Contributions of $10,000 or more
EAB
Edward A. Chernoff, Motors and Armatures, Inc.
Mr. and Mrs. Arthur M. Spiro
CHROMOSOME SUPPORTERS
Contributions of $5,000 or more
Mr. and Mrs. G. Morgan Browne
Laurie J. Landeau, V.M.D.
Newsday
Mr. Denis J. O'Kane
Pall Corporation
GENE SUPPORTERS
Contributions of $2,500 or more
Anonymous
Citibank Private Bank
Louis and Virginia Clemente Foundation, Inc.
Dilworth and Barrese
Herman Development Corporation
KPMG LLP
Meenan Oil Company, LP
Northwood Ventures, LLP
OSI Pharmaceuticals, Inc.
Pittway Corporation Charitable Foundation
Rivkin, Radler and Kremer
Tilles Family Foundation
EXON SUPPORTERS
Contributions of $1,000 or more
Aboff's Inc.
Mrs. and Mrs. Joseph Azznarra
Brinkmann Instruments
Daniel Gale Agency
DNALC Fund
Gale and Wentworth Fund
Harweb Foundation
Mr. and Mrs. Gerard Leeds
Mr. George Roche
Mr. and Mrs. William D. Roche
Mr. Harold Rosenberg and Dr. Laurie Sayet
Rosenberg
The Blankman Group
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Dave Garbus, Huntington Business Products
Centre
John Henry, EAB
Arthur D. Herman, Herman Development
Corporation
John Kean III, Kean Development Company
Laurie J. Landeau, V.M.D.
Ralf Lange, Luitpold Pharmaceuticals, Inc.
Lilo Leeds, Institute for Student Achievement
James Mattutat, The Shattan Group
Patricia Petersen, Daniel Gale Agency
Christiaan B. Reynolds, ASI Solutions, Inc.
William D. Roche
INTRON SUPPORTERS
Contributions of $500 or more
Arthur Andersen, LLP
Mr. and Mrs. Robert Beuerlein
Ms. Rosemary Bourne
Dr. and Mrs. Burke A. Cunha
Dr. and Mrs. Candido E. Fuentes-Felix
Monterey Fund, Inc.
Petunia Productions
Ms. Wendy Vander Poel Russell
Topspin Partners, LP
TRIPLE CODON SUPPORTERS
Contributions of $250 or more
John V and Carole S. Aksak
Mr. and Mrs. Michael Boylan
Emerson Specialty Motor Division
Dr. and Mrs. Steven Goldberg
North Country Medical Associates
State Bank of Long Island
NUCLEOTIDE PAIR SUPPORTERS
Contributions of $100 or more
Drs. John B. Amodio and Eileen M.K. Fontanetta
Dr. and Mrs. Thomas Arcati
Dr. and Mrs. Pierre Beaubrun
Mr. and Mrs. Steven Corwin
Dunetz, Marcus, Brody and Weinstein LLC
Mr. and Mrs. John Genovese
Ms. Louise Johnston
Mr. and Dr. Candido Llovera
Mr. and Mrs. Joseph Lo Cicero
Ms. Anita MacDougall
Mr. and Mrs. Kevin McCarthy
Mr. and Mrs. James Mattutat
Mr. and Mrs. James J. Murphy
Mr. and Mrs. Richard Nick las, in honor of
Leslie C. Quick, Jr
Joseph P. O'Brien Agency
Dr. Christopher Perrone
Mr. and Mrs. John Pufahl
Mr. and Mrs. Thomas K. Reimels
Dr. and Mrs. Newell B. Robinson
Mr. and Mrs. Alexander J. Smith
Mr. and Mrs. Emil Stenger
Total $110,045
Wendy Vander Poel Russell, CSHL Honorary
Trustee
Horst K. Saalbach, Ph.D., Festo Corporation
Peter G. Schiff, Northwood Ventures LLC
Charles Schueler, Cablevision Systems Corp.
Dixie Scovel, Newsday
Jeffrey K. Tupper, U.S. Trust Company of New
York
Robert Van Nostrand, OSI Pharmaceuticals,
Inc.
Frederick Volp, Ph.D., CSH Central School
District
William N. Wham, ISC Inc.
Mr. David Strahl
The Torti Family
Mr. and Mrs. Thomas Tucker
NUCLEOTIDE SUPPORTER
Contributions of $50 or more
Mr. and Mrs. Thomas Amberger
The Bakshi Family
Mr. and Mrs. Richard Canner
Ms. May-Loo Dal
Damin Sales/Mr. Steven Gershman
Dr. Michael Gaffney and Ms. Patricia Lynch
Ms. Jennifer Giwa
Mr. and Mrs. Warren Herman
Ms. Christina Jackowski
Mr. and Mrs. Arthur Lagrega
Ms. Mary Lou Lysaght
Mr. and Mrs. Alan Marks
Dr. and Mrs. Lawrence B. Mogen
Mr. and Mrs. Donald Morrongiello
Mr. and Mrs. Kevin O'Donnell
Ms. Stephanie G. Ovaida, Esq.
Mr. and Mrs. Kenneth Packert
Mr. and Mrs. Luis Paniagua
Ms. Elizabeth D. Pessala
Mr. and Mrs. Philip Rao, Jr.
Mr. Marc Schafler
Mr. and Mrs. Jeffrey Stern
Ms. Norma Whitley
GIFTS IN MEMORY OF MARYBETH ZOEGAL
Mr. and Mrs. Christopher Biagini
Mr. and Mrs. Richard Blum
Mr. and Mrs. Henry Brengel
Mr. and Mrs. Michael J. Costello
Ms. Judith Ann Dazzo
Mr. and Mrs. Thomas Grosse
Mr. and Mrs. Victor E. Rerisi
Mr. Arnold A. Sabino
OTHER CONTRIBUTIONS
Mr. and Mrs. Daniel Golub
Mr. and Mrs. Thomas LoBasso, Jr.
Mr. and Mrs. Anthony Sabino
Ms. Dorothy Schumejda
Mr. and Mrs. John Vargas
The Campaign for the BioMedia Addition
To effectively meet the needs of an ever-increasing number of students and the DNA Learning Center's
expanding programs, The Campaign for the Bio Media Addition is under way. The expansion, to include
a suite of teaching labs, a student research lab, new exhibits space, a broadcast media studio, and
multimedia computer lab, will ensure that future generations of students and teachers receive the lat-
est and most up-to-date molecular biology education that is the hallmark of the DNA Learning Center.
Through the generous support of the Dolan Family Foundation, the DNA Learning Center will be
renamed The Dolan DNA Learning Center.
Campaign Contributors
Construction
The Dolan Family Foundation $ 3 million
CSHL Funding $ 500,000
New York Stock Exchange Foundation $ 10,000
Mr. Denis O'Kane $ 35,000
Edwin Webster Foundation $ 80,000
Equipment
P.E. Biosystems $ 130,000
DNA Learning Center Grants
Josiah Macy, Jr. Foundation
With a grant of $550,000, the DNA Learning Center will build a companion site to its existing Web Site,
DNA from the Beginning, titled Your Genes/Your Health. YGYH is targeted at patients and families deal-
ing with genetic illness interested in learning the biology behind the medical terminology. Further-more,
this new site will provide resources that can assist families participating more effectively in the care of
a loved one. This recent grant from the Macy Foundation brings their total investment in the project to
$1.37 million.
The Pfizer Institute
With a 2-year grant of $150,000, the DNA Learning Center will offer the Pfizer Foundation Leadership
Institute in Human and Molecular Biology during the month of July in 2001 and 2002. The Institute will
provide high-level high school science teachers throughout the country an opportunity for hands-on
laboratory experiences at the DNA Learning Center which will assist them in integrating molecular
genetics into their high school programs.
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SEVENTH ANNUAL GOLF TOURNAMENT SPONSORS
GOLF TOURNAMENT COMMITTEE
Tournament Chairman
Edward A. Chernoff, Motors & Armatures Inc.
Sponsorship Co-Chairmen
W. Dillaway Ayres, CSHL
G. Morgan Browne, CSHL
Photography Chairman
Howard M. Blankman, The Blankman Group
Raffle Co-Chairpersons
Carol Carson, Motors & Armatures Inc.
James Mattutat, The Shattan Group
Tournament Committee
W. Dillaway Ayres, CSHL
Art Brings
G. Morgan Browne, CSHL
Richard L Cosnotti, CSHL
William Keen, CSHL
Charles Prizzi, CSHL
Vincent P. Torti, CSHL
Guest Celebrities
Clark Gil lies
Laura Savini
Founding Tournament Sponsor
J.P. Morgan & Co., Inc.
Major Corporate Sponsors
Cablevision Systems Corp.
Fortunato Son, Inc.
Luitpold Pharmaceuticals, Inc.
Marsh Inc.
Motors & Armatures, Inc.
Quick & Reilly Group, Inc.
Corporate Sponsors
Badge Insurance Agency Inc.
KPMG, LLP
Festo Corporation
Journal Sponsor
Conde Nast Publications
Hole-In-One Sponsors
Badge Insurance Agency Inc.
Competition BMW of Smithtown
Brunch Sponsor
Centerbrook Architects
Cocktail Reception Sponsor
Motors & Armatures, Inc.
Auction Prize
Lufthansa
Registration Table Sponsor
U.S. Trust Company of New York
Refreshment Sponsor
OSI Pharmaceuticals, Inc.
Driving Range Sponsor
Chase Manhattan Bank
Total
Putting Green Sponsor
Jack Berleth & Sons, Inc.
Gold Sponsors
ASI Solutions, Inc.
Barnes 8, Noble Bookstores
Brinkmann Instruments, Inc.
Chase Manhattan Bank
Ciardullo Landscapes & Designs, Inc.
Citibank Private Bank
Corte' Business Systems
Daniel Gale Agency
Dilworth & Barrese
Herman Development Corporation
ISC, Inc. (3)
Kean Development Company
Lufthansa
Luitpold Pharmaceuticals, Inc.
Northwood Ventures LLC
OSI Pharmaceuticals, Inc.
Rivkin, Radler & Kremer
Sbarro Corporation
The Seligson Foundation
Squadron, Ellenoff, Plesent & Sheinfeld LLP
Tradition N.A. Derivative Products
U.S. Trust Company of New York
Silver Sponsors
Bee, Eisman & Ready
Thomas J. Calabrese
Frank Crystal & Company, Inc.
Electronix Systems
The Hartford
Huntington Business Products Centre
State Bank of Long Island
U.S. Trust Company of New York
Bronze Sponsors
Aboff's Inc.
Advantage Title
Burt Building Materials Corp.
Callan, Regenstreich, Koster & Brady, LLP
Dr. Candido Fuentes-Felix
Margolin & Margolin, Esqs.
MCS/Canon
Commemorative Journal Sponsors
Aboff's, Inc.
A Partymaker
Arrow Linen Supply
Charmer Industries
Dimension II Lawn Sprinklers
Farmingdale Ironworks
Hamilton, Brooks, Smith & Reynolds
Janvey & Sons
Key Span Energy
Lewisy Fuel Oil, Inc.
New York Biotechnology Assn.
Rampart Insurance
Paul Rosenvold Inc.
Wendy Vander Poel Russell
The Sheridan Press
Tee & Green Sponsors
The Blankman Group
CII Technologies
Jeff's Seafood
J & M Bakery Products
Josten's
$142,500 -
Total DNA Learning Center Annual Fund
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Riverhead Building Supply
Stirling Creek Associates, Inc.
TIM-CREF
To Jo Provisions, Inc.
UnitedHealthCare
Raffle Prize Contributors
Aboff's Inc.
Ace One-Hour Photo
A Rise Above
All-Star Video
Barmonde Studios
Broadway Cares
Clearwater Restaurant
Cold Spring Harbor Laboratory
Crossroads Restaurant
J. Di Carlo's Restaurant
Distinctive Products Company
Ecco Environmental
Boomer Esiason Foundation
Daniel Gale Agency
Clark Gil lies
Huntington Business Products Centre
Lemongrass Restaurant
London Jewelers
Marsh's of Huntington
Mill River Inn
New Age Technologies & Peter Tosto
OC Tanner
Port-To-Port
Ragtime
Rivkin, Radler & Kremer
John Rosenberg
Sharp Electronics
Spinnaker Travel
Pat Demarest, Sunderland of Scotland
Texas Instruments
Tourneau
Tupelo Honey Restaurant
Tuxedo Park
Winebow Inc., Limited
Favor Bag Sponsors
Fortune Magazine
CSHL Tee Shirts by Barnes & Noble
Bookstores
Golf Balls by Chase Manhattan Bank
Golf Towels by Daniel Gale Agency
Golf Balls by Festo Corporation
Golf Shirts by GE Industrial
Golf Balls by KPMG, LLP
Golf Balls by Vin Torti, CSHL
Golf Tees and Umbrellas by United Healthcare
Special Thanks
The Harold Betters Quartet
Howard Blankman
Eddie Chernoff, Golf Chairman
CSHL & DNALC Staff
Francis X. Harrington
Brian Lynch & Boston Brewery
Jim Mattutat & Pat Petersen
Don Vultaggio, Arizona Beverages
Other Contributors
Anonymous
CDW
Moser & Moser LLP
William D. Roche
$252,545
Cold Spring Harbor Laboratory Association (CSHLA)
Officers
James L. Spingarn, President
Trudy H. Calabrese, First Vice President
John S. Grace, Vice President
Cathy Cyphers Soref, Secretary
Antoine C. Kemper, Jr., Treasurer (February 1999-July 2000)
Joseph T. Donohue, Treasurer
Directors
Nicholas J. Bartilucci
George W. Cutting, Jr.
David H. Deming
Frances N. Elder
Linda Franciscovich
Robert A. Gay
William F. Gerry
Lynn M. Gray
Honorary Directors
John P. Cleary
Mary D. Lindsay
Anne R. Meier
President's Report
Susan Hollo
Allen Dulles Jebsen
E. Coe Kerr
Alan M. Kisner, M.D.
Mary Alice Kolodner
Gilbert R. Ott, Jr.
Eileen K.S. Pulling
Lawrence Remmel
Henry Salzhauer
Ann C. Seifert
Cynthia R. Stebbins
Bruce Stillman, Ph.D.
Marjorie von Stade
James D. Watson, Ph.D.
The year 2000 kept us very busy, as usual, trying to keep up with the innovation, accomplishments,
new happenings, and results at Cold Spring Harbor Laboratory. In many instances, as the "public" face
of the Laboratory, it is we who design, implement, and enact programs, both of educational and enter-
tainment value, intended to encourage support for this great institution.
The support of generous donors enables the Laboratory to staff its various research laboratories
with top scientific research talent. A significant portion of the Annual Fund goes directly to support
promising young postdoctoral fellows. These people are vital to the Laboratory's continuing success.
This year, the Cold Spring Harbor Laboratory Association raised $763,721.95 in our Annual Fund. This
is a new record, which with Annual Fund endowment gifts totaling $250,000 makes our success even
more impressive, surpassing $1 million for the first time.
Leadership is key to the Association's success. In 2000, George W. Cutting, Jr., William F. Gerry,
Lynn M. Gray, Susan Ho llo, and Allen Dulles Jebsen were elected new Directors. We thank Mary Ann
Charlston and Mary D. Lindsay, our retiring Directors, who gave talented and devoted time and effort
to the Association. I am delighted to add that after many unstinting and wonderfully productive years
with the Association, Mary D. Lindsay has been named as Honorary Director. Later on in the year, we
bid farewell to both Linda Franciscovich and Antoine C. Kemper, Jr., who resigned as Directors due to
personal commitments. Many thanks to them for their devoted service.
Our February 5 Annual Meeting was followed by a cocktail buffet dinner and featured Dr. Steven
Pinker, who is Professor of Psychology, Department of Brain and Cognitive Sciences at the
Massachusetts Institute of Technology. Dr. Pinker's fascinating talk related to matters we deal with every
day: "Words and Rules: The Ingredients of Language." On March 11, we had a most productive 1-day
"define our mission and come up with new ideas" retreat. The next Association event was our annual
Jazz at the Lab Concert on April 15, followed by a cocktail buffet dinner. Again, our own Rick Cosnotti
was crucial to its great success as were Directors Joe Donohue and Gil Ott. Featured were the Harold
Betters Quartet, Kenny Blake, and Eric Johnson.
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CSHLA Directors Joseph Donohue and David
Deming and CSHLA President James Spingarn
at 2000 Annual Meeting.
On May 25, the New York City Spring Event was held at the University Club. A Genetic Engineering
Panel discussed "Industrial Strength Food: Commercial Implications of Genetic Engineering," a most
pertinent topic today.
June 4 was the date of our annual blockbuster Dorcas Cummings Lecture when renowned and
younger scientists from around the globe gather to focus upon a particularly important theme. Our guest
speaker was Jan H.J. Hoeijmakers, Ph.D., from Erasmus University of Rotterdam. He eloquently spoke
about "Maintaining Nature's Perfection: Cancer and Aging and the Condition of Our Genes." Dinner par-
ties that followed were organized by Trudy Calabrese, Frances Elder, Bob Gay, Eileen Pulling, Ann
Seifert, and Cathy Soref. We thank them and the generous hosts of these delightful get togethers:
Ms. Mary Lenore Blair
Mr. and Mrs. Thomas J. Calabrese
Mr. and Mrs. John P. Cleary
Mr. and Mrs. Guy A. Fritts
Mr. and Mrs. John S. Grace
Mr. and Mrs. William F. Gerry
Mr. and Mrs. Richard M. Jackson
Mr. and Mrs. E. Coe Kerr Mr. and Mrs. Henry E. Salzhauer
Mr. and Mrs. Michael L. Kolodner Mr. and Mrs. William E. Sheeline
Mrs. Mary D. Lindsay Mr. and Mrs. Douglas S. Soref
Mr. and Mrs. David L. Luke Ill Mr. and Mrs. James L. Spingarn
Mr. and Mrs. Robert O'Connor Mr. and Mrs. Thomas R. Vandeventer
Mr. and Mrs. James J. Pirtle, Jr. Mr. and Mrs. Robert P. Walton
Two other past events reappeared this year to their great success and our great delight. They were
the CSHLA Partnership Picnic on September 24, which promotes relationships between Laboratory sci-
entists and members of the Association. It was hosted, most beautifully again, by David and Betsy Clark.
On October 3, members of the Cosmopolitan Club in New York City came for a tour of the Laboratory
and DNA Learning Center. It was a smash hit and was cohosted by Elizabeth Watson and Mary Lindsay.
October 18 saw our Second Annual Biotechnology Luncheon, which was again generously spon-
sored by The U.S. Trust Company. The main speakers were Thomas O'Karma, M.D., Ph.D., President
and Chief Executive Officer of Geron Corporation, a biopharmaceutical company, and Alan Colman,
Ph.D., Research Director of PPL Therapeutics, a biotechnology firm. Their topic of discussion, which
was introduced by our Director and Chief Executive Officer, Dr. Bruce Stillman, was "Intimations of
Immortality." Many thanks to Eileen Pulling and Larry Remmel for all of their hard work in making this
event such a success. The most gracious Mrs. John (Robin) Hadley hosted our November 11 Major
Donor Cocktail Dinner, at which time we expressed our special appreciation to our exceptionally gen-
erous donors. It was elegant, and the food was delicious. Thank you Robin!
We thank each of you for your wonderfully generous interest, time, and support.
January 2001
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James L. Spingarn
Members of the Cold Spring Harbor Association
ANGELS
Contributions of $10,000 or more
The Ada Howe Kent Foundation
Mr. and Mrs. G. Morgan Browne
Clarkson Family Foundation
Mr. and Mrs. John P. Cleary
The Dorothy Schiff Foundation
Robert B. Gardner, Jr.
Mrs. Oliver R. Grace
Mr. and Mrs. Austen T. Gray, Jr.
J. Aron Charitable Foundation, Inc.
Mrs. Mary D. Lindsay
Mr. and Mrs. David L. Luke III
Mr. and Mrs. William L. Matheson
Dr. and Mrs. Walter C. Meier
Mr. Robert G. Merrill
The Miller Family Foundation
Morris Charity Fund/Mr. and Mrs.
Douglas P. Morris
Mr. and Mrs. Denis J. O'Kane
Mr. and Mrs. Edward L. Palmer
Edward M. Scolnick, M.D.
Mr. and Mrs. James L. Spingarn
Marilyn and Jim Simons
Dr. and Mrs. James D. Watson
BENEFACTORS
Contributions of $5,000 or more
The Alex J. Weinstein Foundation,
Inc.
Anonymous
Roger and Lori Bahnik
Mr. William Braden
Mrs. Helen M. Brooks
The Craigmyle Foundation,
Norris Darrell, Jr.
Mr. and Mrs. David H. Deming
Robin T. Hadley
The Howard Phipps Foundation
Mrs. John H. Livingston
Robert and Joyce Marcus
The Mary G. Turner Charitable
Lead Unitrust
Merlin Biomed Investment
Advisors
Mr. and Mrs. Charles E. Murcott
Norwood Foundation, Inc./The
Bancroft Families
Joyce and John Phelan
Mr. and Mrs. Philip R. Von Stade
The William H. Donner Foundation,
Inc.
PATRONS
Contributions of $2,500 or more
Abby & George O'Neill Trust
Mr. and Mrs. W. Dillaway Ayres, Jr.
Mr. and Mrs. Timothy Broadbent
Mr. and Mrs. George W. Cutting, Jr.
Mr. and Mrs. Edward E. Fessenden
Mr. and Mrs. Robert A. Gay
Michael J. Griffin and Joyce A.
Berto !do
Mr. and Mrs. William H. Grover
Mr. and Mrs. Allen D. Jebsen
Mr. Robert M. Jenney
Joyce Green Family Foundation
Mr. and Mrs. Townsend J. Knight
Laurie J. Landeau V.M.D.
Mrs. Henry Lewis III
Mr. Henry Luce III
Mrs. Ellen Hallowell Pratt
Mr. and Mrs. Thomas L. Pulling
Mr. and Mm. Preston V Pumphrey
Quality King/The Nussdorf Family
The Richard A. and Amelia
Bernstein Foundation, Inc.
John and Hope Reese
The Schiff Foundation
Wellington Foundation, Inc.
The William Ewing Foundation
Mr. and Mrs. Douglas A. Warner III
ASSOCIATES
Contributions of $1,000 or more
Mr. Warren S. Adams II
Robert and Betty Albertson
Anonymous
The Anthony & Claire Pace
Foundation, Inc.
Robert H. Arnow
Mr. and Mrs. Joseph Azznara
Mr. and Mrs. Horace C. Bailey
Banbury Fund
David and Pamela Banker
Mr. and Mrs. Nicholas J. Bartilucci
Mr. Edmund Bartlett
Mr. and Mrs. Cornelius N. Bliss III
Mr. and Mrs. Allen L Boorstein
Dr. David Botstein and Dr. Renee
Rtts
Mary Griggs Burke
Mr. Leonard Butterman
Mr and Mrs. Thomas J. Calabrese, Jr
Ceptyr, Inc.
Mr. and Mrs. Thomas H. Choate
Mr. and Mrs. David C. Clark
Dr. and Mrs. Bayard Delafield
Clarkson
Mrs. Robert L. Clarkson, Jr
Mr. James W. Cleary
Mr. and Mrs. John H. Coleman
Mr. and Mrs. Peter 0. Crisp
Mr. and Mrs. Arthur M. Crocker
Mr. and Mrs. Curtis Cushman
The Davidson Family Foundation
Mr. and Mrs. Donald L. Deming
William Theodore Dens low
Foundation
Jerrold Doros
Nelson Doubleday
Dr. Lester Dubnick
Mr. and Mrs. William T Dunn
Duplex Electrical Supply
Corporation
Jan and Jim Eisenman
Mr. and Mrs. Johnston L. Evans
Mr. and Mrs. William Everdell
Dr. Robert and Marjorie Feeney
Jeffrey Keller and Dolores Fredrich
E.M. Geddes, Jr.
The General William Mayer
Foundation
Mr. and Mrs. E.T. Gerry, Jr.
Helen and Monte Get ler
Mr. and Mrs. Edward M. Giles
Mr. and Mrs. Oliver R. Grace, Jr.
Mr. and Mrs. Edward Greenberg
Mr. and Mrs. Gordon S.
Hargraves
Henry U. Harris, Jr.
Mr. Lindsay C. Harkness III
Mr and Mrs. Mark G. Halls
Mr. and Mrs. Waldo Hutchins III
Mr. Frederic B. Ingraham
Walter B. James Fund #2
Mr. and Mrs. Barclay Jones
Mr. and Mrs. E. Coe Kerr
Julia B. Key
Andrea B. and Peter D. Klein
Mr. and Mrs. Michael L Kolodner
Drs. Egon and Marcia Kramer-
Mayer
Mr. and Mrs. Gordon E. Lamb
Mr. Edward M. Lamont
Mrs. Lois A. Lenahan
Leo Model Foundation, Inc.
Robert V. Lewis, M.D.
Mr. and Mrs. Mario Lipari
Mrs. Vladimir S. Littauer
Dr. David M. Livingston
Mr. and Mrs. Luke D. Lynch, Jr.
Thomas and Ellen McPartland
Mrs. Cynthia R. Mead
Clarence F. Michalis
Mr. and Mrs. Keith M. Moffat
Francis W. Murray III
Mr. and Mrs. William J. Nammack
Mr. and Mrs. Michael S. O'Brien
Thomas W. and Mary Ellen
Ostrander
Mr and Mm. Philip F. Palmedo
Mr and Mrs. Nicholas B.
Paumgarten
Mr and Mrs. Howard Phipps, Jr.
Mr. and Mrs. Whitney Pidot
Mr. and Mrs. Robert A. Pilkington
Mr. and Mrs. Joseph D. Posillico,
Jr.
Mr. and Mrs. Lawrence Remmel
Chuck Riggs and Sheila Mahony
Mr. and Mrs. Luis E. Rinaldini
Mr. John J. Roche
Mr. and Mrs. Arthur M. Rogers, Jr.
Mr and Mrs. J. Wright Rumbough,
Jr.
Mrs. William F. Russell
Salzhauer Family Fund
Mr. and Mrs. Thomas L Seifert
Mr. and Mrs. Enrique F. Senior
Mr. and Mrs. Owen T Smith
Mr. and Mrs. Peter Solbert
Mr. and Mrs. Douglas S. Soref
Dr. Axel Stawski
Mr. and Mrs. James E Stebbins
Grace and Bruce Stillman
Mr. and Ms. Henry Stockman
Mrs. Richard Storrs
Mrs. James Van Alen
Mrs. Martin Victor
Mrs. Taggart Whipple
Mr. Gerald I. White
Mr. and Mrs. Samuel H. Wolcott III
Mr Mayer Wolf
FRIENDS
Contributions of $300 or more
Mr. and Mm. William Achenbaum
Albrecht, Viggiano, Zureck &
Company, P.C.
Norman E. Alexander
Ms. Jean E. Andersen
Mr. and Mrs. David F. Andersen
Dr. and Mrs. Glenn Anderson
Anonymous
Mr. and Mrs. Edward H.
Auchincloss
Mr. and Mrs. Richard Aurelio
Henry and Erica Babcock
Mrs. George de B. Bell
Mr. John Berejka and Dr. Diane
Moriarty
Berger, Torquato & Davis, LLP
William L Bernhard
Pam and Gene Bernstein
Bancker Construction Corporation
Mr John C. Bierwirth
Bladykas Engineering, P.C.
Ms. Rosemary Bourne
Mrs. Walter E. Brunauer
Eleanor and John Campbell
Eleanor Chernick, Ed.D.
James C. Childress
The Christopher D. Smithers
Foundation
Cord Meyer Development
Company
Donna and Barry Cosel-Pieper
Mr. and Mrs. Richard T Cunniff
Claus & Adana Dannasch
Mr. and Mrs. Daniel C. De Roulet
Mrs. W. T Dean
James and Sophie Donaldson
Mr. and Mrs. Kostas Douzinas
Mr. and Mrs. Joseph P. Downer
Mayor E Richard Droesch
Eileen and Charles Dubroff
Mr. and Mrs. Don Durgin
Mrs. Julie C. Eichenberger
Jerry and Gail Ellstein
Claire and Joel Fairman
Mr. and Mrs. Harold L Fates
Anne Marie Raids
Mr. and Mm. Eric 0. Fornell
Dr. and Mrs. Candido E. Fuentes-
Felix
Mr. and Mrs. Richard Gachot
Mr. and Mrs. William C. Gay, Jr.
William and Maxine Glenn
Stephen M. and Judith F
Goodman
Rosalyn C. Gordon
Dr. and Mrs. Maurice Green
Mr. and Mrs. Harold W. Hawkey
Melvin Heller
Mrs. Albert L Hoffman
Sealy and Mark Hopkinson
Mr. and Mm. Francis C. Huntington
Imowitz Koenig & Co., LLP
Michael and Joanne Ingham
Laura J. Ingraham
Thomas lovino/Judlau Contracting
Jaspan Schlesinger Hoffman, LLP
Mr. and Mrs. Jeffrey Keller
Kiwanis Club of Floral Park
Mrs. James Knott
Barbara B. Knowles and Davor
Solter
Mort and Deborah Kunst ler
Maureen and Tony Leness
Mr. and Mrs. Robert V Lindsay
George N. Lindsay, Jr. and Nancy
Metz
Candido and Irene Llovera
Cynthia J. MacKay, M.D.
William H. Mathers
Mr. and Mrs. William B. Matteson
Linda H. McLaughlin
Kim Anh and Jeffrey H. Miller
Mr. and Mrs. John Robinson Miller
IV
Mr. and Mrs. George M. Milne
Elihu and Dorothy Mod lin
Mr. and Mm. James D. Mooney, Jr.
Mr. and Mrs. Charles F. Morgan
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Mr. and Mrs. John P. Morgan II
Jo Anne and Howard Olian
Mr. and Mrs. Peter O'Neill
Mrs. Martha M. Osterhus
Gilbert R. Ott, Jr.
Mrs. Anita H. Page
Mrs. John H. Page
Mr. and Mrs. Charles G.
Papa lcure
Sterling Pile, Jr.
Mr. and Mrs. James Pirtle
Scott and Diane Powers
The Richard Foundation
The Richard M. Rossbach
Memorial Fund
Susan L. Rose
Mr. and Mrs. Michael Evan Saffran
Steven M. Schlussel, Esq.
Gloria and Marvin Sharfin
Mr. Edward E. Shone
Dr. and Mrs. Walter Shropshire, Jr.
Mary and Robert Sibert
Mr. and Mrs. Howard Simpson
Herbert L. Smith III
Georgette A. Spingarn
Mr. and Mrs. Erwin R Staller
Drs. Joan and Thomas Steitz
Mr. Byam K. Stevens, Jr.
Judith and Irwin Tantleff
Mrs. David S. Taylor
Think Tank Consultants, Inc.
Mr. and Mrs. George H. Tilghman
James and Mary Gay Townsend
Stanley S. Trotman
Carl Vernick, P.E./Soil Mechanics
Drilling Corp.
Mrs. Sherwood Waldron
Henry and Rosalind Walter
Walter K. Pulver Landscape
Architect
Charles W.B. Wardell, Jr.
Winifred I. Warner
Mr. and Mrs. George M. Wheatley
III
Mr. and Mrs. Douglas Williams
Don M. Wilson III
Frederick C. Witsell, Jr.
Dr. Charles Yanofsky
YEC, Inc.
BASIC MEMBERSHIP
Contributions of $75 or more
Mr. and Mrs. Thomas H.
Ackerman
Mr. and Mrs. Charles 0. Ames
Carl and Mary Anderson
Mr. and Mrs. J. Bryan Anthony
Mrs. S. Reed Anthony
Marion and Jens Bakke
Daniel P. Barbiero
Dr. Henry H. Bard, M.D.
Mr. and Mrs. David Barrett
Mr. Robert S. Barron and Ms.
Susan Holgate
Phyllis Bartlett
Dr. and Mrs. Neil Barton
Mr. Richard Battenfeld
Mr. and Mrs. Frederick Baum
Philip C. Beers, Ph.D.
Mr. and Mrs. Robert E. Benson
Peter J. Bergen
Mr. and Mrs. Loren C. Berry
Marjorie M. Bhavnani
Mrs. Georgina M. Bissell
Mr. and Mrs. Peter H. Blohm
Lilias K. Bostwick
Dr. and Mrs. Gerald Brogan
404
Shelley and John Broven
Mr. and Mrs. Willard and Jeanette
Bunn, Ill
Charles Buntschuh and Joan Ca ly
Mrs. Jean Cattier
Mr. and Mrs. Robert Citrino
Dr. and Mrs. Howard and Ruth
Cohen
Drs. John E Coraor and Hanna
Nekvasil
Dr. Gerald J. Cordani
Cosmopolitan Club
Mr. and Mrs. Richard L. Cosnotti
Mr. and Mrs. P. Coster
Mr. and Mrs. Miner D. Crary, Jr.
Drs. Michael and Carol
Dannenberg
Dr. E. William Davis
Mr. and Mrs. Daniel P. Davison
George Davison and Judith Rivkin
Edward F. DelFoe III
Mr. and Mrs. John Deming
John R. Drexel IV
Dr. and Mrs. Gerard L Eastman
Mr. and Mrs. John E. Eckelberry
Mr. and Mrs. Duncan Elder
Mr. Stephen Ely
Kristina J. Eng
Mrs. James M. Estabrook
Mr. and Mrs. William M. Evarts, Jr.
Bob and Diane Fagiola
Ms. Emily F. Fairchild
Dr. Francine L. Falco
Mr. and Mrs. John Falk
Mrs. John Fennebresque
Rosemary Ann Foehl
Fort Hill Animal Hospital
Alan Foxman and Linda Swanson
Phyllis R. Fritts
Mrs. David Fuchs
Clarence E. Galston
Sam Gandy
Annette Gangitano
Mm. Robert C. Gardner
Howard J. Gary
Martin Gellert
Mr. and Mrs. Roger M. Gerber
Hugh Jay Gershon
Dr. and Mrs. Stephen A. Gettinger
Mr. and Mrs. Stephen E. Gilhuley
Dr. Morton D. Glantz
Dr. and Mrs. Lewis A. Goldfnger
Mr. and Mrs. James M. Goldrick
George Gorelick
Mr. and Mrs. John S. Grace
Mrs. Austen T Gray
Dr. and Mrs. Raymond B. Griffiths
Mr. and Mrs. Frank Gundersen
Susan Gunduz, M.D., F.A.A.P.
Mrs. Hamilton Hadden
Louisa Thomas Hargrave
Bunny Hart
Dr. and Mrs. Chester Hartenstein
Oliver C. Hazard
Huy ler C. Held
Mrs. W. Peter Henderson
Anthony S. Hendrick
Arno and Elsie Herzog
Charles A. Hickmann
Mr. and Mrs. Lawrence P. Hilbert
Mr. and Mrs. Charles R. Holcomb
Mary Ann Holthausen/The Pall
Family Fund
Irving and Edna Holtzman
Rodney and Deborah Hornbake
George H. Howard
Charles and Elizabeth Hubbard
Hubbinette-Cowell Associates,
Inc.
Philip and Gretchen Hull
Rudolf C. Hunermund
I. Janvey & Sons, Inc.
Jitka and Pavel Illner
Beatrice W. Ingham
Mr. and Mrs. Herbert S. Ingham
Mr. and Mrs. Richard M. Jackson
Mr. and Mrs. Howard S. Jacobs
Mrs. Robert D. Jay
Ms. Charlotte Escande Julhiard
Howard and Sandra Kane
Ms. Bonnie J. Kansler
Mr. and Mrs. Thomas J. Kelly
Mr. and Mrs. A. Claude Kemper
Mr. Antoine C. Kemper, Jr.
Arnold E. Keppler
Doris Ketcham
Brian and Kristi King
Dr. Stanley Kitzis
Mr. and Mrs. Jerome Klein
Angela Koenig
Ms. Phyllis L. Kossoff
Mr. and Mrs. John W. Lapsley
James L. Larocca
Mrs. Thomas LeBoutillier
Harvey Levine
Sanford H. Levy
Dr. and Mrs. Lawrence J. Lippert
Mr. and Mrs. Alan J. Long
Mr. and Mrs. John B. LoRusso
Ms. Mary Anne Lubanko
Mr. Wilfred G. Mackey
Mrs. Henry R. Macy
Mr. Ralph Martins
Prof. Ernst Mayr
Malcolm McClintock
McCormack Smith Engineers,
PLLC
Alfred McDerrow, M.D.
Angus and Barbara McIntyre
Dr. Katherine McIntyre
Mr. and Mrs. Randall P. McIntyre
Mr. Robert M. McLane
Elizabeth Meyer
Mr. and Mrs. George S. Meyer
Richard W. Meyer
Mr. and Mrs. Garfield L. Miller III
William H. Miller
Jonathan Mogen
George G. Montgomery, Jr.
Jonathan and David Mosenson
Dr. Gisela Mosig
Mr. and Mrs. Robert Mountain
Mr. and Mrs. Brent M. Mowery, Jr.
Tess Mullarkey
Elizabeth B. Munier
Rem and Marion Myers
Bob and Anne Petrocelli
Andrea and Barry Newburger
Benny K.C. Ng, M.D.
Junichi Nikawa
North Country Garden Club
North Fork Bank
Mr. and Mrs. David C. Noyes
Mr. and Mrs. Hugh O'Kane, Jr.
Innis 0' Rourke, Jr.
Kathleen Pagliughi
Michael and Nancy Paloian
Mr. and Mrs. Peter J. Pell
Mr. and Mrs. Sterling Pile III
Graham L. Platt
Byrd S. and Thomas C. Platt
Mr. and Mrs. Edward Everett Post
Demetri T Poulis, M.D., F.A.C.S.
Michael Powers
Dr. and Mrs. Richard M. Powers
Mr. and Mrs. Daren A. Rathkopf
Mrs. Ewing W. Reilley
Mr. and Mrs. Charles J. Reina
Mrs. Anne Remsen
Bernard J. Reverdin
Mr. and Mrs. Bernard Richards
Mr. and Mrs. Joseph Rizza, Jr.
Francis and Patricia Roberts
Douglas and Kathleen Robinson
Linda L. Roll
Elizabeth E. Roosevelt
Mrs. Julian Roosevelt
Mr. and Mrs. Stanley W. Roth
Emanuel J. Rubin, M.D.
Charlotte and Bob Rubin
Richard and Pamela Rubinstein
Mr. and Mrs. Leon A. Rushmore,
Jr.
Ms. Charlene A. Russert
Mr. Irving Sager
Dr. Marilyn Moffat Salant
Mrs. Harold P Salembier
Patricia P. Sands
Phyllis Satz
Mr. Allan Schmidlapp
Harvey A. Schneier, M.D.
William J. Scholan
Seymour H. Schpoont, Ph.D.
Jeffrey Schreiber
Mr. and Mrs. John E.
Schwartzberg
Mr. and Mm. Frederick E.
Seymour
Dr. and Mrs. Edward M. Shepard
Col. and Mrs. Robert E. Sheridan
Mr. John D. Simpson
Mrs. William C. Simpson
Maxine F. Singer
Richard Slade
Marjory G. Smith
Smith & Jung Land Surveyors
Paula Sutker
Mr. and Mrs. William S. Smoot
Mr. and Mrs. James
Sommermeyer
Mr. and Mrs. Charles E. Spicer
Dr. and Mrs. David Stacy
Mr. and Mrs. Thomas Staudt
John C. Stevenson
Mr. and Mrs. James M. Stewart
Mr. William M. Stiger
Dr. and Mrs. Joel Strom
Mr. and Mrs. Brian E. Swiggett
Mr. and Mrs. John W. Taylor
Mr. and Mrs. Daniel G. Tenney, Jr.
Mrs. Anne D.R. Thomas
George M. Thomas
Mr. and Mrs. Edward M. Thomas
Dr. and Mrs. Robert W. Tilney
Stanford W. Ting
Alexander C. Tomlinson
Mr. John J. Toscano,
P.L.S./Carman-Dunne, P.C.
Mr. and Mrs. Bronson Trevor
Tri-State Consumer, Inc.
Mr. and Mrs. Stephen Van R.
Ulman
Mr. and Mrs. Cornelius M. Ulman
Mr. and Mrs. Lawrence B. Van
Ingen
Dr. and Mm. Robert N. Van Son
Mrs. Beverly S. VanderPoel
Dr. and Mrs. Thornton A.
Vandersall
Mr. and Mrs. Niklaus Vetsch
Arthur and Hattie Vogel
Dr. and Mrs. Gary I. Wad ler, M.D.
Mr. and Mrs. Eugene D.
Wadsworth
Mr. and Mrs. Colton P. Wagner
Dr. and Mrs. Peter Walker
Terry and Bob Walton
Dr. Heidi Wang
Florence and Eugene Warren
Mrs. Bradford G. Weekes
Richard and Janina Weghorn
Mr. and Mrs. L.B. Wehle, Jr.
Clifford M. Weingarten, M.D.
Mr. Jerry Weiss
Edward C.R. Whitcraft
Mary Louise Whitmarsh
CSHLA CORPORATE AND FOUNDATION MATCHING CONTRIBUTIONS
Bristol-Myers Squibb Foundation, Inc.
Chase Manhattan Bank
Coca Cola Bottling Co.
Dow Jones & Company, Inc.
Florence Corporation
Green Point Financial
Guild Agency, Inc.
CSHLA Annual Fund
Green Point Financial
The Henry Luce Foundation, Inc
iStar Financial, Inc.
J.P. Morgan & Co. Inc.
The Lubrizol Foundation
Marsh & McLennan
Mellon Financial Corporation Foundation
CSHLA Membership and Other Support
Angels, Benefactors, Patrons, Associates
Friends, Basic
Other"
. . .
Total
$597,855.09
$71,093.86
$94,773.00
$763,721.95
Mrs. John C. Wilmerding
Catherine Bostwick Wilson
Mrs. T Scudder Winslow
Margaret W. Wright
Marty Yurate
Morgan Guaranty Trust Company
Morgan Stanley Dean Witter and Company
Newsweek
Pfizer Inc.
Phelps Dodge Foundation
The Prudential Foundation
Union Pacific Corporation
MEMORIAL AND GIFT IN HONOR CONTRIBUTORS
Mrs. Silas Reed Anthony
ASPEC Engineering
Chaplin Bradford Barnes
Dr. and Mrs. Dino Belletti
Mr. and Mrs. Nicholas Biddle, Jr.**
Burt Building Materials Corp.
Mrs. Linda H. Calabrese
Rose D. Callahan
Mrs. Madeline S. Carver
Dr. and Mrs. Bayard Delafield Clarkson
Mr. Charles De Bare
De Silva & Phillips, Inc.
Ms. Sybil K. Dukehart
Jean Eakins
Dr. and Mrs. N. Dennis Eryou
Mr. and Mrs. William Everdell
Mr. Bruce L. Fahlbusch
Mrs. Ruth S. Fahlbusch
Ferran Development Corporation
Mr. and Mrs. Allen A. Goldring
Susan and Andrew Goldstein
Ms. Kim Gronachan
Mrs. Hamilton Hadden
The Hershowitz Family
IN MEMORY OF
Mr. Dennis Begley
Ms. Katharine Montgomery Biddle
Mrs. Toby Brooks
Dr. Peter Casadei
Mr. Charles Cassens
Mr. Robert L. Cummings
Mr. Alex Gordon
H.A. Julich
Mr. Robert Laffan
Mr. William Willis Reese II
Mr. and Mrs. Philip R. Herzig
Meg and Bill Jacobs
Mary and Allan Jay
Mr. and Mrs. Holden Johnson, Jr.
Sarah F. Johnson-Houlihan
Dr. and Mrs. Alan M. Kisner
Mr. Ralph A. Lanza
Mr. and Mrs. John H. Leib
Mr. David L. Luke Ill
Mr. and Mrs. Kenneth MacDonald
Ethel and Bill Mahoney
Mansions & Millionaires, Inc
Robert and Joyce Marcus
Mr. Robert M. McLane
Joan Medvecky and Family
Don and Liz Meyer
Mr. William H. Miller
Mr. Steven S. Miller
Mrs. Grinnell Morris
Brent and Monica Mowery
Ms. Johanna Northam
Mrs. Charles P Noyes
Mrs. John H. Page
Mr. and Mrs. Arnold J. Palmer
Mr. Jack Richards
Dr. Jean Schmidlapp
Ms. Bonnie Schwartz
Ms. Marilyn Sheerin
Mr. Howard Spingarn
Mr. James Stein
Fred and Lotte Stern
Mr. Thomas E. Sullivan
David Thompson
Mr. and Mrs. Joseph Rizza, Jr.
Mr. and Mrs. William S. Robertson
Alison, James, Cecily and Jonathan
Rose
Mrs. William F. Russell
Salzhauer Family Fund of the Jewish
Communal Fund
Regina and Martin Salzman
Barbara Santos
Mr and Mrs. Daniel S. Shapiro
Stephen A. Smiles, M.D.
Mrs. Cathy Cyphers Soref
Ruth Stanton/The Ruth and Oliver
Stanton Foundation
Mrs. Abbey K. Starr
Mr. and Mrs. Larry Steiner
Marty and Carol Sternberg
Mr. Gordon D. Stott
Mr. Robert C. Vincent, Jr.
Mr. Charles W.B. Wardell, Jr.
Mr. and Mrs. Herbert G. Wellington, Jr.
Whaler's Cove Yacht Club, Inc.
Mrs. Ichabod T Williams
Mr. and Mrs. Samuel D. Williams
IN HONOR OF
Andrea Blozen and Charles
Hendrickson
Mr. Allen A. Goldring
Mr. John S.Grace
Mr. Ralph Guild
Mr. and Mrs. Oskar Lewnowski
`Includes "Memorial" and in Honor of Gifts"; Proceeds from Special Events; Annual Fund Endowment Income; and Nonmember Gifts.
"To Establish The Katharine Montgomery Biddle Fund For Research Into Mental Illness.
Mrs. Terry O'Driscoll
Mr. Alan Pekchi & Edward Gauss
Mr. and Mrs. Steven and Eileen
Schlussel
Mrs. Georgette Spingarn
Mr. James L. Spingarn
405
President's Council
The President's Council was formed seven years ago as a means of bringing together leaders from
business, research, and biotechnology who are interested in science and the work at Cold Spring
Harbor Laboratory. President's Council members contribute a minimum of $25,000 in support of the
Laboratory's research fellowships, which allow promising young researchers to pursue their own high-
level, independent research, rather than assisting in the laboratory of an established scientist. The fol-
lowing are members of the 2000 President's Council:
Mr. Abraham Appel
Mr. Roderick H. Cushman
Mr. Michel David-Weill
Mr. Stefan Englehorn
Mr. Jacob Goldfield
Dr. Leo A. Guthart
Mr. Charles E. Harris
Mr. Walter B. Kissinger
Mr. Thomas J. McGrath
Mr. Robert B. Menschel
Mr. Donald A. Pels
Mr. James H. Simons
Dr. Charles L. Stone, Jr.
Total $285,881
406
The Harbor Society
One of the most personal and meaningful ways of saying, "I believe in Cold Spring Harbor Laboratory's
mission," is to make a planned gift. A planned gift takes many forms such as a bequest in your will, a
charitable remainder trust, or a gift of real estate, securities, life insurance, retirement plan or other asset.
The Harbor Society is a distinguished group of individuals, currently numbering 56, who have made
planned gifts to the Laboratory and have given us permission to list their names. In 2000, the following
individuals became members of the Harbor Society.
CONTRIBUTORS
Julia Antal
Mr. and Mrs. Edward A. Chernoff
Donald L. and Meleanor L. Deming
Dr. Jeffrey B. Shellan
Mrs. Georgette Spingarn
Mr. and Mrs. James L. Spingarn
Mr. and Mrs. Oliver Stanton
Undergraduate Research Program
The Undergraduate Research Program introduces college students to the skills they need to become
research scientists. Approximately 25 participants work under the guidance of staff scientists for 10
weeks each summer on projects of mutual interest.
CONTRIBUTORS ENDOWMENTS
Mrs. and Mrs. Cornelius N. Bliss III
Dorcas Cummings
Reverend Linda P. Hancock
Jephson Educational Trust
National Science Foundation
Mrs. Pamela P. Post
Mrs. Joan P. Tilney
Emanuel Ax Fund
Burroughs Wellcome Fund
Garfield Fellowship
H. Bentley Glass Fellowship
Libby Fellowship
Robert H.P. Olney Memorial Fund
Joan Redmond Read Fund
William Shakespeare Fellowship
Frederica von Stade Fund
Total $207,568
Total All Annual Funds $27,574,046
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LABORATORY STAFF
Bruce W. Stillman, Director and Chief Executive
Officer
James D. Watson, President
Winship Herr, Assistant Director/Dean, Watson School
of Biological Sciences
W. Dil laway Ayres, Jr., Chief Operating Officer"
G. Morgan Browne, Chief Financial Officer*
Lan C. Russo, Comptroller*
John P. Maroney, Director, Office of Technology
Transfer/In-House Counsel
Terri I. Grodzicker, Assistant Director for Academic
Affairs
Jan A. Witkowski, Director of Banbury Center
David A. Mick los, Director of DNA Learning Center
John R. Inglis, Executive Director of CSHL Press
David J. Stewart, Director of Meetings and Courses
FACULTY
Professors
Hollis Cline
David Helfman
Nouria Hernandez'
Adrian Krainer
Scott Lowe
Roberto Malinow
Robert Martienssen
David Spector
Nicholas Tonks
Timothy Tully
Michael Wig ler
Associate Professors
Grigori Enikolopov
Gregory Hannon
Michael Hengartner
Tatsuya Hirano
Leemor Joshua-Tor
Ryuji Kobayashi
Yuri Lazebnik
W. Richard McCombie
Jacek Skowronski
Lincoln Stein
Arne Stenlund
Karel Svoboda.
Linda Van Aelst
Rui-Ming Xu
Jerry Yin
Michael Zhang
Yi Zhong
Assistant Professors
Dmitri (Mitya) Chklovskii
Shivinder Grewal
Masaaki Hamaguchi
Z. Josh Huang
David Jackson
Robert Lucito
Zachary Mainen
Vivek Mittal
Andrew Neuwald
William Tansey
Anthony Zador
Cold Spring Harbor
Laboratory Fellows
Gilbert (Lee) Henry
Terence Strick
Marja Timmermans
Research Investigators
Nei lay Dedhia
Natalia Peunova
Andrew Reiner
Mona Spector
Clifford Yen
Adjunct Professor
Bhubaneswar Mishra
Visiting Professor
Eli Hatchwell
Adjunct Associate
Professors
Scott Powers
Craig Ogata+
Visiting Scientists
Vincent Co lot
Anna Giulini
Edith Heard
Boris Kuzin
Tatyana Michurina
Vladimir Scheinker
Jacqueline Vitali
Ying-hua Zhu
Senior Fellows
Michael Myers
Edward Stern
Postdoctoral Fellows
Carlos Aizenman
Harsh Bal
Vivekanand (Vivek) Balija
Andres Barna-Roman
Benjamin Boettner
Katherine Braun
Paula Bubulya
Athanasios (Tom) Bubulya
Ingrid Bureau
Mary Byrne
Isabel Cantallops
Luca Cartegni
Douglas Conklin
Olivier Cuvier
Marc Davenne
Ramana Davuluri
Elisa De Stanchina
Robert Del Vecchio
Michael DeWeese
Joseph Donovan
Eric Drier
Jian Du
Joshua Dubnau
Dominik Duelli
Veronica Egger
Ingrid Ehrlich
Viola Ellison
Eric Enemark
Jose Esteban
Gerardo Ferbeyre
Robert Filipkowski
Lisa Foa
Jordan Fridman
Toshiyuki Fukada
Michael Greenberg
Hui-Fu Guo
Kurt Haas
Frances Hannan
Michelle Hastings
Andreas Herbst
Hiroyuki Higashiyama
Edward Hofmann
Sangeet Honey
Junjiro Horiuchi
Susan Janicki
Jianping Jin
Eric Julien
Natarajan Kannan
Alyson Kass-Eisler
Catherine Kidner
Jae-Yean Kim
Peter Krasnov
Prakash (Patrice) Kumar
Patrice Lassus
Wen-Chuan (Athena) Lin
Ana Losada
David Mac Callum
Stephen Macknik
Miguel Maravall
Carla Margulies
Bruce May
Shanmugam Mayilvahanan'
Juan Mendez
Tzu-Ching (T.C.) Meng
Olaf Merkel
Jinrong Min
Jun-chi Nakayama
Masashi Narita
Esther Nimchinsky
Kenichi Noma
Takashi Odawara
Thomas Oertner
Pol O'Fearghail
Michael Packer
Helena Palka
Xiaokang Pan
Geraldine Pawlak
Shannon Pendergrast
Antonella Piccini
Emmanuelle Querido
Pablo Rabinowicz
Jyotishankar (Jyoti)
Raychaudhuri
Michael Regulski
Francesc (Xavier) Roca
Michael Ronemus
Edward Ruthazer
Bernardo Sabatini
Noriko Saitoh
Cyril Sanders
Clemens Schmitt
Arndt Schmitz
Kenneth Seidenman
Lidia Serina
Yu Shen
*Positions approved November, 2000,
*Employee of the Howard Hughes Me
and effective January 2001.
dical Institute.
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Yi-Jun Sheu
Wun Chey Sin
Tatjana Singer
Maria Soengas
Christian Speck
Yuri Stasiv
Armen Stepanyants
Takuya Takahashi
Joshua Trachtenberg
Naoshige Uchida
Anne Vaahtokari
Erik Vollbrecht
Thomas Volpe
Yalin Wang
Guanming Wu
Shouzhen Xia
Zhenyu Xuan
Ryohei Yasuda+
Qing-Shuo Zhang
Zhiguo Zhang
Lifang Zhang
Tong Tong Zhang
Xinyang Zhao+
Xuemei Zhao
Jun Julius Zhu
Ahmad Zia+
Karen Zito
Graduate Students
Jannik Andersen
Anitra Auster
Nilanjana (Nila) Banerjee
Emily Bernstein
Andrea Calixto
Michelle Carmel]
Amy Caudy
Santanu Chakraborty
Kenneth Chang
Bidisha Chattopadhyaya
Hsu Hsin (May) Chen
Brian Chen
Jeffrey Christensen
Michelle Cilia
Laureen Connell
Ahmet Den li
Sujit Dike
Yi-Chieh (Nancy) Du
Elena Ejkova
Farida Emran
Rebecca Ewald
Lavina Faleiro
Eve-Ellen Govek
Ira Hall
Jill Hemish
Brian Hill
Jennia Hizver
Ping Hu
Ajit Janardhan
Ashkan Javaherian
Kendall Jensen
Michelle Juarez
Flavio Kamenetz
Manpreet Katari
So Young Kim
Edward Kim
Jason Kinchen
Ying Ying Koh
Sungwoo Lee
Soyoung Lee
Arlindam Lee
Guillaume Lettre
Zheng Li
Shih-Chieh (Jack) Lin
Zachary Lippman
Marco Mangone
Michele McDonough
Troy Messick
John Mignone
Stuart Milstein
Masafumi Muratani
Zaher Nahle
Patrick Paddison
Thomas Pologruto
Irina Pugach
Patrick Reilly
Emiliano Rial Verde
Jose Rodriguez
Andrew Samuelson
Ashish Saxena
Laura Schramm
Yvette Seger
Stephanie Shaw
Hang Shi
Songhai Shi
Michael Stebbins
Marcela Tello-Ruiz
Elizabeth Thomas
Niraj Tolia
Jiayuan (James) Tong
Thomas Tubon
Kathryn Tworkowski
Joseph West
Joanna Wysocka
Ming Ming Zhao
Jun Zhu
Research Programmers
Gengxin Chen
Naoya Hata
John Healy
Jerzy (George) Kakol
Michael Morgan
Aleksandar Poleksic
Ravi Sachidanandam
Steven Schmidt
Research Associates
Robert Gasperini
Lisa Manche
Linda Rodgers
Patricia Wendel
Cristina Yordan
Lab Facility Managers
Carmelita Bautista
Diane Esposito
Sang Young Kim
Timothy Mulligan
Spencer Teplin
Ming Wang
Regina Whitaker
Laboratory Manager
Martha Daddario
Scientific Administrators
Sadie Arana
Patricia Bird
Carol Haff-Gear
ldee Mallardi
Carol Marcincuk
Anita Matthes
Barbara Matusik
Lorraine Mclnerny
Jane Reader
Carol Sekunda+
Madeline Wisnewski
Research Assistant
Tomasz (Tomek) Swigut
Laboratory Technicians
Aysha Ahmed
Joan Alexander
Esteban Araya
Juana Arroyo
Deborah Aufiero
Ariana Bahret
Joshua Baker
Jody Barditch
Benjamin Bartel le
Matthew Blennau
Sabrina Boettcher
Kimberly Bronson
Anthony Bug lino
Barry Burbach+
Don-Michael Cunnius
Nancy Dawkins-Pisani
Melissa de la Bastide
Margaret Falkowski
Eugenia Friedman
Scott Gossweiler
Lori Grady
Susan Granat
Karen Greenwood
Inessa Hakker
Michiko Hirano
Lenka Hurton
Wei Jiang
Lisa King
Kristin Kirchoff
Kathy Kuit
Kimberly La Vine
Stacy Lopez
Beicong Ma+
Mila McCurrach
Jennifer Meth
Beth Miller
Barbara Mish
Lidia Nascimento
Aigoul Nourjanova
Peter O'Brien
Ximena Opitz-Araya
Andrew O'Shaughnessy
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